data_2k9z_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k9z _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.1 t . . . . . 0 CA--C 1.536 0.427 0 CA-C-O 121.251 0.548 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.6 tptm -75.0 118.92 18.49 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 175.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 82.8 mt -130.81 129.64 63.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 174.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -155.38 175.58 13.69 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 122.973 0.509 . . . . 0.0 110.631 171.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.06 85.44 5.24 Favored Pre-proline 0 N--CA 1.451 -0.416 0 C-N-CA 124.312 1.045 . . . . 0.0 108.526 -177.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.42 165.18 31.45 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.977 2.452 . . . . 0.0 112.095 -175.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.3 t -61.18 144.22 91.56 Favored Pre-proline 0 C--O 1.239 0.551 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 164.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.81 -18.14 28.56 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.013 1.809 . . . . 0.0 112.146 175.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -64.33 -52.65 57.37 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.908 0.776 . . . . 0.0 110.158 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.4 tttt -61.92 -33.16 73.75 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 123.205 0.602 . . . . 0.0 110.716 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 79.5 mt -63.82 -24.12 67.63 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.401 -0.812 . . . . 0.0 112.408 175.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -67.49 -49.14 64.84 Favored 'General case' 0 CA--C 1.522 -0.134 0 O-C-N 120.667 -1.27 . . . . 0.0 108.428 169.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -66.94 -36.04 81.35 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.093 0.957 . . . . 0.0 110.95 -169.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.28 -12.31 5.39 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.917 1.687 . . . . 0.0 112.932 172.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . 0.255 68.2 p 60.69 35.02 19.86 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 128.27 2.628 . . . . 0.0 113.021 -175.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.6 t -55.76 -30.46 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.074 0.95 . . . . 0.0 112.801 -177.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -60.2 -26.23 66.2 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 120.437 1.471 . . . . 0.0 112.864 172.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.1 mttm -91.78 -9.03 45.04 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.127 1.371 . . . . 0.0 111.004 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 35.7 m0 -73.09 161.48 79.14 Favored Pre-proline 0 C--O 1.237 0.395 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -65.14 136.29 47.22 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.629 1.553 . . . . 0.0 111.063 173.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.6 mt -70.16 152.5 9.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 162.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.404 ' CE3' ' HD2' ' A' ' 84' ' ' LYS . 59.6 t90 -136.21 149.09 48.41 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 156.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.07 152.97 49.31 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 128.779 2.831 . . . . 0.0 107.996 177.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.45 ' HE3' ' CE2' ' A' ' 31' ' ' PHE . 21.6 tptp -156.6 159.33 38.38 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.231 -0.918 . . . . 0.0 109.748 176.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -69.49 167.81 15.91 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 127.759 2.424 . . . . 0.0 114.216 172.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.2 p -79.33 37.99 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 130.461 3.504 . . . . 0.0 112.73 -175.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.7 t -100.3 -167.71 1.48 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.211 1.405 . . . . 0.0 109.603 -173.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -139.6 145.28 38.35 Favored 'General case' 0 C--N 1.333 -0.114 0 O-C-N 120.461 -1.399 . . . . 0.0 108.867 161.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.45 ' CE2' ' HE3' ' A' ' 26' ' ' LYS . 18.4 p90 -151.13 179.22 8.47 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.629 1.572 . . . . 0.0 108.473 176.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -121.59 128.85 52.39 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.386 1.074 . . . . 0.0 108.981 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 40.2 t-105 -115.41 160.77 19.45 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 122.042 0.925 . . . . 0.0 112.626 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -128.74 111.94 13.67 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 127.22 2.208 . . . . 0.0 107.813 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -85.07 127.51 34.25 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 167.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -120.75 -3.12 9.76 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.966 1.706 . . . . 0.0 110.978 -173.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.57 171.61 16.83 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 129.853 3.261 . . . . 0.0 108.193 175.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -71.83 147.56 47.07 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -175.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -149.84 119.59 7.05 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 175.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 39.9 m -96.57 126.36 41.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 175.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -142.09 125.43 16.56 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.681 1.192 . . . . 0.0 109.525 -173.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -105.06 123.51 47.93 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.255 1.422 . . . . 0.0 108.534 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.8 mm -78.19 112.41 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 123.962 0.905 . . . . 0.0 108.702 177.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.509 ' O ' ' HE3' ' A' ' 62' ' ' LYS . 2.4 mp -97.69 -21.75 16.84 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 118.071 -0.966 . . . . 0.0 112.806 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -167.68 149.11 5.47 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 173.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.93 178.76 29.21 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.862 1.22 . . . . 0.0 114.448 173.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.404 ' HE3' ' O ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -133.79 140.61 47.03 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 118.017 0.908 . . . . 0.0 111.145 -173.616 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.404 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 66.1 t -141.19 147.79 22.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -112.68 99.74 8.17 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 160.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.9 t -70.61 157.78 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 164.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -147.86 136.0 21.3 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 164.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 74.5 p -83.3 175.7 9.69 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.027 0.376 . . . . 0.0 110.337 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -65.23 -27.05 68.4 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.423 0.63 . . . . 0.0 111.732 -177.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.08 -4.18 4.53 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.693 1.997 . . . . 0.0 111.94 171.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.27 5.09 65.67 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 126.04 1.781 . . . . 0.0 113.567 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 46.0 mmtt -65.94 127.81 33.54 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 105.547 -2.019 . . . . 0.0 105.547 174.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -86.24 145.51 26.93 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 171.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -134.38 84.82 2.14 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 124.127 1.917 . . . . 0.0 108.683 166.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.6 p -60.28 143.59 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 CA-C-N 111.765 -2.471 . . . . 0.0 109.931 152.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.9 pt -139.09 132.7 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 C-N-CA 128.208 2.603 . . . . 0.0 105.203 177.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -111.81 -179.39 3.68 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.147 0.979 . . . . 0.0 108.84 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.509 ' HE3' ' O ' ' A' ' 44' ' ' LEU . 75.0 tttt -64.25 107.91 1.44 Allowed 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 175.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 128.57 -15.71 5.99 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 118.578 -1.123 . . . . 0.0 112.979 -175.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -85.88 120.58 27.44 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 119.488 1.644 . . . . 0.0 108.408 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 25.3 tp -83.84 146.76 27.93 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 158.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.8 t -132.89 149.5 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 124.788 1.235 . . . . 0.0 108.104 177.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 87.9 m -131.8 111.68 11.83 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 159.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -80.38 144.82 58.28 Favored Pre-proline 0 C--O 1.236 0.363 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 165.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -85.98 178.08 4.37 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.203 1.935 . . . . 0.0 111.357 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -73.49 93.91 2.05 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 113.492 -1.686 . . . . 0.0 109.406 174.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.39 86.72 1.94 Allowed Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.263 1.411 . . . . 0.0 110.775 175.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 33.5 tp -153.67 140.62 19.23 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.084 0.954 . . . . 0.0 109.879 169.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.39 109.47 13.34 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.766 1.626 . . . . 0.0 108.192 -173.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 8.1 p -139.9 166.24 25.16 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.817 1.19 . . . . 0.0 110.179 -172.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.69 162.02 19.85 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.819 -1.176 . . . . 0.0 109.53 174.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -131.99 110.36 10.7 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.468 1.507 . . . . 0.0 107.642 168.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.7 tttp -102.23 103.74 14.26 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 174.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 t -82.75 99.84 5.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 -176.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.6 mt -88.62 -12.76 41.66 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 118.293 -0.861 . . . . 0.0 110.87 -174.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -150.58 154.03 34.86 Favored Pre-proline 0 N--CA 1.45 -0.441 0 C-N-CA 126.616 1.966 . . . . 0.0 106.792 160.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -57.43 139.02 88.86 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 N-CA-C 108.135 -1.525 . . . . 0.0 108.135 177.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.4 p -125.09 156.0 33.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -168.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -130.15 117.0 19.26 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 173.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.404 ' HD2' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -130.09 116.04 17.94 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.408 0.683 . . . . 0.0 112.368 177.713 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 11.4 m80 -66.69 119.95 12.65 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 105.931 -1.878 . . . . 0.0 105.931 170.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -119.51 164.88 15.13 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 123.76 0.824 . . . . 0.0 110.884 -177.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -152.52 125.91 8.74 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 162.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 32.4 mt -73.84 148.47 42.37 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.314 1.446 . . . . 0.0 108.804 174.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.4 p90 . . . . . 0 C--O 1.251 1.155 0 C-N-CA 126.578 1.951 . . . . 0.0 109.681 177.143 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.8 t . . . . . 0 N--CA 1.471 0.615 0 CA-C-O 122.298 1.046 . . . . 0.0 111.639 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -72.4 133.27 44.82 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -173.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.6 mt -134.84 133.18 54.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 171.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -134.36 171.58 14.08 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.632 0.773 . . . . 0.0 109.305 172.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.49 84.93 12.7 Favored Pre-proline 0 N--CA 1.464 0.271 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 175.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -75.07 159.54 40.98 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 121.937 1.758 . . . . 0.0 110.761 -175.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 t -64.87 143.45 98.82 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 170.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.51 -24.74 25.91 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 121.562 1.508 . . . . 0.0 112.439 -177.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -63.3 -42.13 99.02 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.348 1.459 . . . . 0.0 111.115 175.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.9 tptt -57.88 -43.62 86.18 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 175.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -66.97 -30.79 71.01 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 122.755 0.422 . . . . 0.0 110.752 -176.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -58.97 -52.54 65.31 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.122 0.874 . . . . 0.0 109.373 168.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -58.44 -46.48 86.44 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.898 0.879 . . . . 0.0 111.265 -174.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 75.5 mt -60.9 -5.7 1.48 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.703 1.201 . . . . 0.0 113.306 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.5 m 62.49 41.04 10.16 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 126.243 1.817 . . . . 0.0 109.742 167.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.9 t -58.83 -30.45 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 128.176 2.59 . . . . 0.0 110.379 176.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -58.44 -16.32 14.49 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.835 0.854 . . . . 0.0 112.823 170.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -102.44 -2.27 29.07 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.539 1.535 . . . . 0.0 112.048 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 33.2 m0 -82.69 165.28 42.78 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.79 143.04 54.29 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 121.939 1.759 . . . . 0.0 111.172 169.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 75.5 mt -79.32 151.83 4.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 164.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.409 ' CE3' ' HE3' ' A' ' 84' ' ' LYS . 14.9 t90 -138.84 144.99 39.48 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 154.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -145.69 162.8 36.74 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.824 1.25 . . . . 0.0 110.178 175.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.408 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 5.2 tmtt? -156.74 156.85 34.05 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 124.486 1.115 . . . . 0.0 108.036 -176.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.87 168.71 9.28 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 122.248 1.023 . . . . 0.0 112.175 174.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.5 p -75.74 62.97 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 128.711 2.804 . . . . 0.0 109.258 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.7 t -129.72 -162.46 1.21 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.4 2.28 . . . . 0.0 107.974 -175.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.36 159.66 43.43 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 120.337 -1.477 . . . . 0.0 110.321 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -171.41 -164.27 0.33 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.816 2.046 . . . . 0.0 108.399 -171.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -132.88 150.08 52.19 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.79 2.036 . . . . 0.0 107.406 170.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 34.4 t-105 -127.18 150.38 49.54 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.355 0.525 . . . . 0.0 111.04 174.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -120.66 121.98 39.49 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 124.691 1.196 . . . . 0.0 109.181 170.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -91.53 119.21 31.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.093 1.357 . . . . 0.0 107.432 174.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -117.01 12.43 14.59 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.584 1.154 . . . . 0.0 111.075 176.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.6 170.44 15.82 Favored 'General case' 0 CA--C 1.523 -0.079 0 C-N-CA 124.402 1.081 . . . . 0.0 110.65 158.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -60.89 117.07 4.98 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 103.178 -2.897 . . . . 0.0 103.178 166.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -130.63 76.44 1.72 Allowed 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -170.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.3 m -63.96 145.4 55.92 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -175.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 27.7 p -145.43 153.76 41.53 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 119.923 -0.711 . . . . 0.0 112.331 166.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -124.52 112.93 17.45 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.284 1.834 . . . . 0.0 107.854 -176.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.6 mm -69.88 136.67 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 126.487 1.915 . . . . 0.0 107.261 173.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.403 HD12 ' HD1' ' A' ' 85' ' ' HIS . 26.1 mt -125.08 -47.16 1.78 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.317 1.047 . . . . 0.0 108.805 -171.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -147.4 159.91 43.15 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 165.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.13 178.83 31.64 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 124.84 1.21 . . . . 0.0 113.528 174.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.76 144.92 31.43 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.651 0.739 . . . . 0.0 112.483 -170.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.3 t -142.63 159.73 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -122.54 119.61 31.38 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 159.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 41.2 t -103.14 92.29 2.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 51.3 m -79.09 103.1 8.8 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.647 1.179 . . . . 0.0 108.409 177.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 64.1 p -82.97 172.92 12.26 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.873 -0.517 . . . . 0.0 109.928 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -71.8 -29.01 64.0 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.385 0.612 . . . . 0.0 112.596 -166.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -73.62 0.16 13.57 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.464 1.105 . . . . 0.0 111.182 173.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.5 -14.86 64.32 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 127.951 2.691 . . . . 0.0 112.875 177.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -63.52 120.18 11.22 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.624 1.57 . . . . 0.0 107.718 -173.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.06 100.93 9.52 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.637 1.175 . . . . 0.0 110.068 -169.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -83.42 108.2 16.43 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 -177.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 40.3 t -66.92 140.18 19.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 104.77 -2.307 . . . . 0.0 104.77 154.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.1 pt -134.74 99.97 2.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 174.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -81.5 172.9 12.94 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.183 0.993 . . . . 0.0 109.916 168.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.2 pttm -52.87 127.16 22.6 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.812 0.815 . . . . 0.0 109.862 169.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.91 -28.47 13.84 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-O 117.965 -1.464 . . . . 0.0 114.321 175.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.22 101.71 1.94 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 120.736 2.268 . . . . 0.0 107.933 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.4 tp -77.44 134.28 38.42 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.7 t -116.75 146.9 20.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -174.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.8 m -138.83 99.7 3.86 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 125.09 1.356 . . . . 0.0 108.094 165.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -63.18 165.55 10.48 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 124.027 0.931 . . . . 0.0 109.403 161.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -88.41 174.76 4.16 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 CA-C-N 120.098 1.071 . . . . 0.0 112.357 164.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -74.73 91.77 2.41 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 168.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 117.9 84.33 0.99 Allowed Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.281 1.419 . . . . 0.0 110.473 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.5 tt -150.95 130.88 13.32 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.362 1.465 . . . . 0.0 108.806 171.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -104.52 134.31 47.92 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 165.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 26.7 p -151.49 167.3 28.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 119.138 0.881 . . . . 0.0 111.547 169.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.01 164.51 25.0 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.435 0.636 . . . . 0.0 111.484 168.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -143.42 101.02 3.72 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 113.76 -1.563 . . . . 0.0 108.805 -175.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 tptt -95.05 107.68 19.74 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 168.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.1 t -75.67 111.82 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 104.335 -2.469 . . . . 0.0 104.335 165.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 74.7 mt -84.64 -27.32 27.23 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -152.06 153.98 31.96 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 124.966 1.306 . . . . 0.0 109.919 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -53.83 128.32 29.13 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.104 2.536 . . . . 0.0 109.467 175.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.5 p -135.76 138.21 48.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -167.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -128.25 67.98 1.36 Allowed 'General case' 0 C--O 1.223 -0.309 0 CA-C-O 121.16 0.505 . . . . 0.0 110.099 -171.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.409 ' HE3' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -80.1 154.52 28.03 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -175.323 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.403 ' HD1' HD12 ' A' ' 44' ' ' LEU . 4.9 m80 -94.38 142.43 27.43 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 163.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -131.22 159.02 38.99 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.205 0.911 . . . . 0.0 110.959 176.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -146.37 132.96 19.81 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 122.907 0.483 . . . . 0.0 109.71 170.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 90.0 mt -86.04 135.77 33.5 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.45 1.1 . . . . 0.0 108.463 174.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 6.0 p90 . . . . . 0 C--O 1.249 1.046 0 C-N-CA 124.029 0.932 . . . . 0.0 110.953 -176.67 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.1 t . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -104.23 114.59 28.93 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 175.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.4 mt -132.36 129.78 59.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 124.747 1.219 . . . . 0.0 108.258 -176.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -162.42 171.23 17.47 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.395 1.078 . . . . 0.0 109.887 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.49 85.88 2.48 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 123.504 0.722 . . . . 0.0 110.132 176.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -65.56 162.8 32.52 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.474 2.116 . . . . 0.0 112.377 -177.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.4 t -58.3 144.64 77.08 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 123.55 0.74 . . . . 0.0 109.389 169.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.22 -30.77 30.45 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.338 1.359 . . . . 0.0 113.065 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -57.83 -44.55 86.52 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.768 1.167 . . . . 0.0 112.237 -175.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.3 tptt -57.16 -45.53 83.53 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 123.908 0.883 . . . . 0.0 110.143 177.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.49 -23.71 67.51 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.214 0.606 . . . . 0.0 111.527 -174.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.8 mttt -72.17 -48.56 42.43 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -58.67 -43.96 90.06 Favored 'General case' 0 CA--C 1.522 -0.107 0 C-N-CA 124.407 1.083 . . . . 0.0 110.329 -176.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 81.4 mt -62.05 -8.68 5.7 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.866 1.667 . . . . 0.0 114.811 -176.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.0 m 65.97 30.01 9.92 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.228 1.411 . . . . 0.0 112.182 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.9 t -52.27 -33.06 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 125.636 1.574 . . . . 0.0 110.412 173.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -53.62 -32.97 53.4 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 171.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -84.89 -19.69 31.91 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 118.128 -0.939 . . . . 0.0 112.179 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 41.1 m0 -66.01 160.16 65.28 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -171.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -65.96 132.59 30.66 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.84 1.693 . . . . 0.0 111.361 176.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.1 mt -71.14 139.5 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 162.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.541 ' CE3' ' HE3' ' A' ' 84' ' ' LYS . 69.7 t90 -133.49 122.56 23.81 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 161.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -124.47 159.36 30.68 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.462 1.505 . . . . 0.0 107.818 173.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -157.39 164.05 37.93 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -171.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.29 -176.38 2.62 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 122.425 1.107 . . . . 0.0 110.438 175.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.7 p -68.2 0.33 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 126.323 1.849 . . . . 0.0 112.383 167.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 p -71.74 129.59 39.04 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 120.065 -1.647 . . . . 0.0 110.81 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.51 157.5 16.99 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.238 1.015 . . . . 0.0 110.021 -177.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -164.21 -164.25 0.84 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 126.503 1.921 . . . . 0.0 107.122 -171.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -138.75 157.24 46.45 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 126.09 1.756 . . . . 0.0 108.698 173.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 22.1 t-105 -144.27 138.39 27.93 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.561 0.744 . . . . 0.0 111.181 -174.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -103.15 145.1 30.43 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.714 1.606 . . . . 0.0 107.806 168.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -118.04 123.13 44.92 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.399 1.48 . . . . 0.0 107.737 173.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.71 -5.64 12.13 Favored 'General case' 0 N--CA 1.461 0.092 0 C-N-CA 126.232 1.813 . . . . 0.0 112.564 -170.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.81 175.19 9.9 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 131.512 3.925 . . . . 0.0 106.539 166.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -70.32 139.71 52.1 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -122.52 114.45 20.68 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 163.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 20.0 m -89.79 132.98 34.95 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 159.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 27.4 p -138.89 161.82 36.36 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.338 0.589 . . . . 0.0 110.812 164.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -122.52 128.76 51.2 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.0 mm -87.02 102.3 12.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 128.806 2.842 . . . . 0.0 106.797 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.431 ' O ' ' HE2' ' A' ' 62' ' ' LYS . 2.4 mm? -81.41 -26.5 35.35 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 123.504 0.722 . . . . 0.0 111.062 -174.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -176.67 148.94 0.73 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.144 2.177 . . . . 0.0 106.086 -174.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.26 -177.11 28.43 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.275 1.417 . . . . 0.0 113.788 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.0 148.48 38.62 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.116 0.958 . . . . 0.0 109.748 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.5 t -138.22 156.52 30.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 125.039 1.335 . . . . 0.0 107.731 176.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -120.81 139.05 53.68 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 125.597 1.559 . . . . 0.0 108.066 165.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.9 t -133.93 120.2 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 83.2 m -111.83 105.15 13.54 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.531 1.533 . . . . 0.0 107.902 167.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.0 p -68.08 165.5 17.94 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 173.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -74.32 -14.7 60.93 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 123.278 1.513 . . . . 0.0 113.29 -161.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -52.04 -21.63 3.34 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 127.437 2.295 . . . . 0.0 113.083 161.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.41 4.65 90.08 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.686 1.136 . . . . 0.0 111.868 -165.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -71.1 144.97 50.12 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 119.326 1.563 . . . . 0.0 108.125 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -108.09 145.2 34.4 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -173.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -141.73 132.15 25.2 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 69.4 t -136.36 118.59 20.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 -171.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.1 pt -124.63 106.1 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 O-C-N 123.808 0.693 . . . . 0.0 109.151 -169.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -90.72 178.05 6.17 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 122.677 1.227 . . . . 0.0 109.863 171.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.431 ' HE2' ' O ' ' A' ' 44' ' ' LEU . 22.9 tttm -51.11 108.06 0.22 Allowed 'General case' 0 C--O 1.237 0.423 0 C-N-CA 127.527 2.331 . . . . 0.0 109.805 176.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.52 -16.41 26.58 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 117.591 -1.672 . . . . 0.0 114.65 175.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -70.75 102.17 2.26 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 120.368 2.084 . . . . 0.0 108.901 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.0 tp -71.04 141.38 50.91 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.1 t -125.56 145.06 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 97.3 m -129.7 118.1 21.35 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 158.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -88.45 145.77 36.24 Favored Pre-proline 0 C--O 1.237 0.402 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 162.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -84.27 177.26 5.97 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.286 1.991 . . . . 0.0 112.259 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 30.3 tttm -76.82 81.39 3.41 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 113.95 -1.477 . . . . 0.0 107.851 169.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.59 81.32 0.47 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 125.504 1.526 . . . . 0.0 111.774 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.6 tt -148.2 128.24 13.64 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 118.535 1.167 . . . . 0.0 110.694 174.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.407 HH12 ' NH2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -112.7 116.72 30.58 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.377 1.471 . . . . 0.0 108.436 177.659 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 17.6 p -148.85 176.63 10.24 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.509 1.05 . . . . 0.0 113.393 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.407 ' NH2' HH12 ' A' ' 73' ' ' ARG . 0.0 OUTLIER -81.11 177.01 9.3 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.981 1.312 . . . . 0.0 111.855 171.047 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -158.16 100.59 1.7 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 119.932 1.242 . . . . 0.0 109.663 174.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.6 tttt -104.22 111.2 23.71 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.4 t -77.18 116.67 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 N-CA-C 103.157 -2.905 . . . . 0.0 103.157 171.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.9 mt -88.12 -25.52 22.96 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 119.346 -0.941 . . . . 0.0 109.381 171.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -144.36 150.16 47.1 Favored Pre-proline 0 C--O 1.232 0.136 0 CA-C-O 117.819 -1.086 . . . . 0.0 111.051 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -58.81 114.36 1.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.431 2.754 . . . . 0.0 108.232 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.1 p -124.39 143.84 36.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 125.18 1.392 . . . . 0.0 107.446 -163.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.5 mtt180 -115.3 113.57 24.01 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 174.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.541 ' HE3' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -114.37 125.59 54.04 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 167.295 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -76.61 123.53 26.25 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 103.333 -2.84 . . . . 0.0 103.333 169.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -121.66 160.58 24.15 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.058 0.845 . . . . 0.0 110.361 -176.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -142.1 149.59 40.04 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 165.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.5 mt -108.71 129.05 55.36 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.5 p90 . . . . . 0 C--O 1.251 1.172 0 C-N-CA 124.818 1.247 . . . . 0.0 108.597 -173.56 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 p . . . . . 0 C--O 1.236 0.382 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -127.81 147.47 50.43 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.157 1.383 . . . . 0.0 107.379 174.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 90.5 mt -124.73 142.27 42.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 165.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -160.24 177.59 10.49 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.098 1.359 . . . . 0.0 110.283 166.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.468 ' HE2' ' OD1' ' A' ' 64' ' ' ASP . 0.5 OUTLIER -116.86 85.3 17.24 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 124.067 0.947 . . . . 0.0 108.667 -172.237 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.16 -4.42 15.16 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 124.904 3.736 . . . . 0.0 114.687 -164.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.324 2.1 t 55.44 146.29 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 129.187 2.995 . . . . 0.0 113.39 -169.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -58.04 -17.76 32.81 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.632 2.221 . . . . 0.0 112.2 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -47.44 -61.55 1.86 Allowed 'General case' 0 C--O 1.231 0.112 0 CA-C-N 119.517 1.053 . . . . 0.0 111.297 165.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -67.4 -38.28 84.42 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -178.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.17 -24.25 61.4 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 118.562 -0.732 . . . . 0.0 112.937 -175.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -60.93 -55.1 36.9 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 120.397 1.453 . . . . 0.0 107.541 167.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -74.42 -26.64 60.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.769 -164.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 mp -68.0 -9.92 49.47 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.24 1.416 . . . . 0.0 112.766 170.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.3 m 61.54 33.1 18.56 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.311 1.844 . . . . 0.0 112.369 -174.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.2 t -57.19 -27.59 28.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 O-C-N 121.633 -0.667 . . . . 0.0 111.97 -172.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -54.58 -26.39 32.04 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.763 1.165 . . . . 0.0 113.574 173.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? -86.56 -26.28 24.57 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.004 0.921 . . . . 0.0 111.64 -173.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 36.7 m0 -62.84 160.05 40.19 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 124.623 1.169 . . . . 0.0 109.529 -170.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -69.35 118.59 5.77 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.251 1.967 . . . . 0.0 112.407 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.6 mt -61.98 142.08 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 176.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.596 ' CE3' ' HE3' ' A' ' 84' ' ' LYS . 59.5 t90 -135.3 143.14 46.05 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 165.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -151.93 161.84 42.01 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.701 1.601 . . . . 0.0 111.067 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.0 mmtt -143.84 176.35 9.32 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.291 0.636 . . . . 0.0 109.347 -178.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -69.82 -165.95 0.1 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.781 2.033 . . . . 0.0 110.756 169.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.5 p -109.85 25.07 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 126.691 1.996 . . . . 0.0 111.447 -175.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.7 t -96.29 -178.34 4.27 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 126.693 1.997 . . . . 0.0 109.199 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -120.79 161.46 21.44 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 123.937 0.895 . . . . 0.0 110.125 173.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -163.75 -168.03 1.53 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.712 2.005 . . . . 0.0 108.248 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -121.29 152.02 39.4 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 168.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 51.9 t-105 -130.97 179.55 5.92 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.607 0.763 . . . . 0.0 109.936 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -148.02 151.27 35.45 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.398 1.479 . . . . 0.0 107.287 171.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -131.41 98.97 4.68 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.624 1.17 . . . . 0.0 108.534 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -90.89 9.86 28.69 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.966 1.706 . . . . 0.0 112.202 -177.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.426 HG22 ' HE2' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -158.46 162.49 37.53 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 128.486 2.714 . . . . 0.0 108.321 -178.273 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -61.48 138.29 58.27 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -144.58 104.66 4.07 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 74.8 m -72.69 143.14 48.19 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 164.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.7 p -153.53 131.62 11.83 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.49 1.041 . . . . 0.0 111.4 175.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -108.61 108.09 18.83 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 126.349 1.859 . . . . 0.0 108.828 -176.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.3 mm -74.8 114.76 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.812 1.245 . . . . 0.0 107.834 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.486 ' CD1' ' HD1' ' A' ' 85' ' ' HIS . 1.3 mp -101.19 -33.48 10.07 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 118.879 -0.581 . . . . 0.0 112.337 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pm0 -154.04 162.73 40.99 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.975 0.91 . . . . 0.0 109.296 172.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.58 -172.37 48.47 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 127.061 2.267 . . . . 0.0 111.32 -173.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.81 148.28 31.73 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -177.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.3 t -136.95 151.96 27.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -123.07 98.01 5.69 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.362 2.265 . . . . 0.0 106.31 168.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.9 t -86.16 136.33 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 170.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 66.8 m -136.45 122.48 20.21 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.183 0.901 . . . . 0.0 108.776 -178.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 72.1 p -76.36 169.81 17.54 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.304 0.573 . . . . 0.0 109.858 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -62.98 -35.9 81.74 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.364 -0.835 . . . . 0.0 110.713 -178.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -82.65 16.16 2.3 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 128.516 2.726 . . . . 0.0 111.694 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.88 4.95 88.74 Favored Glycine 0 CA--C 1.525 0.687 0 O-C-N 119.884 -1.76 . . . . 0.0 114.649 162.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.2 mmtt -67.0 106.78 2.04 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.765 1.783 . . . . 0.0 107.025 167.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.5 tptt -67.2 157.55 33.5 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 163.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -137.0 155.58 49.52 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 104.064 -2.569 . . . . 0.0 104.064 166.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 75.5 t -138.76 129.07 33.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 103.053 -2.943 . . . . 0.0 103.053 178.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.9 pt -134.08 123.23 43.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -103.67 176.12 5.26 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 126.725 2.01 . . . . 0.0 107.817 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.3 pttp -58.11 125.2 22.16 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 164.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.8 -0.07 56.45 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 117.702 -1.61 . . . . 0.0 115.688 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.468 ' OD1' ' HE2' ' A' ' 7' ' ' LYS . 19.1 m-20 -92.1 123.82 35.73 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 120.832 2.316 . . . . 0.0 106.567 166.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.2 tp -88.15 146.73 25.25 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 160.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.4 t -126.07 150.51 31.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 174.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 58.4 m -132.96 111.41 11.01 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 164.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -74.43 155.69 87.52 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 169.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -74.79 -165.2 0.27 Allowed 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.168 2.579 . . . . 0.0 109.381 174.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.426 ' HE2' HG22 ' A' ' 37' ' ' THR . 56.4 tttm -95.25 120.82 36.14 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 162.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.97 87.66 1.06 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.401 1.477 . . . . 0.0 112.634 176.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 57.9 tp -143.88 143.54 31.34 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.952 1.701 . . . . 0.0 108.207 171.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.47 131.28 56.98 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 125.339 1.456 . . . . 0.0 108.11 167.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 7.8 p -165.43 168.43 16.67 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.48 1.112 . . . . 0.0 111.362 169.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.88 167.96 20.85 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 124.578 1.151 . . . . 0.0 112.028 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -144.4 113.11 6.68 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.462 1.105 . . . . 0.0 109.755 178.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.53 109.27 19.53 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 175.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.0 t -86.8 101.26 10.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 175.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.9 mt -83.39 -18.9 37.18 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-O 118.777 -0.63 . . . . 0.0 111.717 -175.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -148.25 146.15 22.4 Favored Pre-proline 0 C--O 1.236 0.356 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 166.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -61.54 90.74 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.491 1 C-N-CA 125.542 4.161 . . . . 0.0 110.87 -165.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.35 149.31 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 123.936 0.895 . . . . 0.0 109.754 -166.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -129.35 112.6 14.01 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 168.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.596 ' HE3' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -133.28 142.15 48.35 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.266 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.486 ' HD1' ' CD1' ' A' ' 44' ' ' LEU . 18.6 m80 -84.34 100.89 11.56 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 171.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -88.8 154.86 19.93 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.154 0.982 . . . . 0.0 110.546 171.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -151.54 112.93 4.35 Favored 'General case' 0 C--O 1.239 0.523 0 O-C-N 121.676 -0.64 . . . . 0.0 110.517 170.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 61.7 mt -61.59 153.29 28.19 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.406 1.482 . . . . 0.0 108.932 171.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.7 p90 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 116.173 -1.87 . . . . 0.0 110.443 166.332 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.8 p . . . . . 0 CA--C 1.533 0.3 0 N-CA-C 108.588 -0.894 . . . . 0.0 108.588 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 55.9 tttt -75.7 136.68 40.36 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 171.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.3 mt -135.73 139.74 45.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 169.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -165.32 175.22 9.36 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.145 2.178 . . . . 0.0 108.728 162.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.31 86.35 1.32 Allowed Pre-proline 0 C--O 1.237 0.444 0 CA-C-O 117.88 -1.057 . . . . 0.0 109.19 176.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -63.92 168.01 12.91 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.522 1.481 . . . . 0.0 111.014 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.0 t -69.85 143.5 92.18 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -66.42 -19.4 55.29 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.897 1.731 . . . . 0.0 113.178 176.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -59.89 -47.61 85.06 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 119.733 1.151 . . . . 0.0 109.622 171.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 35.9 tptt -65.34 -37.48 87.19 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 121.45 -0.781 . . . . 0.0 110.451 -177.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.3 mt -67.97 -26.91 66.17 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 118.833 -0.603 . . . . 0.0 111.917 177.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -64.83 -46.87 80.13 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 119.386 0.994 . . . . 0.0 109.814 168.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -60.07 -48.58 81.12 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.387 0.613 . . . . 0.0 109.384 -176.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.7 mp -55.03 -14.76 1.65 Allowed 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 125.947 1.699 . . . . 0.0 112.817 176.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.4 m 53.01 45.01 29.69 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.015 1.326 . . . . 0.0 110.743 175.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 45.8 t -56.59 -31.45 34.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.27 1.028 . . . . 0.0 110.505 -175.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -44.92 -34.56 2.44 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.858 2.063 . . . . 0.0 114.454 167.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.9 mtmm -84.12 -23.53 30.66 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 119.531 1.059 . . . . 0.0 111.418 -177.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 35.1 m0 -64.72 164.43 20.84 Favored Pre-proline 0 C--O 1.24 0.574 0 C-N-CA 124.118 0.967 . . . . 0.0 109.816 -171.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -66.6 139.97 55.15 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 121.118 1.212 . . . . 0.0 110.144 171.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.2 mt -81.18 151.98 4.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 164.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.504 ' CE3' ' HE2' ' A' ' 84' ' ' LYS . 68.3 t90 -140.79 148.0 39.93 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 156.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.7 157.07 44.66 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 126.615 1.966 . . . . 0.0 109.169 -178.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -151.02 169.59 21.42 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.482 0.713 . . . . 0.0 111.625 -174.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -66.18 175.07 2.26 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 122.715 1.245 . . . . 0.0 111.006 164.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.3 t -94.62 27.4 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 128.418 2.687 . . . . 0.0 109.866 -167.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.9 t -91.99 176.59 6.45 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.573 1.149 . . . . 0.0 110.521 -173.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -104.61 142.55 34.46 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.448 1.099 . . . . 0.0 108.092 167.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -147.08 -170.34 3.52 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 127.644 2.377 . . . . 0.0 107.392 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.533 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 1.1 m-20 -128.3 154.87 45.45 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 169.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 48.1 t-105 -134.77 146.05 48.99 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.025 0.53 . . . . 0.0 111.787 175.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -113.82 111.11 21.2 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 171.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -79.49 122.61 26.67 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 170.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.9 p-10 -120.19 6.58 10.74 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 125.916 1.687 . . . . 0.0 111.323 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.96 174.31 15.71 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.082 1.353 . . . . 0.0 108.85 167.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -68.33 87.12 0.29 Allowed 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 125.584 1.554 . . . . 0.0 108.773 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.33 110.32 18.02 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 173.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 73.0 m -88.14 134.7 33.7 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 163.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 24.6 p -140.23 149.18 42.56 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 118.714 0.688 . . . . 0.0 110.053 170.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -126.92 116.71 21.23 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.466 1.507 . . . . 0.0 107.979 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 18.9 mm -80.83 124.96 39.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 126.911 2.084 . . . . 0.0 107.567 -172.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.2 mt -103.12 -26.9 12.86 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 118.634 0.652 . . . . 0.0 112.486 -176.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -158.95 169.39 24.44 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.547 1.939 . . . . 0.0 107.404 174.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.23 -172.26 25.2 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.099 0.857 . . . . 0.0 113.078 169.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.95 143.57 30.61 Favored 'General case' 0 CA--C 1.517 -0.307 0 O-C-N 121.526 -0.985 . . . . 0.0 108.363 175.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 71.6 t -138.48 155.97 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -124.55 127.02 46.78 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 126.381 1.872 . . . . 0.0 106.345 163.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.1 t -113.53 113.06 42.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.403 ' HB ' ' HG2' ' A' ' 75' ' ' ARG . 26.2 m -114.72 103.01 10.56 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 -168.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 38.2 p -78.1 173.15 12.53 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -54.65 -40.6 69.17 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.651 0.78 . . . . 0.0 110.578 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -65.09 -17.38 64.41 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 123.794 0.838 . . . . 0.0 112.361 -175.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.68 0.7 88.26 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -163.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.1 mmtp -63.06 118.36 7.76 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 164.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -130.05 133.29 46.62 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -162.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -127.27 116.64 20.87 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -170.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 77.6 t -76.76 144.88 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 160.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.9 pt -140.92 147.4 22.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 C-N-CA 124.795 1.238 . . . . 0.0 108.914 166.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -138.89 -175.33 4.11 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 126.939 2.096 . . . . 0.0 110.374 176.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -66.85 62.88 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 128.132 2.573 . . . . 0.0 115.795 -162.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 159.6 -6.9 0.13 Allowed Glycine 0 C--N 1.317 -0.475 0 CA-C-O 118.021 -1.433 . . . . 0.0 114.027 -178.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -71.47 128.53 36.15 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 166.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 17.0 tp -88.76 142.09 27.96 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 160.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.6 t -122.35 141.05 44.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 175.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.3 m -127.11 101.21 6.43 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 167.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -65.03 161.82 44.37 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 170.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -71.42 -164.03 0.15 Allowed 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.974 2.45 . . . . 0.0 108.684 167.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -110.14 108.85 19.16 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 165.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.69 85.64 1.88 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.453 1.502 . . . . 0.0 110.669 -175.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.1 tt -147.57 113.81 5.89 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.616 1.966 . . . . 0.0 107.499 173.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.1 ttt180 -81.98 133.18 35.28 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 161.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 29.2 p -147.32 -170.66 3.61 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.507 0.67 . . . . 0.0 109.896 159.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' A' ' 32' ' ' ASP . 5.8 ptp180 -108.06 164.7 12.06 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 173.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -134.07 122.87 23.57 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 119.591 1.087 . . . . 0.0 110.085 175.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.1 tttp -116.18 105.97 13.18 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.5 t -72.92 129.52 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 103.536 -2.764 . . . . 0.0 103.536 166.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 95.0 mt -109.9 -16.36 13.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 117.659 -1.162 . . . . 0.0 110.407 173.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -154.13 145.12 16.26 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 126.594 1.958 . . . . 0.0 107.61 167.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -56.92 125.87 20.38 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 124.345 3.363 . . . . 0.0 111.587 -167.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.7 p -121.45 92.76 2.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-O 124.978 2.323 . . . . 0.0 111.491 -161.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.9 mtm-85 -78.95 119.57 22.3 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 170.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.504 ' HE2' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -128.78 157.17 42.2 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.69 0.757 . . . . 0.0 109.257 173.016 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -94.79 135.85 35.8 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 161.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -130.15 160.48 33.67 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 123.052 0.541 . . . . 0.0 109.871 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -156.55 103.43 2.12 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -172.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 65.5 mt -75.48 145.53 41.35 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 171.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 45.2 p90 . . . . . 0 C--O 1.252 1.187 0 CA-C-O 114.576 -2.63 . . . . 0.0 111.156 164.96 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 74.3 t . . . . . 0 N--CA 1.446 -0.654 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.7 tptp -82.2 134.92 35.32 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 168.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.9 mt -140.81 120.2 11.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 168.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -138.45 175.16 9.81 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.323 1.449 . . . . 0.0 109.986 172.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.53 85.47 5.92 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 170.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -65.71 165.24 23.83 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.364 2.043 . . . . 0.0 112.111 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.19 144.72 84.95 Favored Pre-proline 0 C--O 1.239 0.553 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -68.15 -30.74 31.0 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.855 2.37 . . . . 0.0 112.334 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -56.84 -44.04 81.69 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.956 0.798 . . . . 0.0 110.686 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -64.64 -36.95 85.9 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.193 0.597 . . . . 0.0 109.493 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.1 mt -69.09 -28.54 66.58 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.894 -0.504 . . . . 0.0 112.225 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -55.56 -50.82 69.05 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 169.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -60.43 -52.78 63.78 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.408 1.083 . . . . 0.0 110.999 -176.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 93.1 mt -56.39 -20.76 21.02 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 125.962 1.705 . . . . 0.0 112.789 -178.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 74.3 42.51 0.32 Allowed 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.768 2.027 . . . . 0.0 111.149 170.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.7 t -54.33 -33.1 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 118.304 0.502 . . . . 0.0 110.765 -173.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -58.24 -24.76 60.39 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.0 pttp -83.76 -5.66 59.25 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.48 0.712 . . . . 0.0 111.049 -171.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 23.0 m0 -87.54 165.05 32.5 Favored Pre-proline 0 N--CA 1.438 -1.06 0 C-N-CA 124.922 1.289 . . . . 0.0 107.881 -169.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -66.93 135.16 36.88 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 121.653 1.569 . . . . 0.0 110.638 167.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 68.5 mt -78.9 143.1 13.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 164.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -127.24 153.15 46.48 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 162.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -150.72 162.69 40.22 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.902 1.281 . . . . 0.0 109.543 176.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -148.78 157.94 43.8 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 124.957 1.303 . . . . 0.0 109.565 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.3 pm0 -69.47 170.91 9.63 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 124.726 1.266 . . . . 0.0 112.061 167.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.4 t -82.49 74.21 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 125.79 1.636 . . . . 0.0 106.829 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.0 t -145.62 -173.12 4.04 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 175.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.96 149.32 30.22 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 122.417 1.103 . . . . 0.0 112.922 -169.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -157.53 -168.25 2.52 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.146 1.779 . . . . 0.0 108.093 -163.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.0 p30 -119.91 160.64 22.31 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.257 -0.902 . . . . 0.0 108.648 166.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 10.2 t-105 -128.75 168.11 16.32 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.568 0.699 . . . . 0.0 111.257 172.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -142.32 92.35 2.42 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.722 1.609 . . . . 0.0 107.934 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -72.2 118.93 15.69 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 171.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -111.72 -5.12 14.49 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.344 1.458 . . . . 0.0 111.691 -176.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.53 172.56 12.53 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 127.167 2.187 . . . . 0.0 110.233 164.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -62.16 107.64 0.92 Allowed 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 176.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -121.3 75.11 1.14 Allowed 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -175.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.9 m -67.5 135.83 53.63 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 -175.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 29.3 p -142.54 155.96 45.07 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 120.966 0.413 . . . . 0.0 110.128 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -132.66 121.0 22.48 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.323 -170.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 16.1 mm -81.07 124.84 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -174.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.2 mt -122.45 -33.71 3.4 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.439 1.096 . . . . 0.0 111.51 -167.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -154.48 162.34 41.2 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 127.39 2.276 . . . . 0.0 105.252 165.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.44 176.51 51.05 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 124.695 1.14 . . . . 0.0 112.186 177.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.26 144.48 27.67 Favored 'General case' 0 CA--C 1.516 -0.356 0 O-C-N 122.249 -0.559 . . . . 0.0 110.27 -156.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 50.6 t -143.65 152.14 16.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-N 117.692 0.223 . . . . 0.0 110.57 -176.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -109.27 128.0 54.72 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.446 1.899 . . . . 0.0 106.951 153.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 94.0 t -107.42 140.06 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 105.726 -1.954 . . . . 0.0 105.726 170.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.9 m -136.47 104.3 5.54 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.442 1.019 . . . . 0.0 109.72 -173.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.0 p -69.74 169.93 11.95 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.182 -0.949 . . . . 0.0 110.518 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -67.67 -29.7 69.05 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.511 -0.743 . . . . 0.0 110.774 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.74 -4.17 2.91 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.085 1.354 . . . . 0.0 112.279 172.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.38 -3.46 86.25 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-O 118.436 -1.202 . . . . 0.0 113.637 167.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -58.38 152.52 17.52 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 167.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -103.64 161.69 13.7 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 156.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -118.93 159.1 24.43 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 153.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 72.8 t -137.47 128.38 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 102.185 -3.265 . . . . 0.0 102.185 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 pt -139.61 142.95 31.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.413 ' OE1' ' HE3' ' A' ' 62' ' ' LYS . 1.3 pp20? -131.71 -176.22 3.97 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.192 1.797 . . . . 0.0 111.771 177.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.413 ' HE3' ' OE1' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -75.23 54.49 0.7 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.38 2.272 . . . . 0.0 115.844 -157.287 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -177.63 -5.81 0.02 OUTLIER Glycine 0 CA--C 1.53 0.981 0 CA-C-O 118.183 -1.343 . . . . 0.0 113.166 172.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.94 140.83 36.51 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 119.253 1.526 . . . . 0.0 108.236 174.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.08 153.82 18.16 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 123.818 0.847 . . . . 0.0 109.592 167.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.8 t -137.07 137.53 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -174.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 98.0 m -131.15 110.48 11.19 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 166.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -73.53 162.9 72.12 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 126.142 1.777 . . . . 0.0 109.207 167.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -83.47 177.1 6.63 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 CA-C-O 122.921 1.134 . . . . 0.0 110.002 169.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.3 tttm -85.55 82.69 8.16 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.084 1.353 . . . . 0.0 107.715 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.21 86.44 0.66 Allowed Glycine 0 CA--C 1.522 0.522 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.9 tp -148.94 103.57 3.37 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.461 0.704 . . . . 0.0 110.823 174.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 27.2 ttt85 -72.86 126.89 31.0 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 156.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 20.4 p -154.14 170.68 20.61 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.899 1.279 . . . . 0.0 108.19 166.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -79.81 158.68 26.75 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 120.956 -1.09 . . . . 0.0 110.89 172.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -139.4 116.34 10.94 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.347 1.459 . . . . 0.0 108.433 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.0 102.39 8.14 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.632 1.573 . . . . 0.0 106.921 -173.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.2 t -80.26 105.22 9.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 104.402 -2.444 . . . . 0.0 104.402 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 17.6 mt -81.91 -27.45 33.38 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -151.22 153.62 32.88 Favored Pre-proline 0 N--CA 1.469 0.484 0 C-N-CA 125.67 1.588 . . . . 0.0 109.439 171.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -65.0 106.47 0.79 Allowed 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.125 2.55 . . . . 0.0 111.16 -164.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.3 p -93.17 111.31 24.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 121.774 0.797 . . . . 0.0 110.611 -166.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -94.45 43.12 1.1 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.754 0.821 . . . . 0.0 111.42 -171.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.62 146.98 39.0 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 120.967 -1.083 . . . . 0.0 111.133 -175.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -78.03 150.05 33.91 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 156.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -139.87 156.88 46.48 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.328 0.967 . . . . 0.0 110.545 172.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -143.36 131.91 22.37 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.143 0.977 . . . . 0.0 109.4 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 95.2 mt -93.01 129.83 38.79 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.297 1.039 . . . . 0.0 108.59 176.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.3 p90 . . . . . 0 C--O 1.247 0.949 0 C-N-CA 124.298 1.039 . . . . 0.0 110.231 -177.171 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.239 0.52 0 CA-C-O 121.594 0.711 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -109.68 147.82 32.46 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 125.564 1.546 . . . . 0.0 107.961 -176.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.8 mt -139.31 139.32 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 104.04 -2.578 . . . . 0.0 104.04 177.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -154.6 -178.95 7.54 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.729 0.812 . . . . 0.0 109.848 167.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.1 81.16 27.98 Favored Pre-proline 0 C--O 1.236 0.365 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -175.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.64 169.23 22.39 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.329 2.019 . . . . 0.0 111.462 -170.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.489 HG21 ' H ' ' A' ' 12' ' ' LYS . 6.9 t -66.26 145.02 98.96 Favored Pre-proline 0 CA--C 1.543 0.703 0 O-C-N 121.983 -0.448 . . . . 0.0 109.943 171.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.01 -5.2 12.97 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.888 2.392 . . . . 0.0 112.716 169.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -87.8 -51.74 5.69 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.542 1.064 . . . . 0.0 110.752 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.489 ' H ' HG21 ' A' ' 9' ' ' THR . 1.5 tptt -49.92 -45.89 51.52 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.354 1.062 . . . . 0.0 110.207 172.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 34.1 mt -54.97 -33.29 62.29 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.346 1.058 . . . . 0.0 112.555 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.0 mttp -63.76 -51.5 64.57 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 118.911 0.778 . . . . 0.0 109.006 176.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -57.51 -49.11 77.38 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 123.001 1.382 . . . . 0.0 109.827 -172.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 98.5 mt -56.48 -12.04 1.55 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.204 1.801 . . . . 0.0 112.035 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.0 m 62.39 32.6 16.77 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.527 1.931 . . . . 0.0 111.05 174.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.407 ' HA ' ' CD2' ' A' ' 21' ' ' TRP . 59.6 t -50.81 -39.62 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 126.657 1.983 . . . . 0.0 110.496 175.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -57.68 -19.33 26.13 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -92.05 -25.43 18.79 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 124.297 1.039 . . . . 0.0 111.586 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.407 ' CD2' ' HA ' ' A' ' 18' ' ' VAL . 41.9 m0 -60.45 158.01 32.23 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 124.297 1.039 . . . . 0.0 109.49 -174.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.39 118.5 5.68 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.046 1.83 . . . . 0.0 111.401 -175.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.2 mt -62.09 144.75 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 174.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.564 ' CZ3' ' HE3' ' A' ' 84' ' ' LYS . 91.0 t90 -132.59 138.32 47.38 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 165.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -136.2 157.28 47.19 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 128.402 2.681 . . . . 0.0 108.622 -177.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.5 tptt -153.85 166.4 33.04 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 121.973 -0.454 . . . . 0.0 109.94 -177.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.84 175.19 3.77 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 122.25 1.024 . . . . 0.0 110.681 167.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.6 p -80.8 -6.93 10.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 113.381 -1.736 . . . . 0.0 112.533 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.1 t -73.88 152.14 40.28 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 122.863 1.316 . . . . 0.0 109.743 174.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -84.27 168.28 15.82 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 129.132 2.973 . . . . 0.0 109.929 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -169.35 -164.01 0.43 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.954 2.502 . . . . 0.0 107.176 176.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -122.55 164.05 18.84 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 120.206 -1.559 . . . . 0.0 107.213 157.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 54.5 t-105 -134.52 168.94 18.05 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.791 0.836 . . . . 0.0 109.791 -173.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -135.87 153.7 51.39 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.259 1.423 . . . . 0.0 107.858 175.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -134.42 120.23 19.54 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 170.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -123.79 27.29 7.34 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.923 1.238 . . . . 0.0 111.811 168.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.65 172.08 15.14 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 152.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -70.23 107.43 3.71 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 -171.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -107.58 98.87 8.42 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -173.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 88.2 m -68.7 148.0 51.03 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 161.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.7 p -146.75 159.51 43.41 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 121.468 -0.77 . . . . 0.0 111.539 154.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -126.16 126.05 43.49 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 126.385 1.874 . . . . 0.0 107.862 176.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.9 mm -101.28 111.77 32.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 123.24 0.616 . . . . 0.0 109.35 -169.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.413 ' CD1' ' HD1' ' A' ' 85' ' ' HIS . 2.0 mp -93.12 -29.65 15.65 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 123.945 0.898 . . . . 0.0 111.769 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -159.33 166.12 31.88 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.51 0.724 . . . . 0.0 109.086 -177.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.17 -178.85 52.91 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.631 1.11 . . . . 0.0 113.218 -177.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.64 143.17 26.35 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 125.028 1.331 . . . . 0.0 107.583 -178.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.9 t -139.17 149.22 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 176.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -116.87 88.6 2.93 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 103.448 -2.797 . . . . 0.0 103.448 166.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.3 t -75.64 144.39 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 173.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.5 m -145.69 115.06 7.13 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 120.062 1.301 . . . . 0.0 109.052 -175.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 57.5 p -65.72 162.59 18.28 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.94 -21.89 61.54 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.149 -0.97 . . . . 0.0 110.797 175.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -79.48 22.68 0.43 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.239 1.816 . . . . 0.0 111.232 165.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.74 -5.95 10.47 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 125.685 1.612 . . . . 0.0 115.637 166.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -66.95 110.41 3.34 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 119.939 1.869 . . . . 0.0 108.006 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt -87.69 134.08 33.72 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -130.41 85.01 2.24 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 124.26 1.981 . . . . 0.0 108.585 168.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.6 p -56.85 136.35 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 CA-C-N 112.51 -2.132 . . . . 0.0 108.646 146.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 pt -139.3 132.97 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 101.719 -3.437 . . . . 0.0 101.719 173.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -90.46 -176.72 4.86 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 121.893 0.854 . . . . 0.0 108.919 171.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -66.16 126.16 27.79 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 147.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 117.61 14.41 6.87 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-O 118.051 -1.416 . . . . 0.0 114.296 -175.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -119.85 149.31 42.28 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.036 1.334 . . . . 0.0 108.545 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.7 tp -109.1 145.16 36.14 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 156.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.3 t -130.26 153.95 39.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 125.461 1.504 . . . . 0.0 107.476 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.0 m -135.31 108.6 7.78 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 161.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -79.01 153.53 77.48 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 123.831 0.852 . . . . 0.0 109.177 169.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.74 171.42 17.35 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 121.848 1.699 . . . . 0.0 111.305 173.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.9 tttt -78.1 106.67 10.13 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 111.485 -2.598 . . . . 0.0 106.21 161.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.66 70.09 0.9 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.702 1.62 . . . . 0.0 111.918 171.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.1 tp -140.68 150.89 44.07 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.104 1.762 . . . . 0.0 109.125 176.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.35 134.2 43.45 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 126.924 2.09 . . . . 0.0 108.219 176.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 6.0 p -159.52 164.83 34.03 Favored 'General case' 0 C--N 1.334 -0.077 0 C-N-CA 123.082 0.553 . . . . 0.0 111.686 176.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.39 164.24 16.62 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 123.029 0.532 . . . . 0.0 112.009 167.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -144.37 104.9 4.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.859 1.264 . . . . 0.0 108.219 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.7 ttpm? -101.88 111.28 23.48 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 169.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.2 t -77.65 125.84 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 168.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.1 mt -103.03 -16.1 15.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 118.313 -0.851 . . . . 0.0 111.448 168.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -147.85 144.45 19.13 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 117.543 -1.218 . . . . 0.0 109.299 171.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -61.97 100.43 0.2 Allowed 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 124.24 3.293 . . . . 0.0 111.299 -174.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.5 p -70.51 156.49 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 124.535 1.134 . . . . 0.0 111.232 -169.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -139.99 110.21 6.57 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 103.435 -2.802 . . . . 0.0 103.435 161.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.564 ' HE3' ' CZ3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -132.16 148.26 52.46 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.217 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.413 ' HD1' ' CD1' ' A' ' 44' ' ' LEU . 17.3 m80 -90.56 101.04 13.78 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 105.674 -1.972 . . . . 0.0 105.674 174.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -90.92 159.16 16.34 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.69 0.677 . . . . 0.0 110.074 170.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -154.04 140.82 19.08 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 121.44 -0.788 . . . . 0.0 109.972 159.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 42.9 mt -84.23 165.92 17.97 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 124.484 1.113 . . . . 0.0 109.172 175.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.1 p90 . . . . . 0 C--O 1.255 1.367 0 CA-C-O 116.224 -1.846 . . . . 0.0 108.227 164.124 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.9 t . . . . . 0 C--O 1.238 0.468 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.6 ttpt -115.0 91.45 3.62 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 176.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.8 mt -87.77 139.77 16.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 167.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -154.06 171.8 18.51 Favored 'General case' 0 C--O 1.224 -0.26 0 O-C-N 123.998 0.811 . . . . 0.0 111.008 163.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.92 75.77 75.99 Favored Pre-proline 0 N--CA 1.47 0.572 0 C-N-CA 123.419 0.688 . . . . 0.0 111.368 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.71 172.34 10.7 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 125.183 3.922 . . . . 0.0 114.234 -173.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.6 t -66.19 144.3 98.69 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.191 0.996 . . . . 0.0 109.913 173.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.25 -25.07 50.25 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.734 1.623 . . . . 0.0 112.924 176.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -61.24 -55.08 36.06 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.601 0.761 . . . . 0.0 109.184 -177.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -53.34 -38.16 62.99 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.327 1.051 . . . . 0.0 111.208 176.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -71.54 -22.19 61.79 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.325 -176.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -64.93 -48.88 72.55 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 120.053 1.297 . . . . 0.0 108.853 166.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -66.3 -37.93 86.55 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.281 0.632 . . . . 0.0 111.466 -167.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 34.4 mt -55.55 -12.09 1.07 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.93 1.292 . . . . 0.0 113.165 173.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.2 m 63.98 39.57 7.89 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.764 2.025 . . . . 0.0 109.668 172.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.6 t -53.63 -35.62 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 128.302 2.641 . . . . 0.0 110.55 173.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -61.48 -11.98 12.97 Favored 'General case' 0 CA--C 1.548 0.87 0 O-C-N 121.033 -1.042 . . . . 0.0 113.296 173.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.0 mttt -103.13 -3.73 25.44 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 126.271 1.828 . . . . 0.0 112.494 176.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 32.6 m0 -79.99 165.27 48.22 Favored Pre-proline 0 CA--C 1.538 0.49 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 176.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.52 136.13 35.56 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 121.492 1.461 . . . . 0.0 111.455 170.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.5 mt -76.09 149.69 6.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 165.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.486 ' CZ3' ' HE3' ' A' ' 84' ' ' LYS . 6.4 t90 -146.17 148.53 32.64 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.953 1.301 . . . . 0.0 108.261 164.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -138.06 163.22 32.15 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.277 2.231 . . . . 0.0 109.763 -177.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -145.99 159.72 42.85 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.597 1.089 . . . . 0.0 111.309 168.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -61.81 173.92 0.93 Allowed 'General case' 0 C--O 1.232 0.174 0 O-C-N 125.212 1.57 . . . . 0.0 110.792 163.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.9 t -90.78 33.72 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 125.865 1.666 . . . . 0.0 109.885 -173.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.9 t -107.25 -179.04 3.81 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 120.522 -1.361 . . . . 0.0 109.637 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -124.81 144.02 50.5 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.867 1.267 . . . . 0.0 109.724 -171.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -156.54 -164.93 1.76 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.349 1.06 . . . . 0.0 109.145 -174.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.452 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 0.7 OUTLIER -131.34 150.23 52.23 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.945 1.698 . . . . 0.0 109.482 172.503 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 29.6 t-105 -133.97 142.51 47.7 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 123.35 0.406 . . . . 0.0 111.135 177.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -106.7 125.13 50.62 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 173.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -103.67 106.8 17.41 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 168.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -104.08 17.79 23.39 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.469 1.031 . . . . 0.0 111.471 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.89 168.14 26.08 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.177 1.391 . . . . 0.0 109.562 166.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -62.97 124.9 22.28 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 126.236 1.814 . . . . 0.0 107.303 -178.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -140.46 109.37 6.04 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.6 m -77.82 148.02 34.92 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 163.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 25.6 p -142.92 147.33 35.1 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 157.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -109.35 128.7 55.31 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 172.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.8 mm -90.83 129.3 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -108.99 -37.21 5.89 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.012 1.725 . . . . 0.0 113.033 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -163.7 161.11 23.38 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.098 1.759 . . . . 0.0 109.585 175.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.05 -163.64 12.88 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.056 1.312 . . . . 0.0 111.638 -174.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.82 145.12 25.5 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.618 1.209 . . . . 0.0 108.011 157.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 65.6 t -134.46 150.2 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 174.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -118.95 143.08 47.23 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 157.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.6 t -120.42 96.84 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 175.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.4 m -78.51 104.94 9.45 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 174.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.9 p -78.32 171.68 14.71 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -60.34 -31.92 70.77 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.062 -1.023 . . . . 0.0 111.904 -177.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.46 -15.43 60.68 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 127.578 2.351 . . . . 0.0 111.674 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.83 -2.93 87.7 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 124.641 1.115 . . . . 0.0 114.174 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.7 mmtp -59.75 142.25 53.6 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 163.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.0 ptmm? -125.7 94.11 4.03 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 123.118 1.437 . . . . 0.0 107.8 -176.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -89.11 87.43 7.18 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 123.991 1.853 . . . . 0.0 109.01 -175.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.5 p -55.13 144.1 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 CA-C-N 112.092 -2.322 . . . . 0.0 111.103 149.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 pt -144.78 137.3 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 129.478 3.111 . . . . 0.0 104.094 176.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -109.29 -177.25 3.24 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 125.551 1.54 . . . . 0.0 109.412 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.5 pttt -64.62 42.47 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 130.238 3.415 . . . . 0.0 116.446 -174.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -179.46 11.91 0.03 OUTLIER Glycine 0 CA--C 1.524 0.608 0 C-N-CA 124.962 1.268 . . . . 0.0 113.251 169.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.98 131.04 40.36 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.54 1.67 . . . . 0.0 107.022 175.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.0 tp -99.3 91.61 5.04 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.332 1.453 . . . . 0.0 108.025 164.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.631 0.1 OUTLIER -61.89 145.96 12.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 120.808 3.632 . . . . 0.0 120.808 153.042 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.2 m -135.4 121.98 20.75 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 128.289 2.636 . . . . 0.0 105.761 162.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -92.61 148.32 35.97 Favored Pre-proline 0 C--O 1.237 0.422 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 170.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -78.14 179.73 6.22 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.937 2.425 . . . . 0.0 110.16 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -85.77 93.95 9.0 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 114.65 93.57 1.95 Allowed Glycine 0 CA--C 1.523 0.534 0 C-N-CA 125.175 1.369 . . . . 0.0 109.802 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.3 tt -151.23 133.34 15.22 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.038 1.335 . . . . 0.0 108.858 175.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 65.6 ttt-85 -130.23 81.87 2.03 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.616 1.098 . . . . 0.0 111.056 -175.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 87.0 m -137.2 154.8 50.11 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 122.205 1.002 . . . . 0.0 112.634 -168.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.452 ' HA ' ' HA ' ' A' ' 32' ' ' ASP . 0.7 OUTLIER -70.27 152.53 44.08 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 114.043 -1.435 . . . . 0.0 109.858 -174.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -131.58 110.46 10.97 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.927 1.691 . . . . 0.0 107.215 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.4 tttp -108.73 107.96 18.61 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -177.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.5 t -86.09 102.57 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.1 mt -83.95 -21.84 31.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 118.493 -0.765 . . . . 0.0 110.509 175.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -152.6 151.9 27.77 Favored Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 173.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -72.1 86.28 0.95 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 125.05 3.833 . . . . 0.0 111.801 -158.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.3 p -71.69 139.79 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 123.912 0.885 . . . . 0.0 109.251 -172.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.0 ttt180 -120.8 59.37 0.92 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.986 0.898 . . . . 0.0 110.044 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.486 ' HE3' ' CZ3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -70.47 162.13 29.3 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 119.37 -2.081 . . . . 0.0 109.71 -172.554 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -101.18 125.35 47.8 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 104.375 -2.454 . . . . 0.0 104.375 167.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -115.53 160.87 19.4 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.478 1.036 . . . . 0.0 109.251 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -151.01 127.63 10.82 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 118.789 0.722 . . . . 0.0 109.237 173.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 19.8 mt -87.83 139.04 30.93 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 126.411 1.884 . . . . 0.0 108.015 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 34.0 p90 . . . . . 0 C--O 1.259 1.604 0 CA-C-O 117.335 -1.317 . . . . 0.0 110.397 179.063 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 91.5 t . . . . . 0 CA--C 1.543 0.693 0 CA-C-O 121.27 0.557 . . . . 0.0 111.717 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.16 130.81 44.3 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 177.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.0 mt -143.32 134.47 22.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 173.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -159.38 173.73 15.81 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.337 0.655 . . . . 0.0 110.199 172.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.82 85.3 4.87 Favored Pre-proline 0 C--O 1.234 0.256 0 C-N-CA 124.288 1.035 . . . . 0.0 108.911 177.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.87 169.91 19.18 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.248 2.632 . . . . 0.0 112.925 -176.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 t -69.63 149.79 96.85 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.82 1.248 . . . . 0.0 110.642 174.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.09 -31.16 75.91 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.834 2.356 . . . . 0.0 113.79 173.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -63.26 -53.56 50.98 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 118.65 0.659 . . . . 0.0 110.672 -171.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.5 tttp -54.42 -48.48 71.59 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 124.833 1.253 . . . . 0.0 109.298 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.4 mt -58.02 -41.02 82.27 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.933 0.893 . . . . 0.0 112.019 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -59.94 -46.96 87.7 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.012 173.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -59.28 -45.77 90.35 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.129 0.877 . . . . 0.0 110.065 -178.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 59.8 mt -57.16 -12.02 2.0 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.572 1.949 . . . . 0.0 113.05 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.3 m 64.11 39.81 7.43 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.956 1.702 . . . . 0.0 111.844 168.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.3 t -58.03 -26.69 29.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 126.743 2.017 . . . . 0.0 111.92 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -61.53 -20.57 63.38 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 120.324 -1.485 . . . . 0.0 113.439 171.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt -98.02 4.15 49.34 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.159 1.384 . . . . 0.0 110.92 177.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 31.9 m0 -87.54 160.33 47.97 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.37 133.76 27.11 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.186 1.924 . . . . 0.0 112.415 177.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.9 mt -73.41 147.73 9.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 124.485 1.114 . . . . 0.0 109.694 166.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.483 ' CZ3' ' HE3' ' A' ' 84' ' ' LYS . 59.8 t90 -144.36 120.63 10.88 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.292 1.437 . . . . 0.0 107.876 168.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.77 168.51 10.28 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.763 1.625 . . . . 0.0 109.791 164.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.493 ' HD3' ' H ' ' A' ' 27' ' ' GLU . 6.1 tmtt? -152.07 165.73 33.81 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.827 0.822 . . . . 0.0 110.735 167.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.493 ' H ' ' HD3' ' A' ' 26' ' ' LYS . 1.0 OUTLIER -76.97 172.64 12.86 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 126.304 1.842 . . . . 0.0 109.216 174.732 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.2 t -100.33 59.32 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 -164.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.4 t -132.03 -178.29 4.83 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.893 1.677 . . . . 0.0 109.433 -167.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -122.64 150.65 42.39 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.907 0.883 . . . . 0.0 109.095 173.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -163.42 -164.79 0.97 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 125.881 1.673 . . . . 0.0 107.017 -177.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 2.6 p30 -131.0 154.65 47.95 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 120.878 -1.139 . . . . 0.0 109.159 173.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 56.1 t-105 -144.11 152.25 40.69 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.015 0.435 . . . . 0.0 110.062 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -124.89 153.18 43.03 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.572 1.149 . . . . 0.0 108.526 -177.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -123.49 103.84 8.7 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.961 1.305 . . . . 0.0 107.626 175.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -104.74 13.45 31.36 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.232 1.413 . . . . 0.0 110.877 176.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.46 170.78 18.77 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 129.649 3.18 . . . . 0.0 108.624 164.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -68.94 136.41 52.5 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 177.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -133.17 124.26 27.13 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 171.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 53.1 m -99.34 137.79 37.35 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 166.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 24.8 p -138.03 148.04 44.71 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 118.164 0.438 . . . . 0.0 110.101 167.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -112.11 126.03 54.74 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 171.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 17.6 mm -95.55 122.39 46.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 129.499 3.119 . . . . 0.0 107.47 -173.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -105.53 -27.55 11.33 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -175.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -164.86 156.64 15.46 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.508 1.123 . . . . 0.0 108.27 177.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.17 177.87 44.63 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.976 1.274 . . . . 0.0 112.205 -177.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.405 ' HE3' ' O ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -135.61 139.03 43.51 Favored 'General case' 0 CA--C 1.515 -0.378 0 O-C-N 121.618 -0.931 . . . . 0.0 108.857 -170.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.405 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 55.1 t -136.19 146.07 29.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 178.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -112.58 116.82 30.81 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 102.998 -2.964 . . . . 0.0 102.998 156.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.4 t -91.04 122.33 42.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 164.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 57.9 m -123.67 105.78 10.0 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 119.664 1.12 . . . . 0.0 108.386 -172.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 32.5 p -69.75 171.97 8.31 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -80.2 -11.2 59.76 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 120.264 -1.523 . . . . 0.0 112.267 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -65.05 -10.76 32.58 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.011 -1.056 . . . . 0.0 112.076 162.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.86 -9.24 77.93 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 125.115 1.34 . . . . 0.0 112.549 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -61.19 124.01 19.33 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 124.957 1.303 . . . . 0.0 108.134 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.96 127.86 46.11 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 125.322 1.449 . . . . 0.0 108.229 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -124.21 84.01 2.22 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 124.478 2.085 . . . . 0.0 107.1 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.5 p -72.87 148.29 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 111.138 -2.756 . . . . 0.0 109.454 162.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.6 pt -148.31 125.23 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 C-N-CA 126.837 2.055 . . . . 0.0 106.528 -175.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -88.3 178.58 6.55 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 122.454 1.121 . . . . 0.0 109.932 167.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -63.95 54.45 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 130.798 3.639 . . . . 0.0 115.525 176.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 173.64 -13.69 0.04 OUTLIER Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.731 1.634 . . . . 0.0 112.846 176.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -69.09 101.75 1.49 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.222 1.511 . . . . 0.0 108.739 176.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.4 tp -74.81 141.17 44.33 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 175.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.4 t -123.78 160.32 27.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 C-N-CA 123.818 0.847 . . . . 0.0 109.076 -175.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.6 m -143.24 109.94 5.51 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 161.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -80.04 148.37 67.79 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 169.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -87.22 178.57 3.45 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.624 2.216 . . . . 0.0 111.877 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -85.45 83.43 7.94 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.372 1.469 . . . . 0.0 107.524 173.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.8 79.18 0.21 Allowed Glycine 0 CA--C 1.532 1.096 0 C-N-CA 126.749 2.118 . . . . 0.0 111.142 175.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.1 tt -147.92 117.45 7.01 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.978 1.389 . . . . 0.0 111.467 175.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.5 tpp85 -85.92 133.8 33.92 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.945 0.898 . . . . 0.0 109.721 161.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 28.6 p -150.66 178.19 9.34 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.657 0.783 . . . . 0.0 112.973 166.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.401 ' HA ' ' HA ' ' A' ' 32' ' ' ASP . 0.2 OUTLIER -96.2 160.51 14.4 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 124.648 1.179 . . . . 0.0 109.295 167.656 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 2.5 m95 -132.36 117.32 17.97 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 173.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -104.68 112.09 25.04 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 168.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.6 t -81.26 91.3 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 103.833 -2.654 . . . . 0.0 103.833 171.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.7 mt -71.06 -33.83 70.63 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.214 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -142.3 147.01 41.81 Favored Pre-proline 0 C--O 1.234 0.237 0 CA-C-O 117.479 -1.248 . . . . 0.0 108.224 171.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -62.47 94.91 0.14 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 125.072 3.848 . . . . 0.0 110.896 -165.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.1 p -78.3 146.95 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.853 -167.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.01 114.5 17.18 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 169.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.483 ' HE3' ' CZ3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -131.17 139.68 49.79 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 123.164 0.586 . . . . 0.0 109.495 -179.262 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -81.9 114.78 20.73 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 170.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -102.18 165.18 11.29 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.642 1.11 . . . . 0.0 110.013 174.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -152.0 150.82 30.41 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.725 0.693 . . . . 0.0 109.82 163.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 39.0 mt -108.76 147.05 32.59 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.78 1.232 . . . . 0.0 108.751 -174.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.2 p90 . . . . . 0 C--O 1.253 1.244 0 C-N-CA 126.164 1.785 . . . . 0.0 110.035 -179.497 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.5 t . . . . . 0 N--CA 1.446 -0.638 0 CA-C-O 121.794 0.807 . . . . 0.0 112.116 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.9 tttt -69.78 125.3 26.34 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 174.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.0 mt -130.9 135.92 59.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 105.069 -2.196 . . . . 0.0 105.069 172.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -158.6 174.14 15.51 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.838 1.655 . . . . 0.0 109.425 167.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.41 85.0 15.37 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 119.197 0.908 . . . . 0.0 108.799 177.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -65.31 163.16 30.4 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.728 2.952 . . . . 0.0 111.902 -172.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 t -66.98 142.69 97.52 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 175.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -72.54 -16.51 27.16 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.114 1.876 . . . . 0.0 113.73 -178.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -52.54 -62.87 1.37 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.828 0.851 . . . . 0.0 109.022 170.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 48.8 tptt -53.82 -37.06 63.19 Favored 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 124.921 1.288 . . . . 0.0 111.213 -176.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -65.17 -37.19 86.58 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.67 0.788 . . . . 0.0 111.003 -178.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -48.48 72.39 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 117.712 -1.137 . . . . 0.0 108.407 176.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -53.26 -49.17 67.46 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.454 1.102 . . . . 0.0 110.414 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.1 mp -52.24 -15.57 0.63 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 126.616 1.967 . . . . 0.0 113.903 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.431 ' HB3' ' HE3' ' A' ' 20' ' ' LYS . 23.7 m 66.1 30.54 9.38 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.473 1.509 . . . . 0.0 110.783 175.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.5 t -55.16 -30.18 23.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.205 0 C-N-CA 125.159 1.384 . . . . 0.0 111.616 -178.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -55.01 -28.04 48.92 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.407 1.003 . . . . 0.0 112.867 173.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.431 ' HE3' ' HB3' ' A' ' 17' ' ' SER . 5.8 mtmp? -88.92 -23.55 22.68 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 124.742 1.217 . . . . 0.0 111.287 -176.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 37.5 m0 -61.21 156.94 46.97 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 123.26 0.624 . . . . 0.0 109.326 -174.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -71.32 121.47 7.8 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.235 1.957 . . . . 0.0 112.309 -175.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.1 mt -62.51 145.56 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 O-C-N 121.106 -0.996 . . . . 0.0 108.612 176.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.471 ' CE3' ' HE2' ' A' ' 84' ' ' LYS . 81.9 t90 -141.82 148.46 38.89 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 122.171 0.986 . . . . 0.0 108.721 161.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -140.17 168.39 19.91 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 128.286 2.634 . . . . 0.0 107.616 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.448 ' HE3' ' CD1' ' A' ' 31' ' ' PHE . 6.2 tmtt? -149.01 158.29 44.07 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 168.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -58.11 172.44 0.43 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 123.142 1.449 . . . . 0.0 111.09 171.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.6 p -76.31 65.78 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 112.388 -2.187 . . . . 0.0 108.901 169.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.92 156.35 41.0 Favored 'General case' 0 CA--C 1.507 -0.706 0 O-C-N 120.555 -1.341 . . . . 0.0 109.888 172.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -78.14 165.51 23.87 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 113.233 -1.803 . . . . 0.0 109.469 -178.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.448 ' CD1' ' HE3' ' A' ' 26' ' ' LYS . 6.7 p90 -163.65 -173.18 3.17 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 164.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -126.67 140.28 52.52 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 163.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 15.5 t-105 -113.87 140.29 48.47 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.163 -174.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -106.31 111.89 24.68 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 168.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -85.08 119.97 26.06 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 172.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.37 -5.6 9.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 117.854 -1.07 . . . . 0.0 113.613 -158.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 p -141.12 175.08 9.92 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 131.293 3.837 . . . . 0.0 106.853 164.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -67.84 129.35 39.63 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -135.46 107.22 7.01 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -176.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 89.1 m -75.77 142.91 42.23 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 166.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 19.8 p -138.46 146.49 42.15 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 119.5 1.045 . . . . 0.0 110.917 158.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -117.09 112.67 21.22 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 126.414 1.886 . . . . 0.0 107.457 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 29.4 mm -80.22 131.48 33.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -176.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.451 ' CD1' ' HD1' ' A' ' 85' ' ' HIS . 1.8 mp -114.01 -26.62 8.03 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 118.759 -0.639 . . . . 0.0 112.26 178.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -163.43 152.36 14.31 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 118.813 0.733 . . . . 0.0 109.849 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.48 -177.27 21.32 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.721 1.629 . . . . 0.0 112.766 -176.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.54 142.93 45.47 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.11 1.364 . . . . 0.0 107.489 171.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.543 ' CG1' HG13 ' A' ' 60' ' ' ILE 0.634 0.2 OUTLIER -133.89 137.02 53.1 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.309 0 C-N-CA 129.648 3.179 . . . . 0.0 117.067 -176.139 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -125.46 112.68 16.54 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 125.197 1.561 . . . . 0.0 109.157 158.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 70.5 t -91.99 139.57 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 166.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 90.5 m -136.28 115.52 12.55 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 177.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.5 p -72.21 178.57 3.8 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.812 1.245 . . . . 0.0 110.913 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -54.55 -34.17 61.35 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.182 0.593 . . . . 0.0 110.468 170.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.49 1.31 26.16 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.966 2.506 . . . . 0.0 113.124 -171.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.17 3.63 46.3 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 118.745 0.702 . . . . 0.0 114.6 177.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.422 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 6.0 mmpt? -65.42 111.8 3.24 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 166.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.41 150.18 46.51 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 164.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -135.97 118.87 16.26 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 170.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.8 t -89.21 132.09 34.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.543 HG13 ' CG1' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -126.26 136.93 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 174.638 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -138.97 -179.01 5.58 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 172.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.3 81.24 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.192 1.797 . . . . 0.0 111.773 177.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 137.45 11.47 1.0 Allowed Glycine 0 CA--C 1.525 0.708 0 CA-C-O 117.882 -1.51 . . . . 0.0 114.593 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -107.69 134.97 49.91 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 164.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.06 153.66 17.66 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 165.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 36.4 t -133.46 150.24 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 124.057 0.943 . . . . 0.0 109.218 177.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.8 m -133.43 120.24 20.65 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.19 0.996 . . . . 0.0 108.312 162.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -83.28 156.57 66.17 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 125.302 1.441 . . . . 0.0 109.514 170.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -83.96 175.16 7.85 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.5 2.133 . . . . 0.0 109.818 174.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -78.03 102.19 7.29 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 166.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.78 80.79 1.54 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.391 0.996 . . . . 0.0 112.196 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 51.5 tp -141.77 155.45 45.61 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 126.024 1.73 . . . . 0.0 108.374 169.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.81 140.43 45.86 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 126.952 2.101 . . . . 0.0 106.722 175.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 3.9 p -168.73 161.09 11.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 118.55 0.614 . . . . 0.0 110.117 173.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.6 159.33 32.17 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.997 164.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -123.57 136.79 54.72 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 163.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -119.48 97.51 5.68 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 167.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.7 t -73.95 97.21 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.505 0 N-CA-C 103.45 -2.796 . . . . 0.0 103.45 169.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 68.1 mt -72.43 -31.21 65.3 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 119.058 -1.057 . . . . 0.0 108.957 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -143.17 144.34 28.22 Favored Pre-proline 0 N--CA 1.452 -0.339 0 CA-C-O 116.881 -1.533 . . . . 0.0 107.189 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -62.93 98.35 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 124.144 3.229 . . . . 0.0 110.2 -165.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.9 p -74.29 158.6 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.697 -171.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -139.02 120.5 15.01 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 168.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.471 ' HE2' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -131.38 154.29 48.77 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 -178.007 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.451 ' HD1' ' CD1' ' A' ' 44' ' ' LEU . 14.3 m80 -94.06 102.25 14.31 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 167.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -88.61 157.48 18.57 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.906 0.883 . . . . 0.0 110.271 171.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -154.58 122.18 5.78 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 121.333 -0.854 . . . . 0.0 110.403 167.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.6 mt -69.82 157.47 37.3 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.051 1.34 . . . . 0.0 109.335 176.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.251 1.17 0 CA-C-O 115.43 -2.224 . . . . 0.0 108.159 163.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 75.9 t . . . . . 0 C--O 1.235 0.323 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -88.85 139.63 30.26 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 166.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.6 mt -132.73 134.56 58.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 162.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -161.56 176.98 10.46 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.823 1.649 . . . . 0.0 109.199 166.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.38 86.0 3.16 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.777 1.231 . . . . 0.0 110.354 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -64.5 171.49 8.06 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.819 2.346 . . . . 0.0 112.683 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 38.4 p -73.05 146.73 87.65 Favored Pre-proline 0 CA--C 1.536 0.404 0 O-C-N 121.571 -0.706 . . . . 0.0 109.536 173.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -70.45 -25.21 25.65 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.528 1.485 . . . . 0.0 112.198 -178.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -64.13 -45.18 89.67 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.616 0.644 . . . . 0.0 110.369 172.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.3 tptm -57.56 -33.9 68.62 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.846 0.748 . . . . 0.0 110.544 177.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -74.28 -15.06 60.98 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.232 0.613 . . . . 0.0 112.53 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -77.36 -39.73 46.42 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.726 1.148 . . . . 0.0 109.051 164.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -70.85 -20.92 62.49 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 118.254 0.479 . . . . 0.0 112.262 -176.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 mp -78.9 1.93 21.9 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-O 117.474 -1.251 . . . . 0.0 112.611 176.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.7 p 57.99 21.51 7.85 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.155 1.382 . . . . 0.0 114.2 -177.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.9 t -57.87 -37.58 61.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 CA-C-N 119.659 1.118 . . . . 0.0 111.837 -163.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -53.37 -24.63 12.73 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.936 0.895 . . . . 0.0 113.312 175.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.5 mttm -88.43 -25.16 22.79 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 117.677 -1.154 . . . . 0.0 111.153 -177.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 38.7 m0 -61.24 164.74 7.84 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 126.141 1.777 . . . . 0.0 110.261 -175.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.05 140.72 55.24 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 CA-C-N 121.52 1.579 . . . . 0.0 111.165 173.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.8 mt -85.6 155.51 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 169.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 27.8 t90 -141.76 133.93 27.76 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 164.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -138.25 132.88 32.43 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 126.807 2.043 . . . . 0.0 106.82 -177.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -134.27 169.6 16.96 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 121.384 -0.823 . . . . 0.0 110.062 -170.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.481 ' CD ' ' H ' ' A' ' 28' ' ' VAL . 1.4 tm-20 -72.7 177.54 4.71 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 122.755 1.264 . . . . 0.0 111.039 172.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.481 ' H ' ' CD ' ' A' ' 27' ' ' GLU . 16.3 t -102.24 45.87 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 127.351 2.26 . . . . 0.0 108.432 -165.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.7 t -108.52 -175.29 2.73 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 128.076 2.55 . . . . 0.0 108.682 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -109.05 163.26 13.48 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.803 0.811 . . . . 0.0 110.5 159.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -151.14 -164.73 2.08 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 163.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -142.05 148.36 38.33 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 126.095 1.758 . . . . 0.0 106.858 177.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 47.1 t-105 -135.13 145.89 48.28 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.129 0.572 . . . . 0.0 111.804 -172.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -112.54 109.76 19.52 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.543 1.537 . . . . 0.0 107.781 166.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -79.16 95.3 5.56 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 171.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -88.01 18.61 4.11 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.472 1.033 . . . . 0.0 110.4 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -168.31 164.26 13.01 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.779 1.631 . . . . 0.0 109.838 176.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -58.43 103.12 0.13 Allowed 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 126.903 2.081 . . . . 0.0 107.561 174.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -105.97 125.14 50.64 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 166.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 85.6 m -99.54 146.52 26.32 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 168.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 20.9 p -146.67 161.3 40.87 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 118.59 0.632 . . . . 0.0 110.643 164.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -129.63 106.2 8.57 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.494 1.518 . . . . 0.0 108.556 -176.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 26.0 mm -80.45 116.38 24.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 O-C-N 122.011 -0.43 . . . . 0.0 109.937 -169.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.5 mt -92.37 -32.46 14.95 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 117.875 -1.06 . . . . 0.0 112.951 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -165.8 163.58 18.8 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 118.953 0.797 . . . . 0.0 109.245 -173.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.09 -176.6 53.86 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.985 1.279 . . . . 0.0 111.825 -176.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.494 ' HE2' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -139.29 139.1 37.25 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 -171.482 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 76.8 t -136.13 158.24 38.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -131.72 97.44 4.21 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 127.155 2.182 . . . . 0.0 106.799 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . 0.727 0.1 OUTLIER -93.34 71.2 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 C-N-CA 130.822 3.649 . . . . 0.0 118.414 163.322 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 14.9 m -73.46 113.32 10.42 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 164.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.6 p -67.93 169.97 8.99 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 171.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -65.25 -22.3 66.85 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.786 -1.196 . . . . 0.0 110.08 170.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -77.73 3.39 14.19 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.286 1.834 . . . . 0.0 111.481 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.69 -9.1 8.87 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.01 1.29 . . . . 0.0 113.053 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -66.07 108.98 2.41 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 119.502 1.651 . . . . 0.0 106.834 171.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -88.64 131.78 34.84 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 124.214 0.946 . . . . 0.0 109.705 179.13 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.6 m-30 -115.54 85.08 2.21 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 127.685 2.394 . . . . 0.0 105.896 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 71.3 t -66.35 128.34 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 N-CA-C 103.981 -2.6 . . . . 0.0 103.981 156.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.7 pt -128.6 138.88 53.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 169.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -123.97 179.9 4.66 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.188 1.795 . . . . 0.0 107.137 -170.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.0 pttp -73.67 60.85 0.71 Allowed 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 124.988 1.315 . . . . 0.0 112.92 -173.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 164.41 34.36 0.02 OUTLIER Glycine 0 C--N 1.317 -0.524 0 O-C-N 120.15 -1.594 . . . . 0.0 112.458 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -122.18 139.37 53.83 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 118.961 1.38 . . . . 0.0 107.808 175.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.9 tp -94.57 141.09 29.0 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 164.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.5 t -126.35 139.65 51.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 175.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 46.2 m -120.71 102.64 8.53 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 165.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -70.41 151.61 95.64 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 169.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -75.74 -164.53 0.25 Allowed 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.692 2.928 . . . . 0.0 110.077 175.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -98.44 129.14 45.06 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 161.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.52 83.9 0.47 Allowed Glycine 0 CA--C 1.535 1.305 0 C-N-CA 127.494 2.473 . . . . 0.0 113.984 -178.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.6 tt -142.87 130.61 21.46 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 126.909 2.084 . . . . 0.0 108.213 171.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.83 128.09 55.65 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.977 0.911 . . . . 0.0 108.867 171.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 27.4 p -149.24 173.81 13.07 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.634 -0.667 . . . . 0.0 111.088 178.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.19 -178.04 4.86 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 118.386 -0.816 . . . . 0.0 111.079 166.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -155.46 90.4 1.25 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.801 1.24 . . . . 0.0 107.785 172.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -83.86 118.42 23.95 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 172.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.5 t -88.58 94.97 4.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 103.779 -2.674 . . . . 0.0 103.779 167.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.494 HD13 ' HE2' ' A' ' 47' ' ' LYS . 26.7 mt -71.02 -29.23 65.11 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 117.522 -1.228 . . . . 0.0 110.109 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -149.01 148.37 26.91 Favored Pre-proline 0 N--CA 1.453 -0.303 0 C-N-CA 125.143 1.377 . . . . 0.0 108.988 175.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -59.88 105.81 0.29 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 124.559 3.506 . . . . 0.0 109.602 -167.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.9 p -84.36 149.41 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -174.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.7 130.06 46.63 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 164.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.79 146.91 34.69 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 174.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -73.17 127.96 34.11 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 148.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -113.64 164.17 14.03 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 166.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -153.37 150.51 28.93 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 165.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 93.7 mt -101.63 161.45 13.64 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.641 1.176 . . . . 0.0 108.209 177.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 11.1 p90 . . . . . 0 C--O 1.246 0.915 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 159.868 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.7 t . . . . . 0 CA--C 1.536 0.427 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.2 tttt -129.78 89.71 2.86 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.6 mt -86.93 143.9 10.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 176.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -149.11 178.97 8.25 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 122.625 0.37 . . . . 0.0 110.074 154.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . 0.37 0.5 OUTLIER -128.5 85.01 61.47 Favored Pre-proline 0 N--CA 1.451 -0.411 0 O-C-N 121.179 -0.951 . . . . 0.0 111.855 -178.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -81.31 168.7 16.47 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 125.163 3.908 . . . . 0.0 113.517 -169.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.7 t -66.22 143.66 98.42 Favored Pre-proline 0 C--N 1.331 -0.202 0 C-N-CA 126.584 1.954 . . . . 0.0 109.188 172.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -71.01 -21.27 27.91 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.741 1.628 . . . . 0.0 112.166 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.84 -60.36 3.95 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.444 1.098 . . . . 0.0 109.131 -178.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.7 tttt -58.92 -29.7 67.29 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.008 -1.057 . . . . 0.0 111.606 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -71.3 -38.4 71.78 Favored 'General case' 0 C--N 1.334 -0.107 0 O-C-N 121.367 -0.833 . . . . 0.0 110.854 177.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -56.56 -53.55 56.22 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 119.426 1.012 . . . . 0.0 109.142 167.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -57.2 -39.78 76.11 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.266 0.626 . . . . 0.0 111.489 -174.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.43 -10.77 2.31 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.28 2.232 . . . . 0.0 115.266 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 63.4 m 57.32 43.85 22.76 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.929 1.292 . . . . 0.0 111.715 -177.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.415 ' HA ' ' CD2' ' A' ' 21' ' ' TRP . 54.8 t -56.05 -36.49 45.09 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 C-N-CA 126.699 2.0 . . . . 0.0 111.051 174.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -61.52 -13.49 21.69 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 176.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.5 mtpp -95.88 -10.98 27.47 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.467 1.107 . . . . 0.0 111.474 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.415 ' CD2' ' HA ' ' A' ' 18' ' ' VAL . 30.4 m0 -72.86 163.42 68.43 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 178.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -66.7 137.71 46.69 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 121.752 1.635 . . . . 0.0 110.736 170.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 81.4 mt -72.46 152.8 7.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 161.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 14.6 t90 -137.81 150.93 47.61 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 161.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -151.18 156.84 41.78 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.738 1.215 . . . . 0.0 110.465 -178.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.512 ' HE3' ' CE2' ' A' ' 31' ' ' PHE . 16.7 tptp -153.71 162.2 41.45 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 124.598 1.159 . . . . 0.0 108.67 -167.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.408 ' C ' ' H ' ' A' ' 29' ' ' SER . 3.6 tp10 -88.41 -178.07 5.78 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.126 0.971 . . . . 0.0 108.744 175.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.5 p -68.77 8.72 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 127.718 2.407 . . . . 0.0 113.16 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.408 ' H ' ' C ' ' A' ' 27' ' ' GLU . 4.3 p -85.93 124.71 32.7 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 126.417 1.887 . . . . 0.0 111.12 -173.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -79.28 152.62 30.44 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 124.288 0.993 . . . . 0.0 109.713 175.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.512 ' CE2' ' HE3' ' A' ' 26' ' ' LYS . 11.9 p90 -156.51 -170.83 3.47 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 176.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.7 121.0 33.43 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 127.542 2.337 . . . . 0.0 107.233 172.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 43.9 t-105 -109.17 155.77 20.65 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 123.743 0.652 . . . . 0.0 111.012 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -122.61 133.24 54.54 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.68 1.592 . . . . 0.0 110.437 175.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -105.37 108.17 19.55 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 175.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -101.14 4.11 41.78 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.006 1.322 . . . . 0.0 111.061 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.84 163.89 36.82 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 128.112 2.565 . . . . 0.0 108.055 170.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.66 142.0 57.59 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 175.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -147.36 136.99 22.84 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 -176.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.8 m -114.96 121.25 42.59 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 174.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 9.1 p -121.85 145.07 48.44 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.448 0.642 . . . . 0.0 109.357 173.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -121.69 109.1 14.33 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 127.401 2.28 . . . . 0.0 107.032 -175.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.6 mm -69.37 138.49 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 124.831 1.252 . . . . 0.0 107.887 175.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 mp -125.09 -32.19 3.02 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 122.795 0.438 . . . . 0.0 110.845 176.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -138.87 171.75 13.87 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.768 0.827 . . . . 0.0 108.875 168.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.71 -179.77 30.43 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 116.608 1.403 . . . . 0.0 116.608 167.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.423 ' HE2' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -140.07 151.39 45.35 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 127.924 2.49 . . . . 0.0 111.485 170.864 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.496 ' CG1' HG13 ' A' ' 60' ' ' ILE 0.421 0.2 OUTLIER -146.43 146.91 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 1 C-N-CA 133.253 4.621 . . . . 0.0 113.288 -174.914 . . . . . . . . 5 4 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -120.16 149.91 41.48 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.242 145.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.3 t -127.2 101.08 7.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 170.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.5 m -79.32 112.77 16.88 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 166.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.4 p -73.58 161.59 30.16 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 165.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -55.97 -35.58 66.89 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.801 -0.562 . . . . 0.0 111.182 -175.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -68.88 -1.79 8.1 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.054 1.742 . . . . 0.0 113.456 -174.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.66 -14.11 57.78 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 125.802 1.668 . . . . 0.0 112.472 172.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.2 mttt -71.35 123.01 21.34 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 118.809 1.304 . . . . 0.0 109.729 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.82 147.4 26.32 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 168.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -132.12 105.88 7.64 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 170.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 70.9 t -74.94 117.4 19.09 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 172.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.496 HG13 ' CG1' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -108.99 141.09 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-N 118.852 0.751 . . . . 0.0 109.956 175.804 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -145.59 -175.62 4.8 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-O 122.114 0.959 . . . . 0.0 112.607 171.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.3 pttm -57.49 65.24 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 130.528 3.531 . . . . 0.0 112.8 177.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 156.64 2.12 0.1 OUTLIER Glycine 0 CA--C 1.531 1.091 0 CA-C-O 117.323 -1.821 . . . . 0.0 115.636 -158.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -129.33 110.39 11.89 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.899 2.079 . . . . 0.0 107.286 177.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.6 tp -74.82 143.13 44.08 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 120.154 -1.591 . . . . 0.0 107.407 167.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 32.9 t -133.49 128.84 55.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 119.422 1.01 . . . . 0.0 109.676 175.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.8 m -99.16 140.21 33.66 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 160.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -104.83 156.56 35.81 Favored Pre-proline 0 C--O 1.236 0.39 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 163.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -79.65 175.33 10.72 Favored 'Trans proline' 0 N--CA 1.445 -1.348 0 N-CA-C 108.773 -1.28 . . . . 0.0 108.773 174.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -81.81 94.04 6.97 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 166.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 114.46 85.73 1.35 Allowed Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.67 1.605 . . . . 0.0 111.789 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 56.9 tp -162.0 135.08 6.11 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.314 1.557 . . . . 0.0 110.301 170.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.68 85.69 2.41 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 120.11 1.323 . . . . 0.0 112.381 -174.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 61.0 m -121.81 165.82 15.28 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 119.627 -1.921 . . . . 0.0 110.766 -173.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.6 163.07 26.32 Favored 'General case' 0 CA--C 1.515 -0.4 0 O-C-N 121.984 -0.447 . . . . 0.0 111.072 177.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -138.07 102.12 4.6 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.041 1.736 . . . . 0.0 106.875 173.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.32 100.56 12.38 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 168.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.9 t -80.24 92.91 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 103.404 -2.814 . . . . 0.0 103.404 172.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.423 HD13 ' HE2' ' A' ' 47' ' ' LYS . 82.5 mt -69.0 -29.11 67.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.171 178.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -141.06 165.62 28.05 Favored Pre-proline 0 N--CA 1.452 -0.373 0 C-N-CA 125.292 1.437 . . . . 0.0 108.884 176.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -61.35 116.87 3.68 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 123.899 3.066 . . . . 0.0 110.786 169.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.9 p -110.41 143.36 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 -177.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -124.99 29.66 6.08 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.755 0.707 . . . . 0.0 112.83 -168.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.27 161.33 4.37 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.338 1.455 . . . . 0.0 113.28 -159.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.3 m80 -89.05 130.1 35.57 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 163.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -121.39 154.52 36.39 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.42 1.009 . . . . 0.0 108.707 172.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -143.98 116.69 8.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 17.9 mt -71.77 140.07 49.31 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 125.417 1.487 . . . . 0.0 107.092 172.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.248 0.982 0 CA-C-O 117.143 -1.408 . . . . 0.0 109.316 172.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.2 p . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -134.05 152.05 51.68 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.444 1.498 . . . . 0.0 108.009 172.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 93.6 mt -131.71 137.06 55.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 165.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -141.18 172.74 12.27 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 117.841 0.291 . . . . 0.0 110.982 160.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.447 ' HZ2' ' CG ' ' A' ' 64' ' ' ASP . 0.3 OUTLIER -112.22 84.94 6.34 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 171.435 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -76.01 176.55 9.88 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.883 3.056 . . . . 0.0 112.188 -169.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.66 144.48 97.6 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 170.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -70.27 -25.25 26.43 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.857 2.371 . . . . 0.0 111.887 172.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -75.32 -45.17 41.3 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 119.357 0.981 . . . . 0.0 110.362 -171.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.96 -44.14 70.49 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.912 0.778 . . . . 0.0 110.019 174.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.3 mt -62.24 -27.53 69.06 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 118.924 -0.56 . . . . 0.0 112.233 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -63.21 -47.59 81.9 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 119.748 1.158 . . . . 0.0 109.106 172.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -68.0 -43.2 79.4 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 124.402 1.064 . . . . 0.0 110.088 -169.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 18.5 mt -53.36 -20.5 4.53 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.183 0.993 . . . . 0.0 112.016 174.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.8 m 69.85 45.7 0.73 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 127.496 2.318 . . . . 0.0 109.398 172.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.7 t -55.19 -32.67 28.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 126.105 1.762 . . . . 0.0 112.014 -175.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -65.6 -21.76 66.61 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.634 -1.291 . . . . 0.0 113.413 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.3 mttt -78.73 -15.13 58.83 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.019 0.928 . . . . 0.0 110.979 175.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 16.3 m0 -75.68 159.99 80.14 Favored Pre-proline 0 N--CA 1.445 -0.705 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 176.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -64.97 139.14 60.3 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 121.545 1.497 . . . . 0.0 111.777 175.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 57.7 mt -76.21 147.69 7.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 163.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.47 ' CZ3' ' HE3' ' A' ' 84' ' ' LYS . 9.0 t90 -147.39 149.59 33.04 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 164.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -133.36 166.31 22.8 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 127.262 2.225 . . . . 0.0 106.351 -177.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -148.98 163.85 36.3 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 120.572 -1.33 . . . . 0.0 108.803 163.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.74 -172.88 3.19 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 125.348 1.459 . . . . 0.0 109.916 -178.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.3 p -77.34 -5.09 7.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 125.772 1.629 . . . . 0.0 113.636 178.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.97 176.67 4.85 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.02 1.328 . . . . 0.0 110.886 176.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -137.45 157.34 46.77 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.141 -0.974 . . . . 0.0 109.324 -174.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -164.82 -164.3 0.79 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.118 1.367 . . . . 0.0 108.88 -168.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -133.12 160.91 35.83 Favored 'General case' 0 C--O 1.242 0.703 0 O-C-N 120.89 -1.131 . . . . 0.0 108.822 165.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 67.3 t-105 -135.74 146.73 47.98 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.746 0.818 . . . . 0.0 109.811 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -115.69 94.56 4.74 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.712 1.605 . . . . 0.0 107.059 -177.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -65.72 115.01 5.43 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 168.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -108.53 -1.0 20.05 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.408 1.083 . . . . 0.0 111.734 174.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.433 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -144.06 171.42 14.28 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 127.542 2.337 . . . . 0.0 112.331 174.871 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -62.95 108.88 1.3 Allowed 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 103.765 -2.68 . . . . 0.0 103.765 168.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -126.94 80.87 1.98 Allowed 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 -173.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 81.7 m -64.51 152.21 42.38 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 25.4 p -144.93 150.01 36.25 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.458 163.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -122.6 108.27 12.92 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.572 1.549 . . . . 0.0 106.839 175.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.3 mm -64.54 138.21 23.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 127.217 2.207 . . . . 0.0 107.601 172.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 mp -128.05 -26.38 2.89 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 123.28 0.362 . . . . 0.0 111.188 173.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -153.46 158.15 40.94 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.634 1.174 . . . . 0.0 108.188 172.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.69 -178.93 52.38 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.321 0.962 . . . . 0.0 112.111 -175.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.79 146.1 27.87 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -168.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.3 t -137.31 156.57 33.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.319 0.581 . . . . 0.0 109.773 175.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -119.39 110.51 17.03 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.612 1.965 . . . . 0.0 106.872 160.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.7 t -94.16 111.32 25.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 170.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.5 m -112.22 113.19 25.29 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -173.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.9 p -75.4 170.16 16.64 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 122.122 0.963 . . . . 0.0 111.931 -170.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -60.35 -29.9 69.2 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.342 167.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -82.26 8.98 9.71 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.688 1.595 . . . . 0.0 111.547 175.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.1 -2.06 21.25 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 125.55 1.548 . . . . 0.0 114.814 175.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -64.17 136.98 57.72 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.4 mttp -93.33 153.13 18.73 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 121.892 0.853 . . . . 0.0 110.089 162.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -125.73 100.62 6.5 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 102.801 -3.037 . . . . 0.0 102.801 162.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.0 t -81.24 142.73 13.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 167.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 pt -148.01 119.77 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.488 0 C-N-CA 124.314 1.046 . . . . 0.0 108.197 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -80.07 177.44 8.93 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-O 122.196 0.998 . . . . 0.0 110.918 171.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.1 pttt -68.01 45.5 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 131.366 3.866 . . . . 0.0 115.103 178.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -174.41 -7.06 0.02 OUTLIER Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.033 0.825 . . . . 0.0 113.417 178.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.447 ' CG ' ' HZ2' ' A' ' 7' ' ' LYS . 11.5 m-20 -79.16 99.87 7.18 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.102 1.361 . . . . 0.0 111.337 -173.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.3 tp -64.36 136.84 57.52 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.95 1.25 . . . . 0.0 107.636 177.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.1 t -121.32 154.68 25.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 123.865 0.866 . . . . 0.0 108.952 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 67.0 m -143.65 121.36 11.87 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 160.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -87.78 164.58 33.75 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 126.483 1.913 . . . . 0.0 108.879 169.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -79.68 174.8 11.3 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 CA-C-O 122.974 1.156 . . . . 0.0 110.469 170.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.433 ' HG3' ' HA ' ' A' ' 37' ' ' THR . 36.0 tttm -80.18 88.73 5.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.446 -1.707 . . . . 0.0 106.887 173.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 116.66 85.1 1.13 Allowed Glycine 0 CA--C 1.527 0.797 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -176.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 62.1 tp -147.2 141.06 25.8 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.198 1.399 . . . . 0.0 108.848 166.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.5 ptt85 -136.93 103.89 5.3 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.417 1.487 . . . . 0.0 108.453 -176.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 86.0 m -148.61 164.42 34.34 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 125.264 1.426 . . . . 0.0 110.103 -175.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.58 163.01 22.18 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 124.452 1.101 . . . . 0.0 112.035 177.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -148.2 99.59 3.07 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.575 1.95 . . . . 0.0 107.372 -168.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 42.7 tttp -110.96 111.8 23.18 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 -176.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.1 t -87.34 111.68 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 104.264 -2.495 . . . . 0.0 104.264 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 20.6 mt -91.1 -24.04 20.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 118.782 -0.628 . . . . 0.0 109.836 177.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -148.75 152.36 37.31 Favored Pre-proline 0 C--O 1.236 0.384 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 168.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.41 91.69 0.77 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.377 2.718 . . . . 0.0 111.514 -153.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.8 p -69.51 105.82 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.017 -165.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -91.08 116.63 28.95 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 105.215 -2.142 . . . . 0.0 105.215 168.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.47 ' HE3' ' CZ3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -127.58 172.06 11.07 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 122.306 1.051 . . . . 0.0 108.382 175.277 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -113.22 122.77 48.47 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 102.578 -3.119 . . . . 0.0 102.578 168.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -117.89 157.03 27.4 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -152.4 134.83 15.19 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 118.71 0.686 . . . . 0.0 110.024 176.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 65.8 mt -94.45 125.48 39.13 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.401 1.88 . . . . 0.0 107.149 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.4 p90 . . . . . 0 C--O 1.247 0.968 0 C-N-CA 123.96 0.904 . . . . 0.0 110.361 -171.509 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 94.2 t . . . . . 0 CA--C 1.535 0.376 0 CA-C-O 121.41 0.624 . . . . 0.0 112.633 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -100.05 119.49 38.38 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.965 0.906 . . . . 0.0 109.148 -173.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.3 mt -139.81 132.47 35.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 C-N-CA 124.792 1.237 . . . . 0.0 108.022 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -143.97 176.66 9.11 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.483 1.513 . . . . 0.0 110.271 171.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.76 85.77 5.2 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 124.562 1.145 . . . . 0.0 108.151 173.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.09 157.64 60.92 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.442 2.095 . . . . 0.0 111.881 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.9 t -57.42 144.3 71.83 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 124.508 1.123 . . . . 0.0 109.19 169.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.58 -31.21 27.22 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.538 1.492 . . . . 0.0 112.735 -177.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -59.84 -42.72 94.21 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 119.407 1.003 . . . . 0.0 110.729 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.1 tptt -56.49 -41.37 76.53 Favored 'General case' 0 C--O 1.226 -0.167 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -69.9 -32.07 70.19 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.872 1.269 . . . . 0.0 111.511 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -61.46 -49.11 78.12 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 168.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -62.73 -47.99 81.19 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.373 0.533 . . . . 0.0 111.047 -176.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.7 mt -58.78 -7.34 0.97 Allowed 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 125.955 1.702 . . . . 0.0 112.662 -175.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.7 m 74.03 29.22 1.4 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.17 1.788 . . . . 0.0 110.402 165.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.9 t -57.01 -27.45 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 126.371 1.868 . . . . 0.0 112.499 -172.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -59.45 -28.41 66.94 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.828 1.194 . . . . 0.0 113.015 172.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.6 mttm -84.69 -13.21 52.09 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.632 1.173 . . . . 0.0 111.066 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.441 ' CE3' ' HB2' ' A' ' 87' ' ' ASN . 36.5 m0 -74.8 158.9 84.2 Favored Pre-proline 0 N--CA 1.448 -0.527 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -175.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.58 136.79 43.97 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 121.531 1.487 . . . . 0.0 111.44 175.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.1 mt -72.22 149.96 8.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 125.197 1.399 . . . . 0.0 109.332 166.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.407 ' CZ3' ' HE3' ' A' ' 84' ' ' LYS . 87.7 t90 -142.23 112.23 6.92 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 160.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.14 168.4 12.8 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.975 1.31 . . . . 0.0 110.576 164.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.3 tptt -155.94 162.45 40.38 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 120.647 -1.283 . . . . 0.0 109.841 165.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.27 170.59 15.27 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.204 1.001 . . . . 0.0 111.27 172.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.9 p -81.16 71.18 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 127.205 2.202 . . . . 0.0 109.463 175.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.91 -171.14 2.66 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 120.972 -1.08 . . . . 0.0 109.708 -177.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -130.89 154.14 48.39 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.003 -1.06 . . . . 0.0 108.845 170.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -160.6 -167.67 1.93 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.718 1.207 . . . . 0.0 108.511 173.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -121.1 152.52 38.59 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 125.012 1.325 . . . . 0.0 107.896 169.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 25.7 t-105 -136.26 151.97 50.22 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.557 0.218 . . . . 0.0 111.002 178.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.417 ' CD2' ' HB3' ' A' ' 73' ' ' ARG . 1.4 t80 -124.78 129.63 50.83 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.632 1.573 . . . . 0.0 106.844 -175.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -111.29 112.39 24.13 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 175.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.39 2.8 19.23 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 125.148 1.379 . . . . 0.0 112.723 -176.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.8 p -145.9 171.17 15.21 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 130.556 3.543 . . . . 0.0 107.856 166.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -63.36 149.82 44.89 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -146.48 115.2 6.83 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 167.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.0 m -88.52 141.95 28.11 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 167.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.543 ' HG ' ' HA ' ' A' ' 86' ' ' TYR . 0.7 OUTLIER -149.97 150.18 31.45 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.032 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -125.36 112.07 15.9 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.473 1.509 . . . . 0.0 108.36 -177.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 8.5 mm -69.77 120.01 16.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 128.593 2.757 . . . . 0.0 107.601 174.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 mp -110.36 -24.77 10.45 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 178.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -160.14 157.32 28.22 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.898 1.679 . . . . 0.0 107.913 177.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' A' ' 82' ' ' VAL . . . 82.55 177.9 52.13 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.597 2.046 . . . . 0.0 112.699 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.78 143.09 33.28 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.795 -0.827 . . . . 0.0 109.18 -167.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 86.9 t -138.12 156.46 30.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -124.52 118.23 26.13 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 160.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.5 t -94.01 106.8 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 169.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.4 m -93.04 105.95 17.98 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.0 p -69.33 168.6 13.97 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 121.792 -0.567 . . . . 0.0 110.542 -178.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -63.95 -32.8 74.46 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 170.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -68.59 -6.7 27.12 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 121.014 -1.054 . . . . 0.0 109.911 171.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.91 -3.36 70.45 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 125.943 1.735 . . . . 0.0 112.7 170.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.1 tttp -70.02 135.02 48.89 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-N 120.196 1.998 . . . . 0.0 107.964 -176.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.82 105.11 17.17 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.512 174.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -79.56 107.88 12.68 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 164.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.3 t -77.21 147.19 7.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 161.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 pt -148.59 121.78 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 C-N-CA 124.661 1.184 . . . . 0.0 108.499 173.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -101.75 175.4 5.56 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 122.469 1.128 . . . . 0.0 109.764 172.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.5 pttp -64.51 54.58 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 131.237 3.815 . . . . 0.0 116.363 -171.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -178.65 -16.15 0.03 OUTLIER Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.181 1.372 . . . . 0.0 113.42 176.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -77.76 103.63 7.81 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.8 1.3 . . . . 0.0 109.1 -177.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.3 tp -71.35 143.93 50.06 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 120.132 1.333 . . . . 0.0 108.319 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 45.1 t -124.14 154.87 31.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 125.074 1.35 . . . . 0.0 108.69 -174.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.9 m -146.09 103.18 3.71 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.626 1.17 . . . . 0.0 108.196 170.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -74.43 155.13 87.79 Favored Pre-proline 0 C--O 1.235 0.317 0 O-C-N 121.489 -0.757 . . . . 0.0 109.581 171.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -86.87 177.4 4.1 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.715 2.277 . . . . 0.0 110.699 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -81.26 90.6 6.12 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 164.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 110.25 90.33 2.03 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.415 1.483 . . . . 0.0 110.699 178.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 67.2 tp -156.02 152.56 28.26 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.721 2.008 . . . . 0.0 108.936 162.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.417 ' HB3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -137.36 126.07 23.88 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 119.215 0.916 . . . . 0.0 109.76 165.046 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 84.1 m -145.49 170.01 17.23 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.127 1.771 . . . . 0.0 109.268 -178.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.56 159.93 28.94 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 121.352 -0.842 . . . . 0.0 110.18 177.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -134.23 102.69 5.46 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.825 1.65 . . . . 0.0 107.68 177.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -100.78 112.27 24.65 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 174.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.0 t -84.68 106.63 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 173.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 95.6 mt -85.05 -26.03 27.26 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-O 118.878 -0.582 . . . . 0.0 109.743 175.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -147.69 149.35 33.41 Favored Pre-proline 0 N--CA 1.464 0.262 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 174.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -64.55 95.26 0.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.594 2.863 . . . . 0.0 110.673 -169.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.403 ' HA ' ' HA3' ' A' ' 46' ' ' GLY . 4.5 p -71.28 149.88 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.75 -174.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -126.98 112.25 15.04 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 104.232 -2.507 . . . . 0.0 104.232 164.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.407 ' HE3' ' CZ3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -127.91 121.19 29.35 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.244 0.545 . . . . 0.0 110.651 176.725 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -69.32 111.08 4.99 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.543 ' HA ' ' HG ' ' A' ' 41' ' ' CYS . 42.3 p90 -101.3 163.74 12.12 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 121.013 1.733 . . . . 0.0 110.892 -176.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.441 ' HB2' ' CE3' ' A' ' 21' ' ' TRP . 44.2 t30 -153.74 115.51 4.25 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.862 0.865 . . . . 0.0 109.839 171.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.1 mt -66.47 145.63 55.45 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.922 1.289 . . . . 0.0 109.172 173.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.3 p90 . . . . . 0 C--O 1.251 1.143 0 C-N-CA 125.767 1.627 . . . . 0.0 107.852 172.276 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.7 t . . . . . 0 C--O 1.239 0.503 0 CA-C-O 122.846 1.308 . . . . 0.0 112.098 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 51.0 tttt -73.32 101.58 3.47 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.056 -0.974 . . . . 0.0 108.858 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 60.5 mt -103.22 112.67 37.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 104.605 -2.369 . . . . 0.0 104.605 174.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -142.38 178.64 7.44 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 122.829 0.451 . . . . 0.0 111.903 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -125.08 85.05 58.48 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 123.135 0.574 . . . . 0.0 111.387 -165.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.24 153.7 18.7 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.264 2.643 . . . . 0.0 112.998 -173.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.2 t -57.07 144.28 69.59 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 124.417 1.087 . . . . 0.0 109.752 170.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -71.39 -26.26 20.65 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 121.487 1.458 . . . . 0.0 113.003 -176.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -65.81 -42.86 90.14 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.17 0.895 . . . . 0.0 110.102 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.6 tptt -53.57 -45.56 69.97 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 123.461 0.705 . . . . 0.0 109.6 176.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.05 -31.98 73.25 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 121.729 -0.607 . . . . 0.0 111.341 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.56 -50.21 68.15 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 172.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -57.89 -50.78 72.17 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.661 1.184 . . . . 0.0 111.822 -176.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 55.4 mt -56.82 -8.96 0.68 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.29 1.836 . . . . 0.0 112.823 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.5 m 75.21 27.51 1.1 Allowed 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 128.124 2.57 . . . . 0.0 111.276 167.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.9 t -54.21 -28.61 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 128.48 2.712 . . . . 0.0 112.583 177.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.97 -29.31 70.71 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 120.239 1.382 . . . . 0.0 112.49 173.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.4 mtpp -82.51 -15.56 51.95 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.246 1.018 . . . . 0.0 112.205 176.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 38.2 m0 -69.32 165.17 42.25 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 119.169 0.895 . . . . 0.0 109.272 -173.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -67.39 141.73 57.3 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 121.464 1.443 . . . . 0.0 112.066 174.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.1 mt -88.56 142.97 12.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 125.909 1.683 . . . . 0.0 106.839 169.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.474 ' CE3' ' HE2' ' A' ' 84' ' ' LYS . 44.1 t90 -148.75 133.01 17.42 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 165.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.78 174.59 7.41 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.051 1.74 . . . . 0.0 107.677 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -154.21 161.77 41.62 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 173.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -73.68 170.53 15.06 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.625 0.726 . . . . 0.0 111.315 169.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -80.88 74.0 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 125.136 1.375 . . . . 0.0 108.571 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.0 t -141.23 -170.71 3.13 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.417 1.887 . . . . 0.0 107.824 -176.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.94 149.7 31.64 Favored 'General case' 0 CA--C 1.518 -0.263 0 O-C-N 120.386 -1.446 . . . . 0.0 111.733 -173.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -163.23 -164.76 0.98 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.248 1.819 . . . . 0.0 107.214 -171.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -130.02 161.79 30.16 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.095 -1.003 . . . . 0.0 109.184 170.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 12.6 t-105 -131.87 158.43 41.36 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 120.965 0.412 . . . . 0.0 110.471 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -132.73 96.24 3.77 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 176.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -72.05 123.27 22.45 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 176.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.38 1.02 6.32 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -171.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 p -140.87 174.42 10.53 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.553 2.341 . . . . 0.0 108.401 163.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -67.78 136.85 54.84 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -142.61 102.53 4.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -177.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.7 m -84.84 140.44 31.17 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 169.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 14.4 p -144.94 162.6 36.49 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 118.503 0.592 . . . . 0.0 111.577 162.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -124.64 111.85 16.1 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 126.058 1.743 . . . . 0.0 107.998 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 25.6 mm -72.8 111.97 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 128.798 2.839 . . . . 0.0 107.757 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.509 HD12 ' HD1' ' A' ' 85' ' ' HIS . 32.8 mt -92.01 -37.49 12.79 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 122.478 0.311 . . . . 0.0 111.235 -177.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -162.44 165.22 26.56 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.631 0.772 . . . . 0.0 108.988 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' A' ' 82' ' ' VAL . . . 89.88 -176.57 42.67 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 124.246 0.927 . . . . 0.0 111.232 -177.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.48 147.35 30.08 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 117.538 0.669 . . . . 0.0 110.415 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.6 t -139.64 156.34 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -178.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -124.37 133.7 53.34 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 122.589 1.185 . . . . 0.0 108.491 158.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . 0.627 0.1 OUTLIER -108.61 80.53 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.204 1 C-N-CA 133.629 4.771 . . . . 0.0 117.001 165.81 . . . . . . . . 4 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 82.9 m -71.04 122.7 20.53 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.078 162.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 74.9 p -82.52 -173.81 4.82 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.377 1.071 . . . . 0.0 111.811 174.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -62.77 -37.83 88.2 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.077 0.551 . . . . 0.0 110.255 170.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -63.59 -27.09 69.0 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.034 0.933 . . . . 0.0 111.677 177.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 103.86 -10.86 52.61 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-O 118.965 -0.908 . . . . 0.0 113.43 175.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.7 mttm -61.55 129.17 39.81 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 118.422 1.111 . . . . 0.0 108.78 173.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.38 103.84 16.48 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.186 0.994 . . . . 0.0 108.795 177.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -68.29 100.05 1.0 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 167.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.7 t -81.68 137.82 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 165.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.8 pt -140.4 90.75 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -85.86 170.33 12.48 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.71 1.604 . . . . 0.0 110.729 172.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.1 pttm -60.57 111.29 1.54 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.748 1.219 . . . . 0.0 111.152 -176.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 121.5 -23.13 7.63 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 125.858 1.694 . . . . 0.0 113.208 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.24 100.88 3.83 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.26 1.53 . . . . 0.0 108.096 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.3 tp -71.61 145.54 48.93 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.8 t -129.85 138.73 53.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 125.733 1.613 . . . . 0.0 107.46 -171.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 98.5 m -130.38 100.06 5.23 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 162.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -70.68 146.8 94.04 Favored Pre-proline 0 C--O 1.238 0.486 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 165.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -82.54 175.69 8.61 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 122.097 1.864 . . . . 0.0 110.901 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -76.7 90.64 3.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 113.326 -1.761 . . . . 0.0 107.289 171.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 110.92 93.17 2.18 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.7 tp -153.16 142.26 21.37 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.874 1.67 . . . . 0.0 109.517 168.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 -115.96 133.53 55.93 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.821 2.049 . . . . 0.0 108.382 168.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 12.8 p -162.03 175.52 11.69 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.656 1.582 . . . . 0.0 108.365 169.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.56 -175.43 1.05 Allowed 'General case' 0 C--O 1.212 -0.869 0 CA-C-O 117.777 -1.106 . . . . 0.0 113.075 167.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -154.91 105.72 2.59 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.273 2.229 . . . . 0.0 105.65 163.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.0 tttt -103.83 116.77 32.89 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 176.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.0 t -83.84 106.87 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 174.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.9 mt -83.75 -20.95 32.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.042 178.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -158.49 152.05 19.21 Favored Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 126.994 2.118 . . . . 0.0 108.238 169.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -63.35 102.57 0.34 Allowed 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.715 2.944 . . . . 0.0 110.846 -168.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.432 ' HA ' ' HA3' ' A' ' 46' ' ' GLY . 7.1 p -83.38 144.74 9.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 123.699 0.8 . . . . 0.0 110.616 -173.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -116.75 131.88 56.84 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 163.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.474 ' HE2' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -134.62 150.01 50.63 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 173.483 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.509 ' HD1' HD12 ' A' ' 44' ' ' LEU . 1.7 m80 -96.24 114.02 25.67 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 105.844 -1.909 . . . . 0.0 105.844 165.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -106.87 166.6 10.48 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 119.612 1.096 . . . . 0.0 111.089 -176.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -151.54 130.76 12.75 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.694 0.679 . . . . 0.0 110.453 165.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 26.2 mt -85.99 136.44 33.26 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 126.797 2.039 . . . . 0.0 109.177 176.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.8 p90 . . . . . 0 C--O 1.248 1.02 0 C-N-CA 125.368 1.467 . . . . 0.0 111.172 179.439 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 82.7 t . . . . . 0 C--O 1.235 0.314 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -125.73 140.15 52.93 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 171.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.2 mt -137.52 146.5 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 175.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -154.57 -175.07 5.23 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.934 0.893 . . . . 0.0 109.861 160.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -118.96 80.75 18.58 Favored Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 169.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -67.7 172.12 11.03 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.896 2.397 . . . . 0.0 110.994 -177.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.4 t -60.03 144.29 86.84 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 120.034 -0.666 . . . . 0.0 109.469 166.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.78 -20.18 46.26 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.149 1.899 . . . . 0.0 111.296 168.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -60.24 -50.38 73.89 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 119.772 1.169 . . . . 0.0 109.944 -177.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -55.73 -43.71 76.83 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 123.271 0.628 . . . . 0.0 109.762 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 70.6 mt -70.28 -33.66 71.83 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.732 1.213 . . . . 0.0 110.707 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -61.38 -32.3 72.22 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 120.429 -1.42 . . . . 0.0 110.92 168.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -73.75 -55.77 5.82 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 121.012 1.733 . . . . 0.0 109.722 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.1 tp -44.13 -66.25 0.41 Allowed 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 126.512 1.925 . . . . 0.0 112.682 -152.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.1 p 173.34 27.66 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 129.521 3.128 . . . . 0.0 109.784 150.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.1 t -59.92 -30.71 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 O-C-N 120.659 -1.275 . . . . 0.0 113.074 -160.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -60.01 -25.19 65.08 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 120.866 -1.146 . . . . 0.0 112.762 172.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.5 mttt -88.81 -31.4 18.35 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.498 1.519 . . . . 0.0 111.882 177.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -55.53 156.84 8.01 Favored Pre-proline 0 C--O 1.236 0.364 0 C-N-CA 124.021 0.928 . . . . 0.0 110.269 -175.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.91 138.59 40.96 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.465 1.443 . . . . 0.0 111.72 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.8 mt -71.48 150.96 8.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 164.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -137.35 134.86 36.48 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 159.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -141.15 120.71 13.27 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 126.374 1.87 . . . . 0.0 109.468 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.4 mmtt -109.49 152.28 25.63 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 123.733 0.813 . . . . 0.0 109.794 -178.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.5 pm0 -66.02 163.62 16.95 Favored 'General case' 0 N--CA 1.441 -0.876 0 O-C-N 124.915 1.385 . . . . 0.0 111.152 166.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.5 p -73.25 17.05 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 127.898 2.479 . . . . 0.0 113.966 -172.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.9 t -83.64 -171.27 3.49 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.89 1.276 . . . . 0.0 109.48 177.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -136.87 154.17 50.57 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 121.099 -1.0 . . . . 0.0 110.701 175.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -162.38 -164.45 1.04 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.826 1.651 . . . . 0.0 108.523 -172.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -135.28 154.91 51.39 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 126.068 1.747 . . . . 0.0 109.753 168.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 58.0 t-105 -138.16 127.58 24.72 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.059 0.544 . . . . 0.0 111.797 -174.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -80.95 130.48 35.04 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.421 1.089 . . . . 0.0 108.354 169.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -108.84 107.74 18.27 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.137 1.375 . . . . 0.0 107.312 166.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -114.08 21.2 15.02 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.812 0.845 . . . . 0.0 112.974 -179.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.41 167.0 31.48 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 127.445 2.298 . . . . 0.0 108.001 166.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -66.81 127.0 30.8 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -177.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -136.71 99.71 4.13 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -177.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 85.2 m -70.88 141.79 51.2 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 166.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.1 p -150.57 133.61 16.09 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 121.438 -0.788 . . . . 0.0 110.841 172.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -111.55 104.87 13.3 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 126.585 1.954 . . . . 0.0 109.362 -171.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 22.7 mm -76.65 114.92 17.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -175.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.79 -27.19 13.48 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 118.724 -0.655 . . . . 0.0 112.54 -178.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -158.84 153.01 23.76 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 119.492 1.042 . . . . 0.0 108.907 -178.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.64 -171.01 39.13 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.634 1.111 . . . . 0.0 113.035 -176.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.18 146.44 35.25 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.994 1.717 . . . . 0.0 108.171 -177.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.3 t -141.77 147.18 22.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -124.01 122.66 38.5 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 127.754 2.422 . . . . 0.0 107.175 167.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.6 t -110.76 117.24 54.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 46.3 m -111.02 120.55 42.74 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.435 ' HA ' ' SG ' ' A' ' 74' ' ' CYS . 27.2 p -73.43 162.36 29.39 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.517 0.675 . . . . 0.0 110.692 -179.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.83 -30.73 71.4 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.693 -0.63 . . . . 0.0 109.314 172.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -63.34 -15.65 58.0 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 127.342 2.257 . . . . 0.0 112.663 168.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 103.78 -12.25 53.33 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 125.235 1.398 . . . . 0.0 113.763 172.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -60.39 112.45 1.96 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 118.762 1.281 . . . . 0.0 108.45 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -70.12 153.64 42.9 Favored 'General case' 0 C--O 1.231 0.087 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 164.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -135.27 160.91 36.9 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 126.031 1.732 . . . . 0.0 106.724 159.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 88.7 t -123.06 150.22 26.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 170.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.5 pt -142.02 126.36 16.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 164.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -94.97 175.53 6.61 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.215 1.006 . . . . 0.0 109.241 173.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.0 pttm -62.4 68.54 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.664 1.985 . . . . 0.0 111.936 166.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 165.81 -9.44 0.07 OUTLIER Glycine 0 C--N 1.315 -0.618 0 CA-C-O 118.083 -1.399 . . . . 0.0 113.463 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -80.19 136.16 36.43 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.795 1.798 . . . . 0.0 106.545 167.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.7 tp -104.65 139.23 39.79 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 161.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 42.8 t -118.26 157.42 19.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 -177.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.7 m -138.14 101.62 4.46 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 168.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -72.8 153.35 91.26 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 173.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -84.06 173.26 9.15 Favored 'Trans proline' 0 N--CA 1.447 -1.226 0 C-N-CA 122.137 1.891 . . . . 0.0 110.682 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -80.63 90.42 5.75 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 164.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 118.24 78.32 0.62 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 123.812 0.72 . . . . 0.0 113.074 174.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 31.8 tp -147.49 154.77 41.18 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.97 1.308 . . . . 0.0 108.9 169.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.6 ptt85 -144.02 101.27 3.7 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 125.103 1.361 . . . . 0.0 107.664 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . 0.435 ' SG ' ' HA ' ' A' ' 52' ' ' THR . 73.7 m -145.21 161.97 38.25 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.801 0.84 . . . . 0.0 110.777 -170.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.2 152.36 38.39 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 122.846 0.458 . . . . 0.0 111.321 -173.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.8 m95 -127.89 97.1 4.69 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.732 2.013 . . . . 0.0 107.699 174.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.5 tptt -76.07 146.01 39.69 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 104.624 -2.361 . . . . 0.0 104.624 161.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.38 94.07 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 168.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.8 mt -67.08 -32.29 73.36 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 118.148 -0.93 . . . . 0.0 110.902 -177.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -134.64 144.78 52.22 Favored Pre-proline 0 N--CA 1.454 -0.232 0 CA-C-O 117.625 -1.178 . . . . 0.0 109.5 175.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -61.14 95.36 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.938 3.092 . . . . 0.0 109.872 -177.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.9 p -81.77 159.6 3.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 125.112 1.365 . . . . 0.0 110.049 -167.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.1 ttt85 -129.69 134.37 47.61 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 164.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.44 151.73 42.06 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 169.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -83.95 125.12 31.72 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 160.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -112.26 157.26 21.14 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 173.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -151.28 114.43 4.77 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 171.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 55.8 mt -65.96 143.65 57.26 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.192 1.397 . . . . 0.0 107.694 166.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 36.6 p90 . . . . . 0 C--O 1.255 1.359 0 CA-C-O 115.939 -1.981 . . . . 0.0 112.08 174.354 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 p . . . . . 0 C--O 1.239 0.535 0 CA-C-O 120.714 0.292 . . . . 0.0 110.751 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -98.2 140.04 33.1 Favored 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 160.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.2 mt -126.28 142.54 42.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 168.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -155.35 177.45 11.34 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.451 ' HE2' ' OD2' ' A' ' 64' ' ' ASP . 3.6 mmtp -120.6 82.72 33.84 Favored Pre-proline 0 C--N 1.346 0.428 0 C-N-CA 124.894 1.278 . . . . 0.0 110.8 -177.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.21 169.63 19.93 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 123.639 2.893 . . . . 0.0 111.603 -178.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.6 p -77.07 150.23 80.61 Favored Pre-proline 0 C--O 1.235 0.329 0 O-C-N 121.947 -0.471 . . . . 0.0 109.97 178.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -64.62 -32.36 58.25 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 121.661 1.574 . . . . 0.0 111.387 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -57.43 -53.12 61.79 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.766 0.826 . . . . 0.0 110.509 176.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.0 tptt -55.0 -40.08 69.73 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.102 0.561 . . . . 0.0 110.177 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.33 -36.54 84.36 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 123.468 0.707 . . . . 0.0 111.173 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -62.8 -48.16 80.32 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 121.177 -0.952 . . . . 0.0 109.361 171.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -61.45 -40.74 95.59 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.658 0.783 . . . . 0.0 112.364 -174.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 mp -55.46 -14.41 1.97 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.95 1.7 . . . . 0.0 113.133 175.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.4 m 57.97 40.37 25.67 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.302 1.841 . . . . 0.0 110.544 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.7 t -54.56 -31.33 23.22 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.257 0 C-N-CA 127.517 2.327 . . . . 0.0 111.024 174.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -56.92 -17.17 8.59 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 170.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -102.62 -5.76 23.51 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.097 1.759 . . . . 0.0 111.46 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.404 ' CE3' ' HB2' ' A' ' 87' ' ' ASN . 31.0 m0 -77.71 165.22 52.78 Favored Pre-proline 0 C--O 1.24 0.582 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.11 140.72 42.01 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 121.654 1.569 . . . . 0.0 111.151 171.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.0 mt -81.58 151.55 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 165.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.645 ' CE3' ' HE3' ' A' ' 84' ' ' LYS . 7.1 t90 -136.77 141.71 42.98 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 156.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.76 153.0 48.64 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 128.207 2.603 . . . . 0.0 108.917 174.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.45 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 1.7 tttt -153.25 165.14 36.64 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.316 -0.865 . . . . 0.0 109.876 172.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.69 176.78 4.57 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 126.135 1.774 . . . . 0.0 110.245 171.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.6 t -83.77 49.6 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 129.984 3.313 . . . . 0.0 109.088 -169.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.0 t -105.57 -169.07 1.54 Allowed 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 127.302 2.241 . . . . 0.0 109.706 -165.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.07 135.47 19.35 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 120.723 -1.235 . . . . 0.0 108.877 177.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -153.57 -164.94 2.01 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.361 1.064 . . . . 0.0 109.268 -176.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -137.65 152.1 48.97 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.86 1.264 . . . . 0.0 109.663 173.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 15.5 t-105 -128.46 135.2 49.14 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 125.137 1.375 . . . . 0.0 109.615 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -106.99 109.71 21.67 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 171.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -79.58 123.02 27.22 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 171.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -124.81 5.49 8.09 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.692 0.797 . . . . 0.0 111.446 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.94 177.09 9.64 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 126.806 2.042 . . . . 0.0 108.678 165.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -65.15 137.69 57.8 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 178.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -143.94 100.62 3.6 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -174.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 85.6 m -75.67 144.35 41.67 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 116.19 -1.862 . . . . 0.0 106.521 172.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 7.5 p -133.31 162.75 30.96 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 114.269 -2.973 . . . . 0.0 111.039 145.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -125.69 109.43 12.59 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 170.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.8 mm -73.82 131.28 35.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.42 -21.24 8.13 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.317 0.962 . . . . 0.0 112.964 -177.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -154.47 160.65 41.72 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 165.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.18 -174.0 24.74 Favored Glycine 0 N--CA 1.465 0.591 0 C-N-CA 124.11 0.862 . . . . 0.0 113.623 174.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.527 ' HZ2' ' C ' ' A' ' 48' ' ' VAL . 0.1 OUTLIER -145.39 141.95 28.91 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.242 0.544 . . . . 0.0 109.717 173.54 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.527 ' C ' ' HZ2' ' A' ' 47' ' ' LYS . 3.3 t -127.77 136.27 60.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 176.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -99.66 131.62 45.53 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 157.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 94.1 t -114.02 140.78 32.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 171.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.8 m -136.89 108.34 6.9 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -175.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 49.7 p -77.42 177.26 8.13 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.707 -0.621 . . . . 0.0 109.486 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -72.56 -25.72 61.46 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 120.613 -1.304 . . . . 0.0 110.838 -174.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.18 -27.72 65.96 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.109 0.964 . . . . 0.0 111.981 169.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.68 8.79 69.64 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-O 118.648 -1.084 . . . . 0.0 113.357 -177.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp -52.45 117.98 3.25 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 156.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -74.5 153.4 39.13 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 158.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -136.91 150.59 48.31 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 170.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 63.0 t -127.1 141.08 47.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.8 pt -135.52 120.87 29.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 170.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.49 175.23 9.44 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.723 1.209 . . . . 0.0 109.231 169.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -64.13 43.31 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 130.557 3.543 . . . . 0.0 114.905 175.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -179.48 -0.67 0.02 OUTLIER Glycine 0 CA--C 1.525 0.659 0 C-N-CA 124.943 1.258 . . . . 0.0 112.697 -176.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.451 ' OD2' ' HE2' ' A' ' 7' ' ' LYS . 1.3 m-20 -72.54 114.06 10.26 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 166.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.2 tp -74.33 160.78 30.61 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 152.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.444 ' CG2' ' CE1' ' A' ' 68' ' ' PHE . 1.2 p -160.16 149.36 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 C-N-CA 126.958 2.103 . . . . 0.0 109.716 -175.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 84.2 m -136.63 97.56 3.58 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 173.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.444 ' CE1' ' CG2' ' A' ' 66' ' ' VAL . 91.0 m-85 -70.79 145.9 92.66 Favored Pre-proline 0 C--O 1.239 0.512 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 163.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -86.21 174.56 6.1 Favored 'Trans proline' 0 N--CA 1.443 -1.459 0 C-N-CA 121.685 1.59 . . . . 0.0 110.777 -174.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.2 tttm -71.08 96.79 1.38 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 113.214 -1.812 . . . . 0.0 106.838 165.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 102.42 88.64 2.05 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 126.307 1.908 . . . . 0.0 111.485 177.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.9 tt -148.8 139.41 22.68 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 126.861 2.064 . . . . 0.0 107.804 167.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -126.21 108.45 11.31 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.643 1.177 . . . . 0.0 108.156 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 24.6 p -145.85 168.81 19.89 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -175.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.44 162.12 21.09 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 123.478 0.711 . . . . 0.0 111.847 170.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -144.54 97.9 3.11 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 126.98 2.112 . . . . 0.0 109.135 -172.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.5 tptt -98.89 123.32 43.08 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 126.462 1.905 . . . . 0.0 107.445 -176.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.9 t -101.12 100.88 11.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.417 ' CD1' ' HZ1' ' A' ' 47' ' ' LYS . 9.8 mt -82.8 -28.81 30.01 Favored 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 119.679 -0.809 . . . . 0.0 109.196 -177.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -144.95 150.47 46.08 Favored Pre-proline 0 C--O 1.238 0.499 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 175.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -65.65 135.21 41.03 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 122.79 2.326 . . . . 0.0 107.942 -169.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.9 p -131.73 119.88 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.456 -157.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.0 ttt85 -99.43 116.47 31.66 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 171.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.645 ' HE3' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -126.28 146.74 49.89 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 172.265 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 14.3 m80 -85.5 129.05 34.91 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 161.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -117.37 162.21 18.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 172.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.404 ' HB2' ' CE3' ' A' ' 21' ' ' TRP . 23.1 t30 -152.97 121.21 6.23 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 172.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 29.7 mt -75.58 134.59 40.66 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 126.11 1.764 . . . . 0.0 106.837 170.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.8 p90 . . . . . 0 C--O 1.256 1.416 0 CA-C-N 119.648 1.113 . . . . 0.0 110.988 -176.782 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.0 t . . . . . 0 N--CA 1.455 -0.211 0 CA-C-O 122.063 0.935 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.69 115.28 6.34 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.7 mt -110.58 148.19 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 168.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -157.75 175.51 13.79 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.389 1.075 . . . . 0.0 109.694 165.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.36 85.5 10.82 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 173.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -69.83 167.6 24.05 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.74 2.96 . . . . 0.0 111.551 -177.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.4 p -84.09 151.02 59.53 Favored Pre-proline 0 N--CA 1.448 -0.533 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -63.37 -31.49 72.74 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.541 2.161 . . . . 0.0 112.126 175.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -63.54 -48.93 75.47 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 119.292 0.951 . . . . 0.0 110.636 171.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -57.77 -38.14 74.92 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.779 0.718 . . . . 0.0 111.012 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 57.4 mt -63.33 -26.86 68.96 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 118.978 -0.534 . . . . 0.0 112.32 177.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -66.6 -43.22 85.44 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 119.713 1.142 . . . . 0.0 110.268 170.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -61.34 -47.23 86.87 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 122.04 0.924 . . . . 0.0 109.453 -174.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 88.1 mt -65.09 -4.26 4.63 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.094 1.757 . . . . 0.0 112.667 178.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 56.77 33.37 22.89 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.5 1.52 . . . . 0.0 111.945 175.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.1 t -56.6 -23.28 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.076 0.951 . . . . 0.0 111.697 -176.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -53.83 -29.97 43.17 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.416 -1.428 . . . . 0.0 113.954 167.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -84.8 -21.4 29.94 Favored 'General case' 0 C--O 1.226 -0.164 0 O-C-N 121.336 -0.852 . . . . 0.0 110.28 -170.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 31.0 m0 -71.88 163.75 64.18 Favored Pre-proline 0 N--CA 1.448 -0.555 0 C-N-CA 125.229 1.412 . . . . 0.0 109.37 -162.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.03 133.17 30.14 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 121.17 1.247 . . . . 0.0 110.315 172.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 63.6 mt -70.19 145.45 12.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 167.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 88.3 t90 -139.14 141.15 38.06 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 163.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -128.7 165.02 21.68 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 126.886 2.074 . . . . 0.0 107.991 173.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -149.87 158.83 44.55 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 167.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.433 ' C ' ' H ' ' A' ' 29' ' ' SER . 4.3 tt0 -84.45 175.68 9.16 Favored 'General case' 0 N--CA 1.435 -1.207 0 O-C-N 123.979 0.799 . . . . 0.0 111.167 172.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.5 p -66.53 11.34 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 129.128 2.971 . . . . 0.0 113.097 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 27' ' ' GLU . 0.3 OUTLIER -91.03 134.39 34.54 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 126.833 2.053 . . . . 0.0 109.191 178.259 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -72.68 168.09 19.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.915 0.864 . . . . 0.0 110.269 177.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -165.94 -172.13 2.23 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 169.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -123.33 146.72 47.69 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 119.888 -1.758 . . . . 0.0 106.929 157.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 12.8 t-105 -114.97 153.63 30.24 Favored 'General case' 0 C--O 1.239 0.549 0 O-C-N 123.897 0.748 . . . . 0.0 110.39 172.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -123.22 105.27 9.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 170.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -78.75 104.94 9.71 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 174.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -105.22 11.57 32.87 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -179.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.76 168.3 21.71 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 129.04 2.936 . . . . 0.0 107.749 157.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -58.29 137.74 56.91 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 125.433 1.493 . . . . 0.0 107.78 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -141.65 113.96 8.18 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 175.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 97.2 m -79.73 149.12 31.26 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 162.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.1 p -145.38 137.84 25.87 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 119.16 0.891 . . . . 0.0 111.265 157.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -100.93 111.52 23.74 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.928 1.691 . . . . 0.0 107.894 174.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.8 mm -75.31 120.57 25.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 C-N-CA 124.05 0.94 . . . . 0.0 108.734 177.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 mp -101.82 -25.38 13.83 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 118.812 -0.613 . . . . 0.0 111.969 176.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -169.62 158.65 7.82 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.222 1.009 . . . . 0.0 109.592 -177.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.75 -172.14 14.21 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.41 1.481 . . . . 0.0 111.871 177.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.429 ' HD2' ' H ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -138.23 151.87 48.07 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 123.209 1.481 . . . . 0.0 108.522 167.644 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.467 ' CG1' HG13 ' A' ' 60' ' ' ILE 0.266 0.4 OUTLIER -152.98 135.73 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.431 0 C-N-CA 130.206 3.402 . . . . 0.0 112.97 -171.017 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.427 ' HB3' ' HE3' ' A' ' 57' ' ' LYS . 10.3 mt-10 -128.51 107.77 9.99 Favored 'General case' 0 N--CA 1.428 -1.566 0 O-C-N 125.819 1.949 . . . . 0.0 109.231 155.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 78.3 t -83.24 146.45 6.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 168.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.1 m -139.77 117.14 11.32 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 175.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 47.3 p -65.05 169.24 5.58 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 174.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -53.36 -36.68 61.64 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.596 -0.69 . . . . 0.0 110.41 171.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -65.16 -2.06 2.65 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 129.406 3.082 . . . . 0.0 114.328 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.76 6.57 78.18 Favored Glycine 0 CA--C 1.533 1.206 0 O-C-N 121.156 -0.965 . . . . 0.0 113.11 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -73.51 102.32 3.8 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 168.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.427 ' HE3' ' HB3' ' A' ' 49' ' ' GLU . 3.1 tptt -75.12 146.2 41.59 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 170.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -142.35 107.38 4.93 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.451 1.9 . . . . 0.0 107.961 177.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.7 t -69.81 138.47 22.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 164.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.467 HG13 ' CG1' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -124.9 146.8 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 C-N-CA 123.849 0.859 . . . . 0.0 109.807 165.221 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -142.1 -178.37 5.68 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 122.221 1.01 . . . . 0.0 111.525 173.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.5 pttm -61.7 85.22 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.548 1.939 . . . . 0.0 111.548 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 144.83 -11.0 1.89 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 126.121 1.819 . . . . 0.0 113.04 177.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -90.34 106.54 18.56 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 175.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.8 tp -76.47 146.39 38.58 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 168.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.3 t -129.45 155.29 41.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 123.295 0.638 . . . . 0.0 109.403 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.7 m -138.76 123.41 18.57 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.179 0.992 . . . . 0.0 109.263 162.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -86.81 153.03 54.78 Favored Pre-proline 0 C--O 1.239 0.531 0 C-N-CA 125.215 1.406 . . . . 0.0 109.799 171.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -79.99 179.68 6.03 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.506 2.804 . . . . 0.0 109.491 175.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -83.49 103.83 13.15 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 164.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 102.73 62.97 0.71 Allowed Glycine 0 CA--C 1.523 0.547 0 C-N-CA 125.175 1.369 . . . . 0.0 112.297 166.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.8 tp -123.68 147.72 47.17 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.504 1.922 . . . . 0.0 108.501 174.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.22 142.33 47.58 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.624 1.57 . . . . 0.0 109.23 174.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 8.7 p -167.46 163.91 14.93 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 118.86 0.755 . . . . 0.0 112.275 167.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.22 145.33 37.64 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 118.516 -0.754 . . . . 0.0 109.967 167.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 6.6 m95 -104.65 136.97 43.2 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 158.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.0 tttt -113.69 103.75 11.53 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 158.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.6 t -76.88 106.43 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 103.475 -2.787 . . . . 0.0 103.475 174.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.9 mt -88.82 -16.06 33.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.594 -177.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -150.27 151.37 31.34 Favored Pre-proline 0 C--O 1.234 0.273 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.888 161.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -58.14 114.64 2.06 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.925 3.083 . . . . 0.0 110.439 -175.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.9 p -88.08 164.06 2.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 C-N-CA 123.604 0.762 . . . . 0.0 109.949 -168.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -134.97 122.79 22.38 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 155.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.05 140.13 46.45 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 171.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -77.49 104.65 8.14 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 103.763 -2.68 . . . . 0.0 103.763 164.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -85.13 161.28 19.71 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 167.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -149.74 140.1 22.32 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 119.538 -0.865 . . . . 0.0 109.986 152.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 44.4 mt -71.91 163.95 26.94 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 171.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 5.1 p90 . . . . . 0 C--O 1.246 0.891 0 O-C-N 121.305 -0.872 . . . . 0.0 108.747 160.019 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 C--O 1.235 0.298 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.9 tptt -113.73 136.53 52.74 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 171.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 55.7 mt -135.4 112.15 13.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -143.04 174.8 10.36 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.197 0.999 . . . . 0.0 109.615 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.8 82.38 6.54 Favored Pre-proline 0 CA--C 1.532 0.259 0 O-C-N 121.598 -0.689 . . . . 0.0 109.268 176.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -74.8 165.87 30.53 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.542 2.161 . . . . 0.0 113.428 -174.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.9 t -61.58 144.13 92.89 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 124.794 1.238 . . . . 0.0 110.953 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.65 -23.17 63.84 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.786 2.324 . . . . 0.0 113.027 177.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.41 -61.14 2.65 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 125.064 1.345 . . . . 0.0 109.721 -176.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -56.77 -36.85 70.3 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 122.183 -0.323 . . . . 0.0 110.825 -175.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.2 mt -58.28 -41.61 84.72 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 173.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.3 -50.89 71.48 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.513 1.051 . . . . 0.0 108.323 173.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -63.84 -34.38 77.8 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 123.482 0.713 . . . . 0.0 111.847 -174.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.75 -5.97 3.23 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.564 1.546 . . . . 0.0 113.601 177.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . 0.254 98.8 p 63.17 28.24 15.87 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 128.332 2.653 . . . . 0.0 113.943 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 20.1 t -57.28 -31.96 39.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 118.941 0.791 . . . . 0.0 112.985 -170.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -62.96 -23.71 67.54 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.281 1.4 . . . . 0.0 113.027 176.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.9 mttm -88.59 -8.03 55.4 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 126.223 1.809 . . . . 0.0 111.045 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 39.8 m0 -74.36 163.31 69.2 Favored Pre-proline 0 N--CA 1.451 -0.39 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.12 133.58 31.28 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.003 1.136 . . . . 0.0 111.314 173.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.1 mt -70.44 149.18 10.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 124.654 1.182 . . . . 0.0 107.974 165.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.4 ' CE3' ' HE2' ' A' ' 84' ' ' LYS . 28.8 t90 -144.84 145.32 31.56 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.56 -1.2 . . . . 0.0 107.775 162.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.22 162.62 34.83 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.782 2.433 . . . . 0.0 108.344 176.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.491 ' HD3' ' H ' ' A' ' 27' ' ' GLU . 5.3 tmtt? -147.17 173.16 12.78 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.933 -1.105 . . . . 0.0 110.224 178.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.491 ' H ' ' HD3' ' A' ' 26' ' ' LYS . 6.0 tt0 -70.9 -179.77 2.38 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 127.612 2.365 . . . . 0.0 111.288 166.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.47 ' H ' ' HG2' ' A' ' 27' ' ' GLU . 11.3 t -97.89 6.96 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 C-N-CA 127.456 2.302 . . . . 0.0 111.91 -171.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.5 t -81.5 172.91 12.93 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 120.627 -1.296 . . . . 0.0 109.511 173.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -100.42 161.41 13.62 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.321 -0.862 . . . . 0.0 109.31 171.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.476 ' CE2' ' HE3' ' A' ' 26' ' ' LYS . 14.4 p90 -156.75 177.16 11.8 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 125.445 1.498 . . . . 0.0 109.138 170.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.11 129.47 51.81 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.062 2.145 . . . . 0.0 108.186 171.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 35.1 t-105 -118.65 146.15 44.9 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.909 173.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -117.46 143.81 45.65 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.123 1.369 . . . . 0.0 107.907 174.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -118.09 110.81 18.09 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 175.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -107.9 3.01 23.81 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.494 1.118 . . . . 0.0 111.429 -175.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.58 160.4 42.44 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 129.686 3.194 . . . . 0.0 107.318 173.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -64.34 127.74 32.77 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 -174.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -135.1 109.1 8.17 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 177.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 56.1 m -82.07 135.75 35.29 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 167.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 29.2 p -134.65 156.93 47.89 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.084 0.468 . . . . 0.0 110.186 163.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -133.45 116.64 16.25 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.932 1.293 . . . . 0.0 108.502 -175.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.8 mm -72.47 143.19 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 126.475 1.91 . . . . 0.0 109.274 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.0 mt -127.25 -37.14 2.07 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.229 0.611 . . . . 0.0 109.822 171.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -150.82 159.4 44.57 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 173.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' A' ' 82' ' ' VAL . . . 101.17 177.27 29.01 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 126.305 1.907 . . . . 0.0 114.097 177.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.93 154.56 46.15 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-O 123.282 1.515 . . . . 0.0 110.054 -175.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.427 HG11 HG13 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -160.04 150.06 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.995 1 C-N-CA 133.539 4.735 . . . . 0.0 108.033 -161.677 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -135.21 115.61 13.53 Favored 'General case' 0 N--CA 1.414 -2.233 0 N-CA-C 104.23 -2.507 . . . . 0.0 104.23 152.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.4 t -89.56 121.86 40.22 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.993 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 172.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.5 m -111.34 122.84 48.9 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 82.4 p -74.08 178.52 4.96 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -71.77 -23.93 61.67 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 120.209 -1.557 . . . . 0.0 111.698 168.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.43 -7.99 29.64 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.825 1.25 . . . . 0.0 111.653 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.3 -13.56 61.55 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 126.261 1.886 . . . . 0.0 112.951 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -61.13 137.1 58.24 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.565 1.546 . . . . 0.0 107.542 178.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.4 tttm -120.67 130.52 54.15 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -172.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 13.5 m-30 -128.28 84.9 2.28 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 125.618 2.627 . . . . 0.0 108.962 -169.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.5 p -54.36 97.82 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 127.407 2.283 . . . . 0.0 112.587 152.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.437 HG12 ' H ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -80.59 156.54 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.062 0 CA-C-N 112.487 -2.142 . . . . 0.0 109.414 155.803 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -157.82 -179.84 8.52 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 171.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.4 82.42 0.05 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 126.068 1.747 . . . . 0.0 109.326 -176.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 160.32 -12.27 0.16 Allowed Glycine 0 CA--C 1.524 0.634 0 CA-C-O 118.082 -1.399 . . . . 0.0 115.662 -167.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -126.64 104.95 8.38 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 119.186 1.493 . . . . 0.0 109.17 -166.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.3 tp -65.86 150.53 48.44 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 172.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.0 t -128.93 156.68 41.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 121.909 0.862 . . . . 0.0 109.288 168.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 75.7 m -144.48 111.51 5.86 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.365 1.466 . . . . 0.0 108.09 162.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -78.36 155.68 79.06 Favored Pre-proline 0 C--O 1.234 0.272 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 170.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -80.84 177.83 7.58 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 121.396 1.398 . . . . 0.0 110.334 172.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 32.4 tttt -75.08 91.4 2.56 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 112.933 -1.94 . . . . 0.0 107.527 164.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 116.17 90.79 1.63 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.754 1.168 . . . . 0.0 111.441 173.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.9 tp -155.2 150.71 27.33 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.51 1.524 . . . . 0.0 110.087 173.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.2 ttp85 -128.78 122.96 31.69 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 126.285 1.834 . . . . 0.0 109.116 176.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 8.3 p -157.13 167.32 30.74 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.226 0.921 . . . . 0.0 110.919 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.91 173.71 12.26 Favored 'General case' 0 CA--C 1.516 -0.347 0 O-C-N 120.887 -1.133 . . . . 0.0 112.4 168.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 5.9 m95 -142.88 93.65 2.54 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 127.51 2.324 . . . . 0.0 106.728 167.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -79.83 105.31 11.02 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 170.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 t -86.14 86.92 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 -174.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 97.3 mt -64.72 -29.87 70.87 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.451 -178.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -142.74 154.57 62.79 Favored Pre-proline 0 N--CA 1.465 0.281 0 CA-C-N 119.481 1.037 . . . . 0.0 110.382 168.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.51 85.17 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 125.078 3.852 . . . . 0.0 111.753 -168.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.403 ' HA ' ' HA3' ' A' ' 46' ' ' GLY . 8.5 p -75.16 137.62 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 124.725 1.21 . . . . 0.0 109.674 -163.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.5 ttt180 -116.82 106.74 13.8 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 104.108 -2.553 . . . . 0.0 104.108 177.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.4 ' HE2' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -125.11 142.96 51.17 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.557 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 10.5 m80 -78.08 136.79 37.96 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 165.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -124.27 163.17 22.2 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 173.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 22.3 t30 -157.23 137.15 12.48 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 119.4 1.0 . . . . 0.0 109.113 169.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 66.3 mt -94.56 146.16 24.31 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.512 1.125 . . . . 0.0 108.909 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.5 p90 . . . . . 0 C--O 1.247 0.942 0 C-N-CA 125.173 1.389 . . . . 0.0 111.673 -176.427 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.5 t . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt -81.24 102.67 10.51 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 122.073 -0.392 . . . . 0.0 110.862 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 63.5 mt -111.09 124.69 68.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 O-C-N 123.433 0.458 . . . . 0.0 110.655 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -163.89 179.85 6.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.722 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.81 83.65 4.81 Favored Pre-proline 0 C--O 1.241 0.635 0 CA-C-O 121.885 0.85 . . . . 0.0 110.806 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.3 139.44 41.83 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.145 1.896 . . . . 0.0 112.035 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -49.4 146.96 6.03 Favored Pre-proline 0 C--O 1.233 0.185 0 CA-C-O 121.383 0.611 . . . . 0.0 111.18 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.01 -9.13 25.52 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.574 2.182 . . . . 0.0 112.553 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.91 -50.95 12.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.813 0.34 . . . . 0.0 110.673 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.11 -34.34 73.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.855 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 mt -62.82 -42.94 99.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.849 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -57.85 -33.92 69.17 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 119.104 -0.474 . . . . 0.0 110.987 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -78.03 -38.88 43.68 Favored 'General case' 0 C--N 1.332 -0.174 0 O-C-N 124.419 1.074 . . . . 0.0 110.503 -179.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.3 mp -59.11 -19.71 47.01 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 122.997 0.519 . . . . 0.0 111.165 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 63.32 43.2 6.32 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 123.445 0.466 . . . . 0.0 110.466 -178.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.7 t -56.93 -23.53 18.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.971 0.415 . . . . 0.0 110.964 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -72.2 -19.52 61.72 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.417 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.62 -7.75 54.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 179.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 40.1 m0 -79.72 155.16 75.94 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.875 0.369 . . . . 0.0 110.7 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 131.25 20.77 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.447 2.098 . . . . 0.0 112.253 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.0 mt -80.98 141.26 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.751 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 86.5 t90 -139.55 117.36 11.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.611 178.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.49 153.67 31.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.761 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.89 162.94 30.98 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.981 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.3 pm0 -70.12 176.48 3.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.207 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.4 t -77.19 -4.3 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.373 0.606 . . . . 0.0 111.394 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.9 t -77.13 174.02 11.17 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.081 -0.648 . . . . 0.0 112.044 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -107.69 174.51 5.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.485 -177.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 18.7 p90 178.55 179.81 0.35 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.293 -178.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -119.77 111.9 18.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.231 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 10.3 t-105 -97.26 151.87 19.43 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-O 120.847 0.356 . . . . 0.0 110.188 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -131.23 113.17 13.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.453 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -91.89 135.07 34.22 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.556 0.535 . . . . 0.0 110.737 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -125.44 22.88 7.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.983 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -179.74 150.37 0.4 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.867 0.365 . . . . 0.0 110.936 -179.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -51.83 104.35 0.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.75 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -123.29 83.86 2.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.101 0.477 . . . . 0.0 109.97 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 80.2 m -60.1 147.35 39.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.077 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 4.1 p -146.28 133.69 20.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.871 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -116.19 116.25 27.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.935 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 25.0 mm -77.24 136.03 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.829 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.59 -30.04 4.59 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 123.524 0.515 . . . . 0.0 111.417 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.42 ' HA ' ' HB3' ' A' ' 62' ' ' LYS . 15.1 pt-20 -162.15 155.51 20.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.309 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.56 179.75 33.51 Favored Glycine 0 N--CA 1.451 -0.311 0 O-C-N 123.503 0.502 . . . . 0.0 112.217 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.41 ' HB3' ' HE2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -127.17 166.87 16.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.033 0.444 . . . . 0.0 110.886 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.453 HG13 HG13 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -174.08 141.65 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.355 -177.722 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 2.7 mt-10 -132.4 90.97 2.86 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.53 0.681 . . . . 0.0 110.202 178.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.9 t -78.43 110.57 14.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 O-C-N 122.022 -0.424 . . . . 0.0 110.966 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 90.6 m -107.76 105.66 15.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.737 0.303 . . . . 0.0 110.803 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.8 p -64.35 154.91 33.97 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.95 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -51.73 -38.19 54.26 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.023 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -52.84 -29.38 27.58 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.445 0.641 . . . . 0.0 110.85 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 113.79 0.62 24.37 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 121.326 -0.464 . . . . 0.0 112.057 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -85.06 115.9 23.13 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 122.535 -0.391 . . . . 0.0 110.473 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.5 mttm -79.92 157.05 26.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.891 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -148.63 92.26 1.98 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.146 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 1.8 p -83.92 123.7 39.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.154 0.502 . . . . 0.0 111.015 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.456 ' H ' HG12 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -113.68 143.75 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.422 179.656 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -139.93 -173.44 3.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.447 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.42 ' HB3' ' HA ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -69.47 67.06 0.21 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.069 0.461 . . . . 0.0 111.421 179.288 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 160.23 37.66 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.383 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -154.36 102.94 2.47 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 117.206 0.503 . . . . 0.0 110.946 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.32 128.78 33.95 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.568 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.4 ' CG2' HG23 ' A' ' 60' ' ' ILE . 8.2 t -117.91 147.09 21.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 O-C-N 123.647 0.592 . . . . 0.0 110.661 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.2 m -142.97 101.03 3.76 Favored 'General case' 0 C--O 1.25 1.107 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.947 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -77.05 147.53 77.05 Favored Pre-proline 0 C--N 1.344 0.335 0 O-C-N 124.621 1.201 . . . . 0.0 111.259 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.12 -166.34 0.23 Allowed 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 123.51 2.806 . . . . 0.0 111.969 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -95.46 67.05 2.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.853 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.29 82.26 0.13 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.171 178.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 49.3 tp -146.82 146.92 30.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.557 0.218 . . . . 0.0 110.859 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.76 141.98 51.67 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.927 178.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 6.1 p -179.46 175.3 0.92 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.057 0.456 . . . . 0.0 110.962 176.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -95.15 159.61 14.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.018 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 2.0 m95 -131.84 78.22 1.81 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.836 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.69 93.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.642 -0.253 . . . . 0.0 111.0 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.2 t -76.04 67.2 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.006 0.432 . . . . 0.0 110.699 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.1 mt -47.92 -29.41 3.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.292 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -145.2 165.23 22.71 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.35 0.595 . . . . 0.0 111.054 178.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.95 87.49 0.45 Allowed 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 123.203 2.602 . . . . 0.0 112.356 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.7 p -80.13 151.31 4.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.983 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -136.4 64.23 1.56 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.728 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.43 177.27 8.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.134 179.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -116.68 102.7 9.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.614 178.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -85.57 154.74 21.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.11 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -162.46 104.69 1.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.617 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 16.1 mt -68.47 149.36 49.37 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.672 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.8 p90 . . . . . 0 C--O 1.236 0.378 0 CA-C-O 118.773 -0.632 . . . . 0.0 110.712 179.964 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.714 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.329 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.3 mp0 -69.26 164.37 22.91 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 120.404 1.456 . . . . 0.0 109.326 163.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.1 t 50.2 79.88 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 126.909 2.084 . . . . 0.0 110.534 173.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.6 tptm -75.0 118.92 18.49 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 175.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 82.8 mt -130.81 129.64 63.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 174.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -155.38 175.58 13.69 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 122.973 0.509 . . . . 0.0 110.631 171.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.06 85.44 5.24 Favored Pre-proline 0 N--CA 1.451 -0.416 0 C-N-CA 124.312 1.045 . . . . 0.0 108.526 -177.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.42 165.18 31.45 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.977 2.452 . . . . 0.0 112.095 -175.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.3 t -61.18 144.22 91.56 Favored Pre-proline 0 C--O 1.239 0.551 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 164.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.81 -18.14 28.56 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.013 1.809 . . . . 0.0 112.146 175.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -64.33 -52.65 57.37 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.908 0.776 . . . . 0.0 110.158 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.4 tttt -61.92 -33.16 73.75 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 123.205 0.602 . . . . 0.0 110.716 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 79.5 mt -63.82 -24.12 67.63 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.401 -0.812 . . . . 0.0 112.408 175.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -67.49 -49.14 64.84 Favored 'General case' 0 CA--C 1.522 -0.134 0 O-C-N 120.667 -1.27 . . . . 0.0 108.428 169.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -66.94 -36.04 81.35 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.093 0.957 . . . . 0.0 110.95 -169.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.28 -12.31 5.39 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.917 1.687 . . . . 0.0 112.932 172.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . 0.255 68.2 p 60.69 35.02 19.86 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 128.27 2.628 . . . . 0.0 113.021 -175.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.6 t -55.76 -30.46 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.074 0.95 . . . . 0.0 112.801 -177.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -60.2 -26.23 66.2 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 120.437 1.471 . . . . 0.0 112.864 172.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.1 mttm -91.78 -9.03 45.04 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.127 1.371 . . . . 0.0 111.004 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 35.7 m0 -73.09 161.48 79.14 Favored Pre-proline 0 C--O 1.237 0.395 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -65.14 136.29 47.22 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.629 1.553 . . . . 0.0 111.063 173.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.6 mt -70.16 152.5 9.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 162.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.404 ' CE3' ' HD2' ' A' ' 84' ' ' LYS . 59.6 t90 -136.21 149.09 48.41 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 156.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.07 152.97 49.31 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 128.779 2.831 . . . . 0.0 107.996 177.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.45 ' HE3' ' CE2' ' A' ' 31' ' ' PHE . 21.6 tptp -156.6 159.33 38.38 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.231 -0.918 . . . . 0.0 109.748 176.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -69.49 167.81 15.91 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 127.759 2.424 . . . . 0.0 114.216 172.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.2 p -79.33 37.99 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 130.461 3.504 . . . . 0.0 112.73 -175.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.7 t -100.3 -167.71 1.48 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.211 1.405 . . . . 0.0 109.603 -173.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -139.6 145.28 38.35 Favored 'General case' 0 C--N 1.333 -0.114 0 O-C-N 120.461 -1.399 . . . . 0.0 108.867 161.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.45 ' CE2' ' HE3' ' A' ' 26' ' ' LYS . 18.4 p90 -151.13 179.22 8.47 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.629 1.572 . . . . 0.0 108.473 176.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -121.59 128.85 52.39 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.386 1.074 . . . . 0.0 108.981 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 40.2 t-105 -115.41 160.77 19.45 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 122.042 0.925 . . . . 0.0 112.626 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -128.74 111.94 13.67 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 127.22 2.208 . . . . 0.0 107.813 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -85.07 127.51 34.25 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 167.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -120.75 -3.12 9.76 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.966 1.706 . . . . 0.0 110.978 -173.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.57 171.61 16.83 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 129.853 3.261 . . . . 0.0 108.193 175.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -71.83 147.56 47.07 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -175.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -149.84 119.59 7.05 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 175.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 39.9 m -96.57 126.36 41.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 175.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -142.09 125.43 16.56 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.681 1.192 . . . . 0.0 109.525 -173.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -105.06 123.51 47.93 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.255 1.422 . . . . 0.0 108.534 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 48.8 mm -78.19 112.41 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 123.962 0.905 . . . . 0.0 108.702 177.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.509 ' O ' ' HE3' ' A' ' 62' ' ' LYS . 2.4 mp -97.69 -21.75 16.84 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 118.071 -0.966 . . . . 0.0 112.806 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -167.68 149.11 5.47 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 173.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.93 178.76 29.21 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.862 1.22 . . . . 0.0 114.448 173.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.404 ' HE3' ' O ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -133.79 140.61 47.03 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 118.017 0.908 . . . . 0.0 111.145 -173.616 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.404 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 66.1 t -141.19 147.79 22.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -112.68 99.74 8.17 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 160.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.9 t -70.61 157.78 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 164.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -147.86 136.0 21.3 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 164.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 74.5 p -83.3 175.7 9.69 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.027 0.376 . . . . 0.0 110.337 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -65.23 -27.05 68.4 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.423 0.63 . . . . 0.0 111.732 -177.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.08 -4.18 4.53 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.693 1.997 . . . . 0.0 111.94 171.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.27 5.09 65.67 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 126.04 1.781 . . . . 0.0 113.567 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 46.0 mmtt -65.94 127.81 33.54 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 105.547 -2.019 . . . . 0.0 105.547 174.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -86.24 145.51 26.93 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 171.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -134.38 84.82 2.14 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 124.127 1.917 . . . . 0.0 108.683 166.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.6 p -60.28 143.59 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 CA-C-N 111.765 -2.471 . . . . 0.0 109.931 152.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.9 pt -139.09 132.7 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 C-N-CA 128.208 2.603 . . . . 0.0 105.203 177.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -111.81 -179.39 3.68 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.147 0.979 . . . . 0.0 108.84 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.509 ' HE3' ' O ' ' A' ' 44' ' ' LEU . 75.0 tttt -64.25 107.91 1.44 Allowed 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 175.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 128.57 -15.71 5.99 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 118.578 -1.123 . . . . 0.0 112.979 -175.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -85.88 120.58 27.44 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 119.488 1.644 . . . . 0.0 108.408 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 25.3 tp -83.84 146.76 27.93 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 158.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.8 t -132.89 149.5 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 124.788 1.235 . . . . 0.0 108.104 177.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 87.9 m -131.8 111.68 11.83 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 159.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -80.38 144.82 58.28 Favored Pre-proline 0 C--O 1.236 0.363 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 165.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -85.98 178.08 4.37 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.203 1.935 . . . . 0.0 111.357 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -73.49 93.91 2.05 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 113.492 -1.686 . . . . 0.0 109.406 174.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.39 86.72 1.94 Allowed Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.263 1.411 . . . . 0.0 110.775 175.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 33.5 tp -153.67 140.62 19.23 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.084 0.954 . . . . 0.0 109.879 169.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.39 109.47 13.34 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.766 1.626 . . . . 0.0 108.192 -173.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 8.1 p -139.9 166.24 25.16 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.817 1.19 . . . . 0.0 110.179 -172.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.69 162.02 19.85 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.819 -1.176 . . . . 0.0 109.53 174.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -131.99 110.36 10.7 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.468 1.507 . . . . 0.0 107.642 168.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.7 tttp -102.23 103.74 14.26 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 174.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 t -82.75 99.84 5.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 -176.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.6 mt -88.62 -12.76 41.66 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 118.293 -0.861 . . . . 0.0 110.87 -174.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -150.58 154.03 34.86 Favored Pre-proline 0 N--CA 1.45 -0.441 0 C-N-CA 126.616 1.966 . . . . 0.0 106.792 160.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -57.43 139.02 88.86 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 N-CA-C 108.135 -1.525 . . . . 0.0 108.135 177.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.4 p -125.09 156.0 33.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -168.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -130.15 117.0 19.26 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 173.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.404 ' HD2' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -130.09 116.04 17.94 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.408 0.683 . . . . 0.0 112.368 177.713 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 11.4 m80 -66.69 119.95 12.65 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 105.931 -1.878 . . . . 0.0 105.931 170.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -119.51 164.88 15.13 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 123.76 0.824 . . . . 0.0 110.884 -177.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -152.52 125.91 8.74 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 162.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 32.4 mt -73.84 148.47 42.37 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.314 1.446 . . . . 0.0 108.804 174.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.4 p90 . . . . . 0 C--O 1.251 1.155 0 C-N-CA 126.578 1.951 . . . . 0.0 109.681 177.143 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 ttm . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 111.039 0.014 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -153.1 20.88 0.57 Allowed 'General case' 0 N--CA 1.471 0.587 0 O-C-N 120.14 -1.6 . . . . 0.0 112.338 171.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.8 t 49.0 93.62 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 128.447 2.699 . . . . 0.0 111.639 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -72.4 133.27 44.82 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -173.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.6 mt -134.84 133.18 54.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 171.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -134.36 171.58 14.08 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.632 0.773 . . . . 0.0 109.305 172.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.49 84.93 12.7 Favored Pre-proline 0 N--CA 1.464 0.271 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 175.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -75.07 159.54 40.98 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 121.937 1.758 . . . . 0.0 110.761 -175.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 t -64.87 143.45 98.82 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 170.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.51 -24.74 25.91 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 121.562 1.508 . . . . 0.0 112.439 -177.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -63.3 -42.13 99.02 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.348 1.459 . . . . 0.0 111.115 175.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.9 tptt -57.88 -43.62 86.18 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 175.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -66.97 -30.79 71.01 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 122.755 0.422 . . . . 0.0 110.752 -176.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -58.97 -52.54 65.31 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.122 0.874 . . . . 0.0 109.373 168.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -58.44 -46.48 86.44 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.898 0.879 . . . . 0.0 111.265 -174.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 75.5 mt -60.9 -5.7 1.48 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.703 1.201 . . . . 0.0 113.306 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.5 m 62.49 41.04 10.16 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 126.243 1.817 . . . . 0.0 109.742 167.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.9 t -58.83 -30.45 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 128.176 2.59 . . . . 0.0 110.379 176.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -58.44 -16.32 14.49 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.835 0.854 . . . . 0.0 112.823 170.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -102.44 -2.27 29.07 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.539 1.535 . . . . 0.0 112.048 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 33.2 m0 -82.69 165.28 42.78 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.79 143.04 54.29 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 121.939 1.759 . . . . 0.0 111.172 169.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 75.5 mt -79.32 151.83 4.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 164.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.409 ' CE3' ' HE3' ' A' ' 84' ' ' LYS . 14.9 t90 -138.84 144.99 39.48 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 154.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -145.69 162.8 36.74 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.824 1.25 . . . . 0.0 110.178 175.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.408 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 5.2 tmtt? -156.74 156.85 34.05 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 124.486 1.115 . . . . 0.0 108.036 -176.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.87 168.71 9.28 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 122.248 1.023 . . . . 0.0 112.175 174.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.5 p -75.74 62.97 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 128.711 2.804 . . . . 0.0 109.258 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.7 t -129.72 -162.46 1.21 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.4 2.28 . . . . 0.0 107.974 -175.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.36 159.66 43.43 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 120.337 -1.477 . . . . 0.0 110.321 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -171.41 -164.27 0.33 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.816 2.046 . . . . 0.0 108.399 -171.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -132.88 150.08 52.19 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.79 2.036 . . . . 0.0 107.406 170.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 34.4 t-105 -127.18 150.38 49.54 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.355 0.525 . . . . 0.0 111.04 174.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -120.66 121.98 39.49 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 124.691 1.196 . . . . 0.0 109.181 170.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -91.53 119.21 31.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.093 1.357 . . . . 0.0 107.432 174.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -117.01 12.43 14.59 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.584 1.154 . . . . 0.0 111.075 176.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.6 170.44 15.82 Favored 'General case' 0 CA--C 1.523 -0.079 0 C-N-CA 124.402 1.081 . . . . 0.0 110.65 158.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -60.89 117.07 4.98 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 103.178 -2.897 . . . . 0.0 103.178 166.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -130.63 76.44 1.72 Allowed 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -170.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.3 m -63.96 145.4 55.92 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -175.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 27.7 p -145.43 153.76 41.53 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 119.923 -0.711 . . . . 0.0 112.331 166.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -124.52 112.93 17.45 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.284 1.834 . . . . 0.0 107.854 -176.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.6 mm -69.88 136.67 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 126.487 1.915 . . . . 0.0 107.261 173.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.403 HD12 ' HD1' ' A' ' 85' ' ' HIS . 26.1 mt -125.08 -47.16 1.78 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.317 1.047 . . . . 0.0 108.805 -171.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -147.4 159.91 43.15 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 165.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.13 178.83 31.64 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 124.84 1.21 . . . . 0.0 113.528 174.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.76 144.92 31.43 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.651 0.739 . . . . 0.0 112.483 -170.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.3 t -142.63 159.73 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -122.54 119.61 31.38 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 159.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 41.2 t -103.14 92.29 2.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 51.3 m -79.09 103.1 8.8 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.647 1.179 . . . . 0.0 108.409 177.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 64.1 p -82.97 172.92 12.26 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.873 -0.517 . . . . 0.0 109.928 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -71.8 -29.01 64.0 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.385 0.612 . . . . 0.0 112.596 -166.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -73.62 0.16 13.57 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.464 1.105 . . . . 0.0 111.182 173.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.5 -14.86 64.32 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 127.951 2.691 . . . . 0.0 112.875 177.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -63.52 120.18 11.22 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.624 1.57 . . . . 0.0 107.718 -173.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.06 100.93 9.52 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.637 1.175 . . . . 0.0 110.068 -169.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -83.42 108.2 16.43 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 -177.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 40.3 t -66.92 140.18 19.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 104.77 -2.307 . . . . 0.0 104.77 154.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.1 pt -134.74 99.97 2.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 174.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -81.5 172.9 12.94 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.183 0.993 . . . . 0.0 109.916 168.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.2 pttm -52.87 127.16 22.6 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.812 0.815 . . . . 0.0 109.862 169.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.91 -28.47 13.84 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-O 117.965 -1.464 . . . . 0.0 114.321 175.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.22 101.71 1.94 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 120.736 2.268 . . . . 0.0 107.933 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.4 tp -77.44 134.28 38.42 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.7 t -116.75 146.9 20.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -174.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.8 m -138.83 99.7 3.86 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 125.09 1.356 . . . . 0.0 108.094 165.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -63.18 165.55 10.48 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 124.027 0.931 . . . . 0.0 109.403 161.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -88.41 174.76 4.16 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 CA-C-N 120.098 1.071 . . . . 0.0 112.357 164.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -74.73 91.77 2.41 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 168.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 117.9 84.33 0.99 Allowed Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.281 1.419 . . . . 0.0 110.473 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.5 tt -150.95 130.88 13.32 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.362 1.465 . . . . 0.0 108.806 171.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -104.52 134.31 47.92 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 165.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 26.7 p -151.49 167.3 28.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 119.138 0.881 . . . . 0.0 111.547 169.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.01 164.51 25.0 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.435 0.636 . . . . 0.0 111.484 168.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -143.42 101.02 3.72 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 113.76 -1.563 . . . . 0.0 108.805 -175.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 tptt -95.05 107.68 19.74 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 168.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.1 t -75.67 111.82 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 104.335 -2.469 . . . . 0.0 104.335 165.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 74.7 mt -84.64 -27.32 27.23 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -152.06 153.98 31.96 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 124.966 1.306 . . . . 0.0 109.919 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -53.83 128.32 29.13 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.104 2.536 . . . . 0.0 109.467 175.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.5 p -135.76 138.21 48.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -167.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -128.25 67.98 1.36 Allowed 'General case' 0 C--O 1.223 -0.309 0 CA-C-O 121.16 0.505 . . . . 0.0 110.099 -171.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.409 ' HE3' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -80.1 154.52 28.03 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -175.323 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.403 ' HD1' HD12 ' A' ' 44' ' ' LEU . 4.9 m80 -94.38 142.43 27.43 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 163.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -131.22 159.02 38.99 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.205 0.911 . . . . 0.0 110.959 176.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -146.37 132.96 19.81 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 122.907 0.483 . . . . 0.0 109.71 170.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 90.0 mt -86.04 135.77 33.5 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.45 1.1 . . . . 0.0 108.463 174.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 6.0 p90 . . . . . 0 C--O 1.249 1.046 0 C-N-CA 124.029 0.932 . . . . 0.0 110.953 -176.67 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.7 mtp . . . . . 0 N--CA 1.469 0.507 0 CA-C-O 118.495 -0.764 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -70.07 155.78 40.11 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 119.712 1.142 . . . . 0.0 110.452 178.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.1 t -75.12 142.0 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.377 1.471 . . . . 0.0 107.52 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -104.23 114.59 28.93 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 175.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.4 mt -132.36 129.78 59.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 124.747 1.219 . . . . 0.0 108.258 -176.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -162.42 171.23 17.47 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.395 1.078 . . . . 0.0 109.887 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.49 85.88 2.48 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 123.504 0.722 . . . . 0.0 110.132 176.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -65.56 162.8 32.52 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.474 2.116 . . . . 0.0 112.377 -177.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.4 t -58.3 144.64 77.08 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 123.55 0.74 . . . . 0.0 109.389 169.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.22 -30.77 30.45 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.338 1.359 . . . . 0.0 113.065 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -57.83 -44.55 86.52 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.768 1.167 . . . . 0.0 112.237 -175.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.3 tptt -57.16 -45.53 83.53 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 123.908 0.883 . . . . 0.0 110.143 177.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.49 -23.71 67.51 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.214 0.606 . . . . 0.0 111.527 -174.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.8 mttt -72.17 -48.56 42.43 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -58.67 -43.96 90.06 Favored 'General case' 0 CA--C 1.522 -0.107 0 C-N-CA 124.407 1.083 . . . . 0.0 110.329 -176.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 81.4 mt -62.05 -8.68 5.7 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.866 1.667 . . . . 0.0 114.811 -176.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.0 m 65.97 30.01 9.92 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.228 1.411 . . . . 0.0 112.182 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.9 t -52.27 -33.06 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 125.636 1.574 . . . . 0.0 110.412 173.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -53.62 -32.97 53.4 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 171.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -84.89 -19.69 31.91 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 118.128 -0.939 . . . . 0.0 112.179 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 41.1 m0 -66.01 160.16 65.28 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -171.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -65.96 132.59 30.66 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.84 1.693 . . . . 0.0 111.361 176.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.1 mt -71.14 139.5 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 162.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.541 ' CE3' ' HE3' ' A' ' 84' ' ' LYS . 69.7 t90 -133.49 122.56 23.81 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 161.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -124.47 159.36 30.68 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.462 1.505 . . . . 0.0 107.818 173.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -157.39 164.05 37.93 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -171.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.29 -176.38 2.62 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 122.425 1.107 . . . . 0.0 110.438 175.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.7 p -68.2 0.33 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 126.323 1.849 . . . . 0.0 112.383 167.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 p -71.74 129.59 39.04 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 120.065 -1.647 . . . . 0.0 110.81 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.51 157.5 16.99 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.238 1.015 . . . . 0.0 110.021 -177.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -164.21 -164.25 0.84 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 126.503 1.921 . . . . 0.0 107.122 -171.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -138.75 157.24 46.45 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 126.09 1.756 . . . . 0.0 108.698 173.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 22.1 t-105 -144.27 138.39 27.93 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.561 0.744 . . . . 0.0 111.181 -174.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -103.15 145.1 30.43 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.714 1.606 . . . . 0.0 107.806 168.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -118.04 123.13 44.92 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.399 1.48 . . . . 0.0 107.737 173.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.71 -5.64 12.13 Favored 'General case' 0 N--CA 1.461 0.092 0 C-N-CA 126.232 1.813 . . . . 0.0 112.564 -170.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.81 175.19 9.9 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 131.512 3.925 . . . . 0.0 106.539 166.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -70.32 139.71 52.1 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -122.52 114.45 20.68 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 163.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 20.0 m -89.79 132.98 34.95 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 159.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 27.4 p -138.89 161.82 36.36 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.338 0.589 . . . . 0.0 110.812 164.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -122.52 128.76 51.2 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.0 mm -87.02 102.3 12.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 128.806 2.842 . . . . 0.0 106.797 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.431 ' O ' ' HE2' ' A' ' 62' ' ' LYS . 2.4 mm? -81.41 -26.5 35.35 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 123.504 0.722 . . . . 0.0 111.062 -174.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -176.67 148.94 0.73 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.144 2.177 . . . . 0.0 106.086 -174.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.26 -177.11 28.43 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.275 1.417 . . . . 0.0 113.788 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.0 148.48 38.62 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.116 0.958 . . . . 0.0 109.748 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.5 t -138.22 156.52 30.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 125.039 1.335 . . . . 0.0 107.731 176.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -120.81 139.05 53.68 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 125.597 1.559 . . . . 0.0 108.066 165.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.9 t -133.93 120.2 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 83.2 m -111.83 105.15 13.54 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.531 1.533 . . . . 0.0 107.902 167.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.0 p -68.08 165.5 17.94 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 173.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -74.32 -14.7 60.93 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 123.278 1.513 . . . . 0.0 113.29 -161.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -52.04 -21.63 3.34 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 127.437 2.295 . . . . 0.0 113.083 161.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.41 4.65 90.08 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.686 1.136 . . . . 0.0 111.868 -165.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -71.1 144.97 50.12 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 119.326 1.563 . . . . 0.0 108.125 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -108.09 145.2 34.4 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -173.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -141.73 132.15 25.2 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 69.4 t -136.36 118.59 20.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 -171.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.1 pt -124.63 106.1 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 O-C-N 123.808 0.693 . . . . 0.0 109.151 -169.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -90.72 178.05 6.17 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 122.677 1.227 . . . . 0.0 109.863 171.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.431 ' HE2' ' O ' ' A' ' 44' ' ' LEU . 22.9 tttm -51.11 108.06 0.22 Allowed 'General case' 0 C--O 1.237 0.423 0 C-N-CA 127.527 2.331 . . . . 0.0 109.805 176.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.52 -16.41 26.58 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 117.591 -1.672 . . . . 0.0 114.65 175.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -70.75 102.17 2.26 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 120.368 2.084 . . . . 0.0 108.901 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.0 tp -71.04 141.38 50.91 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.1 t -125.56 145.06 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 97.3 m -129.7 118.1 21.35 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 158.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -88.45 145.77 36.24 Favored Pre-proline 0 C--O 1.237 0.402 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 162.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -84.27 177.26 5.97 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.286 1.991 . . . . 0.0 112.259 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 30.3 tttm -76.82 81.39 3.41 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 113.95 -1.477 . . . . 0.0 107.851 169.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.59 81.32 0.47 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 125.504 1.526 . . . . 0.0 111.774 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.6 tt -148.2 128.24 13.64 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 118.535 1.167 . . . . 0.0 110.694 174.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.407 HH12 ' NH2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -112.7 116.72 30.58 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.377 1.471 . . . . 0.0 108.436 177.659 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 17.6 p -148.85 176.63 10.24 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.509 1.05 . . . . 0.0 113.393 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.407 ' NH2' HH12 ' A' ' 73' ' ' ARG . 0.0 OUTLIER -81.11 177.01 9.3 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.981 1.312 . . . . 0.0 111.855 171.047 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -158.16 100.59 1.7 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 119.932 1.242 . . . . 0.0 109.663 174.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.6 tttt -104.22 111.2 23.71 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.4 t -77.18 116.67 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 N-CA-C 103.157 -2.905 . . . . 0.0 103.157 171.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.9 mt -88.12 -25.52 22.96 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 119.346 -0.941 . . . . 0.0 109.381 171.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -144.36 150.16 47.1 Favored Pre-proline 0 C--O 1.232 0.136 0 CA-C-O 117.819 -1.086 . . . . 0.0 111.051 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -58.81 114.36 1.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.431 2.754 . . . . 0.0 108.232 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.1 p -124.39 143.84 36.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 125.18 1.392 . . . . 0.0 107.446 -163.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.5 mtt180 -115.3 113.57 24.01 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 174.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.541 ' HE3' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -114.37 125.59 54.04 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 167.295 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -76.61 123.53 26.25 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 103.333 -2.84 . . . . 0.0 103.333 169.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -121.66 160.58 24.15 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.058 0.845 . . . . 0.0 110.361 -176.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -142.1 149.59 40.04 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 165.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.5 mt -108.71 129.05 55.36 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.5 p90 . . . . . 0 C--O 1.251 1.172 0 C-N-CA 124.818 1.247 . . . . 0.0 108.597 -173.56 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.3 mtt . . . . . 0 N--CA 1.47 0.557 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.446 ' HG2' ' H ' ' A' ' 3' ' ' VAL . 4.9 tt0 57.56 -173.21 0.08 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.148 0.979 . . . . 0.0 109.392 -158.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.446 ' H ' ' HG2' ' A' ' 2' ' ' GLU . 2.2 p -73.99 146.39 10.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 169.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -127.81 147.47 50.43 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.157 1.383 . . . . 0.0 107.379 174.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 90.5 mt -124.73 142.27 42.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 165.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -160.24 177.59 10.49 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.098 1.359 . . . . 0.0 110.283 166.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.468 ' HE2' ' OD1' ' A' ' 64' ' ' ASP . 0.5 OUTLIER -116.86 85.3 17.24 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 124.067 0.947 . . . . 0.0 108.667 -172.237 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.16 -4.42 15.16 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 124.904 3.736 . . . . 0.0 114.687 -164.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.324 2.1 t 55.44 146.29 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 129.187 2.995 . . . . 0.0 113.39 -169.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -58.04 -17.76 32.81 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.632 2.221 . . . . 0.0 112.2 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -47.44 -61.55 1.86 Allowed 'General case' 0 C--O 1.231 0.112 0 CA-C-N 119.517 1.053 . . . . 0.0 111.297 165.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -67.4 -38.28 84.42 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -178.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.17 -24.25 61.4 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 118.562 -0.732 . . . . 0.0 112.937 -175.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -60.93 -55.1 36.9 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 120.397 1.453 . . . . 0.0 107.541 167.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -74.42 -26.64 60.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.769 -164.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 mp -68.0 -9.92 49.47 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.24 1.416 . . . . 0.0 112.766 170.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.3 m 61.54 33.1 18.56 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.311 1.844 . . . . 0.0 112.369 -174.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.2 t -57.19 -27.59 28.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 O-C-N 121.633 -0.667 . . . . 0.0 111.97 -172.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -54.58 -26.39 32.04 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.763 1.165 . . . . 0.0 113.574 173.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? -86.56 -26.28 24.57 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.004 0.921 . . . . 0.0 111.64 -173.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 36.7 m0 -62.84 160.05 40.19 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 124.623 1.169 . . . . 0.0 109.529 -170.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -69.35 118.59 5.77 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.251 1.967 . . . . 0.0 112.407 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.6 mt -61.98 142.08 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 176.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.596 ' CE3' ' HE3' ' A' ' 84' ' ' LYS . 59.5 t90 -135.3 143.14 46.05 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 165.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -151.93 161.84 42.01 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.701 1.601 . . . . 0.0 111.067 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.0 mmtt -143.84 176.35 9.32 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.291 0.636 . . . . 0.0 109.347 -178.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -69.82 -165.95 0.1 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.781 2.033 . . . . 0.0 110.756 169.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.5 p -109.85 25.07 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 126.691 1.996 . . . . 0.0 111.447 -175.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.7 t -96.29 -178.34 4.27 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 126.693 1.997 . . . . 0.0 109.199 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -120.79 161.46 21.44 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 123.937 0.895 . . . . 0.0 110.125 173.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -163.75 -168.03 1.53 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.712 2.005 . . . . 0.0 108.248 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -121.29 152.02 39.4 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 168.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 51.9 t-105 -130.97 179.55 5.92 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.607 0.763 . . . . 0.0 109.936 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -148.02 151.27 35.45 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.398 1.479 . . . . 0.0 107.287 171.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -131.41 98.97 4.68 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.624 1.17 . . . . 0.0 108.534 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -90.89 9.86 28.69 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.966 1.706 . . . . 0.0 112.202 -177.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.426 HG22 ' HE2' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -158.46 162.49 37.53 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 128.486 2.714 . . . . 0.0 108.321 -178.273 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -61.48 138.29 58.27 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -144.58 104.66 4.07 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 74.8 m -72.69 143.14 48.19 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 164.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.7 p -153.53 131.62 11.83 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.49 1.041 . . . . 0.0 111.4 175.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -108.61 108.09 18.83 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 126.349 1.859 . . . . 0.0 108.828 -176.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.3 mm -74.8 114.76 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.812 1.245 . . . . 0.0 107.834 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.486 ' CD1' ' HD1' ' A' ' 85' ' ' HIS . 1.3 mp -101.19 -33.48 10.07 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 118.879 -0.581 . . . . 0.0 112.337 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pm0 -154.04 162.73 40.99 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.975 0.91 . . . . 0.0 109.296 172.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.58 -172.37 48.47 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 127.061 2.267 . . . . 0.0 111.32 -173.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.81 148.28 31.73 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -177.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.3 t -136.95 151.96 27.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -123.07 98.01 5.69 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.362 2.265 . . . . 0.0 106.31 168.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.9 t -86.16 136.33 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 170.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 66.8 m -136.45 122.48 20.21 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.183 0.901 . . . . 0.0 108.776 -178.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 72.1 p -76.36 169.81 17.54 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.304 0.573 . . . . 0.0 109.858 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -62.98 -35.9 81.74 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.364 -0.835 . . . . 0.0 110.713 -178.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -82.65 16.16 2.3 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 128.516 2.726 . . . . 0.0 111.694 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.88 4.95 88.74 Favored Glycine 0 CA--C 1.525 0.687 0 O-C-N 119.884 -1.76 . . . . 0.0 114.649 162.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.2 mmtt -67.0 106.78 2.04 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.765 1.783 . . . . 0.0 107.025 167.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.5 tptt -67.2 157.55 33.5 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 163.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -137.0 155.58 49.52 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 104.064 -2.569 . . . . 0.0 104.064 166.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 75.5 t -138.76 129.07 33.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 103.053 -2.943 . . . . 0.0 103.053 178.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.9 pt -134.08 123.23 43.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -103.67 176.12 5.26 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 126.725 2.01 . . . . 0.0 107.817 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.3 pttp -58.11 125.2 22.16 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 164.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.8 -0.07 56.45 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 117.702 -1.61 . . . . 0.0 115.688 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.468 ' OD1' ' HE2' ' A' ' 7' ' ' LYS . 19.1 m-20 -92.1 123.82 35.73 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 120.832 2.316 . . . . 0.0 106.567 166.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.2 tp -88.15 146.73 25.25 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 160.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.4 t -126.07 150.51 31.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 174.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 58.4 m -132.96 111.41 11.01 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 164.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -74.43 155.69 87.52 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 169.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -74.79 -165.2 0.27 Allowed 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.168 2.579 . . . . 0.0 109.381 174.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.426 ' HE2' HG22 ' A' ' 37' ' ' THR . 56.4 tttm -95.25 120.82 36.14 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 162.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.97 87.66 1.06 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.401 1.477 . . . . 0.0 112.634 176.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 57.9 tp -143.88 143.54 31.34 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.952 1.701 . . . . 0.0 108.207 171.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.47 131.28 56.98 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 125.339 1.456 . . . . 0.0 108.11 167.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 7.8 p -165.43 168.43 16.67 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.48 1.112 . . . . 0.0 111.362 169.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.88 167.96 20.85 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 124.578 1.151 . . . . 0.0 112.028 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -144.4 113.11 6.68 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.462 1.105 . . . . 0.0 109.755 178.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.53 109.27 19.53 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 175.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.0 t -86.8 101.26 10.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 175.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.9 mt -83.39 -18.9 37.18 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-O 118.777 -0.63 . . . . 0.0 111.717 -175.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -148.25 146.15 22.4 Favored Pre-proline 0 C--O 1.236 0.356 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 166.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -61.54 90.74 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.491 1 C-N-CA 125.542 4.161 . . . . 0.0 110.87 -165.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.35 149.31 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 123.936 0.895 . . . . 0.0 109.754 -166.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -129.35 112.6 14.01 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 168.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.596 ' HE3' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -133.28 142.15 48.35 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.266 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.486 ' HD1' ' CD1' ' A' ' 44' ' ' LEU . 18.6 m80 -84.34 100.89 11.56 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 171.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -88.8 154.86 19.93 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.154 0.982 . . . . 0.0 110.546 171.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -151.54 112.93 4.35 Favored 'General case' 0 C--O 1.239 0.523 0 O-C-N 121.676 -0.64 . . . . 0.0 110.517 170.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 61.7 mt -61.59 153.29 28.19 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.406 1.482 . . . . 0.0 108.932 171.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.7 p90 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 116.173 -1.87 . . . . 0.0 110.443 166.332 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.2 mtt . . . . . 0 N--CA 1.471 0.584 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 53.99 -169.99 0.06 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.549 1.54 . . . . 0.0 111.413 -170.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.8 p -76.85 105.08 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 108.588 -0.894 . . . . 0.0 108.588 176.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 55.9 tttt -75.7 136.68 40.36 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 171.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.3 mt -135.73 139.74 45.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 169.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -165.32 175.22 9.36 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.145 2.178 . . . . 0.0 108.728 162.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.31 86.35 1.32 Allowed Pre-proline 0 C--O 1.237 0.444 0 CA-C-O 117.88 -1.057 . . . . 0.0 109.19 176.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -63.92 168.01 12.91 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.522 1.481 . . . . 0.0 111.014 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.0 t -69.85 143.5 92.18 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -66.42 -19.4 55.29 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.897 1.731 . . . . 0.0 113.178 176.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -59.89 -47.61 85.06 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 119.733 1.151 . . . . 0.0 109.622 171.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 35.9 tptt -65.34 -37.48 87.19 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 121.45 -0.781 . . . . 0.0 110.451 -177.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.3 mt -67.97 -26.91 66.17 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 118.833 -0.603 . . . . 0.0 111.917 177.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -64.83 -46.87 80.13 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 119.386 0.994 . . . . 0.0 109.814 168.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -60.07 -48.58 81.12 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.387 0.613 . . . . 0.0 109.384 -176.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.7 mp -55.03 -14.76 1.65 Allowed 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 125.947 1.699 . . . . 0.0 112.817 176.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.4 m 53.01 45.01 29.69 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.015 1.326 . . . . 0.0 110.743 175.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 45.8 t -56.59 -31.45 34.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.27 1.028 . . . . 0.0 110.505 -175.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -44.92 -34.56 2.44 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.858 2.063 . . . . 0.0 114.454 167.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.9 mtmm -84.12 -23.53 30.66 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 119.531 1.059 . . . . 0.0 111.418 -177.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 35.1 m0 -64.72 164.43 20.84 Favored Pre-proline 0 C--O 1.24 0.574 0 C-N-CA 124.118 0.967 . . . . 0.0 109.816 -171.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -66.6 139.97 55.15 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 121.118 1.212 . . . . 0.0 110.144 171.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.2 mt -81.18 151.98 4.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 164.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.504 ' CE3' ' HE2' ' A' ' 84' ' ' LYS . 68.3 t90 -140.79 148.0 39.93 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 156.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.7 157.07 44.66 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 126.615 1.966 . . . . 0.0 109.169 -178.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -151.02 169.59 21.42 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.482 0.713 . . . . 0.0 111.625 -174.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -66.18 175.07 2.26 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 122.715 1.245 . . . . 0.0 111.006 164.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.3 t -94.62 27.4 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 128.418 2.687 . . . . 0.0 109.866 -167.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.9 t -91.99 176.59 6.45 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.573 1.149 . . . . 0.0 110.521 -173.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -104.61 142.55 34.46 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.448 1.099 . . . . 0.0 108.092 167.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -147.08 -170.34 3.52 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 127.644 2.377 . . . . 0.0 107.392 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.533 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 1.1 m-20 -128.3 154.87 45.45 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 169.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 48.1 t-105 -134.77 146.05 48.99 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.025 0.53 . . . . 0.0 111.787 175.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -113.82 111.11 21.2 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 171.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -79.49 122.61 26.67 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 170.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.9 p-10 -120.19 6.58 10.74 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 125.916 1.687 . . . . 0.0 111.323 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.96 174.31 15.71 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.082 1.353 . . . . 0.0 108.85 167.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -68.33 87.12 0.29 Allowed 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 125.584 1.554 . . . . 0.0 108.773 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.33 110.32 18.02 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 173.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 73.0 m -88.14 134.7 33.7 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 163.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 24.6 p -140.23 149.18 42.56 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 118.714 0.688 . . . . 0.0 110.053 170.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -126.92 116.71 21.23 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.466 1.507 . . . . 0.0 107.979 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 18.9 mm -80.83 124.96 39.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 126.911 2.084 . . . . 0.0 107.567 -172.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.2 mt -103.12 -26.9 12.86 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 118.634 0.652 . . . . 0.0 112.486 -176.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -158.95 169.39 24.44 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.547 1.939 . . . . 0.0 107.404 174.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.23 -172.26 25.2 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.099 0.857 . . . . 0.0 113.078 169.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.95 143.57 30.61 Favored 'General case' 0 CA--C 1.517 -0.307 0 O-C-N 121.526 -0.985 . . . . 0.0 108.363 175.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 71.6 t -138.48 155.97 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -124.55 127.02 46.78 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 126.381 1.872 . . . . 0.0 106.345 163.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.1 t -113.53 113.06 42.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.403 ' HB ' ' HG2' ' A' ' 75' ' ' ARG . 26.2 m -114.72 103.01 10.56 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 -168.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 38.2 p -78.1 173.15 12.53 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -54.65 -40.6 69.17 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.651 0.78 . . . . 0.0 110.578 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -65.09 -17.38 64.41 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 123.794 0.838 . . . . 0.0 112.361 -175.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.68 0.7 88.26 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -163.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.1 mmtp -63.06 118.36 7.76 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 164.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -130.05 133.29 46.62 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -162.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -127.27 116.64 20.87 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -170.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 77.6 t -76.76 144.88 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 160.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.9 pt -140.92 147.4 22.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 C-N-CA 124.795 1.238 . . . . 0.0 108.914 166.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -138.89 -175.33 4.11 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 126.939 2.096 . . . . 0.0 110.374 176.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -66.85 62.88 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 128.132 2.573 . . . . 0.0 115.795 -162.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 159.6 -6.9 0.13 Allowed Glycine 0 C--N 1.317 -0.475 0 CA-C-O 118.021 -1.433 . . . . 0.0 114.027 -178.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -71.47 128.53 36.15 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 166.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 17.0 tp -88.76 142.09 27.96 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 160.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.6 t -122.35 141.05 44.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 175.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.3 m -127.11 101.21 6.43 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 167.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -65.03 161.82 44.37 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 170.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -71.42 -164.03 0.15 Allowed 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.974 2.45 . . . . 0.0 108.684 167.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -110.14 108.85 19.16 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 165.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.69 85.64 1.88 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.453 1.502 . . . . 0.0 110.669 -175.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.1 tt -147.57 113.81 5.89 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.616 1.966 . . . . 0.0 107.499 173.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.1 ttt180 -81.98 133.18 35.28 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 161.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 29.2 p -147.32 -170.66 3.61 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.507 0.67 . . . . 0.0 109.896 159.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' A' ' 32' ' ' ASP . 5.8 ptp180 -108.06 164.7 12.06 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 173.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -134.07 122.87 23.57 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 119.591 1.087 . . . . 0.0 110.085 175.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.1 tttp -116.18 105.97 13.18 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.5 t -72.92 129.52 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 103.536 -2.764 . . . . 0.0 103.536 166.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 95.0 mt -109.9 -16.36 13.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 117.659 -1.162 . . . . 0.0 110.407 173.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -154.13 145.12 16.26 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 126.594 1.958 . . . . 0.0 107.61 167.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -56.92 125.87 20.38 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 124.345 3.363 . . . . 0.0 111.587 -167.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.7 p -121.45 92.76 2.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-O 124.978 2.323 . . . . 0.0 111.491 -161.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.9 mtm-85 -78.95 119.57 22.3 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 170.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.504 ' HE2' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -128.78 157.17 42.2 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.69 0.757 . . . . 0.0 109.257 173.016 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -94.79 135.85 35.8 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 161.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -130.15 160.48 33.67 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 123.052 0.541 . . . . 0.0 109.871 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -156.55 103.43 2.12 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -172.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 65.5 mt -75.48 145.53 41.35 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 171.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 45.2 p90 . . . . . 0 C--O 1.252 1.187 0 CA-C-O 114.576 -2.63 . . . . 0.0 111.156 164.96 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 mpp? . . . . . 0 N--CA 1.471 0.6 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -150.73 173.65 13.94 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -175.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 74.3 t -95.57 106.84 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 C-N-CA 128.197 2.599 . . . . 0.0 106.868 -176.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.7 tptp -82.2 134.92 35.32 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 168.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.9 mt -140.81 120.2 11.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 168.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -138.45 175.16 9.81 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.323 1.449 . . . . 0.0 109.986 172.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.53 85.47 5.92 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 170.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -65.71 165.24 23.83 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.364 2.043 . . . . 0.0 112.111 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.19 144.72 84.95 Favored Pre-proline 0 C--O 1.239 0.553 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -68.15 -30.74 31.0 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.855 2.37 . . . . 0.0 112.334 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -56.84 -44.04 81.69 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.956 0.798 . . . . 0.0 110.686 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -64.64 -36.95 85.9 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.193 0.597 . . . . 0.0 109.493 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.1 mt -69.09 -28.54 66.58 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.894 -0.504 . . . . 0.0 112.225 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -55.56 -50.82 69.05 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 169.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -60.43 -52.78 63.78 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.408 1.083 . . . . 0.0 110.999 -176.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 93.1 mt -56.39 -20.76 21.02 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 125.962 1.705 . . . . 0.0 112.789 -178.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 74.3 42.51 0.32 Allowed 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.768 2.027 . . . . 0.0 111.149 170.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.7 t -54.33 -33.1 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 118.304 0.502 . . . . 0.0 110.765 -173.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -58.24 -24.76 60.39 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.0 pttp -83.76 -5.66 59.25 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.48 0.712 . . . . 0.0 111.049 -171.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 23.0 m0 -87.54 165.05 32.5 Favored Pre-proline 0 N--CA 1.438 -1.06 0 C-N-CA 124.922 1.289 . . . . 0.0 107.881 -169.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -66.93 135.16 36.88 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 121.653 1.569 . . . . 0.0 110.638 167.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 68.5 mt -78.9 143.1 13.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 164.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -127.24 153.15 46.48 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 162.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -150.72 162.69 40.22 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.902 1.281 . . . . 0.0 109.543 176.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -148.78 157.94 43.8 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 124.957 1.303 . . . . 0.0 109.565 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.3 pm0 -69.47 170.91 9.63 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 124.726 1.266 . . . . 0.0 112.061 167.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.4 t -82.49 74.21 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 125.79 1.636 . . . . 0.0 106.829 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.0 t -145.62 -173.12 4.04 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 175.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.96 149.32 30.22 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 122.417 1.103 . . . . 0.0 112.922 -169.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -157.53 -168.25 2.52 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.146 1.779 . . . . 0.0 108.093 -163.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.0 p30 -119.91 160.64 22.31 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.257 -0.902 . . . . 0.0 108.648 166.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 10.2 t-105 -128.75 168.11 16.32 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.568 0.699 . . . . 0.0 111.257 172.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -142.32 92.35 2.42 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.722 1.609 . . . . 0.0 107.934 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -72.2 118.93 15.69 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 171.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -111.72 -5.12 14.49 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.344 1.458 . . . . 0.0 111.691 -176.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.53 172.56 12.53 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 127.167 2.187 . . . . 0.0 110.233 164.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -62.16 107.64 0.92 Allowed 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 176.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -121.3 75.11 1.14 Allowed 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -175.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.9 m -67.5 135.83 53.63 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 -175.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 29.3 p -142.54 155.96 45.07 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 120.966 0.413 . . . . 0.0 110.128 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 30.8 t80 -132.66 121.0 22.48 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.323 -170.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 16.1 mm -81.07 124.84 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -174.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.2 mt -122.45 -33.71 3.4 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.439 1.096 . . . . 0.0 111.51 -167.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -154.48 162.34 41.2 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 127.39 2.276 . . . . 0.0 105.252 165.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.44 176.51 51.05 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 124.695 1.14 . . . . 0.0 112.186 177.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.26 144.48 27.67 Favored 'General case' 0 CA--C 1.516 -0.356 0 O-C-N 122.249 -0.559 . . . . 0.0 110.27 -156.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 50.6 t -143.65 152.14 16.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-N 117.692 0.223 . . . . 0.0 110.57 -176.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -109.27 128.0 54.72 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.446 1.899 . . . . 0.0 106.951 153.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 94.0 t -107.42 140.06 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 105.726 -1.954 . . . . 0.0 105.726 170.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.9 m -136.47 104.3 5.54 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.442 1.019 . . . . 0.0 109.72 -173.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.0 p -69.74 169.93 11.95 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.182 -0.949 . . . . 0.0 110.518 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -67.67 -29.7 69.05 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.511 -0.743 . . . . 0.0 110.774 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.74 -4.17 2.91 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.085 1.354 . . . . 0.0 112.279 172.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.38 -3.46 86.25 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-O 118.436 -1.202 . . . . 0.0 113.637 167.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -58.38 152.52 17.52 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 167.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -103.64 161.69 13.7 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 156.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -118.93 159.1 24.43 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 153.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 72.8 t -137.47 128.38 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 102.185 -3.265 . . . . 0.0 102.185 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 pt -139.61 142.95 31.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.413 ' OE1' ' HE3' ' A' ' 62' ' ' LYS . 1.3 pp20? -131.71 -176.22 3.97 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.192 1.797 . . . . 0.0 111.771 177.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.413 ' HE3' ' OE1' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -75.23 54.49 0.7 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.38 2.272 . . . . 0.0 115.844 -157.287 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -177.63 -5.81 0.02 OUTLIER Glycine 0 CA--C 1.53 0.981 0 CA-C-O 118.183 -1.343 . . . . 0.0 113.166 172.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.94 140.83 36.51 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 119.253 1.526 . . . . 0.0 108.236 174.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.08 153.82 18.16 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 123.818 0.847 . . . . 0.0 109.592 167.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.8 t -137.07 137.53 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -174.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 98.0 m -131.15 110.48 11.19 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 166.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -73.53 162.9 72.12 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 126.142 1.777 . . . . 0.0 109.207 167.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -83.47 177.1 6.63 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 CA-C-O 122.921 1.134 . . . . 0.0 110.002 169.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.3 tttm -85.55 82.69 8.16 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.084 1.353 . . . . 0.0 107.715 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.21 86.44 0.66 Allowed Glycine 0 CA--C 1.522 0.522 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.9 tp -148.94 103.57 3.37 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.461 0.704 . . . . 0.0 110.823 174.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 27.2 ttt85 -72.86 126.89 31.0 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 156.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 20.4 p -154.14 170.68 20.61 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.899 1.279 . . . . 0.0 108.19 166.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -79.81 158.68 26.75 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 120.956 -1.09 . . . . 0.0 110.89 172.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -139.4 116.34 10.94 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.347 1.459 . . . . 0.0 108.433 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.0 102.39 8.14 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.632 1.573 . . . . 0.0 106.921 -173.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.2 t -80.26 105.22 9.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 104.402 -2.444 . . . . 0.0 104.402 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 17.6 mt -81.91 -27.45 33.38 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -151.22 153.62 32.88 Favored Pre-proline 0 N--CA 1.469 0.484 0 C-N-CA 125.67 1.588 . . . . 0.0 109.439 171.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -65.0 106.47 0.79 Allowed 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.125 2.55 . . . . 0.0 111.16 -164.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.3 p -93.17 111.31 24.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 121.774 0.797 . . . . 0.0 110.611 -166.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -94.45 43.12 1.1 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.754 0.821 . . . . 0.0 111.42 -171.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.62 146.98 39.0 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 120.967 -1.083 . . . . 0.0 111.133 -175.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -78.03 150.05 33.91 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 156.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -139.87 156.88 46.48 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.328 0.967 . . . . 0.0 110.545 172.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -143.36 131.91 22.37 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.143 0.977 . . . . 0.0 109.4 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 95.2 mt -93.01 129.83 38.79 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.297 1.039 . . . . 0.0 108.59 176.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.3 p90 . . . . . 0 C--O 1.247 0.949 0 C-N-CA 124.298 1.039 . . . . 0.0 110.231 -177.171 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.437 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -54.39 151.61 7.42 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.089 0.956 . . . . 0.0 110.015 178.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.1 p -54.33 110.84 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-O 121.594 0.711 . . . . 0.0 110.06 -174.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -109.68 147.82 32.46 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 125.564 1.546 . . . . 0.0 107.961 -176.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.8 mt -139.31 139.32 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 104.04 -2.578 . . . . 0.0 104.04 177.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -154.6 -178.95 7.54 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.729 0.812 . . . . 0.0 109.848 167.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.1 81.16 27.98 Favored Pre-proline 0 C--O 1.236 0.365 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -175.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.64 169.23 22.39 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.329 2.019 . . . . 0.0 111.462 -170.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.489 HG21 ' H ' ' A' ' 12' ' ' LYS . 6.9 t -66.26 145.02 98.96 Favored Pre-proline 0 CA--C 1.543 0.703 0 O-C-N 121.983 -0.448 . . . . 0.0 109.943 171.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.01 -5.2 12.97 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.888 2.392 . . . . 0.0 112.716 169.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -87.8 -51.74 5.69 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.542 1.064 . . . . 0.0 110.752 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.489 ' H ' HG21 ' A' ' 9' ' ' THR . 1.5 tptt -49.92 -45.89 51.52 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.354 1.062 . . . . 0.0 110.207 172.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 34.1 mt -54.97 -33.29 62.29 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.346 1.058 . . . . 0.0 112.555 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.0 mttp -63.76 -51.5 64.57 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 118.911 0.778 . . . . 0.0 109.006 176.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -57.51 -49.11 77.38 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 123.001 1.382 . . . . 0.0 109.827 -172.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 98.5 mt -56.48 -12.04 1.55 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.204 1.801 . . . . 0.0 112.035 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.0 m 62.39 32.6 16.77 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.527 1.931 . . . . 0.0 111.05 174.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.407 ' HA ' ' CD2' ' A' ' 21' ' ' TRP . 59.6 t -50.81 -39.62 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 126.657 1.983 . . . . 0.0 110.496 175.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -57.68 -19.33 26.13 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -92.05 -25.43 18.79 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 124.297 1.039 . . . . 0.0 111.586 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.407 ' CD2' ' HA ' ' A' ' 18' ' ' VAL . 41.9 m0 -60.45 158.01 32.23 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 124.297 1.039 . . . . 0.0 109.49 -174.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.39 118.5 5.68 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.046 1.83 . . . . 0.0 111.401 -175.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.2 mt -62.09 144.75 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 174.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.564 ' CZ3' ' HE3' ' A' ' 84' ' ' LYS . 91.0 t90 -132.59 138.32 47.38 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 165.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -136.2 157.28 47.19 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 128.402 2.681 . . . . 0.0 108.622 -177.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.5 tptt -153.85 166.4 33.04 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 121.973 -0.454 . . . . 0.0 109.94 -177.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.84 175.19 3.77 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 122.25 1.024 . . . . 0.0 110.681 167.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.6 p -80.8 -6.93 10.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 113.381 -1.736 . . . . 0.0 112.533 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.1 t -73.88 152.14 40.28 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 122.863 1.316 . . . . 0.0 109.743 174.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -84.27 168.28 15.82 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 129.132 2.973 . . . . 0.0 109.929 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -169.35 -164.01 0.43 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.954 2.502 . . . . 0.0 107.176 176.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -122.55 164.05 18.84 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 120.206 -1.559 . . . . 0.0 107.213 157.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 54.5 t-105 -134.52 168.94 18.05 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.791 0.836 . . . . 0.0 109.791 -173.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -135.87 153.7 51.39 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.259 1.423 . . . . 0.0 107.858 175.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -134.42 120.23 19.54 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 170.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -123.79 27.29 7.34 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.923 1.238 . . . . 0.0 111.811 168.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.65 172.08 15.14 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 152.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -70.23 107.43 3.71 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 -171.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -107.58 98.87 8.42 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -173.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 88.2 m -68.7 148.0 51.03 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 161.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.7 p -146.75 159.51 43.41 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 121.468 -0.77 . . . . 0.0 111.539 154.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -126.16 126.05 43.49 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 126.385 1.874 . . . . 0.0 107.862 176.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.9 mm -101.28 111.77 32.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 123.24 0.616 . . . . 0.0 109.35 -169.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.413 ' CD1' ' HD1' ' A' ' 85' ' ' HIS . 2.0 mp -93.12 -29.65 15.65 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 123.945 0.898 . . . . 0.0 111.769 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -159.33 166.12 31.88 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.51 0.724 . . . . 0.0 109.086 -177.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.17 -178.85 52.91 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.631 1.11 . . . . 0.0 113.218 -177.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.64 143.17 26.35 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 125.028 1.331 . . . . 0.0 107.583 -178.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.9 t -139.17 149.22 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 176.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -116.87 88.6 2.93 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 103.448 -2.797 . . . . 0.0 103.448 166.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.3 t -75.64 144.39 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 173.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.5 m -145.69 115.06 7.13 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 120.062 1.301 . . . . 0.0 109.052 -175.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 57.5 p -65.72 162.59 18.28 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.94 -21.89 61.54 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.149 -0.97 . . . . 0.0 110.797 175.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -79.48 22.68 0.43 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.239 1.816 . . . . 0.0 111.232 165.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.74 -5.95 10.47 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 125.685 1.612 . . . . 0.0 115.637 166.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -66.95 110.41 3.34 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 119.939 1.869 . . . . 0.0 108.006 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt -87.69 134.08 33.72 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -130.41 85.01 2.24 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 124.26 1.981 . . . . 0.0 108.585 168.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.6 p -56.85 136.35 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 CA-C-N 112.51 -2.132 . . . . 0.0 108.646 146.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 pt -139.3 132.97 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 101.719 -3.437 . . . . 0.0 101.719 173.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -90.46 -176.72 4.86 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 121.893 0.854 . . . . 0.0 108.919 171.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -66.16 126.16 27.79 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 147.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 117.61 14.41 6.87 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-O 118.051 -1.416 . . . . 0.0 114.296 -175.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -119.85 149.31 42.28 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.036 1.334 . . . . 0.0 108.545 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.7 tp -109.1 145.16 36.14 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 156.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.3 t -130.26 153.95 39.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 125.461 1.504 . . . . 0.0 107.476 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.0 m -135.31 108.6 7.78 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 161.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -79.01 153.53 77.48 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 123.831 0.852 . . . . 0.0 109.177 169.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.74 171.42 17.35 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 121.848 1.699 . . . . 0.0 111.305 173.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.9 tttt -78.1 106.67 10.13 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 111.485 -2.598 . . . . 0.0 106.21 161.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.66 70.09 0.9 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.702 1.62 . . . . 0.0 111.918 171.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.1 tp -140.68 150.89 44.07 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.104 1.762 . . . . 0.0 109.125 176.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.35 134.2 43.45 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 126.924 2.09 . . . . 0.0 108.219 176.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 6.0 p -159.52 164.83 34.03 Favored 'General case' 0 C--N 1.334 -0.077 0 C-N-CA 123.082 0.553 . . . . 0.0 111.686 176.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.39 164.24 16.62 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 123.029 0.532 . . . . 0.0 112.009 167.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -144.37 104.9 4.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.859 1.264 . . . . 0.0 108.219 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.7 ttpm? -101.88 111.28 23.48 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 169.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.2 t -77.65 125.84 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 168.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.1 mt -103.03 -16.1 15.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 118.313 -0.851 . . . . 0.0 111.448 168.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -147.85 144.45 19.13 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 117.543 -1.218 . . . . 0.0 109.299 171.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -61.97 100.43 0.2 Allowed 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 124.24 3.293 . . . . 0.0 111.299 -174.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.5 p -70.51 156.49 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 124.535 1.134 . . . . 0.0 111.232 -169.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -139.99 110.21 6.57 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 103.435 -2.802 . . . . 0.0 103.435 161.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.564 ' HE3' ' CZ3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -132.16 148.26 52.46 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.217 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.413 ' HD1' ' CD1' ' A' ' 44' ' ' LEU . 17.3 m80 -90.56 101.04 13.78 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 105.674 -1.972 . . . . 0.0 105.674 174.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -90.92 159.16 16.34 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.69 0.677 . . . . 0.0 110.074 170.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -154.04 140.82 19.08 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 121.44 -0.788 . . . . 0.0 109.972 159.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 42.9 mt -84.23 165.92 17.97 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 124.484 1.113 . . . . 0.0 109.172 175.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.1 p90 . . . . . 0 C--O 1.255 1.367 0 CA-C-O 116.224 -1.846 . . . . 0.0 108.227 164.124 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mtm . . . . . 0 N--CA 1.473 0.682 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -154.43 172.82 17.13 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.449 1.099 . . . . 0.0 108.233 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.9 t -77.92 136.23 24.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 O-C-N 121.466 -0.771 . . . . 0.0 110.086 -171.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.6 ttpt -115.0 91.45 3.62 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 176.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.8 mt -87.77 139.77 16.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 167.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -154.06 171.8 18.51 Favored 'General case' 0 C--O 1.224 -0.26 0 O-C-N 123.998 0.811 . . . . 0.0 111.008 163.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.92 75.77 75.99 Favored Pre-proline 0 N--CA 1.47 0.572 0 C-N-CA 123.419 0.688 . . . . 0.0 111.368 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.71 172.34 10.7 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 125.183 3.922 . . . . 0.0 114.234 -173.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.6 t -66.19 144.3 98.69 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.191 0.996 . . . . 0.0 109.913 173.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.25 -25.07 50.25 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.734 1.623 . . . . 0.0 112.924 176.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -61.24 -55.08 36.06 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.601 0.761 . . . . 0.0 109.184 -177.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -53.34 -38.16 62.99 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.327 1.051 . . . . 0.0 111.208 176.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -71.54 -22.19 61.79 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.325 -176.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -64.93 -48.88 72.55 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 120.053 1.297 . . . . 0.0 108.853 166.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -66.3 -37.93 86.55 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.281 0.632 . . . . 0.0 111.466 -167.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 34.4 mt -55.55 -12.09 1.07 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.93 1.292 . . . . 0.0 113.165 173.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.2 m 63.98 39.57 7.89 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.764 2.025 . . . . 0.0 109.668 172.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.6 t -53.63 -35.62 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 128.302 2.641 . . . . 0.0 110.55 173.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -61.48 -11.98 12.97 Favored 'General case' 0 CA--C 1.548 0.87 0 O-C-N 121.033 -1.042 . . . . 0.0 113.296 173.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.0 mttt -103.13 -3.73 25.44 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 126.271 1.828 . . . . 0.0 112.494 176.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 32.6 m0 -79.99 165.27 48.22 Favored Pre-proline 0 CA--C 1.538 0.49 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 176.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.52 136.13 35.56 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 121.492 1.461 . . . . 0.0 111.455 170.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.5 mt -76.09 149.69 6.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 165.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.486 ' CZ3' ' HE3' ' A' ' 84' ' ' LYS . 6.4 t90 -146.17 148.53 32.64 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.953 1.301 . . . . 0.0 108.261 164.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -138.06 163.22 32.15 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.277 2.231 . . . . 0.0 109.763 -177.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -145.99 159.72 42.85 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.597 1.089 . . . . 0.0 111.309 168.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -61.81 173.92 0.93 Allowed 'General case' 0 C--O 1.232 0.174 0 O-C-N 125.212 1.57 . . . . 0.0 110.792 163.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.9 t -90.78 33.72 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 125.865 1.666 . . . . 0.0 109.885 -173.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.9 t -107.25 -179.04 3.81 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 120.522 -1.361 . . . . 0.0 109.637 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -124.81 144.02 50.5 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.867 1.267 . . . . 0.0 109.724 -171.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -156.54 -164.93 1.76 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.349 1.06 . . . . 0.0 109.145 -174.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.452 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 0.7 OUTLIER -131.34 150.23 52.23 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.945 1.698 . . . . 0.0 109.482 172.503 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 29.6 t-105 -133.97 142.51 47.7 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 123.35 0.406 . . . . 0.0 111.135 177.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -106.7 125.13 50.62 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 173.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -103.67 106.8 17.41 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 168.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -104.08 17.79 23.39 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.469 1.031 . . . . 0.0 111.471 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.89 168.14 26.08 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.177 1.391 . . . . 0.0 109.562 166.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -62.97 124.9 22.28 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 126.236 1.814 . . . . 0.0 107.303 -178.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -140.46 109.37 6.04 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.6 m -77.82 148.02 34.92 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 163.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 25.6 p -142.92 147.33 35.1 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 157.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -109.35 128.7 55.31 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 172.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.8 mm -90.83 129.3 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -108.99 -37.21 5.89 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.012 1.725 . . . . 0.0 113.033 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -163.7 161.11 23.38 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.098 1.759 . . . . 0.0 109.585 175.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.05 -163.64 12.88 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.056 1.312 . . . . 0.0 111.638 -174.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.82 145.12 25.5 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.618 1.209 . . . . 0.0 108.011 157.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 65.6 t -134.46 150.2 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 174.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -118.95 143.08 47.23 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 157.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.6 t -120.42 96.84 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 175.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.4 m -78.51 104.94 9.45 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 174.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.9 p -78.32 171.68 14.71 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -60.34 -31.92 70.77 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.062 -1.023 . . . . 0.0 111.904 -177.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.46 -15.43 60.68 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 127.578 2.351 . . . . 0.0 111.674 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.83 -2.93 87.7 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 124.641 1.115 . . . . 0.0 114.174 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.7 mmtp -59.75 142.25 53.6 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 163.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.0 ptmm? -125.7 94.11 4.03 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 123.118 1.437 . . . . 0.0 107.8 -176.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -89.11 87.43 7.18 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 123.991 1.853 . . . . 0.0 109.01 -175.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.5 p -55.13 144.1 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 CA-C-N 112.092 -2.322 . . . . 0.0 111.103 149.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 pt -144.78 137.3 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 129.478 3.111 . . . . 0.0 104.094 176.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -109.29 -177.25 3.24 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 125.551 1.54 . . . . 0.0 109.412 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.5 pttt -64.62 42.47 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 130.238 3.415 . . . . 0.0 116.446 -174.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -179.46 11.91 0.03 OUTLIER Glycine 0 CA--C 1.524 0.608 0 C-N-CA 124.962 1.268 . . . . 0.0 113.251 169.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.98 131.04 40.36 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.54 1.67 . . . . 0.0 107.022 175.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.0 tp -99.3 91.61 5.04 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.332 1.453 . . . . 0.0 108.025 164.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . 0.631 0.1 OUTLIER -61.89 145.96 12.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 120.808 3.632 . . . . 0.0 120.808 153.042 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.2 m -135.4 121.98 20.75 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 128.289 2.636 . . . . 0.0 105.761 162.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -92.61 148.32 35.97 Favored Pre-proline 0 C--O 1.237 0.422 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 170.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -78.14 179.73 6.22 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.937 2.425 . . . . 0.0 110.16 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -85.77 93.95 9.0 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 114.65 93.57 1.95 Allowed Glycine 0 CA--C 1.523 0.534 0 C-N-CA 125.175 1.369 . . . . 0.0 109.802 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.3 tt -151.23 133.34 15.22 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.038 1.335 . . . . 0.0 108.858 175.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 65.6 ttt-85 -130.23 81.87 2.03 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.616 1.098 . . . . 0.0 111.056 -175.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 87.0 m -137.2 154.8 50.11 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 122.205 1.002 . . . . 0.0 112.634 -168.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.452 ' HA ' ' HA ' ' A' ' 32' ' ' ASP . 0.7 OUTLIER -70.27 152.53 44.08 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 114.043 -1.435 . . . . 0.0 109.858 -174.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -131.58 110.46 10.97 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.927 1.691 . . . . 0.0 107.215 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.4 tttp -108.73 107.96 18.61 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -177.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.5 t -86.09 102.57 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.1 mt -83.95 -21.84 31.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 118.493 -0.765 . . . . 0.0 110.509 175.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -152.6 151.9 27.77 Favored Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 173.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -72.1 86.28 0.95 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 125.05 3.833 . . . . 0.0 111.801 -158.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.3 p -71.69 139.79 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 123.912 0.885 . . . . 0.0 109.251 -172.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.0 ttt180 -120.8 59.37 0.92 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.986 0.898 . . . . 0.0 110.044 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.486 ' HE3' ' CZ3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -70.47 162.13 29.3 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 119.37 -2.081 . . . . 0.0 109.71 -172.554 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -101.18 125.35 47.8 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 104.375 -2.454 . . . . 0.0 104.375 167.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -115.53 160.87 19.4 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.478 1.036 . . . . 0.0 109.251 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -151.01 127.63 10.82 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 118.789 0.722 . . . . 0.0 109.237 173.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 19.8 mt -87.83 139.04 30.93 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 126.411 1.884 . . . . 0.0 108.015 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 34.0 p90 . . . . . 0 C--O 1.259 1.604 0 CA-C-O 117.335 -1.317 . . . . 0.0 110.397 179.063 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.471 0.575 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -159.69 12.89 0.13 Allowed 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 91.5 t 49.37 108.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.693 1 C-N-CA 132.616 4.366 . . . . 0.0 111.717 -174.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.16 130.81 44.3 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 177.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.0 mt -143.32 134.47 22.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 173.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -159.38 173.73 15.81 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.337 0.655 . . . . 0.0 110.199 172.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.82 85.3 4.87 Favored Pre-proline 0 C--O 1.234 0.256 0 C-N-CA 124.288 1.035 . . . . 0.0 108.911 177.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.87 169.91 19.18 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.248 2.632 . . . . 0.0 112.925 -176.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 t -69.63 149.79 96.85 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.82 1.248 . . . . 0.0 110.642 174.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.09 -31.16 75.91 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.834 2.356 . . . . 0.0 113.79 173.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -63.26 -53.56 50.98 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 118.65 0.659 . . . . 0.0 110.672 -171.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.5 tttp -54.42 -48.48 71.59 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 124.833 1.253 . . . . 0.0 109.298 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.4 mt -58.02 -41.02 82.27 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.933 0.893 . . . . 0.0 112.019 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -59.94 -46.96 87.7 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.012 173.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -59.28 -45.77 90.35 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.129 0.877 . . . . 0.0 110.065 -178.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 59.8 mt -57.16 -12.02 2.0 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.572 1.949 . . . . 0.0 113.05 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.3 m 64.11 39.81 7.43 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.956 1.702 . . . . 0.0 111.844 168.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.3 t -58.03 -26.69 29.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 126.743 2.017 . . . . 0.0 111.92 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -61.53 -20.57 63.38 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 120.324 -1.485 . . . . 0.0 113.439 171.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt -98.02 4.15 49.34 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.159 1.384 . . . . 0.0 110.92 177.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 31.9 m0 -87.54 160.33 47.97 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.37 133.76 27.11 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.186 1.924 . . . . 0.0 112.415 177.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.9 mt -73.41 147.73 9.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 124.485 1.114 . . . . 0.0 109.694 166.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.483 ' CZ3' ' HE3' ' A' ' 84' ' ' LYS . 59.8 t90 -144.36 120.63 10.88 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.292 1.437 . . . . 0.0 107.876 168.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.77 168.51 10.28 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.763 1.625 . . . . 0.0 109.791 164.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.493 ' HD3' ' H ' ' A' ' 27' ' ' GLU . 6.1 tmtt? -152.07 165.73 33.81 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.827 0.822 . . . . 0.0 110.735 167.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.493 ' H ' ' HD3' ' A' ' 26' ' ' LYS . 1.0 OUTLIER -76.97 172.64 12.86 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 126.304 1.842 . . . . 0.0 109.216 174.732 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.2 t -100.33 59.32 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 -164.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.4 t -132.03 -178.29 4.83 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.893 1.677 . . . . 0.0 109.433 -167.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -122.64 150.65 42.39 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.907 0.883 . . . . 0.0 109.095 173.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -163.42 -164.79 0.97 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 125.881 1.673 . . . . 0.0 107.017 -177.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 2.6 p30 -131.0 154.65 47.95 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 120.878 -1.139 . . . . 0.0 109.159 173.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 56.1 t-105 -144.11 152.25 40.69 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.015 0.435 . . . . 0.0 110.062 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -124.89 153.18 43.03 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.572 1.149 . . . . 0.0 108.526 -177.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -123.49 103.84 8.7 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.961 1.305 . . . . 0.0 107.626 175.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -104.74 13.45 31.36 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.232 1.413 . . . . 0.0 110.877 176.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.46 170.78 18.77 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 129.649 3.18 . . . . 0.0 108.624 164.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -68.94 136.41 52.5 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 177.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -133.17 124.26 27.13 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 171.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 53.1 m -99.34 137.79 37.35 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 166.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 24.8 p -138.03 148.04 44.71 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 118.164 0.438 . . . . 0.0 110.101 167.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -112.11 126.03 54.74 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 171.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 17.6 mm -95.55 122.39 46.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 129.499 3.119 . . . . 0.0 107.47 -173.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -105.53 -27.55 11.33 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -175.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -164.86 156.64 15.46 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.508 1.123 . . . . 0.0 108.27 177.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.17 177.87 44.63 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.976 1.274 . . . . 0.0 112.205 -177.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.405 ' HE3' ' O ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -135.61 139.03 43.51 Favored 'General case' 0 CA--C 1.515 -0.378 0 O-C-N 121.618 -0.931 . . . . 0.0 108.857 -170.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.405 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 55.1 t -136.19 146.07 29.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 178.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -112.58 116.82 30.81 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 102.998 -2.964 . . . . 0.0 102.998 156.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.4 t -91.04 122.33 42.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 164.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 57.9 m -123.67 105.78 10.0 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 119.664 1.12 . . . . 0.0 108.386 -172.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 32.5 p -69.75 171.97 8.31 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -80.2 -11.2 59.76 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 120.264 -1.523 . . . . 0.0 112.267 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -65.05 -10.76 32.58 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.011 -1.056 . . . . 0.0 112.076 162.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.86 -9.24 77.93 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 125.115 1.34 . . . . 0.0 112.549 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -61.19 124.01 19.33 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 124.957 1.303 . . . . 0.0 108.134 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.96 127.86 46.11 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 125.322 1.449 . . . . 0.0 108.229 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -124.21 84.01 2.22 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 124.478 2.085 . . . . 0.0 107.1 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.5 p -72.87 148.29 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 111.138 -2.756 . . . . 0.0 109.454 162.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.6 pt -148.31 125.23 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 C-N-CA 126.837 2.055 . . . . 0.0 106.528 -175.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -88.3 178.58 6.55 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 122.454 1.121 . . . . 0.0 109.932 167.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -63.95 54.45 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 130.798 3.639 . . . . 0.0 115.525 176.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 173.64 -13.69 0.04 OUTLIER Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.731 1.634 . . . . 0.0 112.846 176.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -69.09 101.75 1.49 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.222 1.511 . . . . 0.0 108.739 176.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.4 tp -74.81 141.17 44.33 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 175.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.4 t -123.78 160.32 27.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 C-N-CA 123.818 0.847 . . . . 0.0 109.076 -175.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.6 m -143.24 109.94 5.51 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 161.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -80.04 148.37 67.79 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 169.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -87.22 178.57 3.45 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.624 2.216 . . . . 0.0 111.877 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -85.45 83.43 7.94 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.372 1.469 . . . . 0.0 107.524 173.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.8 79.18 0.21 Allowed Glycine 0 CA--C 1.532 1.096 0 C-N-CA 126.749 2.118 . . . . 0.0 111.142 175.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.1 tt -147.92 117.45 7.01 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.978 1.389 . . . . 0.0 111.467 175.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.5 tpp85 -85.92 133.8 33.92 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.945 0.898 . . . . 0.0 109.721 161.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 28.6 p -150.66 178.19 9.34 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.657 0.783 . . . . 0.0 112.973 166.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.401 ' HA ' ' HA ' ' A' ' 32' ' ' ASP . 0.2 OUTLIER -96.2 160.51 14.4 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 124.648 1.179 . . . . 0.0 109.295 167.656 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 2.5 m95 -132.36 117.32 17.97 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 173.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.6 tmtp? -104.68 112.09 25.04 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 168.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.6 t -81.26 91.3 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 103.833 -2.654 . . . . 0.0 103.833 171.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.7 mt -71.06 -33.83 70.63 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.214 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -142.3 147.01 41.81 Favored Pre-proline 0 C--O 1.234 0.237 0 CA-C-O 117.479 -1.248 . . . . 0.0 108.224 171.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -62.47 94.91 0.14 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 125.072 3.848 . . . . 0.0 110.896 -165.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.1 p -78.3 146.95 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.853 -167.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.01 114.5 17.18 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 169.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.483 ' HE3' ' CZ3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -131.17 139.68 49.79 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 123.164 0.586 . . . . 0.0 109.495 -179.262 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -81.9 114.78 20.73 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 170.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -102.18 165.18 11.29 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.642 1.11 . . . . 0.0 110.013 174.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -152.0 150.82 30.41 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.725 0.693 . . . . 0.0 109.82 163.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 39.0 mt -108.76 147.05 32.59 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.78 1.232 . . . . 0.0 108.751 -174.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.2 p90 . . . . . 0 C--O 1.253 1.244 0 C-N-CA 126.164 1.785 . . . . 0.0 110.035 -179.497 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.8 ptp . . . . . 0 N--CA 1.471 0.61 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -156.3 14.33 0.31 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.999 0.818 . . . . 0.0 111.561 -175.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.5 t 49.93 107.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 C-N-CA 131.611 3.964 . . . . 0.0 112.116 -161.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.9 tttt -69.78 125.3 26.34 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 174.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.0 mt -130.9 135.92 59.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 105.069 -2.196 . . . . 0.0 105.069 172.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -158.6 174.14 15.51 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.838 1.655 . . . . 0.0 109.425 167.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.41 85.0 15.37 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 119.197 0.908 . . . . 0.0 108.799 177.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -65.31 163.16 30.4 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.728 2.952 . . . . 0.0 111.902 -172.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 t -66.98 142.69 97.52 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 175.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -72.54 -16.51 27.16 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.114 1.876 . . . . 0.0 113.73 -178.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -52.54 -62.87 1.37 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.828 0.851 . . . . 0.0 109.022 170.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 48.8 tptt -53.82 -37.06 63.19 Favored 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 124.921 1.288 . . . . 0.0 111.213 -176.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -65.17 -37.19 86.58 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.67 0.788 . . . . 0.0 111.003 -178.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -48.48 72.39 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 117.712 -1.137 . . . . 0.0 108.407 176.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -53.26 -49.17 67.46 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.454 1.102 . . . . 0.0 110.414 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.1 mp -52.24 -15.57 0.63 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 126.616 1.967 . . . . 0.0 113.903 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.431 ' HB3' ' HE3' ' A' ' 20' ' ' LYS . 23.7 m 66.1 30.54 9.38 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.473 1.509 . . . . 0.0 110.783 175.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.5 t -55.16 -30.18 23.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.205 0 C-N-CA 125.159 1.384 . . . . 0.0 111.616 -178.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -55.01 -28.04 48.92 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.407 1.003 . . . . 0.0 112.867 173.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.431 ' HE3' ' HB3' ' A' ' 17' ' ' SER . 5.8 mtmp? -88.92 -23.55 22.68 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 124.742 1.217 . . . . 0.0 111.287 -176.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 37.5 m0 -61.21 156.94 46.97 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 123.26 0.624 . . . . 0.0 109.326 -174.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -71.32 121.47 7.8 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.235 1.957 . . . . 0.0 112.309 -175.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.1 mt -62.51 145.56 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 O-C-N 121.106 -0.996 . . . . 0.0 108.612 176.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.471 ' CE3' ' HE2' ' A' ' 84' ' ' LYS . 81.9 t90 -141.82 148.46 38.89 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 122.171 0.986 . . . . 0.0 108.721 161.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -140.17 168.39 19.91 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 128.286 2.634 . . . . 0.0 107.616 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.448 ' HE3' ' CD1' ' A' ' 31' ' ' PHE . 6.2 tmtt? -149.01 158.29 44.07 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 168.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -58.11 172.44 0.43 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 123.142 1.449 . . . . 0.0 111.09 171.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.6 p -76.31 65.78 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 112.388 -2.187 . . . . 0.0 108.901 169.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.92 156.35 41.0 Favored 'General case' 0 CA--C 1.507 -0.706 0 O-C-N 120.555 -1.341 . . . . 0.0 109.888 172.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -78.14 165.51 23.87 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 113.233 -1.803 . . . . 0.0 109.469 -178.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.448 ' CD1' ' HE3' ' A' ' 26' ' ' LYS . 6.7 p90 -163.65 -173.18 3.17 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 164.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -126.67 140.28 52.52 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 163.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 15.5 t-105 -113.87 140.29 48.47 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.163 -174.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -106.31 111.89 24.68 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 168.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -85.08 119.97 26.06 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 172.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.37 -5.6 9.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 117.854 -1.07 . . . . 0.0 113.613 -158.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 p -141.12 175.08 9.92 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 131.293 3.837 . . . . 0.0 106.853 164.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -67.84 129.35 39.63 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -135.46 107.22 7.01 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -176.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 89.1 m -75.77 142.91 42.23 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 166.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 19.8 p -138.46 146.49 42.15 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 119.5 1.045 . . . . 0.0 110.917 158.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -117.09 112.67 21.22 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 126.414 1.886 . . . . 0.0 107.457 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 29.4 mm -80.22 131.48 33.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -176.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.451 ' CD1' ' HD1' ' A' ' 85' ' ' HIS . 1.8 mp -114.01 -26.62 8.03 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 118.759 -0.639 . . . . 0.0 112.26 178.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -163.43 152.36 14.31 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 118.813 0.733 . . . . 0.0 109.849 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.48 -177.27 21.32 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.721 1.629 . . . . 0.0 112.766 -176.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.54 142.93 45.47 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.11 1.364 . . . . 0.0 107.489 171.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.543 ' CG1' HG13 ' A' ' 60' ' ' ILE 0.634 0.2 OUTLIER -133.89 137.02 53.1 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.309 0 C-N-CA 129.648 3.179 . . . . 0.0 117.067 -176.139 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -125.46 112.68 16.54 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 125.197 1.561 . . . . 0.0 109.157 158.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 70.5 t -91.99 139.57 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 166.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 90.5 m -136.28 115.52 12.55 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 177.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.5 p -72.21 178.57 3.8 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.812 1.245 . . . . 0.0 110.913 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -54.55 -34.17 61.35 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.182 0.593 . . . . 0.0 110.468 170.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.49 1.31 26.16 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.966 2.506 . . . . 0.0 113.124 -171.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.17 3.63 46.3 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 118.745 0.702 . . . . 0.0 114.6 177.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.422 ' HA ' ' HE2' ' A' ' 56' ' ' LYS . 6.0 mmpt? -65.42 111.8 3.24 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 166.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.41 150.18 46.51 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 164.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -135.97 118.87 16.26 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 170.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.8 t -89.21 132.09 34.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.543 HG13 ' CG1' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -126.26 136.93 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 174.638 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -138.97 -179.01 5.58 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 172.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.3 81.24 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.192 1.797 . . . . 0.0 111.773 177.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 137.45 11.47 1.0 Allowed Glycine 0 CA--C 1.525 0.708 0 CA-C-O 117.882 -1.51 . . . . 0.0 114.593 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -107.69 134.97 49.91 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 164.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.06 153.66 17.66 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 165.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 36.4 t -133.46 150.24 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 124.057 0.943 . . . . 0.0 109.218 177.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.8 m -133.43 120.24 20.65 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.19 0.996 . . . . 0.0 108.312 162.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -83.28 156.57 66.17 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 125.302 1.441 . . . . 0.0 109.514 170.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -83.96 175.16 7.85 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.5 2.133 . . . . 0.0 109.818 174.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -78.03 102.19 7.29 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 166.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.78 80.79 1.54 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.391 0.996 . . . . 0.0 112.196 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 51.5 tp -141.77 155.45 45.61 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 126.024 1.73 . . . . 0.0 108.374 169.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.81 140.43 45.86 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 126.952 2.101 . . . . 0.0 106.722 175.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 3.9 p -168.73 161.09 11.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 118.55 0.614 . . . . 0.0 110.117 173.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.6 159.33 32.17 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.997 164.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -123.57 136.79 54.72 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 163.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -119.48 97.51 5.68 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 167.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.7 t -73.95 97.21 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.505 0 N-CA-C 103.45 -2.796 . . . . 0.0 103.45 169.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 68.1 mt -72.43 -31.21 65.3 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 119.058 -1.057 . . . . 0.0 108.957 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -143.17 144.34 28.22 Favored Pre-proline 0 N--CA 1.452 -0.339 0 CA-C-O 116.881 -1.533 . . . . 0.0 107.189 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -62.93 98.35 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 124.144 3.229 . . . . 0.0 110.2 -165.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.9 p -74.29 158.6 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.697 -171.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -139.02 120.5 15.01 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 168.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.471 ' HE2' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -131.38 154.29 48.77 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 -178.007 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.451 ' HD1' ' CD1' ' A' ' 44' ' ' LEU . 14.3 m80 -94.06 102.25 14.31 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 167.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -88.61 157.48 18.57 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.906 0.883 . . . . 0.0 110.271 171.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -154.58 122.18 5.78 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 121.333 -0.854 . . . . 0.0 110.403 167.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.6 mt -69.82 157.47 37.3 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.051 1.34 . . . . 0.0 109.335 176.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.251 1.17 0 CA-C-O 115.43 -2.224 . . . . 0.0 108.159 163.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 ttt . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 57.72 178.72 0.06 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.49 0.716 . . . . 0.0 109.197 -161.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 75.9 t -86.19 117.69 31.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 160.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -88.85 139.63 30.26 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 166.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.6 mt -132.73 134.56 58.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 162.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -161.56 176.98 10.46 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.823 1.649 . . . . 0.0 109.199 166.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.38 86.0 3.16 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.777 1.231 . . . . 0.0 110.354 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -64.5 171.49 8.06 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.819 2.346 . . . . 0.0 112.683 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 38.4 p -73.05 146.73 87.65 Favored Pre-proline 0 CA--C 1.536 0.404 0 O-C-N 121.571 -0.706 . . . . 0.0 109.536 173.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -70.45 -25.21 25.65 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.528 1.485 . . . . 0.0 112.198 -178.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -64.13 -45.18 89.67 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.616 0.644 . . . . 0.0 110.369 172.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.3 tptm -57.56 -33.9 68.62 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.846 0.748 . . . . 0.0 110.544 177.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -74.28 -15.06 60.98 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.232 0.613 . . . . 0.0 112.53 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -77.36 -39.73 46.42 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.726 1.148 . . . . 0.0 109.051 164.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -70.85 -20.92 62.49 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 118.254 0.479 . . . . 0.0 112.262 -176.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 mp -78.9 1.93 21.9 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-O 117.474 -1.251 . . . . 0.0 112.611 176.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.7 p 57.99 21.51 7.85 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.155 1.382 . . . . 0.0 114.2 -177.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.9 t -57.87 -37.58 61.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 CA-C-N 119.659 1.118 . . . . 0.0 111.837 -163.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -53.37 -24.63 12.73 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.936 0.895 . . . . 0.0 113.312 175.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.5 mttm -88.43 -25.16 22.79 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 117.677 -1.154 . . . . 0.0 111.153 -177.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 38.7 m0 -61.24 164.74 7.84 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 126.141 1.777 . . . . 0.0 110.261 -175.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.05 140.72 55.24 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 CA-C-N 121.52 1.579 . . . . 0.0 111.165 173.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.8 mt -85.6 155.51 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 169.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 27.8 t90 -141.76 133.93 27.76 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 164.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -138.25 132.88 32.43 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 126.807 2.043 . . . . 0.0 106.82 -177.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -134.27 169.6 16.96 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 121.384 -0.823 . . . . 0.0 110.062 -170.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.481 ' CD ' ' H ' ' A' ' 28' ' ' VAL . 1.4 tm-20 -72.7 177.54 4.71 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 122.755 1.264 . . . . 0.0 111.039 172.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.481 ' H ' ' CD ' ' A' ' 27' ' ' GLU . 16.3 t -102.24 45.87 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 127.351 2.26 . . . . 0.0 108.432 -165.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.7 t -108.52 -175.29 2.73 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 128.076 2.55 . . . . 0.0 108.682 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -109.05 163.26 13.48 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.803 0.811 . . . . 0.0 110.5 159.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -151.14 -164.73 2.08 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 163.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -142.05 148.36 38.33 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 126.095 1.758 . . . . 0.0 106.858 177.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 47.1 t-105 -135.13 145.89 48.28 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.129 0.572 . . . . 0.0 111.804 -172.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -112.54 109.76 19.52 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.543 1.537 . . . . 0.0 107.781 166.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -79.16 95.3 5.56 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 171.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -88.01 18.61 4.11 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.472 1.033 . . . . 0.0 110.4 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -168.31 164.26 13.01 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.779 1.631 . . . . 0.0 109.838 176.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -58.43 103.12 0.13 Allowed 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 126.903 2.081 . . . . 0.0 107.561 174.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -105.97 125.14 50.64 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 166.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 85.6 m -99.54 146.52 26.32 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 168.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 20.9 p -146.67 161.3 40.87 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 118.59 0.632 . . . . 0.0 110.643 164.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -129.63 106.2 8.57 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.494 1.518 . . . . 0.0 108.556 -176.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 26.0 mm -80.45 116.38 24.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 O-C-N 122.011 -0.43 . . . . 0.0 109.937 -169.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.5 mt -92.37 -32.46 14.95 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 117.875 -1.06 . . . . 0.0 112.951 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -165.8 163.58 18.8 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 118.953 0.797 . . . . 0.0 109.245 -173.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.09 -176.6 53.86 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.985 1.279 . . . . 0.0 111.825 -176.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.494 ' HE2' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -139.29 139.1 37.25 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 -171.482 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 76.8 t -136.13 158.24 38.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -131.72 97.44 4.21 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 127.155 2.182 . . . . 0.0 106.799 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . 0.727 0.1 OUTLIER -93.34 71.2 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 C-N-CA 130.822 3.649 . . . . 0.0 118.414 163.322 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 14.9 m -73.46 113.32 10.42 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 164.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.6 p -67.93 169.97 8.99 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 171.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -65.25 -22.3 66.85 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.786 -1.196 . . . . 0.0 110.08 170.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -77.73 3.39 14.19 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.286 1.834 . . . . 0.0 111.481 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.69 -9.1 8.87 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.01 1.29 . . . . 0.0 113.053 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -66.07 108.98 2.41 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 119.502 1.651 . . . . 0.0 106.834 171.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -88.64 131.78 34.84 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 124.214 0.946 . . . . 0.0 109.705 179.13 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.6 m-30 -115.54 85.08 2.21 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 127.685 2.394 . . . . 0.0 105.896 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 71.3 t -66.35 128.34 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 N-CA-C 103.981 -2.6 . . . . 0.0 103.981 156.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.7 pt -128.6 138.88 53.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 169.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -123.97 179.9 4.66 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.188 1.795 . . . . 0.0 107.137 -170.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.0 pttp -73.67 60.85 0.71 Allowed 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 124.988 1.315 . . . . 0.0 112.92 -173.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 164.41 34.36 0.02 OUTLIER Glycine 0 C--N 1.317 -0.524 0 O-C-N 120.15 -1.594 . . . . 0.0 112.458 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -122.18 139.37 53.83 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 118.961 1.38 . . . . 0.0 107.808 175.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.9 tp -94.57 141.09 29.0 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 164.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.5 t -126.35 139.65 51.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 175.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 46.2 m -120.71 102.64 8.53 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 165.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -70.41 151.61 95.64 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 169.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -75.74 -164.53 0.25 Allowed 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.692 2.928 . . . . 0.0 110.077 175.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -98.44 129.14 45.06 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 161.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.52 83.9 0.47 Allowed Glycine 0 CA--C 1.535 1.305 0 C-N-CA 127.494 2.473 . . . . 0.0 113.984 -178.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.6 tt -142.87 130.61 21.46 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 126.909 2.084 . . . . 0.0 108.213 171.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.83 128.09 55.65 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.977 0.911 . . . . 0.0 108.867 171.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 27.4 p -149.24 173.81 13.07 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.634 -0.667 . . . . 0.0 111.088 178.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.19 -178.04 4.86 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 118.386 -0.816 . . . . 0.0 111.079 166.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -155.46 90.4 1.25 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.801 1.24 . . . . 0.0 107.785 172.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -83.86 118.42 23.95 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 172.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.5 t -88.58 94.97 4.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 103.779 -2.674 . . . . 0.0 103.779 167.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.494 HD13 ' HE2' ' A' ' 47' ' ' LYS . 26.7 mt -71.02 -29.23 65.11 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 117.522 -1.228 . . . . 0.0 110.109 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -149.01 148.37 26.91 Favored Pre-proline 0 N--CA 1.453 -0.303 0 C-N-CA 125.143 1.377 . . . . 0.0 108.988 175.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -59.88 105.81 0.29 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 124.559 3.506 . . . . 0.0 109.602 -167.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.9 p -84.36 149.41 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -174.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.7 130.06 46.63 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 164.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.79 146.91 34.69 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 174.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -73.17 127.96 34.11 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 148.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -113.64 164.17 14.03 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 166.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -153.37 150.51 28.93 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 165.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 93.7 mt -101.63 161.45 13.64 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.641 1.176 . . . . 0.0 108.209 177.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 11.1 p90 . . . . . 0 C--O 1.246 0.915 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 159.868 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.1 ttt . . . . . 0 N--CA 1.47 0.527 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -164.42 164.9 21.93 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 -174.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.7 t -58.96 140.49 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 168.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.2 tttt -129.78 89.71 2.86 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.6 mt -86.93 143.9 10.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 176.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -149.11 178.97 8.25 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 122.625 0.37 . . . . 0.0 110.074 154.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . 0.37 0.5 OUTLIER -128.5 85.01 61.47 Favored Pre-proline 0 N--CA 1.451 -0.411 0 O-C-N 121.179 -0.951 . . . . 0.0 111.855 -178.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -81.31 168.7 16.47 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 125.163 3.908 . . . . 0.0 113.517 -169.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.7 t -66.22 143.66 98.42 Favored Pre-proline 0 C--N 1.331 -0.202 0 C-N-CA 126.584 1.954 . . . . 0.0 109.188 172.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -71.01 -21.27 27.91 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.741 1.628 . . . . 0.0 112.166 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.84 -60.36 3.95 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.444 1.098 . . . . 0.0 109.131 -178.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.7 tttt -58.92 -29.7 67.29 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.008 -1.057 . . . . 0.0 111.606 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -71.3 -38.4 71.78 Favored 'General case' 0 C--N 1.334 -0.107 0 O-C-N 121.367 -0.833 . . . . 0.0 110.854 177.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -56.56 -53.55 56.22 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 119.426 1.012 . . . . 0.0 109.142 167.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -57.2 -39.78 76.11 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.266 0.626 . . . . 0.0 111.489 -174.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.43 -10.77 2.31 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.28 2.232 . . . . 0.0 115.266 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 63.4 m 57.32 43.85 22.76 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.929 1.292 . . . . 0.0 111.715 -177.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.415 ' HA ' ' CD2' ' A' ' 21' ' ' TRP . 54.8 t -56.05 -36.49 45.09 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 C-N-CA 126.699 2.0 . . . . 0.0 111.051 174.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -61.52 -13.49 21.69 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 176.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.5 mtpp -95.88 -10.98 27.47 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.467 1.107 . . . . 0.0 111.474 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.415 ' CD2' ' HA ' ' A' ' 18' ' ' VAL . 30.4 m0 -72.86 163.42 68.43 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 178.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -66.7 137.71 46.69 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 121.752 1.635 . . . . 0.0 110.736 170.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 81.4 mt -72.46 152.8 7.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 161.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 14.6 t90 -137.81 150.93 47.61 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 161.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -151.18 156.84 41.78 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.738 1.215 . . . . 0.0 110.465 -178.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.512 ' HE3' ' CE2' ' A' ' 31' ' ' PHE . 16.7 tptp -153.71 162.2 41.45 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 124.598 1.159 . . . . 0.0 108.67 -167.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.408 ' C ' ' H ' ' A' ' 29' ' ' SER . 3.6 tp10 -88.41 -178.07 5.78 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.126 0.971 . . . . 0.0 108.744 175.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.5 p -68.77 8.72 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 127.718 2.407 . . . . 0.0 113.16 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.408 ' H ' ' C ' ' A' ' 27' ' ' GLU . 4.3 p -85.93 124.71 32.7 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 126.417 1.887 . . . . 0.0 111.12 -173.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -79.28 152.62 30.44 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 124.288 0.993 . . . . 0.0 109.713 175.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.512 ' CE2' ' HE3' ' A' ' 26' ' ' LYS . 11.9 p90 -156.51 -170.83 3.47 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 176.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.7 121.0 33.43 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 127.542 2.337 . . . . 0.0 107.233 172.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 43.9 t-105 -109.17 155.77 20.65 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 123.743 0.652 . . . . 0.0 111.012 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -122.61 133.24 54.54 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.68 1.592 . . . . 0.0 110.437 175.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -105.37 108.17 19.55 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 175.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -101.14 4.11 41.78 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.006 1.322 . . . . 0.0 111.061 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.84 163.89 36.82 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 128.112 2.565 . . . . 0.0 108.055 170.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.66 142.0 57.59 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 175.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -147.36 136.99 22.84 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 -176.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.8 m -114.96 121.25 42.59 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 174.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 9.1 p -121.85 145.07 48.44 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.448 0.642 . . . . 0.0 109.357 173.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -121.69 109.1 14.33 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 127.401 2.28 . . . . 0.0 107.032 -175.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.6 mm -69.37 138.49 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 124.831 1.252 . . . . 0.0 107.887 175.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 mp -125.09 -32.19 3.02 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 122.795 0.438 . . . . 0.0 110.845 176.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -138.87 171.75 13.87 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.768 0.827 . . . . 0.0 108.875 168.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.71 -179.77 30.43 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 116.608 1.403 . . . . 0.0 116.608 167.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.423 ' HE2' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -140.07 151.39 45.35 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 127.924 2.49 . . . . 0.0 111.485 170.864 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.496 ' CG1' HG13 ' A' ' 60' ' ' ILE 0.421 0.2 OUTLIER -146.43 146.91 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 1 C-N-CA 133.253 4.621 . . . . 0.0 113.288 -174.914 . . . . . . . . 5 4 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -120.16 149.91 41.48 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.242 145.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.3 t -127.2 101.08 7.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 170.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.5 m -79.32 112.77 16.88 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 166.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.4 p -73.58 161.59 30.16 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 165.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -55.97 -35.58 66.89 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.801 -0.562 . . . . 0.0 111.182 -175.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -68.88 -1.79 8.1 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.054 1.742 . . . . 0.0 113.456 -174.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.66 -14.11 57.78 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 125.802 1.668 . . . . 0.0 112.472 172.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.2 mttt -71.35 123.01 21.34 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 118.809 1.304 . . . . 0.0 109.729 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.82 147.4 26.32 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 168.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -132.12 105.88 7.64 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 170.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 70.9 t -74.94 117.4 19.09 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 172.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.496 HG13 ' CG1' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -108.99 141.09 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-N 118.852 0.751 . . . . 0.0 109.956 175.804 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -145.59 -175.62 4.8 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-O 122.114 0.959 . . . . 0.0 112.607 171.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.3 pttm -57.49 65.24 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 130.528 3.531 . . . . 0.0 112.8 177.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 156.64 2.12 0.1 OUTLIER Glycine 0 CA--C 1.531 1.091 0 CA-C-O 117.323 -1.821 . . . . 0.0 115.636 -158.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -129.33 110.39 11.89 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.899 2.079 . . . . 0.0 107.286 177.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.6 tp -74.82 143.13 44.08 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 120.154 -1.591 . . . . 0.0 107.407 167.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 32.9 t -133.49 128.84 55.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 119.422 1.01 . . . . 0.0 109.676 175.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.8 m -99.16 140.21 33.66 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 160.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -104.83 156.56 35.81 Favored Pre-proline 0 C--O 1.236 0.39 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 163.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -79.65 175.33 10.72 Favored 'Trans proline' 0 N--CA 1.445 -1.348 0 N-CA-C 108.773 -1.28 . . . . 0.0 108.773 174.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -81.81 94.04 6.97 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 166.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 114.46 85.73 1.35 Allowed Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.67 1.605 . . . . 0.0 111.789 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 56.9 tp -162.0 135.08 6.11 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.314 1.557 . . . . 0.0 110.301 170.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.68 85.69 2.41 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 120.11 1.323 . . . . 0.0 112.381 -174.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 61.0 m -121.81 165.82 15.28 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 119.627 -1.921 . . . . 0.0 110.766 -173.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.6 163.07 26.32 Favored 'General case' 0 CA--C 1.515 -0.4 0 O-C-N 121.984 -0.447 . . . . 0.0 111.072 177.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -138.07 102.12 4.6 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.041 1.736 . . . . 0.0 106.875 173.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.32 100.56 12.38 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 168.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.9 t -80.24 92.91 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 103.404 -2.814 . . . . 0.0 103.404 172.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.423 HD13 ' HE2' ' A' ' 47' ' ' LYS . 82.5 mt -69.0 -29.11 67.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.171 178.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -141.06 165.62 28.05 Favored Pre-proline 0 N--CA 1.452 -0.373 0 C-N-CA 125.292 1.437 . . . . 0.0 108.884 176.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -61.35 116.87 3.68 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 123.899 3.066 . . . . 0.0 110.786 169.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.9 p -110.41 143.36 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 -177.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -124.99 29.66 6.08 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.755 0.707 . . . . 0.0 112.83 -168.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.27 161.33 4.37 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.338 1.455 . . . . 0.0 113.28 -159.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.3 m80 -89.05 130.1 35.57 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 163.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -121.39 154.52 36.39 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.42 1.009 . . . . 0.0 108.707 172.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -143.98 116.69 8.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 17.9 mt -71.77 140.07 49.31 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 125.417 1.487 . . . . 0.0 107.092 172.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.248 0.982 0 CA-C-O 117.143 -1.408 . . . . 0.0 109.316 172.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.9 mmt . . . . . 0 N--CA 1.476 0.848 0 CA-C-O 120.793 0.33 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.461 ' HG2' ' H ' ' A' ' 3' ' ' VAL . 18.6 tt0 55.66 -164.89 0.13 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.567 1.547 . . . . 0.0 109.961 -174.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.461 ' H ' ' HG2' ' A' ' 2' ' ' GLU . 3.2 p -70.39 142.13 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 176.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -134.05 152.05 51.68 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.444 1.498 . . . . 0.0 108.009 172.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 93.6 mt -131.71 137.06 55.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 165.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -141.18 172.74 12.27 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 117.841 0.291 . . . . 0.0 110.982 160.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.447 ' HZ2' ' CG ' ' A' ' 64' ' ' ASP . 0.3 OUTLIER -112.22 84.94 6.34 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 171.435 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -76.01 176.55 9.88 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.883 3.056 . . . . 0.0 112.188 -169.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.66 144.48 97.6 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 170.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -70.27 -25.25 26.43 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.857 2.371 . . . . 0.0 111.887 172.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -75.32 -45.17 41.3 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 119.357 0.981 . . . . 0.0 110.362 -171.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.96 -44.14 70.49 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.912 0.778 . . . . 0.0 110.019 174.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.3 mt -62.24 -27.53 69.06 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 118.924 -0.56 . . . . 0.0 112.233 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -63.21 -47.59 81.9 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 119.748 1.158 . . . . 0.0 109.106 172.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -68.0 -43.2 79.4 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 124.402 1.064 . . . . 0.0 110.088 -169.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 18.5 mt -53.36 -20.5 4.53 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.183 0.993 . . . . 0.0 112.016 174.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.8 m 69.85 45.7 0.73 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 127.496 2.318 . . . . 0.0 109.398 172.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.7 t -55.19 -32.67 28.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 126.105 1.762 . . . . 0.0 112.014 -175.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -65.6 -21.76 66.61 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.634 -1.291 . . . . 0.0 113.413 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.3 mttt -78.73 -15.13 58.83 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.019 0.928 . . . . 0.0 110.979 175.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 16.3 m0 -75.68 159.99 80.14 Favored Pre-proline 0 N--CA 1.445 -0.705 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 176.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -64.97 139.14 60.3 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 121.545 1.497 . . . . 0.0 111.777 175.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 57.7 mt -76.21 147.69 7.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 163.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.47 ' CZ3' ' HE3' ' A' ' 84' ' ' LYS . 9.0 t90 -147.39 149.59 33.04 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 164.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -133.36 166.31 22.8 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 127.262 2.225 . . . . 0.0 106.351 -177.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -148.98 163.85 36.3 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 120.572 -1.33 . . . . 0.0 108.803 163.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.74 -172.88 3.19 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 125.348 1.459 . . . . 0.0 109.916 -178.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.3 p -77.34 -5.09 7.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 125.772 1.629 . . . . 0.0 113.636 178.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.97 176.67 4.85 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.02 1.328 . . . . 0.0 110.886 176.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -137.45 157.34 46.77 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.141 -0.974 . . . . 0.0 109.324 -174.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -164.82 -164.3 0.79 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.118 1.367 . . . . 0.0 108.88 -168.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -133.12 160.91 35.83 Favored 'General case' 0 C--O 1.242 0.703 0 O-C-N 120.89 -1.131 . . . . 0.0 108.822 165.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 67.3 t-105 -135.74 146.73 47.98 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.746 0.818 . . . . 0.0 109.811 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -115.69 94.56 4.74 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.712 1.605 . . . . 0.0 107.059 -177.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -65.72 115.01 5.43 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 168.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -108.53 -1.0 20.05 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.408 1.083 . . . . 0.0 111.734 174.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.433 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -144.06 171.42 14.28 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 127.542 2.337 . . . . 0.0 112.331 174.871 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -62.95 108.88 1.3 Allowed 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 103.765 -2.68 . . . . 0.0 103.765 168.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -126.94 80.87 1.98 Allowed 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 -173.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 81.7 m -64.51 152.21 42.38 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 25.4 p -144.93 150.01 36.25 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.458 163.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -122.6 108.27 12.92 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.572 1.549 . . . . 0.0 106.839 175.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.3 mm -64.54 138.21 23.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 127.217 2.207 . . . . 0.0 107.601 172.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 mp -128.05 -26.38 2.89 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 123.28 0.362 . . . . 0.0 111.188 173.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -153.46 158.15 40.94 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.634 1.174 . . . . 0.0 108.188 172.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.69 -178.93 52.38 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.321 0.962 . . . . 0.0 112.111 -175.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.79 146.1 27.87 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -168.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.3 t -137.31 156.57 33.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.319 0.581 . . . . 0.0 109.773 175.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -119.39 110.51 17.03 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.612 1.965 . . . . 0.0 106.872 160.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.7 t -94.16 111.32 25.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 170.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.5 m -112.22 113.19 25.29 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -173.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.9 p -75.4 170.16 16.64 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 122.122 0.963 . . . . 0.0 111.931 -170.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -60.35 -29.9 69.2 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.342 167.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -82.26 8.98 9.71 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.688 1.595 . . . . 0.0 111.547 175.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.1 -2.06 21.25 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 125.55 1.548 . . . . 0.0 114.814 175.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -64.17 136.98 57.72 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.4 mttp -93.33 153.13 18.73 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 121.892 0.853 . . . . 0.0 110.089 162.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -125.73 100.62 6.5 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 102.801 -3.037 . . . . 0.0 102.801 162.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.0 t -81.24 142.73 13.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 167.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 pt -148.01 119.77 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.488 0 C-N-CA 124.314 1.046 . . . . 0.0 108.197 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -80.07 177.44 8.93 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-O 122.196 0.998 . . . . 0.0 110.918 171.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.1 pttt -68.01 45.5 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 131.366 3.866 . . . . 0.0 115.103 178.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -174.41 -7.06 0.02 OUTLIER Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.033 0.825 . . . . 0.0 113.417 178.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.447 ' CG ' ' HZ2' ' A' ' 7' ' ' LYS . 11.5 m-20 -79.16 99.87 7.18 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.102 1.361 . . . . 0.0 111.337 -173.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.3 tp -64.36 136.84 57.52 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.95 1.25 . . . . 0.0 107.636 177.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.1 t -121.32 154.68 25.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 123.865 0.866 . . . . 0.0 108.952 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 67.0 m -143.65 121.36 11.87 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 160.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -87.78 164.58 33.75 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 126.483 1.913 . . . . 0.0 108.879 169.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -79.68 174.8 11.3 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 CA-C-O 122.974 1.156 . . . . 0.0 110.469 170.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.433 ' HG3' ' HA ' ' A' ' 37' ' ' THR . 36.0 tttm -80.18 88.73 5.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.446 -1.707 . . . . 0.0 106.887 173.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 116.66 85.1 1.13 Allowed Glycine 0 CA--C 1.527 0.797 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -176.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 62.1 tp -147.2 141.06 25.8 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.198 1.399 . . . . 0.0 108.848 166.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.5 ptt85 -136.93 103.89 5.3 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.417 1.487 . . . . 0.0 108.453 -176.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 86.0 m -148.61 164.42 34.34 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 125.264 1.426 . . . . 0.0 110.103 -175.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.58 163.01 22.18 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 124.452 1.101 . . . . 0.0 112.035 177.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -148.2 99.59 3.07 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.575 1.95 . . . . 0.0 107.372 -168.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 42.7 tttp -110.96 111.8 23.18 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 -176.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.1 t -87.34 111.68 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 104.264 -2.495 . . . . 0.0 104.264 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 20.6 mt -91.1 -24.04 20.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 118.782 -0.628 . . . . 0.0 109.836 177.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -148.75 152.36 37.31 Favored Pre-proline 0 C--O 1.236 0.384 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 168.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.41 91.69 0.77 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.377 2.718 . . . . 0.0 111.514 -153.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.8 p -69.51 105.82 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.017 -165.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -91.08 116.63 28.95 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 105.215 -2.142 . . . . 0.0 105.215 168.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.47 ' HE3' ' CZ3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -127.58 172.06 11.07 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 122.306 1.051 . . . . 0.0 108.382 175.277 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -113.22 122.77 48.47 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 102.578 -3.119 . . . . 0.0 102.578 168.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -117.89 157.03 27.4 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -152.4 134.83 15.19 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 118.71 0.686 . . . . 0.0 110.024 176.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 65.8 mt -94.45 125.48 39.13 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.401 1.88 . . . . 0.0 107.149 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.4 p90 . . . . . 0 C--O 1.247 0.968 0 C-N-CA 123.96 0.904 . . . . 0.0 110.361 -171.509 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.7 mtp . . . . . 0 N--CA 1.47 0.526 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -83.07 146.83 28.48 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.27 -0.893 . . . . 0.0 110.474 164.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 94.2 t 53.04 106.77 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 130.872 3.669 . . . . 0.0 112.633 173.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -100.05 119.49 38.38 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.965 0.906 . . . . 0.0 109.148 -173.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.3 mt -139.81 132.47 35.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 C-N-CA 124.792 1.237 . . . . 0.0 108.022 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -143.97 176.66 9.11 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.483 1.513 . . . . 0.0 110.271 171.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.76 85.77 5.2 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 124.562 1.145 . . . . 0.0 108.151 173.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.09 157.64 60.92 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.442 2.095 . . . . 0.0 111.881 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.9 t -57.42 144.3 71.83 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 124.508 1.123 . . . . 0.0 109.19 169.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.58 -31.21 27.22 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.538 1.492 . . . . 0.0 112.735 -177.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -59.84 -42.72 94.21 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 119.407 1.003 . . . . 0.0 110.729 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.1 tptt -56.49 -41.37 76.53 Favored 'General case' 0 C--O 1.226 -0.167 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -69.9 -32.07 70.19 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.872 1.269 . . . . 0.0 111.511 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -61.46 -49.11 78.12 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 168.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -62.73 -47.99 81.19 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.373 0.533 . . . . 0.0 111.047 -176.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.7 mt -58.78 -7.34 0.97 Allowed 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 125.955 1.702 . . . . 0.0 112.662 -175.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.7 m 74.03 29.22 1.4 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.17 1.788 . . . . 0.0 110.402 165.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.9 t -57.01 -27.45 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 126.371 1.868 . . . . 0.0 112.499 -172.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -59.45 -28.41 66.94 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.828 1.194 . . . . 0.0 113.015 172.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.6 mttm -84.69 -13.21 52.09 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.632 1.173 . . . . 0.0 111.066 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.441 ' CE3' ' HB2' ' A' ' 87' ' ' ASN . 36.5 m0 -74.8 158.9 84.2 Favored Pre-proline 0 N--CA 1.448 -0.527 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -175.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.58 136.79 43.97 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 121.531 1.487 . . . . 0.0 111.44 175.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.1 mt -72.22 149.96 8.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 125.197 1.399 . . . . 0.0 109.332 166.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.407 ' CZ3' ' HE3' ' A' ' 84' ' ' LYS . 87.7 t90 -142.23 112.23 6.92 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 160.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.14 168.4 12.8 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.975 1.31 . . . . 0.0 110.576 164.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.3 tptt -155.94 162.45 40.38 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 120.647 -1.283 . . . . 0.0 109.841 165.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.27 170.59 15.27 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.204 1.001 . . . . 0.0 111.27 172.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.9 p -81.16 71.18 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 127.205 2.202 . . . . 0.0 109.463 175.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.91 -171.14 2.66 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 120.972 -1.08 . . . . 0.0 109.708 -177.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -130.89 154.14 48.39 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.003 -1.06 . . . . 0.0 108.845 170.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -160.6 -167.67 1.93 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.718 1.207 . . . . 0.0 108.511 173.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -121.1 152.52 38.59 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 125.012 1.325 . . . . 0.0 107.896 169.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 25.7 t-105 -136.26 151.97 50.22 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.557 0.218 . . . . 0.0 111.002 178.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.417 ' CD2' ' HB3' ' A' ' 73' ' ' ARG . 1.4 t80 -124.78 129.63 50.83 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.632 1.573 . . . . 0.0 106.844 -175.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -111.29 112.39 24.13 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 175.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.39 2.8 19.23 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 125.148 1.379 . . . . 0.0 112.723 -176.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.8 p -145.9 171.17 15.21 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 130.556 3.543 . . . . 0.0 107.856 166.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -63.36 149.82 44.89 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -146.48 115.2 6.83 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 167.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.0 m -88.52 141.95 28.11 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 167.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.543 ' HG ' ' HA ' ' A' ' 86' ' ' TYR . 0.7 OUTLIER -149.97 150.18 31.45 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.032 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -125.36 112.07 15.9 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.473 1.509 . . . . 0.0 108.36 -177.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 8.5 mm -69.77 120.01 16.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 128.593 2.757 . . . . 0.0 107.601 174.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 mp -110.36 -24.77 10.45 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 178.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -160.14 157.32 28.22 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.898 1.679 . . . . 0.0 107.913 177.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' A' ' 82' ' ' VAL . . . 82.55 177.9 52.13 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.597 2.046 . . . . 0.0 112.699 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.78 143.09 33.28 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.795 -0.827 . . . . 0.0 109.18 -167.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 86.9 t -138.12 156.46 30.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -124.52 118.23 26.13 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 160.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.5 t -94.01 106.8 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 169.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.4 m -93.04 105.95 17.98 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.0 p -69.33 168.6 13.97 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 121.792 -0.567 . . . . 0.0 110.542 -178.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -63.95 -32.8 74.46 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 170.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -68.59 -6.7 27.12 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 121.014 -1.054 . . . . 0.0 109.911 171.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.91 -3.36 70.45 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 125.943 1.735 . . . . 0.0 112.7 170.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.1 tttp -70.02 135.02 48.89 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-N 120.196 1.998 . . . . 0.0 107.964 -176.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.82 105.11 17.17 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.512 174.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -79.56 107.88 12.68 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 164.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.3 t -77.21 147.19 7.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 161.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 pt -148.59 121.78 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 C-N-CA 124.661 1.184 . . . . 0.0 108.499 173.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -101.75 175.4 5.56 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 122.469 1.128 . . . . 0.0 109.764 172.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.5 pttp -64.51 54.58 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 131.237 3.815 . . . . 0.0 116.363 -171.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -178.65 -16.15 0.03 OUTLIER Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.181 1.372 . . . . 0.0 113.42 176.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -77.76 103.63 7.81 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.8 1.3 . . . . 0.0 109.1 -177.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.3 tp -71.35 143.93 50.06 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 120.132 1.333 . . . . 0.0 108.319 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 45.1 t -124.14 154.87 31.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 125.074 1.35 . . . . 0.0 108.69 -174.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.9 m -146.09 103.18 3.71 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.626 1.17 . . . . 0.0 108.196 170.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -74.43 155.13 87.79 Favored Pre-proline 0 C--O 1.235 0.317 0 O-C-N 121.489 -0.757 . . . . 0.0 109.581 171.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -86.87 177.4 4.1 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.715 2.277 . . . . 0.0 110.699 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -81.26 90.6 6.12 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 164.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 110.25 90.33 2.03 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.415 1.483 . . . . 0.0 110.699 178.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 67.2 tp -156.02 152.56 28.26 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.721 2.008 . . . . 0.0 108.936 162.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.417 ' HB3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -137.36 126.07 23.88 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 119.215 0.916 . . . . 0.0 109.76 165.046 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 84.1 m -145.49 170.01 17.23 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.127 1.771 . . . . 0.0 109.268 -178.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.56 159.93 28.94 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 121.352 -0.842 . . . . 0.0 110.18 177.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -134.23 102.69 5.46 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.825 1.65 . . . . 0.0 107.68 177.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -100.78 112.27 24.65 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 174.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.0 t -84.68 106.63 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 173.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 95.6 mt -85.05 -26.03 27.26 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-O 118.878 -0.582 . . . . 0.0 109.743 175.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -147.69 149.35 33.41 Favored Pre-proline 0 N--CA 1.464 0.262 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 174.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -64.55 95.26 0.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.594 2.863 . . . . 0.0 110.673 -169.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.403 ' HA ' ' HA3' ' A' ' 46' ' ' GLY . 4.5 p -71.28 149.88 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.75 -174.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -126.98 112.25 15.04 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 104.232 -2.507 . . . . 0.0 104.232 164.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.407 ' HE3' ' CZ3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -127.91 121.19 29.35 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.244 0.545 . . . . 0.0 110.651 176.725 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -69.32 111.08 4.99 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.543 ' HA ' ' HG ' ' A' ' 41' ' ' CYS . 42.3 p90 -101.3 163.74 12.12 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 121.013 1.733 . . . . 0.0 110.892 -176.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.441 ' HB2' ' CE3' ' A' ' 21' ' ' TRP . 44.2 t30 -153.74 115.51 4.25 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.862 0.865 . . . . 0.0 109.839 171.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.1 mt -66.47 145.63 55.45 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.922 1.289 . . . . 0.0 109.172 173.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.3 p90 . . . . . 0 C--O 1.251 1.143 0 C-N-CA 125.767 1.627 . . . . 0.0 107.852 172.276 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.7 tpp . . . . . 0 N--CA 1.468 0.426 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -81.17 151.34 28.27 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 120.99 -1.069 . . . . 0.0 109.381 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.7 t 44.36 78.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 127.374 2.27 . . . . 0.0 112.098 164.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 51.0 tttt -73.32 101.58 3.47 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.056 -0.974 . . . . 0.0 108.858 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 60.5 mt -103.22 112.67 37.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 104.605 -2.369 . . . . 0.0 104.605 174.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -142.38 178.64 7.44 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 122.829 0.451 . . . . 0.0 111.903 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -125.08 85.05 58.48 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 123.135 0.574 . . . . 0.0 111.387 -165.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.24 153.7 18.7 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.264 2.643 . . . . 0.0 112.998 -173.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.2 t -57.07 144.28 69.59 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 124.417 1.087 . . . . 0.0 109.752 170.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -71.39 -26.26 20.65 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 121.487 1.458 . . . . 0.0 113.003 -176.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -65.81 -42.86 90.14 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.17 0.895 . . . . 0.0 110.102 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.6 tptt -53.57 -45.56 69.97 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 123.461 0.705 . . . . 0.0 109.6 176.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.05 -31.98 73.25 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 121.729 -0.607 . . . . 0.0 111.341 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.56 -50.21 68.15 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 172.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -57.89 -50.78 72.17 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.661 1.184 . . . . 0.0 111.822 -176.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 55.4 mt -56.82 -8.96 0.68 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.29 1.836 . . . . 0.0 112.823 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.5 m 75.21 27.51 1.1 Allowed 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 128.124 2.57 . . . . 0.0 111.276 167.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.9 t -54.21 -28.61 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 128.48 2.712 . . . . 0.0 112.583 177.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.97 -29.31 70.71 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 120.239 1.382 . . . . 0.0 112.49 173.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.4 mtpp -82.51 -15.56 51.95 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.246 1.018 . . . . 0.0 112.205 176.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 38.2 m0 -69.32 165.17 42.25 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 119.169 0.895 . . . . 0.0 109.272 -173.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -67.39 141.73 57.3 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 121.464 1.443 . . . . 0.0 112.066 174.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.1 mt -88.56 142.97 12.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 125.909 1.683 . . . . 0.0 106.839 169.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.474 ' CE3' ' HE2' ' A' ' 84' ' ' LYS . 44.1 t90 -148.75 133.01 17.42 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 165.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.78 174.59 7.41 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.051 1.74 . . . . 0.0 107.677 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -154.21 161.77 41.62 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 173.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -73.68 170.53 15.06 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.625 0.726 . . . . 0.0 111.315 169.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -80.88 74.0 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 125.136 1.375 . . . . 0.0 108.571 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.0 t -141.23 -170.71 3.13 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.417 1.887 . . . . 0.0 107.824 -176.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.94 149.7 31.64 Favored 'General case' 0 CA--C 1.518 -0.263 0 O-C-N 120.386 -1.446 . . . . 0.0 111.733 -173.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -163.23 -164.76 0.98 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.248 1.819 . . . . 0.0 107.214 -171.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -130.02 161.79 30.16 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.095 -1.003 . . . . 0.0 109.184 170.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 12.6 t-105 -131.87 158.43 41.36 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 120.965 0.412 . . . . 0.0 110.471 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -132.73 96.24 3.77 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 176.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -72.05 123.27 22.45 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 176.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.38 1.02 6.32 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -171.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 p -140.87 174.42 10.53 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.553 2.341 . . . . 0.0 108.401 163.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -67.78 136.85 54.84 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -142.61 102.53 4.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -177.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.7 m -84.84 140.44 31.17 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 169.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 14.4 p -144.94 162.6 36.49 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 118.503 0.592 . . . . 0.0 111.577 162.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -124.64 111.85 16.1 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 126.058 1.743 . . . . 0.0 107.998 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 25.6 mm -72.8 111.97 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 128.798 2.839 . . . . 0.0 107.757 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.509 HD12 ' HD1' ' A' ' 85' ' ' HIS . 32.8 mt -92.01 -37.49 12.79 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 122.478 0.311 . . . . 0.0 111.235 -177.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -162.44 165.22 26.56 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.631 0.772 . . . . 0.0 108.988 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' A' ' 82' ' ' VAL . . . 89.88 -176.57 42.67 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 124.246 0.927 . . . . 0.0 111.232 -177.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.48 147.35 30.08 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 117.538 0.669 . . . . 0.0 110.415 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.6 t -139.64 156.34 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -178.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -124.37 133.7 53.34 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 122.589 1.185 . . . . 0.0 108.491 158.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . 0.627 0.1 OUTLIER -108.61 80.53 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.204 1 C-N-CA 133.629 4.771 . . . . 0.0 117.001 165.81 . . . . . . . . 4 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 82.9 m -71.04 122.7 20.53 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.078 162.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 74.9 p -82.52 -173.81 4.82 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.377 1.071 . . . . 0.0 111.811 174.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -62.77 -37.83 88.2 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.077 0.551 . . . . 0.0 110.255 170.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -63.59 -27.09 69.0 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.034 0.933 . . . . 0.0 111.677 177.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 103.86 -10.86 52.61 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-O 118.965 -0.908 . . . . 0.0 113.43 175.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.7 mttm -61.55 129.17 39.81 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 118.422 1.111 . . . . 0.0 108.78 173.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.38 103.84 16.48 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.186 0.994 . . . . 0.0 108.795 177.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.2 m-30 -68.29 100.05 1.0 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 167.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.7 t -81.68 137.82 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 165.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.8 pt -140.4 90.75 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -85.86 170.33 12.48 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.71 1.604 . . . . 0.0 110.729 172.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.1 pttm -60.57 111.29 1.54 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.748 1.219 . . . . 0.0 111.152 -176.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 121.5 -23.13 7.63 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 125.858 1.694 . . . . 0.0 113.208 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.24 100.88 3.83 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.26 1.53 . . . . 0.0 108.096 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.3 tp -71.61 145.54 48.93 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.8 t -129.85 138.73 53.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 125.733 1.613 . . . . 0.0 107.46 -171.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 98.5 m -130.38 100.06 5.23 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 162.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -70.68 146.8 94.04 Favored Pre-proline 0 C--O 1.238 0.486 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 165.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -82.54 175.69 8.61 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 122.097 1.864 . . . . 0.0 110.901 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -76.7 90.64 3.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 113.326 -1.761 . . . . 0.0 107.289 171.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 110.92 93.17 2.18 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.7 tp -153.16 142.26 21.37 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.874 1.67 . . . . 0.0 109.517 168.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 -115.96 133.53 55.93 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.821 2.049 . . . . 0.0 108.382 168.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 12.8 p -162.03 175.52 11.69 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.656 1.582 . . . . 0.0 108.365 169.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.56 -175.43 1.05 Allowed 'General case' 0 C--O 1.212 -0.869 0 CA-C-O 117.777 -1.106 . . . . 0.0 113.075 167.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -154.91 105.72 2.59 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.273 2.229 . . . . 0.0 105.65 163.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.0 tttt -103.83 116.77 32.89 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 176.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.0 t -83.84 106.87 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 174.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.9 mt -83.75 -20.95 32.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.042 178.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -158.49 152.05 19.21 Favored Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 126.994 2.118 . . . . 0.0 108.238 169.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -63.35 102.57 0.34 Allowed 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.715 2.944 . . . . 0.0 110.846 -168.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.432 ' HA ' ' HA3' ' A' ' 46' ' ' GLY . 7.1 p -83.38 144.74 9.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 123.699 0.8 . . . . 0.0 110.616 -173.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -116.75 131.88 56.84 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 163.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.474 ' HE2' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -134.62 150.01 50.63 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 173.483 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.509 ' HD1' HD12 ' A' ' 44' ' ' LEU . 1.7 m80 -96.24 114.02 25.67 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 105.844 -1.909 . . . . 0.0 105.844 165.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -106.87 166.6 10.48 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 119.612 1.096 . . . . 0.0 111.089 -176.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -151.54 130.76 12.75 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.694 0.679 . . . . 0.0 110.453 165.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 26.2 mt -85.99 136.44 33.26 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 126.797 2.039 . . . . 0.0 109.177 176.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.8 p90 . . . . . 0 C--O 1.248 1.02 0 C-N-CA 125.368 1.467 . . . . 0.0 111.172 179.439 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.8 mtm . . . . . 0 N--CA 1.469 0.506 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.543 ' HG2' ' H ' ' A' ' 3' ' ' VAL . 15.1 tt0 52.84 -164.88 0.08 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.481 1.112 . . . . 0.0 109.834 -166.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.543 ' H ' ' HG2' ' A' ' 2' ' ' GLU . 82.7 t -102.43 158.08 4.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 126.496 1.919 . . . . 0.0 106.34 169.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -125.73 140.15 52.93 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 171.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.2 mt -137.52 146.5 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 175.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -154.57 -175.07 5.23 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.934 0.893 . . . . 0.0 109.861 160.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -118.96 80.75 18.58 Favored Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 169.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -67.7 172.12 11.03 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.896 2.397 . . . . 0.0 110.994 -177.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.4 t -60.03 144.29 86.84 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 120.034 -0.666 . . . . 0.0 109.469 166.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.78 -20.18 46.26 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.149 1.899 . . . . 0.0 111.296 168.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -60.24 -50.38 73.89 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 119.772 1.169 . . . . 0.0 109.944 -177.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -55.73 -43.71 76.83 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 123.271 0.628 . . . . 0.0 109.762 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 70.6 mt -70.28 -33.66 71.83 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.732 1.213 . . . . 0.0 110.707 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -61.38 -32.3 72.22 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 120.429 -1.42 . . . . 0.0 110.92 168.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -73.75 -55.77 5.82 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 121.012 1.733 . . . . 0.0 109.722 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.1 tp -44.13 -66.25 0.41 Allowed 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 126.512 1.925 . . . . 0.0 112.682 -152.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.1 p 173.34 27.66 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 129.521 3.128 . . . . 0.0 109.784 150.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.1 t -59.92 -30.71 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 O-C-N 120.659 -1.275 . . . . 0.0 113.074 -160.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -60.01 -25.19 65.08 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 120.866 -1.146 . . . . 0.0 112.762 172.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.5 mttt -88.81 -31.4 18.35 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.498 1.519 . . . . 0.0 111.882 177.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 41.0 m0 -55.53 156.84 8.01 Favored Pre-proline 0 C--O 1.236 0.364 0 C-N-CA 124.021 0.928 . . . . 0.0 110.269 -175.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.91 138.59 40.96 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.465 1.443 . . . . 0.0 111.72 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.8 mt -71.48 150.96 8.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 164.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -137.35 134.86 36.48 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 159.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -141.15 120.71 13.27 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 126.374 1.87 . . . . 0.0 109.468 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.4 mmtt -109.49 152.28 25.63 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 123.733 0.813 . . . . 0.0 109.794 -178.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.5 pm0 -66.02 163.62 16.95 Favored 'General case' 0 N--CA 1.441 -0.876 0 O-C-N 124.915 1.385 . . . . 0.0 111.152 166.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.5 p -73.25 17.05 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 127.898 2.479 . . . . 0.0 113.966 -172.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.9 t -83.64 -171.27 3.49 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.89 1.276 . . . . 0.0 109.48 177.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -136.87 154.17 50.57 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 121.099 -1.0 . . . . 0.0 110.701 175.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -162.38 -164.45 1.04 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.826 1.651 . . . . 0.0 108.523 -172.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -135.28 154.91 51.39 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 126.068 1.747 . . . . 0.0 109.753 168.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 58.0 t-105 -138.16 127.58 24.72 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.059 0.544 . . . . 0.0 111.797 -174.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -80.95 130.48 35.04 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.421 1.089 . . . . 0.0 108.354 169.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -108.84 107.74 18.27 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.137 1.375 . . . . 0.0 107.312 166.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -114.08 21.2 15.02 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.812 0.845 . . . . 0.0 112.974 -179.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.41 167.0 31.48 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 127.445 2.298 . . . . 0.0 108.001 166.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -66.81 127.0 30.8 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -177.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -136.71 99.71 4.13 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -177.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 85.2 m -70.88 141.79 51.2 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 166.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.1 p -150.57 133.61 16.09 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 121.438 -0.788 . . . . 0.0 110.841 172.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -111.55 104.87 13.3 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 126.585 1.954 . . . . 0.0 109.362 -171.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 22.7 mm -76.65 114.92 17.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -175.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.79 -27.19 13.48 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 118.724 -0.655 . . . . 0.0 112.54 -178.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -158.84 153.01 23.76 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 119.492 1.042 . . . . 0.0 108.907 -178.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.64 -171.01 39.13 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.634 1.111 . . . . 0.0 113.035 -176.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.18 146.44 35.25 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.994 1.717 . . . . 0.0 108.171 -177.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.3 t -141.77 147.18 22.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -124.01 122.66 38.5 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 127.754 2.422 . . . . 0.0 107.175 167.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.6 t -110.76 117.24 54.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 46.3 m -111.02 120.55 42.74 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.435 ' HA ' ' SG ' ' A' ' 74' ' ' CYS . 27.2 p -73.43 162.36 29.39 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.517 0.675 . . . . 0.0 110.692 -179.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.83 -30.73 71.4 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.693 -0.63 . . . . 0.0 109.314 172.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -63.34 -15.65 58.0 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 127.342 2.257 . . . . 0.0 112.663 168.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 103.78 -12.25 53.33 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 125.235 1.398 . . . . 0.0 113.763 172.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -60.39 112.45 1.96 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 118.762 1.281 . . . . 0.0 108.45 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -70.12 153.64 42.9 Favored 'General case' 0 C--O 1.231 0.087 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 164.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -135.27 160.91 36.9 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 126.031 1.732 . . . . 0.0 106.724 159.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 88.7 t -123.06 150.22 26.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 170.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.5 pt -142.02 126.36 16.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 164.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -94.97 175.53 6.61 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.215 1.006 . . . . 0.0 109.241 173.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.0 pttm -62.4 68.54 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.664 1.985 . . . . 0.0 111.936 166.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 165.81 -9.44 0.07 OUTLIER Glycine 0 C--N 1.315 -0.618 0 CA-C-O 118.083 -1.399 . . . . 0.0 113.463 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -80.19 136.16 36.43 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.795 1.798 . . . . 0.0 106.545 167.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.7 tp -104.65 139.23 39.79 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 161.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 42.8 t -118.26 157.42 19.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 -177.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.7 m -138.14 101.62 4.46 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 168.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -72.8 153.35 91.26 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 173.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -84.06 173.26 9.15 Favored 'Trans proline' 0 N--CA 1.447 -1.226 0 C-N-CA 122.137 1.891 . . . . 0.0 110.682 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -80.63 90.42 5.75 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 164.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 118.24 78.32 0.62 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 123.812 0.72 . . . . 0.0 113.074 174.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 31.8 tp -147.49 154.77 41.18 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.97 1.308 . . . . 0.0 108.9 169.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.6 ptt85 -144.02 101.27 3.7 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 125.103 1.361 . . . . 0.0 107.664 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . 0.435 ' SG ' ' HA ' ' A' ' 52' ' ' THR . 73.7 m -145.21 161.97 38.25 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.801 0.84 . . . . 0.0 110.777 -170.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.2 152.36 38.39 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 122.846 0.458 . . . . 0.0 111.321 -173.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.8 m95 -127.89 97.1 4.69 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.732 2.013 . . . . 0.0 107.699 174.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.5 tptt -76.07 146.01 39.69 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 104.624 -2.361 . . . . 0.0 104.624 161.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.38 94.07 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 168.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.8 mt -67.08 -32.29 73.36 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 118.148 -0.93 . . . . 0.0 110.902 -177.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -134.64 144.78 52.22 Favored Pre-proline 0 N--CA 1.454 -0.232 0 CA-C-O 117.625 -1.178 . . . . 0.0 109.5 175.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -61.14 95.36 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.938 3.092 . . . . 0.0 109.872 -177.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.9 p -81.77 159.6 3.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 125.112 1.365 . . . . 0.0 110.049 -167.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.1 ttt85 -129.69 134.37 47.61 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 164.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.44 151.73 42.06 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 169.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -83.95 125.12 31.72 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 160.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -112.26 157.26 21.14 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 173.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -151.28 114.43 4.77 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 171.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 55.8 mt -65.96 143.65 57.26 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.192 1.397 . . . . 0.0 107.694 166.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 36.6 p90 . . . . . 0 C--O 1.255 1.359 0 CA-C-O 115.939 -1.981 . . . . 0.0 112.08 174.354 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 mtp . . . . . 0 N--CA 1.471 0.62 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -146.67 168.53 21.09 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.192 -0.942 . . . . 0.0 108.867 -174.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 p -73.53 125.63 32.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 124.489 1.115 . . . . 0.0 110.751 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -98.2 140.04 33.1 Favored 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 160.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.2 mt -126.28 142.54 42.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 168.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -155.35 177.45 11.34 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.451 ' HE2' ' OD2' ' A' ' 64' ' ' ASP . 3.6 mmtp -120.6 82.72 33.84 Favored Pre-proline 0 C--N 1.346 0.428 0 C-N-CA 124.894 1.278 . . . . 0.0 110.8 -177.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -78.21 169.63 19.93 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 123.639 2.893 . . . . 0.0 111.603 -178.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.6 p -77.07 150.23 80.61 Favored Pre-proline 0 C--O 1.235 0.329 0 O-C-N 121.947 -0.471 . . . . 0.0 109.97 178.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -64.62 -32.36 58.25 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 121.661 1.574 . . . . 0.0 111.387 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -57.43 -53.12 61.79 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.766 0.826 . . . . 0.0 110.509 176.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.0 tptt -55.0 -40.08 69.73 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.102 0.561 . . . . 0.0 110.177 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.33 -36.54 84.36 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 123.468 0.707 . . . . 0.0 111.173 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -62.8 -48.16 80.32 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 121.177 -0.952 . . . . 0.0 109.361 171.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -61.45 -40.74 95.59 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.658 0.783 . . . . 0.0 112.364 -174.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 mp -55.46 -14.41 1.97 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.95 1.7 . . . . 0.0 113.133 175.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.4 m 57.97 40.37 25.67 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.302 1.841 . . . . 0.0 110.544 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.7 t -54.56 -31.33 23.22 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.257 0 C-N-CA 127.517 2.327 . . . . 0.0 111.024 174.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -56.92 -17.17 8.59 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 170.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -102.62 -5.76 23.51 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.097 1.759 . . . . 0.0 111.46 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.404 ' CE3' ' HB2' ' A' ' 87' ' ' ASN . 31.0 m0 -77.71 165.22 52.78 Favored Pre-proline 0 C--O 1.24 0.582 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.11 140.72 42.01 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 121.654 1.569 . . . . 0.0 111.151 171.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.0 mt -81.58 151.55 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 165.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.645 ' CE3' ' HE3' ' A' ' 84' ' ' LYS . 7.1 t90 -136.77 141.71 42.98 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 156.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.76 153.0 48.64 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 128.207 2.603 . . . . 0.0 108.917 174.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.45 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 1.7 tttt -153.25 165.14 36.64 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.316 -0.865 . . . . 0.0 109.876 172.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.69 176.78 4.57 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 126.135 1.774 . . . . 0.0 110.245 171.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.6 t -83.77 49.6 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 129.984 3.313 . . . . 0.0 109.088 -169.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.0 t -105.57 -169.07 1.54 Allowed 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 127.302 2.241 . . . . 0.0 109.706 -165.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.07 135.47 19.35 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 120.723 -1.235 . . . . 0.0 108.877 177.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -153.57 -164.94 2.01 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.361 1.064 . . . . 0.0 109.268 -176.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -137.65 152.1 48.97 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.86 1.264 . . . . 0.0 109.663 173.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 15.5 t-105 -128.46 135.2 49.14 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 125.137 1.375 . . . . 0.0 109.615 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -106.99 109.71 21.67 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 171.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -79.58 123.02 27.22 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 171.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -124.81 5.49 8.09 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.692 0.797 . . . . 0.0 111.446 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.94 177.09 9.64 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 126.806 2.042 . . . . 0.0 108.678 165.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -65.15 137.69 57.8 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 178.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -143.94 100.62 3.6 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -174.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 85.6 m -75.67 144.35 41.67 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 116.19 -1.862 . . . . 0.0 106.521 172.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 7.5 p -133.31 162.75 30.96 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 114.269 -2.973 . . . . 0.0 111.039 145.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -125.69 109.43 12.59 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 170.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.8 mm -73.82 131.28 35.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.42 -21.24 8.13 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.317 0.962 . . . . 0.0 112.964 -177.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -154.47 160.65 41.72 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 165.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.18 -174.0 24.74 Favored Glycine 0 N--CA 1.465 0.591 0 C-N-CA 124.11 0.862 . . . . 0.0 113.623 174.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.527 ' HZ2' ' C ' ' A' ' 48' ' ' VAL . 0.1 OUTLIER -145.39 141.95 28.91 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.242 0.544 . . . . 0.0 109.717 173.54 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.527 ' C ' ' HZ2' ' A' ' 47' ' ' LYS . 3.3 t -127.77 136.27 60.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 176.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -99.66 131.62 45.53 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 157.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 94.1 t -114.02 140.78 32.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 171.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.8 m -136.89 108.34 6.9 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -175.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 49.7 p -77.42 177.26 8.13 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.707 -0.621 . . . . 0.0 109.486 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -72.56 -25.72 61.46 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 120.613 -1.304 . . . . 0.0 110.838 -174.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.18 -27.72 65.96 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.109 0.964 . . . . 0.0 111.981 169.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.68 8.79 69.64 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-O 118.648 -1.084 . . . . 0.0 113.357 -177.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp -52.45 117.98 3.25 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 156.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -74.5 153.4 39.13 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 158.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -136.91 150.59 48.31 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 170.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 63.0 t -127.1 141.08 47.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.8 pt -135.52 120.87 29.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 170.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.49 175.23 9.44 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.723 1.209 . . . . 0.0 109.231 169.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -64.13 43.31 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 130.557 3.543 . . . . 0.0 114.905 175.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -179.48 -0.67 0.02 OUTLIER Glycine 0 CA--C 1.525 0.659 0 C-N-CA 124.943 1.258 . . . . 0.0 112.697 -176.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.451 ' OD2' ' HE2' ' A' ' 7' ' ' LYS . 1.3 m-20 -72.54 114.06 10.26 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 166.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.2 tp -74.33 160.78 30.61 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 152.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.444 ' CG2' ' CE1' ' A' ' 68' ' ' PHE . 1.2 p -160.16 149.36 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 C-N-CA 126.958 2.103 . . . . 0.0 109.716 -175.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 84.2 m -136.63 97.56 3.58 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 173.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.444 ' CE1' ' CG2' ' A' ' 66' ' ' VAL . 91.0 m-85 -70.79 145.9 92.66 Favored Pre-proline 0 C--O 1.239 0.512 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 163.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -86.21 174.56 6.1 Favored 'Trans proline' 0 N--CA 1.443 -1.459 0 C-N-CA 121.685 1.59 . . . . 0.0 110.777 -174.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.2 tttm -71.08 96.79 1.38 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 113.214 -1.812 . . . . 0.0 106.838 165.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 102.42 88.64 2.05 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 126.307 1.908 . . . . 0.0 111.485 177.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.9 tt -148.8 139.41 22.68 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 126.861 2.064 . . . . 0.0 107.804 167.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -126.21 108.45 11.31 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.643 1.177 . . . . 0.0 108.156 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 24.6 p -145.85 168.81 19.89 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -175.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.44 162.12 21.09 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 123.478 0.711 . . . . 0.0 111.847 170.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -144.54 97.9 3.11 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 126.98 2.112 . . . . 0.0 109.135 -172.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.5 tptt -98.89 123.32 43.08 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 126.462 1.905 . . . . 0.0 107.445 -176.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.9 t -101.12 100.88 11.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.417 ' CD1' ' HZ1' ' A' ' 47' ' ' LYS . 9.8 mt -82.8 -28.81 30.01 Favored 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 119.679 -0.809 . . . . 0.0 109.196 -177.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -144.95 150.47 46.08 Favored Pre-proline 0 C--O 1.238 0.499 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 175.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -65.65 135.21 41.03 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 122.79 2.326 . . . . 0.0 107.942 -169.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.9 p -131.73 119.88 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.456 -157.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.0 ttt85 -99.43 116.47 31.66 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 171.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.645 ' HE3' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -126.28 146.74 49.89 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 172.265 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 14.3 m80 -85.5 129.05 34.91 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 161.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -117.37 162.21 18.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 172.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.404 ' HB2' ' CE3' ' A' ' 21' ' ' TRP . 23.1 t30 -152.97 121.21 6.23 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 172.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 29.7 mt -75.58 134.59 40.66 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 126.11 1.764 . . . . 0.0 106.837 170.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.8 p90 . . . . . 0 C--O 1.256 1.416 0 CA-C-N 119.648 1.113 . . . . 0.0 110.988 -176.782 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptt? . . . . . 0 N--CA 1.473 0.711 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -118.94 155.12 31.87 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 118.738 0.699 . . . . 0.0 110.095 172.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.0 t 44.89 85.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 129.035 2.934 . . . . 0.0 110.959 173.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.69 115.28 6.34 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.7 mt -110.58 148.19 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 168.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -157.75 175.51 13.79 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.389 1.075 . . . . 0.0 109.694 165.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.36 85.5 10.82 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 173.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -69.83 167.6 24.05 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.74 2.96 . . . . 0.0 111.551 -177.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.4 p -84.09 151.02 59.53 Favored Pre-proline 0 N--CA 1.448 -0.533 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -63.37 -31.49 72.74 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.541 2.161 . . . . 0.0 112.126 175.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -63.54 -48.93 75.47 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 119.292 0.951 . . . . 0.0 110.636 171.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -57.77 -38.14 74.92 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.779 0.718 . . . . 0.0 111.012 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 57.4 mt -63.33 -26.86 68.96 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 118.978 -0.534 . . . . 0.0 112.32 177.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -66.6 -43.22 85.44 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 119.713 1.142 . . . . 0.0 110.268 170.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -61.34 -47.23 86.87 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 122.04 0.924 . . . . 0.0 109.453 -174.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 88.1 mt -65.09 -4.26 4.63 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.094 1.757 . . . . 0.0 112.667 178.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 56.77 33.37 22.89 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.5 1.52 . . . . 0.0 111.945 175.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.1 t -56.6 -23.28 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.076 0.951 . . . . 0.0 111.697 -176.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -53.83 -29.97 43.17 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.416 -1.428 . . . . 0.0 113.954 167.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -84.8 -21.4 29.94 Favored 'General case' 0 C--O 1.226 -0.164 0 O-C-N 121.336 -0.852 . . . . 0.0 110.28 -170.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 31.0 m0 -71.88 163.75 64.18 Favored Pre-proline 0 N--CA 1.448 -0.555 0 C-N-CA 125.229 1.412 . . . . 0.0 109.37 -162.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.03 133.17 30.14 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 121.17 1.247 . . . . 0.0 110.315 172.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 63.6 mt -70.19 145.45 12.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 167.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 88.3 t90 -139.14 141.15 38.06 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 163.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -128.7 165.02 21.68 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 126.886 2.074 . . . . 0.0 107.991 173.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -149.87 158.83 44.55 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 167.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.433 ' C ' ' H ' ' A' ' 29' ' ' SER . 4.3 tt0 -84.45 175.68 9.16 Favored 'General case' 0 N--CA 1.435 -1.207 0 O-C-N 123.979 0.799 . . . . 0.0 111.167 172.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.5 p -66.53 11.34 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 129.128 2.971 . . . . 0.0 113.097 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 27' ' ' GLU . 0.3 OUTLIER -91.03 134.39 34.54 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 126.833 2.053 . . . . 0.0 109.191 178.259 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -72.68 168.09 19.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.915 0.864 . . . . 0.0 110.269 177.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -165.94 -172.13 2.23 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 169.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -123.33 146.72 47.69 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 119.888 -1.758 . . . . 0.0 106.929 157.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 12.8 t-105 -114.97 153.63 30.24 Favored 'General case' 0 C--O 1.239 0.549 0 O-C-N 123.897 0.748 . . . . 0.0 110.39 172.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -123.22 105.27 9.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 170.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -78.75 104.94 9.71 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 174.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -105.22 11.57 32.87 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -179.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.76 168.3 21.71 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 129.04 2.936 . . . . 0.0 107.749 157.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -58.29 137.74 56.91 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 125.433 1.493 . . . . 0.0 107.78 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -141.65 113.96 8.18 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 175.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 97.2 m -79.73 149.12 31.26 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 162.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.1 p -145.38 137.84 25.87 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 119.16 0.891 . . . . 0.0 111.265 157.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -100.93 111.52 23.74 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.928 1.691 . . . . 0.0 107.894 174.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.8 mm -75.31 120.57 25.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 C-N-CA 124.05 0.94 . . . . 0.0 108.734 177.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 mp -101.82 -25.38 13.83 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 118.812 -0.613 . . . . 0.0 111.969 176.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -169.62 158.65 7.82 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.222 1.009 . . . . 0.0 109.592 -177.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.75 -172.14 14.21 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.41 1.481 . . . . 0.0 111.871 177.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.429 ' HD2' ' H ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -138.23 151.87 48.07 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 123.209 1.481 . . . . 0.0 108.522 167.644 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.467 ' CG1' HG13 ' A' ' 60' ' ' ILE 0.266 0.4 OUTLIER -152.98 135.73 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.431 0 C-N-CA 130.206 3.402 . . . . 0.0 112.97 -171.017 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.427 ' HB3' ' HE3' ' A' ' 57' ' ' LYS . 10.3 mt-10 -128.51 107.77 9.99 Favored 'General case' 0 N--CA 1.428 -1.566 0 O-C-N 125.819 1.949 . . . . 0.0 109.231 155.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 78.3 t -83.24 146.45 6.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 168.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.1 m -139.77 117.14 11.32 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 175.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 47.3 p -65.05 169.24 5.58 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 174.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -53.36 -36.68 61.64 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.596 -0.69 . . . . 0.0 110.41 171.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -65.16 -2.06 2.65 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 129.406 3.082 . . . . 0.0 114.328 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.76 6.57 78.18 Favored Glycine 0 CA--C 1.533 1.206 0 O-C-N 121.156 -0.965 . . . . 0.0 113.11 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -73.51 102.32 3.8 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 168.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.427 ' HE3' ' HB3' ' A' ' 49' ' ' GLU . 3.1 tptt -75.12 146.2 41.59 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 170.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -142.35 107.38 4.93 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.451 1.9 . . . . 0.0 107.961 177.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.7 t -69.81 138.47 22.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 164.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.467 HG13 ' CG1' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -124.9 146.8 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 C-N-CA 123.849 0.859 . . . . 0.0 109.807 165.221 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -142.1 -178.37 5.68 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 122.221 1.01 . . . . 0.0 111.525 173.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.5 pttm -61.7 85.22 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.548 1.939 . . . . 0.0 111.548 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 144.83 -11.0 1.89 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 126.121 1.819 . . . . 0.0 113.04 177.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -90.34 106.54 18.56 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 175.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.8 tp -76.47 146.39 38.58 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 168.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.3 t -129.45 155.29 41.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 123.295 0.638 . . . . 0.0 109.403 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.7 m -138.76 123.41 18.57 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.179 0.992 . . . . 0.0 109.263 162.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -86.81 153.03 54.78 Favored Pre-proline 0 C--O 1.239 0.531 0 C-N-CA 125.215 1.406 . . . . 0.0 109.799 171.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -79.99 179.68 6.03 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.506 2.804 . . . . 0.0 109.491 175.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -83.49 103.83 13.15 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 164.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 102.73 62.97 0.71 Allowed Glycine 0 CA--C 1.523 0.547 0 C-N-CA 125.175 1.369 . . . . 0.0 112.297 166.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.8 tp -123.68 147.72 47.17 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.504 1.922 . . . . 0.0 108.501 174.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.22 142.33 47.58 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.624 1.57 . . . . 0.0 109.23 174.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 8.7 p -167.46 163.91 14.93 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 118.86 0.755 . . . . 0.0 112.275 167.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.22 145.33 37.64 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 118.516 -0.754 . . . . 0.0 109.967 167.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 6.6 m95 -104.65 136.97 43.2 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 158.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.0 tttt -113.69 103.75 11.53 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 158.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.6 t -76.88 106.43 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 103.475 -2.787 . . . . 0.0 103.475 174.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.9 mt -88.82 -16.06 33.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.594 -177.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -150.27 151.37 31.34 Favored Pre-proline 0 C--O 1.234 0.273 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.888 161.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -58.14 114.64 2.06 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.925 3.083 . . . . 0.0 110.439 -175.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.9 p -88.08 164.06 2.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 C-N-CA 123.604 0.762 . . . . 0.0 109.949 -168.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -134.97 122.79 22.38 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 155.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.05 140.13 46.45 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 171.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -77.49 104.65 8.14 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 103.763 -2.68 . . . . 0.0 103.763 164.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -85.13 161.28 19.71 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 167.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -149.74 140.1 22.32 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 119.538 -0.865 . . . . 0.0 109.986 152.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 44.4 mt -71.91 163.95 26.94 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 171.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 5.1 p90 . . . . . 0 C--O 1.246 0.891 0 O-C-N 121.305 -0.872 . . . . 0.0 108.747 160.019 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.481 1.123 0 CA-C-O 118.547 -0.739 . . . . 0.0 110.982 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 49.18 -176.71 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 128.035 2.534 . . . . 0.0 113.846 -178.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.64 137.26 24.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 167.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.9 tptt -113.73 136.53 52.74 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 171.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 55.7 mt -135.4 112.15 13.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -143.04 174.8 10.36 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.197 0.999 . . . . 0.0 109.615 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.8 82.38 6.54 Favored Pre-proline 0 CA--C 1.532 0.259 0 O-C-N 121.598 -0.689 . . . . 0.0 109.268 176.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -74.8 165.87 30.53 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.542 2.161 . . . . 0.0 113.428 -174.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.9 t -61.58 144.13 92.89 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 124.794 1.238 . . . . 0.0 110.953 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.65 -23.17 63.84 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.786 2.324 . . . . 0.0 113.027 177.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.41 -61.14 2.65 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 125.064 1.345 . . . . 0.0 109.721 -176.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -56.77 -36.85 70.3 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 122.183 -0.323 . . . . 0.0 110.825 -175.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.2 mt -58.28 -41.61 84.72 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 173.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.3 -50.89 71.48 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.513 1.051 . . . . 0.0 108.323 173.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -63.84 -34.38 77.8 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 123.482 0.713 . . . . 0.0 111.847 -174.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.75 -5.97 3.23 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.564 1.546 . . . . 0.0 113.601 177.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . 0.254 98.8 p 63.17 28.24 15.87 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 128.332 2.653 . . . . 0.0 113.943 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 20.1 t -57.28 -31.96 39.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 118.941 0.791 . . . . 0.0 112.985 -170.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -62.96 -23.71 67.54 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.281 1.4 . . . . 0.0 113.027 176.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.9 mttm -88.59 -8.03 55.4 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 126.223 1.809 . . . . 0.0 111.045 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 39.8 m0 -74.36 163.31 69.2 Favored Pre-proline 0 N--CA 1.451 -0.39 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.12 133.58 31.28 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.003 1.136 . . . . 0.0 111.314 173.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.1 mt -70.44 149.18 10.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 124.654 1.182 . . . . 0.0 107.974 165.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.4 ' CE3' ' HE2' ' A' ' 84' ' ' LYS . 28.8 t90 -144.84 145.32 31.56 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.56 -1.2 . . . . 0.0 107.775 162.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.22 162.62 34.83 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.782 2.433 . . . . 0.0 108.344 176.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.491 ' HD3' ' H ' ' A' ' 27' ' ' GLU . 5.3 tmtt? -147.17 173.16 12.78 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.933 -1.105 . . . . 0.0 110.224 178.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.491 ' H ' ' HD3' ' A' ' 26' ' ' LYS . 6.0 tt0 -70.9 -179.77 2.38 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 127.612 2.365 . . . . 0.0 111.288 166.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.47 ' H ' ' HG2' ' A' ' 27' ' ' GLU . 11.3 t -97.89 6.96 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 C-N-CA 127.456 2.302 . . . . 0.0 111.91 -171.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.5 t -81.5 172.91 12.93 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 120.627 -1.296 . . . . 0.0 109.511 173.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -100.42 161.41 13.62 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.321 -0.862 . . . . 0.0 109.31 171.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.476 ' CE2' ' HE3' ' A' ' 26' ' ' LYS . 14.4 p90 -156.75 177.16 11.8 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 125.445 1.498 . . . . 0.0 109.138 170.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.11 129.47 51.81 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.062 2.145 . . . . 0.0 108.186 171.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 35.1 t-105 -118.65 146.15 44.9 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.909 173.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -117.46 143.81 45.65 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.123 1.369 . . . . 0.0 107.907 174.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -118.09 110.81 18.09 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 175.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -107.9 3.01 23.81 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.494 1.118 . . . . 0.0 111.429 -175.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.58 160.4 42.44 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 129.686 3.194 . . . . 0.0 107.318 173.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -64.34 127.74 32.77 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 -174.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -135.1 109.1 8.17 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 177.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 56.1 m -82.07 135.75 35.29 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 167.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 29.2 p -134.65 156.93 47.89 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.084 0.468 . . . . 0.0 110.186 163.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -133.45 116.64 16.25 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.932 1.293 . . . . 0.0 108.502 -175.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.8 mm -72.47 143.19 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 126.475 1.91 . . . . 0.0 109.274 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.0 mt -127.25 -37.14 2.07 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.229 0.611 . . . . 0.0 109.822 171.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -150.82 159.4 44.57 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 173.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' A' ' 82' ' ' VAL . . . 101.17 177.27 29.01 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 126.305 1.907 . . . . 0.0 114.097 177.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.93 154.56 46.15 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-O 123.282 1.515 . . . . 0.0 110.054 -175.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.427 HG11 HG13 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -160.04 150.06 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.995 1 C-N-CA 133.539 4.735 . . . . 0.0 108.033 -161.677 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -135.21 115.61 13.53 Favored 'General case' 0 N--CA 1.414 -2.233 0 N-CA-C 104.23 -2.507 . . . . 0.0 104.23 152.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.4 t -89.56 121.86 40.22 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.993 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 172.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.5 m -111.34 122.84 48.9 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 82.4 p -74.08 178.52 4.96 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -71.77 -23.93 61.67 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 120.209 -1.557 . . . . 0.0 111.698 168.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.43 -7.99 29.64 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.825 1.25 . . . . 0.0 111.653 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.3 -13.56 61.55 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 126.261 1.886 . . . . 0.0 112.951 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -61.13 137.1 58.24 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.565 1.546 . . . . 0.0 107.542 178.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.4 tttm -120.67 130.52 54.15 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -172.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 13.5 m-30 -128.28 84.9 2.28 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 125.618 2.627 . . . . 0.0 108.962 -169.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.5 p -54.36 97.82 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 127.407 2.283 . . . . 0.0 112.587 152.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.437 HG12 ' H ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -80.59 156.54 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.062 0 CA-C-N 112.487 -2.142 . . . . 0.0 109.414 155.803 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -157.82 -179.84 8.52 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 171.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.4 82.42 0.05 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 126.068 1.747 . . . . 0.0 109.326 -176.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 160.32 -12.27 0.16 Allowed Glycine 0 CA--C 1.524 0.634 0 CA-C-O 118.082 -1.399 . . . . 0.0 115.662 -167.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -126.64 104.95 8.38 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 119.186 1.493 . . . . 0.0 109.17 -166.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 19.3 tp -65.86 150.53 48.44 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 172.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.0 t -128.93 156.68 41.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 121.909 0.862 . . . . 0.0 109.288 168.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 75.7 m -144.48 111.51 5.86 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.365 1.466 . . . . 0.0 108.09 162.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -78.36 155.68 79.06 Favored Pre-proline 0 C--O 1.234 0.272 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 170.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -80.84 177.83 7.58 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 121.396 1.398 . . . . 0.0 110.334 172.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 32.4 tttt -75.08 91.4 2.56 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 112.933 -1.94 . . . . 0.0 107.527 164.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 116.17 90.79 1.63 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.754 1.168 . . . . 0.0 111.441 173.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.9 tp -155.2 150.71 27.33 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.51 1.524 . . . . 0.0 110.087 173.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.2 ttp85 -128.78 122.96 31.69 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 126.285 1.834 . . . . 0.0 109.116 176.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 8.3 p -157.13 167.32 30.74 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.226 0.921 . . . . 0.0 110.919 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.91 173.71 12.26 Favored 'General case' 0 CA--C 1.516 -0.347 0 O-C-N 120.887 -1.133 . . . . 0.0 112.4 168.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 5.9 m95 -142.88 93.65 2.54 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 127.51 2.324 . . . . 0.0 106.728 167.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -79.83 105.31 11.02 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 170.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 t -86.14 86.92 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 -174.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 97.3 mt -64.72 -29.87 70.87 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.451 -178.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -142.74 154.57 62.79 Favored Pre-proline 0 N--CA 1.465 0.281 0 CA-C-N 119.481 1.037 . . . . 0.0 110.382 168.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.51 85.17 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 125.078 3.852 . . . . 0.0 111.753 -168.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.403 ' HA ' ' HA3' ' A' ' 46' ' ' GLY . 8.5 p -75.16 137.62 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 124.725 1.21 . . . . 0.0 109.674 -163.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.5 ttt180 -116.82 106.74 13.8 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 104.108 -2.553 . . . . 0.0 104.108 177.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.4 ' HE2' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -125.11 142.96 51.17 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.557 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 10.5 m80 -78.08 136.79 37.96 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 165.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -124.27 163.17 22.2 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 173.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 22.3 t30 -157.23 137.15 12.48 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 119.4 1.0 . . . . 0.0 109.113 169.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 66.3 mt -94.56 146.16 24.31 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.512 1.125 . . . . 0.0 108.909 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.5 p90 . . . . . 0 C--O 1.247 0.942 0 C-N-CA 125.173 1.389 . . . . 0.0 111.673 -176.427 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.422 -0.799 . . . . 0.0 110.788 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -109.58 161.05 15.74 Favored 'General case' 0 CA--C 1.515 -0.396 0 O-C-N 125.859 1.975 . . . . 0.0 110.078 -178.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.5 t 40.16 91.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -174.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt -81.24 102.67 10.51 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 122.073 -0.392 . . . . 0.0 110.862 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 63.5 mt -111.09 124.69 68.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 O-C-N 123.433 0.458 . . . . 0.0 110.655 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -163.89 179.85 6.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.722 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.81 83.65 4.81 Favored Pre-proline 0 C--O 1.241 0.635 0 CA-C-O 121.885 0.85 . . . . 0.0 110.806 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.3 139.44 41.83 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.145 1.896 . . . . 0.0 112.035 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -49.4 146.96 6.03 Favored Pre-proline 0 C--O 1.233 0.185 0 CA-C-O 121.383 0.611 . . . . 0.0 111.18 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.01 -9.13 25.52 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.574 2.182 . . . . 0.0 112.553 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.91 -50.95 12.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.813 0.34 . . . . 0.0 110.673 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.11 -34.34 73.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.855 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 mt -62.82 -42.94 99.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.849 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -57.85 -33.92 69.17 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 119.104 -0.474 . . . . 0.0 110.987 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -78.03 -38.88 43.68 Favored 'General case' 0 C--N 1.332 -0.174 0 O-C-N 124.419 1.074 . . . . 0.0 110.503 -179.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.3 mp -59.11 -19.71 47.01 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 122.997 0.519 . . . . 0.0 111.165 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 63.32 43.2 6.32 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 123.445 0.466 . . . . 0.0 110.466 -178.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.7 t -56.93 -23.53 18.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.971 0.415 . . . . 0.0 110.964 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -72.2 -19.52 61.72 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.417 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.62 -7.75 54.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 179.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 40.1 m0 -79.72 155.16 75.94 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.875 0.369 . . . . 0.0 110.7 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 131.25 20.77 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.447 2.098 . . . . 0.0 112.253 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.0 mt -80.98 141.26 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.751 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 86.5 t90 -139.55 117.36 11.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.611 178.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.49 153.67 31.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.761 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.89 162.94 30.98 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.981 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.3 pm0 -70.12 176.48 3.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.207 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.4 t -77.19 -4.3 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.373 0.606 . . . . 0.0 111.394 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.9 t -77.13 174.02 11.17 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.081 -0.648 . . . . 0.0 112.044 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -107.69 174.51 5.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.485 -177.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 18.7 p90 178.55 179.81 0.35 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.293 -178.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -119.77 111.9 18.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.231 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 10.3 t-105 -97.26 151.87 19.43 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-O 120.847 0.356 . . . . 0.0 110.188 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -131.23 113.17 13.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.453 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -91.89 135.07 34.22 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.556 0.535 . . . . 0.0 110.737 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -125.44 22.88 7.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.983 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -179.74 150.37 0.4 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.867 0.365 . . . . 0.0 110.936 -179.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -51.83 104.35 0.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.75 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -123.29 83.86 2.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.101 0.477 . . . . 0.0 109.97 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 80.2 m -60.1 147.35 39.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.077 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 4.1 p -146.28 133.69 20.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.871 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -116.19 116.25 27.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.935 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 25.0 mm -77.24 136.03 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.829 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.59 -30.04 4.59 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 123.524 0.515 . . . . 0.0 111.417 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.42 ' HA ' ' HB3' ' A' ' 62' ' ' LYS . 15.1 pt-20 -162.15 155.51 20.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.309 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.56 179.75 33.51 Favored Glycine 0 N--CA 1.451 -0.311 0 O-C-N 123.503 0.502 . . . . 0.0 112.217 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.41 ' HB3' ' HE2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -127.17 166.87 16.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.033 0.444 . . . . 0.0 110.886 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.453 HG13 HG13 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -174.08 141.65 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.355 -177.722 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 2.7 mt-10 -132.4 90.97 2.86 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.53 0.681 . . . . 0.0 110.202 178.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.9 t -78.43 110.57 14.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 O-C-N 122.022 -0.424 . . . . 0.0 110.966 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 90.6 m -107.76 105.66 15.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.737 0.303 . . . . 0.0 110.803 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.8 p -64.35 154.91 33.97 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.95 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -51.73 -38.19 54.26 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.023 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -52.84 -29.38 27.58 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.445 0.641 . . . . 0.0 110.85 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 113.79 0.62 24.37 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 121.326 -0.464 . . . . 0.0 112.057 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -85.06 115.9 23.13 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 122.535 -0.391 . . . . 0.0 110.473 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.5 mttm -79.92 157.05 26.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.891 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -148.63 92.26 1.98 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.146 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 1.8 p -83.92 123.7 39.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.154 0.502 . . . . 0.0 111.015 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.456 ' H ' HG12 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -113.68 143.75 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.422 179.656 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -139.93 -173.44 3.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.447 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.42 ' HB3' ' HA ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -69.47 67.06 0.21 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.069 0.461 . . . . 0.0 111.421 179.288 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 160.23 37.66 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.383 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -154.36 102.94 2.47 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 117.206 0.503 . . . . 0.0 110.946 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.32 128.78 33.95 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.568 -179.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.4 ' CG2' HG23 ' A' ' 60' ' ' ILE . 8.2 t -117.91 147.09 21.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 O-C-N 123.647 0.592 . . . . 0.0 110.661 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.2 m -142.97 101.03 3.76 Favored 'General case' 0 C--O 1.25 1.107 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.947 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -77.05 147.53 77.05 Favored Pre-proline 0 C--N 1.344 0.335 0 O-C-N 124.621 1.201 . . . . 0.0 111.259 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.12 -166.34 0.23 Allowed 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 123.51 2.806 . . . . 0.0 111.969 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -95.46 67.05 2.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.853 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.29 82.26 0.13 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.171 178.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 49.3 tp -146.82 146.92 30.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.557 0.218 . . . . 0.0 110.859 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.76 141.98 51.67 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.927 178.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 6.1 p -179.46 175.3 0.92 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.057 0.456 . . . . 0.0 110.962 176.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -95.15 159.61 14.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.018 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 2.0 m95 -131.84 78.22 1.81 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.836 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.69 93.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.642 -0.253 . . . . 0.0 111.0 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.2 t -76.04 67.2 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.006 0.432 . . . . 0.0 110.699 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 81.1 mt -47.92 -29.41 3.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.292 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -145.2 165.23 22.71 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.35 0.595 . . . . 0.0 111.054 178.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.95 87.49 0.45 Allowed 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 123.203 2.602 . . . . 0.0 112.356 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.7 p -80.13 151.31 4.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.983 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 3.5 ttt180 -136.4 64.23 1.56 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.728 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.43 177.27 8.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.134 179.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -116.68 102.7 9.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.614 178.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -85.57 154.74 21.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.11 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -162.46 104.69 1.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.617 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 16.1 mt -68.47 149.36 49.37 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.672 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.8 p90 . . . . . 0 C--O 1.236 0.378 0 CA-C-O 118.773 -0.632 . . . . 0.0 110.712 179.964 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.1 t . . . . . 0 CA--C 1.536 0.427 0 CA-C-O 121.251 0.548 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.6 tptm -75.0 118.92 18.49 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 175.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 82.8 mt -130.81 129.64 63.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 174.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -155.38 175.58 13.69 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 122.973 0.509 . . . . 0.0 110.631 171.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.06 85.44 5.24 Favored Pre-proline 0 N--CA 1.451 -0.416 0 C-N-CA 124.312 1.045 . . . . 0.0 108.526 -177.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.42 165.18 31.45 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.977 2.452 . . . . 0.0 112.095 -175.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.3 t -61.18 144.22 91.56 Favored Pre-proline 0 C--O 1.239 0.551 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 164.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.81 -18.14 28.56 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.013 1.809 . . . . 0.0 112.146 175.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -64.33 -52.65 57.37 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.908 0.776 . . . . 0.0 110.158 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.4 tttt -61.92 -33.16 73.75 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 123.205 0.602 . . . . 0.0 110.716 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 79.5 mt -63.82 -24.12 67.63 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.401 -0.812 . . . . 0.0 112.408 175.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -67.49 -49.14 64.84 Favored 'General case' 0 CA--C 1.522 -0.134 0 O-C-N 120.667 -1.27 . . . . 0.0 108.428 169.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -66.94 -36.04 81.35 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.093 0.957 . . . . 0.0 110.95 -169.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.28 -12.31 5.39 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.917 1.687 . . . . 0.0 112.932 172.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . 0.255 68.2 p 60.69 35.02 19.86 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 128.27 2.628 . . . . 0.0 113.021 -175.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.6 t -55.76 -30.46 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.074 0.95 . . . . 0.0 112.801 -177.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -60.2 -26.23 66.2 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 120.437 1.471 . . . . 0.0 112.864 172.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.1 mttm -91.78 -9.03 45.04 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.127 1.371 . . . . 0.0 111.004 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 35.7 m0 -73.09 161.48 79.14 Favored Pre-proline 0 C--O 1.237 0.395 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -65.14 136.29 47.22 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.629 1.553 . . . . 0.0 111.063 173.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.6 mt -70.16 152.5 9.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 162.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.436 ' CE3' ' HD2' ' A' ' 84' ' ' LYS . 59.6 t90 -136.21 149.09 48.41 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 156.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.07 152.97 49.31 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 128.779 2.831 . . . . 0.0 107.996 177.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.514 ' HE3' ' CE2' ' A' ' 31' ' ' PHE . 21.6 tptp -156.6 159.33 38.38 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.231 -0.918 . . . . 0.0 109.748 176.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -69.49 167.81 15.91 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 127.759 2.424 . . . . 0.0 114.216 172.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.2 p -79.33 37.99 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 130.461 3.504 . . . . 0.0 112.73 -175.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.7 t -100.3 -167.71 1.48 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.211 1.405 . . . . 0.0 109.603 -173.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -139.6 145.28 38.35 Favored 'General case' 0 C--N 1.333 -0.114 0 O-C-N 120.461 -1.399 . . . . 0.0 108.867 161.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.514 ' CE2' ' HE3' ' A' ' 26' ' ' LYS . 18.4 p90 -151.13 179.22 8.47 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.629 1.572 . . . . 0.0 108.473 176.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -121.59 128.85 52.39 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.386 1.074 . . . . 0.0 108.981 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 40.2 t-105 -115.41 160.77 19.45 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 122.042 0.925 . . . . 0.0 112.626 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -128.74 111.94 13.67 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 127.22 2.208 . . . . 0.0 107.813 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -85.07 127.51 34.25 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 167.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -120.75 -3.12 9.76 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.966 1.706 . . . . 0.0 110.978 -173.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.57 171.61 16.83 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 129.853 3.261 . . . . 0.0 108.193 175.173 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -71.83 147.56 47.07 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -175.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -149.84 119.59 7.05 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 175.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 39.9 m -96.57 126.36 41.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 175.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -142.09 125.43 16.56 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.681 1.192 . . . . 0.0 109.525 -173.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -105.06 123.51 47.93 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.255 1.422 . . . . 0.0 108.534 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.545 HD13 ' HB3' ' A' ' 84' ' ' LYS . 48.8 mm -78.19 112.41 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 123.962 0.905 . . . . 0.0 108.702 177.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.5 ' O ' ' HE3' ' A' ' 62' ' ' LYS . 2.4 mp -97.69 -21.75 16.84 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 118.071 -0.966 . . . . 0.0 112.806 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -167.68 149.11 5.47 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 173.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.93 178.76 29.21 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.862 1.22 . . . . 0.0 114.448 173.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.451 ' HE3' HG23 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -133.79 140.61 47.03 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 118.017 0.908 . . . . 0.0 111.145 -173.616 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.428 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 66.1 t -141.19 147.79 22.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -112.68 99.74 8.17 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 160.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.9 t -70.61 157.78 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 164.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -147.86 136.0 21.3 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 164.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 74.5 p -83.3 175.7 9.69 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.027 0.376 . . . . 0.0 110.337 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -65.23 -27.05 68.4 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.423 0.63 . . . . 0.0 111.732 -177.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.08 -4.18 4.53 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.693 1.997 . . . . 0.0 111.94 171.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.27 5.09 65.67 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 126.04 1.781 . . . . 0.0 113.567 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 46.0 mmtt -65.94 127.81 33.54 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 105.547 -2.019 . . . . 0.0 105.547 174.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -86.24 145.51 26.93 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 171.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -134.38 84.82 2.14 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 124.127 1.917 . . . . 0.0 108.683 166.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.451 HG23 ' HE3' ' A' ' 47' ' ' LYS . 1.6 p -60.28 143.59 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 CA-C-N 111.765 -2.471 . . . . 0.0 109.931 152.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.402 HD12 HD11 ' A' ' 43' ' ' ILE . 2.9 pt -139.09 132.7 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 C-N-CA 128.208 2.603 . . . . 0.0 105.203 177.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -111.81 -179.39 3.68 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.147 0.979 . . . . 0.0 108.84 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.5 ' HE3' ' O ' ' A' ' 44' ' ' LEU . 75.0 tttt -64.25 107.91 1.44 Allowed 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 175.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 128.57 -15.71 5.99 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 118.578 -1.123 . . . . 0.0 112.979 -175.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -85.88 120.58 27.44 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 119.488 1.644 . . . . 0.0 108.408 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 25.3 tp -83.84 146.76 27.93 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 158.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.8 t -132.89 149.5 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 124.788 1.235 . . . . 0.0 108.104 177.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 87.9 m -131.8 111.68 11.83 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 159.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -80.38 144.82 58.28 Favored Pre-proline 0 C--O 1.236 0.363 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 165.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -85.98 178.08 4.37 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.203 1.935 . . . . 0.0 111.357 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -73.49 93.91 2.05 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 113.492 -1.686 . . . . 0.0 109.406 174.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.39 86.72 1.94 Allowed Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.263 1.411 . . . . 0.0 110.775 175.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 33.5 tp -153.67 140.62 19.23 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.084 0.954 . . . . 0.0 109.879 169.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.39 109.47 13.34 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.766 1.626 . . . . 0.0 108.192 -173.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 8.1 p -139.9 166.24 25.16 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.817 1.19 . . . . 0.0 110.179 -172.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.69 162.02 19.85 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.819 -1.176 . . . . 0.0 109.53 174.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -131.99 110.36 10.7 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.468 1.507 . . . . 0.0 107.642 168.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.7 tttp -102.23 103.74 14.26 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 174.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 t -82.75 99.84 5.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 -176.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.6 mt -88.62 -12.76 41.66 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 118.293 -0.861 . . . . 0.0 110.87 -174.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -150.58 154.03 34.86 Favored Pre-proline 0 N--CA 1.45 -0.441 0 C-N-CA 126.616 1.966 . . . . 0.0 106.792 160.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -57.43 139.02 88.86 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 N-CA-C 108.135 -1.525 . . . . 0.0 108.135 177.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.4 p -125.09 156.0 33.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -168.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -130.15 117.0 19.26 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 173.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.545 ' HB3' HD13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -130.09 116.04 17.94 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.408 0.683 . . . . 0.0 112.368 177.713 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 11.4 m80 -66.69 119.95 12.65 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 105.931 -1.878 . . . . 0.0 105.931 170.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -119.51 164.88 15.13 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 123.76 0.824 . . . . 0.0 110.884 -177.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -152.52 125.91 8.74 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 162.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 32.4 mt -73.84 148.47 42.37 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.314 1.446 . . . . 0.0 108.804 174.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.4 p90 . . . . . 0 C--O 1.251 1.155 0 C-N-CA 126.578 1.951 . . . . 0.0 109.681 177.143 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.8 t . . . . . 0 N--CA 1.471 0.615 0 CA-C-O 122.298 1.046 . . . . 0.0 111.639 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -72.4 133.27 44.82 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -173.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.6 mt -134.84 133.18 54.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 171.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -134.36 171.58 14.08 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.632 0.773 . . . . 0.0 109.305 172.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.49 84.93 12.7 Favored Pre-proline 0 N--CA 1.464 0.271 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 175.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -75.07 159.54 40.98 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 121.937 1.758 . . . . 0.0 110.761 -175.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.4 ' H ' HG22 ' A' ' 9' ' ' THR . 1.7 t -64.87 143.45 98.82 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 170.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.51 -24.74 25.91 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 121.562 1.508 . . . . 0.0 112.439 -177.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -63.3 -42.13 99.02 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.348 1.459 . . . . 0.0 111.115 175.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.9 tptt -57.88 -43.62 86.18 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 175.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -66.97 -30.79 71.01 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 122.755 0.422 . . . . 0.0 110.752 -176.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -58.97 -52.54 65.31 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.122 0.874 . . . . 0.0 109.373 168.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -58.44 -46.48 86.44 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.898 0.879 . . . . 0.0 111.265 -174.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 75.5 mt -60.9 -5.7 1.48 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.703 1.201 . . . . 0.0 113.306 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.5 m 62.49 41.04 10.16 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 126.243 1.817 . . . . 0.0 109.742 167.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.9 t -58.83 -30.45 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 128.176 2.59 . . . . 0.0 110.379 176.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -58.44 -16.32 14.49 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.835 0.854 . . . . 0.0 112.823 170.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -102.44 -2.27 29.07 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.539 1.535 . . . . 0.0 112.048 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 33.2 m0 -82.69 165.28 42.78 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.79 143.04 54.29 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 121.939 1.759 . . . . 0.0 111.172 169.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 75.5 mt -79.32 151.83 4.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 164.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.441 ' CH2' ' HB2' ' A' ' 26' ' ' LYS . 14.9 t90 -138.84 144.99 39.48 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 154.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -145.69 162.8 36.74 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.824 1.25 . . . . 0.0 110.178 175.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.441 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 5.2 tmtt? -156.74 156.85 34.05 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 124.486 1.115 . . . . 0.0 108.036 -176.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.87 168.71 9.28 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 122.248 1.023 . . . . 0.0 112.175 174.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.5 p -75.74 62.97 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 128.711 2.804 . . . . 0.0 109.258 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.7 t -129.72 -162.46 1.21 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.4 2.28 . . . . 0.0 107.974 -175.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.36 159.66 43.43 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 120.337 -1.477 . . . . 0.0 110.321 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -171.41 -164.27 0.33 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.816 2.046 . . . . 0.0 108.399 -171.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -132.88 150.08 52.19 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.79 2.036 . . . . 0.0 107.406 170.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 34.4 t-105 -127.18 150.38 49.54 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.355 0.525 . . . . 0.0 111.04 174.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -120.66 121.98 39.49 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 124.691 1.196 . . . . 0.0 109.181 170.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -91.53 119.21 31.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.093 1.357 . . . . 0.0 107.432 174.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -117.01 12.43 14.59 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.584 1.154 . . . . 0.0 111.075 176.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.6 170.44 15.82 Favored 'General case' 0 CA--C 1.523 -0.079 0 C-N-CA 124.402 1.081 . . . . 0.0 110.65 158.228 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -60.89 117.07 4.98 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 103.178 -2.897 . . . . 0.0 103.178 166.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -130.63 76.44 1.72 Allowed 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -170.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.3 m -63.96 145.4 55.92 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -175.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 27.7 p -145.43 153.76 41.53 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 119.923 -0.711 . . . . 0.0 112.331 166.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -124.52 112.93 17.45 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.284 1.834 . . . . 0.0 107.854 -176.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.6 mm -69.88 136.67 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 126.487 1.915 . . . . 0.0 107.261 173.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 26.1 mt -125.08 -47.16 1.78 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.317 1.047 . . . . 0.0 108.805 -171.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -147.4 159.91 43.15 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 165.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.13 178.83 31.64 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 124.84 1.21 . . . . 0.0 113.528 174.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.432 ' HE2' HD12 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -144.76 144.92 31.43 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.651 0.739 . . . . 0.0 112.483 -170.343 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.3 t -142.63 159.73 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -122.54 119.61 31.38 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 159.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 41.2 t -103.14 92.29 2.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 51.3 m -79.09 103.1 8.8 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.647 1.179 . . . . 0.0 108.409 177.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 64.1 p -82.97 172.92 12.26 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.873 -0.517 . . . . 0.0 109.928 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -71.8 -29.01 64.0 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.385 0.612 . . . . 0.0 112.596 -166.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -73.62 0.16 13.57 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.464 1.105 . . . . 0.0 111.182 173.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.5 -14.86 64.32 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 127.951 2.691 . . . . 0.0 112.875 177.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -63.52 120.18 11.22 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.624 1.57 . . . . 0.0 107.718 -173.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.06 100.93 9.52 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.637 1.175 . . . . 0.0 110.068 -169.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -83.42 108.2 16.43 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 -177.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 40.3 t -66.92 140.18 19.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 104.77 -2.307 . . . . 0.0 104.77 154.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.1 pt -134.74 99.97 2.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 174.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -81.5 172.9 12.94 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.183 0.993 . . . . 0.0 109.916 168.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.2 pttm -52.87 127.16 22.6 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.812 0.815 . . . . 0.0 109.862 169.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.91 -28.47 13.84 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-O 117.965 -1.464 . . . . 0.0 114.321 175.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.22 101.71 1.94 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 120.736 2.268 . . . . 0.0 107.933 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.4 tp -77.44 134.28 38.42 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.7 t -116.75 146.9 20.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -174.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.8 m -138.83 99.7 3.86 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 125.09 1.356 . . . . 0.0 108.094 165.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -63.18 165.55 10.48 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 124.027 0.931 . . . . 0.0 109.403 161.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -88.41 174.76 4.16 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 CA-C-N 120.098 1.071 . . . . 0.0 112.357 164.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -74.73 91.77 2.41 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 168.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 117.9 84.33 0.99 Allowed Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.281 1.419 . . . . 0.0 110.473 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.5 tt -150.95 130.88 13.32 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.362 1.465 . . . . 0.0 108.806 171.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -104.52 134.31 47.92 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 165.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 26.7 p -151.49 167.3 28.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 119.138 0.881 . . . . 0.0 111.547 169.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.01 164.51 25.0 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.435 0.636 . . . . 0.0 111.484 168.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -143.42 101.02 3.72 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 113.76 -1.563 . . . . 0.0 108.805 -175.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 tptt -95.05 107.68 19.74 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 168.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.1 t -75.67 111.82 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 104.335 -2.469 . . . . 0.0 104.335 165.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.432 HD12 ' HE2' ' A' ' 47' ' ' LYS . 74.7 mt -84.64 -27.32 27.23 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -152.06 153.98 31.96 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 124.966 1.306 . . . . 0.0 109.919 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -53.83 128.32 29.13 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.104 2.536 . . . . 0.0 109.467 175.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.5 p -135.76 138.21 48.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -167.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -128.25 67.98 1.36 Allowed 'General case' 0 C--O 1.223 -0.309 0 CA-C-O 121.16 0.505 . . . . 0.0 110.099 -171.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.436 ' HE3' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -80.1 154.52 28.03 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -175.323 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -94.38 142.43 27.43 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 163.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -131.22 159.02 38.99 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.205 0.911 . . . . 0.0 110.959 176.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -146.37 132.96 19.81 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 122.907 0.483 . . . . 0.0 109.71 170.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 90.0 mt -86.04 135.77 33.5 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.45 1.1 . . . . 0.0 108.463 174.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 6.0 p90 . . . . . 0 C--O 1.249 1.046 0 C-N-CA 124.029 0.932 . . . . 0.0 110.953 -176.67 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.1 t . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -104.23 114.59 28.93 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 175.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.4 mt -132.36 129.78 59.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 124.747 1.219 . . . . 0.0 108.258 -176.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -162.42 171.23 17.47 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.395 1.078 . . . . 0.0 109.887 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.49 85.88 2.48 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 123.504 0.722 . . . . 0.0 110.132 176.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -65.56 162.8 32.52 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.474 2.116 . . . . 0.0 112.377 -177.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.4 t -58.3 144.64 77.08 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 123.55 0.74 . . . . 0.0 109.389 169.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.22 -30.77 30.45 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.338 1.359 . . . . 0.0 113.065 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -57.83 -44.55 86.52 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.768 1.167 . . . . 0.0 112.237 -175.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.3 tptt -57.16 -45.53 83.53 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 123.908 0.883 . . . . 0.0 110.143 177.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.49 -23.71 67.51 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.214 0.606 . . . . 0.0 111.527 -174.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.8 mttt -72.17 -48.56 42.43 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -58.67 -43.96 90.06 Favored 'General case' 0 CA--C 1.522 -0.107 0 C-N-CA 124.407 1.083 . . . . 0.0 110.329 -176.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 81.4 mt -62.05 -8.68 5.7 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.866 1.667 . . . . 0.0 114.811 -176.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.0 m 65.97 30.01 9.92 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.228 1.411 . . . . 0.0 112.182 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.9 t -52.27 -33.06 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 125.636 1.574 . . . . 0.0 110.412 173.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -53.62 -32.97 53.4 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 171.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -84.89 -19.69 31.91 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 118.128 -0.939 . . . . 0.0 112.179 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 41.1 m0 -66.01 160.16 65.28 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -171.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -65.96 132.59 30.66 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.84 1.693 . . . . 0.0 111.361 176.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.1 mt -71.14 139.5 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 162.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.531 ' CE3' ' HE3' ' A' ' 84' ' ' LYS . 69.7 t90 -133.49 122.56 23.81 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 161.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -124.47 159.36 30.68 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.462 1.505 . . . . 0.0 107.818 173.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -157.39 164.05 37.93 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -171.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.29 -176.38 2.62 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 122.425 1.107 . . . . 0.0 110.438 175.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.7 p -68.2 0.33 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 126.323 1.849 . . . . 0.0 112.383 167.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 p -71.74 129.59 39.04 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 120.065 -1.647 . . . . 0.0 110.81 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.51 157.5 16.99 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.238 1.015 . . . . 0.0 110.021 -177.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -164.21 -164.25 0.84 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 126.503 1.921 . . . . 0.0 107.122 -171.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -138.75 157.24 46.45 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 126.09 1.756 . . . . 0.0 108.698 173.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 22.1 t-105 -144.27 138.39 27.93 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.561 0.744 . . . . 0.0 111.181 -174.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -103.15 145.1 30.43 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.714 1.606 . . . . 0.0 107.806 168.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -118.04 123.13 44.92 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.399 1.48 . . . . 0.0 107.737 173.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.71 -5.64 12.13 Favored 'General case' 0 N--CA 1.461 0.092 0 C-N-CA 126.232 1.813 . . . . 0.0 112.564 -170.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.81 175.19 9.9 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 131.512 3.925 . . . . 0.0 106.539 166.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -70.32 139.71 52.1 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -122.52 114.45 20.68 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 163.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 20.0 m -89.79 132.98 34.95 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 159.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 27.4 p -138.89 161.82 36.36 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.338 0.589 . . . . 0.0 110.812 164.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -122.52 128.76 51.2 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.0 mm -87.02 102.3 12.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 128.806 2.842 . . . . 0.0 106.797 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.442 ' O ' ' HE2' ' A' ' 62' ' ' LYS . 2.4 mm? -81.41 -26.5 35.35 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 123.504 0.722 . . . . 0.0 111.062 -174.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -176.67 148.94 0.73 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.144 2.177 . . . . 0.0 106.086 -174.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.26 -177.11 28.43 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.275 1.417 . . . . 0.0 113.788 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.0 148.48 38.62 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.116 0.958 . . . . 0.0 109.748 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.5 t -138.22 156.52 30.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 125.039 1.335 . . . . 0.0 107.731 176.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -120.81 139.05 53.68 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 125.597 1.559 . . . . 0.0 108.066 165.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.9 t -133.93 120.2 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 83.2 m -111.83 105.15 13.54 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.531 1.533 . . . . 0.0 107.902 167.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.0 p -68.08 165.5 17.94 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 173.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -74.32 -14.7 60.93 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 123.278 1.513 . . . . 0.0 113.29 -161.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -52.04 -21.63 3.34 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 127.437 2.295 . . . . 0.0 113.083 161.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.41 4.65 90.08 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.686 1.136 . . . . 0.0 111.868 -165.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -71.1 144.97 50.12 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 119.326 1.563 . . . . 0.0 108.125 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -108.09 145.2 34.4 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -173.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -141.73 132.15 25.2 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 69.4 t -136.36 118.59 20.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 -171.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.1 pt -124.63 106.1 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 O-C-N 123.808 0.693 . . . . 0.0 109.151 -169.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -90.72 178.05 6.17 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 122.677 1.227 . . . . 0.0 109.863 171.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.442 ' HE2' ' O ' ' A' ' 44' ' ' LEU . 22.9 tttm -51.11 108.06 0.22 Allowed 'General case' 0 C--O 1.237 0.423 0 C-N-CA 127.527 2.331 . . . . 0.0 109.805 176.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.52 -16.41 26.58 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 117.591 -1.672 . . . . 0.0 114.65 175.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -70.75 102.17 2.26 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 120.368 2.084 . . . . 0.0 108.901 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.0 tp -71.04 141.38 50.91 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.1 t -125.56 145.06 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 97.3 m -129.7 118.1 21.35 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 158.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -88.45 145.77 36.24 Favored Pre-proline 0 C--O 1.237 0.402 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 162.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -84.27 177.26 5.97 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.286 1.991 . . . . 0.0 112.259 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 30.3 tttm -76.82 81.39 3.41 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 113.95 -1.477 . . . . 0.0 107.851 169.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.59 81.32 0.47 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 125.504 1.526 . . . . 0.0 111.774 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.6 tt -148.2 128.24 13.64 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 118.535 1.167 . . . . 0.0 110.694 174.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.7 116.72 30.58 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.377 1.471 . . . . 0.0 108.436 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 17.6 p -148.85 176.63 10.24 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.509 1.05 . . . . 0.0 113.393 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.11 177.01 9.3 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.981 1.312 . . . . 0.0 111.855 171.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -158.16 100.59 1.7 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 119.932 1.242 . . . . 0.0 109.663 174.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.6 tttt -104.22 111.2 23.71 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.4 t -77.18 116.67 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 N-CA-C 103.157 -2.905 . . . . 0.0 103.157 171.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.9 mt -88.12 -25.52 22.96 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 119.346 -0.941 . . . . 0.0 109.381 171.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -144.36 150.16 47.1 Favored Pre-proline 0 C--O 1.232 0.136 0 CA-C-O 117.819 -1.086 . . . . 0.0 111.051 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -58.81 114.36 1.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.431 2.754 . . . . 0.0 108.232 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.1 p -124.39 143.84 36.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 125.18 1.392 . . . . 0.0 107.446 -163.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.5 mtt180 -115.3 113.57 24.01 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 174.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.531 ' HE3' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -114.37 125.59 54.04 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 167.295 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -76.61 123.53 26.25 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 103.333 -2.84 . . . . 0.0 103.333 169.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -121.66 160.58 24.15 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.058 0.845 . . . . 0.0 110.361 -176.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -142.1 149.59 40.04 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 165.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.5 mt -108.71 129.05 55.36 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.5 p90 . . . . . 0 C--O 1.251 1.172 0 C-N-CA 124.818 1.247 . . . . 0.0 108.597 -173.56 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 p . . . . . 0 C--O 1.236 0.382 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -127.81 147.47 50.43 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.157 1.383 . . . . 0.0 107.379 174.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 90.5 mt -124.73 142.27 42.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 165.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -160.24 177.59 10.49 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.098 1.359 . . . . 0.0 110.283 166.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.448 ' HE2' ' OD1' ' A' ' 64' ' ' ASP . 0.5 OUTLIER -116.86 85.3 17.24 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 124.067 0.947 . . . . 0.0 108.667 -172.237 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.527 ' HG3' HD22 ' A' ' 65' ' ' LEU . 61.6 Cg_endo -72.16 -4.42 15.16 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 124.904 3.736 . . . . 0.0 114.687 -164.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.324 2.1 t 55.44 146.29 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 129.187 2.995 . . . . 0.0 113.39 -169.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -58.04 -17.76 32.81 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.632 2.221 . . . . 0.0 112.2 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -47.44 -61.55 1.86 Allowed 'General case' 0 C--O 1.231 0.112 0 CA-C-N 119.517 1.053 . . . . 0.0 111.297 165.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -67.4 -38.28 84.42 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -178.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.422 HD21 ' HG2' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -72.17 -24.25 61.4 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 118.562 -0.732 . . . . 0.0 112.937 -175.434 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -60.93 -55.1 36.9 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 120.397 1.453 . . . . 0.0 107.541 167.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -74.42 -26.64 60.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.769 -164.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 mp -68.0 -9.92 49.47 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.24 1.416 . . . . 0.0 112.766 170.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.3 m 61.54 33.1 18.56 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.311 1.844 . . . . 0.0 112.369 -174.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.2 t -57.19 -27.59 28.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 O-C-N 121.633 -0.667 . . . . 0.0 111.97 -172.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -54.58 -26.39 32.04 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.763 1.165 . . . . 0.0 113.574 173.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? -86.56 -26.28 24.57 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.004 0.921 . . . . 0.0 111.64 -173.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 36.7 m0 -62.84 160.05 40.19 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 124.623 1.169 . . . . 0.0 109.529 -170.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -69.35 118.59 5.77 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.251 1.967 . . . . 0.0 112.407 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.6 mt -61.98 142.08 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 176.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.598 ' CE3' ' HE3' ' A' ' 84' ' ' LYS . 59.5 t90 -135.3 143.14 46.05 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 165.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -151.93 161.84 42.01 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.701 1.601 . . . . 0.0 111.067 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.0 mmtt -143.84 176.35 9.32 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.291 0.636 . . . . 0.0 109.347 -178.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.471 ' HG3' ' H ' ' A' ' 29' ' ' SER . 6.6 pt-20 -69.82 -165.95 0.1 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.781 2.033 . . . . 0.0 110.756 169.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.5 p -109.85 25.07 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 126.691 1.996 . . . . 0.0 111.447 -175.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.471 ' H ' ' HG3' ' A' ' 27' ' ' GLU . 14.7 t -96.29 -178.34 4.27 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 126.693 1.997 . . . . 0.0 109.199 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -120.79 161.46 21.44 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 123.937 0.895 . . . . 0.0 110.125 173.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -163.75 -168.03 1.53 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.712 2.005 . . . . 0.0 108.248 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -121.29 152.02 39.4 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 168.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 51.9 t-105 -130.97 179.55 5.92 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.607 0.763 . . . . 0.0 109.936 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -148.02 151.27 35.45 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.398 1.479 . . . . 0.0 107.287 171.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -131.41 98.97 4.68 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.624 1.17 . . . . 0.0 108.534 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -90.89 9.86 28.69 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.966 1.706 . . . . 0.0 112.202 -177.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -158.46 162.49 37.53 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 128.486 2.714 . . . . 0.0 108.321 -178.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -61.48 138.29 58.27 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -144.58 104.66 4.07 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.484 HG22 HD11 ' A' ' 65' ' ' LEU . 74.8 m -72.69 143.14 48.19 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 164.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.436 ' O ' HD12 ' A' ' 65' ' ' LEU . 1.7 p -153.53 131.62 11.83 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.49 1.041 . . . . 0.0 111.4 175.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -108.61 108.09 18.83 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 126.349 1.859 . . . . 0.0 108.828 -176.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.3 mm -74.8 114.76 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.812 1.245 . . . . 0.0 107.834 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.3 mp -101.19 -33.48 10.07 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 118.879 -0.581 . . . . 0.0 112.337 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pm0 -154.04 162.73 40.99 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.975 0.91 . . . . 0.0 109.296 172.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.58 -172.37 48.47 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 127.061 2.267 . . . . 0.0 111.32 -173.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.81 148.28 31.73 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -177.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.3 t -136.95 151.96 27.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -123.07 98.01 5.69 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.362 2.265 . . . . 0.0 106.31 168.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.9 t -86.16 136.33 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 170.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 66.8 m -136.45 122.48 20.21 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.183 0.901 . . . . 0.0 108.776 -178.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 72.1 p -76.36 169.81 17.54 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.304 0.573 . . . . 0.0 109.858 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -62.98 -35.9 81.74 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.364 -0.835 . . . . 0.0 110.713 -178.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -82.65 16.16 2.3 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 128.516 2.726 . . . . 0.0 111.694 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.88 4.95 88.74 Favored Glycine 0 CA--C 1.525 0.687 0 O-C-N 119.884 -1.76 . . . . 0.0 114.649 162.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.2 mmtt -67.0 106.78 2.04 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.765 1.783 . . . . 0.0 107.025 167.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.5 tptt -67.2 157.55 33.5 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 163.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -137.0 155.58 49.52 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 104.064 -2.569 . . . . 0.0 104.064 166.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 75.5 t -138.76 129.07 33.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 103.053 -2.943 . . . . 0.0 103.053 178.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.9 pt -134.08 123.23 43.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -103.67 176.12 5.26 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 126.725 2.01 . . . . 0.0 107.817 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.3 pttp -58.11 125.2 22.16 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 164.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.8 -0.07 56.45 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 117.702 -1.61 . . . . 0.0 115.688 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.448 ' OD1' ' HE2' ' A' ' 7' ' ' LYS . 19.1 m-20 -92.1 123.82 35.73 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 120.832 2.316 . . . . 0.0 106.567 166.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.527 HD22 ' HG3' ' A' ' 8' ' ' PRO . 14.2 tp -88.15 146.73 25.25 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 160.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.4 t -126.07 150.51 31.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 174.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 58.4 m -132.96 111.41 11.01 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 164.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -74.43 155.69 87.52 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 169.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -74.79 -165.2 0.27 Allowed 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.168 2.579 . . . . 0.0 109.381 174.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -95.25 120.82 36.14 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 162.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.97 87.66 1.06 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.401 1.477 . . . . 0.0 112.634 176.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 57.9 tp -143.88 143.54 31.34 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.952 1.701 . . . . 0.0 108.207 171.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.47 131.28 56.98 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 125.339 1.456 . . . . 0.0 108.11 167.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 7.8 p -165.43 168.43 16.67 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.48 1.112 . . . . 0.0 111.362 169.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.88 167.96 20.85 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 124.578 1.151 . . . . 0.0 112.028 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -144.4 113.11 6.68 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.462 1.105 . . . . 0.0 109.755 178.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.53 109.27 19.53 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 175.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.0 t -86.8 101.26 10.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 175.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.9 mt -83.39 -18.9 37.18 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-O 118.777 -0.63 . . . . 0.0 111.717 -175.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -148.25 146.15 22.4 Favored Pre-proline 0 C--O 1.236 0.356 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 166.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -61.54 90.74 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.491 1 C-N-CA 125.542 4.161 . . . . 0.0 110.87 -165.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.35 149.31 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 123.936 0.895 . . . . 0.0 109.754 -166.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -129.35 112.6 14.01 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 168.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.598 ' HE3' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -133.28 142.15 48.35 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.266 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -84.34 100.89 11.56 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 171.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -88.8 154.86 19.93 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.154 0.982 . . . . 0.0 110.546 171.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -151.54 112.93 4.35 Favored 'General case' 0 C--O 1.239 0.523 0 O-C-N 121.676 -0.64 . . . . 0.0 110.517 170.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 61.7 mt -61.59 153.29 28.19 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.406 1.482 . . . . 0.0 108.932 171.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.7 p90 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 116.173 -1.87 . . . . 0.0 110.443 166.332 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.8 p . . . . . 0 CA--C 1.533 0.3 0 N-CA-C 108.588 -0.894 . . . . 0.0 108.588 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 55.9 tttt -75.7 136.68 40.36 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 171.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.3 mt -135.73 139.74 45.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 169.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -165.32 175.22 9.36 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.145 2.178 . . . . 0.0 108.728 162.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.31 86.35 1.32 Allowed Pre-proline 0 C--O 1.237 0.444 0 CA-C-O 117.88 -1.057 . . . . 0.0 109.19 176.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -63.92 168.01 12.91 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.522 1.481 . . . . 0.0 111.014 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.0 t -69.85 143.5 92.18 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -66.42 -19.4 55.29 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.897 1.731 . . . . 0.0 113.178 176.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -59.89 -47.61 85.06 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 119.733 1.151 . . . . 0.0 109.622 171.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 35.9 tptt -65.34 -37.48 87.19 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 121.45 -0.781 . . . . 0.0 110.451 -177.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.3 mt -67.97 -26.91 66.17 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 118.833 -0.603 . . . . 0.0 111.917 177.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -64.83 -46.87 80.13 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 119.386 0.994 . . . . 0.0 109.814 168.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -60.07 -48.58 81.12 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.387 0.613 . . . . 0.0 109.384 -176.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.7 mp -55.03 -14.76 1.65 Allowed 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 125.947 1.699 . . . . 0.0 112.817 176.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.4 m 53.01 45.01 29.69 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.015 1.326 . . . . 0.0 110.743 175.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 45.8 t -56.59 -31.45 34.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.27 1.028 . . . . 0.0 110.505 -175.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -44.92 -34.56 2.44 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.858 2.063 . . . . 0.0 114.454 167.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.9 mtmm -84.12 -23.53 30.66 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 119.531 1.059 . . . . 0.0 111.418 -177.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.401 ' CE3' ' HB2' ' A' ' 87' ' ' ASN . 35.1 m0 -64.72 164.43 20.84 Favored Pre-proline 0 C--O 1.24 0.574 0 C-N-CA 124.118 0.967 . . . . 0.0 109.816 -171.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -66.6 139.97 55.15 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 121.118 1.212 . . . . 0.0 110.144 171.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.2 mt -81.18 151.98 4.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 164.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.514 ' CE3' ' HE2' ' A' ' 84' ' ' LYS . 68.3 t90 -140.79 148.0 39.93 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 156.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.7 157.07 44.66 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 126.615 1.966 . . . . 0.0 109.169 -178.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -151.02 169.59 21.42 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.482 0.713 . . . . 0.0 111.625 -174.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -66.18 175.07 2.26 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 122.715 1.245 . . . . 0.0 111.006 164.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.3 t -94.62 27.4 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 128.418 2.687 . . . . 0.0 109.866 -167.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.9 t -91.99 176.59 6.45 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.573 1.149 . . . . 0.0 110.521 -173.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -104.61 142.55 34.46 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.448 1.099 . . . . 0.0 108.092 167.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -147.08 -170.34 3.52 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 127.644 2.377 . . . . 0.0 107.392 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.62 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 1.1 m-20 -128.3 154.87 45.45 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 169.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 48.1 t-105 -134.77 146.05 48.99 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.025 0.53 . . . . 0.0 111.787 175.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -113.82 111.11 21.2 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 171.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -79.49 122.61 26.67 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 170.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.9 p-10 -120.19 6.58 10.74 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 125.916 1.687 . . . . 0.0 111.323 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.96 174.31 15.71 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.082 1.353 . . . . 0.0 108.85 167.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -68.33 87.12 0.29 Allowed 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 125.584 1.554 . . . . 0.0 108.773 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.33 110.32 18.02 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 173.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 73.0 m -88.14 134.7 33.7 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 163.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 24.6 p -140.23 149.18 42.56 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 118.714 0.688 . . . . 0.0 110.053 170.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -126.92 116.71 21.23 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.466 1.507 . . . . 0.0 107.979 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 18.9 mm -80.83 124.96 39.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 126.911 2.084 . . . . 0.0 107.567 -172.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.2 mt -103.12 -26.9 12.86 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 118.634 0.652 . . . . 0.0 112.486 -176.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -158.95 169.39 24.44 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.547 1.939 . . . . 0.0 107.404 174.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.23 -172.26 25.2 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.099 0.857 . . . . 0.0 113.078 169.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.95 143.57 30.61 Favored 'General case' 0 CA--C 1.517 -0.307 0 O-C-N 121.526 -0.985 . . . . 0.0 108.363 175.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 71.6 t -138.48 155.97 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -124.55 127.02 46.78 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 126.381 1.872 . . . . 0.0 106.345 163.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.1 t -113.53 113.06 42.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.53 ' HB ' ' HG2' ' A' ' 75' ' ' ARG . 26.2 m -114.72 103.01 10.56 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 -168.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 38.2 p -78.1 173.15 12.53 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -54.65 -40.6 69.17 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.651 0.78 . . . . 0.0 110.578 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -65.09 -17.38 64.41 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 123.794 0.838 . . . . 0.0 112.361 -175.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.68 0.7 88.26 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -163.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.1 mmtp -63.06 118.36 7.76 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 164.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -130.05 133.29 46.62 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -162.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -127.27 116.64 20.87 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -170.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 77.6 t -76.76 144.88 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 160.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.9 pt -140.92 147.4 22.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 C-N-CA 124.795 1.238 . . . . 0.0 108.914 166.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -138.89 -175.33 4.11 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 126.939 2.096 . . . . 0.0 110.374 176.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -66.85 62.88 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 128.132 2.573 . . . . 0.0 115.795 -162.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 159.6 -6.9 0.13 Allowed Glycine 0 C--N 1.317 -0.475 0 CA-C-O 118.021 -1.433 . . . . 0.0 114.027 -178.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -71.47 128.53 36.15 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 166.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 17.0 tp -88.76 142.09 27.96 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 160.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.6 t -122.35 141.05 44.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 175.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.3 m -127.11 101.21 6.43 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 167.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -65.03 161.82 44.37 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 170.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -71.42 -164.03 0.15 Allowed 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.974 2.45 . . . . 0.0 108.684 167.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -110.14 108.85 19.16 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 165.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.69 85.64 1.88 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.453 1.502 . . . . 0.0 110.669 -175.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.1 tt -147.57 113.81 5.89 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.616 1.966 . . . . 0.0 107.499 173.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.1 ttt180 -81.98 133.18 35.28 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 161.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 29.2 p -147.32 -170.66 3.61 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.507 0.67 . . . . 0.0 109.896 159.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.62 ' HA ' ' HA ' ' A' ' 32' ' ' ASP . 5.8 ptp180 -108.06 164.7 12.06 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 173.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -134.07 122.87 23.57 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 119.591 1.087 . . . . 0.0 110.085 175.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.1 tttp -116.18 105.97 13.18 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.5 t -72.92 129.52 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 103.536 -2.764 . . . . 0.0 103.536 166.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 95.0 mt -109.9 -16.36 13.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 117.659 -1.162 . . . . 0.0 110.407 173.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -154.13 145.12 16.26 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 126.594 1.958 . . . . 0.0 107.61 167.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -56.92 125.87 20.38 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 124.345 3.363 . . . . 0.0 111.587 -167.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.419 ' O ' HG13 ' A' ' 82' ' ' VAL . 8.7 p -121.45 92.76 2.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-O 124.978 2.323 . . . . 0.0 111.491 -161.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.9 mtm-85 -78.95 119.57 22.3 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 170.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.514 ' HE2' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -128.78 157.17 42.2 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.69 0.757 . . . . 0.0 109.257 173.016 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -94.79 135.85 35.8 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 161.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -130.15 160.48 33.67 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 123.052 0.541 . . . . 0.0 109.871 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.401 ' HB2' ' CE3' ' A' ' 21' ' ' TRP . 27.3 t-20 -156.55 103.43 2.12 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -172.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 65.5 mt -75.48 145.53 41.35 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 171.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 45.2 p90 . . . . . 0 C--O 1.252 1.187 0 CA-C-O 114.576 -2.63 . . . . 0.0 111.156 164.96 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 74.3 t . . . . . 0 N--CA 1.446 -0.654 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.7 tptp -82.2 134.92 35.32 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 168.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.9 mt -140.81 120.2 11.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 168.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -138.45 175.16 9.81 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.323 1.449 . . . . 0.0 109.986 172.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.53 85.47 5.92 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 170.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -65.71 165.24 23.83 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.364 2.043 . . . . 0.0 112.111 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.19 144.72 84.95 Favored Pre-proline 0 C--O 1.239 0.553 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -68.15 -30.74 31.0 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.855 2.37 . . . . 0.0 112.334 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -56.84 -44.04 81.69 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.956 0.798 . . . . 0.0 110.686 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -64.64 -36.95 85.9 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.193 0.597 . . . . 0.0 109.493 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.494 HD21 ' CD1' ' A' ' 65' ' ' LEU . 96.1 mt -69.09 -28.54 66.58 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.894 -0.504 . . . . 0.0 112.225 177.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -55.56 -50.82 69.05 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 169.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -60.43 -52.78 63.78 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.408 1.083 . . . . 0.0 110.999 -176.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.453 HD12 HD23 ' A' ' 13' ' ' LEU . 93.1 mt -56.39 -20.76 21.02 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 125.962 1.705 . . . . 0.0 112.789 -178.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 74.3 42.51 0.32 Allowed 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.768 2.027 . . . . 0.0 111.149 170.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.7 t -54.33 -33.1 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 118.304 0.502 . . . . 0.0 110.765 -173.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -58.24 -24.76 60.39 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.0 pttp -83.76 -5.66 59.25 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.48 0.712 . . . . 0.0 111.049 -171.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 23.0 m0 -87.54 165.05 32.5 Favored Pre-proline 0 N--CA 1.438 -1.06 0 C-N-CA 124.922 1.289 . . . . 0.0 107.881 -169.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -66.93 135.16 36.88 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 121.653 1.569 . . . . 0.0 110.638 167.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 68.5 mt -78.9 143.1 13.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 164.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -127.24 153.15 46.48 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 162.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -150.72 162.69 40.22 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.902 1.281 . . . . 0.0 109.543 176.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -148.78 157.94 43.8 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 124.957 1.303 . . . . 0.0 109.565 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.3 pm0 -69.47 170.91 9.63 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 124.726 1.266 . . . . 0.0 112.061 167.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.4 t -82.49 74.21 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 125.79 1.636 . . . . 0.0 106.829 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.0 t -145.62 -173.12 4.04 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 175.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.96 149.32 30.22 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 122.417 1.103 . . . . 0.0 112.922 -169.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -157.53 -168.25 2.52 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.146 1.779 . . . . 0.0 108.093 -163.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 37.0 p30 -119.91 160.64 22.31 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.257 -0.902 . . . . 0.0 108.648 166.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 10.2 t-105 -128.75 168.11 16.32 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.568 0.699 . . . . 0.0 111.257 172.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -142.32 92.35 2.42 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.722 1.609 . . . . 0.0 107.934 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -72.2 118.93 15.69 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 171.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -111.72 -5.12 14.49 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.344 1.458 . . . . 0.0 111.691 -176.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.53 172.56 12.53 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 127.167 2.187 . . . . 0.0 110.233 164.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -62.16 107.64 0.92 Allowed 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 176.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -121.3 75.11 1.14 Allowed 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -175.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.9 m -67.5 135.83 53.63 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 -175.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 29.3 p -142.54 155.96 45.07 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 120.966 0.413 . . . . 0.0 110.128 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.421 ' HD1' ' HG ' ' A' ' 65' ' ' LEU . 30.8 t80 -132.66 121.0 22.48 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.323 -170.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 16.1 mm -81.07 124.84 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -174.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.2 mt -122.45 -33.71 3.4 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.439 1.096 . . . . 0.0 111.51 -167.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -154.48 162.34 41.2 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 127.39 2.276 . . . . 0.0 105.252 165.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.44 176.51 51.05 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 124.695 1.14 . . . . 0.0 112.186 177.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.26 144.48 27.67 Favored 'General case' 0 CA--C 1.516 -0.356 0 O-C-N 122.249 -0.559 . . . . 0.0 110.27 -156.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 50.6 t -143.65 152.14 16.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-N 117.692 0.223 . . . . 0.0 110.57 -176.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -109.27 128.0 54.72 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.446 1.899 . . . . 0.0 106.951 153.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 94.0 t -107.42 140.06 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 105.726 -1.954 . . . . 0.0 105.726 170.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.9 m -136.47 104.3 5.54 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.442 1.019 . . . . 0.0 109.72 -173.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.0 p -69.74 169.93 11.95 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.182 -0.949 . . . . 0.0 110.518 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -67.67 -29.7 69.05 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.511 -0.743 . . . . 0.0 110.774 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.74 -4.17 2.91 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.085 1.354 . . . . 0.0 112.279 172.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.38 -3.46 86.25 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-O 118.436 -1.202 . . . . 0.0 113.637 167.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -58.38 152.52 17.52 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 167.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -103.64 161.69 13.7 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 156.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -118.93 159.1 24.43 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 153.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 72.8 t -137.47 128.38 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 102.185 -3.265 . . . . 0.0 102.185 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 pt -139.61 142.95 31.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.432 ' OE1' ' HE3' ' A' ' 62' ' ' LYS . 1.3 pp20? -131.71 -176.22 3.97 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.192 1.797 . . . . 0.0 111.771 177.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.432 ' HE3' ' OE1' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -75.23 54.49 0.7 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.38 2.272 . . . . 0.0 115.844 -157.287 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -177.63 -5.81 0.02 OUTLIER Glycine 0 CA--C 1.53 0.981 0 CA-C-O 118.183 -1.343 . . . . 0.0 113.166 172.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.94 140.83 36.51 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 119.253 1.526 . . . . 0.0 108.236 174.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.494 ' CD1' HD21 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -98.08 153.82 18.16 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 123.818 0.847 . . . . 0.0 109.592 167.596 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.8 t -137.07 137.53 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -174.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 98.0 m -131.15 110.48 11.19 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 166.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -73.53 162.9 72.12 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 126.142 1.777 . . . . 0.0 109.207 167.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -83.47 177.1 6.63 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 CA-C-O 122.921 1.134 . . . . 0.0 110.002 169.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.3 tttm -85.55 82.69 8.16 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.084 1.353 . . . . 0.0 107.715 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.21 86.44 0.66 Allowed Glycine 0 CA--C 1.522 0.522 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.9 tp -148.94 103.57 3.37 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.461 0.704 . . . . 0.0 110.823 174.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 27.2 ttt85 -72.86 126.89 31.0 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 156.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 20.4 p -154.14 170.68 20.61 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.899 1.279 . . . . 0.0 108.19 166.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' A' ' 32' ' ' ASP . 1.6 mpp_? -79.81 158.68 26.75 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 120.956 -1.09 . . . . 0.0 110.89 172.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -139.4 116.34 10.94 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.347 1.459 . . . . 0.0 108.433 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.0 102.39 8.14 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.632 1.573 . . . . 0.0 106.921 -173.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.2 t -80.26 105.22 9.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 104.402 -2.444 . . . . 0.0 104.402 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 17.6 mt -81.91 -27.45 33.38 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -151.22 153.62 32.88 Favored Pre-proline 0 N--CA 1.469 0.484 0 C-N-CA 125.67 1.588 . . . . 0.0 109.439 171.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -65.0 106.47 0.79 Allowed 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.125 2.55 . . . . 0.0 111.16 -164.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.3 p -93.17 111.31 24.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 121.774 0.797 . . . . 0.0 110.611 -166.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -94.45 43.12 1.1 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.754 0.821 . . . . 0.0 111.42 -171.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.62 146.98 39.0 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 120.967 -1.083 . . . . 0.0 111.133 -175.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -78.03 150.05 33.91 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 156.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -139.87 156.88 46.48 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.328 0.967 . . . . 0.0 110.545 172.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -143.36 131.91 22.37 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.143 0.977 . . . . 0.0 109.4 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 95.2 mt -93.01 129.83 38.79 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.297 1.039 . . . . 0.0 108.59 176.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.3 p90 . . . . . 0 C--O 1.247 0.949 0 C-N-CA 124.298 1.039 . . . . 0.0 110.231 -177.171 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.239 0.52 0 CA-C-O 121.594 0.711 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -109.68 147.82 32.46 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 125.564 1.546 . . . . 0.0 107.961 -176.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.8 mt -139.31 139.32 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 104.04 -2.578 . . . . 0.0 104.04 177.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -154.6 -178.95 7.54 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.729 0.812 . . . . 0.0 109.848 167.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.1 81.16 27.98 Favored Pre-proline 0 C--O 1.236 0.365 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -175.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.64 169.23 22.39 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.329 2.019 . . . . 0.0 111.462 -170.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.702 HG23 ' H ' ' A' ' 12' ' ' LYS . 6.9 t -66.26 145.02 98.96 Favored Pre-proline 0 CA--C 1.543 0.703 0 O-C-N 121.983 -0.448 . . . . 0.0 109.943 171.221 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.411 ' HA ' HD12 ' A' ' 13' ' ' LEU . 72.8 Cg_endo -67.01 -5.2 12.97 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.888 2.392 . . . . 0.0 112.716 169.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -87.8 -51.74 5.69 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.542 1.064 . . . . 0.0 110.752 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.702 ' H ' HG23 ' A' ' 9' ' ' THR . 1.5 tptt -49.92 -45.89 51.52 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.354 1.062 . . . . 0.0 110.207 172.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 10' ' ' PRO . 34.1 mt -54.97 -33.29 62.29 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.346 1.058 . . . . 0.0 112.555 178.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.0 mttp -63.76 -51.5 64.57 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 118.911 0.778 . . . . 0.0 109.006 176.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -57.51 -49.11 77.38 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 123.001 1.382 . . . . 0.0 109.827 -172.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 98.5 mt -56.48 -12.04 1.55 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.204 1.801 . . . . 0.0 112.035 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.0 m 62.39 32.6 16.77 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.527 1.931 . . . . 0.0 111.05 174.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.412 ' HA ' ' CD2' ' A' ' 21' ' ' TRP . 59.6 t -50.81 -39.62 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 126.657 1.983 . . . . 0.0 110.496 175.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -57.68 -19.33 26.13 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -92.05 -25.43 18.79 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 124.297 1.039 . . . . 0.0 111.586 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.412 ' CD2' ' HA ' ' A' ' 18' ' ' VAL . 41.9 m0 -60.45 158.01 32.23 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 124.297 1.039 . . . . 0.0 109.49 -174.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.39 118.5 5.68 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.046 1.83 . . . . 0.0 111.401 -175.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.2 mt -62.09 144.75 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 174.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.558 ' CZ3' ' HE3' ' A' ' 84' ' ' LYS . 91.0 t90 -132.59 138.32 47.38 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 165.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -136.2 157.28 47.19 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 128.402 2.681 . . . . 0.0 108.622 -177.081 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.5 tptt -153.85 166.4 33.04 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 121.973 -0.454 . . . . 0.0 109.94 -177.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.84 175.19 3.77 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 122.25 1.024 . . . . 0.0 110.681 167.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.6 p -80.8 -6.93 10.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 113.381 -1.736 . . . . 0.0 112.533 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.1 t -73.88 152.14 40.28 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 122.863 1.316 . . . . 0.0 109.743 174.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -84.27 168.28 15.82 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 129.132 2.973 . . . . 0.0 109.929 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -169.35 -164.01 0.43 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.954 2.502 . . . . 0.0 107.176 176.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -122.55 164.05 18.84 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 120.206 -1.559 . . . . 0.0 107.213 157.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 54.5 t-105 -134.52 168.94 18.05 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.791 0.836 . . . . 0.0 109.791 -173.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -135.87 153.7 51.39 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.259 1.423 . . . . 0.0 107.858 175.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -134.42 120.23 19.54 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 170.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -123.79 27.29 7.34 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.923 1.238 . . . . 0.0 111.811 168.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.65 172.08 15.14 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 152.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -70.23 107.43 3.71 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 -171.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -107.58 98.87 8.42 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -173.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 88.2 m -68.7 148.0 51.03 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 161.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.7 p -146.75 159.51 43.41 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 121.468 -0.77 . . . . 0.0 111.539 154.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -126.16 126.05 43.49 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 126.385 1.874 . . . . 0.0 107.862 176.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.9 mm -101.28 111.77 32.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 123.24 0.616 . . . . 0.0 109.35 -169.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.0 mp -93.12 -29.65 15.65 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 123.945 0.898 . . . . 0.0 111.769 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -159.33 166.12 31.88 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.51 0.724 . . . . 0.0 109.086 -177.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.17 -178.85 52.91 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.631 1.11 . . . . 0.0 113.218 -177.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.55 ' HE3' HG23 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -148.64 143.17 26.35 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 125.028 1.331 . . . . 0.0 107.583 -178.653 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.9 t -139.17 149.22 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 176.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -116.87 88.6 2.93 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 103.448 -2.797 . . . . 0.0 103.448 166.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.3 t -75.64 144.39 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 173.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.5 m -145.69 115.06 7.13 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 120.062 1.301 . . . . 0.0 109.052 -175.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 57.5 p -65.72 162.59 18.28 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.94 -21.89 61.54 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.149 -0.97 . . . . 0.0 110.797 175.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -79.48 22.68 0.43 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.239 1.816 . . . . 0.0 111.232 165.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.74 -5.95 10.47 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 125.685 1.612 . . . . 0.0 115.637 166.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -66.95 110.41 3.34 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 119.939 1.869 . . . . 0.0 108.006 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt -87.69 134.08 33.72 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -130.41 85.01 2.24 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 124.26 1.981 . . . . 0.0 108.585 168.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.55 HG23 ' HE3' ' A' ' 47' ' ' LYS . 1.6 p -56.85 136.35 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 CA-C-N 112.51 -2.132 . . . . 0.0 108.646 146.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 pt -139.3 132.97 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 101.719 -3.437 . . . . 0.0 101.719 173.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -90.46 -176.72 4.86 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 121.893 0.854 . . . . 0.0 108.919 171.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -66.16 126.16 27.79 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 147.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 117.61 14.41 6.87 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-O 118.051 -1.416 . . . . 0.0 114.296 -175.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -119.85 149.31 42.28 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.036 1.334 . . . . 0.0 108.545 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.7 tp -109.1 145.16 36.14 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 156.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.3 t -130.26 153.95 39.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 125.461 1.504 . . . . 0.0 107.476 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.0 m -135.31 108.6 7.78 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 161.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -79.01 153.53 77.48 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 123.831 0.852 . . . . 0.0 109.177 169.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.74 171.42 17.35 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 121.848 1.699 . . . . 0.0 111.305 173.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.9 tttt -78.1 106.67 10.13 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 111.485 -2.598 . . . . 0.0 106.21 161.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.66 70.09 0.9 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.702 1.62 . . . . 0.0 111.918 171.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.1 tp -140.68 150.89 44.07 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.104 1.762 . . . . 0.0 109.125 176.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.35 134.2 43.45 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 126.924 2.09 . . . . 0.0 108.219 176.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 6.0 p -159.52 164.83 34.03 Favored 'General case' 0 C--N 1.334 -0.077 0 C-N-CA 123.082 0.553 . . . . 0.0 111.686 176.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.39 164.24 16.62 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 123.029 0.532 . . . . 0.0 112.009 167.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -144.37 104.9 4.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.859 1.264 . . . . 0.0 108.219 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.7 ttpm? -101.88 111.28 23.48 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 169.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.2 t -77.65 125.84 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 168.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.1 mt -103.03 -16.1 15.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 118.313 -0.851 . . . . 0.0 111.448 168.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -147.85 144.45 19.13 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 117.543 -1.218 . . . . 0.0 109.299 171.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -61.97 100.43 0.2 Allowed 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 124.24 3.293 . . . . 0.0 111.299 -174.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.5 p -70.51 156.49 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 124.535 1.134 . . . . 0.0 111.232 -169.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -139.99 110.21 6.57 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 103.435 -2.802 . . . . 0.0 103.435 161.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.558 ' HE3' ' CZ3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -132.16 148.26 52.46 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.217 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -90.56 101.04 13.78 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 105.674 -1.972 . . . . 0.0 105.674 174.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -90.92 159.16 16.34 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.69 0.677 . . . . 0.0 110.074 170.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -154.04 140.82 19.08 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 121.44 -0.788 . . . . 0.0 109.972 159.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 42.9 mt -84.23 165.92 17.97 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 124.484 1.113 . . . . 0.0 109.172 175.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.1 p90 . . . . . 0 C--O 1.255 1.367 0 CA-C-O 116.224 -1.846 . . . . 0.0 108.227 164.124 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.9 t . . . . . 0 C--O 1.238 0.468 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.6 ttpt -115.0 91.45 3.62 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 176.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.509 ' CG1' HG13 ' A' ' 66' ' ' VAL . 22.8 mt -87.77 139.77 16.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 167.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -154.06 171.8 18.51 Favored 'General case' 0 C--O 1.224 -0.26 0 O-C-N 123.998 0.811 . . . . 0.0 111.008 163.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.92 75.77 75.99 Favored Pre-proline 0 N--CA 1.47 0.572 0 C-N-CA 123.419 0.688 . . . . 0.0 111.368 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.468 ' HG2' HD21 ' A' ' 13' ' ' LEU . 41.5 Cg_endo -67.71 172.34 10.7 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 125.183 3.922 . . . . 0.0 114.234 -173.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.6 t -66.19 144.3 98.69 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.191 0.996 . . . . 0.0 109.913 173.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.25 -25.07 50.25 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.734 1.623 . . . . 0.0 112.924 176.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -61.24 -55.08 36.06 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.601 0.761 . . . . 0.0 109.184 -177.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -53.34 -38.16 62.99 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.327 1.051 . . . . 0.0 111.208 176.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.468 HD21 ' HG2' ' A' ' 8' ' ' PRO . 4.3 mm? -71.54 -22.19 61.79 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.325 -176.008 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -64.93 -48.88 72.55 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 120.053 1.297 . . . . 0.0 108.853 166.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -66.3 -37.93 86.55 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.281 0.632 . . . . 0.0 111.466 -167.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 34.4 mt -55.55 -12.09 1.07 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.93 1.292 . . . . 0.0 113.165 173.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.2 m 63.98 39.57 7.89 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.764 2.025 . . . . 0.0 109.668 172.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.6 t -53.63 -35.62 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 128.302 2.641 . . . . 0.0 110.55 173.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -61.48 -11.98 12.97 Favored 'General case' 0 CA--C 1.548 0.87 0 O-C-N 121.033 -1.042 . . . . 0.0 113.296 173.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.0 mttt -103.13 -3.73 25.44 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 126.271 1.828 . . . . 0.0 112.494 176.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 32.6 m0 -79.99 165.27 48.22 Favored Pre-proline 0 CA--C 1.538 0.49 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 176.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.52 136.13 35.56 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 121.492 1.461 . . . . 0.0 111.455 170.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.5 mt -76.09 149.69 6.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 165.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.483 ' CZ3' ' HE3' ' A' ' 84' ' ' LYS . 6.4 t90 -146.17 148.53 32.64 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.953 1.301 . . . . 0.0 108.261 164.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -138.06 163.22 32.15 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.277 2.231 . . . . 0.0 109.763 -177.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -145.99 159.72 42.85 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.597 1.089 . . . . 0.0 111.309 168.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -61.81 173.92 0.93 Allowed 'General case' 0 C--O 1.232 0.174 0 O-C-N 125.212 1.57 . . . . 0.0 110.792 163.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.9 t -90.78 33.72 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 125.865 1.666 . . . . 0.0 109.885 -173.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.9 t -107.25 -179.04 3.81 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 120.522 -1.361 . . . . 0.0 109.637 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -124.81 144.02 50.5 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.867 1.267 . . . . 0.0 109.724 -171.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -156.54 -164.93 1.76 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.349 1.06 . . . . 0.0 109.145 -174.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.51 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 0.7 OUTLIER -131.34 150.23 52.23 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.945 1.698 . . . . 0.0 109.482 172.503 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 29.6 t-105 -133.97 142.51 47.7 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 123.35 0.406 . . . . 0.0 111.135 177.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -106.7 125.13 50.62 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 173.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -103.67 106.8 17.41 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 168.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -104.08 17.79 23.39 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.469 1.031 . . . . 0.0 111.471 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.89 168.14 26.08 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.177 1.391 . . . . 0.0 109.562 166.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -62.97 124.9 22.28 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 126.236 1.814 . . . . 0.0 107.303 -178.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -140.46 109.37 6.04 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.44 ' CG2' HD11 ' A' ' 65' ' ' LEU . 24.6 m -77.82 148.02 34.92 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 163.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 25.6 p -142.92 147.33 35.1 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 157.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -109.35 128.7 55.31 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 172.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.8 mm -90.83 129.3 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -108.99 -37.21 5.89 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.012 1.725 . . . . 0.0 113.033 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -163.7 161.11 23.38 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.098 1.759 . . . . 0.0 109.585 175.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.05 -163.64 12.88 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.056 1.312 . . . . 0.0 111.638 -174.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.404 ' HE3' ' O ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -150.82 145.12 25.5 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.618 1.209 . . . . 0.0 108.011 157.206 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.404 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 65.6 t -134.46 150.2 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 174.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -118.95 143.08 47.23 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 157.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.6 t -120.42 96.84 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 175.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.4 m -78.51 104.94 9.45 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 174.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.459 ' HA ' ' SG ' ' A' ' 74' ' ' CYS . 23.9 p -78.32 171.68 14.71 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -60.34 -31.92 70.77 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.062 -1.023 . . . . 0.0 111.904 -177.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.46 -15.43 60.68 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 127.578 2.351 . . . . 0.0 111.674 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.83 -2.93 87.7 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 124.641 1.115 . . . . 0.0 114.174 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.7 mmtp -59.75 142.25 53.6 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 163.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.0 ptmm? -125.7 94.11 4.03 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 123.118 1.437 . . . . 0.0 107.8 -176.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.441 ' HB3' HD11 ' A' ' 5' ' ' ILE . 92.4 m-85 -89.11 87.43 7.18 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 123.991 1.853 . . . . 0.0 109.01 -175.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.5 p -55.13 144.1 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 CA-C-N 112.092 -2.322 . . . . 0.0 111.103 149.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 pt -144.78 137.3 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 129.478 3.111 . . . . 0.0 104.094 176.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -109.29 -177.25 3.24 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 125.551 1.54 . . . . 0.0 109.412 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.5 pttt -64.62 42.47 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 130.238 3.415 . . . . 0.0 116.446 -174.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -179.46 11.91 0.03 OUTLIER Glycine 0 CA--C 1.524 0.608 0 C-N-CA 124.962 1.268 . . . . 0.0 113.251 169.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.98 131.04 40.36 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.54 1.67 . . . . 0.0 107.022 175.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.44 HD11 ' CG2' ' A' ' 40' ' ' THR . 26.0 tp -99.3 91.61 5.04 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.332 1.453 . . . . 0.0 108.025 164.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.509 HG13 ' CG1' ' A' ' 5' ' ' ILE 0.631 0.1 OUTLIER -61.89 145.96 12.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 120.808 3.632 . . . . 0.0 120.808 153.042 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.2 m -135.4 121.98 20.75 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 128.289 2.636 . . . . 0.0 105.761 162.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -92.61 148.32 35.97 Favored Pre-proline 0 C--O 1.237 0.422 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 170.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -78.14 179.73 6.22 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.937 2.425 . . . . 0.0 110.16 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -85.77 93.95 9.0 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 114.65 93.57 1.95 Allowed Glycine 0 CA--C 1.523 0.534 0 C-N-CA 125.175 1.369 . . . . 0.0 109.802 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.3 tt -151.23 133.34 15.22 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.038 1.335 . . . . 0.0 108.858 175.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 65.6 ttt-85 -130.23 81.87 2.03 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.616 1.098 . . . . 0.0 111.056 -175.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.459 ' SG ' ' HA ' ' A' ' 52' ' ' THR . 87.0 m -137.2 154.8 50.11 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 122.205 1.002 . . . . 0.0 112.634 -168.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.51 ' HA ' ' HA ' ' A' ' 32' ' ' ASP . 0.7 OUTLIER -70.27 152.53 44.08 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 114.043 -1.435 . . . . 0.0 109.858 -174.95 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -131.58 110.46 10.97 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.927 1.691 . . . . 0.0 107.215 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.4 tttp -108.73 107.96 18.61 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -177.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.5 t -86.09 102.57 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.1 mt -83.95 -21.84 31.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 118.493 -0.765 . . . . 0.0 110.509 175.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -152.6 151.9 27.77 Favored Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 173.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -72.1 86.28 0.95 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 125.05 3.833 . . . . 0.0 111.801 -158.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.3 p -71.69 139.79 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 123.912 0.885 . . . . 0.0 109.251 -172.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.0 ttt180 -120.8 59.37 0.92 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.986 0.898 . . . . 0.0 110.044 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.483 ' HE3' ' CZ3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -70.47 162.13 29.3 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 119.37 -2.081 . . . . 0.0 109.71 -172.554 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -101.18 125.35 47.8 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 104.375 -2.454 . . . . 0.0 104.375 167.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -115.53 160.87 19.4 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.478 1.036 . . . . 0.0 109.251 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -151.01 127.63 10.82 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 118.789 0.722 . . . . 0.0 109.237 173.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 19.8 mt -87.83 139.04 30.93 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 126.411 1.884 . . . . 0.0 108.015 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 34.0 p90 . . . . . 0 C--O 1.259 1.604 0 CA-C-O 117.335 -1.317 . . . . 0.0 110.397 179.063 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 91.5 t . . . . . 0 CA--C 1.543 0.693 0 CA-C-O 121.27 0.557 . . . . 0.0 111.717 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.16 130.81 44.3 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 177.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.0 mt -143.32 134.47 22.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 173.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -159.38 173.73 15.81 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.337 0.655 . . . . 0.0 110.199 172.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.82 85.3 4.87 Favored Pre-proline 0 C--O 1.234 0.256 0 C-N-CA 124.288 1.035 . . . . 0.0 108.911 177.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.87 169.91 19.18 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.248 2.632 . . . . 0.0 112.925 -176.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 t -69.63 149.79 96.85 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.82 1.248 . . . . 0.0 110.642 174.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.09 -31.16 75.91 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.834 2.356 . . . . 0.0 113.79 173.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -63.26 -53.56 50.98 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 118.65 0.659 . . . . 0.0 110.672 -171.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.5 tttp -54.42 -48.48 71.59 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 124.833 1.253 . . . . 0.0 109.298 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.4 mt -58.02 -41.02 82.27 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.933 0.893 . . . . 0.0 112.019 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -59.94 -46.96 87.7 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.012 173.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -59.28 -45.77 90.35 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.129 0.877 . . . . 0.0 110.065 -178.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 59.8 mt -57.16 -12.02 2.0 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.572 1.949 . . . . 0.0 113.05 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.3 m 64.11 39.81 7.43 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.956 1.702 . . . . 0.0 111.844 168.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.3 t -58.03 -26.69 29.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 126.743 2.017 . . . . 0.0 111.92 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -61.53 -20.57 63.38 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 120.324 -1.485 . . . . 0.0 113.439 171.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt -98.02 4.15 49.34 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.159 1.384 . . . . 0.0 110.92 177.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 31.9 m0 -87.54 160.33 47.97 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.37 133.76 27.11 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.186 1.924 . . . . 0.0 112.415 177.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.9 mt -73.41 147.73 9.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 124.485 1.114 . . . . 0.0 109.694 166.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.482 ' CZ3' ' HE3' ' A' ' 84' ' ' LYS . 59.8 t90 -144.36 120.63 10.88 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.292 1.437 . . . . 0.0 107.876 168.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.77 168.51 10.28 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.763 1.625 . . . . 0.0 109.791 164.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.534 ' HD3' ' H ' ' A' ' 27' ' ' GLU . 6.1 tmtt? -152.07 165.73 33.81 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.827 0.822 . . . . 0.0 110.735 167.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.534 ' H ' ' HD3' ' A' ' 26' ' ' LYS . 1.0 OUTLIER -76.97 172.64 12.86 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 126.304 1.842 . . . . 0.0 109.216 174.732 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.2 t -100.33 59.32 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 -164.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.4 t -132.03 -178.29 4.83 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.893 1.677 . . . . 0.0 109.433 -167.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -122.64 150.65 42.39 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.907 0.883 . . . . 0.0 109.095 173.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -163.42 -164.79 0.97 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 125.881 1.673 . . . . 0.0 107.017 -177.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 2.6 p30 -131.0 154.65 47.95 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 120.878 -1.139 . . . . 0.0 109.159 173.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 56.1 t-105 -144.11 152.25 40.69 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.015 0.435 . . . . 0.0 110.062 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -124.89 153.18 43.03 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.572 1.149 . . . . 0.0 108.526 -177.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -123.49 103.84 8.7 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.961 1.305 . . . . 0.0 107.626 175.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -104.74 13.45 31.36 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.232 1.413 . . . . 0.0 110.877 176.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.46 170.78 18.77 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 129.649 3.18 . . . . 0.0 108.624 164.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -68.94 136.41 52.5 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 177.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -133.17 124.26 27.13 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 171.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 53.1 m -99.34 137.79 37.35 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 166.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 24.8 p -138.03 148.04 44.71 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 118.164 0.438 . . . . 0.0 110.101 167.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -112.11 126.03 54.74 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 171.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 17.6 mm -95.55 122.39 46.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 129.499 3.119 . . . . 0.0 107.47 -173.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -105.53 -27.55 11.33 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -175.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -164.86 156.64 15.46 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.508 1.123 . . . . 0.0 108.27 177.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.17 177.87 44.63 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.976 1.274 . . . . 0.0 112.205 -177.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.491 ' HE3' HG23 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -135.61 139.03 43.51 Favored 'General case' 0 CA--C 1.515 -0.378 0 O-C-N 121.618 -0.931 . . . . 0.0 108.857 -170.968 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.426 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 55.1 t -136.19 146.07 29.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 178.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -112.58 116.82 30.81 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 102.998 -2.964 . . . . 0.0 102.998 156.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.4 t -91.04 122.33 42.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 164.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 57.9 m -123.67 105.78 10.0 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 119.664 1.12 . . . . 0.0 108.386 -172.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 32.5 p -69.75 171.97 8.31 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -80.2 -11.2 59.76 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 120.264 -1.523 . . . . 0.0 112.267 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -65.05 -10.76 32.58 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.011 -1.056 . . . . 0.0 112.076 162.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.86 -9.24 77.93 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 125.115 1.34 . . . . 0.0 112.549 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -61.19 124.01 19.33 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 124.957 1.303 . . . . 0.0 108.134 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.96 127.86 46.11 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 125.322 1.449 . . . . 0.0 108.229 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -124.21 84.01 2.22 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 124.478 2.085 . . . . 0.0 107.1 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.491 HG23 ' HE3' ' A' ' 47' ' ' LYS . 1.5 p -72.87 148.29 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 111.138 -2.756 . . . . 0.0 109.454 162.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.6 pt -148.31 125.23 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 C-N-CA 126.837 2.055 . . . . 0.0 106.528 -175.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -88.3 178.58 6.55 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 122.454 1.121 . . . . 0.0 109.932 167.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -63.95 54.45 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 130.798 3.639 . . . . 0.0 115.525 176.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 173.64 -13.69 0.04 OUTLIER Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.731 1.634 . . . . 0.0 112.846 176.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -69.09 101.75 1.49 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.222 1.511 . . . . 0.0 108.739 176.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.4 tp -74.81 141.17 44.33 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 175.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.4 t -123.78 160.32 27.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 C-N-CA 123.818 0.847 . . . . 0.0 109.076 -175.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.6 m -143.24 109.94 5.51 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 161.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -80.04 148.37 67.79 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 169.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -87.22 178.57 3.45 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.624 2.216 . . . . 0.0 111.877 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -85.45 83.43 7.94 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.372 1.469 . . . . 0.0 107.524 173.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.8 79.18 0.21 Allowed Glycine 0 CA--C 1.532 1.096 0 C-N-CA 126.749 2.118 . . . . 0.0 111.142 175.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.445 HD21 ' HB3' ' A' ' 74' ' ' CYS . 8.1 tt -147.92 117.45 7.01 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.978 1.389 . . . . 0.0 111.467 175.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.5 tpp85 -85.92 133.8 33.92 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.945 0.898 . . . . 0.0 109.721 161.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.445 ' HB3' HD21 ' A' ' 72' ' ' LEU . 28.6 p -150.66 178.19 9.34 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.657 0.783 . . . . 0.0 112.973 166.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' A' ' 32' ' ' ASP . 0.2 OUTLIER -96.2 160.51 14.4 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 124.648 1.179 . . . . 0.0 109.295 167.656 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 2.5 m95 -132.36 117.32 17.97 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 173.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.403 ' HD2' HD23 ' A' ' 79' ' ' LEU . 3.6 tmtp? -104.68 112.09 25.04 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 168.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.6 t -81.26 91.3 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 103.833 -2.654 . . . . 0.0 103.833 171.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.465 HD12 ' HE2' ' A' ' 47' ' ' LYS . 50.7 mt -71.06 -33.83 70.63 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.214 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -142.3 147.01 41.81 Favored Pre-proline 0 C--O 1.234 0.237 0 CA-C-O 117.479 -1.248 . . . . 0.0 108.224 171.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -62.47 94.91 0.14 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 125.072 3.848 . . . . 0.0 110.896 -165.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.1 p -78.3 146.95 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.853 -167.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.01 114.5 17.18 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 169.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.482 ' HE3' ' CZ3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -131.17 139.68 49.79 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 123.164 0.586 . . . . 0.0 109.495 -179.262 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -81.9 114.78 20.73 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 170.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -102.18 165.18 11.29 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.642 1.11 . . . . 0.0 110.013 174.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -152.0 150.82 30.41 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.725 0.693 . . . . 0.0 109.82 163.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 39.0 mt -108.76 147.05 32.59 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.78 1.232 . . . . 0.0 108.751 -174.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.2 p90 . . . . . 0 C--O 1.253 1.244 0 C-N-CA 126.164 1.785 . . . . 0.0 110.035 -179.497 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.5 t . . . . . 0 N--CA 1.446 -0.638 0 CA-C-O 121.794 0.807 . . . . 0.0 112.116 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.9 tttt -69.78 125.3 26.34 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 174.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.0 mt -130.9 135.92 59.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 105.069 -2.196 . . . . 0.0 105.069 172.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -158.6 174.14 15.51 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.838 1.655 . . . . 0.0 109.425 167.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.41 85.0 15.37 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 119.197 0.908 . . . . 0.0 108.799 177.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.493 ' HG2' HD21 ' A' ' 13' ' ' LEU . 19.3 Cg_endo -65.31 163.16 30.4 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.728 2.952 . . . . 0.0 111.902 -172.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 t -66.98 142.69 97.52 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 175.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -72.54 -16.51 27.16 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.114 1.876 . . . . 0.0 113.73 -178.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -52.54 -62.87 1.37 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.828 0.851 . . . . 0.0 109.022 170.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 48.8 tptt -53.82 -37.06 63.19 Favored 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 124.921 1.288 . . . . 0.0 111.213 -176.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.493 HD21 ' HG2' ' A' ' 8' ' ' PRO . 3.9 mm? -65.17 -37.19 86.58 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.67 0.788 . . . . 0.0 111.003 -178.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -48.48 72.39 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 117.712 -1.137 . . . . 0.0 108.407 176.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -53.26 -49.17 67.46 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.454 1.102 . . . . 0.0 110.414 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.1 mp -52.24 -15.57 0.63 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 126.616 1.967 . . . . 0.0 113.903 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.455 ' HB3' ' HE3' ' A' ' 20' ' ' LYS . 23.7 m 66.1 30.54 9.38 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.473 1.509 . . . . 0.0 110.783 175.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.5 t -55.16 -30.18 23.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.205 0 C-N-CA 125.159 1.384 . . . . 0.0 111.616 -178.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -55.01 -28.04 48.92 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.407 1.003 . . . . 0.0 112.867 173.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.455 ' HE3' ' HB3' ' A' ' 17' ' ' SER . 5.8 mtmp? -88.92 -23.55 22.68 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 124.742 1.217 . . . . 0.0 111.287 -176.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.422 ' CE3' ' HB2' ' A' ' 87' ' ' ASN . 37.5 m0 -61.21 156.94 46.97 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 123.26 0.624 . . . . 0.0 109.326 -174.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -71.32 121.47 7.8 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.235 1.957 . . . . 0.0 112.309 -175.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.1 mt -62.51 145.56 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 O-C-N 121.106 -0.996 . . . . 0.0 108.612 176.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.453 ' CE3' ' HE2' ' A' ' 84' ' ' LYS . 81.9 t90 -141.82 148.46 38.89 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 122.171 0.986 . . . . 0.0 108.721 161.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -140.17 168.39 19.91 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 128.286 2.634 . . . . 0.0 107.616 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.457 ' HE3' ' CD1' ' A' ' 31' ' ' PHE . 6.2 tmtt? -149.01 158.29 44.07 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 168.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -58.11 172.44 0.43 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 123.142 1.449 . . . . 0.0 111.09 171.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.6 p -76.31 65.78 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 112.388 -2.187 . . . . 0.0 108.901 169.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.92 156.35 41.0 Favored 'General case' 0 CA--C 1.507 -0.706 0 O-C-N 120.555 -1.341 . . . . 0.0 109.888 172.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -78.14 165.51 23.87 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 113.233 -1.803 . . . . 0.0 109.469 -178.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.457 ' CD1' ' HE3' ' A' ' 26' ' ' LYS . 6.7 p90 -163.65 -173.18 3.17 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 164.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 8.8 p-10 -126.67 140.28 52.52 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 163.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 15.5 t-105 -113.87 140.29 48.47 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.163 -174.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -106.31 111.89 24.68 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 168.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -85.08 119.97 26.06 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 172.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.37 -5.6 9.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 117.854 -1.07 . . . . 0.0 113.613 -158.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 p -141.12 175.08 9.92 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 131.293 3.837 . . . . 0.0 106.853 164.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -67.84 129.35 39.63 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -135.46 107.22 7.01 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -176.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 89.1 m -75.77 142.91 42.23 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 166.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 19.8 p -138.46 146.49 42.15 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 119.5 1.045 . . . . 0.0 110.917 158.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -117.09 112.67 21.22 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 126.414 1.886 . . . . 0.0 107.457 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 29.4 mm -80.22 131.48 33.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -176.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.8 mp -114.01 -26.62 8.03 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 118.759 -0.639 . . . . 0.0 112.26 178.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -163.43 152.36 14.31 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 118.813 0.733 . . . . 0.0 109.849 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.48 -177.27 21.32 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.721 1.629 . . . . 0.0 112.766 -176.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.578 ' HE2' HD12 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -135.54 142.93 45.47 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.11 1.364 . . . . 0.0 107.489 171.341 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.656 HG13 ' CG1' ' A' ' 60' ' ' ILE 0.634 0.2 OUTLIER -133.89 137.02 53.1 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.309 0 C-N-CA 129.648 3.179 . . . . 0.0 117.067 -176.139 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -125.46 112.68 16.54 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 125.197 1.561 . . . . 0.0 109.157 158.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.499 HG23 HD11 ' A' ' 60' ' ' ILE . 70.5 t -91.99 139.57 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 166.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 90.5 m -136.28 115.52 12.55 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 177.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.5 p -72.21 178.57 3.8 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.812 1.245 . . . . 0.0 110.913 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -54.55 -34.17 61.35 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.182 0.593 . . . . 0.0 110.468 170.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.49 1.31 26.16 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.966 2.506 . . . . 0.0 113.124 -171.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.17 3.63 46.3 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 118.745 0.702 . . . . 0.0 114.6 177.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.497 ' HE2' ' HA ' ' A' ' 56' ' ' LYS . 6.0 mmpt? -65.42 111.8 3.24 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 166.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.41 150.18 46.51 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 164.042 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -135.97 118.87 16.26 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 170.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.8 t -89.21 132.09 34.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.656 ' CG1' HG13 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -126.26 136.93 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 174.638 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -138.97 -179.01 5.58 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 172.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.3 81.24 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.192 1.797 . . . . 0.0 111.773 177.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 137.45 11.47 1.0 Allowed Glycine 0 CA--C 1.525 0.708 0 CA-C-O 117.882 -1.51 . . . . 0.0 114.593 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -107.69 134.97 49.91 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 164.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.416 ' CD1' HD11 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -96.06 153.66 17.66 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 165.756 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 36.4 t -133.46 150.24 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 124.057 0.943 . . . . 0.0 109.218 177.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.8 m -133.43 120.24 20.65 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.19 0.996 . . . . 0.0 108.312 162.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -83.28 156.57 66.17 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 125.302 1.441 . . . . 0.0 109.514 170.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -83.96 175.16 7.85 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.5 2.133 . . . . 0.0 109.818 174.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -78.03 102.19 7.29 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 166.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.78 80.79 1.54 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.391 0.996 . . . . 0.0 112.196 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 51.5 tp -141.77 155.45 45.61 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 126.024 1.73 . . . . 0.0 108.374 169.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.81 140.43 45.86 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 126.952 2.101 . . . . 0.0 106.722 175.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 3.9 p -168.73 161.09 11.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 118.55 0.614 . . . . 0.0 110.117 173.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -68.6 159.33 32.17 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.997 164.593 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -123.57 136.79 54.72 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 163.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -119.48 97.51 5.68 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 167.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.7 t -73.95 97.21 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.505 0 N-CA-C 103.45 -2.796 . . . . 0.0 103.45 169.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.578 HD12 ' HE2' ' A' ' 47' ' ' LYS . 68.1 mt -72.43 -31.21 65.3 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 119.058 -1.057 . . . . 0.0 108.957 178.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -143.17 144.34 28.22 Favored Pre-proline 0 N--CA 1.452 -0.339 0 CA-C-O 116.881 -1.533 . . . . 0.0 107.189 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -62.93 98.35 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 124.144 3.229 . . . . 0.0 110.2 -165.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.9 p -74.29 158.6 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.697 -171.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -139.02 120.5 15.01 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 168.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.453 ' HE2' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -131.38 154.29 48.77 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 -178.007 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 14.3 m80 -94.06 102.25 14.31 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 167.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -88.61 157.48 18.57 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.906 0.883 . . . . 0.0 110.271 171.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.422 ' HB2' ' CE3' ' A' ' 21' ' ' TRP . 34.3 t30 -154.58 122.18 5.78 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 121.333 -0.854 . . . . 0.0 110.403 167.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.6 mt -69.82 157.47 37.3 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.051 1.34 . . . . 0.0 109.335 176.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.251 1.17 0 CA-C-O 115.43 -2.224 . . . . 0.0 108.159 163.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 75.9 t . . . . . 0 C--O 1.235 0.323 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -88.85 139.63 30.26 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 166.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.6 mt -132.73 134.56 58.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 162.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -161.56 176.98 10.46 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.823 1.649 . . . . 0.0 109.199 166.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.38 86.0 3.16 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.777 1.231 . . . . 0.0 110.354 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.416 ' HG2' HD21 ' A' ' 13' ' ' LEU . 57.2 Cg_endo -64.5 171.49 8.06 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.819 2.346 . . . . 0.0 112.683 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 38.4 p -73.05 146.73 87.65 Favored Pre-proline 0 CA--C 1.536 0.404 0 O-C-N 121.571 -0.706 . . . . 0.0 109.536 173.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -70.45 -25.21 25.65 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.528 1.485 . . . . 0.0 112.198 -178.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -64.13 -45.18 89.67 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.616 0.644 . . . . 0.0 110.369 172.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.3 tptm -57.56 -33.9 68.62 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.846 0.748 . . . . 0.0 110.544 177.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.416 HD21 ' HG2' ' A' ' 8' ' ' PRO . 3.9 mm? -74.28 -15.06 60.98 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.232 0.613 . . . . 0.0 112.53 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -77.36 -39.73 46.42 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.726 1.148 . . . . 0.0 109.051 164.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -70.85 -20.92 62.49 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 118.254 0.479 . . . . 0.0 112.262 -176.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 mp -78.9 1.93 21.9 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-O 117.474 -1.251 . . . . 0.0 112.611 176.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.7 p 57.99 21.51 7.85 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.155 1.382 . . . . 0.0 114.2 -177.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.9 t -57.87 -37.58 61.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 CA-C-N 119.659 1.118 . . . . 0.0 111.837 -163.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -53.37 -24.63 12.73 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.936 0.895 . . . . 0.0 113.312 175.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.5 mttm -88.43 -25.16 22.79 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 117.677 -1.154 . . . . 0.0 111.153 -177.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 38.7 m0 -61.24 164.74 7.84 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 126.141 1.777 . . . . 0.0 110.261 -175.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.05 140.72 55.24 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 CA-C-N 121.52 1.579 . . . . 0.0 111.165 173.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.8 mt -85.6 155.51 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 169.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 27.8 t90 -141.76 133.93 27.76 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 164.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -138.25 132.88 32.43 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 126.807 2.043 . . . . 0.0 106.82 -177.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -134.27 169.6 16.96 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 121.384 -0.823 . . . . 0.0 110.062 -170.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.437 ' CD ' ' H ' ' A' ' 28' ' ' VAL . 1.4 tm-20 -72.7 177.54 4.71 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 122.755 1.264 . . . . 0.0 111.039 172.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.437 ' H ' ' CD ' ' A' ' 27' ' ' GLU . 16.3 t -102.24 45.87 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 127.351 2.26 . . . . 0.0 108.432 -165.026 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.7 t -108.52 -175.29 2.73 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 128.076 2.55 . . . . 0.0 108.682 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -109.05 163.26 13.48 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.803 0.811 . . . . 0.0 110.5 159.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -151.14 -164.73 2.08 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 163.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -142.05 148.36 38.33 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 126.095 1.758 . . . . 0.0 106.858 177.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 47.1 t-105 -135.13 145.89 48.28 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.129 0.572 . . . . 0.0 111.804 -172.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -112.54 109.76 19.52 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.543 1.537 . . . . 0.0 107.781 166.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -79.16 95.3 5.56 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 171.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -88.01 18.61 4.11 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.472 1.033 . . . . 0.0 110.4 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -168.31 164.26 13.01 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.779 1.631 . . . . 0.0 109.838 176.35 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -58.43 103.12 0.13 Allowed 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 126.903 2.081 . . . . 0.0 107.561 174.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -105.97 125.14 50.64 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 166.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 85.6 m -99.54 146.52 26.32 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 168.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 20.9 p -146.67 161.3 40.87 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 118.59 0.632 . . . . 0.0 110.643 164.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -129.63 106.2 8.57 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.494 1.518 . . . . 0.0 108.556 -176.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 26.0 mm -80.45 116.38 24.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 O-C-N 122.011 -0.43 . . . . 0.0 109.937 -169.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.5 mt -92.37 -32.46 14.95 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 117.875 -1.06 . . . . 0.0 112.951 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -165.8 163.58 18.8 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 118.953 0.797 . . . . 0.0 109.245 -173.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.09 -176.6 53.86 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.985 1.279 . . . . 0.0 111.825 -176.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.578 ' HE2' HD12 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -139.29 139.1 37.25 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 -171.482 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 76.8 t -136.13 158.24 38.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -131.72 97.44 4.21 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 127.155 2.182 . . . . 0.0 106.799 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . 0.727 0.1 OUTLIER -93.34 71.2 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 C-N-CA 130.822 3.649 . . . . 0.0 118.414 163.322 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 14.9 m -73.46 113.32 10.42 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 164.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.6 p -67.93 169.97 8.99 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 171.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -65.25 -22.3 66.85 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.786 -1.196 . . . . 0.0 110.08 170.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -77.73 3.39 14.19 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.286 1.834 . . . . 0.0 111.481 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.69 -9.1 8.87 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.01 1.29 . . . . 0.0 113.053 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -66.07 108.98 2.41 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 119.502 1.651 . . . . 0.0 106.834 171.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -88.64 131.78 34.84 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 124.214 0.946 . . . . 0.0 109.705 179.13 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.6 m-30 -115.54 85.08 2.21 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 127.685 2.394 . . . . 0.0 105.896 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.547 HG13 ' HE3' ' A' ' 47' ' ' LYS . 71.3 t -66.35 128.34 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 N-CA-C 103.981 -2.6 . . . . 0.0 103.981 156.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.7 pt -128.6 138.88 53.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 169.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -123.97 179.9 4.66 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.188 1.795 . . . . 0.0 107.137 -170.064 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.0 pttp -73.67 60.85 0.71 Allowed 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 124.988 1.315 . . . . 0.0 112.92 -173.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 164.41 34.36 0.02 OUTLIER Glycine 0 C--N 1.317 -0.524 0 O-C-N 120.15 -1.594 . . . . 0.0 112.458 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -122.18 139.37 53.83 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 118.961 1.38 . . . . 0.0 107.808 175.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.9 tp -94.57 141.09 29.0 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 164.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.5 t -126.35 139.65 51.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 175.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 46.2 m -120.71 102.64 8.53 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 165.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -70.41 151.61 95.64 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 169.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -75.74 -164.53 0.25 Allowed 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.692 2.928 . . . . 0.0 110.077 175.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -98.44 129.14 45.06 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 161.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.52 83.9 0.47 Allowed Glycine 0 CA--C 1.535 1.305 0 C-N-CA 127.494 2.473 . . . . 0.0 113.984 -178.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.6 tt -142.87 130.61 21.46 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 126.909 2.084 . . . . 0.0 108.213 171.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.83 128.09 55.65 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.977 0.911 . . . . 0.0 108.867 171.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 27.4 p -149.24 173.81 13.07 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.634 -0.667 . . . . 0.0 111.088 178.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.19 -178.04 4.86 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 118.386 -0.816 . . . . 0.0 111.079 166.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -155.46 90.4 1.25 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.801 1.24 . . . . 0.0 107.785 172.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -83.86 118.42 23.95 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 172.024 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.5 t -88.58 94.97 4.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 103.779 -2.674 . . . . 0.0 103.779 167.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.578 HD12 ' HE2' ' A' ' 47' ' ' LYS . 26.7 mt -71.02 -29.23 65.11 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 117.522 -1.228 . . . . 0.0 110.109 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -149.01 148.37 26.91 Favored Pre-proline 0 N--CA 1.453 -0.303 0 C-N-CA 125.143 1.377 . . . . 0.0 108.988 175.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -59.88 105.81 0.29 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 124.559 3.506 . . . . 0.0 109.602 -167.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.9 p -84.36 149.41 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -174.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.7 130.06 46.63 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 164.023 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.79 146.91 34.69 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 174.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -73.17 127.96 34.11 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 148.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -113.64 164.17 14.03 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 166.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -153.37 150.51 28.93 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 165.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 93.7 mt -101.63 161.45 13.64 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.641 1.176 . . . . 0.0 108.209 177.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 11.1 p90 . . . . . 0 C--O 1.246 0.915 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 159.868 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.7 t . . . . . 0 CA--C 1.536 0.427 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.2 tttt -129.78 89.71 2.86 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.6 mt -86.93 143.9 10.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 176.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -149.11 178.97 8.25 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 122.625 0.37 . . . . 0.0 110.074 154.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . 0.37 0.5 OUTLIER -128.5 85.01 61.47 Favored Pre-proline 0 N--CA 1.451 -0.411 0 O-C-N 121.179 -0.951 . . . . 0.0 111.855 -178.917 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -81.31 168.7 16.47 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 125.163 3.908 . . . . 0.0 113.517 -169.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.7 t -66.22 143.66 98.42 Favored Pre-proline 0 C--N 1.331 -0.202 0 C-N-CA 126.584 1.954 . . . . 0.0 109.188 172.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -71.01 -21.27 27.91 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.741 1.628 . . . . 0.0 112.166 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.84 -60.36 3.95 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.444 1.098 . . . . 0.0 109.131 -178.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.7 tttt -58.92 -29.7 67.29 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.008 -1.057 . . . . 0.0 111.606 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -71.3 -38.4 71.78 Favored 'General case' 0 C--N 1.334 -0.107 0 O-C-N 121.367 -0.833 . . . . 0.0 110.854 177.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -56.56 -53.55 56.22 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 119.426 1.012 . . . . 0.0 109.142 167.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -57.2 -39.78 76.11 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.266 0.626 . . . . 0.0 111.489 -174.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.43 -10.77 2.31 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.28 2.232 . . . . 0.0 115.266 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 63.4 m 57.32 43.85 22.76 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.929 1.292 . . . . 0.0 111.715 -177.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.428 ' HA ' ' CD2' ' A' ' 21' ' ' TRP . 54.8 t -56.05 -36.49 45.09 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 C-N-CA 126.699 2.0 . . . . 0.0 111.051 174.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -61.52 -13.49 21.69 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 176.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.5 mtpp -95.88 -10.98 27.47 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.467 1.107 . . . . 0.0 111.474 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.428 ' CD2' ' HA ' ' A' ' 18' ' ' VAL . 30.4 m0 -72.86 163.42 68.43 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 178.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -66.7 137.71 46.69 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 121.752 1.635 . . . . 0.0 110.736 170.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 81.4 mt -72.46 152.8 7.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 161.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 14.6 t90 -137.81 150.93 47.61 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 161.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -151.18 156.84 41.78 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.738 1.215 . . . . 0.0 110.465 -178.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.554 ' HE3' ' CE2' ' A' ' 31' ' ' PHE . 16.7 tptp -153.71 162.2 41.45 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 124.598 1.159 . . . . 0.0 108.67 -167.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -88.41 -178.07 5.78 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.126 0.971 . . . . 0.0 108.744 175.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.5 p -68.77 8.72 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 127.718 2.407 . . . . 0.0 113.16 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.3 p -85.93 124.71 32.7 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 126.417 1.887 . . . . 0.0 111.12 -173.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -79.28 152.62 30.44 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 124.288 0.993 . . . . 0.0 109.713 175.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.554 ' CE2' ' HE3' ' A' ' 26' ' ' LYS . 11.9 p90 -156.51 -170.83 3.47 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 176.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -124.7 121.0 33.43 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 127.542 2.337 . . . . 0.0 107.233 172.271 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 43.9 t-105 -109.17 155.77 20.65 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 123.743 0.652 . . . . 0.0 111.012 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -122.61 133.24 54.54 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.68 1.592 . . . . 0.0 110.437 175.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -105.37 108.17 19.55 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 175.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -101.14 4.11 41.78 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.006 1.322 . . . . 0.0 111.061 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.84 163.89 36.82 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 128.112 2.565 . . . . 0.0 108.055 170.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.66 142.0 57.59 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 175.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -147.36 136.99 22.84 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 -176.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.8 m -114.96 121.25 42.59 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 174.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 9.1 p -121.85 145.07 48.44 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.448 0.642 . . . . 0.0 109.357 173.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -121.69 109.1 14.33 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 127.401 2.28 . . . . 0.0 107.032 -175.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.6 mm -69.37 138.49 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 124.831 1.252 . . . . 0.0 107.887 175.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 mp -125.09 -32.19 3.02 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 122.795 0.438 . . . . 0.0 110.845 176.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -138.87 171.75 13.87 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.768 0.827 . . . . 0.0 108.875 168.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.71 -179.77 30.43 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 116.608 1.403 . . . . 0.0 116.608 167.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.821 ' HE3' HG13 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -140.07 151.39 45.35 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 127.924 2.49 . . . . 0.0 111.485 170.864 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.631 HG13 ' CG1' ' A' ' 60' ' ' ILE 0.421 0.2 OUTLIER -146.43 146.91 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 1 C-N-CA 133.253 4.621 . . . . 0.0 113.288 -174.914 . . . . . . . . 5 4 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -120.16 149.91 41.48 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.242 145.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.3 t -127.2 101.08 7.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 170.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.5 m -79.32 112.77 16.88 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 166.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.417 ' HA ' ' HB3' ' A' ' 74' ' ' CYS . 26.4 p -73.58 161.59 30.16 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 165.209 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -55.97 -35.58 66.89 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.801 -0.562 . . . . 0.0 111.182 -175.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -68.88 -1.79 8.1 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.054 1.742 . . . . 0.0 113.456 -174.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.66 -14.11 57.78 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 125.802 1.668 . . . . 0.0 112.472 172.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.2 mttt -71.35 123.01 21.34 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 118.809 1.304 . . . . 0.0 109.729 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.449 ' HD2' ' H ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -85.82 147.4 26.32 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 168.291 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -132.12 105.88 7.64 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 170.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.821 HG13 ' HE3' ' A' ' 47' ' ' LYS . 70.9 t -74.94 117.4 19.09 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 172.009 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.631 ' CG1' HG13 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -108.99 141.09 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-N 118.852 0.751 . . . . 0.0 109.956 175.804 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -145.59 -175.62 4.8 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-O 122.114 0.959 . . . . 0.0 112.607 171.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.3 pttm -57.49 65.24 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 130.528 3.531 . . . . 0.0 112.8 177.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 156.64 2.12 0.1 OUTLIER Glycine 0 CA--C 1.531 1.091 0 CA-C-O 117.323 -1.821 . . . . 0.0 115.636 -158.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -129.33 110.39 11.89 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.899 2.079 . . . . 0.0 107.286 177.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.6 tp -74.82 143.13 44.08 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 120.154 -1.591 . . . . 0.0 107.407 167.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 32.9 t -133.49 128.84 55.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 119.422 1.01 . . . . 0.0 109.676 175.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.8 m -99.16 140.21 33.66 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 160.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -104.83 156.56 35.81 Favored Pre-proline 0 C--O 1.236 0.39 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 163.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -79.65 175.33 10.72 Favored 'Trans proline' 0 N--CA 1.445 -1.348 0 N-CA-C 108.773 -1.28 . . . . 0.0 108.773 174.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -81.81 94.04 6.97 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 166.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 114.46 85.73 1.35 Allowed Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.67 1.605 . . . . 0.0 111.789 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 56.9 tp -162.0 135.08 6.11 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.314 1.557 . . . . 0.0 110.301 170.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.68 85.69 2.41 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 120.11 1.323 . . . . 0.0 112.381 -174.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.417 ' HB3' ' HA ' ' A' ' 52' ' ' THR . 61.0 m -121.81 165.82 15.28 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 119.627 -1.921 . . . . 0.0 110.766 -173.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 32' ' ' ASP . 0.3 OUTLIER -69.6 163.07 26.32 Favored 'General case' 0 CA--C 1.515 -0.4 0 O-C-N 121.984 -0.447 . . . . 0.0 111.072 177.033 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.4 ' CZ3' HG21 ' A' ' 48' ' ' VAL . 4.8 m95 -138.07 102.12 4.6 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.041 1.736 . . . . 0.0 106.875 173.037 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.32 100.56 12.38 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 168.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 80' ' ' GLU . 1.9 t -80.24 92.91 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 103.404 -2.814 . . . . 0.0 103.404 172.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.626 HD12 ' HE2' ' A' ' 47' ' ' LYS . 82.5 mt -69.0 -29.11 67.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.171 178.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.647 ' O ' HG12 ' A' ' 78' ' ' VAL . 3.2 mt-10 -141.06 165.62 28.05 Favored Pre-proline 0 N--CA 1.452 -0.373 0 C-N-CA 125.292 1.437 . . . . 0.0 108.884 176.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -61.35 116.87 3.68 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 123.899 3.066 . . . . 0.0 110.786 169.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.9 p -110.41 143.36 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 -177.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -124.99 29.66 6.08 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.755 0.707 . . . . 0.0 112.83 -168.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.27 161.33 4.37 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.338 1.455 . . . . 0.0 113.28 -159.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.3 m80 -89.05 130.1 35.57 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 163.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -121.39 154.52 36.39 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.42 1.009 . . . . 0.0 108.707 172.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.419 ' HB2' ' CE3' ' A' ' 21' ' ' TRP . 57.1 t30 -143.98 116.69 8.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 17.9 mt -71.77 140.07 49.31 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 125.417 1.487 . . . . 0.0 107.092 172.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.248 0.982 0 CA-C-O 117.143 -1.408 . . . . 0.0 109.316 172.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.2 p . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -134.05 152.05 51.68 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.444 1.498 . . . . 0.0 108.009 172.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 93.6 mt -131.71 137.06 55.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 165.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -141.18 172.74 12.27 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 117.841 0.291 . . . . 0.0 110.982 160.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.22 84.94 6.34 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 171.435 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -76.01 176.55 9.88 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.883 3.056 . . . . 0.0 112.188 -169.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.442 HG22 ' H ' ' A' ' 9' ' ' THR . 0.0 OUTLIER -67.66 144.48 97.6 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 170.302 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -70.27 -25.25 26.43 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.857 2.371 . . . . 0.0 111.887 172.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -75.32 -45.17 41.3 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 119.357 0.981 . . . . 0.0 110.362 -171.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.96 -44.14 70.49 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.912 0.778 . . . . 0.0 110.019 174.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.3 mt -62.24 -27.53 69.06 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 118.924 -0.56 . . . . 0.0 112.233 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -63.21 -47.59 81.9 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 119.748 1.158 . . . . 0.0 109.106 172.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -68.0 -43.2 79.4 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 124.402 1.064 . . . . 0.0 110.088 -169.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 18.5 mt -53.36 -20.5 4.53 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.183 0.993 . . . . 0.0 112.016 174.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.8 m 69.85 45.7 0.73 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 127.496 2.318 . . . . 0.0 109.398 172.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.7 t -55.19 -32.67 28.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 126.105 1.762 . . . . 0.0 112.014 -175.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -65.6 -21.76 66.61 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.634 -1.291 . . . . 0.0 113.413 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.3 mttt -78.73 -15.13 58.83 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.019 0.928 . . . . 0.0 110.979 175.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 16.3 m0 -75.68 159.99 80.14 Favored Pre-proline 0 N--CA 1.445 -0.705 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 176.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -64.97 139.14 60.3 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 121.545 1.497 . . . . 0.0 111.777 175.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 57.7 mt -76.21 147.69 7.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 163.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.473 ' CZ3' ' HE3' ' A' ' 84' ' ' LYS . 9.0 t90 -147.39 149.59 33.04 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 164.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -133.36 166.31 22.8 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 127.262 2.225 . . . . 0.0 106.351 -177.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -148.98 163.85 36.3 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 120.572 -1.33 . . . . 0.0 108.803 163.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.74 -172.88 3.19 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 125.348 1.459 . . . . 0.0 109.916 -178.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.3 p -77.34 -5.09 7.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 125.772 1.629 . . . . 0.0 113.636 178.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.97 176.67 4.85 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.02 1.328 . . . . 0.0 110.886 176.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -137.45 157.34 46.77 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.141 -0.974 . . . . 0.0 109.324 -174.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -164.82 -164.3 0.79 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.118 1.367 . . . . 0.0 108.88 -168.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -133.12 160.91 35.83 Favored 'General case' 0 C--O 1.242 0.703 0 O-C-N 120.89 -1.131 . . . . 0.0 108.822 165.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 67.3 t-105 -135.74 146.73 47.98 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.746 0.818 . . . . 0.0 109.811 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.415 ' CE2' ' HD3' ' A' ' 73' ' ' ARG . 1.2 t80 -115.69 94.56 4.74 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.712 1.605 . . . . 0.0 107.059 -177.251 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -65.72 115.01 5.43 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 168.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -108.53 -1.0 20.05 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.408 1.083 . . . . 0.0 111.734 174.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.415 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -144.06 171.42 14.28 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 127.542 2.337 . . . . 0.0 112.331 174.871 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -62.95 108.88 1.3 Allowed 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 103.765 -2.68 . . . . 0.0 103.765 168.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -126.94 80.87 1.98 Allowed 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 -173.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 81.7 m -64.51 152.21 42.38 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 25.4 p -144.93 150.01 36.25 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.458 163.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -122.6 108.27 12.92 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.572 1.549 . . . . 0.0 106.839 175.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.3 mm -64.54 138.21 23.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 127.217 2.207 . . . . 0.0 107.601 172.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 mp -128.05 -26.38 2.89 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 123.28 0.362 . . . . 0.0 111.188 173.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -153.46 158.15 40.94 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.634 1.174 . . . . 0.0 108.188 172.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.69 -178.93 52.38 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.321 0.962 . . . . 0.0 112.111 -175.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.79 146.1 27.87 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -168.181 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.3 t -137.31 156.57 33.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.319 0.581 . . . . 0.0 109.773 175.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -119.39 110.51 17.03 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.612 1.965 . . . . 0.0 106.872 160.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.7 t -94.16 111.32 25.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 170.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.5 m -112.22 113.19 25.29 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -173.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.9 p -75.4 170.16 16.64 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 122.122 0.963 . . . . 0.0 111.931 -170.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -60.35 -29.9 69.2 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.342 167.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -82.26 8.98 9.71 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.688 1.595 . . . . 0.0 111.547 175.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.1 -2.06 21.25 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 125.55 1.548 . . . . 0.0 114.814 175.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -64.17 136.98 57.72 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.4 mttp -93.33 153.13 18.73 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 121.892 0.853 . . . . 0.0 110.089 162.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -125.73 100.62 6.5 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 102.801 -3.037 . . . . 0.0 102.801 162.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.0 t -81.24 142.73 13.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 167.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 pt -148.01 119.77 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.488 0 C-N-CA 124.314 1.046 . . . . 0.0 108.197 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -80.07 177.44 8.93 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-O 122.196 0.998 . . . . 0.0 110.918 171.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.1 pttt -68.01 45.5 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 131.366 3.866 . . . . 0.0 115.103 178.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -174.41 -7.06 0.02 OUTLIER Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.033 0.825 . . . . 0.0 113.417 178.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -79.16 99.87 7.18 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.102 1.361 . . . . 0.0 111.337 -173.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.3 tp -64.36 136.84 57.52 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.95 1.25 . . . . 0.0 107.636 177.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.1 t -121.32 154.68 25.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 123.865 0.866 . . . . 0.0 108.952 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 67.0 m -143.65 121.36 11.87 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 160.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -87.78 164.58 33.75 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 126.483 1.913 . . . . 0.0 108.879 169.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -79.68 174.8 11.3 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 CA-C-O 122.974 1.156 . . . . 0.0 110.469 170.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.415 ' HG3' ' HA ' ' A' ' 37' ' ' THR . 36.0 tttm -80.18 88.73 5.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.446 -1.707 . . . . 0.0 106.887 173.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 116.66 85.1 1.13 Allowed Glycine 0 CA--C 1.527 0.797 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -176.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 62.1 tp -147.2 141.06 25.8 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.198 1.399 . . . . 0.0 108.848 166.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.415 ' HD3' ' CE2' ' A' ' 34' ' ' TYR . 3.5 ptt85 -136.93 103.89 5.3 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.417 1.487 . . . . 0.0 108.453 -176.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 86.0 m -148.61 164.42 34.34 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 125.264 1.426 . . . . 0.0 110.103 -175.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.58 163.01 22.18 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 124.452 1.101 . . . . 0.0 112.035 177.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -148.2 99.59 3.07 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.575 1.95 . . . . 0.0 107.372 -168.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 42.7 tttp -110.96 111.8 23.18 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 -176.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.1 t -87.34 111.68 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 104.264 -2.495 . . . . 0.0 104.264 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 20.6 mt -91.1 -24.04 20.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 118.782 -0.628 . . . . 0.0 109.836 177.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -148.75 152.36 37.31 Favored Pre-proline 0 C--O 1.236 0.384 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 168.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.41 91.69 0.77 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.377 2.718 . . . . 0.0 111.514 -153.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.8 p -69.51 105.82 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.017 -165.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -91.08 116.63 28.95 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 105.215 -2.142 . . . . 0.0 105.215 168.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.473 ' HE3' ' CZ3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -127.58 172.06 11.07 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 122.306 1.051 . . . . 0.0 108.382 175.277 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -113.22 122.77 48.47 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 102.578 -3.119 . . . . 0.0 102.578 168.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -117.89 157.03 27.4 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -152.4 134.83 15.19 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 118.71 0.686 . . . . 0.0 110.024 176.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 65.8 mt -94.45 125.48 39.13 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.401 1.88 . . . . 0.0 107.149 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.4 p90 . . . . . 0 C--O 1.247 0.968 0 C-N-CA 123.96 0.904 . . . . 0.0 110.361 -171.509 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 94.2 t . . . . . 0 CA--C 1.535 0.376 0 CA-C-O 121.41 0.624 . . . . 0.0 112.633 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -100.05 119.49 38.38 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.965 0.906 . . . . 0.0 109.148 -173.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.3 mt -139.81 132.47 35.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 C-N-CA 124.792 1.237 . . . . 0.0 108.022 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -143.97 176.66 9.11 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.483 1.513 . . . . 0.0 110.271 171.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.76 85.77 5.2 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 124.562 1.145 . . . . 0.0 108.151 173.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.09 157.64 60.92 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.442 2.095 . . . . 0.0 111.881 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.9 t -57.42 144.3 71.83 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 124.508 1.123 . . . . 0.0 109.19 169.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.58 -31.21 27.22 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.538 1.492 . . . . 0.0 112.735 -177.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -59.84 -42.72 94.21 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 119.407 1.003 . . . . 0.0 110.729 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.1 tptt -56.49 -41.37 76.53 Favored 'General case' 0 C--O 1.226 -0.167 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -69.9 -32.07 70.19 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.872 1.269 . . . . 0.0 111.511 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -61.46 -49.11 78.12 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 168.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -62.73 -47.99 81.19 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.373 0.533 . . . . 0.0 111.047 -176.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.7 mt -58.78 -7.34 0.97 Allowed 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 125.955 1.702 . . . . 0.0 112.662 -175.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.7 m 74.03 29.22 1.4 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.17 1.788 . . . . 0.0 110.402 165.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.9 t -57.01 -27.45 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 126.371 1.868 . . . . 0.0 112.499 -172.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -59.45 -28.41 66.94 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.828 1.194 . . . . 0.0 113.015 172.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.6 mttm -84.69 -13.21 52.09 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.632 1.173 . . . . 0.0 111.066 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.502 ' CE3' ' HB2' ' A' ' 87' ' ' ASN . 36.5 m0 -74.8 158.9 84.2 Favored Pre-proline 0 N--CA 1.448 -0.527 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -175.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.58 136.79 43.97 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 121.531 1.487 . . . . 0.0 111.44 175.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.1 mt -72.22 149.96 8.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 125.197 1.399 . . . . 0.0 109.332 166.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.432 ' CZ3' ' HE3' ' A' ' 84' ' ' LYS . 87.7 t90 -142.23 112.23 6.92 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 160.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.14 168.4 12.8 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.975 1.31 . . . . 0.0 110.576 164.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.3 tptt -155.94 162.45 40.38 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 120.647 -1.283 . . . . 0.0 109.841 165.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.27 170.59 15.27 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.204 1.001 . . . . 0.0 111.27 172.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.9 p -81.16 71.18 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 127.205 2.202 . . . . 0.0 109.463 175.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.91 -171.14 2.66 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 120.972 -1.08 . . . . 0.0 109.708 -177.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -130.89 154.14 48.39 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.003 -1.06 . . . . 0.0 108.845 170.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -160.6 -167.67 1.93 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.718 1.207 . . . . 0.0 108.511 173.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 4.6 p-10 -121.1 152.52 38.59 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 125.012 1.325 . . . . 0.0 107.896 169.068 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 25.7 t-105 -136.26 151.97 50.22 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.557 0.218 . . . . 0.0 111.002 178.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.435 ' CD2' ' HB3' ' A' ' 73' ' ' ARG . 1.4 t80 -124.78 129.63 50.83 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.632 1.573 . . . . 0.0 106.844 -175.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -111.29 112.39 24.13 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 175.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.39 2.8 19.23 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 125.148 1.379 . . . . 0.0 112.723 -176.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.8 p -145.9 171.17 15.21 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 130.556 3.543 . . . . 0.0 107.856 166.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -63.36 149.82 44.89 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -146.48 115.2 6.83 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 167.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.0 m -88.52 141.95 28.11 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 167.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.495 ' SG ' ' HB2' ' A' ' 84' ' ' LYS . 0.7 OUTLIER -149.97 150.18 31.45 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.032 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -125.36 112.07 15.9 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.473 1.509 . . . . 0.0 108.36 -177.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 8.5 mm -69.77 120.01 16.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 128.593 2.757 . . . . 0.0 107.601 174.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 mp -110.36 -24.77 10.45 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 178.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -160.14 157.32 28.22 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.898 1.679 . . . . 0.0 107.913 177.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 82' ' ' VAL . . . 82.55 177.9 52.13 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.597 2.046 . . . . 0.0 112.699 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.78 143.09 33.28 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.795 -0.827 . . . . 0.0 109.18 -167.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 86.9 t -138.12 156.46 30.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -124.52 118.23 26.13 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 160.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.5 t -94.01 106.8 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 169.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.4 m -93.04 105.95 17.98 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.439 ' HA ' ' SG ' ' A' ' 74' ' ' CYS . 18.0 p -69.33 168.6 13.97 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 121.792 -0.567 . . . . 0.0 110.542 -178.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -63.95 -32.8 74.46 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 170.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -68.59 -6.7 27.12 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 121.014 -1.054 . . . . 0.0 109.911 171.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.91 -3.36 70.45 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 125.943 1.735 . . . . 0.0 112.7 170.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.1 tttp -70.02 135.02 48.89 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-N 120.196 1.998 . . . . 0.0 107.964 -176.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.82 105.11 17.17 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.512 174.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -79.56 107.88 12.68 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 164.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.3 t -77.21 147.19 7.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 161.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 pt -148.59 121.78 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 C-N-CA 124.661 1.184 . . . . 0.0 108.499 173.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -101.75 175.4 5.56 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 122.469 1.128 . . . . 0.0 109.764 172.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.5 pttp -64.51 54.58 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 131.237 3.815 . . . . 0.0 116.363 -171.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -178.65 -16.15 0.03 OUTLIER Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.181 1.372 . . . . 0.0 113.42 176.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -77.76 103.63 7.81 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.8 1.3 . . . . 0.0 109.1 -177.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.3 tp -71.35 143.93 50.06 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 120.132 1.333 . . . . 0.0 108.319 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 45.1 t -124.14 154.87 31.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 125.074 1.35 . . . . 0.0 108.69 -174.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.9 m -146.09 103.18 3.71 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.626 1.17 . . . . 0.0 108.196 170.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -74.43 155.13 87.79 Favored Pre-proline 0 C--O 1.235 0.317 0 O-C-N 121.489 -0.757 . . . . 0.0 109.581 171.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -86.87 177.4 4.1 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.715 2.277 . . . . 0.0 110.699 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -81.26 90.6 6.12 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 164.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 110.25 90.33 2.03 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.415 1.483 . . . . 0.0 110.699 178.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 67.2 tp -156.02 152.56 28.26 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.721 2.008 . . . . 0.0 108.936 162.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.435 ' HB3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -137.36 126.07 23.88 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 119.215 0.916 . . . . 0.0 109.76 165.046 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.439 ' SG ' ' HA ' ' A' ' 52' ' ' THR . 84.1 m -145.49 170.01 17.23 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.127 1.771 . . . . 0.0 109.268 -178.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.418 ' HA ' ' HA ' ' A' ' 32' ' ' ASP . 0.6 OUTLIER -77.56 159.93 28.94 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 121.352 -0.842 . . . . 0.0 110.18 177.373 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -134.23 102.69 5.46 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.825 1.65 . . . . 0.0 107.68 177.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -100.78 112.27 24.65 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 174.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.0 t -84.68 106.63 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 173.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 95.6 mt -85.05 -26.03 27.26 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-O 118.878 -0.582 . . . . 0.0 109.743 175.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -147.69 149.35 33.41 Favored Pre-proline 0 N--CA 1.464 0.262 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 174.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -64.55 95.26 0.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.594 2.863 . . . . 0.0 110.673 -169.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.41 ' HA ' ' HA3' ' A' ' 46' ' ' GLY . 4.5 p -71.28 149.88 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.75 -174.596 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -126.98 112.25 15.04 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 104.232 -2.507 . . . . 0.0 104.232 164.044 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.495 ' HB2' ' SG ' ' A' ' 41' ' ' CYS . 0.0 OUTLIER -127.91 121.19 29.35 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.244 0.545 . . . . 0.0 110.651 176.725 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -69.32 111.08 4.99 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -101.3 163.74 12.12 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 121.013 1.733 . . . . 0.0 110.892 -176.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.502 ' HB2' ' CE3' ' A' ' 21' ' ' TRP . 44.2 t30 -153.74 115.51 4.25 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.862 0.865 . . . . 0.0 109.839 171.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.1 mt -66.47 145.63 55.45 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.922 1.289 . . . . 0.0 109.172 173.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.3 p90 . . . . . 0 C--O 1.251 1.143 0 C-N-CA 125.767 1.627 . . . . 0.0 107.852 172.276 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.7 t . . . . . 0 C--O 1.239 0.503 0 CA-C-O 122.846 1.308 . . . . 0.0 112.098 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 51.0 tttt -73.32 101.58 3.47 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.056 -0.974 . . . . 0.0 108.858 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 60.5 mt -103.22 112.67 37.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 104.605 -2.369 . . . . 0.0 104.605 174.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -142.38 178.64 7.44 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 122.829 0.451 . . . . 0.0 111.903 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -125.08 85.05 58.48 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 123.135 0.574 . . . . 0.0 111.387 -165.486 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.24 153.7 18.7 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.264 2.643 . . . . 0.0 112.998 -173.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.2 t -57.07 144.28 69.59 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 124.417 1.087 . . . . 0.0 109.752 170.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -71.39 -26.26 20.65 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 121.487 1.458 . . . . 0.0 113.003 -176.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -65.81 -42.86 90.14 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.17 0.895 . . . . 0.0 110.102 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.6 tptt -53.57 -45.56 69.97 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 123.461 0.705 . . . . 0.0 109.6 176.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.05 -31.98 73.25 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 121.729 -0.607 . . . . 0.0 111.341 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.56 -50.21 68.15 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 172.056 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -57.89 -50.78 72.17 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.661 1.184 . . . . 0.0 111.822 -176.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 55.4 mt -56.82 -8.96 0.68 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.29 1.836 . . . . 0.0 112.823 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.5 m 75.21 27.51 1.1 Allowed 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 128.124 2.57 . . . . 0.0 111.276 167.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.9 t -54.21 -28.61 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 128.48 2.712 . . . . 0.0 112.583 177.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.97 -29.31 70.71 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 120.239 1.382 . . . . 0.0 112.49 173.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.4 mtpp -82.51 -15.56 51.95 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.246 1.018 . . . . 0.0 112.205 176.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 38.2 m0 -69.32 165.17 42.25 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 119.169 0.895 . . . . 0.0 109.272 -173.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -67.39 141.73 57.3 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 121.464 1.443 . . . . 0.0 112.066 174.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.1 mt -88.56 142.97 12.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 125.909 1.683 . . . . 0.0 106.839 169.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.472 ' CE3' ' HE2' ' A' ' 84' ' ' LYS . 44.1 t90 -148.75 133.01 17.42 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 165.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.78 174.59 7.41 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.051 1.74 . . . . 0.0 107.677 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -154.21 161.77 41.62 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 173.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -73.68 170.53 15.06 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.625 0.726 . . . . 0.0 111.315 169.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -80.88 74.0 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 125.136 1.375 . . . . 0.0 108.571 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.0 t -141.23 -170.71 3.13 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.417 1.887 . . . . 0.0 107.824 -176.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.94 149.7 31.64 Favored 'General case' 0 CA--C 1.518 -0.263 0 O-C-N 120.386 -1.446 . . . . 0.0 111.733 -173.178 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -163.23 -164.76 0.98 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.248 1.819 . . . . 0.0 107.214 -171.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -130.02 161.79 30.16 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.095 -1.003 . . . . 0.0 109.184 170.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 12.6 t-105 -131.87 158.43 41.36 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 120.965 0.412 . . . . 0.0 110.471 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -132.73 96.24 3.77 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 176.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -72.05 123.27 22.45 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 176.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.38 1.02 6.32 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -171.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 p -140.87 174.42 10.53 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.553 2.341 . . . . 0.0 108.401 163.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -67.78 136.85 54.84 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -142.61 102.53 4.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -177.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.7 m -84.84 140.44 31.17 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 169.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 14.4 p -144.94 162.6 36.49 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 118.503 0.592 . . . . 0.0 111.577 162.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -124.64 111.85 16.1 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 126.058 1.743 . . . . 0.0 107.998 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 25.6 mm -72.8 111.97 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 128.798 2.839 . . . . 0.0 107.757 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.8 mt -92.01 -37.49 12.79 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 122.478 0.311 . . . . 0.0 111.235 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -162.44 165.22 26.56 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.631 0.772 . . . . 0.0 108.988 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.447 ' HA3' ' HA ' ' A' ' 82' ' ' VAL . . . 89.88 -176.57 42.67 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 124.246 0.927 . . . . 0.0 111.232 -177.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.495 ' HE2' HD12 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -147.48 147.35 30.08 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 117.538 0.669 . . . . 0.0 110.415 -179.424 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.6 t -139.64 156.34 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -178.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -124.37 133.7 53.34 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 122.589 1.185 . . . . 0.0 108.491 158.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.539 HG23 ' HB2' ' A' ' 58' ' ' TYR 0.627 0.1 OUTLIER -108.61 80.53 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.204 1 C-N-CA 133.629 4.771 . . . . 0.0 117.001 165.81 . . . . . . . . 5 4 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 82.9 m -71.04 122.7 20.53 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.078 162.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 74.9 p -82.52 -173.81 4.82 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.377 1.071 . . . . 0.0 111.811 174.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -62.77 -37.83 88.2 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.077 0.551 . . . . 0.0 110.255 170.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -63.59 -27.09 69.0 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.034 0.933 . . . . 0.0 111.677 177.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 103.86 -10.86 52.61 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-O 118.965 -0.908 . . . . 0.0 113.43 175.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.7 mttm -61.55 129.17 39.81 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 118.422 1.111 . . . . 0.0 108.78 173.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.38 103.84 16.48 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.186 0.994 . . . . 0.0 108.795 177.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.539 ' HB2' HG23 ' A' ' 50' ' ' VAL . 10.2 m-30 -68.29 100.05 1.0 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 167.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.7 t -81.68 137.82 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 165.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.8 pt -140.4 90.75 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -85.86 170.33 12.48 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.71 1.604 . . . . 0.0 110.729 172.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.1 pttm -60.57 111.29 1.54 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.748 1.219 . . . . 0.0 111.152 -176.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 121.5 -23.13 7.63 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 125.858 1.694 . . . . 0.0 113.208 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.24 100.88 3.83 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.26 1.53 . . . . 0.0 108.096 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.3 tp -71.61 145.54 48.93 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.8 t -129.85 138.73 53.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 125.733 1.613 . . . . 0.0 107.46 -171.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 98.5 m -130.38 100.06 5.23 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 162.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -70.68 146.8 94.04 Favored Pre-proline 0 C--O 1.238 0.486 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 165.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -82.54 175.69 8.61 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 122.097 1.864 . . . . 0.0 110.901 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -76.7 90.64 3.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 113.326 -1.761 . . . . 0.0 107.289 171.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 110.92 93.17 2.18 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.7 tp -153.16 142.26 21.37 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.874 1.67 . . . . 0.0 109.517 168.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 -115.96 133.53 55.93 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.821 2.049 . . . . 0.0 108.382 168.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 12.8 p -162.03 175.52 11.69 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.656 1.582 . . . . 0.0 108.365 169.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.56 -175.43 1.05 Allowed 'General case' 0 C--O 1.212 -0.869 0 CA-C-O 117.777 -1.106 . . . . 0.0 113.075 167.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -154.91 105.72 2.59 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.273 2.229 . . . . 0.0 105.65 163.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.0 tttt -103.83 116.77 32.89 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 176.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.0 t -83.84 106.87 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 174.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.495 HD12 ' HE2' ' A' ' 47' ' ' LYS . 81.9 mt -83.75 -20.95 32.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.042 178.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -158.49 152.05 19.21 Favored Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 126.994 2.118 . . . . 0.0 108.238 169.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -63.35 102.57 0.34 Allowed 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.715 2.944 . . . . 0.0 110.846 -168.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.447 ' HA ' ' HA3' ' A' ' 46' ' ' GLY . 7.1 p -83.38 144.74 9.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 123.699 0.8 . . . . 0.0 110.616 -173.036 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -116.75 131.88 56.84 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 163.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.472 ' HE2' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -134.62 150.01 50.63 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 173.483 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -96.24 114.02 25.67 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 105.844 -1.909 . . . . 0.0 105.844 165.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -106.87 166.6 10.48 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 119.612 1.096 . . . . 0.0 111.089 -176.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -151.54 130.76 12.75 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.694 0.679 . . . . 0.0 110.453 165.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 26.2 mt -85.99 136.44 33.26 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 126.797 2.039 . . . . 0.0 109.177 176.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.8 p90 . . . . . 0 C--O 1.248 1.02 0 C-N-CA 125.368 1.467 . . . . 0.0 111.172 179.439 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 82.7 t . . . . . 0 C--O 1.235 0.314 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -125.73 140.15 52.93 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 171.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.2 mt -137.52 146.5 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 175.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -154.57 -175.07 5.23 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.934 0.893 . . . . 0.0 109.861 160.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -118.96 80.75 18.58 Favored Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 169.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -67.7 172.12 11.03 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.896 2.397 . . . . 0.0 110.994 -177.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.414 HG23 ' H ' ' A' ' 12' ' ' LYS . 4.4 t -60.03 144.29 86.84 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 120.034 -0.666 . . . . 0.0 109.469 166.098 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.78 -20.18 46.26 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.149 1.899 . . . . 0.0 111.296 168.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -60.24 -50.38 73.89 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 119.772 1.169 . . . . 0.0 109.944 -177.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.414 ' H ' HG23 ' A' ' 9' ' ' THR . 47.8 tptt -55.73 -43.71 76.83 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 123.271 0.628 . . . . 0.0 109.762 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 70.6 mt -70.28 -33.66 71.83 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.732 1.213 . . . . 0.0 110.707 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -61.38 -32.3 72.22 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 120.429 -1.42 . . . . 0.0 110.92 168.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -73.75 -55.77 5.82 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 121.012 1.733 . . . . 0.0 109.722 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.1 tp -44.13 -66.25 0.41 Allowed 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 126.512 1.925 . . . . 0.0 112.682 -152.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.1 p 173.34 27.66 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 129.521 3.128 . . . . 0.0 109.784 150.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.1 t -59.92 -30.71 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 O-C-N 120.659 -1.275 . . . . 0.0 113.074 -160.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -60.01 -25.19 65.08 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 120.866 -1.146 . . . . 0.0 112.762 172.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.5 mttt -88.81 -31.4 18.35 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.498 1.519 . . . . 0.0 111.882 177.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.4 ' CD2' ' HB2' ' A' ' 87' ' ' ASN . 41.0 m0 -55.53 156.84 8.01 Favored Pre-proline 0 C--O 1.236 0.364 0 C-N-CA 124.021 0.928 . . . . 0.0 110.269 -175.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.91 138.59 40.96 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.465 1.443 . . . . 0.0 111.72 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.8 mt -71.48 150.96 8.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 164.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -137.35 134.86 36.48 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 159.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -141.15 120.71 13.27 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 126.374 1.87 . . . . 0.0 109.468 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.4 mmtt -109.49 152.28 25.63 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 123.733 0.813 . . . . 0.0 109.794 -178.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.5 pm0 -66.02 163.62 16.95 Favored 'General case' 0 N--CA 1.441 -0.876 0 O-C-N 124.915 1.385 . . . . 0.0 111.152 166.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.5 p -73.25 17.05 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 127.898 2.479 . . . . 0.0 113.966 -172.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.9 t -83.64 -171.27 3.49 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.89 1.276 . . . . 0.0 109.48 177.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -136.87 154.17 50.57 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 121.099 -1.0 . . . . 0.0 110.701 175.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -162.38 -164.45 1.04 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.826 1.651 . . . . 0.0 108.523 -172.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -135.28 154.91 51.39 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 126.068 1.747 . . . . 0.0 109.753 168.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 58.0 t-105 -138.16 127.58 24.72 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.059 0.544 . . . . 0.0 111.797 -174.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -80.95 130.48 35.04 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.421 1.089 . . . . 0.0 108.354 169.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -108.84 107.74 18.27 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.137 1.375 . . . . 0.0 107.312 166.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -114.08 21.2 15.02 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.812 0.845 . . . . 0.0 112.974 -179.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.41 167.0 31.48 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 127.445 2.298 . . . . 0.0 108.001 166.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -66.81 127.0 30.8 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -177.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -136.71 99.71 4.13 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -177.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 85.2 m -70.88 141.79 51.2 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 166.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.1 p -150.57 133.61 16.09 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 121.438 -0.788 . . . . 0.0 110.841 172.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -111.55 104.87 13.3 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 126.585 1.954 . . . . 0.0 109.362 -171.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 22.7 mm -76.65 114.92 17.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -175.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.79 -27.19 13.48 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 118.724 -0.655 . . . . 0.0 112.54 -178.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -158.84 153.01 23.76 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 119.492 1.042 . . . . 0.0 108.907 -178.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.64 -171.01 39.13 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.634 1.111 . . . . 0.0 113.035 -176.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.18 146.44 35.25 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.994 1.717 . . . . 0.0 108.171 -177.092 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.3 t -141.77 147.18 22.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -124.01 122.66 38.5 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 127.754 2.422 . . . . 0.0 107.175 167.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.6 t -110.76 117.24 54.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 46.3 m -111.02 120.55 42.74 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.484 ' HA ' ' SG ' ' A' ' 74' ' ' CYS . 27.2 p -73.43 162.36 29.39 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.517 0.675 . . . . 0.0 110.692 -179.386 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.83 -30.73 71.4 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.693 -0.63 . . . . 0.0 109.314 172.081 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -63.34 -15.65 58.0 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 127.342 2.257 . . . . 0.0 112.663 168.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 103.78 -12.25 53.33 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 125.235 1.398 . . . . 0.0 113.763 172.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -60.39 112.45 1.96 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 118.762 1.281 . . . . 0.0 108.45 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -70.12 153.64 42.9 Favored 'General case' 0 C--O 1.231 0.087 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 164.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -135.27 160.91 36.9 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 126.031 1.732 . . . . 0.0 106.724 159.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 88.7 t -123.06 150.22 26.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 170.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.5 pt -142.02 126.36 16.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 164.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -94.97 175.53 6.61 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.215 1.006 . . . . 0.0 109.241 173.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.0 pttm -62.4 68.54 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.664 1.985 . . . . 0.0 111.936 166.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 165.81 -9.44 0.07 OUTLIER Glycine 0 C--N 1.315 -0.618 0 CA-C-O 118.083 -1.399 . . . . 0.0 113.463 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -80.19 136.16 36.43 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.795 1.798 . . . . 0.0 106.545 167.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.7 tp -104.65 139.23 39.79 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 161.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 42.8 t -118.26 157.42 19.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 -177.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.7 m -138.14 101.62 4.46 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 168.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -72.8 153.35 91.26 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 173.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -84.06 173.26 9.15 Favored 'Trans proline' 0 N--CA 1.447 -1.226 0 C-N-CA 122.137 1.891 . . . . 0.0 110.682 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -80.63 90.42 5.75 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 164.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 118.24 78.32 0.62 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 123.812 0.72 . . . . 0.0 113.074 174.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 31.8 tp -147.49 154.77 41.18 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.97 1.308 . . . . 0.0 108.9 169.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.6 ptt85 -144.02 101.27 3.7 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 125.103 1.361 . . . . 0.0 107.664 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' CYS . . . . . 0.484 ' SG ' ' HA ' ' A' ' 52' ' ' THR . 73.7 m -145.21 161.97 38.25 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.801 0.84 . . . . 0.0 110.777 -170.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.2 152.36 38.39 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 122.846 0.458 . . . . 0.0 111.321 -173.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.8 m95 -127.89 97.1 4.69 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.732 2.013 . . . . 0.0 107.699 174.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.5 tptt -76.07 146.01 39.69 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 104.624 -2.361 . . . . 0.0 104.624 161.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.38 94.07 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 168.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.8 mt -67.08 -32.29 73.36 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 118.148 -0.93 . . . . 0.0 110.902 -177.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -134.64 144.78 52.22 Favored Pre-proline 0 N--CA 1.454 -0.232 0 CA-C-O 117.625 -1.178 . . . . 0.0 109.5 175.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -61.14 95.36 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.938 3.092 . . . . 0.0 109.872 -177.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.9 p -81.77 159.6 3.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 125.112 1.365 . . . . 0.0 110.049 -167.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.1 ttt85 -129.69 134.37 47.61 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 164.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.44 151.73 42.06 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 169.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -83.95 125.12 31.72 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 160.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -112.26 157.26 21.14 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 173.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.4 ' HB2' ' CD2' ' A' ' 21' ' ' TRP . 49.5 t30 -151.28 114.43 4.77 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 171.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 55.8 mt -65.96 143.65 57.26 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.192 1.397 . . . . 0.0 107.694 166.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 36.6 p90 . . . . . 0 C--O 1.255 1.359 0 CA-C-O 115.939 -1.981 . . . . 0.0 112.08 174.354 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 p . . . . . 0 C--O 1.239 0.535 0 CA-C-O 120.714 0.292 . . . . 0.0 110.751 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -98.2 140.04 33.1 Favored 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 160.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.2 mt -126.28 142.54 42.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 168.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -155.35 177.45 11.34 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.473 ' HE2' ' OD2' ' A' ' 64' ' ' ASP . 3.6 mmtp -120.6 82.72 33.84 Favored Pre-proline 0 C--N 1.346 0.428 0 C-N-CA 124.894 1.278 . . . . 0.0 110.8 -177.098 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.584 ' HG2' HD21 ' A' ' 13' ' ' LEU . 71.9 Cg_endo -78.21 169.63 19.93 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 123.639 2.893 . . . . 0.0 111.603 -178.044 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.6 p -77.07 150.23 80.61 Favored Pre-proline 0 C--O 1.235 0.329 0 O-C-N 121.947 -0.471 . . . . 0.0 109.97 178.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -64.62 -32.36 58.25 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 121.661 1.574 . . . . 0.0 111.387 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -57.43 -53.12 61.79 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.766 0.826 . . . . 0.0 110.509 176.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.0 tptt -55.0 -40.08 69.73 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.102 0.561 . . . . 0.0 110.177 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.584 HD21 ' HG2' ' A' ' 8' ' ' PRO . 4.1 mm? -65.33 -36.54 84.36 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 123.468 0.707 . . . . 0.0 111.173 -178.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -62.8 -48.16 80.32 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 121.177 -0.952 . . . . 0.0 109.361 171.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -61.45 -40.74 95.59 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.658 0.783 . . . . 0.0 112.364 -174.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 mp -55.46 -14.41 1.97 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.95 1.7 . . . . 0.0 113.133 175.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.4 m 57.97 40.37 25.67 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.302 1.841 . . . . 0.0 110.544 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.7 t -54.56 -31.33 23.22 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.257 0 C-N-CA 127.517 2.327 . . . . 0.0 111.024 174.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -56.92 -17.17 8.59 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 170.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -102.62 -5.76 23.51 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.097 1.759 . . . . 0.0 111.46 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.484 ' CE3' ' HB2' ' A' ' 87' ' ' ASN . 31.0 m0 -77.71 165.22 52.78 Favored Pre-proline 0 C--O 1.24 0.582 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.11 140.72 42.01 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 121.654 1.569 . . . . 0.0 111.151 171.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.0 mt -81.58 151.55 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 165.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.635 ' CE3' ' HE3' ' A' ' 84' ' ' LYS . 7.1 t90 -136.77 141.71 42.98 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 156.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.76 153.0 48.64 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 128.207 2.603 . . . . 0.0 108.917 174.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.523 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 1.7 tttt -153.25 165.14 36.64 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.316 -0.865 . . . . 0.0 109.876 172.133 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.69 176.78 4.57 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 126.135 1.774 . . . . 0.0 110.245 171.399 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.6 t -83.77 49.6 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 129.984 3.313 . . . . 0.0 109.088 -169.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.0 t -105.57 -169.07 1.54 Allowed 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 127.302 2.241 . . . . 0.0 109.706 -165.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.07 135.47 19.35 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 120.723 -1.235 . . . . 0.0 108.877 177.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -153.57 -164.94 2.01 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.361 1.064 . . . . 0.0 109.268 -176.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -137.65 152.1 48.97 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.86 1.264 . . . . 0.0 109.663 173.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 15.5 t-105 -128.46 135.2 49.14 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 125.137 1.375 . . . . 0.0 109.615 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -106.99 109.71 21.67 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 171.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -79.58 123.02 27.22 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 171.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -124.81 5.49 8.09 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.692 0.797 . . . . 0.0 111.446 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.94 177.09 9.64 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 126.806 2.042 . . . . 0.0 108.678 165.054 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -65.15 137.69 57.8 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 178.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -143.94 100.62 3.6 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -174.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 85.6 m -75.67 144.35 41.67 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 116.19 -1.862 . . . . 0.0 106.521 172.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 7.5 p -133.31 162.75 30.96 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 114.269 -2.973 . . . . 0.0 111.039 145.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -125.69 109.43 12.59 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 170.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.8 mm -73.82 131.28 35.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.42 -21.24 8.13 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.317 0.962 . . . . 0.0 112.964 -177.354 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -154.47 160.65 41.72 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 165.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.18 -174.0 24.74 Favored Glycine 0 N--CA 1.465 0.591 0 C-N-CA 124.11 0.862 . . . . 0.0 113.623 174.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.568 ' HE2' HG13 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -145.39 141.95 28.91 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.242 0.544 . . . . 0.0 109.717 173.54 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.526 ' C ' ' HZ3' ' A' ' 47' ' ' LYS . 3.3 t -127.77 136.27 60.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 176.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -99.66 131.62 45.53 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 157.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 94.1 t -114.02 140.78 32.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 171.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.8 m -136.89 108.34 6.9 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -175.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 49.7 p -77.42 177.26 8.13 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.707 -0.621 . . . . 0.0 109.486 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -72.56 -25.72 61.46 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 120.613 -1.304 . . . . 0.0 110.838 -174.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.18 -27.72 65.96 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.109 0.964 . . . . 0.0 111.981 169.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.68 8.79 69.64 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-O 118.648 -1.084 . . . . 0.0 113.357 -177.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp -52.45 117.98 3.25 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 156.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -74.5 153.4 39.13 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 158.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -136.91 150.59 48.31 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 170.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.568 HG13 ' HE2' ' A' ' 47' ' ' LYS . 63.0 t -127.1 141.08 47.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 176.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.8 pt -135.52 120.87 29.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 170.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.49 175.23 9.44 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.723 1.209 . . . . 0.0 109.231 169.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -64.13 43.31 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 130.557 3.543 . . . . 0.0 114.905 175.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -179.48 -0.67 0.02 OUTLIER Glycine 0 CA--C 1.525 0.659 0 C-N-CA 124.943 1.258 . . . . 0.0 112.697 -176.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.473 ' OD2' ' HE2' ' A' ' 7' ' ' LYS . 1.3 m-20 -72.54 114.06 10.26 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 166.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.2 tp -74.33 160.78 30.61 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 152.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.526 HG21 ' CE1' ' A' ' 68' ' ' PHE . 1.2 p -160.16 149.36 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 C-N-CA 126.958 2.103 . . . . 0.0 109.716 -175.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 84.2 m -136.63 97.56 3.58 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 173.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.526 ' CE1' HG21 ' A' ' 66' ' ' VAL . 91.0 m-85 -70.79 145.9 92.66 Favored Pre-proline 0 C--O 1.239 0.512 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 163.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -86.21 174.56 6.1 Favored 'Trans proline' 0 N--CA 1.443 -1.459 0 C-N-CA 121.685 1.59 . . . . 0.0 110.777 -174.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.2 tttm -71.08 96.79 1.38 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 113.214 -1.812 . . . . 0.0 106.838 165.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 102.42 88.64 2.05 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 126.307 1.908 . . . . 0.0 111.485 177.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.9 tt -148.8 139.41 22.68 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 126.861 2.064 . . . . 0.0 107.804 167.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -126.21 108.45 11.31 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.643 1.177 . . . . 0.0 108.156 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 24.6 p -145.85 168.81 19.89 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -175.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.44 162.12 21.09 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 123.478 0.711 . . . . 0.0 111.847 170.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -144.54 97.9 3.11 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 126.98 2.112 . . . . 0.0 109.135 -172.346 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.5 tptt -98.89 123.32 43.08 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 126.462 1.905 . . . . 0.0 107.445 -176.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.9 t -101.12 100.88 11.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.8 mt -82.8 -28.81 30.01 Favored 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 119.679 -0.809 . . . . 0.0 109.196 -177.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -144.95 150.47 46.08 Favored Pre-proline 0 C--O 1.238 0.499 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 175.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -65.65 135.21 41.03 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 122.79 2.326 . . . . 0.0 107.942 -169.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.9 p -131.73 119.88 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.456 -157.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.0 ttt85 -99.43 116.47 31.66 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 171.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.635 ' HE3' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -126.28 146.74 49.89 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 172.265 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 14.3 m80 -85.5 129.05 34.91 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 161.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -117.37 162.21 18.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 172.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.484 ' HB2' ' CE3' ' A' ' 21' ' ' TRP . 23.1 t30 -152.97 121.21 6.23 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 172.287 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 29.7 mt -75.58 134.59 40.66 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 126.11 1.764 . . . . 0.0 106.837 170.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.8 p90 . . . . . 0 C--O 1.256 1.416 0 CA-C-N 119.648 1.113 . . . . 0.0 110.988 -176.782 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.0 t . . . . . 0 N--CA 1.455 -0.211 0 CA-C-O 122.063 0.935 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.69 115.28 6.34 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.7 mt -110.58 148.19 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 168.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -157.75 175.51 13.79 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.389 1.075 . . . . 0.0 109.694 165.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.36 85.5 10.82 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 173.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -69.83 167.6 24.05 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.74 2.96 . . . . 0.0 111.551 -177.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.4 p -84.09 151.02 59.53 Favored Pre-proline 0 N--CA 1.448 -0.533 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -63.37 -31.49 72.74 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.541 2.161 . . . . 0.0 112.126 175.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -63.54 -48.93 75.47 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 119.292 0.951 . . . . 0.0 110.636 171.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -57.77 -38.14 74.92 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.779 0.718 . . . . 0.0 111.012 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 57.4 mt -63.33 -26.86 68.96 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 118.978 -0.534 . . . . 0.0 112.32 177.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -66.6 -43.22 85.44 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 119.713 1.142 . . . . 0.0 110.268 170.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -61.34 -47.23 86.87 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 122.04 0.924 . . . . 0.0 109.453 -174.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 88.1 mt -65.09 -4.26 4.63 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.094 1.757 . . . . 0.0 112.667 178.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 56.77 33.37 22.89 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.5 1.52 . . . . 0.0 111.945 175.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.1 t -56.6 -23.28 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.076 0.951 . . . . 0.0 111.697 -176.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -53.83 -29.97 43.17 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.416 -1.428 . . . . 0.0 113.954 167.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -84.8 -21.4 29.94 Favored 'General case' 0 C--O 1.226 -0.164 0 O-C-N 121.336 -0.852 . . . . 0.0 110.28 -170.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 31.0 m0 -71.88 163.75 64.18 Favored Pre-proline 0 N--CA 1.448 -0.555 0 C-N-CA 125.229 1.412 . . . . 0.0 109.37 -162.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.03 133.17 30.14 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 121.17 1.247 . . . . 0.0 110.315 172.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 63.6 mt -70.19 145.45 12.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 167.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.555 ' HE3' ' HD2' ' A' ' 84' ' ' LYS . 88.3 t90 -139.14 141.15 38.06 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 163.162 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -128.7 165.02 21.68 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 126.886 2.074 . . . . 0.0 107.991 173.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -149.87 158.83 44.55 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 167.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -84.45 175.68 9.16 Favored 'General case' 0 N--CA 1.435 -1.207 0 O-C-N 123.979 0.799 . . . . 0.0 111.167 172.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.5 p -66.53 11.34 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 129.128 2.971 . . . . 0.0 113.097 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.03 134.39 34.54 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 126.833 2.053 . . . . 0.0 109.191 178.259 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -72.68 168.09 19.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.915 0.864 . . . . 0.0 110.269 177.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -165.94 -172.13 2.23 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 169.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.438 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 1.8 p30 -123.33 146.72 47.69 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 119.888 -1.758 . . . . 0.0 106.929 157.254 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 12.8 t-105 -114.97 153.63 30.24 Favored 'General case' 0 C--O 1.239 0.549 0 O-C-N 123.897 0.748 . . . . 0.0 110.39 172.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -123.22 105.27 9.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 170.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -78.75 104.94 9.71 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 174.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -105.22 11.57 32.87 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -179.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.76 168.3 21.71 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 129.04 2.936 . . . . 0.0 107.749 157.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -58.29 137.74 56.91 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 125.433 1.493 . . . . 0.0 107.78 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -141.65 113.96 8.18 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 175.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 97.2 m -79.73 149.12 31.26 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 162.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.1 p -145.38 137.84 25.87 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 119.16 0.891 . . . . 0.0 111.265 157.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -100.93 111.52 23.74 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.928 1.691 . . . . 0.0 107.894 174.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.8 mm -75.31 120.57 25.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 C-N-CA 124.05 0.94 . . . . 0.0 108.734 177.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 mp -101.82 -25.38 13.83 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 118.812 -0.613 . . . . 0.0 111.969 176.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -169.62 158.65 7.82 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.222 1.009 . . . . 0.0 109.592 -177.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.75 -172.14 14.21 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.41 1.481 . . . . 0.0 111.871 177.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.533 ' HD2' ' H ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -138.23 151.87 48.07 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 123.209 1.481 . . . . 0.0 108.522 167.644 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.572 HG13 ' CG1' ' A' ' 60' ' ' ILE 0.266 0.4 OUTLIER -152.98 135.73 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.431 0 C-N-CA 130.206 3.402 . . . . 0.0 112.97 -171.017 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.436 ' HB3' ' HE3' ' A' ' 57' ' ' LYS . 10.3 mt-10 -128.51 107.77 9.99 Favored 'General case' 0 N--CA 1.428 -1.566 0 O-C-N 125.819 1.949 . . . . 0.0 109.231 155.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 78.3 t -83.24 146.45 6.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 168.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.1 m -139.77 117.14 11.32 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 175.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 47.3 p -65.05 169.24 5.58 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 174.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -53.36 -36.68 61.64 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.596 -0.69 . . . . 0.0 110.41 171.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -65.16 -2.06 2.65 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 129.406 3.082 . . . . 0.0 114.328 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.76 6.57 78.18 Favored Glycine 0 CA--C 1.533 1.206 0 O-C-N 121.156 -0.965 . . . . 0.0 113.11 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -73.51 102.32 3.8 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 168.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.436 ' HE3' ' HB3' ' A' ' 49' ' ' GLU . 3.1 tptt -75.12 146.2 41.59 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 170.014 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -142.35 107.38 4.93 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.451 1.9 . . . . 0.0 107.961 177.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.7 t -69.81 138.47 22.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 164.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.572 ' CG1' HG13 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -124.9 146.8 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 C-N-CA 123.849 0.859 . . . . 0.0 109.807 165.221 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -142.1 -178.37 5.68 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 122.221 1.01 . . . . 0.0 111.525 173.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.5 pttm -61.7 85.22 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.548 1.939 . . . . 0.0 111.548 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 144.83 -11.0 1.89 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 126.121 1.819 . . . . 0.0 113.04 177.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -90.34 106.54 18.56 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 175.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.8 tp -76.47 146.39 38.58 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 168.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.3 t -129.45 155.29 41.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 123.295 0.638 . . . . 0.0 109.403 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.7 m -138.76 123.41 18.57 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.179 0.992 . . . . 0.0 109.263 162.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -86.81 153.03 54.78 Favored Pre-proline 0 C--O 1.239 0.531 0 C-N-CA 125.215 1.406 . . . . 0.0 109.799 171.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -79.99 179.68 6.03 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.506 2.804 . . . . 0.0 109.491 175.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -83.49 103.83 13.15 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 164.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 102.73 62.97 0.71 Allowed Glycine 0 CA--C 1.523 0.547 0 C-N-CA 125.175 1.369 . . . . 0.0 112.297 166.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.8 tp -123.68 147.72 47.17 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.504 1.922 . . . . 0.0 108.501 174.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.22 142.33 47.58 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.624 1.57 . . . . 0.0 109.23 174.012 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 8.7 p -167.46 163.91 14.93 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 118.86 0.755 . . . . 0.0 112.275 167.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -77.22 145.33 37.64 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 118.516 -0.754 . . . . 0.0 109.967 167.544 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 6.6 m95 -104.65 136.97 43.2 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 158.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.0 tttt -113.69 103.75 11.53 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 158.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.6 t -76.88 106.43 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 103.475 -2.787 . . . . 0.0 103.475 174.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.9 mt -88.82 -16.06 33.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.594 -177.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -150.27 151.37 31.34 Favored Pre-proline 0 C--O 1.234 0.273 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.888 161.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -58.14 114.64 2.06 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.925 3.083 . . . . 0.0 110.439 -175.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.9 p -88.08 164.06 2.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 C-N-CA 123.604 0.762 . . . . 0.0 109.949 -168.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -134.97 122.79 22.38 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 155.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.555 ' HD2' ' HE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -134.05 140.13 46.45 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 171.489 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -77.49 104.65 8.14 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 103.763 -2.68 . . . . 0.0 103.763 164.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -85.13 161.28 19.71 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 167.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -149.74 140.1 22.32 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 119.538 -0.865 . . . . 0.0 109.986 152.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 44.4 mt -71.91 163.95 26.94 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 171.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 5.1 p90 . . . . . 0 C--O 1.246 0.891 0 O-C-N 121.305 -0.872 . . . . 0.0 108.747 160.019 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 C--O 1.235 0.298 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.9 tptt -113.73 136.53 52.74 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 171.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 55.7 mt -135.4 112.15 13.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -143.04 174.8 10.36 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.197 0.999 . . . . 0.0 109.615 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.8 82.38 6.54 Favored Pre-proline 0 CA--C 1.532 0.259 0 O-C-N 121.598 -0.689 . . . . 0.0 109.268 176.004 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.414 ' HG3' HD22 ' A' ' 65' ' ' LEU . 92.1 Cg_endo -74.8 165.87 30.53 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.542 2.161 . . . . 0.0 113.428 -174.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.9 t -61.58 144.13 92.89 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 124.794 1.238 . . . . 0.0 110.953 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.65 -23.17 63.84 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.786 2.324 . . . . 0.0 113.027 177.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.41 -61.14 2.65 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 125.064 1.345 . . . . 0.0 109.721 -176.54 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -56.77 -36.85 70.3 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 122.183 -0.323 . . . . 0.0 110.825 -175.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.2 mt -58.28 -41.61 84.72 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 173.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.3 -50.89 71.48 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.513 1.051 . . . . 0.0 108.323 173.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -63.84 -34.38 77.8 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 123.482 0.713 . . . . 0.0 111.847 -174.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.75 -5.97 3.23 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.564 1.546 . . . . 0.0 113.601 177.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . 0.254 98.8 p 63.17 28.24 15.87 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 128.332 2.653 . . . . 0.0 113.943 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 20.1 t -57.28 -31.96 39.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 118.941 0.791 . . . . 0.0 112.985 -170.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -62.96 -23.71 67.54 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.281 1.4 . . . . 0.0 113.027 176.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.9 mttm -88.59 -8.03 55.4 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 126.223 1.809 . . . . 0.0 111.045 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 39.8 m0 -74.36 163.31 69.2 Favored Pre-proline 0 N--CA 1.451 -0.39 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.12 133.58 31.28 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.003 1.136 . . . . 0.0 111.314 173.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.1 mt -70.44 149.18 10.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 124.654 1.182 . . . . 0.0 107.974 165.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.8 t90 -144.84 145.32 31.56 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.56 -1.2 . . . . 0.0 107.775 162.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.22 162.62 34.83 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.782 2.433 . . . . 0.0 108.344 176.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.525 ' HD3' ' H ' ' A' ' 27' ' ' GLU . 5.3 tmtt? -147.17 173.16 12.78 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.933 -1.105 . . . . 0.0 110.224 178.098 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.525 ' H ' ' HD3' ' A' ' 26' ' ' LYS . 6.0 tt0 -70.9 -179.77 2.38 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 127.612 2.365 . . . . 0.0 111.288 166.253 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.453 ' H ' ' HG2' ' A' ' 27' ' ' GLU . 11.3 t -97.89 6.96 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 C-N-CA 127.456 2.302 . . . . 0.0 111.91 -171.072 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.5 t -81.5 172.91 12.93 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 120.627 -1.296 . . . . 0.0 109.511 173.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -100.42 161.41 13.62 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.321 -0.862 . . . . 0.0 109.31 171.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.469 ' CE2' ' HE3' ' A' ' 26' ' ' LYS . 14.4 p90 -156.75 177.16 11.8 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 125.445 1.498 . . . . 0.0 109.138 170.195 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.11 129.47 51.81 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.062 2.145 . . . . 0.0 108.186 171.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 35.1 t-105 -118.65 146.15 44.9 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.909 173.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -117.46 143.81 45.65 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.123 1.369 . . . . 0.0 107.907 174.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -118.09 110.81 18.09 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 175.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -107.9 3.01 23.81 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.494 1.118 . . . . 0.0 111.429 -175.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.58 160.4 42.44 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 129.686 3.194 . . . . 0.0 107.318 173.425 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -64.34 127.74 32.77 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 -174.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -135.1 109.1 8.17 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 177.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 56.1 m -82.07 135.75 35.29 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 167.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 29.2 p -134.65 156.93 47.89 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.084 0.468 . . . . 0.0 110.186 163.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -133.45 116.64 16.25 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.932 1.293 . . . . 0.0 108.502 -175.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.8 mm -72.47 143.19 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 126.475 1.91 . . . . 0.0 109.274 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.0 mt -127.25 -37.14 2.07 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.229 0.611 . . . . 0.0 109.822 171.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -150.82 159.4 44.57 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 173.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 82' ' ' VAL . . . 101.17 177.27 29.01 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 126.305 1.907 . . . . 0.0 114.097 177.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.667 ' HE3' HG23 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -140.93 154.56 46.15 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-O 123.282 1.515 . . . . 0.0 110.054 -175.427 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.483 HG13 HG12 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -160.04 150.06 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.995 1 C-N-CA 133.539 4.735 . . . . 0.0 108.033 -161.677 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.422 ' OE1' HD11 ' A' ' 79' ' ' LEU . 15.8 mt-10 -135.21 115.61 13.53 Favored 'General case' 0 N--CA 1.414 -2.233 0 N-CA-C 104.23 -2.507 . . . . 0.0 104.23 152.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.4 t -89.56 121.86 40.22 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.993 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 172.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.5 m -111.34 122.84 48.9 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 82.4 p -74.08 178.52 4.96 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -71.77 -23.93 61.67 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 120.209 -1.557 . . . . 0.0 111.698 168.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.43 -7.99 29.64 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.825 1.25 . . . . 0.0 111.653 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.3 -13.56 61.55 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 126.261 1.886 . . . . 0.0 112.951 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -61.13 137.1 58.24 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.565 1.546 . . . . 0.0 107.542 178.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.4 tttm -120.67 130.52 54.15 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -172.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 13.5 m-30 -128.28 84.9 2.28 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 125.618 2.627 . . . . 0.0 108.962 -169.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.667 HG23 ' HE3' ' A' ' 47' ' ' LYS . 1.5 p -54.36 97.82 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 127.407 2.283 . . . . 0.0 112.587 152.524 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.483 HG12 HG13 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -80.59 156.54 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.062 0 CA-C-N 112.487 -2.142 . . . . 0.0 109.414 155.803 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -157.82 -179.84 8.52 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 171.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.4 82.42 0.05 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 126.068 1.747 . . . . 0.0 109.326 -176.261 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 160.32 -12.27 0.16 Allowed Glycine 0 CA--C 1.524 0.634 0 CA-C-O 118.082 -1.399 . . . . 0.0 115.662 -167.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -126.64 104.95 8.38 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 119.186 1.493 . . . . 0.0 109.17 -166.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.414 HD22 ' HG3' ' A' ' 8' ' ' PRO . 19.3 tp -65.86 150.53 48.44 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 172.437 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.0 t -128.93 156.68 41.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 121.909 0.862 . . . . 0.0 109.288 168.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 75.7 m -144.48 111.51 5.86 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.365 1.466 . . . . 0.0 108.09 162.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -78.36 155.68 79.06 Favored Pre-proline 0 C--O 1.234 0.272 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 170.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -80.84 177.83 7.58 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 121.396 1.398 . . . . 0.0 110.334 172.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 32.4 tttt -75.08 91.4 2.56 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 112.933 -1.94 . . . . 0.0 107.527 164.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 116.17 90.79 1.63 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.754 1.168 . . . . 0.0 111.441 173.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.9 tp -155.2 150.71 27.33 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.51 1.524 . . . . 0.0 110.087 173.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.2 ttp85 -128.78 122.96 31.69 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 126.285 1.834 . . . . 0.0 109.116 176.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 8.3 p -157.13 167.32 30.74 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.226 0.921 . . . . 0.0 110.919 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.91 173.71 12.26 Favored 'General case' 0 CA--C 1.516 -0.347 0 O-C-N 120.887 -1.133 . . . . 0.0 112.4 168.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 5.9 m95 -142.88 93.65 2.54 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 127.51 2.324 . . . . 0.0 106.728 167.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -79.83 105.31 11.02 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 170.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 t -86.14 86.92 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 -174.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.481 HD12 ' HE2' ' A' ' 47' ' ' LYS . 97.3 mt -64.72 -29.87 70.87 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.451 -178.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -142.74 154.57 62.79 Favored Pre-proline 0 N--CA 1.465 0.281 0 CA-C-N 119.481 1.037 . . . . 0.0 110.382 168.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.51 85.17 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 125.078 3.852 . . . . 0.0 111.753 -168.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.409 ' HA ' ' HA3' ' A' ' 46' ' ' GLY . 8.5 p -75.16 137.62 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 124.725 1.21 . . . . 0.0 109.674 -163.44 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.5 ttt180 -116.82 106.74 13.8 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 104.108 -2.553 . . . . 0.0 104.108 177.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.11 142.96 51.17 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 10.5 m80 -78.08 136.79 37.96 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 165.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -124.27 163.17 22.2 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 173.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 22.3 t30 -157.23 137.15 12.48 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 119.4 1.0 . . . . 0.0 109.113 169.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 66.3 mt -94.56 146.16 24.31 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.512 1.125 . . . . 0.0 108.909 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.5 p90 . . . . . 0 C--O 1.247 0.942 0 C-N-CA 125.173 1.389 . . . . 0.0 111.673 -176.427 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.639 HG12 HG13 ' A' ' 5' ' ' ILE . 85.5 t . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt -81.24 102.67 10.51 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 122.073 -0.392 . . . . 0.0 110.862 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.639 HG13 HG12 ' A' ' 3' ' ' VAL . 63.5 mt -111.09 124.69 68.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 O-C-N 123.433 0.458 . . . . 0.0 110.655 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -163.89 179.85 6.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.722 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.81 83.65 4.81 Favored Pre-proline 0 C--O 1.241 0.635 0 CA-C-O 121.885 0.85 . . . . 0.0 110.806 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.512 ' HG3' HD13 ' A' ' 65' ' ' LEU . 51.7 Cg_endo -69.3 139.44 41.83 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.145 1.896 . . . . 0.0 112.035 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -49.4 146.96 6.03 Favored Pre-proline 0 C--O 1.233 0.185 0 CA-C-O 121.383 0.611 . . . . 0.0 111.18 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.536 ' HA ' HD12 ' A' ' 13' ' ' LEU . 50.1 Cg_endo -69.01 -9.13 25.52 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.574 2.182 . . . . 0.0 112.553 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.91 -50.95 12.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.813 0.34 . . . . 0.0 110.673 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.11 -34.34 73.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.855 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.583 HD23 HG21 ' A' ' 18' ' ' VAL . 3.5 mt -62.82 -42.94 99.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.849 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -57.85 -33.92 69.17 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 119.104 -0.474 . . . . 0.0 110.987 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -78.03 -38.88 43.68 Favored 'General case' 0 C--N 1.332 -0.174 0 O-C-N 124.419 1.074 . . . . 0.0 110.503 -179.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.3 mp -59.11 -19.71 47.01 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 122.997 0.519 . . . . 0.0 111.165 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 63.32 43.2 6.32 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 123.445 0.466 . . . . 0.0 110.466 -178.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.583 HG21 HD23 ' A' ' 13' ' ' LEU . 22.7 t -56.93 -23.53 18.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.971 0.415 . . . . 0.0 110.964 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -72.2 -19.52 61.72 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.417 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.62 -7.75 54.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 179.15 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 40.1 m0 -79.72 155.16 75.94 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.875 0.369 . . . . 0.0 110.7 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 131.25 20.77 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.447 2.098 . . . . 0.0 112.253 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.0 mt -80.98 141.26 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.751 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 86.5 t90 -139.55 117.36 11.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.611 178.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.49 153.67 31.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.761 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.89 162.94 30.98 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.981 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.3 pm0 -70.12 176.48 3.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.207 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.483 HG13 ' O ' ' A' ' 79' ' ' LEU . 30.4 t -77.19 -4.3 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.373 0.606 . . . . 0.0 111.394 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.9 t -77.13 174.02 11.17 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.081 -0.648 . . . . 0.0 112.044 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -107.69 174.51 5.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.485 -177.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 18.7 p90 178.55 179.81 0.35 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.293 -178.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -119.77 111.9 18.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.231 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 10.3 t-105 -97.26 151.87 19.43 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-O 120.847 0.356 . . . . 0.0 110.188 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -131.23 113.17 13.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.453 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -91.89 135.07 34.22 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.556 0.535 . . . . 0.0 110.737 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.474 ' O ' HG23 ' A' ' 37' ' ' THR . 2.0 p30 -125.44 22.88 7.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.983 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -179.74 150.37 0.4 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.867 0.365 . . . . 0.0 110.936 -179.122 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -51.83 104.35 0.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.75 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -123.29 83.86 2.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.101 0.477 . . . . 0.0 109.97 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 80.2 m -60.1 147.35 39.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.077 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 4.1 p -146.28 133.69 20.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.871 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.457 ' CD1' HD12 ' A' ' 65' ' ' LEU . 51.1 t80 -116.19 116.25 27.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.935 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.566 HD13 ' HB3' ' A' ' 84' ' ' LYS . 25.0 mm -77.24 136.03 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.829 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.463 HD12 ' O ' ' A' ' 83' ' ' ARG . 0.9 OUTLIER -120.59 -30.04 4.59 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 123.524 0.515 . . . . 0.0 111.417 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.44 ' HA ' ' HB3' ' A' ' 62' ' ' LYS . 15.1 pt-20 -162.15 155.51 20.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.309 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.56 179.75 33.51 Favored Glycine 0 N--CA 1.451 -0.311 0 O-C-N 123.503 0.502 . . . . 0.0 112.217 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.786 ' HE3' HG23 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -127.17 166.87 16.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.033 0.444 . . . . 0.0 110.886 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.66 HG13 ' CG1' ' A' ' 60' ' ' ILE . 0.1 OUTLIER -174.08 141.65 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.355 -177.722 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 2.7 mt-10 -132.4 90.97 2.86 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.53 0.681 . . . . 0.0 110.202 178.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.655 HG23 HD11 ' A' ' 60' ' ' ILE . 48.9 t -78.43 110.57 14.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 O-C-N 122.022 -0.424 . . . . 0.0 110.966 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 90.6 m -107.76 105.66 15.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.737 0.303 . . . . 0.0 110.803 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.8 p -64.35 154.91 33.97 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.95 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -51.73 -38.19 54.26 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.023 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -52.84 -29.38 27.58 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.445 0.641 . . . . 0.0 110.85 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 113.79 0.62 24.37 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 121.326 -0.464 . . . . 0.0 112.057 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -85.06 115.9 23.13 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 122.535 -0.391 . . . . 0.0 110.473 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.5 mttm -79.92 157.05 26.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.891 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -148.63 92.26 1.98 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.146 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.786 HG23 ' HE3' ' A' ' 47' ' ' LYS . 1.8 p -83.92 123.7 39.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.154 0.502 . . . . 0.0 111.015 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.66 ' CG1' HG13 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -113.68 143.75 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.422 179.656 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -139.93 -173.44 3.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.447 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.44 ' HB3' ' HA ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -69.47 67.06 0.21 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.069 0.461 . . . . 0.0 111.421 179.288 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 160.23 37.66 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.383 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -154.36 102.94 2.47 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 117.206 0.503 . . . . 0.0 110.946 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.524 ' CD1' HD21 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -80.32 128.78 33.95 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.568 -179.397 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.605 HG22 HG12 ' A' ' 5' ' ' ILE . 8.2 t -117.91 147.09 21.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 O-C-N 123.647 0.592 . . . . 0.0 110.661 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.2 m -142.97 101.03 3.76 Favored 'General case' 0 C--O 1.25 1.107 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.947 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.6 ' CD1' HG22 ' A' ' 3' ' ' VAL . 59.5 m-85 -77.05 147.53 77.05 Favored Pre-proline 0 C--N 1.344 0.335 0 O-C-N 124.621 1.201 . . . . 0.0 111.259 178.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.12 -166.34 0.23 Allowed 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 123.51 2.806 . . . . 0.0 111.969 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -95.46 67.05 2.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.853 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.29 82.26 0.13 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.171 178.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.418 HD12 ' H ' ' A' ' 73' ' ' ARG . 49.3 tp -146.82 146.92 30.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.557 0.218 . . . . 0.0 110.859 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.418 ' H ' HD12 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -126.76 141.98 51.67 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.927 178.835 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 6.1 p -179.46 175.3 0.92 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.057 0.456 . . . . 0.0 110.962 176.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.624 ' O ' HG13 ' A' ' 50' ' ' VAL . 0.2 OUTLIER -95.15 159.61 14.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.018 179.635 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 2.0 m95 -131.84 78.22 1.81 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.836 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.69 93.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.642 -0.253 . . . . 0.0 111.0 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 80' ' ' GLU . 2.2 t -76.04 67.2 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.006 0.432 . . . . 0.0 110.699 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.75 HD12 ' HE2' ' A' ' 47' ' ' LYS . 81.1 mt -47.92 -29.41 3.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.292 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.64 ' O ' HG12 ' A' ' 78' ' ' VAL . 2.6 mt-10 -145.2 165.23 22.71 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.35 0.595 . . . . 0.0 111.054 178.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.95 87.49 0.45 Allowed 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 123.203 2.602 . . . . 0.0 112.356 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 45' ' ' GLU . 4.7 p -80.13 151.31 4.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.983 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.463 ' O ' HD12 ' A' ' 44' ' ' LEU . 3.5 ttt180 -136.4 64.23 1.56 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.728 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.566 ' HB3' HD13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -77.43 177.27 8.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.134 179.187 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -116.68 102.7 9.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.614 178.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -85.57 154.74 21.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.11 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -162.46 104.69 1.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.617 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 16.1 mt -68.47 149.36 49.37 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.672 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.8 p90 . . . . . 0 C--O 1.236 0.378 0 CA-C-O 118.773 -0.632 . . . . 0.0 110.712 179.964 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.714 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.329 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.3 mp0 -69.26 164.37 22.91 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 120.404 1.456 . . . . 0.0 109.326 163.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.1 t 50.2 79.88 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 126.909 2.084 . . . . 0.0 110.534 173.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.6 tptm -75.0 118.92 18.49 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 175.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 82.8 mt -130.81 129.64 63.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 174.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -155.38 175.58 13.69 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 122.973 0.509 . . . . 0.0 110.631 171.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.06 85.44 5.24 Favored Pre-proline 0 N--CA 1.451 -0.416 0 C-N-CA 124.312 1.045 . . . . 0.0 108.526 -177.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.42 165.18 31.45 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.977 2.452 . . . . 0.0 112.095 -175.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.3 t -61.18 144.22 91.56 Favored Pre-proline 0 C--O 1.239 0.551 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 164.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.81 -18.14 28.56 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.013 1.809 . . . . 0.0 112.146 175.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -64.33 -52.65 57.37 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.908 0.776 . . . . 0.0 110.158 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.4 tttt -61.92 -33.16 73.75 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 123.205 0.602 . . . . 0.0 110.716 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 79.5 mt -63.82 -24.12 67.63 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.401 -0.812 . . . . 0.0 112.408 175.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -67.49 -49.14 64.84 Favored 'General case' 0 CA--C 1.522 -0.134 0 O-C-N 120.667 -1.27 . . . . 0.0 108.428 169.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -66.94 -36.04 81.35 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.093 0.957 . . . . 0.0 110.95 -169.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.28 -12.31 5.39 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.917 1.687 . . . . 0.0 112.932 172.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . 0.255 68.2 p 60.69 35.02 19.86 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 128.27 2.628 . . . . 0.0 113.021 -175.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.6 t -55.76 -30.46 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.074 0.95 . . . . 0.0 112.801 -177.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -60.2 -26.23 66.2 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 120.437 1.471 . . . . 0.0 112.864 172.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.1 mttm -91.78 -9.03 45.04 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.127 1.371 . . . . 0.0 111.004 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 35.7 m0 -73.09 161.48 79.14 Favored Pre-proline 0 C--O 1.237 0.395 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -65.14 136.29 47.22 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.629 1.553 . . . . 0.0 111.063 173.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.6 mt -70.16 152.5 9.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 162.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.436 ' CE3' ' HD2' ' A' ' 84' ' ' LYS . 59.6 t90 -136.21 149.09 48.41 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 156.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.07 152.97 49.31 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 128.779 2.831 . . . . 0.0 107.996 177.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.514 ' HE3' ' CE2' ' A' ' 31' ' ' PHE . 21.6 tptp -156.6 159.33 38.38 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.231 -0.918 . . . . 0.0 109.748 176.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -69.49 167.81 15.91 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 127.759 2.424 . . . . 0.0 114.216 172.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.2 p -79.33 37.99 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 130.461 3.504 . . . . 0.0 112.73 -175.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.7 t -100.3 -167.71 1.48 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.211 1.405 . . . . 0.0 109.603 -173.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -139.6 145.28 38.35 Favored 'General case' 0 C--N 1.333 -0.114 0 O-C-N 120.461 -1.399 . . . . 0.0 108.867 161.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.514 ' CE2' ' HE3' ' A' ' 26' ' ' LYS . 18.4 p90 -151.13 179.22 8.47 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.629 1.572 . . . . 0.0 108.473 176.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -121.59 128.85 52.39 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.386 1.074 . . . . 0.0 108.981 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 40.2 t-105 -115.41 160.77 19.45 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 122.042 0.925 . . . . 0.0 112.626 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -128.74 111.94 13.67 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 127.22 2.208 . . . . 0.0 107.813 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -85.07 127.51 34.25 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 167.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -120.75 -3.12 9.76 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.966 1.706 . . . . 0.0 110.978 -173.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.57 171.61 16.83 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 129.853 3.261 . . . . 0.0 108.193 175.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -71.83 147.56 47.07 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -175.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -149.84 119.59 7.05 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 175.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 39.9 m -96.57 126.36 41.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 175.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -142.09 125.43 16.56 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.681 1.192 . . . . 0.0 109.525 -173.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -105.06 123.51 47.93 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.255 1.422 . . . . 0.0 108.534 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.545 HD13 ' HB3' ' A' ' 84' ' ' LYS . 48.8 mm -78.19 112.41 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 123.962 0.905 . . . . 0.0 108.702 177.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.5 ' O ' ' HE3' ' A' ' 62' ' ' LYS . 2.4 mp -97.69 -21.75 16.84 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 118.071 -0.966 . . . . 0.0 112.806 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -167.68 149.11 5.47 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 173.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.93 178.76 29.21 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.862 1.22 . . . . 0.0 114.448 173.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.451 ' HE3' HG23 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -133.79 140.61 47.03 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 118.017 0.908 . . . . 0.0 111.145 -173.616 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.428 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 66.1 t -141.19 147.79 22.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -112.68 99.74 8.17 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 160.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.9 t -70.61 157.78 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 164.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -147.86 136.0 21.3 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 164.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 74.5 p -83.3 175.7 9.69 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.027 0.376 . . . . 0.0 110.337 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -65.23 -27.05 68.4 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.423 0.63 . . . . 0.0 111.732 -177.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.08 -4.18 4.53 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.693 1.997 . . . . 0.0 111.94 171.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.27 5.09 65.67 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 126.04 1.781 . . . . 0.0 113.567 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 46.0 mmtt -65.94 127.81 33.54 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 105.547 -2.019 . . . . 0.0 105.547 174.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -86.24 145.51 26.93 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 171.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -134.38 84.82 2.14 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 124.127 1.917 . . . . 0.0 108.683 166.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.451 HG23 ' HE3' ' A' ' 47' ' ' LYS . 1.6 p -60.28 143.59 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 CA-C-N 111.765 -2.471 . . . . 0.0 109.931 152.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.402 HD12 HD11 ' A' ' 43' ' ' ILE . 2.9 pt -139.09 132.7 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 C-N-CA 128.208 2.603 . . . . 0.0 105.203 177.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -111.81 -179.39 3.68 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.147 0.979 . . . . 0.0 108.84 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.5 ' HE3' ' O ' ' A' ' 44' ' ' LEU . 75.0 tttt -64.25 107.91 1.44 Allowed 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 175.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 128.57 -15.71 5.99 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 118.578 -1.123 . . . . 0.0 112.979 -175.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -85.88 120.58 27.44 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 119.488 1.644 . . . . 0.0 108.408 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 25.3 tp -83.84 146.76 27.93 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 158.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.8 t -132.89 149.5 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 124.788 1.235 . . . . 0.0 108.104 177.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 87.9 m -131.8 111.68 11.83 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 159.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -80.38 144.82 58.28 Favored Pre-proline 0 C--O 1.236 0.363 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 165.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -85.98 178.08 4.37 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.203 1.935 . . . . 0.0 111.357 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -73.49 93.91 2.05 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 113.492 -1.686 . . . . 0.0 109.406 174.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.39 86.72 1.94 Allowed Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.263 1.411 . . . . 0.0 110.775 175.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 33.5 tp -153.67 140.62 19.23 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.084 0.954 . . . . 0.0 109.879 169.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.39 109.47 13.34 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.766 1.626 . . . . 0.0 108.192 -173.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 8.1 p -139.9 166.24 25.16 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.817 1.19 . . . . 0.0 110.179 -172.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.69 162.02 19.85 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.819 -1.176 . . . . 0.0 109.53 174.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -131.99 110.36 10.7 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.468 1.507 . . . . 0.0 107.642 168.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.7 tttp -102.23 103.74 14.26 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 174.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 t -82.75 99.84 5.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 -176.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.6 mt -88.62 -12.76 41.66 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 118.293 -0.861 . . . . 0.0 110.87 -174.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -150.58 154.03 34.86 Favored Pre-proline 0 N--CA 1.45 -0.441 0 C-N-CA 126.616 1.966 . . . . 0.0 106.792 160.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -57.43 139.02 88.86 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 N-CA-C 108.135 -1.525 . . . . 0.0 108.135 177.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.4 p -125.09 156.0 33.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -168.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -130.15 117.0 19.26 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 173.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.545 ' HB3' HD13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -130.09 116.04 17.94 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.408 0.683 . . . . 0.0 112.368 177.713 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 11.4 m80 -66.69 119.95 12.65 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 105.931 -1.878 . . . . 0.0 105.931 170.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -119.51 164.88 15.13 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 123.76 0.824 . . . . 0.0 110.884 -177.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -152.52 125.91 8.74 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 162.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 32.4 mt -73.84 148.47 42.37 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.314 1.446 . . . . 0.0 108.804 174.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.4 p90 . . . . . 0 C--O 1.251 1.155 0 C-N-CA 126.578 1.951 . . . . 0.0 109.681 177.143 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 ttm . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 111.039 0.014 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -153.1 20.88 0.57 Allowed 'General case' 0 N--CA 1.471 0.587 0 O-C-N 120.14 -1.6 . . . . 0.0 112.338 171.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.8 t 49.0 93.62 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 128.447 2.699 . . . . 0.0 111.639 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -72.4 133.27 44.82 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -173.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.6 mt -134.84 133.18 54.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 171.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -134.36 171.58 14.08 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.632 0.773 . . . . 0.0 109.305 172.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.49 84.93 12.7 Favored Pre-proline 0 N--CA 1.464 0.271 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 175.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -75.07 159.54 40.98 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 121.937 1.758 . . . . 0.0 110.761 -175.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.4 ' H ' HG22 ' A' ' 9' ' ' THR . 1.7 t -64.87 143.45 98.82 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 170.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.51 -24.74 25.91 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 121.562 1.508 . . . . 0.0 112.439 -177.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -63.3 -42.13 99.02 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.348 1.459 . . . . 0.0 111.115 175.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.9 tptt -57.88 -43.62 86.18 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 175.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -66.97 -30.79 71.01 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 122.755 0.422 . . . . 0.0 110.752 -176.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -58.97 -52.54 65.31 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.122 0.874 . . . . 0.0 109.373 168.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -58.44 -46.48 86.44 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.898 0.879 . . . . 0.0 111.265 -174.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 75.5 mt -60.9 -5.7 1.48 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.703 1.201 . . . . 0.0 113.306 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.5 m 62.49 41.04 10.16 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 126.243 1.817 . . . . 0.0 109.742 167.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.9 t -58.83 -30.45 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 128.176 2.59 . . . . 0.0 110.379 176.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -58.44 -16.32 14.49 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.835 0.854 . . . . 0.0 112.823 170.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -102.44 -2.27 29.07 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.539 1.535 . . . . 0.0 112.048 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 33.2 m0 -82.69 165.28 42.78 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.79 143.04 54.29 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 121.939 1.759 . . . . 0.0 111.172 169.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 75.5 mt -79.32 151.83 4.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 164.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.441 ' CH2' ' HB2' ' A' ' 26' ' ' LYS . 14.9 t90 -138.84 144.99 39.48 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 154.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -145.69 162.8 36.74 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.824 1.25 . . . . 0.0 110.178 175.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.441 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 5.2 tmtt? -156.74 156.85 34.05 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 124.486 1.115 . . . . 0.0 108.036 -176.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.87 168.71 9.28 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 122.248 1.023 . . . . 0.0 112.175 174.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.5 p -75.74 62.97 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 128.711 2.804 . . . . 0.0 109.258 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.7 t -129.72 -162.46 1.21 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.4 2.28 . . . . 0.0 107.974 -175.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.36 159.66 43.43 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 120.337 -1.477 . . . . 0.0 110.321 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -171.41 -164.27 0.33 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.816 2.046 . . . . 0.0 108.399 -171.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -132.88 150.08 52.19 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.79 2.036 . . . . 0.0 107.406 170.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 34.4 t-105 -127.18 150.38 49.54 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.355 0.525 . . . . 0.0 111.04 174.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -120.66 121.98 39.49 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 124.691 1.196 . . . . 0.0 109.181 170.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -91.53 119.21 31.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.093 1.357 . . . . 0.0 107.432 174.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -117.01 12.43 14.59 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.584 1.154 . . . . 0.0 111.075 176.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.6 170.44 15.82 Favored 'General case' 0 CA--C 1.523 -0.079 0 C-N-CA 124.402 1.081 . . . . 0.0 110.65 158.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -60.89 117.07 4.98 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 103.178 -2.897 . . . . 0.0 103.178 166.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -130.63 76.44 1.72 Allowed 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -170.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.3 m -63.96 145.4 55.92 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -175.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 27.7 p -145.43 153.76 41.53 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 119.923 -0.711 . . . . 0.0 112.331 166.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -124.52 112.93 17.45 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.284 1.834 . . . . 0.0 107.854 -176.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.6 mm -69.88 136.67 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 126.487 1.915 . . . . 0.0 107.261 173.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 26.1 mt -125.08 -47.16 1.78 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.317 1.047 . . . . 0.0 108.805 -171.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -147.4 159.91 43.15 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 165.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.13 178.83 31.64 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 124.84 1.21 . . . . 0.0 113.528 174.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.432 ' HE2' HD12 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -144.76 144.92 31.43 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.651 0.739 . . . . 0.0 112.483 -170.343 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.3 t -142.63 159.73 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -122.54 119.61 31.38 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 159.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 41.2 t -103.14 92.29 2.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 51.3 m -79.09 103.1 8.8 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.647 1.179 . . . . 0.0 108.409 177.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 64.1 p -82.97 172.92 12.26 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.873 -0.517 . . . . 0.0 109.928 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -71.8 -29.01 64.0 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.385 0.612 . . . . 0.0 112.596 -166.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -73.62 0.16 13.57 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.464 1.105 . . . . 0.0 111.182 173.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.5 -14.86 64.32 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 127.951 2.691 . . . . 0.0 112.875 177.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -63.52 120.18 11.22 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.624 1.57 . . . . 0.0 107.718 -173.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.06 100.93 9.52 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.637 1.175 . . . . 0.0 110.068 -169.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -83.42 108.2 16.43 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 -177.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 40.3 t -66.92 140.18 19.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 104.77 -2.307 . . . . 0.0 104.77 154.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.1 pt -134.74 99.97 2.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 174.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -81.5 172.9 12.94 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.183 0.993 . . . . 0.0 109.916 168.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.2 pttm -52.87 127.16 22.6 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.812 0.815 . . . . 0.0 109.862 169.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.91 -28.47 13.84 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-O 117.965 -1.464 . . . . 0.0 114.321 175.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.22 101.71 1.94 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 120.736 2.268 . . . . 0.0 107.933 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.4 tp -77.44 134.28 38.42 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.7 t -116.75 146.9 20.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -174.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.8 m -138.83 99.7 3.86 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 125.09 1.356 . . . . 0.0 108.094 165.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -63.18 165.55 10.48 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 124.027 0.931 . . . . 0.0 109.403 161.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -88.41 174.76 4.16 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 CA-C-N 120.098 1.071 . . . . 0.0 112.357 164.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -74.73 91.77 2.41 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 168.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 117.9 84.33 0.99 Allowed Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.281 1.419 . . . . 0.0 110.473 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.5 tt -150.95 130.88 13.32 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.362 1.465 . . . . 0.0 108.806 171.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -104.52 134.31 47.92 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 165.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 26.7 p -151.49 167.3 28.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 119.138 0.881 . . . . 0.0 111.547 169.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.01 164.51 25.0 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.435 0.636 . . . . 0.0 111.484 168.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -143.42 101.02 3.72 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 113.76 -1.563 . . . . 0.0 108.805 -175.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 tptt -95.05 107.68 19.74 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 168.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.1 t -75.67 111.82 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 104.335 -2.469 . . . . 0.0 104.335 165.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.432 HD12 ' HE2' ' A' ' 47' ' ' LYS . 74.7 mt -84.64 -27.32 27.23 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -152.06 153.98 31.96 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 124.966 1.306 . . . . 0.0 109.919 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -53.83 128.32 29.13 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.104 2.536 . . . . 0.0 109.467 175.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.5 p -135.76 138.21 48.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -167.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -128.25 67.98 1.36 Allowed 'General case' 0 C--O 1.223 -0.309 0 CA-C-O 121.16 0.505 . . . . 0.0 110.099 -171.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.436 ' HE3' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -80.1 154.52 28.03 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -175.323 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -94.38 142.43 27.43 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 163.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -131.22 159.02 38.99 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.205 0.911 . . . . 0.0 110.959 176.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -146.37 132.96 19.81 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 122.907 0.483 . . . . 0.0 109.71 170.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 90.0 mt -86.04 135.77 33.5 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.45 1.1 . . . . 0.0 108.463 174.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 6.0 p90 . . . . . 0 C--O 1.249 1.046 0 C-N-CA 124.029 0.932 . . . . 0.0 110.953 -176.67 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.7 mtp . . . . . 0 N--CA 1.469 0.507 0 CA-C-O 118.495 -0.764 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -70.07 155.78 40.11 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 119.712 1.142 . . . . 0.0 110.452 178.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.1 t -75.12 142.0 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.377 1.471 . . . . 0.0 107.52 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -104.23 114.59 28.93 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 175.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.4 mt -132.36 129.78 59.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 124.747 1.219 . . . . 0.0 108.258 -176.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -162.42 171.23 17.47 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.395 1.078 . . . . 0.0 109.887 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.49 85.88 2.48 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 123.504 0.722 . . . . 0.0 110.132 176.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -65.56 162.8 32.52 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.474 2.116 . . . . 0.0 112.377 -177.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.4 t -58.3 144.64 77.08 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 123.55 0.74 . . . . 0.0 109.389 169.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.22 -30.77 30.45 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.338 1.359 . . . . 0.0 113.065 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -57.83 -44.55 86.52 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.768 1.167 . . . . 0.0 112.237 -175.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.3 tptt -57.16 -45.53 83.53 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 123.908 0.883 . . . . 0.0 110.143 177.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.49 -23.71 67.51 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.214 0.606 . . . . 0.0 111.527 -174.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.8 mttt -72.17 -48.56 42.43 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -58.67 -43.96 90.06 Favored 'General case' 0 CA--C 1.522 -0.107 0 C-N-CA 124.407 1.083 . . . . 0.0 110.329 -176.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 81.4 mt -62.05 -8.68 5.7 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.866 1.667 . . . . 0.0 114.811 -176.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.0 m 65.97 30.01 9.92 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.228 1.411 . . . . 0.0 112.182 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.9 t -52.27 -33.06 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 125.636 1.574 . . . . 0.0 110.412 173.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -53.62 -32.97 53.4 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 171.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -84.89 -19.69 31.91 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 118.128 -0.939 . . . . 0.0 112.179 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 41.1 m0 -66.01 160.16 65.28 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -171.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -65.96 132.59 30.66 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.84 1.693 . . . . 0.0 111.361 176.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.1 mt -71.14 139.5 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 162.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.531 ' CE3' ' HE3' ' A' ' 84' ' ' LYS . 69.7 t90 -133.49 122.56 23.81 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 161.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -124.47 159.36 30.68 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.462 1.505 . . . . 0.0 107.818 173.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -157.39 164.05 37.93 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -171.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.29 -176.38 2.62 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 122.425 1.107 . . . . 0.0 110.438 175.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.7 p -68.2 0.33 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 126.323 1.849 . . . . 0.0 112.383 167.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 p -71.74 129.59 39.04 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 120.065 -1.647 . . . . 0.0 110.81 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.51 157.5 16.99 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.238 1.015 . . . . 0.0 110.021 -177.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -164.21 -164.25 0.84 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 126.503 1.921 . . . . 0.0 107.122 -171.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -138.75 157.24 46.45 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 126.09 1.756 . . . . 0.0 108.698 173.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 22.1 t-105 -144.27 138.39 27.93 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.561 0.744 . . . . 0.0 111.181 -174.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -103.15 145.1 30.43 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.714 1.606 . . . . 0.0 107.806 168.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -118.04 123.13 44.92 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.399 1.48 . . . . 0.0 107.737 173.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.71 -5.64 12.13 Favored 'General case' 0 N--CA 1.461 0.092 0 C-N-CA 126.232 1.813 . . . . 0.0 112.564 -170.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.81 175.19 9.9 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 131.512 3.925 . . . . 0.0 106.539 166.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -70.32 139.71 52.1 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -122.52 114.45 20.68 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 163.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 20.0 m -89.79 132.98 34.95 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 159.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 27.4 p -138.89 161.82 36.36 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.338 0.589 . . . . 0.0 110.812 164.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -122.52 128.76 51.2 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.0 mm -87.02 102.3 12.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 128.806 2.842 . . . . 0.0 106.797 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.442 ' O ' ' HE2' ' A' ' 62' ' ' LYS . 2.4 mm? -81.41 -26.5 35.35 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 123.504 0.722 . . . . 0.0 111.062 -174.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -176.67 148.94 0.73 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.144 2.177 . . . . 0.0 106.086 -174.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.26 -177.11 28.43 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.275 1.417 . . . . 0.0 113.788 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.0 148.48 38.62 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.116 0.958 . . . . 0.0 109.748 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.5 t -138.22 156.52 30.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 125.039 1.335 . . . . 0.0 107.731 176.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -120.81 139.05 53.68 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 125.597 1.559 . . . . 0.0 108.066 165.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.9 t -133.93 120.2 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 83.2 m -111.83 105.15 13.54 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.531 1.533 . . . . 0.0 107.902 167.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.0 p -68.08 165.5 17.94 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 173.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -74.32 -14.7 60.93 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 123.278 1.513 . . . . 0.0 113.29 -161.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -52.04 -21.63 3.34 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 127.437 2.295 . . . . 0.0 113.083 161.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.41 4.65 90.08 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.686 1.136 . . . . 0.0 111.868 -165.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -71.1 144.97 50.12 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 119.326 1.563 . . . . 0.0 108.125 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -108.09 145.2 34.4 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -173.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -141.73 132.15 25.2 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 69.4 t -136.36 118.59 20.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 -171.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.1 pt -124.63 106.1 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 O-C-N 123.808 0.693 . . . . 0.0 109.151 -169.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -90.72 178.05 6.17 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 122.677 1.227 . . . . 0.0 109.863 171.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.442 ' HE2' ' O ' ' A' ' 44' ' ' LEU . 22.9 tttm -51.11 108.06 0.22 Allowed 'General case' 0 C--O 1.237 0.423 0 C-N-CA 127.527 2.331 . . . . 0.0 109.805 176.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.52 -16.41 26.58 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 117.591 -1.672 . . . . 0.0 114.65 175.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -70.75 102.17 2.26 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 120.368 2.084 . . . . 0.0 108.901 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.0 tp -71.04 141.38 50.91 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.1 t -125.56 145.06 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 97.3 m -129.7 118.1 21.35 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 158.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -88.45 145.77 36.24 Favored Pre-proline 0 C--O 1.237 0.402 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 162.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -84.27 177.26 5.97 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.286 1.991 . . . . 0.0 112.259 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 30.3 tttm -76.82 81.39 3.41 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 113.95 -1.477 . . . . 0.0 107.851 169.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.59 81.32 0.47 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 125.504 1.526 . . . . 0.0 111.774 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.6 tt -148.2 128.24 13.64 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 118.535 1.167 . . . . 0.0 110.694 174.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.7 116.72 30.58 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.377 1.471 . . . . 0.0 108.436 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 17.6 p -148.85 176.63 10.24 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.509 1.05 . . . . 0.0 113.393 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.11 177.01 9.3 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.981 1.312 . . . . 0.0 111.855 171.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -158.16 100.59 1.7 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 119.932 1.242 . . . . 0.0 109.663 174.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.6 tttt -104.22 111.2 23.71 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.4 t -77.18 116.67 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 N-CA-C 103.157 -2.905 . . . . 0.0 103.157 171.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.9 mt -88.12 -25.52 22.96 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 119.346 -0.941 . . . . 0.0 109.381 171.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -144.36 150.16 47.1 Favored Pre-proline 0 C--O 1.232 0.136 0 CA-C-O 117.819 -1.086 . . . . 0.0 111.051 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -58.81 114.36 1.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.431 2.754 . . . . 0.0 108.232 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.1 p -124.39 143.84 36.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 125.18 1.392 . . . . 0.0 107.446 -163.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.5 mtt180 -115.3 113.57 24.01 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 174.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.531 ' HE3' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -114.37 125.59 54.04 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 167.295 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -76.61 123.53 26.25 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 103.333 -2.84 . . . . 0.0 103.333 169.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -121.66 160.58 24.15 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.058 0.845 . . . . 0.0 110.361 -176.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -142.1 149.59 40.04 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 165.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.5 mt -108.71 129.05 55.36 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.5 p90 . . . . . 0 C--O 1.251 1.172 0 C-N-CA 124.818 1.247 . . . . 0.0 108.597 -173.56 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.3 mtt . . . . . 0 N--CA 1.47 0.557 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.42 ' HG2' ' H ' ' A' ' 3' ' ' VAL . 4.9 tt0 57.56 -173.21 0.08 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.148 0.979 . . . . 0.0 109.392 -158.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.42 ' H ' ' HG2' ' A' ' 2' ' ' GLU . 2.2 p -73.99 146.39 10.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 169.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -127.81 147.47 50.43 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.157 1.383 . . . . 0.0 107.379 174.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 90.5 mt -124.73 142.27 42.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 165.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -160.24 177.59 10.49 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.098 1.359 . . . . 0.0 110.283 166.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.448 ' HE2' ' OD1' ' A' ' 64' ' ' ASP . 0.5 OUTLIER -116.86 85.3 17.24 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 124.067 0.947 . . . . 0.0 108.667 -172.237 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.527 ' HG3' HD22 ' A' ' 65' ' ' LEU . 61.6 Cg_endo -72.16 -4.42 15.16 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 124.904 3.736 . . . . 0.0 114.687 -164.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.324 2.1 t 55.44 146.29 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 129.187 2.995 . . . . 0.0 113.39 -169.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -58.04 -17.76 32.81 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.632 2.221 . . . . 0.0 112.2 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -47.44 -61.55 1.86 Allowed 'General case' 0 C--O 1.231 0.112 0 CA-C-N 119.517 1.053 . . . . 0.0 111.297 165.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -67.4 -38.28 84.42 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -178.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.422 HD21 ' HG2' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -72.17 -24.25 61.4 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 118.562 -0.732 . . . . 0.0 112.937 -175.434 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -60.93 -55.1 36.9 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 120.397 1.453 . . . . 0.0 107.541 167.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -74.42 -26.64 60.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.769 -164.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 mp -68.0 -9.92 49.47 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.24 1.416 . . . . 0.0 112.766 170.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.3 m 61.54 33.1 18.56 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.311 1.844 . . . . 0.0 112.369 -174.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.2 t -57.19 -27.59 28.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 O-C-N 121.633 -0.667 . . . . 0.0 111.97 -172.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -54.58 -26.39 32.04 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.763 1.165 . . . . 0.0 113.574 173.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? -86.56 -26.28 24.57 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.004 0.921 . . . . 0.0 111.64 -173.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 36.7 m0 -62.84 160.05 40.19 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 124.623 1.169 . . . . 0.0 109.529 -170.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -69.35 118.59 5.77 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.251 1.967 . . . . 0.0 112.407 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.6 mt -61.98 142.08 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 176.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.598 ' CE3' ' HE3' ' A' ' 84' ' ' LYS . 59.5 t90 -135.3 143.14 46.05 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 165.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -151.93 161.84 42.01 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.701 1.601 . . . . 0.0 111.067 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.0 mmtt -143.84 176.35 9.32 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.291 0.636 . . . . 0.0 109.347 -178.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.471 ' HG3' ' H ' ' A' ' 29' ' ' SER . 6.6 pt-20 -69.82 -165.95 0.1 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.781 2.033 . . . . 0.0 110.756 169.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.5 p -109.85 25.07 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 126.691 1.996 . . . . 0.0 111.447 -175.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.471 ' H ' ' HG3' ' A' ' 27' ' ' GLU . 14.7 t -96.29 -178.34 4.27 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 126.693 1.997 . . . . 0.0 109.199 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -120.79 161.46 21.44 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 123.937 0.895 . . . . 0.0 110.125 173.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -163.75 -168.03 1.53 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.712 2.005 . . . . 0.0 108.248 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -121.29 152.02 39.4 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 168.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 51.9 t-105 -130.97 179.55 5.92 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.607 0.763 . . . . 0.0 109.936 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -148.02 151.27 35.45 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.398 1.479 . . . . 0.0 107.287 171.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -131.41 98.97 4.68 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.624 1.17 . . . . 0.0 108.534 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -90.89 9.86 28.69 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.966 1.706 . . . . 0.0 112.202 -177.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -158.46 162.49 37.53 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 128.486 2.714 . . . . 0.0 108.321 -178.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -61.48 138.29 58.27 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -144.58 104.66 4.07 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.484 HG22 HD11 ' A' ' 65' ' ' LEU . 74.8 m -72.69 143.14 48.19 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 164.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.436 ' O ' HD12 ' A' ' 65' ' ' LEU . 1.7 p -153.53 131.62 11.83 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.49 1.041 . . . . 0.0 111.4 175.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -108.61 108.09 18.83 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 126.349 1.859 . . . . 0.0 108.828 -176.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.3 mm -74.8 114.76 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.812 1.245 . . . . 0.0 107.834 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.3 mp -101.19 -33.48 10.07 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 118.879 -0.581 . . . . 0.0 112.337 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pm0 -154.04 162.73 40.99 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.975 0.91 . . . . 0.0 109.296 172.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.58 -172.37 48.47 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 127.061 2.267 . . . . 0.0 111.32 -173.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.81 148.28 31.73 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -177.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.3 t -136.95 151.96 27.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -123.07 98.01 5.69 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.362 2.265 . . . . 0.0 106.31 168.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.9 t -86.16 136.33 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 170.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 66.8 m -136.45 122.48 20.21 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.183 0.901 . . . . 0.0 108.776 -178.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 72.1 p -76.36 169.81 17.54 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.304 0.573 . . . . 0.0 109.858 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -62.98 -35.9 81.74 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.364 -0.835 . . . . 0.0 110.713 -178.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -82.65 16.16 2.3 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 128.516 2.726 . . . . 0.0 111.694 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.88 4.95 88.74 Favored Glycine 0 CA--C 1.525 0.687 0 O-C-N 119.884 -1.76 . . . . 0.0 114.649 162.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.2 mmtt -67.0 106.78 2.04 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.765 1.783 . . . . 0.0 107.025 167.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.5 tptt -67.2 157.55 33.5 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 163.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -137.0 155.58 49.52 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 104.064 -2.569 . . . . 0.0 104.064 166.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 75.5 t -138.76 129.07 33.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 103.053 -2.943 . . . . 0.0 103.053 178.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.9 pt -134.08 123.23 43.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -103.67 176.12 5.26 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 126.725 2.01 . . . . 0.0 107.817 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.3 pttp -58.11 125.2 22.16 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 164.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.8 -0.07 56.45 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 117.702 -1.61 . . . . 0.0 115.688 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.448 ' OD1' ' HE2' ' A' ' 7' ' ' LYS . 19.1 m-20 -92.1 123.82 35.73 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 120.832 2.316 . . . . 0.0 106.567 166.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.527 HD22 ' HG3' ' A' ' 8' ' ' PRO . 14.2 tp -88.15 146.73 25.25 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 160.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.4 t -126.07 150.51 31.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 174.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 58.4 m -132.96 111.41 11.01 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 164.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -74.43 155.69 87.52 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 169.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -74.79 -165.2 0.27 Allowed 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.168 2.579 . . . . 0.0 109.381 174.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -95.25 120.82 36.14 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 162.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.97 87.66 1.06 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.401 1.477 . . . . 0.0 112.634 176.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 57.9 tp -143.88 143.54 31.34 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.952 1.701 . . . . 0.0 108.207 171.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.47 131.28 56.98 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 125.339 1.456 . . . . 0.0 108.11 167.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 7.8 p -165.43 168.43 16.67 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.48 1.112 . . . . 0.0 111.362 169.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.88 167.96 20.85 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 124.578 1.151 . . . . 0.0 112.028 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -144.4 113.11 6.68 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.462 1.105 . . . . 0.0 109.755 178.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.53 109.27 19.53 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 175.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.0 t -86.8 101.26 10.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 175.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.9 mt -83.39 -18.9 37.18 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-O 118.777 -0.63 . . . . 0.0 111.717 -175.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -148.25 146.15 22.4 Favored Pre-proline 0 C--O 1.236 0.356 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 166.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -61.54 90.74 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.491 1 C-N-CA 125.542 4.161 . . . . 0.0 110.87 -165.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.35 149.31 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 123.936 0.895 . . . . 0.0 109.754 -166.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -129.35 112.6 14.01 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 168.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.598 ' HE3' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -133.28 142.15 48.35 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.266 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -84.34 100.89 11.56 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 171.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -88.8 154.86 19.93 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.154 0.982 . . . . 0.0 110.546 171.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -151.54 112.93 4.35 Favored 'General case' 0 C--O 1.239 0.523 0 O-C-N 121.676 -0.64 . . . . 0.0 110.517 170.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 61.7 mt -61.59 153.29 28.19 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.406 1.482 . . . . 0.0 108.932 171.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.7 p90 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 116.173 -1.87 . . . . 0.0 110.443 166.332 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.2 mtt . . . . . 0 N--CA 1.471 0.584 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 53.99 -169.99 0.06 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.549 1.54 . . . . 0.0 111.413 -170.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.8 p -76.85 105.08 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 108.588 -0.894 . . . . 0.0 108.588 176.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 55.9 tttt -75.7 136.68 40.36 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 171.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.3 mt -135.73 139.74 45.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 169.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -165.32 175.22 9.36 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.145 2.178 . . . . 0.0 108.728 162.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.31 86.35 1.32 Allowed Pre-proline 0 C--O 1.237 0.444 0 CA-C-O 117.88 -1.057 . . . . 0.0 109.19 176.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -63.92 168.01 12.91 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.522 1.481 . . . . 0.0 111.014 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.0 t -69.85 143.5 92.18 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -66.42 -19.4 55.29 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.897 1.731 . . . . 0.0 113.178 176.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -59.89 -47.61 85.06 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 119.733 1.151 . . . . 0.0 109.622 171.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 35.9 tptt -65.34 -37.48 87.19 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 121.45 -0.781 . . . . 0.0 110.451 -177.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.3 mt -67.97 -26.91 66.17 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 118.833 -0.603 . . . . 0.0 111.917 177.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -64.83 -46.87 80.13 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 119.386 0.994 . . . . 0.0 109.814 168.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -60.07 -48.58 81.12 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.387 0.613 . . . . 0.0 109.384 -176.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.7 mp -55.03 -14.76 1.65 Allowed 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 125.947 1.699 . . . . 0.0 112.817 176.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.4 m 53.01 45.01 29.69 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.015 1.326 . . . . 0.0 110.743 175.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 45.8 t -56.59 -31.45 34.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.27 1.028 . . . . 0.0 110.505 -175.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -44.92 -34.56 2.44 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.858 2.063 . . . . 0.0 114.454 167.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.9 mtmm -84.12 -23.53 30.66 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 119.531 1.059 . . . . 0.0 111.418 -177.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.401 ' CE3' ' HB2' ' A' ' 87' ' ' ASN . 35.1 m0 -64.72 164.43 20.84 Favored Pre-proline 0 C--O 1.24 0.574 0 C-N-CA 124.118 0.967 . . . . 0.0 109.816 -171.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -66.6 139.97 55.15 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 121.118 1.212 . . . . 0.0 110.144 171.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.2 mt -81.18 151.98 4.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 164.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.514 ' CE3' ' HE2' ' A' ' 84' ' ' LYS . 68.3 t90 -140.79 148.0 39.93 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 156.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.7 157.07 44.66 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 126.615 1.966 . . . . 0.0 109.169 -178.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -151.02 169.59 21.42 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.482 0.713 . . . . 0.0 111.625 -174.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -66.18 175.07 2.26 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 122.715 1.245 . . . . 0.0 111.006 164.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.3 t -94.62 27.4 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 128.418 2.687 . . . . 0.0 109.866 -167.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.9 t -91.99 176.59 6.45 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.573 1.149 . . . . 0.0 110.521 -173.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -104.61 142.55 34.46 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.448 1.099 . . . . 0.0 108.092 167.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -147.08 -170.34 3.52 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 127.644 2.377 . . . . 0.0 107.392 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.62 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 1.1 m-20 -128.3 154.87 45.45 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 169.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 48.1 t-105 -134.77 146.05 48.99 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.025 0.53 . . . . 0.0 111.787 175.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -113.82 111.11 21.2 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 171.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -79.49 122.61 26.67 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 170.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.9 p-10 -120.19 6.58 10.74 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 125.916 1.687 . . . . 0.0 111.323 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.96 174.31 15.71 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.082 1.353 . . . . 0.0 108.85 167.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -68.33 87.12 0.29 Allowed 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 125.584 1.554 . . . . 0.0 108.773 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.33 110.32 18.02 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 173.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 73.0 m -88.14 134.7 33.7 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 163.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 24.6 p -140.23 149.18 42.56 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 118.714 0.688 . . . . 0.0 110.053 170.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -126.92 116.71 21.23 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.466 1.507 . . . . 0.0 107.979 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 18.9 mm -80.83 124.96 39.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 126.911 2.084 . . . . 0.0 107.567 -172.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.2 mt -103.12 -26.9 12.86 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 118.634 0.652 . . . . 0.0 112.486 -176.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -158.95 169.39 24.44 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.547 1.939 . . . . 0.0 107.404 174.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.23 -172.26 25.2 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.099 0.857 . . . . 0.0 113.078 169.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.95 143.57 30.61 Favored 'General case' 0 CA--C 1.517 -0.307 0 O-C-N 121.526 -0.985 . . . . 0.0 108.363 175.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 71.6 t -138.48 155.97 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -124.55 127.02 46.78 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 126.381 1.872 . . . . 0.0 106.345 163.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.1 t -113.53 113.06 42.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.53 ' HB ' ' HG2' ' A' ' 75' ' ' ARG . 26.2 m -114.72 103.01 10.56 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 -168.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 38.2 p -78.1 173.15 12.53 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -54.65 -40.6 69.17 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.651 0.78 . . . . 0.0 110.578 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -65.09 -17.38 64.41 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 123.794 0.838 . . . . 0.0 112.361 -175.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.68 0.7 88.26 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -163.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.1 mmtp -63.06 118.36 7.76 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 164.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -130.05 133.29 46.62 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -162.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -127.27 116.64 20.87 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -170.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 77.6 t -76.76 144.88 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 160.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.9 pt -140.92 147.4 22.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 C-N-CA 124.795 1.238 . . . . 0.0 108.914 166.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -138.89 -175.33 4.11 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 126.939 2.096 . . . . 0.0 110.374 176.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -66.85 62.88 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 128.132 2.573 . . . . 0.0 115.795 -162.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 159.6 -6.9 0.13 Allowed Glycine 0 C--N 1.317 -0.475 0 CA-C-O 118.021 -1.433 . . . . 0.0 114.027 -178.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -71.47 128.53 36.15 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 166.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 17.0 tp -88.76 142.09 27.96 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 160.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.6 t -122.35 141.05 44.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 175.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.3 m -127.11 101.21 6.43 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 167.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -65.03 161.82 44.37 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 170.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -71.42 -164.03 0.15 Allowed 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.974 2.45 . . . . 0.0 108.684 167.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -110.14 108.85 19.16 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 165.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.69 85.64 1.88 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.453 1.502 . . . . 0.0 110.669 -175.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.1 tt -147.57 113.81 5.89 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.616 1.966 . . . . 0.0 107.499 173.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.1 ttt180 -81.98 133.18 35.28 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 161.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 29.2 p -147.32 -170.66 3.61 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.507 0.67 . . . . 0.0 109.896 159.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.62 ' HA ' ' HA ' ' A' ' 32' ' ' ASP . 5.8 ptp180 -108.06 164.7 12.06 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 173.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -134.07 122.87 23.57 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 119.591 1.087 . . . . 0.0 110.085 175.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.1 tttp -116.18 105.97 13.18 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.5 t -72.92 129.52 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 103.536 -2.764 . . . . 0.0 103.536 166.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 95.0 mt -109.9 -16.36 13.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 117.659 -1.162 . . . . 0.0 110.407 173.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -154.13 145.12 16.26 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 126.594 1.958 . . . . 0.0 107.61 167.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -56.92 125.87 20.38 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 124.345 3.363 . . . . 0.0 111.587 -167.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.419 ' O ' HG13 ' A' ' 82' ' ' VAL . 8.7 p -121.45 92.76 2.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-O 124.978 2.323 . . . . 0.0 111.491 -161.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.9 mtm-85 -78.95 119.57 22.3 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 170.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.514 ' HE2' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -128.78 157.17 42.2 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.69 0.757 . . . . 0.0 109.257 173.016 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -94.79 135.85 35.8 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 161.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -130.15 160.48 33.67 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 123.052 0.541 . . . . 0.0 109.871 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.401 ' HB2' ' CE3' ' A' ' 21' ' ' TRP . 27.3 t-20 -156.55 103.43 2.12 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -172.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 65.5 mt -75.48 145.53 41.35 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 171.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 45.2 p90 . . . . . 0 C--O 1.252 1.187 0 CA-C-O 114.576 -2.63 . . . . 0.0 111.156 164.96 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 mpp? . . . . . 0 N--CA 1.471 0.6 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -150.73 173.65 13.94 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -175.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 74.3 t -95.57 106.84 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 C-N-CA 128.197 2.599 . . . . 0.0 106.868 -176.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.7 tptp -82.2 134.92 35.32 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 168.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.9 mt -140.81 120.2 11.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 168.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -138.45 175.16 9.81 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.323 1.449 . . . . 0.0 109.986 172.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.53 85.47 5.92 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 170.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -65.71 165.24 23.83 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.364 2.043 . . . . 0.0 112.111 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.19 144.72 84.95 Favored Pre-proline 0 C--O 1.239 0.553 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -68.15 -30.74 31.0 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.855 2.37 . . . . 0.0 112.334 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -56.84 -44.04 81.69 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.956 0.798 . . . . 0.0 110.686 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -64.64 -36.95 85.9 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.193 0.597 . . . . 0.0 109.493 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.494 HD21 ' CD1' ' A' ' 65' ' ' LEU . 96.1 mt -69.09 -28.54 66.58 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.894 -0.504 . . . . 0.0 112.225 177.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -55.56 -50.82 69.05 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 169.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -60.43 -52.78 63.78 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.408 1.083 . . . . 0.0 110.999 -176.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.453 HD12 HD23 ' A' ' 13' ' ' LEU . 93.1 mt -56.39 -20.76 21.02 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 125.962 1.705 . . . . 0.0 112.789 -178.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 74.3 42.51 0.32 Allowed 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.768 2.027 . . . . 0.0 111.149 170.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.7 t -54.33 -33.1 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 118.304 0.502 . . . . 0.0 110.765 -173.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -58.24 -24.76 60.39 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.0 pttp -83.76 -5.66 59.25 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.48 0.712 . . . . 0.0 111.049 -171.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 23.0 m0 -87.54 165.05 32.5 Favored Pre-proline 0 N--CA 1.438 -1.06 0 C-N-CA 124.922 1.289 . . . . 0.0 107.881 -169.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -66.93 135.16 36.88 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 121.653 1.569 . . . . 0.0 110.638 167.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 68.5 mt -78.9 143.1 13.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 164.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -127.24 153.15 46.48 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 162.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -150.72 162.69 40.22 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.902 1.281 . . . . 0.0 109.543 176.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -148.78 157.94 43.8 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 124.957 1.303 . . . . 0.0 109.565 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.3 pm0 -69.47 170.91 9.63 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 124.726 1.266 . . . . 0.0 112.061 167.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.4 t -82.49 74.21 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 125.79 1.636 . . . . 0.0 106.829 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.0 t -145.62 -173.12 4.04 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 175.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.96 149.32 30.22 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 122.417 1.103 . . . . 0.0 112.922 -169.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -157.53 -168.25 2.52 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.146 1.779 . . . . 0.0 108.093 -163.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 37.0 p30 -119.91 160.64 22.31 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.257 -0.902 . . . . 0.0 108.648 166.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 10.2 t-105 -128.75 168.11 16.32 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.568 0.699 . . . . 0.0 111.257 172.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -142.32 92.35 2.42 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.722 1.609 . . . . 0.0 107.934 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -72.2 118.93 15.69 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 171.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -111.72 -5.12 14.49 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.344 1.458 . . . . 0.0 111.691 -176.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.53 172.56 12.53 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 127.167 2.187 . . . . 0.0 110.233 164.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -62.16 107.64 0.92 Allowed 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 176.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -121.3 75.11 1.14 Allowed 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -175.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.9 m -67.5 135.83 53.63 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 -175.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 29.3 p -142.54 155.96 45.07 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 120.966 0.413 . . . . 0.0 110.128 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.421 ' HD1' ' HG ' ' A' ' 65' ' ' LEU . 30.8 t80 -132.66 121.0 22.48 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.323 -170.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 16.1 mm -81.07 124.84 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -174.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.2 mt -122.45 -33.71 3.4 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.439 1.096 . . . . 0.0 111.51 -167.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -154.48 162.34 41.2 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 127.39 2.276 . . . . 0.0 105.252 165.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.44 176.51 51.05 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 124.695 1.14 . . . . 0.0 112.186 177.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.26 144.48 27.67 Favored 'General case' 0 CA--C 1.516 -0.356 0 O-C-N 122.249 -0.559 . . . . 0.0 110.27 -156.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 50.6 t -143.65 152.14 16.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-N 117.692 0.223 . . . . 0.0 110.57 -176.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -109.27 128.0 54.72 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.446 1.899 . . . . 0.0 106.951 153.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 94.0 t -107.42 140.06 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 105.726 -1.954 . . . . 0.0 105.726 170.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.9 m -136.47 104.3 5.54 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.442 1.019 . . . . 0.0 109.72 -173.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.0 p -69.74 169.93 11.95 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.182 -0.949 . . . . 0.0 110.518 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -67.67 -29.7 69.05 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.511 -0.743 . . . . 0.0 110.774 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.74 -4.17 2.91 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.085 1.354 . . . . 0.0 112.279 172.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.38 -3.46 86.25 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-O 118.436 -1.202 . . . . 0.0 113.637 167.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -58.38 152.52 17.52 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 167.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -103.64 161.69 13.7 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 156.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -118.93 159.1 24.43 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 153.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 72.8 t -137.47 128.38 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 102.185 -3.265 . . . . 0.0 102.185 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 pt -139.61 142.95 31.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.432 ' OE1' ' HE3' ' A' ' 62' ' ' LYS . 1.3 pp20? -131.71 -176.22 3.97 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.192 1.797 . . . . 0.0 111.771 177.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.432 ' HE3' ' OE1' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -75.23 54.49 0.7 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.38 2.272 . . . . 0.0 115.844 -157.287 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -177.63 -5.81 0.02 OUTLIER Glycine 0 CA--C 1.53 0.981 0 CA-C-O 118.183 -1.343 . . . . 0.0 113.166 172.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.94 140.83 36.51 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 119.253 1.526 . . . . 0.0 108.236 174.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.494 ' CD1' HD21 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -98.08 153.82 18.16 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 123.818 0.847 . . . . 0.0 109.592 167.596 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.8 t -137.07 137.53 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -174.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 98.0 m -131.15 110.48 11.19 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 166.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -73.53 162.9 72.12 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 126.142 1.777 . . . . 0.0 109.207 167.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -83.47 177.1 6.63 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 CA-C-O 122.921 1.134 . . . . 0.0 110.002 169.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.3 tttm -85.55 82.69 8.16 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.084 1.353 . . . . 0.0 107.715 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.21 86.44 0.66 Allowed Glycine 0 CA--C 1.522 0.522 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.9 tp -148.94 103.57 3.37 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.461 0.704 . . . . 0.0 110.823 174.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 27.2 ttt85 -72.86 126.89 31.0 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 156.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 20.4 p -154.14 170.68 20.61 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.899 1.279 . . . . 0.0 108.19 166.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' A' ' 32' ' ' ASP . 1.6 mpp_? -79.81 158.68 26.75 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 120.956 -1.09 . . . . 0.0 110.89 172.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -139.4 116.34 10.94 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.347 1.459 . . . . 0.0 108.433 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.0 102.39 8.14 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.632 1.573 . . . . 0.0 106.921 -173.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.2 t -80.26 105.22 9.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 104.402 -2.444 . . . . 0.0 104.402 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 17.6 mt -81.91 -27.45 33.38 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -151.22 153.62 32.88 Favored Pre-proline 0 N--CA 1.469 0.484 0 C-N-CA 125.67 1.588 . . . . 0.0 109.439 171.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -65.0 106.47 0.79 Allowed 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.125 2.55 . . . . 0.0 111.16 -164.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.3 p -93.17 111.31 24.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 121.774 0.797 . . . . 0.0 110.611 -166.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -94.45 43.12 1.1 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.754 0.821 . . . . 0.0 111.42 -171.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.62 146.98 39.0 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 120.967 -1.083 . . . . 0.0 111.133 -175.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -78.03 150.05 33.91 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 156.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -139.87 156.88 46.48 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.328 0.967 . . . . 0.0 110.545 172.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -143.36 131.91 22.37 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.143 0.977 . . . . 0.0 109.4 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 95.2 mt -93.01 129.83 38.79 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.297 1.039 . . . . 0.0 108.59 176.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.3 p90 . . . . . 0 C--O 1.247 0.949 0 C-N-CA 124.298 1.039 . . . . 0.0 110.231 -177.171 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.437 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -54.39 151.61 7.42 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.089 0.956 . . . . 0.0 110.015 178.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.1 p -54.33 110.84 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-O 121.594 0.711 . . . . 0.0 110.06 -174.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -109.68 147.82 32.46 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 125.564 1.546 . . . . 0.0 107.961 -176.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.8 mt -139.31 139.32 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 104.04 -2.578 . . . . 0.0 104.04 177.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -154.6 -178.95 7.54 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.729 0.812 . . . . 0.0 109.848 167.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.1 81.16 27.98 Favored Pre-proline 0 C--O 1.236 0.365 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -175.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.64 169.23 22.39 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.329 2.019 . . . . 0.0 111.462 -170.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.702 HG23 ' H ' ' A' ' 12' ' ' LYS . 6.9 t -66.26 145.02 98.96 Favored Pre-proline 0 CA--C 1.543 0.703 0 O-C-N 121.983 -0.448 . . . . 0.0 109.943 171.221 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.411 ' HA ' HD12 ' A' ' 13' ' ' LEU . 72.8 Cg_endo -67.01 -5.2 12.97 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.888 2.392 . . . . 0.0 112.716 169.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -87.8 -51.74 5.69 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.542 1.064 . . . . 0.0 110.752 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.702 ' H ' HG23 ' A' ' 9' ' ' THR . 1.5 tptt -49.92 -45.89 51.52 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.354 1.062 . . . . 0.0 110.207 172.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 10' ' ' PRO . 34.1 mt -54.97 -33.29 62.29 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.346 1.058 . . . . 0.0 112.555 178.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.0 mttp -63.76 -51.5 64.57 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 118.911 0.778 . . . . 0.0 109.006 176.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -57.51 -49.11 77.38 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 123.001 1.382 . . . . 0.0 109.827 -172.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 98.5 mt -56.48 -12.04 1.55 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.204 1.801 . . . . 0.0 112.035 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.0 m 62.39 32.6 16.77 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.527 1.931 . . . . 0.0 111.05 174.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.412 ' HA ' ' CD2' ' A' ' 21' ' ' TRP . 59.6 t -50.81 -39.62 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 126.657 1.983 . . . . 0.0 110.496 175.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -57.68 -19.33 26.13 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -92.05 -25.43 18.79 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 124.297 1.039 . . . . 0.0 111.586 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.412 ' CD2' ' HA ' ' A' ' 18' ' ' VAL . 41.9 m0 -60.45 158.01 32.23 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 124.297 1.039 . . . . 0.0 109.49 -174.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.39 118.5 5.68 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.046 1.83 . . . . 0.0 111.401 -175.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.2 mt -62.09 144.75 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 174.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.558 ' CZ3' ' HE3' ' A' ' 84' ' ' LYS . 91.0 t90 -132.59 138.32 47.38 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 165.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -136.2 157.28 47.19 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 128.402 2.681 . . . . 0.0 108.622 -177.081 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.5 tptt -153.85 166.4 33.04 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 121.973 -0.454 . . . . 0.0 109.94 -177.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.84 175.19 3.77 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 122.25 1.024 . . . . 0.0 110.681 167.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.6 p -80.8 -6.93 10.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 113.381 -1.736 . . . . 0.0 112.533 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.1 t -73.88 152.14 40.28 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 122.863 1.316 . . . . 0.0 109.743 174.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -84.27 168.28 15.82 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 129.132 2.973 . . . . 0.0 109.929 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -169.35 -164.01 0.43 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.954 2.502 . . . . 0.0 107.176 176.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -122.55 164.05 18.84 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 120.206 -1.559 . . . . 0.0 107.213 157.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 54.5 t-105 -134.52 168.94 18.05 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.791 0.836 . . . . 0.0 109.791 -173.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -135.87 153.7 51.39 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.259 1.423 . . . . 0.0 107.858 175.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -134.42 120.23 19.54 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 170.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -123.79 27.29 7.34 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.923 1.238 . . . . 0.0 111.811 168.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.65 172.08 15.14 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 152.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -70.23 107.43 3.71 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 -171.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -107.58 98.87 8.42 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -173.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 88.2 m -68.7 148.0 51.03 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 161.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.7 p -146.75 159.51 43.41 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 121.468 -0.77 . . . . 0.0 111.539 154.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -126.16 126.05 43.49 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 126.385 1.874 . . . . 0.0 107.862 176.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.9 mm -101.28 111.77 32.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 123.24 0.616 . . . . 0.0 109.35 -169.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.0 mp -93.12 -29.65 15.65 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 123.945 0.898 . . . . 0.0 111.769 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -159.33 166.12 31.88 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.51 0.724 . . . . 0.0 109.086 -177.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.17 -178.85 52.91 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.631 1.11 . . . . 0.0 113.218 -177.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.55 ' HE3' HG23 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -148.64 143.17 26.35 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 125.028 1.331 . . . . 0.0 107.583 -178.653 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.9 t -139.17 149.22 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 176.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -116.87 88.6 2.93 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 103.448 -2.797 . . . . 0.0 103.448 166.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.3 t -75.64 144.39 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 173.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.5 m -145.69 115.06 7.13 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 120.062 1.301 . . . . 0.0 109.052 -175.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 57.5 p -65.72 162.59 18.28 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.94 -21.89 61.54 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.149 -0.97 . . . . 0.0 110.797 175.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -79.48 22.68 0.43 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.239 1.816 . . . . 0.0 111.232 165.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.74 -5.95 10.47 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 125.685 1.612 . . . . 0.0 115.637 166.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -66.95 110.41 3.34 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 119.939 1.869 . . . . 0.0 108.006 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt -87.69 134.08 33.72 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -130.41 85.01 2.24 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 124.26 1.981 . . . . 0.0 108.585 168.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.55 HG23 ' HE3' ' A' ' 47' ' ' LYS . 1.6 p -56.85 136.35 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 CA-C-N 112.51 -2.132 . . . . 0.0 108.646 146.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 pt -139.3 132.97 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 101.719 -3.437 . . . . 0.0 101.719 173.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -90.46 -176.72 4.86 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 121.893 0.854 . . . . 0.0 108.919 171.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -66.16 126.16 27.79 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 147.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 117.61 14.41 6.87 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-O 118.051 -1.416 . . . . 0.0 114.296 -175.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -119.85 149.31 42.28 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.036 1.334 . . . . 0.0 108.545 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.7 tp -109.1 145.16 36.14 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 156.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.3 t -130.26 153.95 39.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 125.461 1.504 . . . . 0.0 107.476 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.0 m -135.31 108.6 7.78 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 161.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -79.01 153.53 77.48 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 123.831 0.852 . . . . 0.0 109.177 169.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.74 171.42 17.35 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 121.848 1.699 . . . . 0.0 111.305 173.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.9 tttt -78.1 106.67 10.13 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 111.485 -2.598 . . . . 0.0 106.21 161.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.66 70.09 0.9 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.702 1.62 . . . . 0.0 111.918 171.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.1 tp -140.68 150.89 44.07 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.104 1.762 . . . . 0.0 109.125 176.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.35 134.2 43.45 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 126.924 2.09 . . . . 0.0 108.219 176.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 6.0 p -159.52 164.83 34.03 Favored 'General case' 0 C--N 1.334 -0.077 0 C-N-CA 123.082 0.553 . . . . 0.0 111.686 176.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.39 164.24 16.62 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 123.029 0.532 . . . . 0.0 112.009 167.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -144.37 104.9 4.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.859 1.264 . . . . 0.0 108.219 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.7 ttpm? -101.88 111.28 23.48 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 169.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.2 t -77.65 125.84 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 168.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.1 mt -103.03 -16.1 15.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 118.313 -0.851 . . . . 0.0 111.448 168.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -147.85 144.45 19.13 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 117.543 -1.218 . . . . 0.0 109.299 171.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -61.97 100.43 0.2 Allowed 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 124.24 3.293 . . . . 0.0 111.299 -174.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.5 p -70.51 156.49 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 124.535 1.134 . . . . 0.0 111.232 -169.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -139.99 110.21 6.57 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 103.435 -2.802 . . . . 0.0 103.435 161.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.558 ' HE3' ' CZ3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -132.16 148.26 52.46 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.217 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -90.56 101.04 13.78 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 105.674 -1.972 . . . . 0.0 105.674 174.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -90.92 159.16 16.34 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.69 0.677 . . . . 0.0 110.074 170.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -154.04 140.82 19.08 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 121.44 -0.788 . . . . 0.0 109.972 159.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 42.9 mt -84.23 165.92 17.97 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 124.484 1.113 . . . . 0.0 109.172 175.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.1 p90 . . . . . 0 C--O 1.255 1.367 0 CA-C-O 116.224 -1.846 . . . . 0.0 108.227 164.124 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mtm . . . . . 0 N--CA 1.473 0.682 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -154.43 172.82 17.13 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.449 1.099 . . . . 0.0 108.233 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.9 t -77.92 136.23 24.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 O-C-N 121.466 -0.771 . . . . 0.0 110.086 -171.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.6 ttpt -115.0 91.45 3.62 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 176.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.509 ' CG1' HG13 ' A' ' 66' ' ' VAL . 22.8 mt -87.77 139.77 16.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 167.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -154.06 171.8 18.51 Favored 'General case' 0 C--O 1.224 -0.26 0 O-C-N 123.998 0.811 . . . . 0.0 111.008 163.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.92 75.77 75.99 Favored Pre-proline 0 N--CA 1.47 0.572 0 C-N-CA 123.419 0.688 . . . . 0.0 111.368 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.468 ' HG2' HD21 ' A' ' 13' ' ' LEU . 41.5 Cg_endo -67.71 172.34 10.7 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 125.183 3.922 . . . . 0.0 114.234 -173.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.6 t -66.19 144.3 98.69 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.191 0.996 . . . . 0.0 109.913 173.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.25 -25.07 50.25 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.734 1.623 . . . . 0.0 112.924 176.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -61.24 -55.08 36.06 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.601 0.761 . . . . 0.0 109.184 -177.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -53.34 -38.16 62.99 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.327 1.051 . . . . 0.0 111.208 176.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.468 HD21 ' HG2' ' A' ' 8' ' ' PRO . 4.3 mm? -71.54 -22.19 61.79 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.325 -176.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -64.93 -48.88 72.55 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 120.053 1.297 . . . . 0.0 108.853 166.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -66.3 -37.93 86.55 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.281 0.632 . . . . 0.0 111.466 -167.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 34.4 mt -55.55 -12.09 1.07 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.93 1.292 . . . . 0.0 113.165 173.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.2 m 63.98 39.57 7.89 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.764 2.025 . . . . 0.0 109.668 172.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.6 t -53.63 -35.62 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 128.302 2.641 . . . . 0.0 110.55 173.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -61.48 -11.98 12.97 Favored 'General case' 0 CA--C 1.548 0.87 0 O-C-N 121.033 -1.042 . . . . 0.0 113.296 173.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.0 mttt -103.13 -3.73 25.44 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 126.271 1.828 . . . . 0.0 112.494 176.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 32.6 m0 -79.99 165.27 48.22 Favored Pre-proline 0 CA--C 1.538 0.49 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 176.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.52 136.13 35.56 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 121.492 1.461 . . . . 0.0 111.455 170.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.5 mt -76.09 149.69 6.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 165.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.483 ' CZ3' ' HE3' ' A' ' 84' ' ' LYS . 6.4 t90 -146.17 148.53 32.64 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.953 1.301 . . . . 0.0 108.261 164.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -138.06 163.22 32.15 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.277 2.231 . . . . 0.0 109.763 -177.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -145.99 159.72 42.85 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.597 1.089 . . . . 0.0 111.309 168.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -61.81 173.92 0.93 Allowed 'General case' 0 C--O 1.232 0.174 0 O-C-N 125.212 1.57 . . . . 0.0 110.792 163.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.9 t -90.78 33.72 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 125.865 1.666 . . . . 0.0 109.885 -173.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.9 t -107.25 -179.04 3.81 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 120.522 -1.361 . . . . 0.0 109.637 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -124.81 144.02 50.5 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.867 1.267 . . . . 0.0 109.724 -171.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -156.54 -164.93 1.76 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.349 1.06 . . . . 0.0 109.145 -174.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.51 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 0.7 OUTLIER -131.34 150.23 52.23 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.945 1.698 . . . . 0.0 109.482 172.503 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 29.6 t-105 -133.97 142.51 47.7 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 123.35 0.406 . . . . 0.0 111.135 177.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -106.7 125.13 50.62 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 173.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -103.67 106.8 17.41 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 168.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -104.08 17.79 23.39 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.469 1.031 . . . . 0.0 111.471 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.89 168.14 26.08 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.177 1.391 . . . . 0.0 109.562 166.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -62.97 124.9 22.28 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 126.236 1.814 . . . . 0.0 107.303 -178.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -140.46 109.37 6.04 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.44 ' CG2' HD11 ' A' ' 65' ' ' LEU . 24.6 m -77.82 148.02 34.92 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 163.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 25.6 p -142.92 147.33 35.1 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 157.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -109.35 128.7 55.31 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 172.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.8 mm -90.83 129.3 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -108.99 -37.21 5.89 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.012 1.725 . . . . 0.0 113.033 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -163.7 161.11 23.38 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.098 1.759 . . . . 0.0 109.585 175.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.05 -163.64 12.88 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.056 1.312 . . . . 0.0 111.638 -174.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.404 ' HE3' ' O ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -150.82 145.12 25.5 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.618 1.209 . . . . 0.0 108.011 157.206 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.404 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 65.6 t -134.46 150.2 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 174.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -118.95 143.08 47.23 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 157.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.6 t -120.42 96.84 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 175.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.4 m -78.51 104.94 9.45 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 174.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.459 ' HA ' ' SG ' ' A' ' 74' ' ' CYS . 23.9 p -78.32 171.68 14.71 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -60.34 -31.92 70.77 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.062 -1.023 . . . . 0.0 111.904 -177.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.46 -15.43 60.68 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 127.578 2.351 . . . . 0.0 111.674 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.83 -2.93 87.7 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 124.641 1.115 . . . . 0.0 114.174 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.7 mmtp -59.75 142.25 53.6 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 163.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.0 ptmm? -125.7 94.11 4.03 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 123.118 1.437 . . . . 0.0 107.8 -176.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.441 ' HB3' HD11 ' A' ' 5' ' ' ILE . 92.4 m-85 -89.11 87.43 7.18 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 123.991 1.853 . . . . 0.0 109.01 -175.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.5 p -55.13 144.1 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 CA-C-N 112.092 -2.322 . . . . 0.0 111.103 149.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 pt -144.78 137.3 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 129.478 3.111 . . . . 0.0 104.094 176.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -109.29 -177.25 3.24 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 125.551 1.54 . . . . 0.0 109.412 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.5 pttt -64.62 42.47 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 130.238 3.415 . . . . 0.0 116.446 -174.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -179.46 11.91 0.03 OUTLIER Glycine 0 CA--C 1.524 0.608 0 C-N-CA 124.962 1.268 . . . . 0.0 113.251 169.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.98 131.04 40.36 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.54 1.67 . . . . 0.0 107.022 175.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.44 HD11 ' CG2' ' A' ' 40' ' ' THR . 26.0 tp -99.3 91.61 5.04 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.332 1.453 . . . . 0.0 108.025 164.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.509 HG13 ' CG1' ' A' ' 5' ' ' ILE 0.631 0.1 OUTLIER -61.89 145.96 12.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 120.808 3.632 . . . . 0.0 120.808 153.042 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.2 m -135.4 121.98 20.75 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 128.289 2.636 . . . . 0.0 105.761 162.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -92.61 148.32 35.97 Favored Pre-proline 0 C--O 1.237 0.422 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 170.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -78.14 179.73 6.22 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.937 2.425 . . . . 0.0 110.16 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -85.77 93.95 9.0 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 114.65 93.57 1.95 Allowed Glycine 0 CA--C 1.523 0.534 0 C-N-CA 125.175 1.369 . . . . 0.0 109.802 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.3 tt -151.23 133.34 15.22 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.038 1.335 . . . . 0.0 108.858 175.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 65.6 ttt-85 -130.23 81.87 2.03 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.616 1.098 . . . . 0.0 111.056 -175.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.459 ' SG ' ' HA ' ' A' ' 52' ' ' THR . 87.0 m -137.2 154.8 50.11 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 122.205 1.002 . . . . 0.0 112.634 -168.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.51 ' HA ' ' HA ' ' A' ' 32' ' ' ASP . 0.7 OUTLIER -70.27 152.53 44.08 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 114.043 -1.435 . . . . 0.0 109.858 -174.95 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -131.58 110.46 10.97 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.927 1.691 . . . . 0.0 107.215 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.4 tttp -108.73 107.96 18.61 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -177.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.5 t -86.09 102.57 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.1 mt -83.95 -21.84 31.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 118.493 -0.765 . . . . 0.0 110.509 175.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -152.6 151.9 27.77 Favored Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 173.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -72.1 86.28 0.95 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 125.05 3.833 . . . . 0.0 111.801 -158.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.3 p -71.69 139.79 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 123.912 0.885 . . . . 0.0 109.251 -172.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.0 ttt180 -120.8 59.37 0.92 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.986 0.898 . . . . 0.0 110.044 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.483 ' HE3' ' CZ3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -70.47 162.13 29.3 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 119.37 -2.081 . . . . 0.0 109.71 -172.554 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -101.18 125.35 47.8 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 104.375 -2.454 . . . . 0.0 104.375 167.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -115.53 160.87 19.4 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.478 1.036 . . . . 0.0 109.251 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -151.01 127.63 10.82 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 118.789 0.722 . . . . 0.0 109.237 173.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 19.8 mt -87.83 139.04 30.93 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 126.411 1.884 . . . . 0.0 108.015 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 34.0 p90 . . . . . 0 C--O 1.259 1.604 0 CA-C-O 117.335 -1.317 . . . . 0.0 110.397 179.063 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.471 0.575 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -159.69 12.89 0.13 Allowed 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 91.5 t 49.37 108.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.693 1 C-N-CA 132.616 4.366 . . . . 0.0 111.717 -174.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.16 130.81 44.3 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 177.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.0 mt -143.32 134.47 22.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 173.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -159.38 173.73 15.81 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.337 0.655 . . . . 0.0 110.199 172.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.82 85.3 4.87 Favored Pre-proline 0 C--O 1.234 0.256 0 C-N-CA 124.288 1.035 . . . . 0.0 108.911 177.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.87 169.91 19.18 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.248 2.632 . . . . 0.0 112.925 -176.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 t -69.63 149.79 96.85 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.82 1.248 . . . . 0.0 110.642 174.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.09 -31.16 75.91 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.834 2.356 . . . . 0.0 113.79 173.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -63.26 -53.56 50.98 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 118.65 0.659 . . . . 0.0 110.672 -171.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.5 tttp -54.42 -48.48 71.59 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 124.833 1.253 . . . . 0.0 109.298 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.4 mt -58.02 -41.02 82.27 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.933 0.893 . . . . 0.0 112.019 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -59.94 -46.96 87.7 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.012 173.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -59.28 -45.77 90.35 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.129 0.877 . . . . 0.0 110.065 -178.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 59.8 mt -57.16 -12.02 2.0 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.572 1.949 . . . . 0.0 113.05 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.3 m 64.11 39.81 7.43 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.956 1.702 . . . . 0.0 111.844 168.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.3 t -58.03 -26.69 29.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 126.743 2.017 . . . . 0.0 111.92 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -61.53 -20.57 63.38 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 120.324 -1.485 . . . . 0.0 113.439 171.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt -98.02 4.15 49.34 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.159 1.384 . . . . 0.0 110.92 177.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 31.9 m0 -87.54 160.33 47.97 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.37 133.76 27.11 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.186 1.924 . . . . 0.0 112.415 177.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.9 mt -73.41 147.73 9.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 124.485 1.114 . . . . 0.0 109.694 166.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.482 ' CZ3' ' HE3' ' A' ' 84' ' ' LYS . 59.8 t90 -144.36 120.63 10.88 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.292 1.437 . . . . 0.0 107.876 168.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.77 168.51 10.28 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.763 1.625 . . . . 0.0 109.791 164.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.534 ' HD3' ' H ' ' A' ' 27' ' ' GLU . 6.1 tmtt? -152.07 165.73 33.81 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.827 0.822 . . . . 0.0 110.735 167.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.534 ' H ' ' HD3' ' A' ' 26' ' ' LYS . 1.0 OUTLIER -76.97 172.64 12.86 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 126.304 1.842 . . . . 0.0 109.216 174.732 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.2 t -100.33 59.32 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 -164.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.4 t -132.03 -178.29 4.83 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.893 1.677 . . . . 0.0 109.433 -167.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -122.64 150.65 42.39 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.907 0.883 . . . . 0.0 109.095 173.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -163.42 -164.79 0.97 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 125.881 1.673 . . . . 0.0 107.017 -177.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 2.6 p30 -131.0 154.65 47.95 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 120.878 -1.139 . . . . 0.0 109.159 173.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 56.1 t-105 -144.11 152.25 40.69 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.015 0.435 . . . . 0.0 110.062 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -124.89 153.18 43.03 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.572 1.149 . . . . 0.0 108.526 -177.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -123.49 103.84 8.7 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.961 1.305 . . . . 0.0 107.626 175.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -104.74 13.45 31.36 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.232 1.413 . . . . 0.0 110.877 176.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.46 170.78 18.77 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 129.649 3.18 . . . . 0.0 108.624 164.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -68.94 136.41 52.5 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 177.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -133.17 124.26 27.13 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 171.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 53.1 m -99.34 137.79 37.35 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 166.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 24.8 p -138.03 148.04 44.71 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 118.164 0.438 . . . . 0.0 110.101 167.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -112.11 126.03 54.74 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 171.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 17.6 mm -95.55 122.39 46.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 129.499 3.119 . . . . 0.0 107.47 -173.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -105.53 -27.55 11.33 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -175.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -164.86 156.64 15.46 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.508 1.123 . . . . 0.0 108.27 177.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.17 177.87 44.63 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.976 1.274 . . . . 0.0 112.205 -177.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.491 ' HE3' HG23 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -135.61 139.03 43.51 Favored 'General case' 0 CA--C 1.515 -0.378 0 O-C-N 121.618 -0.931 . . . . 0.0 108.857 -170.968 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.426 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 55.1 t -136.19 146.07 29.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 178.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -112.58 116.82 30.81 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 102.998 -2.964 . . . . 0.0 102.998 156.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.4 t -91.04 122.33 42.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 164.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 57.9 m -123.67 105.78 10.0 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 119.664 1.12 . . . . 0.0 108.386 -172.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 32.5 p -69.75 171.97 8.31 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -80.2 -11.2 59.76 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 120.264 -1.523 . . . . 0.0 112.267 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -65.05 -10.76 32.58 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.011 -1.056 . . . . 0.0 112.076 162.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.86 -9.24 77.93 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 125.115 1.34 . . . . 0.0 112.549 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -61.19 124.01 19.33 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 124.957 1.303 . . . . 0.0 108.134 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.96 127.86 46.11 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 125.322 1.449 . . . . 0.0 108.229 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -124.21 84.01 2.22 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 124.478 2.085 . . . . 0.0 107.1 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.491 HG23 ' HE3' ' A' ' 47' ' ' LYS . 1.5 p -72.87 148.29 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 111.138 -2.756 . . . . 0.0 109.454 162.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.6 pt -148.31 125.23 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 C-N-CA 126.837 2.055 . . . . 0.0 106.528 -175.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -88.3 178.58 6.55 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 122.454 1.121 . . . . 0.0 109.932 167.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -63.95 54.45 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 130.798 3.639 . . . . 0.0 115.525 176.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 173.64 -13.69 0.04 OUTLIER Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.731 1.634 . . . . 0.0 112.846 176.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -69.09 101.75 1.49 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.222 1.511 . . . . 0.0 108.739 176.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.4 tp -74.81 141.17 44.33 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 175.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.4 t -123.78 160.32 27.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 C-N-CA 123.818 0.847 . . . . 0.0 109.076 -175.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.6 m -143.24 109.94 5.51 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 161.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -80.04 148.37 67.79 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 169.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -87.22 178.57 3.45 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.624 2.216 . . . . 0.0 111.877 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -85.45 83.43 7.94 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.372 1.469 . . . . 0.0 107.524 173.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.8 79.18 0.21 Allowed Glycine 0 CA--C 1.532 1.096 0 C-N-CA 126.749 2.118 . . . . 0.0 111.142 175.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.445 HD21 ' HB3' ' A' ' 74' ' ' CYS . 8.1 tt -147.92 117.45 7.01 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.978 1.389 . . . . 0.0 111.467 175.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.5 tpp85 -85.92 133.8 33.92 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.945 0.898 . . . . 0.0 109.721 161.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.445 ' HB3' HD21 ' A' ' 72' ' ' LEU . 28.6 p -150.66 178.19 9.34 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.657 0.783 . . . . 0.0 112.973 166.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' A' ' 32' ' ' ASP . 0.2 OUTLIER -96.2 160.51 14.4 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 124.648 1.179 . . . . 0.0 109.295 167.656 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 2.5 m95 -132.36 117.32 17.97 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 173.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.403 ' HD2' HD23 ' A' ' 79' ' ' LEU . 3.6 tmtp? -104.68 112.09 25.04 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 168.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.6 t -81.26 91.3 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 103.833 -2.654 . . . . 0.0 103.833 171.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.465 HD12 ' HE2' ' A' ' 47' ' ' LYS . 50.7 mt -71.06 -33.83 70.63 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.214 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -142.3 147.01 41.81 Favored Pre-proline 0 C--O 1.234 0.237 0 CA-C-O 117.479 -1.248 . . . . 0.0 108.224 171.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -62.47 94.91 0.14 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 125.072 3.848 . . . . 0.0 110.896 -165.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.1 p -78.3 146.95 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.853 -167.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.01 114.5 17.18 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 169.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.482 ' HE3' ' CZ3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -131.17 139.68 49.79 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 123.164 0.586 . . . . 0.0 109.495 -179.262 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -81.9 114.78 20.73 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 170.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -102.18 165.18 11.29 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.642 1.11 . . . . 0.0 110.013 174.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -152.0 150.82 30.41 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.725 0.693 . . . . 0.0 109.82 163.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 39.0 mt -108.76 147.05 32.59 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.78 1.232 . . . . 0.0 108.751 -174.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.2 p90 . . . . . 0 C--O 1.253 1.244 0 C-N-CA 126.164 1.785 . . . . 0.0 110.035 -179.497 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.8 ptp . . . . . 0 N--CA 1.471 0.61 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -156.3 14.33 0.31 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.999 0.818 . . . . 0.0 111.561 -175.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.5 t 49.93 107.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 C-N-CA 131.611 3.964 . . . . 0.0 112.116 -161.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.9 tttt -69.78 125.3 26.34 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 174.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.0 mt -130.9 135.92 59.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 105.069 -2.196 . . . . 0.0 105.069 172.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -158.6 174.14 15.51 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.838 1.655 . . . . 0.0 109.425 167.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.41 85.0 15.37 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 119.197 0.908 . . . . 0.0 108.799 177.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.493 ' HG2' HD21 ' A' ' 13' ' ' LEU . 19.3 Cg_endo -65.31 163.16 30.4 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.728 2.952 . . . . 0.0 111.902 -172.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 t -66.98 142.69 97.52 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 175.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -72.54 -16.51 27.16 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.114 1.876 . . . . 0.0 113.73 -178.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -52.54 -62.87 1.37 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.828 0.851 . . . . 0.0 109.022 170.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 48.8 tptt -53.82 -37.06 63.19 Favored 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 124.921 1.288 . . . . 0.0 111.213 -176.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.493 HD21 ' HG2' ' A' ' 8' ' ' PRO . 3.9 mm? -65.17 -37.19 86.58 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.67 0.788 . . . . 0.0 111.003 -178.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -48.48 72.39 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 117.712 -1.137 . . . . 0.0 108.407 176.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -53.26 -49.17 67.46 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.454 1.102 . . . . 0.0 110.414 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.1 mp -52.24 -15.57 0.63 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 126.616 1.967 . . . . 0.0 113.903 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.455 ' HB3' ' HE3' ' A' ' 20' ' ' LYS . 23.7 m 66.1 30.54 9.38 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.473 1.509 . . . . 0.0 110.783 175.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.5 t -55.16 -30.18 23.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.205 0 C-N-CA 125.159 1.384 . . . . 0.0 111.616 -178.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -55.01 -28.04 48.92 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.407 1.003 . . . . 0.0 112.867 173.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.455 ' HE3' ' HB3' ' A' ' 17' ' ' SER . 5.8 mtmp? -88.92 -23.55 22.68 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 124.742 1.217 . . . . 0.0 111.287 -176.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.422 ' CE3' ' HB2' ' A' ' 87' ' ' ASN . 37.5 m0 -61.21 156.94 46.97 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 123.26 0.624 . . . . 0.0 109.326 -174.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -71.32 121.47 7.8 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.235 1.957 . . . . 0.0 112.309 -175.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.1 mt -62.51 145.56 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 O-C-N 121.106 -0.996 . . . . 0.0 108.612 176.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.453 ' CE3' ' HE2' ' A' ' 84' ' ' LYS . 81.9 t90 -141.82 148.46 38.89 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 122.171 0.986 . . . . 0.0 108.721 161.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -140.17 168.39 19.91 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 128.286 2.634 . . . . 0.0 107.616 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.457 ' HE3' ' CD1' ' A' ' 31' ' ' PHE . 6.2 tmtt? -149.01 158.29 44.07 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 168.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -58.11 172.44 0.43 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 123.142 1.449 . . . . 0.0 111.09 171.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.6 p -76.31 65.78 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 112.388 -2.187 . . . . 0.0 108.901 169.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.92 156.35 41.0 Favored 'General case' 0 CA--C 1.507 -0.706 0 O-C-N 120.555 -1.341 . . . . 0.0 109.888 172.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -78.14 165.51 23.87 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 113.233 -1.803 . . . . 0.0 109.469 -178.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.457 ' CD1' ' HE3' ' A' ' 26' ' ' LYS . 6.7 p90 -163.65 -173.18 3.17 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 164.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 8.8 p-10 -126.67 140.28 52.52 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 163.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 15.5 t-105 -113.87 140.29 48.47 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.163 -174.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -106.31 111.89 24.68 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 168.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -85.08 119.97 26.06 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 172.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.37 -5.6 9.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 117.854 -1.07 . . . . 0.0 113.613 -158.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 p -141.12 175.08 9.92 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 131.293 3.837 . . . . 0.0 106.853 164.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -67.84 129.35 39.63 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -135.46 107.22 7.01 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -176.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 89.1 m -75.77 142.91 42.23 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 166.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 19.8 p -138.46 146.49 42.15 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 119.5 1.045 . . . . 0.0 110.917 158.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -117.09 112.67 21.22 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 126.414 1.886 . . . . 0.0 107.457 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 29.4 mm -80.22 131.48 33.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -176.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.8 mp -114.01 -26.62 8.03 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 118.759 -0.639 . . . . 0.0 112.26 178.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -163.43 152.36 14.31 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 118.813 0.733 . . . . 0.0 109.849 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.48 -177.27 21.32 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.721 1.629 . . . . 0.0 112.766 -176.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.578 ' HE2' HD12 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -135.54 142.93 45.47 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.11 1.364 . . . . 0.0 107.489 171.341 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.656 HG13 ' CG1' ' A' ' 60' ' ' ILE 0.634 0.2 OUTLIER -133.89 137.02 53.1 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.309 0 C-N-CA 129.648 3.179 . . . . 0.0 117.067 -176.139 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -125.46 112.68 16.54 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 125.197 1.561 . . . . 0.0 109.157 158.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.499 HG23 HD11 ' A' ' 60' ' ' ILE . 70.5 t -91.99 139.57 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 166.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 90.5 m -136.28 115.52 12.55 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 177.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.5 p -72.21 178.57 3.8 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.812 1.245 . . . . 0.0 110.913 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -54.55 -34.17 61.35 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.182 0.593 . . . . 0.0 110.468 170.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.49 1.31 26.16 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.966 2.506 . . . . 0.0 113.124 -171.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.17 3.63 46.3 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 118.745 0.702 . . . . 0.0 114.6 177.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.497 ' HE2' ' HA ' ' A' ' 56' ' ' LYS . 6.0 mmpt? -65.42 111.8 3.24 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 166.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.41 150.18 46.51 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 164.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -135.97 118.87 16.26 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 170.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.8 t -89.21 132.09 34.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.656 ' CG1' HG13 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -126.26 136.93 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 174.638 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -138.97 -179.01 5.58 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 172.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.3 81.24 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.192 1.797 . . . . 0.0 111.773 177.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 137.45 11.47 1.0 Allowed Glycine 0 CA--C 1.525 0.708 0 CA-C-O 117.882 -1.51 . . . . 0.0 114.593 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -107.69 134.97 49.91 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 164.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.416 ' CD1' HD11 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -96.06 153.66 17.66 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 165.756 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 36.4 t -133.46 150.24 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 124.057 0.943 . . . . 0.0 109.218 177.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.8 m -133.43 120.24 20.65 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.19 0.996 . . . . 0.0 108.312 162.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -83.28 156.57 66.17 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 125.302 1.441 . . . . 0.0 109.514 170.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -83.96 175.16 7.85 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.5 2.133 . . . . 0.0 109.818 174.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -78.03 102.19 7.29 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 166.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.78 80.79 1.54 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.391 0.996 . . . . 0.0 112.196 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 51.5 tp -141.77 155.45 45.61 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 126.024 1.73 . . . . 0.0 108.374 169.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.81 140.43 45.86 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 126.952 2.101 . . . . 0.0 106.722 175.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 3.9 p -168.73 161.09 11.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 118.55 0.614 . . . . 0.0 110.117 173.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -68.6 159.33 32.17 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.997 164.593 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -123.57 136.79 54.72 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 163.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -119.48 97.51 5.68 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 167.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.7 t -73.95 97.21 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.505 0 N-CA-C 103.45 -2.796 . . . . 0.0 103.45 169.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.578 HD12 ' HE2' ' A' ' 47' ' ' LYS . 68.1 mt -72.43 -31.21 65.3 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 119.058 -1.057 . . . . 0.0 108.957 178.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -143.17 144.34 28.22 Favored Pre-proline 0 N--CA 1.452 -0.339 0 CA-C-O 116.881 -1.533 . . . . 0.0 107.189 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -62.93 98.35 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 124.144 3.229 . . . . 0.0 110.2 -165.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.9 p -74.29 158.6 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.697 -171.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -139.02 120.5 15.01 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 168.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.453 ' HE2' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -131.38 154.29 48.77 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 -178.007 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 14.3 m80 -94.06 102.25 14.31 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 167.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -88.61 157.48 18.57 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.906 0.883 . . . . 0.0 110.271 171.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.422 ' HB2' ' CE3' ' A' ' 21' ' ' TRP . 34.3 t30 -154.58 122.18 5.78 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 121.333 -0.854 . . . . 0.0 110.403 167.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.6 mt -69.82 157.47 37.3 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.051 1.34 . . . . 0.0 109.335 176.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.251 1.17 0 CA-C-O 115.43 -2.224 . . . . 0.0 108.159 163.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 ttt . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 57.72 178.72 0.06 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.49 0.716 . . . . 0.0 109.197 -161.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 75.9 t -86.19 117.69 31.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 160.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -88.85 139.63 30.26 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 166.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.6 mt -132.73 134.56 58.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 162.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -161.56 176.98 10.46 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.823 1.649 . . . . 0.0 109.199 166.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.38 86.0 3.16 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.777 1.231 . . . . 0.0 110.354 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.416 ' HG2' HD21 ' A' ' 13' ' ' LEU . 57.2 Cg_endo -64.5 171.49 8.06 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.819 2.346 . . . . 0.0 112.683 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 38.4 p -73.05 146.73 87.65 Favored Pre-proline 0 CA--C 1.536 0.404 0 O-C-N 121.571 -0.706 . . . . 0.0 109.536 173.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -70.45 -25.21 25.65 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.528 1.485 . . . . 0.0 112.198 -178.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -64.13 -45.18 89.67 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.616 0.644 . . . . 0.0 110.369 172.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.3 tptm -57.56 -33.9 68.62 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.846 0.748 . . . . 0.0 110.544 177.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.416 HD21 ' HG2' ' A' ' 8' ' ' PRO . 3.9 mm? -74.28 -15.06 60.98 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.232 0.613 . . . . 0.0 112.53 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -77.36 -39.73 46.42 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.726 1.148 . . . . 0.0 109.051 164.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -70.85 -20.92 62.49 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 118.254 0.479 . . . . 0.0 112.262 -176.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 mp -78.9 1.93 21.9 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-O 117.474 -1.251 . . . . 0.0 112.611 176.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.7 p 57.99 21.51 7.85 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.155 1.382 . . . . 0.0 114.2 -177.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.9 t -57.87 -37.58 61.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 CA-C-N 119.659 1.118 . . . . 0.0 111.837 -163.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -53.37 -24.63 12.73 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.936 0.895 . . . . 0.0 113.312 175.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.5 mttm -88.43 -25.16 22.79 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 117.677 -1.154 . . . . 0.0 111.153 -177.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 38.7 m0 -61.24 164.74 7.84 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 126.141 1.777 . . . . 0.0 110.261 -175.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.05 140.72 55.24 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 CA-C-N 121.52 1.579 . . . . 0.0 111.165 173.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.8 mt -85.6 155.51 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 169.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 27.8 t90 -141.76 133.93 27.76 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 164.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -138.25 132.88 32.43 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 126.807 2.043 . . . . 0.0 106.82 -177.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -134.27 169.6 16.96 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 121.384 -0.823 . . . . 0.0 110.062 -170.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.437 ' CD ' ' H ' ' A' ' 28' ' ' VAL . 1.4 tm-20 -72.7 177.54 4.71 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 122.755 1.264 . . . . 0.0 111.039 172.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.437 ' H ' ' CD ' ' A' ' 27' ' ' GLU . 16.3 t -102.24 45.87 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 127.351 2.26 . . . . 0.0 108.432 -165.026 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.7 t -108.52 -175.29 2.73 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 128.076 2.55 . . . . 0.0 108.682 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -109.05 163.26 13.48 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.803 0.811 . . . . 0.0 110.5 159.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -151.14 -164.73 2.08 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 163.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -142.05 148.36 38.33 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 126.095 1.758 . . . . 0.0 106.858 177.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 47.1 t-105 -135.13 145.89 48.28 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.129 0.572 . . . . 0.0 111.804 -172.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -112.54 109.76 19.52 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.543 1.537 . . . . 0.0 107.781 166.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -79.16 95.3 5.56 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 171.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -88.01 18.61 4.11 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.472 1.033 . . . . 0.0 110.4 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -168.31 164.26 13.01 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.779 1.631 . . . . 0.0 109.838 176.35 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -58.43 103.12 0.13 Allowed 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 126.903 2.081 . . . . 0.0 107.561 174.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -105.97 125.14 50.64 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 166.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 85.6 m -99.54 146.52 26.32 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 168.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 20.9 p -146.67 161.3 40.87 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 118.59 0.632 . . . . 0.0 110.643 164.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -129.63 106.2 8.57 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.494 1.518 . . . . 0.0 108.556 -176.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 26.0 mm -80.45 116.38 24.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 O-C-N 122.011 -0.43 . . . . 0.0 109.937 -169.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.5 mt -92.37 -32.46 14.95 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 117.875 -1.06 . . . . 0.0 112.951 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -165.8 163.58 18.8 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 118.953 0.797 . . . . 0.0 109.245 -173.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.09 -176.6 53.86 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.985 1.279 . . . . 0.0 111.825 -176.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.578 ' HE2' HD12 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -139.29 139.1 37.25 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 -171.482 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 76.8 t -136.13 158.24 38.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -131.72 97.44 4.21 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 127.155 2.182 . . . . 0.0 106.799 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . 0.727 0.1 OUTLIER -93.34 71.2 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 C-N-CA 130.822 3.649 . . . . 0.0 118.414 163.322 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 14.9 m -73.46 113.32 10.42 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 164.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.6 p -67.93 169.97 8.99 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 171.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -65.25 -22.3 66.85 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.786 -1.196 . . . . 0.0 110.08 170.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -77.73 3.39 14.19 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.286 1.834 . . . . 0.0 111.481 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.69 -9.1 8.87 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.01 1.29 . . . . 0.0 113.053 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -66.07 108.98 2.41 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 119.502 1.651 . . . . 0.0 106.834 171.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -88.64 131.78 34.84 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 124.214 0.946 . . . . 0.0 109.705 179.13 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.6 m-30 -115.54 85.08 2.21 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 127.685 2.394 . . . . 0.0 105.896 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.547 HG13 ' HE3' ' A' ' 47' ' ' LYS . 71.3 t -66.35 128.34 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 N-CA-C 103.981 -2.6 . . . . 0.0 103.981 156.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.7 pt -128.6 138.88 53.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 169.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -123.97 179.9 4.66 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.188 1.795 . . . . 0.0 107.137 -170.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.0 pttp -73.67 60.85 0.71 Allowed 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 124.988 1.315 . . . . 0.0 112.92 -173.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 164.41 34.36 0.02 OUTLIER Glycine 0 C--N 1.317 -0.524 0 O-C-N 120.15 -1.594 . . . . 0.0 112.458 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -122.18 139.37 53.83 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 118.961 1.38 . . . . 0.0 107.808 175.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.9 tp -94.57 141.09 29.0 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 164.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.5 t -126.35 139.65 51.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 175.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 46.2 m -120.71 102.64 8.53 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 165.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -70.41 151.61 95.64 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 169.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -75.74 -164.53 0.25 Allowed 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.692 2.928 . . . . 0.0 110.077 175.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -98.44 129.14 45.06 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 161.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.52 83.9 0.47 Allowed Glycine 0 CA--C 1.535 1.305 0 C-N-CA 127.494 2.473 . . . . 0.0 113.984 -178.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.6 tt -142.87 130.61 21.46 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 126.909 2.084 . . . . 0.0 108.213 171.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.83 128.09 55.65 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.977 0.911 . . . . 0.0 108.867 171.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 27.4 p -149.24 173.81 13.07 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.634 -0.667 . . . . 0.0 111.088 178.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.19 -178.04 4.86 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 118.386 -0.816 . . . . 0.0 111.079 166.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -155.46 90.4 1.25 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.801 1.24 . . . . 0.0 107.785 172.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -83.86 118.42 23.95 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 172.024 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.5 t -88.58 94.97 4.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 103.779 -2.674 . . . . 0.0 103.779 167.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.578 HD12 ' HE2' ' A' ' 47' ' ' LYS . 26.7 mt -71.02 -29.23 65.11 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 117.522 -1.228 . . . . 0.0 110.109 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -149.01 148.37 26.91 Favored Pre-proline 0 N--CA 1.453 -0.303 0 C-N-CA 125.143 1.377 . . . . 0.0 108.988 175.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -59.88 105.81 0.29 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 124.559 3.506 . . . . 0.0 109.602 -167.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.9 p -84.36 149.41 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -174.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.7 130.06 46.63 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 164.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.79 146.91 34.69 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 174.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -73.17 127.96 34.11 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 148.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -113.64 164.17 14.03 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 166.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -153.37 150.51 28.93 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 165.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 93.7 mt -101.63 161.45 13.64 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.641 1.176 . . . . 0.0 108.209 177.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 11.1 p90 . . . . . 0 C--O 1.246 0.915 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 159.868 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.1 ttt . . . . . 0 N--CA 1.47 0.527 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -164.42 164.9 21.93 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 -174.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.7 t -58.96 140.49 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 168.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.2 tttt -129.78 89.71 2.86 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.6 mt -86.93 143.9 10.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 176.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -149.11 178.97 8.25 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 122.625 0.37 . . . . 0.0 110.074 154.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . 0.37 0.5 OUTLIER -128.5 85.01 61.47 Favored Pre-proline 0 N--CA 1.451 -0.411 0 O-C-N 121.179 -0.951 . . . . 0.0 111.855 -178.917 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -81.31 168.7 16.47 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 125.163 3.908 . . . . 0.0 113.517 -169.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.7 t -66.22 143.66 98.42 Favored Pre-proline 0 C--N 1.331 -0.202 0 C-N-CA 126.584 1.954 . . . . 0.0 109.188 172.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -71.01 -21.27 27.91 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.741 1.628 . . . . 0.0 112.166 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.84 -60.36 3.95 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.444 1.098 . . . . 0.0 109.131 -178.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.7 tttt -58.92 -29.7 67.29 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.008 -1.057 . . . . 0.0 111.606 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -71.3 -38.4 71.78 Favored 'General case' 0 C--N 1.334 -0.107 0 O-C-N 121.367 -0.833 . . . . 0.0 110.854 177.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -56.56 -53.55 56.22 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 119.426 1.012 . . . . 0.0 109.142 167.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -57.2 -39.78 76.11 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.266 0.626 . . . . 0.0 111.489 -174.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.43 -10.77 2.31 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.28 2.232 . . . . 0.0 115.266 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 63.4 m 57.32 43.85 22.76 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.929 1.292 . . . . 0.0 111.715 -177.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.428 ' HA ' ' CD2' ' A' ' 21' ' ' TRP . 54.8 t -56.05 -36.49 45.09 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 C-N-CA 126.699 2.0 . . . . 0.0 111.051 174.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -61.52 -13.49 21.69 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 176.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.5 mtpp -95.88 -10.98 27.47 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.467 1.107 . . . . 0.0 111.474 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.428 ' CD2' ' HA ' ' A' ' 18' ' ' VAL . 30.4 m0 -72.86 163.42 68.43 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 178.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -66.7 137.71 46.69 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 121.752 1.635 . . . . 0.0 110.736 170.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 81.4 mt -72.46 152.8 7.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 161.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 14.6 t90 -137.81 150.93 47.61 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 161.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -151.18 156.84 41.78 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.738 1.215 . . . . 0.0 110.465 -178.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.554 ' HE3' ' CE2' ' A' ' 31' ' ' PHE . 16.7 tptp -153.71 162.2 41.45 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 124.598 1.159 . . . . 0.0 108.67 -167.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -88.41 -178.07 5.78 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.126 0.971 . . . . 0.0 108.744 175.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.5 p -68.77 8.72 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 127.718 2.407 . . . . 0.0 113.16 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.3 p -85.93 124.71 32.7 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 126.417 1.887 . . . . 0.0 111.12 -173.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -79.28 152.62 30.44 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 124.288 0.993 . . . . 0.0 109.713 175.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.554 ' CE2' ' HE3' ' A' ' 26' ' ' LYS . 11.9 p90 -156.51 -170.83 3.47 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 176.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -124.7 121.0 33.43 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 127.542 2.337 . . . . 0.0 107.233 172.271 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 43.9 t-105 -109.17 155.77 20.65 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 123.743 0.652 . . . . 0.0 111.012 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -122.61 133.24 54.54 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.68 1.592 . . . . 0.0 110.437 175.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -105.37 108.17 19.55 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 175.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -101.14 4.11 41.78 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.006 1.322 . . . . 0.0 111.061 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.84 163.89 36.82 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 128.112 2.565 . . . . 0.0 108.055 170.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.66 142.0 57.59 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 175.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -147.36 136.99 22.84 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 -176.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.8 m -114.96 121.25 42.59 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 174.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 9.1 p -121.85 145.07 48.44 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.448 0.642 . . . . 0.0 109.357 173.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -121.69 109.1 14.33 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 127.401 2.28 . . . . 0.0 107.032 -175.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.6 mm -69.37 138.49 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 124.831 1.252 . . . . 0.0 107.887 175.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 mp -125.09 -32.19 3.02 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 122.795 0.438 . . . . 0.0 110.845 176.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -138.87 171.75 13.87 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.768 0.827 . . . . 0.0 108.875 168.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.71 -179.77 30.43 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 116.608 1.403 . . . . 0.0 116.608 167.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.821 ' HE3' HG13 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -140.07 151.39 45.35 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 127.924 2.49 . . . . 0.0 111.485 170.864 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.631 HG13 ' CG1' ' A' ' 60' ' ' ILE 0.421 0.2 OUTLIER -146.43 146.91 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 1 C-N-CA 133.253 4.621 . . . . 0.0 113.288 -174.914 . . . . . . . . 5 4 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -120.16 149.91 41.48 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.242 145.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.3 t -127.2 101.08 7.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 170.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.5 m -79.32 112.77 16.88 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 166.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.417 ' HA ' ' HB3' ' A' ' 74' ' ' CYS . 26.4 p -73.58 161.59 30.16 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 165.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -55.97 -35.58 66.89 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.801 -0.562 . . . . 0.0 111.182 -175.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -68.88 -1.79 8.1 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.054 1.742 . . . . 0.0 113.456 -174.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.66 -14.11 57.78 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 125.802 1.668 . . . . 0.0 112.472 172.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.2 mttt -71.35 123.01 21.34 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 118.809 1.304 . . . . 0.0 109.729 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.449 ' HD2' ' H ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -85.82 147.4 26.32 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 168.291 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -132.12 105.88 7.64 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 170.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.821 HG13 ' HE3' ' A' ' 47' ' ' LYS . 70.9 t -74.94 117.4 19.09 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 172.009 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.631 ' CG1' HG13 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -108.99 141.09 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-N 118.852 0.751 . . . . 0.0 109.956 175.804 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -145.59 -175.62 4.8 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-O 122.114 0.959 . . . . 0.0 112.607 171.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.3 pttm -57.49 65.24 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 130.528 3.531 . . . . 0.0 112.8 177.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 156.64 2.12 0.1 OUTLIER Glycine 0 CA--C 1.531 1.091 0 CA-C-O 117.323 -1.821 . . . . 0.0 115.636 -158.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -129.33 110.39 11.89 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.899 2.079 . . . . 0.0 107.286 177.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.6 tp -74.82 143.13 44.08 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 120.154 -1.591 . . . . 0.0 107.407 167.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 32.9 t -133.49 128.84 55.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 119.422 1.01 . . . . 0.0 109.676 175.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.8 m -99.16 140.21 33.66 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 160.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -104.83 156.56 35.81 Favored Pre-proline 0 C--O 1.236 0.39 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 163.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -79.65 175.33 10.72 Favored 'Trans proline' 0 N--CA 1.445 -1.348 0 N-CA-C 108.773 -1.28 . . . . 0.0 108.773 174.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -81.81 94.04 6.97 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 166.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 114.46 85.73 1.35 Allowed Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.67 1.605 . . . . 0.0 111.789 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 56.9 tp -162.0 135.08 6.11 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.314 1.557 . . . . 0.0 110.301 170.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.68 85.69 2.41 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 120.11 1.323 . . . . 0.0 112.381 -174.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.417 ' HB3' ' HA ' ' A' ' 52' ' ' THR . 61.0 m -121.81 165.82 15.28 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 119.627 -1.921 . . . . 0.0 110.766 -173.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 32' ' ' ASP . 0.3 OUTLIER -69.6 163.07 26.32 Favored 'General case' 0 CA--C 1.515 -0.4 0 O-C-N 121.984 -0.447 . . . . 0.0 111.072 177.033 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.4 ' CZ3' HG21 ' A' ' 48' ' ' VAL . 4.8 m95 -138.07 102.12 4.6 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.041 1.736 . . . . 0.0 106.875 173.037 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.32 100.56 12.38 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 168.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 80' ' ' GLU . 1.9 t -80.24 92.91 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 103.404 -2.814 . . . . 0.0 103.404 172.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.626 HD12 ' HE2' ' A' ' 47' ' ' LYS . 82.5 mt -69.0 -29.11 67.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.171 178.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.647 ' O ' HG12 ' A' ' 78' ' ' VAL . 3.2 mt-10 -141.06 165.62 28.05 Favored Pre-proline 0 N--CA 1.452 -0.373 0 C-N-CA 125.292 1.437 . . . . 0.0 108.884 176.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -61.35 116.87 3.68 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 123.899 3.066 . . . . 0.0 110.786 169.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.9 p -110.41 143.36 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 -177.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -124.99 29.66 6.08 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.755 0.707 . . . . 0.0 112.83 -168.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.27 161.33 4.37 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.338 1.455 . . . . 0.0 113.28 -159.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.3 m80 -89.05 130.1 35.57 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 163.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -121.39 154.52 36.39 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.42 1.009 . . . . 0.0 108.707 172.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.419 ' HB2' ' CE3' ' A' ' 21' ' ' TRP . 57.1 t30 -143.98 116.69 8.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 17.9 mt -71.77 140.07 49.31 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 125.417 1.487 . . . . 0.0 107.092 172.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.248 0.982 0 CA-C-O 117.143 -1.408 . . . . 0.0 109.316 172.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.9 mmt . . . . . 0 N--CA 1.476 0.848 0 CA-C-O 120.793 0.33 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.433 ' HG2' ' H ' ' A' ' 3' ' ' VAL . 18.6 tt0 55.66 -164.89 0.13 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.567 1.547 . . . . 0.0 109.961 -174.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.433 ' H ' ' HG2' ' A' ' 2' ' ' GLU . 3.2 p -70.39 142.13 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 176.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -134.05 152.05 51.68 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.444 1.498 . . . . 0.0 108.009 172.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 93.6 mt -131.71 137.06 55.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 165.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -141.18 172.74 12.27 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 117.841 0.291 . . . . 0.0 110.982 160.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.22 84.94 6.34 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 171.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -76.01 176.55 9.88 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.883 3.056 . . . . 0.0 112.188 -169.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.442 HG22 ' H ' ' A' ' 9' ' ' THR . 0.0 OUTLIER -67.66 144.48 97.6 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 170.302 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -70.27 -25.25 26.43 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.857 2.371 . . . . 0.0 111.887 172.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -75.32 -45.17 41.3 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 119.357 0.981 . . . . 0.0 110.362 -171.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.96 -44.14 70.49 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.912 0.778 . . . . 0.0 110.019 174.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.3 mt -62.24 -27.53 69.06 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 118.924 -0.56 . . . . 0.0 112.233 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -63.21 -47.59 81.9 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 119.748 1.158 . . . . 0.0 109.106 172.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -68.0 -43.2 79.4 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 124.402 1.064 . . . . 0.0 110.088 -169.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 18.5 mt -53.36 -20.5 4.53 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.183 0.993 . . . . 0.0 112.016 174.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.8 m 69.85 45.7 0.73 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 127.496 2.318 . . . . 0.0 109.398 172.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.7 t -55.19 -32.67 28.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 126.105 1.762 . . . . 0.0 112.014 -175.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -65.6 -21.76 66.61 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.634 -1.291 . . . . 0.0 113.413 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.3 mttt -78.73 -15.13 58.83 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.019 0.928 . . . . 0.0 110.979 175.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 16.3 m0 -75.68 159.99 80.14 Favored Pre-proline 0 N--CA 1.445 -0.705 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 176.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -64.97 139.14 60.3 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 121.545 1.497 . . . . 0.0 111.777 175.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 57.7 mt -76.21 147.69 7.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 163.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.473 ' CZ3' ' HE3' ' A' ' 84' ' ' LYS . 9.0 t90 -147.39 149.59 33.04 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 164.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -133.36 166.31 22.8 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 127.262 2.225 . . . . 0.0 106.351 -177.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -148.98 163.85 36.3 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 120.572 -1.33 . . . . 0.0 108.803 163.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.74 -172.88 3.19 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 125.348 1.459 . . . . 0.0 109.916 -178.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.3 p -77.34 -5.09 7.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 125.772 1.629 . . . . 0.0 113.636 178.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.97 176.67 4.85 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.02 1.328 . . . . 0.0 110.886 176.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -137.45 157.34 46.77 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.141 -0.974 . . . . 0.0 109.324 -174.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -164.82 -164.3 0.79 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.118 1.367 . . . . 0.0 108.88 -168.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -133.12 160.91 35.83 Favored 'General case' 0 C--O 1.242 0.703 0 O-C-N 120.89 -1.131 . . . . 0.0 108.822 165.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 67.3 t-105 -135.74 146.73 47.98 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.746 0.818 . . . . 0.0 109.811 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.415 ' CE2' ' HD3' ' A' ' 73' ' ' ARG . 1.2 t80 -115.69 94.56 4.74 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.712 1.605 . . . . 0.0 107.059 -177.251 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -65.72 115.01 5.43 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 168.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -108.53 -1.0 20.05 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.408 1.083 . . . . 0.0 111.734 174.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.415 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -144.06 171.42 14.28 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 127.542 2.337 . . . . 0.0 112.331 174.871 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -62.95 108.88 1.3 Allowed 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 103.765 -2.68 . . . . 0.0 103.765 168.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -126.94 80.87 1.98 Allowed 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 -173.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 81.7 m -64.51 152.21 42.38 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 25.4 p -144.93 150.01 36.25 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.458 163.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -122.6 108.27 12.92 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.572 1.549 . . . . 0.0 106.839 175.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.3 mm -64.54 138.21 23.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 127.217 2.207 . . . . 0.0 107.601 172.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 mp -128.05 -26.38 2.89 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 123.28 0.362 . . . . 0.0 111.188 173.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -153.46 158.15 40.94 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.634 1.174 . . . . 0.0 108.188 172.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.69 -178.93 52.38 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.321 0.962 . . . . 0.0 112.111 -175.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.79 146.1 27.87 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -168.181 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.3 t -137.31 156.57 33.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.319 0.581 . . . . 0.0 109.773 175.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -119.39 110.51 17.03 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.612 1.965 . . . . 0.0 106.872 160.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.7 t -94.16 111.32 25.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 170.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.5 m -112.22 113.19 25.29 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -173.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.9 p -75.4 170.16 16.64 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 122.122 0.963 . . . . 0.0 111.931 -170.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -60.35 -29.9 69.2 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.342 167.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -82.26 8.98 9.71 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.688 1.595 . . . . 0.0 111.547 175.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.1 -2.06 21.25 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 125.55 1.548 . . . . 0.0 114.814 175.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -64.17 136.98 57.72 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.4 mttp -93.33 153.13 18.73 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 121.892 0.853 . . . . 0.0 110.089 162.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -125.73 100.62 6.5 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 102.801 -3.037 . . . . 0.0 102.801 162.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.0 t -81.24 142.73 13.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 167.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 pt -148.01 119.77 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.488 0 C-N-CA 124.314 1.046 . . . . 0.0 108.197 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -80.07 177.44 8.93 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-O 122.196 0.998 . . . . 0.0 110.918 171.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.1 pttt -68.01 45.5 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 131.366 3.866 . . . . 0.0 115.103 178.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -174.41 -7.06 0.02 OUTLIER Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.033 0.825 . . . . 0.0 113.417 178.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -79.16 99.87 7.18 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.102 1.361 . . . . 0.0 111.337 -173.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.3 tp -64.36 136.84 57.52 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.95 1.25 . . . . 0.0 107.636 177.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.1 t -121.32 154.68 25.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 123.865 0.866 . . . . 0.0 108.952 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 67.0 m -143.65 121.36 11.87 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 160.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -87.78 164.58 33.75 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 126.483 1.913 . . . . 0.0 108.879 169.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -79.68 174.8 11.3 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 CA-C-O 122.974 1.156 . . . . 0.0 110.469 170.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.415 ' HG3' ' HA ' ' A' ' 37' ' ' THR . 36.0 tttm -80.18 88.73 5.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.446 -1.707 . . . . 0.0 106.887 173.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 116.66 85.1 1.13 Allowed Glycine 0 CA--C 1.527 0.797 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -176.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 62.1 tp -147.2 141.06 25.8 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.198 1.399 . . . . 0.0 108.848 166.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.415 ' HD3' ' CE2' ' A' ' 34' ' ' TYR . 3.5 ptt85 -136.93 103.89 5.3 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.417 1.487 . . . . 0.0 108.453 -176.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 86.0 m -148.61 164.42 34.34 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 125.264 1.426 . . . . 0.0 110.103 -175.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.58 163.01 22.18 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 124.452 1.101 . . . . 0.0 112.035 177.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -148.2 99.59 3.07 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.575 1.95 . . . . 0.0 107.372 -168.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 42.7 tttp -110.96 111.8 23.18 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 -176.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.1 t -87.34 111.68 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 104.264 -2.495 . . . . 0.0 104.264 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 20.6 mt -91.1 -24.04 20.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 118.782 -0.628 . . . . 0.0 109.836 177.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -148.75 152.36 37.31 Favored Pre-proline 0 C--O 1.236 0.384 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 168.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.41 91.69 0.77 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.377 2.718 . . . . 0.0 111.514 -153.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.8 p -69.51 105.82 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.017 -165.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -91.08 116.63 28.95 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 105.215 -2.142 . . . . 0.0 105.215 168.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.473 ' HE3' ' CZ3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -127.58 172.06 11.07 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 122.306 1.051 . . . . 0.0 108.382 175.277 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -113.22 122.77 48.47 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 102.578 -3.119 . . . . 0.0 102.578 168.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -117.89 157.03 27.4 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -152.4 134.83 15.19 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 118.71 0.686 . . . . 0.0 110.024 176.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 65.8 mt -94.45 125.48 39.13 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.401 1.88 . . . . 0.0 107.149 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.4 p90 . . . . . 0 C--O 1.247 0.968 0 C-N-CA 123.96 0.904 . . . . 0.0 110.361 -171.509 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.7 mtp . . . . . 0 N--CA 1.47 0.526 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -83.07 146.83 28.48 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.27 -0.893 . . . . 0.0 110.474 164.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 94.2 t 53.04 106.77 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 130.872 3.669 . . . . 0.0 112.633 173.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -100.05 119.49 38.38 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.965 0.906 . . . . 0.0 109.148 -173.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.3 mt -139.81 132.47 35.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 C-N-CA 124.792 1.237 . . . . 0.0 108.022 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -143.97 176.66 9.11 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.483 1.513 . . . . 0.0 110.271 171.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.76 85.77 5.2 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 124.562 1.145 . . . . 0.0 108.151 173.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.09 157.64 60.92 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.442 2.095 . . . . 0.0 111.881 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.9 t -57.42 144.3 71.83 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 124.508 1.123 . . . . 0.0 109.19 169.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.58 -31.21 27.22 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.538 1.492 . . . . 0.0 112.735 -177.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -59.84 -42.72 94.21 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 119.407 1.003 . . . . 0.0 110.729 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.1 tptt -56.49 -41.37 76.53 Favored 'General case' 0 C--O 1.226 -0.167 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -69.9 -32.07 70.19 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.872 1.269 . . . . 0.0 111.511 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -61.46 -49.11 78.12 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 168.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -62.73 -47.99 81.19 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.373 0.533 . . . . 0.0 111.047 -176.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.7 mt -58.78 -7.34 0.97 Allowed 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 125.955 1.702 . . . . 0.0 112.662 -175.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.7 m 74.03 29.22 1.4 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.17 1.788 . . . . 0.0 110.402 165.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.9 t -57.01 -27.45 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 126.371 1.868 . . . . 0.0 112.499 -172.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -59.45 -28.41 66.94 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.828 1.194 . . . . 0.0 113.015 172.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.6 mttm -84.69 -13.21 52.09 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.632 1.173 . . . . 0.0 111.066 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.502 ' CE3' ' HB2' ' A' ' 87' ' ' ASN . 36.5 m0 -74.8 158.9 84.2 Favored Pre-proline 0 N--CA 1.448 -0.527 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -175.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.58 136.79 43.97 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 121.531 1.487 . . . . 0.0 111.44 175.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.1 mt -72.22 149.96 8.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 125.197 1.399 . . . . 0.0 109.332 166.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.432 ' CZ3' ' HE3' ' A' ' 84' ' ' LYS . 87.7 t90 -142.23 112.23 6.92 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 160.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.14 168.4 12.8 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.975 1.31 . . . . 0.0 110.576 164.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.3 tptt -155.94 162.45 40.38 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 120.647 -1.283 . . . . 0.0 109.841 165.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.27 170.59 15.27 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.204 1.001 . . . . 0.0 111.27 172.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.9 p -81.16 71.18 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 127.205 2.202 . . . . 0.0 109.463 175.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.91 -171.14 2.66 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 120.972 -1.08 . . . . 0.0 109.708 -177.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -130.89 154.14 48.39 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.003 -1.06 . . . . 0.0 108.845 170.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -160.6 -167.67 1.93 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.718 1.207 . . . . 0.0 108.511 173.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 4.6 p-10 -121.1 152.52 38.59 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 125.012 1.325 . . . . 0.0 107.896 169.068 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 25.7 t-105 -136.26 151.97 50.22 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.557 0.218 . . . . 0.0 111.002 178.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.435 ' CD2' ' HB3' ' A' ' 73' ' ' ARG . 1.4 t80 -124.78 129.63 50.83 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.632 1.573 . . . . 0.0 106.844 -175.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -111.29 112.39 24.13 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 175.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.39 2.8 19.23 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 125.148 1.379 . . . . 0.0 112.723 -176.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.8 p -145.9 171.17 15.21 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 130.556 3.543 . . . . 0.0 107.856 166.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -63.36 149.82 44.89 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -146.48 115.2 6.83 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 167.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.0 m -88.52 141.95 28.11 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 167.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.495 ' SG ' ' HB2' ' A' ' 84' ' ' LYS . 0.7 OUTLIER -149.97 150.18 31.45 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.032 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -125.36 112.07 15.9 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.473 1.509 . . . . 0.0 108.36 -177.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 8.5 mm -69.77 120.01 16.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 128.593 2.757 . . . . 0.0 107.601 174.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 mp -110.36 -24.77 10.45 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 178.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -160.14 157.32 28.22 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.898 1.679 . . . . 0.0 107.913 177.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 82' ' ' VAL . . . 82.55 177.9 52.13 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.597 2.046 . . . . 0.0 112.699 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.78 143.09 33.28 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.795 -0.827 . . . . 0.0 109.18 -167.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 86.9 t -138.12 156.46 30.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -124.52 118.23 26.13 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 160.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.5 t -94.01 106.8 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 169.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.4 m -93.04 105.95 17.98 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.439 ' HA ' ' SG ' ' A' ' 74' ' ' CYS . 18.0 p -69.33 168.6 13.97 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 121.792 -0.567 . . . . 0.0 110.542 -178.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -63.95 -32.8 74.46 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 170.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -68.59 -6.7 27.12 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 121.014 -1.054 . . . . 0.0 109.911 171.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.91 -3.36 70.45 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 125.943 1.735 . . . . 0.0 112.7 170.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.1 tttp -70.02 135.02 48.89 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-N 120.196 1.998 . . . . 0.0 107.964 -176.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.82 105.11 17.17 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.512 174.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -79.56 107.88 12.68 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 164.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.3 t -77.21 147.19 7.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 161.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 pt -148.59 121.78 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 C-N-CA 124.661 1.184 . . . . 0.0 108.499 173.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -101.75 175.4 5.56 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 122.469 1.128 . . . . 0.0 109.764 172.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.5 pttp -64.51 54.58 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 131.237 3.815 . . . . 0.0 116.363 -171.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -178.65 -16.15 0.03 OUTLIER Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.181 1.372 . . . . 0.0 113.42 176.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -77.76 103.63 7.81 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.8 1.3 . . . . 0.0 109.1 -177.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.3 tp -71.35 143.93 50.06 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 120.132 1.333 . . . . 0.0 108.319 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 45.1 t -124.14 154.87 31.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 125.074 1.35 . . . . 0.0 108.69 -174.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.9 m -146.09 103.18 3.71 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.626 1.17 . . . . 0.0 108.196 170.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -74.43 155.13 87.79 Favored Pre-proline 0 C--O 1.235 0.317 0 O-C-N 121.489 -0.757 . . . . 0.0 109.581 171.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -86.87 177.4 4.1 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.715 2.277 . . . . 0.0 110.699 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -81.26 90.6 6.12 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 164.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 110.25 90.33 2.03 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.415 1.483 . . . . 0.0 110.699 178.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 67.2 tp -156.02 152.56 28.26 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.721 2.008 . . . . 0.0 108.936 162.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.435 ' HB3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -137.36 126.07 23.88 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 119.215 0.916 . . . . 0.0 109.76 165.046 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.439 ' SG ' ' HA ' ' A' ' 52' ' ' THR . 84.1 m -145.49 170.01 17.23 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.127 1.771 . . . . 0.0 109.268 -178.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.418 ' HA ' ' HA ' ' A' ' 32' ' ' ASP . 0.6 OUTLIER -77.56 159.93 28.94 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 121.352 -0.842 . . . . 0.0 110.18 177.373 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -134.23 102.69 5.46 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.825 1.65 . . . . 0.0 107.68 177.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -100.78 112.27 24.65 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 174.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.0 t -84.68 106.63 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 173.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 95.6 mt -85.05 -26.03 27.26 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-O 118.878 -0.582 . . . . 0.0 109.743 175.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -147.69 149.35 33.41 Favored Pre-proline 0 N--CA 1.464 0.262 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 174.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -64.55 95.26 0.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.594 2.863 . . . . 0.0 110.673 -169.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.41 ' HA ' ' HA3' ' A' ' 46' ' ' GLY . 4.5 p -71.28 149.88 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.75 -174.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -126.98 112.25 15.04 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 104.232 -2.507 . . . . 0.0 104.232 164.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.495 ' HB2' ' SG ' ' A' ' 41' ' ' CYS . 0.0 OUTLIER -127.91 121.19 29.35 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.244 0.545 . . . . 0.0 110.651 176.725 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -69.32 111.08 4.99 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -101.3 163.74 12.12 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 121.013 1.733 . . . . 0.0 110.892 -176.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.502 ' HB2' ' CE3' ' A' ' 21' ' ' TRP . 44.2 t30 -153.74 115.51 4.25 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.862 0.865 . . . . 0.0 109.839 171.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.1 mt -66.47 145.63 55.45 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.922 1.289 . . . . 0.0 109.172 173.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.3 p90 . . . . . 0 C--O 1.251 1.143 0 C-N-CA 125.767 1.627 . . . . 0.0 107.852 172.276 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.7 tpp . . . . . 0 N--CA 1.468 0.426 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -81.17 151.34 28.27 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 120.99 -1.069 . . . . 0.0 109.381 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.7 t 44.36 78.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 127.374 2.27 . . . . 0.0 112.098 164.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 51.0 tttt -73.32 101.58 3.47 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.056 -0.974 . . . . 0.0 108.858 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 60.5 mt -103.22 112.67 37.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 104.605 -2.369 . . . . 0.0 104.605 174.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -142.38 178.64 7.44 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 122.829 0.451 . . . . 0.0 111.903 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -125.08 85.05 58.48 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 123.135 0.574 . . . . 0.0 111.387 -165.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.24 153.7 18.7 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.264 2.643 . . . . 0.0 112.998 -173.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.2 t -57.07 144.28 69.59 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 124.417 1.087 . . . . 0.0 109.752 170.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -71.39 -26.26 20.65 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 121.487 1.458 . . . . 0.0 113.003 -176.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -65.81 -42.86 90.14 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.17 0.895 . . . . 0.0 110.102 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.6 tptt -53.57 -45.56 69.97 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 123.461 0.705 . . . . 0.0 109.6 176.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.05 -31.98 73.25 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 121.729 -0.607 . . . . 0.0 111.341 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.56 -50.21 68.15 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 172.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -57.89 -50.78 72.17 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.661 1.184 . . . . 0.0 111.822 -176.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 55.4 mt -56.82 -8.96 0.68 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.29 1.836 . . . . 0.0 112.823 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.5 m 75.21 27.51 1.1 Allowed 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 128.124 2.57 . . . . 0.0 111.276 167.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.9 t -54.21 -28.61 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 128.48 2.712 . . . . 0.0 112.583 177.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.97 -29.31 70.71 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 120.239 1.382 . . . . 0.0 112.49 173.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.4 mtpp -82.51 -15.56 51.95 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.246 1.018 . . . . 0.0 112.205 176.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 38.2 m0 -69.32 165.17 42.25 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 119.169 0.895 . . . . 0.0 109.272 -173.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -67.39 141.73 57.3 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 121.464 1.443 . . . . 0.0 112.066 174.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.1 mt -88.56 142.97 12.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 125.909 1.683 . . . . 0.0 106.839 169.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.472 ' CE3' ' HE2' ' A' ' 84' ' ' LYS . 44.1 t90 -148.75 133.01 17.42 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 165.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.78 174.59 7.41 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.051 1.74 . . . . 0.0 107.677 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -154.21 161.77 41.62 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 173.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -73.68 170.53 15.06 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.625 0.726 . . . . 0.0 111.315 169.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -80.88 74.0 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 125.136 1.375 . . . . 0.0 108.571 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.0 t -141.23 -170.71 3.13 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.417 1.887 . . . . 0.0 107.824 -176.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.94 149.7 31.64 Favored 'General case' 0 CA--C 1.518 -0.263 0 O-C-N 120.386 -1.446 . . . . 0.0 111.733 -173.178 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -163.23 -164.76 0.98 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.248 1.819 . . . . 0.0 107.214 -171.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -130.02 161.79 30.16 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.095 -1.003 . . . . 0.0 109.184 170.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 12.6 t-105 -131.87 158.43 41.36 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 120.965 0.412 . . . . 0.0 110.471 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -132.73 96.24 3.77 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 176.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -72.05 123.27 22.45 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 176.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.38 1.02 6.32 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -171.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 p -140.87 174.42 10.53 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.553 2.341 . . . . 0.0 108.401 163.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -67.78 136.85 54.84 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -142.61 102.53 4.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -177.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.7 m -84.84 140.44 31.17 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 169.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 14.4 p -144.94 162.6 36.49 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 118.503 0.592 . . . . 0.0 111.577 162.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -124.64 111.85 16.1 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 126.058 1.743 . . . . 0.0 107.998 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 25.6 mm -72.8 111.97 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 128.798 2.839 . . . . 0.0 107.757 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.8 mt -92.01 -37.49 12.79 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 122.478 0.311 . . . . 0.0 111.235 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -162.44 165.22 26.56 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.631 0.772 . . . . 0.0 108.988 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.447 ' HA3' ' HA ' ' A' ' 82' ' ' VAL . . . 89.88 -176.57 42.67 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 124.246 0.927 . . . . 0.0 111.232 -177.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.495 ' HE2' HD12 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -147.48 147.35 30.08 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 117.538 0.669 . . . . 0.0 110.415 -179.424 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.6 t -139.64 156.34 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -178.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -124.37 133.7 53.34 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 122.589 1.185 . . . . 0.0 108.491 158.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.539 HG23 ' HB2' ' A' ' 58' ' ' TYR 0.627 0.1 OUTLIER -108.61 80.53 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.204 1 C-N-CA 133.629 4.771 . . . . 0.0 117.001 165.81 . . . . . . . . 5 4 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 82.9 m -71.04 122.7 20.53 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.078 162.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 74.9 p -82.52 -173.81 4.82 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.377 1.071 . . . . 0.0 111.811 174.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -62.77 -37.83 88.2 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.077 0.551 . . . . 0.0 110.255 170.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -63.59 -27.09 69.0 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.034 0.933 . . . . 0.0 111.677 177.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 103.86 -10.86 52.61 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-O 118.965 -0.908 . . . . 0.0 113.43 175.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.7 mttm -61.55 129.17 39.81 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 118.422 1.111 . . . . 0.0 108.78 173.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.38 103.84 16.48 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.186 0.994 . . . . 0.0 108.795 177.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.539 ' HB2' HG23 ' A' ' 50' ' ' VAL . 10.2 m-30 -68.29 100.05 1.0 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 167.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.7 t -81.68 137.82 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 165.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.8 pt -140.4 90.75 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -85.86 170.33 12.48 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.71 1.604 . . . . 0.0 110.729 172.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.1 pttm -60.57 111.29 1.54 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.748 1.219 . . . . 0.0 111.152 -176.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 121.5 -23.13 7.63 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 125.858 1.694 . . . . 0.0 113.208 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.24 100.88 3.83 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.26 1.53 . . . . 0.0 108.096 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.3 tp -71.61 145.54 48.93 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.8 t -129.85 138.73 53.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 125.733 1.613 . . . . 0.0 107.46 -171.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 98.5 m -130.38 100.06 5.23 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 162.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -70.68 146.8 94.04 Favored Pre-proline 0 C--O 1.238 0.486 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 165.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -82.54 175.69 8.61 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 122.097 1.864 . . . . 0.0 110.901 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -76.7 90.64 3.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 113.326 -1.761 . . . . 0.0 107.289 171.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 110.92 93.17 2.18 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.7 tp -153.16 142.26 21.37 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.874 1.67 . . . . 0.0 109.517 168.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 -115.96 133.53 55.93 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.821 2.049 . . . . 0.0 108.382 168.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 12.8 p -162.03 175.52 11.69 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.656 1.582 . . . . 0.0 108.365 169.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.56 -175.43 1.05 Allowed 'General case' 0 C--O 1.212 -0.869 0 CA-C-O 117.777 -1.106 . . . . 0.0 113.075 167.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -154.91 105.72 2.59 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.273 2.229 . . . . 0.0 105.65 163.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.0 tttt -103.83 116.77 32.89 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 176.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.0 t -83.84 106.87 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 174.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.495 HD12 ' HE2' ' A' ' 47' ' ' LYS . 81.9 mt -83.75 -20.95 32.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.042 178.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -158.49 152.05 19.21 Favored Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 126.994 2.118 . . . . 0.0 108.238 169.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -63.35 102.57 0.34 Allowed 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.715 2.944 . . . . 0.0 110.846 -168.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.447 ' HA ' ' HA3' ' A' ' 46' ' ' GLY . 7.1 p -83.38 144.74 9.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 123.699 0.8 . . . . 0.0 110.616 -173.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -116.75 131.88 56.84 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 163.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.472 ' HE2' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -134.62 150.01 50.63 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 173.483 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -96.24 114.02 25.67 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 105.844 -1.909 . . . . 0.0 105.844 165.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -106.87 166.6 10.48 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 119.612 1.096 . . . . 0.0 111.089 -176.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -151.54 130.76 12.75 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.694 0.679 . . . . 0.0 110.453 165.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 26.2 mt -85.99 136.44 33.26 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 126.797 2.039 . . . . 0.0 109.177 176.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.8 p90 . . . . . 0 C--O 1.248 1.02 0 C-N-CA 125.368 1.467 . . . . 0.0 111.172 179.439 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.8 mtm . . . . . 0 N--CA 1.469 0.506 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.495 ' HG2' ' H ' ' A' ' 3' ' ' VAL . 15.1 tt0 52.84 -164.88 0.08 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.481 1.112 . . . . 0.0 109.834 -166.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.495 ' H ' ' HG2' ' A' ' 2' ' ' GLU . 82.7 t -102.43 158.08 4.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 126.496 1.919 . . . . 0.0 106.34 169.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -125.73 140.15 52.93 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 171.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.2 mt -137.52 146.5 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 175.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -154.57 -175.07 5.23 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.934 0.893 . . . . 0.0 109.861 160.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -118.96 80.75 18.58 Favored Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 169.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -67.7 172.12 11.03 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.896 2.397 . . . . 0.0 110.994 -177.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.414 HG23 ' H ' ' A' ' 12' ' ' LYS . 4.4 t -60.03 144.29 86.84 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 120.034 -0.666 . . . . 0.0 109.469 166.098 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.78 -20.18 46.26 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.149 1.899 . . . . 0.0 111.296 168.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -60.24 -50.38 73.89 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 119.772 1.169 . . . . 0.0 109.944 -177.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.414 ' H ' HG23 ' A' ' 9' ' ' THR . 47.8 tptt -55.73 -43.71 76.83 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 123.271 0.628 . . . . 0.0 109.762 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 70.6 mt -70.28 -33.66 71.83 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.732 1.213 . . . . 0.0 110.707 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -61.38 -32.3 72.22 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 120.429 -1.42 . . . . 0.0 110.92 168.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -73.75 -55.77 5.82 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 121.012 1.733 . . . . 0.0 109.722 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.1 tp -44.13 -66.25 0.41 Allowed 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 126.512 1.925 . . . . 0.0 112.682 -152.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.1 p 173.34 27.66 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 129.521 3.128 . . . . 0.0 109.784 150.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.1 t -59.92 -30.71 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 O-C-N 120.659 -1.275 . . . . 0.0 113.074 -160.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -60.01 -25.19 65.08 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 120.866 -1.146 . . . . 0.0 112.762 172.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.5 mttt -88.81 -31.4 18.35 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.498 1.519 . . . . 0.0 111.882 177.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.4 ' CD2' ' HB2' ' A' ' 87' ' ' ASN . 41.0 m0 -55.53 156.84 8.01 Favored Pre-proline 0 C--O 1.236 0.364 0 C-N-CA 124.021 0.928 . . . . 0.0 110.269 -175.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.91 138.59 40.96 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.465 1.443 . . . . 0.0 111.72 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.8 mt -71.48 150.96 8.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 164.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -137.35 134.86 36.48 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 159.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -141.15 120.71 13.27 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 126.374 1.87 . . . . 0.0 109.468 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.4 mmtt -109.49 152.28 25.63 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 123.733 0.813 . . . . 0.0 109.794 -178.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.5 pm0 -66.02 163.62 16.95 Favored 'General case' 0 N--CA 1.441 -0.876 0 O-C-N 124.915 1.385 . . . . 0.0 111.152 166.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.5 p -73.25 17.05 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 127.898 2.479 . . . . 0.0 113.966 -172.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.9 t -83.64 -171.27 3.49 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.89 1.276 . . . . 0.0 109.48 177.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -136.87 154.17 50.57 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 121.099 -1.0 . . . . 0.0 110.701 175.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -162.38 -164.45 1.04 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.826 1.651 . . . . 0.0 108.523 -172.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -135.28 154.91 51.39 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 126.068 1.747 . . . . 0.0 109.753 168.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 58.0 t-105 -138.16 127.58 24.72 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.059 0.544 . . . . 0.0 111.797 -174.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -80.95 130.48 35.04 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.421 1.089 . . . . 0.0 108.354 169.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -108.84 107.74 18.27 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.137 1.375 . . . . 0.0 107.312 166.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -114.08 21.2 15.02 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.812 0.845 . . . . 0.0 112.974 -179.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.41 167.0 31.48 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 127.445 2.298 . . . . 0.0 108.001 166.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -66.81 127.0 30.8 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -177.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -136.71 99.71 4.13 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -177.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 85.2 m -70.88 141.79 51.2 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 166.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.1 p -150.57 133.61 16.09 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 121.438 -0.788 . . . . 0.0 110.841 172.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -111.55 104.87 13.3 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 126.585 1.954 . . . . 0.0 109.362 -171.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 22.7 mm -76.65 114.92 17.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -175.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.79 -27.19 13.48 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 118.724 -0.655 . . . . 0.0 112.54 -178.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -158.84 153.01 23.76 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 119.492 1.042 . . . . 0.0 108.907 -178.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.64 -171.01 39.13 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.634 1.111 . . . . 0.0 113.035 -176.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.18 146.44 35.25 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.994 1.717 . . . . 0.0 108.171 -177.092 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.3 t -141.77 147.18 22.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -124.01 122.66 38.5 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 127.754 2.422 . . . . 0.0 107.175 167.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.6 t -110.76 117.24 54.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 46.3 m -111.02 120.55 42.74 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.484 ' HA ' ' SG ' ' A' ' 74' ' ' CYS . 27.2 p -73.43 162.36 29.39 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.517 0.675 . . . . 0.0 110.692 -179.386 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.83 -30.73 71.4 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.693 -0.63 . . . . 0.0 109.314 172.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -63.34 -15.65 58.0 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 127.342 2.257 . . . . 0.0 112.663 168.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 103.78 -12.25 53.33 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 125.235 1.398 . . . . 0.0 113.763 172.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -60.39 112.45 1.96 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 118.762 1.281 . . . . 0.0 108.45 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -70.12 153.64 42.9 Favored 'General case' 0 C--O 1.231 0.087 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 164.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -135.27 160.91 36.9 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 126.031 1.732 . . . . 0.0 106.724 159.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 88.7 t -123.06 150.22 26.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 170.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.5 pt -142.02 126.36 16.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 164.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -94.97 175.53 6.61 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.215 1.006 . . . . 0.0 109.241 173.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.0 pttm -62.4 68.54 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.664 1.985 . . . . 0.0 111.936 166.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 165.81 -9.44 0.07 OUTLIER Glycine 0 C--N 1.315 -0.618 0 CA-C-O 118.083 -1.399 . . . . 0.0 113.463 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -80.19 136.16 36.43 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.795 1.798 . . . . 0.0 106.545 167.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.7 tp -104.65 139.23 39.79 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 161.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 42.8 t -118.26 157.42 19.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 -177.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.7 m -138.14 101.62 4.46 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 168.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -72.8 153.35 91.26 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 173.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -84.06 173.26 9.15 Favored 'Trans proline' 0 N--CA 1.447 -1.226 0 C-N-CA 122.137 1.891 . . . . 0.0 110.682 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -80.63 90.42 5.75 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 164.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 118.24 78.32 0.62 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 123.812 0.72 . . . . 0.0 113.074 174.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 31.8 tp -147.49 154.77 41.18 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.97 1.308 . . . . 0.0 108.9 169.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.6 ptt85 -144.02 101.27 3.7 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 125.103 1.361 . . . . 0.0 107.664 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' CYS . . . . . 0.484 ' SG ' ' HA ' ' A' ' 52' ' ' THR . 73.7 m -145.21 161.97 38.25 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.801 0.84 . . . . 0.0 110.777 -170.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.2 152.36 38.39 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 122.846 0.458 . . . . 0.0 111.321 -173.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.8 m95 -127.89 97.1 4.69 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.732 2.013 . . . . 0.0 107.699 174.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.5 tptt -76.07 146.01 39.69 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 104.624 -2.361 . . . . 0.0 104.624 161.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.38 94.07 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 168.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.8 mt -67.08 -32.29 73.36 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 118.148 -0.93 . . . . 0.0 110.902 -177.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -134.64 144.78 52.22 Favored Pre-proline 0 N--CA 1.454 -0.232 0 CA-C-O 117.625 -1.178 . . . . 0.0 109.5 175.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -61.14 95.36 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.938 3.092 . . . . 0.0 109.872 -177.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.9 p -81.77 159.6 3.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 125.112 1.365 . . . . 0.0 110.049 -167.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.1 ttt85 -129.69 134.37 47.61 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 164.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.44 151.73 42.06 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 169.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -83.95 125.12 31.72 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 160.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -112.26 157.26 21.14 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 173.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.4 ' HB2' ' CD2' ' A' ' 21' ' ' TRP . 49.5 t30 -151.28 114.43 4.77 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 171.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 55.8 mt -65.96 143.65 57.26 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.192 1.397 . . . . 0.0 107.694 166.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 36.6 p90 . . . . . 0 C--O 1.255 1.359 0 CA-C-O 115.939 -1.981 . . . . 0.0 112.08 174.354 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 mtp . . . . . 0 N--CA 1.471 0.62 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -146.67 168.53 21.09 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.192 -0.942 . . . . 0.0 108.867 -174.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 p -73.53 125.63 32.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 124.489 1.115 . . . . 0.0 110.751 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -98.2 140.04 33.1 Favored 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 160.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.2 mt -126.28 142.54 42.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 168.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -155.35 177.45 11.34 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.473 ' HE2' ' OD2' ' A' ' 64' ' ' ASP . 3.6 mmtp -120.6 82.72 33.84 Favored Pre-proline 0 C--N 1.346 0.428 0 C-N-CA 124.894 1.278 . . . . 0.0 110.8 -177.098 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.584 ' HG2' HD21 ' A' ' 13' ' ' LEU . 71.9 Cg_endo -78.21 169.63 19.93 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 123.639 2.893 . . . . 0.0 111.603 -178.044 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.6 p -77.07 150.23 80.61 Favored Pre-proline 0 C--O 1.235 0.329 0 O-C-N 121.947 -0.471 . . . . 0.0 109.97 178.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -64.62 -32.36 58.25 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 121.661 1.574 . . . . 0.0 111.387 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -57.43 -53.12 61.79 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.766 0.826 . . . . 0.0 110.509 176.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.0 tptt -55.0 -40.08 69.73 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.102 0.561 . . . . 0.0 110.177 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.584 HD21 ' HG2' ' A' ' 8' ' ' PRO . 4.1 mm? -65.33 -36.54 84.36 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 123.468 0.707 . . . . 0.0 111.173 -178.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -62.8 -48.16 80.32 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 121.177 -0.952 . . . . 0.0 109.361 171.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -61.45 -40.74 95.59 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.658 0.783 . . . . 0.0 112.364 -174.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 mp -55.46 -14.41 1.97 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.95 1.7 . . . . 0.0 113.133 175.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.4 m 57.97 40.37 25.67 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.302 1.841 . . . . 0.0 110.544 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.7 t -54.56 -31.33 23.22 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.257 0 C-N-CA 127.517 2.327 . . . . 0.0 111.024 174.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -56.92 -17.17 8.59 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 170.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -102.62 -5.76 23.51 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.097 1.759 . . . . 0.0 111.46 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.484 ' CE3' ' HB2' ' A' ' 87' ' ' ASN . 31.0 m0 -77.71 165.22 52.78 Favored Pre-proline 0 C--O 1.24 0.582 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.11 140.72 42.01 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 121.654 1.569 . . . . 0.0 111.151 171.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.0 mt -81.58 151.55 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 165.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.635 ' CE3' ' HE3' ' A' ' 84' ' ' LYS . 7.1 t90 -136.77 141.71 42.98 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 156.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.76 153.0 48.64 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 128.207 2.603 . . . . 0.0 108.917 174.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.523 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 1.7 tttt -153.25 165.14 36.64 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.316 -0.865 . . . . 0.0 109.876 172.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.69 176.78 4.57 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 126.135 1.774 . . . . 0.0 110.245 171.399 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.6 t -83.77 49.6 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 129.984 3.313 . . . . 0.0 109.088 -169.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.0 t -105.57 -169.07 1.54 Allowed 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 127.302 2.241 . . . . 0.0 109.706 -165.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.07 135.47 19.35 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 120.723 -1.235 . . . . 0.0 108.877 177.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -153.57 -164.94 2.01 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.361 1.064 . . . . 0.0 109.268 -176.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -137.65 152.1 48.97 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.86 1.264 . . . . 0.0 109.663 173.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 15.5 t-105 -128.46 135.2 49.14 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 125.137 1.375 . . . . 0.0 109.615 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -106.99 109.71 21.67 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 171.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -79.58 123.02 27.22 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 171.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -124.81 5.49 8.09 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.692 0.797 . . . . 0.0 111.446 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.94 177.09 9.64 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 126.806 2.042 . . . . 0.0 108.678 165.054 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -65.15 137.69 57.8 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 178.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -143.94 100.62 3.6 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -174.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 85.6 m -75.67 144.35 41.67 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 116.19 -1.862 . . . . 0.0 106.521 172.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 7.5 p -133.31 162.75 30.96 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 114.269 -2.973 . . . . 0.0 111.039 145.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -125.69 109.43 12.59 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 170.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.8 mm -73.82 131.28 35.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.42 -21.24 8.13 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.317 0.962 . . . . 0.0 112.964 -177.354 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -154.47 160.65 41.72 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 165.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.18 -174.0 24.74 Favored Glycine 0 N--CA 1.465 0.591 0 C-N-CA 124.11 0.862 . . . . 0.0 113.623 174.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.568 ' HE2' HG13 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -145.39 141.95 28.91 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.242 0.544 . . . . 0.0 109.717 173.54 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.526 ' C ' ' HZ3' ' A' ' 47' ' ' LYS . 3.3 t -127.77 136.27 60.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 176.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -99.66 131.62 45.53 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 157.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 94.1 t -114.02 140.78 32.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 171.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.8 m -136.89 108.34 6.9 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -175.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 49.7 p -77.42 177.26 8.13 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.707 -0.621 . . . . 0.0 109.486 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -72.56 -25.72 61.46 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 120.613 -1.304 . . . . 0.0 110.838 -174.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.18 -27.72 65.96 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.109 0.964 . . . . 0.0 111.981 169.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.68 8.79 69.64 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-O 118.648 -1.084 . . . . 0.0 113.357 -177.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp -52.45 117.98 3.25 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 156.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -74.5 153.4 39.13 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 158.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -136.91 150.59 48.31 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 170.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.568 HG13 ' HE2' ' A' ' 47' ' ' LYS . 63.0 t -127.1 141.08 47.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 176.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.8 pt -135.52 120.87 29.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 170.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.49 175.23 9.44 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.723 1.209 . . . . 0.0 109.231 169.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -64.13 43.31 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 130.557 3.543 . . . . 0.0 114.905 175.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -179.48 -0.67 0.02 OUTLIER Glycine 0 CA--C 1.525 0.659 0 C-N-CA 124.943 1.258 . . . . 0.0 112.697 -176.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.473 ' OD2' ' HE2' ' A' ' 7' ' ' LYS . 1.3 m-20 -72.54 114.06 10.26 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 166.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.2 tp -74.33 160.78 30.61 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 152.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.526 HG21 ' CE1' ' A' ' 68' ' ' PHE . 1.2 p -160.16 149.36 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 C-N-CA 126.958 2.103 . . . . 0.0 109.716 -175.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 84.2 m -136.63 97.56 3.58 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 173.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.526 ' CE1' HG21 ' A' ' 66' ' ' VAL . 91.0 m-85 -70.79 145.9 92.66 Favored Pre-proline 0 C--O 1.239 0.512 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 163.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -86.21 174.56 6.1 Favored 'Trans proline' 0 N--CA 1.443 -1.459 0 C-N-CA 121.685 1.59 . . . . 0.0 110.777 -174.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.2 tttm -71.08 96.79 1.38 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 113.214 -1.812 . . . . 0.0 106.838 165.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 102.42 88.64 2.05 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 126.307 1.908 . . . . 0.0 111.485 177.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.9 tt -148.8 139.41 22.68 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 126.861 2.064 . . . . 0.0 107.804 167.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -126.21 108.45 11.31 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.643 1.177 . . . . 0.0 108.156 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 24.6 p -145.85 168.81 19.89 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -175.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.44 162.12 21.09 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 123.478 0.711 . . . . 0.0 111.847 170.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -144.54 97.9 3.11 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 126.98 2.112 . . . . 0.0 109.135 -172.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.5 tptt -98.89 123.32 43.08 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 126.462 1.905 . . . . 0.0 107.445 -176.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.9 t -101.12 100.88 11.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.8 mt -82.8 -28.81 30.01 Favored 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 119.679 -0.809 . . . . 0.0 109.196 -177.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -144.95 150.47 46.08 Favored Pre-proline 0 C--O 1.238 0.499 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 175.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -65.65 135.21 41.03 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 122.79 2.326 . . . . 0.0 107.942 -169.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.9 p -131.73 119.88 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.456 -157.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.0 ttt85 -99.43 116.47 31.66 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 171.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.635 ' HE3' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -126.28 146.74 49.89 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 172.265 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 14.3 m80 -85.5 129.05 34.91 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 161.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -117.37 162.21 18.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 172.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.484 ' HB2' ' CE3' ' A' ' 21' ' ' TRP . 23.1 t30 -152.97 121.21 6.23 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 172.287 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 29.7 mt -75.58 134.59 40.66 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 126.11 1.764 . . . . 0.0 106.837 170.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.8 p90 . . . . . 0 C--O 1.256 1.416 0 CA-C-N 119.648 1.113 . . . . 0.0 110.988 -176.782 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptt? . . . . . 0 N--CA 1.473 0.711 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -118.94 155.12 31.87 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 118.738 0.699 . . . . 0.0 110.095 172.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.0 t 44.89 85.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 129.035 2.934 . . . . 0.0 110.959 173.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.69 115.28 6.34 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.7 mt -110.58 148.19 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 168.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -157.75 175.51 13.79 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.389 1.075 . . . . 0.0 109.694 165.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.36 85.5 10.82 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 173.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -69.83 167.6 24.05 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.74 2.96 . . . . 0.0 111.551 -177.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.4 p -84.09 151.02 59.53 Favored Pre-proline 0 N--CA 1.448 -0.533 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -63.37 -31.49 72.74 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.541 2.161 . . . . 0.0 112.126 175.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -63.54 -48.93 75.47 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 119.292 0.951 . . . . 0.0 110.636 171.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -57.77 -38.14 74.92 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.779 0.718 . . . . 0.0 111.012 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 57.4 mt -63.33 -26.86 68.96 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 118.978 -0.534 . . . . 0.0 112.32 177.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -66.6 -43.22 85.44 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 119.713 1.142 . . . . 0.0 110.268 170.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -61.34 -47.23 86.87 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 122.04 0.924 . . . . 0.0 109.453 -174.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 88.1 mt -65.09 -4.26 4.63 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.094 1.757 . . . . 0.0 112.667 178.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 56.77 33.37 22.89 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.5 1.52 . . . . 0.0 111.945 175.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.1 t -56.6 -23.28 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.076 0.951 . . . . 0.0 111.697 -176.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -53.83 -29.97 43.17 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.416 -1.428 . . . . 0.0 113.954 167.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -84.8 -21.4 29.94 Favored 'General case' 0 C--O 1.226 -0.164 0 O-C-N 121.336 -0.852 . . . . 0.0 110.28 -170.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 31.0 m0 -71.88 163.75 64.18 Favored Pre-proline 0 N--CA 1.448 -0.555 0 C-N-CA 125.229 1.412 . . . . 0.0 109.37 -162.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.03 133.17 30.14 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 121.17 1.247 . . . . 0.0 110.315 172.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 63.6 mt -70.19 145.45 12.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 167.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.555 ' HE3' ' HD2' ' A' ' 84' ' ' LYS . 88.3 t90 -139.14 141.15 38.06 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 163.162 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -128.7 165.02 21.68 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 126.886 2.074 . . . . 0.0 107.991 173.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -149.87 158.83 44.55 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 167.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -84.45 175.68 9.16 Favored 'General case' 0 N--CA 1.435 -1.207 0 O-C-N 123.979 0.799 . . . . 0.0 111.167 172.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.5 p -66.53 11.34 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 129.128 2.971 . . . . 0.0 113.097 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.03 134.39 34.54 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 126.833 2.053 . . . . 0.0 109.191 178.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -72.68 168.09 19.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.915 0.864 . . . . 0.0 110.269 177.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -165.94 -172.13 2.23 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 169.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.438 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 1.8 p30 -123.33 146.72 47.69 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 119.888 -1.758 . . . . 0.0 106.929 157.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 12.8 t-105 -114.97 153.63 30.24 Favored 'General case' 0 C--O 1.239 0.549 0 O-C-N 123.897 0.748 . . . . 0.0 110.39 172.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -123.22 105.27 9.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 170.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -78.75 104.94 9.71 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 174.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -105.22 11.57 32.87 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -179.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.76 168.3 21.71 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 129.04 2.936 . . . . 0.0 107.749 157.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -58.29 137.74 56.91 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 125.433 1.493 . . . . 0.0 107.78 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -141.65 113.96 8.18 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 175.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 97.2 m -79.73 149.12 31.26 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 162.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.1 p -145.38 137.84 25.87 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 119.16 0.891 . . . . 0.0 111.265 157.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -100.93 111.52 23.74 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.928 1.691 . . . . 0.0 107.894 174.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.8 mm -75.31 120.57 25.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 C-N-CA 124.05 0.94 . . . . 0.0 108.734 177.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 mp -101.82 -25.38 13.83 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 118.812 -0.613 . . . . 0.0 111.969 176.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -169.62 158.65 7.82 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.222 1.009 . . . . 0.0 109.592 -177.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.75 -172.14 14.21 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.41 1.481 . . . . 0.0 111.871 177.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.533 ' HD2' ' H ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -138.23 151.87 48.07 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 123.209 1.481 . . . . 0.0 108.522 167.644 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.572 HG13 ' CG1' ' A' ' 60' ' ' ILE 0.266 0.4 OUTLIER -152.98 135.73 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.431 0 C-N-CA 130.206 3.402 . . . . 0.0 112.97 -171.017 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.436 ' HB3' ' HE3' ' A' ' 57' ' ' LYS . 10.3 mt-10 -128.51 107.77 9.99 Favored 'General case' 0 N--CA 1.428 -1.566 0 O-C-N 125.819 1.949 . . . . 0.0 109.231 155.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 78.3 t -83.24 146.45 6.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 168.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.1 m -139.77 117.14 11.32 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 175.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 47.3 p -65.05 169.24 5.58 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 174.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -53.36 -36.68 61.64 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.596 -0.69 . . . . 0.0 110.41 171.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -65.16 -2.06 2.65 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 129.406 3.082 . . . . 0.0 114.328 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.76 6.57 78.18 Favored Glycine 0 CA--C 1.533 1.206 0 O-C-N 121.156 -0.965 . . . . 0.0 113.11 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -73.51 102.32 3.8 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 168.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.436 ' HE3' ' HB3' ' A' ' 49' ' ' GLU . 3.1 tptt -75.12 146.2 41.59 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 170.014 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -142.35 107.38 4.93 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.451 1.9 . . . . 0.0 107.961 177.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.7 t -69.81 138.47 22.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 164.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.572 ' CG1' HG13 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -124.9 146.8 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 C-N-CA 123.849 0.859 . . . . 0.0 109.807 165.221 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -142.1 -178.37 5.68 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 122.221 1.01 . . . . 0.0 111.525 173.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.5 pttm -61.7 85.22 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.548 1.939 . . . . 0.0 111.548 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 144.83 -11.0 1.89 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 126.121 1.819 . . . . 0.0 113.04 177.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -90.34 106.54 18.56 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 175.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.8 tp -76.47 146.39 38.58 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 168.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.3 t -129.45 155.29 41.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 123.295 0.638 . . . . 0.0 109.403 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.7 m -138.76 123.41 18.57 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.179 0.992 . . . . 0.0 109.263 162.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -86.81 153.03 54.78 Favored Pre-proline 0 C--O 1.239 0.531 0 C-N-CA 125.215 1.406 . . . . 0.0 109.799 171.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -79.99 179.68 6.03 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.506 2.804 . . . . 0.0 109.491 175.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -83.49 103.83 13.15 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 164.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 102.73 62.97 0.71 Allowed Glycine 0 CA--C 1.523 0.547 0 C-N-CA 125.175 1.369 . . . . 0.0 112.297 166.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.8 tp -123.68 147.72 47.17 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.504 1.922 . . . . 0.0 108.501 174.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.22 142.33 47.58 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.624 1.57 . . . . 0.0 109.23 174.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 8.7 p -167.46 163.91 14.93 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 118.86 0.755 . . . . 0.0 112.275 167.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -77.22 145.33 37.64 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 118.516 -0.754 . . . . 0.0 109.967 167.544 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 6.6 m95 -104.65 136.97 43.2 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 158.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.0 tttt -113.69 103.75 11.53 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 158.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.6 t -76.88 106.43 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 103.475 -2.787 . . . . 0.0 103.475 174.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.9 mt -88.82 -16.06 33.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.594 -177.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -150.27 151.37 31.34 Favored Pre-proline 0 C--O 1.234 0.273 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.888 161.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -58.14 114.64 2.06 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.925 3.083 . . . . 0.0 110.439 -175.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.9 p -88.08 164.06 2.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 C-N-CA 123.604 0.762 . . . . 0.0 109.949 -168.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -134.97 122.79 22.38 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 155.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.555 ' HD2' ' HE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -134.05 140.13 46.45 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 171.489 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -77.49 104.65 8.14 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 103.763 -2.68 . . . . 0.0 103.763 164.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -85.13 161.28 19.71 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 167.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -149.74 140.1 22.32 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 119.538 -0.865 . . . . 0.0 109.986 152.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 44.4 mt -71.91 163.95 26.94 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 171.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 5.1 p90 . . . . . 0 C--O 1.246 0.891 0 O-C-N 121.305 -0.872 . . . . 0.0 108.747 160.019 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.481 1.123 0 CA-C-O 118.547 -0.739 . . . . 0.0 110.982 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 49.18 -176.71 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 128.035 2.534 . . . . 0.0 113.846 -178.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.64 137.26 24.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 167.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.9 tptt -113.73 136.53 52.74 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 171.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 55.7 mt -135.4 112.15 13.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -143.04 174.8 10.36 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.197 0.999 . . . . 0.0 109.615 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.8 82.38 6.54 Favored Pre-proline 0 CA--C 1.532 0.259 0 O-C-N 121.598 -0.689 . . . . 0.0 109.268 176.004 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.414 ' HG3' HD22 ' A' ' 65' ' ' LEU . 92.1 Cg_endo -74.8 165.87 30.53 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.542 2.161 . . . . 0.0 113.428 -174.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.9 t -61.58 144.13 92.89 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 124.794 1.238 . . . . 0.0 110.953 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.65 -23.17 63.84 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.786 2.324 . . . . 0.0 113.027 177.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.41 -61.14 2.65 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 125.064 1.345 . . . . 0.0 109.721 -176.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -56.77 -36.85 70.3 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 122.183 -0.323 . . . . 0.0 110.825 -175.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.2 mt -58.28 -41.61 84.72 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 173.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.3 -50.89 71.48 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.513 1.051 . . . . 0.0 108.323 173.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -63.84 -34.38 77.8 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 123.482 0.713 . . . . 0.0 111.847 -174.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.75 -5.97 3.23 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.564 1.546 . . . . 0.0 113.601 177.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . 0.254 98.8 p 63.17 28.24 15.87 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 128.332 2.653 . . . . 0.0 113.943 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 20.1 t -57.28 -31.96 39.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 118.941 0.791 . . . . 0.0 112.985 -170.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -62.96 -23.71 67.54 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.281 1.4 . . . . 0.0 113.027 176.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.9 mttm -88.59 -8.03 55.4 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 126.223 1.809 . . . . 0.0 111.045 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 39.8 m0 -74.36 163.31 69.2 Favored Pre-proline 0 N--CA 1.451 -0.39 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.12 133.58 31.28 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.003 1.136 . . . . 0.0 111.314 173.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.1 mt -70.44 149.18 10.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 124.654 1.182 . . . . 0.0 107.974 165.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.8 t90 -144.84 145.32 31.56 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.56 -1.2 . . . . 0.0 107.775 162.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.22 162.62 34.83 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.782 2.433 . . . . 0.0 108.344 176.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.525 ' HD3' ' H ' ' A' ' 27' ' ' GLU . 5.3 tmtt? -147.17 173.16 12.78 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.933 -1.105 . . . . 0.0 110.224 178.098 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.525 ' H ' ' HD3' ' A' ' 26' ' ' LYS . 6.0 tt0 -70.9 -179.77 2.38 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 127.612 2.365 . . . . 0.0 111.288 166.253 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.453 ' H ' ' HG2' ' A' ' 27' ' ' GLU . 11.3 t -97.89 6.96 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 C-N-CA 127.456 2.302 . . . . 0.0 111.91 -171.072 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.5 t -81.5 172.91 12.93 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 120.627 -1.296 . . . . 0.0 109.511 173.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -100.42 161.41 13.62 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.321 -0.862 . . . . 0.0 109.31 171.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.469 ' CE2' ' HE3' ' A' ' 26' ' ' LYS . 14.4 p90 -156.75 177.16 11.8 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 125.445 1.498 . . . . 0.0 109.138 170.195 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.11 129.47 51.81 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.062 2.145 . . . . 0.0 108.186 171.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 35.1 t-105 -118.65 146.15 44.9 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.909 173.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -117.46 143.81 45.65 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.123 1.369 . . . . 0.0 107.907 174.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -118.09 110.81 18.09 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 175.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -107.9 3.01 23.81 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.494 1.118 . . . . 0.0 111.429 -175.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.58 160.4 42.44 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 129.686 3.194 . . . . 0.0 107.318 173.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -64.34 127.74 32.77 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 -174.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -135.1 109.1 8.17 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 177.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 56.1 m -82.07 135.75 35.29 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 167.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 29.2 p -134.65 156.93 47.89 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.084 0.468 . . . . 0.0 110.186 163.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -133.45 116.64 16.25 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.932 1.293 . . . . 0.0 108.502 -175.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.8 mm -72.47 143.19 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 126.475 1.91 . . . . 0.0 109.274 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.0 mt -127.25 -37.14 2.07 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.229 0.611 . . . . 0.0 109.822 171.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -150.82 159.4 44.57 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 173.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 82' ' ' VAL . . . 101.17 177.27 29.01 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 126.305 1.907 . . . . 0.0 114.097 177.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.667 ' HE3' HG23 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -140.93 154.56 46.15 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-O 123.282 1.515 . . . . 0.0 110.054 -175.427 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.483 HG13 HG12 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -160.04 150.06 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.995 1 C-N-CA 133.539 4.735 . . . . 0.0 108.033 -161.677 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.422 ' OE1' HD11 ' A' ' 79' ' ' LEU . 15.8 mt-10 -135.21 115.61 13.53 Favored 'General case' 0 N--CA 1.414 -2.233 0 N-CA-C 104.23 -2.507 . . . . 0.0 104.23 152.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.4 t -89.56 121.86 40.22 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.993 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 172.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.5 m -111.34 122.84 48.9 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 82.4 p -74.08 178.52 4.96 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -71.77 -23.93 61.67 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 120.209 -1.557 . . . . 0.0 111.698 168.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.43 -7.99 29.64 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.825 1.25 . . . . 0.0 111.653 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.3 -13.56 61.55 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 126.261 1.886 . . . . 0.0 112.951 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -61.13 137.1 58.24 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.565 1.546 . . . . 0.0 107.542 178.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.4 tttm -120.67 130.52 54.15 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -172.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 13.5 m-30 -128.28 84.9 2.28 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 125.618 2.627 . . . . 0.0 108.962 -169.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.667 HG23 ' HE3' ' A' ' 47' ' ' LYS . 1.5 p -54.36 97.82 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 127.407 2.283 . . . . 0.0 112.587 152.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.483 HG12 HG13 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -80.59 156.54 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.062 0 CA-C-N 112.487 -2.142 . . . . 0.0 109.414 155.803 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -157.82 -179.84 8.52 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 171.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.4 82.42 0.05 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 126.068 1.747 . . . . 0.0 109.326 -176.261 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 160.32 -12.27 0.16 Allowed Glycine 0 CA--C 1.524 0.634 0 CA-C-O 118.082 -1.399 . . . . 0.0 115.662 -167.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -126.64 104.95 8.38 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 119.186 1.493 . . . . 0.0 109.17 -166.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.414 HD22 ' HG3' ' A' ' 8' ' ' PRO . 19.3 tp -65.86 150.53 48.44 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 172.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.0 t -128.93 156.68 41.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 121.909 0.862 . . . . 0.0 109.288 168.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 75.7 m -144.48 111.51 5.86 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.365 1.466 . . . . 0.0 108.09 162.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -78.36 155.68 79.06 Favored Pre-proline 0 C--O 1.234 0.272 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 170.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -80.84 177.83 7.58 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 121.396 1.398 . . . . 0.0 110.334 172.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 32.4 tttt -75.08 91.4 2.56 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 112.933 -1.94 . . . . 0.0 107.527 164.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 116.17 90.79 1.63 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.754 1.168 . . . . 0.0 111.441 173.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.9 tp -155.2 150.71 27.33 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.51 1.524 . . . . 0.0 110.087 173.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.2 ttp85 -128.78 122.96 31.69 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 126.285 1.834 . . . . 0.0 109.116 176.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 8.3 p -157.13 167.32 30.74 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.226 0.921 . . . . 0.0 110.919 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.91 173.71 12.26 Favored 'General case' 0 CA--C 1.516 -0.347 0 O-C-N 120.887 -1.133 . . . . 0.0 112.4 168.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 5.9 m95 -142.88 93.65 2.54 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 127.51 2.324 . . . . 0.0 106.728 167.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -79.83 105.31 11.02 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 170.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 t -86.14 86.92 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 -174.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.481 HD12 ' HE2' ' A' ' 47' ' ' LYS . 97.3 mt -64.72 -29.87 70.87 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.451 -178.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -142.74 154.57 62.79 Favored Pre-proline 0 N--CA 1.465 0.281 0 CA-C-N 119.481 1.037 . . . . 0.0 110.382 168.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.51 85.17 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 125.078 3.852 . . . . 0.0 111.753 -168.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.409 ' HA ' ' HA3' ' A' ' 46' ' ' GLY . 8.5 p -75.16 137.62 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 124.725 1.21 . . . . 0.0 109.674 -163.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.5 ttt180 -116.82 106.74 13.8 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 104.108 -2.553 . . . . 0.0 104.108 177.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.11 142.96 51.17 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 10.5 m80 -78.08 136.79 37.96 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 165.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -124.27 163.17 22.2 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 173.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 22.3 t30 -157.23 137.15 12.48 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 119.4 1.0 . . . . 0.0 109.113 169.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 66.3 mt -94.56 146.16 24.31 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.512 1.125 . . . . 0.0 108.909 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.5 p90 . . . . . 0 C--O 1.247 0.942 0 C-N-CA 125.173 1.389 . . . . 0.0 111.673 -176.427 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.422 -0.799 . . . . 0.0 110.788 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -109.58 161.05 15.74 Favored 'General case' 0 CA--C 1.515 -0.396 0 O-C-N 125.859 1.975 . . . . 0.0 110.078 -178.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.639 HG12 HG13 ' A' ' 5' ' ' ILE . 85.5 t 40.16 91.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -174.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt -81.24 102.67 10.51 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 122.073 -0.392 . . . . 0.0 110.862 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.639 HG13 HG12 ' A' ' 3' ' ' VAL . 63.5 mt -111.09 124.69 68.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 O-C-N 123.433 0.458 . . . . 0.0 110.655 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -163.89 179.85 6.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.722 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.81 83.65 4.81 Favored Pre-proline 0 C--O 1.241 0.635 0 CA-C-O 121.885 0.85 . . . . 0.0 110.806 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.512 ' HG3' HD13 ' A' ' 65' ' ' LEU . 51.7 Cg_endo -69.3 139.44 41.83 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.145 1.896 . . . . 0.0 112.035 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -49.4 146.96 6.03 Favored Pre-proline 0 C--O 1.233 0.185 0 CA-C-O 121.383 0.611 . . . . 0.0 111.18 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.536 ' HA ' HD12 ' A' ' 13' ' ' LEU . 50.1 Cg_endo -69.01 -9.13 25.52 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.574 2.182 . . . . 0.0 112.553 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.91 -50.95 12.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.813 0.34 . . . . 0.0 110.673 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.11 -34.34 73.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.855 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.583 HD23 HG21 ' A' ' 18' ' ' VAL . 3.5 mt -62.82 -42.94 99.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.849 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -57.85 -33.92 69.17 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 119.104 -0.474 . . . . 0.0 110.987 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -78.03 -38.88 43.68 Favored 'General case' 0 C--N 1.332 -0.174 0 O-C-N 124.419 1.074 . . . . 0.0 110.503 -179.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.3 mp -59.11 -19.71 47.01 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 122.997 0.519 . . . . 0.0 111.165 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 63.32 43.2 6.32 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 123.445 0.466 . . . . 0.0 110.466 -178.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.583 HG21 HD23 ' A' ' 13' ' ' LEU . 22.7 t -56.93 -23.53 18.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.971 0.415 . . . . 0.0 110.964 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -72.2 -19.52 61.72 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.417 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.62 -7.75 54.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 179.15 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 40.1 m0 -79.72 155.16 75.94 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.875 0.369 . . . . 0.0 110.7 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 131.25 20.77 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.447 2.098 . . . . 0.0 112.253 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.0 mt -80.98 141.26 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.751 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 86.5 t90 -139.55 117.36 11.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.611 178.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.49 153.67 31.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.761 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.89 162.94 30.98 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.981 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.3 pm0 -70.12 176.48 3.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.207 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.483 HG13 ' O ' ' A' ' 79' ' ' LEU . 30.4 t -77.19 -4.3 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.373 0.606 . . . . 0.0 111.394 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.9 t -77.13 174.02 11.17 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.081 -0.648 . . . . 0.0 112.044 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -107.69 174.51 5.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.485 -177.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 18.7 p90 178.55 179.81 0.35 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.293 -178.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -119.77 111.9 18.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.231 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 10.3 t-105 -97.26 151.87 19.43 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-O 120.847 0.356 . . . . 0.0 110.188 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -131.23 113.17 13.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.453 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -91.89 135.07 34.22 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.556 0.535 . . . . 0.0 110.737 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.474 ' O ' HG23 ' A' ' 37' ' ' THR . 2.0 p30 -125.44 22.88 7.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.983 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -179.74 150.37 0.4 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.867 0.365 . . . . 0.0 110.936 -179.122 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -51.83 104.35 0.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.75 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -123.29 83.86 2.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.101 0.477 . . . . 0.0 109.97 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 80.2 m -60.1 147.35 39.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.077 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 4.1 p -146.28 133.69 20.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.871 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.457 ' CD1' HD12 ' A' ' 65' ' ' LEU . 51.1 t80 -116.19 116.25 27.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.935 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.566 HD13 ' HB3' ' A' ' 84' ' ' LYS . 25.0 mm -77.24 136.03 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.829 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.463 HD12 ' O ' ' A' ' 83' ' ' ARG . 0.9 OUTLIER -120.59 -30.04 4.59 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 123.524 0.515 . . . . 0.0 111.417 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.44 ' HA ' ' HB3' ' A' ' 62' ' ' LYS . 15.1 pt-20 -162.15 155.51 20.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.309 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.56 179.75 33.51 Favored Glycine 0 N--CA 1.451 -0.311 0 O-C-N 123.503 0.502 . . . . 0.0 112.217 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.786 ' HE3' HG23 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -127.17 166.87 16.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.033 0.444 . . . . 0.0 110.886 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.66 HG13 ' CG1' ' A' ' 60' ' ' ILE . 0.1 OUTLIER -174.08 141.65 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.355 -177.722 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 2.7 mt-10 -132.4 90.97 2.86 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.53 0.681 . . . . 0.0 110.202 178.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.655 HG23 HD11 ' A' ' 60' ' ' ILE . 48.9 t -78.43 110.57 14.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 O-C-N 122.022 -0.424 . . . . 0.0 110.966 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 90.6 m -107.76 105.66 15.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.737 0.303 . . . . 0.0 110.803 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.8 p -64.35 154.91 33.97 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.95 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -51.73 -38.19 54.26 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.023 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -52.84 -29.38 27.58 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.445 0.641 . . . . 0.0 110.85 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 113.79 0.62 24.37 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 121.326 -0.464 . . . . 0.0 112.057 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -85.06 115.9 23.13 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 122.535 -0.391 . . . . 0.0 110.473 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.5 mttm -79.92 157.05 26.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.891 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -148.63 92.26 1.98 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.146 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.786 HG23 ' HE3' ' A' ' 47' ' ' LYS . 1.8 p -83.92 123.7 39.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.154 0.502 . . . . 0.0 111.015 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.66 ' CG1' HG13 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -113.68 143.75 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.422 179.656 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -139.93 -173.44 3.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.447 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.44 ' HB3' ' HA ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -69.47 67.06 0.21 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.069 0.461 . . . . 0.0 111.421 179.288 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 160.23 37.66 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.383 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -154.36 102.94 2.47 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 117.206 0.503 . . . . 0.0 110.946 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.524 ' CD1' HD21 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -80.32 128.78 33.95 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.568 -179.397 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.605 HG22 HG12 ' A' ' 5' ' ' ILE . 8.2 t -117.91 147.09 21.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 O-C-N 123.647 0.592 . . . . 0.0 110.661 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.2 m -142.97 101.03 3.76 Favored 'General case' 0 C--O 1.25 1.107 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.947 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.6 ' CD1' HG22 ' A' ' 3' ' ' VAL . 59.5 m-85 -77.05 147.53 77.05 Favored Pre-proline 0 C--N 1.344 0.335 0 O-C-N 124.621 1.201 . . . . 0.0 111.259 178.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.12 -166.34 0.23 Allowed 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 123.51 2.806 . . . . 0.0 111.969 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -95.46 67.05 2.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.853 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.29 82.26 0.13 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.171 178.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.418 HD12 ' H ' ' A' ' 73' ' ' ARG . 49.3 tp -146.82 146.92 30.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.557 0.218 . . . . 0.0 110.859 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.418 ' H ' HD12 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -126.76 141.98 51.67 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.927 178.835 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 6.1 p -179.46 175.3 0.92 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.057 0.456 . . . . 0.0 110.962 176.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.624 ' O ' HG13 ' A' ' 50' ' ' VAL . 0.2 OUTLIER -95.15 159.61 14.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.018 179.635 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 2.0 m95 -131.84 78.22 1.81 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.836 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.69 93.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.642 -0.253 . . . . 0.0 111.0 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 80' ' ' GLU . 2.2 t -76.04 67.2 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.006 0.432 . . . . 0.0 110.699 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.75 HD12 ' HE2' ' A' ' 47' ' ' LYS . 81.1 mt -47.92 -29.41 3.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.292 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.64 ' O ' HG12 ' A' ' 78' ' ' VAL . 2.6 mt-10 -145.2 165.23 22.71 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.35 0.595 . . . . 0.0 111.054 178.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.95 87.49 0.45 Allowed 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 123.203 2.602 . . . . 0.0 112.356 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 45' ' ' GLU . 4.7 p -80.13 151.31 4.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.983 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.463 ' O ' HD12 ' A' ' 44' ' ' LEU . 3.5 ttt180 -136.4 64.23 1.56 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.728 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.566 ' HB3' HD13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -77.43 177.27 8.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.134 179.187 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -116.68 102.7 9.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.614 178.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -85.57 154.74 21.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.11 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -162.46 104.69 1.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.617 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 16.1 mt -68.47 149.36 49.37 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.672 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.8 p90 . . . . . 0 C--O 1.236 0.378 0 CA-C-O 118.773 -0.632 . . . . 0.0 110.712 179.964 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.1 t . . . . . 0 CA--C 1.536 0.427 0 CA-C-O 121.251 0.548 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.6 tptm -75.0 118.92 18.49 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 175.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 82.8 mt -130.81 129.64 63.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 174.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -155.38 175.58 13.69 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 122.973 0.509 . . . . 0.0 110.631 171.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.06 85.44 5.24 Favored Pre-proline 0 N--CA 1.451 -0.416 0 C-N-CA 124.312 1.045 . . . . 0.0 108.526 -177.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.42 165.18 31.45 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.977 2.452 . . . . 0.0 112.095 -175.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.3 t -61.18 144.22 91.56 Favored Pre-proline 0 C--O 1.239 0.551 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 164.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.81 -18.14 28.56 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.013 1.809 . . . . 0.0 112.146 175.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -64.33 -52.65 57.37 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.908 0.776 . . . . 0.0 110.158 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.4 tttt -61.92 -33.16 73.75 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 123.205 0.602 . . . . 0.0 110.716 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 79.5 mt -63.82 -24.12 67.63 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.401 -0.812 . . . . 0.0 112.408 175.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -67.49 -49.14 64.84 Favored 'General case' 0 CA--C 1.522 -0.134 0 O-C-N 120.667 -1.27 . . . . 0.0 108.428 169.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -66.94 -36.04 81.35 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.093 0.957 . . . . 0.0 110.95 -169.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.28 -12.31 5.39 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.917 1.687 . . . . 0.0 112.932 172.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . 0.255 68.2 p 60.69 35.02 19.86 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 128.27 2.628 . . . . 0.0 113.021 -175.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.6 t -55.76 -30.46 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.074 0.95 . . . . 0.0 112.801 -177.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -60.2 -26.23 66.2 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 120.437 1.471 . . . . 0.0 112.864 172.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.1 mttm -91.78 -9.03 45.04 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.127 1.371 . . . . 0.0 111.004 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 35.7 m0 -73.09 161.48 79.14 Favored Pre-proline 0 C--O 1.237 0.395 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -65.14 136.29 47.22 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.629 1.553 . . . . 0.0 111.063 173.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.6 mt -70.16 152.5 9.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 162.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.436 ' CE3' ' HD2' ' A' ' 84' ' ' LYS . 59.6 t90 -136.21 149.09 48.41 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 156.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.07 152.97 49.31 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 128.779 2.831 . . . . 0.0 107.996 177.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.514 ' HE3' ' CE2' ' A' ' 31' ' ' PHE . 21.6 tptp -156.6 159.33 38.38 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.231 -0.918 . . . . 0.0 109.748 176.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -69.49 167.81 15.91 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 127.759 2.424 . . . . 0.0 114.216 172.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.2 p -79.33 37.99 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 130.461 3.504 . . . . 0.0 112.73 -175.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.7 t -100.3 -167.71 1.48 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.211 1.405 . . . . 0.0 109.603 -173.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -139.6 145.28 38.35 Favored 'General case' 0 C--N 1.333 -0.114 0 O-C-N 120.461 -1.399 . . . . 0.0 108.867 161.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.514 ' CE2' ' HE3' ' A' ' 26' ' ' LYS . 18.4 p90 -151.13 179.22 8.47 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.629 1.572 . . . . 0.0 108.473 176.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -121.59 128.85 52.39 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.386 1.074 . . . . 0.0 108.981 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 40.2 t-105 -115.41 160.77 19.45 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 122.042 0.925 . . . . 0.0 112.626 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -128.74 111.94 13.67 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 127.22 2.208 . . . . 0.0 107.813 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -85.07 127.51 34.25 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 167.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -120.75 -3.12 9.76 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.966 1.706 . . . . 0.0 110.978 -173.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.57 171.61 16.83 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 129.853 3.261 . . . . 0.0 108.193 175.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -71.83 147.56 47.07 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -175.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -149.84 119.59 7.05 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 175.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 39.9 m -96.57 126.36 41.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 175.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -142.09 125.43 16.56 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.681 1.192 . . . . 0.0 109.525 -173.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -105.06 123.51 47.93 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.255 1.422 . . . . 0.0 108.534 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.545 HD13 ' HB3' ' A' ' 84' ' ' LYS . 48.8 mm -78.19 112.41 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 123.962 0.905 . . . . 0.0 108.702 177.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.5 ' O ' ' HE3' ' A' ' 62' ' ' LYS . 2.4 mp -97.69 -21.75 16.84 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 118.071 -0.966 . . . . 0.0 112.806 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -167.68 149.11 5.47 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 173.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.93 178.76 29.21 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.862 1.22 . . . . 0.0 114.448 173.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.451 ' HE3' HG23 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -133.79 140.61 47.03 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 118.017 0.908 . . . . 0.0 111.145 -173.616 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.428 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 66.1 t -141.19 147.79 22.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -112.68 99.74 8.17 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 160.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.9 t -70.61 157.78 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 164.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -147.86 136.0 21.3 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 164.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 74.5 p -83.3 175.7 9.69 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.027 0.376 . . . . 0.0 110.337 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -65.23 -27.05 68.4 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.423 0.63 . . . . 0.0 111.732 -177.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.08 -4.18 4.53 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.693 1.997 . . . . 0.0 111.94 171.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.27 5.09 65.67 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 126.04 1.781 . . . . 0.0 113.567 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 46.0 mmtt -65.94 127.81 33.54 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 105.547 -2.019 . . . . 0.0 105.547 174.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -86.24 145.51 26.93 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 171.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -134.38 84.82 2.14 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 124.127 1.917 . . . . 0.0 108.683 166.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.451 HG23 ' HE3' ' A' ' 47' ' ' LYS . 1.6 p -60.28 143.59 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 CA-C-N 111.765 -2.471 . . . . 0.0 109.931 152.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.402 HD12 HD11 ' A' ' 43' ' ' ILE . 2.9 pt -139.09 132.7 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 C-N-CA 128.208 2.603 . . . . 0.0 105.203 177.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -111.81 -179.39 3.68 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.147 0.979 . . . . 0.0 108.84 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.5 ' HE3' ' O ' ' A' ' 44' ' ' LEU . 75.0 tttt -64.25 107.91 1.44 Allowed 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 175.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 128.57 -15.71 5.99 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 118.578 -1.123 . . . . 0.0 112.979 -175.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -85.88 120.58 27.44 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 119.488 1.644 . . . . 0.0 108.408 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 25.3 tp -83.84 146.76 27.93 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 158.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.8 t -132.89 149.5 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 124.788 1.235 . . . . 0.0 108.104 177.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 87.9 m -131.8 111.68 11.83 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 159.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -80.38 144.82 58.28 Favored Pre-proline 0 C--O 1.236 0.363 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 165.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -85.98 178.08 4.37 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.203 1.935 . . . . 0.0 111.357 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -73.49 93.91 2.05 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 113.492 -1.686 . . . . 0.0 109.406 174.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.39 86.72 1.94 Allowed Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.263 1.411 . . . . 0.0 110.775 175.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 33.5 tp -153.67 140.62 19.23 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.084 0.954 . . . . 0.0 109.879 169.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.39 109.47 13.34 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.766 1.626 . . . . 0.0 108.192 -173.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 8.1 p -139.9 166.24 25.16 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.817 1.19 . . . . 0.0 110.179 -172.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.69 162.02 19.85 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.819 -1.176 . . . . 0.0 109.53 174.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -131.99 110.36 10.7 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.468 1.507 . . . . 0.0 107.642 168.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.7 tttp -102.23 103.74 14.26 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 174.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 t -82.75 99.84 5.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 -176.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.6 mt -88.62 -12.76 41.66 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 118.293 -0.861 . . . . 0.0 110.87 -174.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -150.58 154.03 34.86 Favored Pre-proline 0 N--CA 1.45 -0.441 0 C-N-CA 126.616 1.966 . . . . 0.0 106.792 160.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -57.43 139.02 88.86 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 N-CA-C 108.135 -1.525 . . . . 0.0 108.135 177.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.4 p -125.09 156.0 33.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -168.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -130.15 117.0 19.26 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 173.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.545 ' HB3' HD13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -130.09 116.04 17.94 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.408 0.683 . . . . 0.0 112.368 177.713 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 11.4 m80 -66.69 119.95 12.65 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 105.931 -1.878 . . . . 0.0 105.931 170.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -119.51 164.88 15.13 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 123.76 0.824 . . . . 0.0 110.884 -177.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -152.52 125.91 8.74 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 162.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 32.4 mt -73.84 148.47 42.37 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.314 1.446 . . . . 0.0 108.804 174.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.4 p90 . . . . . 0 C--O 1.251 1.155 0 C-N-CA 126.578 1.951 . . . . 0.0 109.681 177.143 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.8 t . . . . . 0 N--CA 1.471 0.615 0 CA-C-O 122.298 1.046 . . . . 0.0 111.639 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -72.4 133.27 44.82 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -173.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.6 mt -134.84 133.18 54.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 171.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -134.36 171.58 14.08 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.632 0.773 . . . . 0.0 109.305 172.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.49 84.93 12.7 Favored Pre-proline 0 N--CA 1.464 0.271 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 175.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -75.07 159.54 40.98 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 121.937 1.758 . . . . 0.0 110.761 -175.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.4 ' H ' HG22 ' A' ' 9' ' ' THR . 1.7 t -64.87 143.45 98.82 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 170.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.51 -24.74 25.91 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 121.562 1.508 . . . . 0.0 112.439 -177.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -63.3 -42.13 99.02 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.348 1.459 . . . . 0.0 111.115 175.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.9 tptt -57.88 -43.62 86.18 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 175.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -66.97 -30.79 71.01 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 122.755 0.422 . . . . 0.0 110.752 -176.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -58.97 -52.54 65.31 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.122 0.874 . . . . 0.0 109.373 168.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -58.44 -46.48 86.44 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.898 0.879 . . . . 0.0 111.265 -174.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 75.5 mt -60.9 -5.7 1.48 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.703 1.201 . . . . 0.0 113.306 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.5 m 62.49 41.04 10.16 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 126.243 1.817 . . . . 0.0 109.742 167.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.9 t -58.83 -30.45 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 128.176 2.59 . . . . 0.0 110.379 176.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -58.44 -16.32 14.49 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.835 0.854 . . . . 0.0 112.823 170.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -102.44 -2.27 29.07 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.539 1.535 . . . . 0.0 112.048 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 33.2 m0 -82.69 165.28 42.78 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.79 143.04 54.29 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 121.939 1.759 . . . . 0.0 111.172 169.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 75.5 mt -79.32 151.83 4.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 164.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.441 ' CH2' ' HB2' ' A' ' 26' ' ' LYS . 14.9 t90 -138.84 144.99 39.48 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 154.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -145.69 162.8 36.74 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.824 1.25 . . . . 0.0 110.178 175.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.441 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 5.2 tmtt? -156.74 156.85 34.05 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 124.486 1.115 . . . . 0.0 108.036 -176.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.87 168.71 9.28 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 122.248 1.023 . . . . 0.0 112.175 174.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.5 p -75.74 62.97 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 128.711 2.804 . . . . 0.0 109.258 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.7 t -129.72 -162.46 1.21 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.4 2.28 . . . . 0.0 107.974 -175.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.36 159.66 43.43 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 120.337 -1.477 . . . . 0.0 110.321 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -171.41 -164.27 0.33 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.816 2.046 . . . . 0.0 108.399 -171.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -132.88 150.08 52.19 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.79 2.036 . . . . 0.0 107.406 170.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 34.4 t-105 -127.18 150.38 49.54 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.355 0.525 . . . . 0.0 111.04 174.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -120.66 121.98 39.49 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 124.691 1.196 . . . . 0.0 109.181 170.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -91.53 119.21 31.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.093 1.357 . . . . 0.0 107.432 174.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -117.01 12.43 14.59 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.584 1.154 . . . . 0.0 111.075 176.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.6 170.44 15.82 Favored 'General case' 0 CA--C 1.523 -0.079 0 C-N-CA 124.402 1.081 . . . . 0.0 110.65 158.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -60.89 117.07 4.98 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 103.178 -2.897 . . . . 0.0 103.178 166.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -130.63 76.44 1.72 Allowed 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -170.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.3 m -63.96 145.4 55.92 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -175.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 27.7 p -145.43 153.76 41.53 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 119.923 -0.711 . . . . 0.0 112.331 166.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -124.52 112.93 17.45 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.284 1.834 . . . . 0.0 107.854 -176.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.6 mm -69.88 136.67 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 126.487 1.915 . . . . 0.0 107.261 173.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 26.1 mt -125.08 -47.16 1.78 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.317 1.047 . . . . 0.0 108.805 -171.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -147.4 159.91 43.15 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 165.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.13 178.83 31.64 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 124.84 1.21 . . . . 0.0 113.528 174.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.432 ' HE2' HD12 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -144.76 144.92 31.43 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.651 0.739 . . . . 0.0 112.483 -170.343 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.3 t -142.63 159.73 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -122.54 119.61 31.38 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 159.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 41.2 t -103.14 92.29 2.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 51.3 m -79.09 103.1 8.8 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.647 1.179 . . . . 0.0 108.409 177.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 64.1 p -82.97 172.92 12.26 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.873 -0.517 . . . . 0.0 109.928 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -71.8 -29.01 64.0 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.385 0.612 . . . . 0.0 112.596 -166.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -73.62 0.16 13.57 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.464 1.105 . . . . 0.0 111.182 173.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.5 -14.86 64.32 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 127.951 2.691 . . . . 0.0 112.875 177.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -63.52 120.18 11.22 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.624 1.57 . . . . 0.0 107.718 -173.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.06 100.93 9.52 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.637 1.175 . . . . 0.0 110.068 -169.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -83.42 108.2 16.43 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 -177.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 40.3 t -66.92 140.18 19.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 104.77 -2.307 . . . . 0.0 104.77 154.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.1 pt -134.74 99.97 2.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 174.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -81.5 172.9 12.94 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.183 0.993 . . . . 0.0 109.916 168.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.2 pttm -52.87 127.16 22.6 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.812 0.815 . . . . 0.0 109.862 169.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.91 -28.47 13.84 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-O 117.965 -1.464 . . . . 0.0 114.321 175.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.22 101.71 1.94 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 120.736 2.268 . . . . 0.0 107.933 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.4 tp -77.44 134.28 38.42 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.7 t -116.75 146.9 20.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -174.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.8 m -138.83 99.7 3.86 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 125.09 1.356 . . . . 0.0 108.094 165.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -63.18 165.55 10.48 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 124.027 0.931 . . . . 0.0 109.403 161.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -88.41 174.76 4.16 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 CA-C-N 120.098 1.071 . . . . 0.0 112.357 164.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -74.73 91.77 2.41 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 168.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 117.9 84.33 0.99 Allowed Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.281 1.419 . . . . 0.0 110.473 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.5 tt -150.95 130.88 13.32 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.362 1.465 . . . . 0.0 108.806 171.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -104.52 134.31 47.92 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 165.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 26.7 p -151.49 167.3 28.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 119.138 0.881 . . . . 0.0 111.547 169.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.01 164.51 25.0 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.435 0.636 . . . . 0.0 111.484 168.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -143.42 101.02 3.72 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 113.76 -1.563 . . . . 0.0 108.805 -175.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 tptt -95.05 107.68 19.74 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 168.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.1 t -75.67 111.82 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 104.335 -2.469 . . . . 0.0 104.335 165.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.432 HD12 ' HE2' ' A' ' 47' ' ' LYS . 74.7 mt -84.64 -27.32 27.23 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -152.06 153.98 31.96 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 124.966 1.306 . . . . 0.0 109.919 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -53.83 128.32 29.13 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.104 2.536 . . . . 0.0 109.467 175.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.5 p -135.76 138.21 48.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -167.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -128.25 67.98 1.36 Allowed 'General case' 0 C--O 1.223 -0.309 0 CA-C-O 121.16 0.505 . . . . 0.0 110.099 -171.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.436 ' HE3' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -80.1 154.52 28.03 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -175.323 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -94.38 142.43 27.43 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 163.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -131.22 159.02 38.99 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.205 0.911 . . . . 0.0 110.959 176.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -146.37 132.96 19.81 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 122.907 0.483 . . . . 0.0 109.71 170.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 90.0 mt -86.04 135.77 33.5 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.45 1.1 . . . . 0.0 108.463 174.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 6.0 p90 . . . . . 0 C--O 1.249 1.046 0 C-N-CA 124.029 0.932 . . . . 0.0 110.953 -176.67 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.1 t . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -104.23 114.59 28.93 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 175.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.4 mt -132.36 129.78 59.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 124.747 1.219 . . . . 0.0 108.258 -176.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -162.42 171.23 17.47 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.395 1.078 . . . . 0.0 109.887 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.49 85.88 2.48 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 123.504 0.722 . . . . 0.0 110.132 176.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -65.56 162.8 32.52 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.474 2.116 . . . . 0.0 112.377 -177.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.4 t -58.3 144.64 77.08 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 123.55 0.74 . . . . 0.0 109.389 169.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.22 -30.77 30.45 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.338 1.359 . . . . 0.0 113.065 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -57.83 -44.55 86.52 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.768 1.167 . . . . 0.0 112.237 -175.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.3 tptt -57.16 -45.53 83.53 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 123.908 0.883 . . . . 0.0 110.143 177.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.49 -23.71 67.51 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.214 0.606 . . . . 0.0 111.527 -174.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.8 mttt -72.17 -48.56 42.43 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -58.67 -43.96 90.06 Favored 'General case' 0 CA--C 1.522 -0.107 0 C-N-CA 124.407 1.083 . . . . 0.0 110.329 -176.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 81.4 mt -62.05 -8.68 5.7 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.866 1.667 . . . . 0.0 114.811 -176.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.0 m 65.97 30.01 9.92 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.228 1.411 . . . . 0.0 112.182 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.9 t -52.27 -33.06 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 125.636 1.574 . . . . 0.0 110.412 173.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -53.62 -32.97 53.4 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 171.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -84.89 -19.69 31.91 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 118.128 -0.939 . . . . 0.0 112.179 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 41.1 m0 -66.01 160.16 65.28 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -171.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -65.96 132.59 30.66 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.84 1.693 . . . . 0.0 111.361 176.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.1 mt -71.14 139.5 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 162.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.531 ' CE3' ' HE3' ' A' ' 84' ' ' LYS . 69.7 t90 -133.49 122.56 23.81 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 161.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -124.47 159.36 30.68 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.462 1.505 . . . . 0.0 107.818 173.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -157.39 164.05 37.93 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -171.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.29 -176.38 2.62 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 122.425 1.107 . . . . 0.0 110.438 175.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.7 p -68.2 0.33 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 126.323 1.849 . . . . 0.0 112.383 167.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 p -71.74 129.59 39.04 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 120.065 -1.647 . . . . 0.0 110.81 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.51 157.5 16.99 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.238 1.015 . . . . 0.0 110.021 -177.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -164.21 -164.25 0.84 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 126.503 1.921 . . . . 0.0 107.122 -171.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -138.75 157.24 46.45 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 126.09 1.756 . . . . 0.0 108.698 173.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 22.1 t-105 -144.27 138.39 27.93 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.561 0.744 . . . . 0.0 111.181 -174.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -103.15 145.1 30.43 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.714 1.606 . . . . 0.0 107.806 168.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -118.04 123.13 44.92 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.399 1.48 . . . . 0.0 107.737 173.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.71 -5.64 12.13 Favored 'General case' 0 N--CA 1.461 0.092 0 C-N-CA 126.232 1.813 . . . . 0.0 112.564 -170.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.81 175.19 9.9 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 131.512 3.925 . . . . 0.0 106.539 166.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -70.32 139.71 52.1 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -122.52 114.45 20.68 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 163.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 20.0 m -89.79 132.98 34.95 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 159.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 27.4 p -138.89 161.82 36.36 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.338 0.589 . . . . 0.0 110.812 164.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -122.52 128.76 51.2 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.0 mm -87.02 102.3 12.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 128.806 2.842 . . . . 0.0 106.797 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.442 ' O ' ' HE2' ' A' ' 62' ' ' LYS . 2.4 mm? -81.41 -26.5 35.35 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 123.504 0.722 . . . . 0.0 111.062 -174.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -176.67 148.94 0.73 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.144 2.177 . . . . 0.0 106.086 -174.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.26 -177.11 28.43 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.275 1.417 . . . . 0.0 113.788 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.0 148.48 38.62 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.116 0.958 . . . . 0.0 109.748 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.5 t -138.22 156.52 30.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 125.039 1.335 . . . . 0.0 107.731 176.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -120.81 139.05 53.68 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 125.597 1.559 . . . . 0.0 108.066 165.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.9 t -133.93 120.2 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 83.2 m -111.83 105.15 13.54 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.531 1.533 . . . . 0.0 107.902 167.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.0 p -68.08 165.5 17.94 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 173.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -74.32 -14.7 60.93 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 123.278 1.513 . . . . 0.0 113.29 -161.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -52.04 -21.63 3.34 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 127.437 2.295 . . . . 0.0 113.083 161.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.41 4.65 90.08 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.686 1.136 . . . . 0.0 111.868 -165.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -71.1 144.97 50.12 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 119.326 1.563 . . . . 0.0 108.125 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -108.09 145.2 34.4 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -173.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -141.73 132.15 25.2 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 69.4 t -136.36 118.59 20.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 -171.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.1 pt -124.63 106.1 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 O-C-N 123.808 0.693 . . . . 0.0 109.151 -169.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -90.72 178.05 6.17 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 122.677 1.227 . . . . 0.0 109.863 171.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.442 ' HE2' ' O ' ' A' ' 44' ' ' LEU . 22.9 tttm -51.11 108.06 0.22 Allowed 'General case' 0 C--O 1.237 0.423 0 C-N-CA 127.527 2.331 . . . . 0.0 109.805 176.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.52 -16.41 26.58 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 117.591 -1.672 . . . . 0.0 114.65 175.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -70.75 102.17 2.26 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 120.368 2.084 . . . . 0.0 108.901 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.0 tp -71.04 141.38 50.91 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.1 t -125.56 145.06 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 97.3 m -129.7 118.1 21.35 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 158.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -88.45 145.77 36.24 Favored Pre-proline 0 C--O 1.237 0.402 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 162.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -84.27 177.26 5.97 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.286 1.991 . . . . 0.0 112.259 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 30.3 tttm -76.82 81.39 3.41 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 113.95 -1.477 . . . . 0.0 107.851 169.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.59 81.32 0.47 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 125.504 1.526 . . . . 0.0 111.774 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.6 tt -148.2 128.24 13.64 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 118.535 1.167 . . . . 0.0 110.694 174.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.7 116.72 30.58 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.377 1.471 . . . . 0.0 108.436 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 17.6 p -148.85 176.63 10.24 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.509 1.05 . . . . 0.0 113.393 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.11 177.01 9.3 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.981 1.312 . . . . 0.0 111.855 171.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -158.16 100.59 1.7 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 119.932 1.242 . . . . 0.0 109.663 174.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.6 tttt -104.22 111.2 23.71 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.4 t -77.18 116.67 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 N-CA-C 103.157 -2.905 . . . . 0.0 103.157 171.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.9 mt -88.12 -25.52 22.96 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 119.346 -0.941 . . . . 0.0 109.381 171.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -144.36 150.16 47.1 Favored Pre-proline 0 C--O 1.232 0.136 0 CA-C-O 117.819 -1.086 . . . . 0.0 111.051 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -58.81 114.36 1.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.431 2.754 . . . . 0.0 108.232 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.1 p -124.39 143.84 36.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 125.18 1.392 . . . . 0.0 107.446 -163.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.5 mtt180 -115.3 113.57 24.01 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 174.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.531 ' HE3' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -114.37 125.59 54.04 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 167.295 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -76.61 123.53 26.25 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 103.333 -2.84 . . . . 0.0 103.333 169.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -121.66 160.58 24.15 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.058 0.845 . . . . 0.0 110.361 -176.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -142.1 149.59 40.04 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 165.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.5 mt -108.71 129.05 55.36 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.5 p90 . . . . . 0 C--O 1.251 1.172 0 C-N-CA 124.818 1.247 . . . . 0.0 108.597 -173.56 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 p . . . . . 0 C--O 1.236 0.382 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -127.81 147.47 50.43 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.157 1.383 . . . . 0.0 107.379 174.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 90.5 mt -124.73 142.27 42.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 165.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -160.24 177.59 10.49 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.098 1.359 . . . . 0.0 110.283 166.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.448 ' HE2' ' OD1' ' A' ' 64' ' ' ASP . 0.5 OUTLIER -116.86 85.3 17.24 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 124.067 0.947 . . . . 0.0 108.667 -172.237 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.527 ' HG3' HD22 ' A' ' 65' ' ' LEU . 61.6 Cg_endo -72.16 -4.42 15.16 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 124.904 3.736 . . . . 0.0 114.687 -164.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.324 2.1 t 55.44 146.29 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 129.187 2.995 . . . . 0.0 113.39 -169.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -58.04 -17.76 32.81 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.632 2.221 . . . . 0.0 112.2 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -47.44 -61.55 1.86 Allowed 'General case' 0 C--O 1.231 0.112 0 CA-C-N 119.517 1.053 . . . . 0.0 111.297 165.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -67.4 -38.28 84.42 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -178.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.422 HD21 ' HG2' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -72.17 -24.25 61.4 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 118.562 -0.732 . . . . 0.0 112.937 -175.434 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -60.93 -55.1 36.9 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 120.397 1.453 . . . . 0.0 107.541 167.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -74.42 -26.64 60.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.769 -164.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 mp -68.0 -9.92 49.47 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.24 1.416 . . . . 0.0 112.766 170.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.3 m 61.54 33.1 18.56 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.311 1.844 . . . . 0.0 112.369 -174.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.2 t -57.19 -27.59 28.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 O-C-N 121.633 -0.667 . . . . 0.0 111.97 -172.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -54.58 -26.39 32.04 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.763 1.165 . . . . 0.0 113.574 173.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? -86.56 -26.28 24.57 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.004 0.921 . . . . 0.0 111.64 -173.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 36.7 m0 -62.84 160.05 40.19 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 124.623 1.169 . . . . 0.0 109.529 -170.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -69.35 118.59 5.77 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.251 1.967 . . . . 0.0 112.407 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.6 mt -61.98 142.08 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 176.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.598 ' CE3' ' HE3' ' A' ' 84' ' ' LYS . 59.5 t90 -135.3 143.14 46.05 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 165.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -151.93 161.84 42.01 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.701 1.601 . . . . 0.0 111.067 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.0 mmtt -143.84 176.35 9.32 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.291 0.636 . . . . 0.0 109.347 -178.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.471 ' HG3' ' H ' ' A' ' 29' ' ' SER . 6.6 pt-20 -69.82 -165.95 0.1 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.781 2.033 . . . . 0.0 110.756 169.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.5 p -109.85 25.07 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 126.691 1.996 . . . . 0.0 111.447 -175.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.471 ' H ' ' HG3' ' A' ' 27' ' ' GLU . 14.7 t -96.29 -178.34 4.27 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 126.693 1.997 . . . . 0.0 109.199 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -120.79 161.46 21.44 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 123.937 0.895 . . . . 0.0 110.125 173.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -163.75 -168.03 1.53 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.712 2.005 . . . . 0.0 108.248 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -121.29 152.02 39.4 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 168.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 51.9 t-105 -130.97 179.55 5.92 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.607 0.763 . . . . 0.0 109.936 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -148.02 151.27 35.45 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.398 1.479 . . . . 0.0 107.287 171.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -131.41 98.97 4.68 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.624 1.17 . . . . 0.0 108.534 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -90.89 9.86 28.69 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.966 1.706 . . . . 0.0 112.202 -177.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -158.46 162.49 37.53 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 128.486 2.714 . . . . 0.0 108.321 -178.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -61.48 138.29 58.27 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -144.58 104.66 4.07 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.484 HG22 HD11 ' A' ' 65' ' ' LEU . 74.8 m -72.69 143.14 48.19 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 164.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.436 ' O ' HD12 ' A' ' 65' ' ' LEU . 1.7 p -153.53 131.62 11.83 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.49 1.041 . . . . 0.0 111.4 175.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -108.61 108.09 18.83 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 126.349 1.859 . . . . 0.0 108.828 -176.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.3 mm -74.8 114.76 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.812 1.245 . . . . 0.0 107.834 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.3 mp -101.19 -33.48 10.07 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 118.879 -0.581 . . . . 0.0 112.337 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pm0 -154.04 162.73 40.99 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.975 0.91 . . . . 0.0 109.296 172.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.58 -172.37 48.47 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 127.061 2.267 . . . . 0.0 111.32 -173.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.81 148.28 31.73 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -177.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.3 t -136.95 151.96 27.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -123.07 98.01 5.69 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.362 2.265 . . . . 0.0 106.31 168.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.9 t -86.16 136.33 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 170.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 66.8 m -136.45 122.48 20.21 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.183 0.901 . . . . 0.0 108.776 -178.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 72.1 p -76.36 169.81 17.54 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.304 0.573 . . . . 0.0 109.858 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -62.98 -35.9 81.74 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.364 -0.835 . . . . 0.0 110.713 -178.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -82.65 16.16 2.3 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 128.516 2.726 . . . . 0.0 111.694 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.88 4.95 88.74 Favored Glycine 0 CA--C 1.525 0.687 0 O-C-N 119.884 -1.76 . . . . 0.0 114.649 162.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.2 mmtt -67.0 106.78 2.04 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.765 1.783 . . . . 0.0 107.025 167.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.5 tptt -67.2 157.55 33.5 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 163.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -137.0 155.58 49.52 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 104.064 -2.569 . . . . 0.0 104.064 166.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 75.5 t -138.76 129.07 33.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 103.053 -2.943 . . . . 0.0 103.053 178.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.9 pt -134.08 123.23 43.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -103.67 176.12 5.26 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 126.725 2.01 . . . . 0.0 107.817 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.3 pttp -58.11 125.2 22.16 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 164.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.8 -0.07 56.45 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 117.702 -1.61 . . . . 0.0 115.688 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.448 ' OD1' ' HE2' ' A' ' 7' ' ' LYS . 19.1 m-20 -92.1 123.82 35.73 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 120.832 2.316 . . . . 0.0 106.567 166.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.527 HD22 ' HG3' ' A' ' 8' ' ' PRO . 14.2 tp -88.15 146.73 25.25 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 160.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.4 t -126.07 150.51 31.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 174.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 58.4 m -132.96 111.41 11.01 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 164.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -74.43 155.69 87.52 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 169.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -74.79 -165.2 0.27 Allowed 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.168 2.579 . . . . 0.0 109.381 174.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -95.25 120.82 36.14 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 162.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.97 87.66 1.06 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.401 1.477 . . . . 0.0 112.634 176.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 57.9 tp -143.88 143.54 31.34 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.952 1.701 . . . . 0.0 108.207 171.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.47 131.28 56.98 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 125.339 1.456 . . . . 0.0 108.11 167.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 7.8 p -165.43 168.43 16.67 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.48 1.112 . . . . 0.0 111.362 169.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.88 167.96 20.85 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 124.578 1.151 . . . . 0.0 112.028 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -144.4 113.11 6.68 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.462 1.105 . . . . 0.0 109.755 178.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.53 109.27 19.53 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 175.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.0 t -86.8 101.26 10.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 175.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.9 mt -83.39 -18.9 37.18 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-O 118.777 -0.63 . . . . 0.0 111.717 -175.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -148.25 146.15 22.4 Favored Pre-proline 0 C--O 1.236 0.356 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 166.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -61.54 90.74 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.491 1 C-N-CA 125.542 4.161 . . . . 0.0 110.87 -165.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.35 149.31 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 123.936 0.895 . . . . 0.0 109.754 -166.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -129.35 112.6 14.01 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 168.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.598 ' HE3' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -133.28 142.15 48.35 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.266 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -84.34 100.89 11.56 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 171.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -88.8 154.86 19.93 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.154 0.982 . . . . 0.0 110.546 171.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -151.54 112.93 4.35 Favored 'General case' 0 C--O 1.239 0.523 0 O-C-N 121.676 -0.64 . . . . 0.0 110.517 170.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 61.7 mt -61.59 153.29 28.19 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.406 1.482 . . . . 0.0 108.932 171.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.7 p90 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 116.173 -1.87 . . . . 0.0 110.443 166.332 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.8 p . . . . . 0 CA--C 1.533 0.3 0 N-CA-C 108.588 -0.894 . . . . 0.0 108.588 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 55.9 tttt -75.7 136.68 40.36 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 171.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.3 mt -135.73 139.74 45.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 169.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -165.32 175.22 9.36 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.145 2.178 . . . . 0.0 108.728 162.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.31 86.35 1.32 Allowed Pre-proline 0 C--O 1.237 0.444 0 CA-C-O 117.88 -1.057 . . . . 0.0 109.19 176.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -63.92 168.01 12.91 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.522 1.481 . . . . 0.0 111.014 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.0 t -69.85 143.5 92.18 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -66.42 -19.4 55.29 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.897 1.731 . . . . 0.0 113.178 176.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -59.89 -47.61 85.06 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 119.733 1.151 . . . . 0.0 109.622 171.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 35.9 tptt -65.34 -37.48 87.19 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 121.45 -0.781 . . . . 0.0 110.451 -177.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.3 mt -67.97 -26.91 66.17 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 118.833 -0.603 . . . . 0.0 111.917 177.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -64.83 -46.87 80.13 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 119.386 0.994 . . . . 0.0 109.814 168.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -60.07 -48.58 81.12 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.387 0.613 . . . . 0.0 109.384 -176.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.7 mp -55.03 -14.76 1.65 Allowed 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 125.947 1.699 . . . . 0.0 112.817 176.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.4 m 53.01 45.01 29.69 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.015 1.326 . . . . 0.0 110.743 175.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 45.8 t -56.59 -31.45 34.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.27 1.028 . . . . 0.0 110.505 -175.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -44.92 -34.56 2.44 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.858 2.063 . . . . 0.0 114.454 167.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.9 mtmm -84.12 -23.53 30.66 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 119.531 1.059 . . . . 0.0 111.418 -177.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.401 ' CE3' ' HB2' ' A' ' 87' ' ' ASN . 35.1 m0 -64.72 164.43 20.84 Favored Pre-proline 0 C--O 1.24 0.574 0 C-N-CA 124.118 0.967 . . . . 0.0 109.816 -171.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -66.6 139.97 55.15 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 121.118 1.212 . . . . 0.0 110.144 171.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.2 mt -81.18 151.98 4.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 164.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.514 ' CE3' ' HE2' ' A' ' 84' ' ' LYS . 68.3 t90 -140.79 148.0 39.93 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 156.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.7 157.07 44.66 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 126.615 1.966 . . . . 0.0 109.169 -178.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -151.02 169.59 21.42 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.482 0.713 . . . . 0.0 111.625 -174.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -66.18 175.07 2.26 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 122.715 1.245 . . . . 0.0 111.006 164.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.3 t -94.62 27.4 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 128.418 2.687 . . . . 0.0 109.866 -167.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.9 t -91.99 176.59 6.45 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.573 1.149 . . . . 0.0 110.521 -173.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -104.61 142.55 34.46 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.448 1.099 . . . . 0.0 108.092 167.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -147.08 -170.34 3.52 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 127.644 2.377 . . . . 0.0 107.392 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.62 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 1.1 m-20 -128.3 154.87 45.45 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 169.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 48.1 t-105 -134.77 146.05 48.99 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.025 0.53 . . . . 0.0 111.787 175.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -113.82 111.11 21.2 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 171.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -79.49 122.61 26.67 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 170.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.9 p-10 -120.19 6.58 10.74 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 125.916 1.687 . . . . 0.0 111.323 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.96 174.31 15.71 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.082 1.353 . . . . 0.0 108.85 167.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -68.33 87.12 0.29 Allowed 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 125.584 1.554 . . . . 0.0 108.773 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.33 110.32 18.02 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 173.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 73.0 m -88.14 134.7 33.7 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 163.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 24.6 p -140.23 149.18 42.56 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 118.714 0.688 . . . . 0.0 110.053 170.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -126.92 116.71 21.23 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.466 1.507 . . . . 0.0 107.979 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 18.9 mm -80.83 124.96 39.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 126.911 2.084 . . . . 0.0 107.567 -172.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.2 mt -103.12 -26.9 12.86 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 118.634 0.652 . . . . 0.0 112.486 -176.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -158.95 169.39 24.44 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.547 1.939 . . . . 0.0 107.404 174.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.23 -172.26 25.2 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.099 0.857 . . . . 0.0 113.078 169.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.95 143.57 30.61 Favored 'General case' 0 CA--C 1.517 -0.307 0 O-C-N 121.526 -0.985 . . . . 0.0 108.363 175.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 71.6 t -138.48 155.97 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -124.55 127.02 46.78 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 126.381 1.872 . . . . 0.0 106.345 163.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.1 t -113.53 113.06 42.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.53 ' HB ' ' HG2' ' A' ' 75' ' ' ARG . 26.2 m -114.72 103.01 10.56 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 -168.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 38.2 p -78.1 173.15 12.53 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -54.65 -40.6 69.17 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.651 0.78 . . . . 0.0 110.578 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -65.09 -17.38 64.41 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 123.794 0.838 . . . . 0.0 112.361 -175.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.68 0.7 88.26 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -163.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.1 mmtp -63.06 118.36 7.76 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 164.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -130.05 133.29 46.62 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -162.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -127.27 116.64 20.87 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -170.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 77.6 t -76.76 144.88 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 160.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.9 pt -140.92 147.4 22.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 C-N-CA 124.795 1.238 . . . . 0.0 108.914 166.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -138.89 -175.33 4.11 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 126.939 2.096 . . . . 0.0 110.374 176.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -66.85 62.88 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 128.132 2.573 . . . . 0.0 115.795 -162.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 159.6 -6.9 0.13 Allowed Glycine 0 C--N 1.317 -0.475 0 CA-C-O 118.021 -1.433 . . . . 0.0 114.027 -178.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -71.47 128.53 36.15 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 166.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 17.0 tp -88.76 142.09 27.96 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 160.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.6 t -122.35 141.05 44.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 175.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.3 m -127.11 101.21 6.43 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 167.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -65.03 161.82 44.37 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 170.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -71.42 -164.03 0.15 Allowed 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.974 2.45 . . . . 0.0 108.684 167.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -110.14 108.85 19.16 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 165.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.69 85.64 1.88 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.453 1.502 . . . . 0.0 110.669 -175.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.1 tt -147.57 113.81 5.89 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.616 1.966 . . . . 0.0 107.499 173.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.1 ttt180 -81.98 133.18 35.28 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 161.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 29.2 p -147.32 -170.66 3.61 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.507 0.67 . . . . 0.0 109.896 159.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.62 ' HA ' ' HA ' ' A' ' 32' ' ' ASP . 5.8 ptp180 -108.06 164.7 12.06 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 173.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -134.07 122.87 23.57 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 119.591 1.087 . . . . 0.0 110.085 175.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.1 tttp -116.18 105.97 13.18 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.5 t -72.92 129.52 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 103.536 -2.764 . . . . 0.0 103.536 166.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 95.0 mt -109.9 -16.36 13.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 117.659 -1.162 . . . . 0.0 110.407 173.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -154.13 145.12 16.26 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 126.594 1.958 . . . . 0.0 107.61 167.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -56.92 125.87 20.38 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 124.345 3.363 . . . . 0.0 111.587 -167.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.419 ' O ' HG13 ' A' ' 82' ' ' VAL . 8.7 p -121.45 92.76 2.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-O 124.978 2.323 . . . . 0.0 111.491 -161.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.9 mtm-85 -78.95 119.57 22.3 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 170.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.514 ' HE2' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -128.78 157.17 42.2 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.69 0.757 . . . . 0.0 109.257 173.016 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -94.79 135.85 35.8 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 161.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -130.15 160.48 33.67 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 123.052 0.541 . . . . 0.0 109.871 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.401 ' HB2' ' CE3' ' A' ' 21' ' ' TRP . 27.3 t-20 -156.55 103.43 2.12 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -172.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 65.5 mt -75.48 145.53 41.35 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 171.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 45.2 p90 . . . . . 0 C--O 1.252 1.187 0 CA-C-O 114.576 -2.63 . . . . 0.0 111.156 164.96 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 74.3 t . . . . . 0 N--CA 1.446 -0.654 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.7 tptp -82.2 134.92 35.32 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 168.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.9 mt -140.81 120.2 11.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 168.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -138.45 175.16 9.81 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.323 1.449 . . . . 0.0 109.986 172.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.53 85.47 5.92 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 170.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -65.71 165.24 23.83 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.364 2.043 . . . . 0.0 112.111 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.19 144.72 84.95 Favored Pre-proline 0 C--O 1.239 0.553 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -68.15 -30.74 31.0 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.855 2.37 . . . . 0.0 112.334 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -56.84 -44.04 81.69 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.956 0.798 . . . . 0.0 110.686 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -64.64 -36.95 85.9 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.193 0.597 . . . . 0.0 109.493 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.494 HD21 ' CD1' ' A' ' 65' ' ' LEU . 96.1 mt -69.09 -28.54 66.58 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.894 -0.504 . . . . 0.0 112.225 177.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -55.56 -50.82 69.05 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 169.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -60.43 -52.78 63.78 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.408 1.083 . . . . 0.0 110.999 -176.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.453 HD12 HD23 ' A' ' 13' ' ' LEU . 93.1 mt -56.39 -20.76 21.02 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 125.962 1.705 . . . . 0.0 112.789 -178.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 74.3 42.51 0.32 Allowed 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.768 2.027 . . . . 0.0 111.149 170.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.7 t -54.33 -33.1 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 118.304 0.502 . . . . 0.0 110.765 -173.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -58.24 -24.76 60.39 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.0 pttp -83.76 -5.66 59.25 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.48 0.712 . . . . 0.0 111.049 -171.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 23.0 m0 -87.54 165.05 32.5 Favored Pre-proline 0 N--CA 1.438 -1.06 0 C-N-CA 124.922 1.289 . . . . 0.0 107.881 -169.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -66.93 135.16 36.88 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 121.653 1.569 . . . . 0.0 110.638 167.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 68.5 mt -78.9 143.1 13.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 164.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -127.24 153.15 46.48 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 162.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -150.72 162.69 40.22 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.902 1.281 . . . . 0.0 109.543 176.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -148.78 157.94 43.8 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 124.957 1.303 . . . . 0.0 109.565 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.3 pm0 -69.47 170.91 9.63 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 124.726 1.266 . . . . 0.0 112.061 167.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.4 t -82.49 74.21 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 125.79 1.636 . . . . 0.0 106.829 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.0 t -145.62 -173.12 4.04 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 175.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.96 149.32 30.22 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 122.417 1.103 . . . . 0.0 112.922 -169.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -157.53 -168.25 2.52 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.146 1.779 . . . . 0.0 108.093 -163.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 37.0 p30 -119.91 160.64 22.31 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.257 -0.902 . . . . 0.0 108.648 166.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 10.2 t-105 -128.75 168.11 16.32 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.568 0.699 . . . . 0.0 111.257 172.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -142.32 92.35 2.42 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.722 1.609 . . . . 0.0 107.934 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -72.2 118.93 15.69 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 171.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -111.72 -5.12 14.49 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.344 1.458 . . . . 0.0 111.691 -176.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.53 172.56 12.53 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 127.167 2.187 . . . . 0.0 110.233 164.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -62.16 107.64 0.92 Allowed 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 176.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -121.3 75.11 1.14 Allowed 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -175.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.9 m -67.5 135.83 53.63 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 -175.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 29.3 p -142.54 155.96 45.07 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 120.966 0.413 . . . . 0.0 110.128 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.421 ' HD1' ' HG ' ' A' ' 65' ' ' LEU . 30.8 t80 -132.66 121.0 22.48 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.323 -170.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 16.1 mm -81.07 124.84 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -174.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.2 mt -122.45 -33.71 3.4 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.439 1.096 . . . . 0.0 111.51 -167.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -154.48 162.34 41.2 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 127.39 2.276 . . . . 0.0 105.252 165.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.44 176.51 51.05 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 124.695 1.14 . . . . 0.0 112.186 177.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.26 144.48 27.67 Favored 'General case' 0 CA--C 1.516 -0.356 0 O-C-N 122.249 -0.559 . . . . 0.0 110.27 -156.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 50.6 t -143.65 152.14 16.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-N 117.692 0.223 . . . . 0.0 110.57 -176.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -109.27 128.0 54.72 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.446 1.899 . . . . 0.0 106.951 153.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 94.0 t -107.42 140.06 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 105.726 -1.954 . . . . 0.0 105.726 170.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.9 m -136.47 104.3 5.54 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.442 1.019 . . . . 0.0 109.72 -173.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.0 p -69.74 169.93 11.95 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.182 -0.949 . . . . 0.0 110.518 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -67.67 -29.7 69.05 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.511 -0.743 . . . . 0.0 110.774 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.74 -4.17 2.91 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.085 1.354 . . . . 0.0 112.279 172.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.38 -3.46 86.25 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-O 118.436 -1.202 . . . . 0.0 113.637 167.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -58.38 152.52 17.52 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 167.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -103.64 161.69 13.7 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 156.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -118.93 159.1 24.43 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 153.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 72.8 t -137.47 128.38 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 102.185 -3.265 . . . . 0.0 102.185 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 pt -139.61 142.95 31.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.432 ' OE1' ' HE3' ' A' ' 62' ' ' LYS . 1.3 pp20? -131.71 -176.22 3.97 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.192 1.797 . . . . 0.0 111.771 177.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.432 ' HE3' ' OE1' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -75.23 54.49 0.7 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.38 2.272 . . . . 0.0 115.844 -157.287 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -177.63 -5.81 0.02 OUTLIER Glycine 0 CA--C 1.53 0.981 0 CA-C-O 118.183 -1.343 . . . . 0.0 113.166 172.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.94 140.83 36.51 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 119.253 1.526 . . . . 0.0 108.236 174.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.494 ' CD1' HD21 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -98.08 153.82 18.16 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 123.818 0.847 . . . . 0.0 109.592 167.596 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.8 t -137.07 137.53 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -174.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 98.0 m -131.15 110.48 11.19 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 166.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -73.53 162.9 72.12 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 126.142 1.777 . . . . 0.0 109.207 167.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -83.47 177.1 6.63 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 CA-C-O 122.921 1.134 . . . . 0.0 110.002 169.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.3 tttm -85.55 82.69 8.16 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.084 1.353 . . . . 0.0 107.715 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.21 86.44 0.66 Allowed Glycine 0 CA--C 1.522 0.522 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.9 tp -148.94 103.57 3.37 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.461 0.704 . . . . 0.0 110.823 174.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 27.2 ttt85 -72.86 126.89 31.0 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 156.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 20.4 p -154.14 170.68 20.61 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.899 1.279 . . . . 0.0 108.19 166.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' A' ' 32' ' ' ASP . 1.6 mpp_? -79.81 158.68 26.75 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 120.956 -1.09 . . . . 0.0 110.89 172.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -139.4 116.34 10.94 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.347 1.459 . . . . 0.0 108.433 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.0 102.39 8.14 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.632 1.573 . . . . 0.0 106.921 -173.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.2 t -80.26 105.22 9.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 104.402 -2.444 . . . . 0.0 104.402 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 17.6 mt -81.91 -27.45 33.38 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -151.22 153.62 32.88 Favored Pre-proline 0 N--CA 1.469 0.484 0 C-N-CA 125.67 1.588 . . . . 0.0 109.439 171.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -65.0 106.47 0.79 Allowed 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.125 2.55 . . . . 0.0 111.16 -164.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.3 p -93.17 111.31 24.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 121.774 0.797 . . . . 0.0 110.611 -166.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -94.45 43.12 1.1 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.754 0.821 . . . . 0.0 111.42 -171.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.62 146.98 39.0 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 120.967 -1.083 . . . . 0.0 111.133 -175.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -78.03 150.05 33.91 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 156.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -139.87 156.88 46.48 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.328 0.967 . . . . 0.0 110.545 172.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -143.36 131.91 22.37 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.143 0.977 . . . . 0.0 109.4 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 95.2 mt -93.01 129.83 38.79 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.297 1.039 . . . . 0.0 108.59 176.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.3 p90 . . . . . 0 C--O 1.247 0.949 0 C-N-CA 124.298 1.039 . . . . 0.0 110.231 -177.171 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.239 0.52 0 CA-C-O 121.594 0.711 . . . . 0.0 110.06 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -109.68 147.82 32.46 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 125.564 1.546 . . . . 0.0 107.961 -176.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.8 mt -139.31 139.32 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 104.04 -2.578 . . . . 0.0 104.04 177.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -154.6 -178.95 7.54 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.729 0.812 . . . . 0.0 109.848 167.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.1 81.16 27.98 Favored Pre-proline 0 C--O 1.236 0.365 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -175.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.64 169.23 22.39 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.329 2.019 . . . . 0.0 111.462 -170.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.702 HG23 ' H ' ' A' ' 12' ' ' LYS . 6.9 t -66.26 145.02 98.96 Favored Pre-proline 0 CA--C 1.543 0.703 0 O-C-N 121.983 -0.448 . . . . 0.0 109.943 171.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.411 ' HA ' HD12 ' A' ' 13' ' ' LEU . 72.8 Cg_endo -67.01 -5.2 12.97 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.888 2.392 . . . . 0.0 112.716 169.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -87.8 -51.74 5.69 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.542 1.064 . . . . 0.0 110.752 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.702 ' H ' HG23 ' A' ' 9' ' ' THR . 1.5 tptt -49.92 -45.89 51.52 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.354 1.062 . . . . 0.0 110.207 172.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 10' ' ' PRO . 34.1 mt -54.97 -33.29 62.29 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.346 1.058 . . . . 0.0 112.555 178.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.0 mttp -63.76 -51.5 64.57 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 118.911 0.778 . . . . 0.0 109.006 176.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -57.51 -49.11 77.38 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 123.001 1.382 . . . . 0.0 109.827 -172.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 98.5 mt -56.48 -12.04 1.55 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.204 1.801 . . . . 0.0 112.035 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.0 m 62.39 32.6 16.77 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.527 1.931 . . . . 0.0 111.05 174.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.412 ' HA ' ' CD2' ' A' ' 21' ' ' TRP . 59.6 t -50.81 -39.62 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 126.657 1.983 . . . . 0.0 110.496 175.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -57.68 -19.33 26.13 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -92.05 -25.43 18.79 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 124.297 1.039 . . . . 0.0 111.586 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.412 ' CD2' ' HA ' ' A' ' 18' ' ' VAL . 41.9 m0 -60.45 158.01 32.23 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 124.297 1.039 . . . . 0.0 109.49 -174.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.39 118.5 5.68 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.046 1.83 . . . . 0.0 111.401 -175.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.2 mt -62.09 144.75 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 174.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.558 ' CZ3' ' HE3' ' A' ' 84' ' ' LYS . 91.0 t90 -132.59 138.32 47.38 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 165.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -136.2 157.28 47.19 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 128.402 2.681 . . . . 0.0 108.622 -177.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.5 tptt -153.85 166.4 33.04 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 121.973 -0.454 . . . . 0.0 109.94 -177.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.84 175.19 3.77 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 122.25 1.024 . . . . 0.0 110.681 167.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.6 p -80.8 -6.93 10.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 113.381 -1.736 . . . . 0.0 112.533 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.1 t -73.88 152.14 40.28 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 122.863 1.316 . . . . 0.0 109.743 174.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -84.27 168.28 15.82 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 129.132 2.973 . . . . 0.0 109.929 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -169.35 -164.01 0.43 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.954 2.502 . . . . 0.0 107.176 176.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -122.55 164.05 18.84 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 120.206 -1.559 . . . . 0.0 107.213 157.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 54.5 t-105 -134.52 168.94 18.05 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.791 0.836 . . . . 0.0 109.791 -173.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -135.87 153.7 51.39 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.259 1.423 . . . . 0.0 107.858 175.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -134.42 120.23 19.54 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 170.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -123.79 27.29 7.34 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.923 1.238 . . . . 0.0 111.811 168.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.65 172.08 15.14 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 152.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -70.23 107.43 3.71 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 -171.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -107.58 98.87 8.42 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -173.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 88.2 m -68.7 148.0 51.03 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 161.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.7 p -146.75 159.51 43.41 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 121.468 -0.77 . . . . 0.0 111.539 154.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -126.16 126.05 43.49 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 126.385 1.874 . . . . 0.0 107.862 176.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.9 mm -101.28 111.77 32.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 123.24 0.616 . . . . 0.0 109.35 -169.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.0 mp -93.12 -29.65 15.65 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 123.945 0.898 . . . . 0.0 111.769 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -159.33 166.12 31.88 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.51 0.724 . . . . 0.0 109.086 -177.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.17 -178.85 52.91 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.631 1.11 . . . . 0.0 113.218 -177.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.55 ' HE3' HG23 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -148.64 143.17 26.35 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 125.028 1.331 . . . . 0.0 107.583 -178.653 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.9 t -139.17 149.22 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 176.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -116.87 88.6 2.93 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 103.448 -2.797 . . . . 0.0 103.448 166.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.3 t -75.64 144.39 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 173.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.5 m -145.69 115.06 7.13 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 120.062 1.301 . . . . 0.0 109.052 -175.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 57.5 p -65.72 162.59 18.28 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.94 -21.89 61.54 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.149 -0.97 . . . . 0.0 110.797 175.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -79.48 22.68 0.43 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.239 1.816 . . . . 0.0 111.232 165.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.74 -5.95 10.47 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 125.685 1.612 . . . . 0.0 115.637 166.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -66.95 110.41 3.34 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 119.939 1.869 . . . . 0.0 108.006 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt -87.69 134.08 33.72 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -130.41 85.01 2.24 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 124.26 1.981 . . . . 0.0 108.585 168.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.55 HG23 ' HE3' ' A' ' 47' ' ' LYS . 1.6 p -56.85 136.35 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 CA-C-N 112.51 -2.132 . . . . 0.0 108.646 146.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 pt -139.3 132.97 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 101.719 -3.437 . . . . 0.0 101.719 173.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -90.46 -176.72 4.86 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 121.893 0.854 . . . . 0.0 108.919 171.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -66.16 126.16 27.79 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 147.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 117.61 14.41 6.87 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-O 118.051 -1.416 . . . . 0.0 114.296 -175.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -119.85 149.31 42.28 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.036 1.334 . . . . 0.0 108.545 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.7 tp -109.1 145.16 36.14 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 156.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.3 t -130.26 153.95 39.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 125.461 1.504 . . . . 0.0 107.476 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.0 m -135.31 108.6 7.78 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 161.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -79.01 153.53 77.48 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 123.831 0.852 . . . . 0.0 109.177 169.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.74 171.42 17.35 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 121.848 1.699 . . . . 0.0 111.305 173.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.9 tttt -78.1 106.67 10.13 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 111.485 -2.598 . . . . 0.0 106.21 161.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.66 70.09 0.9 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.702 1.62 . . . . 0.0 111.918 171.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.1 tp -140.68 150.89 44.07 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.104 1.762 . . . . 0.0 109.125 176.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.35 134.2 43.45 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 126.924 2.09 . . . . 0.0 108.219 176.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 6.0 p -159.52 164.83 34.03 Favored 'General case' 0 C--N 1.334 -0.077 0 C-N-CA 123.082 0.553 . . . . 0.0 111.686 176.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.39 164.24 16.62 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 123.029 0.532 . . . . 0.0 112.009 167.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -144.37 104.9 4.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.859 1.264 . . . . 0.0 108.219 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.7 ttpm? -101.88 111.28 23.48 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 169.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.2 t -77.65 125.84 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 168.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.1 mt -103.03 -16.1 15.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 118.313 -0.851 . . . . 0.0 111.448 168.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -147.85 144.45 19.13 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 117.543 -1.218 . . . . 0.0 109.299 171.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -61.97 100.43 0.2 Allowed 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 124.24 3.293 . . . . 0.0 111.299 -174.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.5 p -70.51 156.49 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 124.535 1.134 . . . . 0.0 111.232 -169.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -139.99 110.21 6.57 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 103.435 -2.802 . . . . 0.0 103.435 161.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.558 ' HE3' ' CZ3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -132.16 148.26 52.46 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.217 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -90.56 101.04 13.78 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 105.674 -1.972 . . . . 0.0 105.674 174.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -90.92 159.16 16.34 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.69 0.677 . . . . 0.0 110.074 170.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -154.04 140.82 19.08 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 121.44 -0.788 . . . . 0.0 109.972 159.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 42.9 mt -84.23 165.92 17.97 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 124.484 1.113 . . . . 0.0 109.172 175.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.1 p90 . . . . . 0 C--O 1.255 1.367 0 CA-C-O 116.224 -1.846 . . . . 0.0 108.227 164.124 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.9 t . . . . . 0 C--O 1.238 0.468 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.6 ttpt -115.0 91.45 3.62 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 176.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.509 ' CG1' HG13 ' A' ' 66' ' ' VAL . 22.8 mt -87.77 139.77 16.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 167.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -154.06 171.8 18.51 Favored 'General case' 0 C--O 1.224 -0.26 0 O-C-N 123.998 0.811 . . . . 0.0 111.008 163.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.92 75.77 75.99 Favored Pre-proline 0 N--CA 1.47 0.572 0 C-N-CA 123.419 0.688 . . . . 0.0 111.368 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.468 ' HG2' HD21 ' A' ' 13' ' ' LEU . 41.5 Cg_endo -67.71 172.34 10.7 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 125.183 3.922 . . . . 0.0 114.234 -173.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.6 t -66.19 144.3 98.69 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.191 0.996 . . . . 0.0 109.913 173.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.25 -25.07 50.25 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.734 1.623 . . . . 0.0 112.924 176.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -61.24 -55.08 36.06 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.601 0.761 . . . . 0.0 109.184 -177.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -53.34 -38.16 62.99 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.327 1.051 . . . . 0.0 111.208 176.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.468 HD21 ' HG2' ' A' ' 8' ' ' PRO . 4.3 mm? -71.54 -22.19 61.79 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.325 -176.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -64.93 -48.88 72.55 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 120.053 1.297 . . . . 0.0 108.853 166.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -66.3 -37.93 86.55 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.281 0.632 . . . . 0.0 111.466 -167.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 34.4 mt -55.55 -12.09 1.07 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.93 1.292 . . . . 0.0 113.165 173.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.2 m 63.98 39.57 7.89 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.764 2.025 . . . . 0.0 109.668 172.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.6 t -53.63 -35.62 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 128.302 2.641 . . . . 0.0 110.55 173.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -61.48 -11.98 12.97 Favored 'General case' 0 CA--C 1.548 0.87 0 O-C-N 121.033 -1.042 . . . . 0.0 113.296 173.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.0 mttt -103.13 -3.73 25.44 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 126.271 1.828 . . . . 0.0 112.494 176.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 32.6 m0 -79.99 165.27 48.22 Favored Pre-proline 0 CA--C 1.538 0.49 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 176.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.52 136.13 35.56 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 121.492 1.461 . . . . 0.0 111.455 170.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.5 mt -76.09 149.69 6.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 165.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.483 ' CZ3' ' HE3' ' A' ' 84' ' ' LYS . 6.4 t90 -146.17 148.53 32.64 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.953 1.301 . . . . 0.0 108.261 164.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -138.06 163.22 32.15 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.277 2.231 . . . . 0.0 109.763 -177.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -145.99 159.72 42.85 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.597 1.089 . . . . 0.0 111.309 168.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -61.81 173.92 0.93 Allowed 'General case' 0 C--O 1.232 0.174 0 O-C-N 125.212 1.57 . . . . 0.0 110.792 163.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.9 t -90.78 33.72 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 125.865 1.666 . . . . 0.0 109.885 -173.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.9 t -107.25 -179.04 3.81 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 120.522 -1.361 . . . . 0.0 109.637 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -124.81 144.02 50.5 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.867 1.267 . . . . 0.0 109.724 -171.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -156.54 -164.93 1.76 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.349 1.06 . . . . 0.0 109.145 -174.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.51 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 0.7 OUTLIER -131.34 150.23 52.23 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.945 1.698 . . . . 0.0 109.482 172.503 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 29.6 t-105 -133.97 142.51 47.7 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 123.35 0.406 . . . . 0.0 111.135 177.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -106.7 125.13 50.62 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 173.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -103.67 106.8 17.41 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 168.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -104.08 17.79 23.39 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.469 1.031 . . . . 0.0 111.471 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.89 168.14 26.08 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.177 1.391 . . . . 0.0 109.562 166.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -62.97 124.9 22.28 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 126.236 1.814 . . . . 0.0 107.303 -178.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -140.46 109.37 6.04 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.44 ' CG2' HD11 ' A' ' 65' ' ' LEU . 24.6 m -77.82 148.02 34.92 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 163.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 25.6 p -142.92 147.33 35.1 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 157.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -109.35 128.7 55.31 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 172.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.8 mm -90.83 129.3 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -108.99 -37.21 5.89 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.012 1.725 . . . . 0.0 113.033 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -163.7 161.11 23.38 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.098 1.759 . . . . 0.0 109.585 175.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.05 -163.64 12.88 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.056 1.312 . . . . 0.0 111.638 -174.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.404 ' HE3' ' O ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -150.82 145.12 25.5 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.618 1.209 . . . . 0.0 108.011 157.206 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.404 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 65.6 t -134.46 150.2 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 174.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -118.95 143.08 47.23 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 157.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.6 t -120.42 96.84 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 175.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.4 m -78.51 104.94 9.45 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 174.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.459 ' HA ' ' SG ' ' A' ' 74' ' ' CYS . 23.9 p -78.32 171.68 14.71 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -60.34 -31.92 70.77 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.062 -1.023 . . . . 0.0 111.904 -177.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.46 -15.43 60.68 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 127.578 2.351 . . . . 0.0 111.674 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.83 -2.93 87.7 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 124.641 1.115 . . . . 0.0 114.174 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.7 mmtp -59.75 142.25 53.6 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 163.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.0 ptmm? -125.7 94.11 4.03 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 123.118 1.437 . . . . 0.0 107.8 -176.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.441 ' HB3' HD11 ' A' ' 5' ' ' ILE . 92.4 m-85 -89.11 87.43 7.18 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 123.991 1.853 . . . . 0.0 109.01 -175.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.5 p -55.13 144.1 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 CA-C-N 112.092 -2.322 . . . . 0.0 111.103 149.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 pt -144.78 137.3 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 129.478 3.111 . . . . 0.0 104.094 176.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -109.29 -177.25 3.24 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 125.551 1.54 . . . . 0.0 109.412 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.5 pttt -64.62 42.47 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 130.238 3.415 . . . . 0.0 116.446 -174.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -179.46 11.91 0.03 OUTLIER Glycine 0 CA--C 1.524 0.608 0 C-N-CA 124.962 1.268 . . . . 0.0 113.251 169.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.98 131.04 40.36 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.54 1.67 . . . . 0.0 107.022 175.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.44 HD11 ' CG2' ' A' ' 40' ' ' THR . 26.0 tp -99.3 91.61 5.04 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.332 1.453 . . . . 0.0 108.025 164.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.509 HG13 ' CG1' ' A' ' 5' ' ' ILE 0.631 0.1 OUTLIER -61.89 145.96 12.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 120.808 3.632 . . . . 0.0 120.808 153.042 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.2 m -135.4 121.98 20.75 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 128.289 2.636 . . . . 0.0 105.761 162.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -92.61 148.32 35.97 Favored Pre-proline 0 C--O 1.237 0.422 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 170.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -78.14 179.73 6.22 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.937 2.425 . . . . 0.0 110.16 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -85.77 93.95 9.0 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 114.65 93.57 1.95 Allowed Glycine 0 CA--C 1.523 0.534 0 C-N-CA 125.175 1.369 . . . . 0.0 109.802 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.3 tt -151.23 133.34 15.22 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.038 1.335 . . . . 0.0 108.858 175.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 65.6 ttt-85 -130.23 81.87 2.03 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.616 1.098 . . . . 0.0 111.056 -175.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.459 ' SG ' ' HA ' ' A' ' 52' ' ' THR . 87.0 m -137.2 154.8 50.11 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 122.205 1.002 . . . . 0.0 112.634 -168.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.51 ' HA ' ' HA ' ' A' ' 32' ' ' ASP . 0.7 OUTLIER -70.27 152.53 44.08 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 114.043 -1.435 . . . . 0.0 109.858 -174.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -131.58 110.46 10.97 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.927 1.691 . . . . 0.0 107.215 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.4 tttp -108.73 107.96 18.61 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -177.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.5 t -86.09 102.57 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.1 mt -83.95 -21.84 31.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 118.493 -0.765 . . . . 0.0 110.509 175.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -152.6 151.9 27.77 Favored Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 173.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -72.1 86.28 0.95 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 125.05 3.833 . . . . 0.0 111.801 -158.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.3 p -71.69 139.79 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 123.912 0.885 . . . . 0.0 109.251 -172.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.0 ttt180 -120.8 59.37 0.92 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.986 0.898 . . . . 0.0 110.044 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.483 ' HE3' ' CZ3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -70.47 162.13 29.3 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 119.37 -2.081 . . . . 0.0 109.71 -172.554 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -101.18 125.35 47.8 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 104.375 -2.454 . . . . 0.0 104.375 167.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -115.53 160.87 19.4 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.478 1.036 . . . . 0.0 109.251 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -151.01 127.63 10.82 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 118.789 0.722 . . . . 0.0 109.237 173.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 19.8 mt -87.83 139.04 30.93 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 126.411 1.884 . . . . 0.0 108.015 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 34.0 p90 . . . . . 0 C--O 1.259 1.604 0 CA-C-O 117.335 -1.317 . . . . 0.0 110.397 179.063 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 91.5 t . . . . . 0 CA--C 1.543 0.693 0 CA-C-O 121.27 0.557 . . . . 0.0 111.717 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.16 130.81 44.3 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 177.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.0 mt -143.32 134.47 22.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 173.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -159.38 173.73 15.81 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.337 0.655 . . . . 0.0 110.199 172.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.82 85.3 4.87 Favored Pre-proline 0 C--O 1.234 0.256 0 C-N-CA 124.288 1.035 . . . . 0.0 108.911 177.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.87 169.91 19.18 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.248 2.632 . . . . 0.0 112.925 -176.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 t -69.63 149.79 96.85 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.82 1.248 . . . . 0.0 110.642 174.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.09 -31.16 75.91 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.834 2.356 . . . . 0.0 113.79 173.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -63.26 -53.56 50.98 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 118.65 0.659 . . . . 0.0 110.672 -171.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.5 tttp -54.42 -48.48 71.59 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 124.833 1.253 . . . . 0.0 109.298 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.4 mt -58.02 -41.02 82.27 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.933 0.893 . . . . 0.0 112.019 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -59.94 -46.96 87.7 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.012 173.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -59.28 -45.77 90.35 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.129 0.877 . . . . 0.0 110.065 -178.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 59.8 mt -57.16 -12.02 2.0 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.572 1.949 . . . . 0.0 113.05 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.3 m 64.11 39.81 7.43 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.956 1.702 . . . . 0.0 111.844 168.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.3 t -58.03 -26.69 29.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 126.743 2.017 . . . . 0.0 111.92 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -61.53 -20.57 63.38 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 120.324 -1.485 . . . . 0.0 113.439 171.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt -98.02 4.15 49.34 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.159 1.384 . . . . 0.0 110.92 177.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 31.9 m0 -87.54 160.33 47.97 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.37 133.76 27.11 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.186 1.924 . . . . 0.0 112.415 177.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.9 mt -73.41 147.73 9.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 124.485 1.114 . . . . 0.0 109.694 166.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.482 ' CZ3' ' HE3' ' A' ' 84' ' ' LYS . 59.8 t90 -144.36 120.63 10.88 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.292 1.437 . . . . 0.0 107.876 168.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.77 168.51 10.28 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.763 1.625 . . . . 0.0 109.791 164.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.534 ' HD3' ' H ' ' A' ' 27' ' ' GLU . 6.1 tmtt? -152.07 165.73 33.81 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.827 0.822 . . . . 0.0 110.735 167.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.534 ' H ' ' HD3' ' A' ' 26' ' ' LYS . 1.0 OUTLIER -76.97 172.64 12.86 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 126.304 1.842 . . . . 0.0 109.216 174.732 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.2 t -100.33 59.32 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 -164.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.4 t -132.03 -178.29 4.83 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.893 1.677 . . . . 0.0 109.433 -167.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -122.64 150.65 42.39 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.907 0.883 . . . . 0.0 109.095 173.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -163.42 -164.79 0.97 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 125.881 1.673 . . . . 0.0 107.017 -177.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 2.6 p30 -131.0 154.65 47.95 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 120.878 -1.139 . . . . 0.0 109.159 173.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 56.1 t-105 -144.11 152.25 40.69 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.015 0.435 . . . . 0.0 110.062 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -124.89 153.18 43.03 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.572 1.149 . . . . 0.0 108.526 -177.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -123.49 103.84 8.7 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.961 1.305 . . . . 0.0 107.626 175.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -104.74 13.45 31.36 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.232 1.413 . . . . 0.0 110.877 176.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.46 170.78 18.77 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 129.649 3.18 . . . . 0.0 108.624 164.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -68.94 136.41 52.5 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 177.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -133.17 124.26 27.13 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 171.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 53.1 m -99.34 137.79 37.35 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 166.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 24.8 p -138.03 148.04 44.71 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 118.164 0.438 . . . . 0.0 110.101 167.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -112.11 126.03 54.74 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 171.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 17.6 mm -95.55 122.39 46.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 129.499 3.119 . . . . 0.0 107.47 -173.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -105.53 -27.55 11.33 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -175.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -164.86 156.64 15.46 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.508 1.123 . . . . 0.0 108.27 177.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.17 177.87 44.63 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.976 1.274 . . . . 0.0 112.205 -177.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.491 ' HE3' HG23 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -135.61 139.03 43.51 Favored 'General case' 0 CA--C 1.515 -0.378 0 O-C-N 121.618 -0.931 . . . . 0.0 108.857 -170.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.426 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 55.1 t -136.19 146.07 29.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 178.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -112.58 116.82 30.81 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 102.998 -2.964 . . . . 0.0 102.998 156.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.4 t -91.04 122.33 42.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 164.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 57.9 m -123.67 105.78 10.0 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 119.664 1.12 . . . . 0.0 108.386 -172.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 32.5 p -69.75 171.97 8.31 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -80.2 -11.2 59.76 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 120.264 -1.523 . . . . 0.0 112.267 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -65.05 -10.76 32.58 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.011 -1.056 . . . . 0.0 112.076 162.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.86 -9.24 77.93 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 125.115 1.34 . . . . 0.0 112.549 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -61.19 124.01 19.33 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 124.957 1.303 . . . . 0.0 108.134 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.96 127.86 46.11 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 125.322 1.449 . . . . 0.0 108.229 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -124.21 84.01 2.22 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 124.478 2.085 . . . . 0.0 107.1 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.491 HG23 ' HE3' ' A' ' 47' ' ' LYS . 1.5 p -72.87 148.29 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 111.138 -2.756 . . . . 0.0 109.454 162.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.6 pt -148.31 125.23 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 C-N-CA 126.837 2.055 . . . . 0.0 106.528 -175.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -88.3 178.58 6.55 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 122.454 1.121 . . . . 0.0 109.932 167.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -63.95 54.45 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 130.798 3.639 . . . . 0.0 115.525 176.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 173.64 -13.69 0.04 OUTLIER Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.731 1.634 . . . . 0.0 112.846 176.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -69.09 101.75 1.49 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.222 1.511 . . . . 0.0 108.739 176.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.4 tp -74.81 141.17 44.33 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 175.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.4 t -123.78 160.32 27.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 C-N-CA 123.818 0.847 . . . . 0.0 109.076 -175.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.6 m -143.24 109.94 5.51 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 161.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -80.04 148.37 67.79 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 169.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -87.22 178.57 3.45 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.624 2.216 . . . . 0.0 111.877 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -85.45 83.43 7.94 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.372 1.469 . . . . 0.0 107.524 173.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.8 79.18 0.21 Allowed Glycine 0 CA--C 1.532 1.096 0 C-N-CA 126.749 2.118 . . . . 0.0 111.142 175.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.445 HD21 ' HB3' ' A' ' 74' ' ' CYS . 8.1 tt -147.92 117.45 7.01 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.978 1.389 . . . . 0.0 111.467 175.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.5 tpp85 -85.92 133.8 33.92 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.945 0.898 . . . . 0.0 109.721 161.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.445 ' HB3' HD21 ' A' ' 72' ' ' LEU . 28.6 p -150.66 178.19 9.34 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.657 0.783 . . . . 0.0 112.973 166.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' A' ' 32' ' ' ASP . 0.2 OUTLIER -96.2 160.51 14.4 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 124.648 1.179 . . . . 0.0 109.295 167.656 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 2.5 m95 -132.36 117.32 17.97 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 173.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.403 ' HD2' HD23 ' A' ' 79' ' ' LEU . 3.6 tmtp? -104.68 112.09 25.04 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 168.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.6 t -81.26 91.3 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 103.833 -2.654 . . . . 0.0 103.833 171.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.465 HD12 ' HE2' ' A' ' 47' ' ' LYS . 50.7 mt -71.06 -33.83 70.63 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.214 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -142.3 147.01 41.81 Favored Pre-proline 0 C--O 1.234 0.237 0 CA-C-O 117.479 -1.248 . . . . 0.0 108.224 171.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -62.47 94.91 0.14 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 125.072 3.848 . . . . 0.0 110.896 -165.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.1 p -78.3 146.95 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.853 -167.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.01 114.5 17.18 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 169.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.482 ' HE3' ' CZ3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -131.17 139.68 49.79 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 123.164 0.586 . . . . 0.0 109.495 -179.262 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -81.9 114.78 20.73 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 170.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -102.18 165.18 11.29 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.642 1.11 . . . . 0.0 110.013 174.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -152.0 150.82 30.41 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.725 0.693 . . . . 0.0 109.82 163.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 39.0 mt -108.76 147.05 32.59 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.78 1.232 . . . . 0.0 108.751 -174.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.2 p90 . . . . . 0 C--O 1.253 1.244 0 C-N-CA 126.164 1.785 . . . . 0.0 110.035 -179.497 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.5 t . . . . . 0 N--CA 1.446 -0.638 0 CA-C-O 121.794 0.807 . . . . 0.0 112.116 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.9 tttt -69.78 125.3 26.34 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 174.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.0 mt -130.9 135.92 59.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 105.069 -2.196 . . . . 0.0 105.069 172.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -158.6 174.14 15.51 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.838 1.655 . . . . 0.0 109.425 167.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.41 85.0 15.37 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 119.197 0.908 . . . . 0.0 108.799 177.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.493 ' HG2' HD21 ' A' ' 13' ' ' LEU . 19.3 Cg_endo -65.31 163.16 30.4 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.728 2.952 . . . . 0.0 111.902 -172.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 t -66.98 142.69 97.52 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 175.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -72.54 -16.51 27.16 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.114 1.876 . . . . 0.0 113.73 -178.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -52.54 -62.87 1.37 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.828 0.851 . . . . 0.0 109.022 170.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 48.8 tptt -53.82 -37.06 63.19 Favored 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 124.921 1.288 . . . . 0.0 111.213 -176.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.493 HD21 ' HG2' ' A' ' 8' ' ' PRO . 3.9 mm? -65.17 -37.19 86.58 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.67 0.788 . . . . 0.0 111.003 -178.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -48.48 72.39 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 117.712 -1.137 . . . . 0.0 108.407 176.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -53.26 -49.17 67.46 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.454 1.102 . . . . 0.0 110.414 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.1 mp -52.24 -15.57 0.63 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 126.616 1.967 . . . . 0.0 113.903 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.455 ' HB3' ' HE3' ' A' ' 20' ' ' LYS . 23.7 m 66.1 30.54 9.38 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.473 1.509 . . . . 0.0 110.783 175.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.5 t -55.16 -30.18 23.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.205 0 C-N-CA 125.159 1.384 . . . . 0.0 111.616 -178.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -55.01 -28.04 48.92 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.407 1.003 . . . . 0.0 112.867 173.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.455 ' HE3' ' HB3' ' A' ' 17' ' ' SER . 5.8 mtmp? -88.92 -23.55 22.68 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 124.742 1.217 . . . . 0.0 111.287 -176.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.422 ' CE3' ' HB2' ' A' ' 87' ' ' ASN . 37.5 m0 -61.21 156.94 46.97 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 123.26 0.624 . . . . 0.0 109.326 -174.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -71.32 121.47 7.8 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.235 1.957 . . . . 0.0 112.309 -175.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.1 mt -62.51 145.56 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 O-C-N 121.106 -0.996 . . . . 0.0 108.612 176.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.453 ' CE3' ' HE2' ' A' ' 84' ' ' LYS . 81.9 t90 -141.82 148.46 38.89 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 122.171 0.986 . . . . 0.0 108.721 161.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -140.17 168.39 19.91 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 128.286 2.634 . . . . 0.0 107.616 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.457 ' HE3' ' CD1' ' A' ' 31' ' ' PHE . 6.2 tmtt? -149.01 158.29 44.07 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 168.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -58.11 172.44 0.43 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 123.142 1.449 . . . . 0.0 111.09 171.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.6 p -76.31 65.78 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 112.388 -2.187 . . . . 0.0 108.901 169.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.92 156.35 41.0 Favored 'General case' 0 CA--C 1.507 -0.706 0 O-C-N 120.555 -1.341 . . . . 0.0 109.888 172.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -78.14 165.51 23.87 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 113.233 -1.803 . . . . 0.0 109.469 -178.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.457 ' CD1' ' HE3' ' A' ' 26' ' ' LYS . 6.7 p90 -163.65 -173.18 3.17 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 164.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 8.8 p-10 -126.67 140.28 52.52 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 163.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 15.5 t-105 -113.87 140.29 48.47 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.163 -174.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -106.31 111.89 24.68 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 168.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -85.08 119.97 26.06 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 172.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.37 -5.6 9.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 117.854 -1.07 . . . . 0.0 113.613 -158.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 p -141.12 175.08 9.92 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 131.293 3.837 . . . . 0.0 106.853 164.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -67.84 129.35 39.63 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -135.46 107.22 7.01 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -176.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 89.1 m -75.77 142.91 42.23 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 166.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 19.8 p -138.46 146.49 42.15 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 119.5 1.045 . . . . 0.0 110.917 158.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -117.09 112.67 21.22 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 126.414 1.886 . . . . 0.0 107.457 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 29.4 mm -80.22 131.48 33.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -176.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.8 mp -114.01 -26.62 8.03 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 118.759 -0.639 . . . . 0.0 112.26 178.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -163.43 152.36 14.31 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 118.813 0.733 . . . . 0.0 109.849 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.48 -177.27 21.32 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.721 1.629 . . . . 0.0 112.766 -176.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.578 ' HE2' HD12 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -135.54 142.93 45.47 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.11 1.364 . . . . 0.0 107.489 171.341 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.656 HG13 ' CG1' ' A' ' 60' ' ' ILE 0.634 0.2 OUTLIER -133.89 137.02 53.1 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.309 0 C-N-CA 129.648 3.179 . . . . 0.0 117.067 -176.139 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -125.46 112.68 16.54 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 125.197 1.561 . . . . 0.0 109.157 158.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.499 HG23 HD11 ' A' ' 60' ' ' ILE . 70.5 t -91.99 139.57 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 166.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 90.5 m -136.28 115.52 12.55 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 177.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.5 p -72.21 178.57 3.8 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.812 1.245 . . . . 0.0 110.913 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -54.55 -34.17 61.35 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.182 0.593 . . . . 0.0 110.468 170.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.49 1.31 26.16 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.966 2.506 . . . . 0.0 113.124 -171.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.17 3.63 46.3 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 118.745 0.702 . . . . 0.0 114.6 177.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.497 ' HE2' ' HA ' ' A' ' 56' ' ' LYS . 6.0 mmpt? -65.42 111.8 3.24 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 166.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.41 150.18 46.51 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 164.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -135.97 118.87 16.26 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 170.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.8 t -89.21 132.09 34.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.656 ' CG1' HG13 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -126.26 136.93 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 174.638 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -138.97 -179.01 5.58 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 172.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.3 81.24 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.192 1.797 . . . . 0.0 111.773 177.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 137.45 11.47 1.0 Allowed Glycine 0 CA--C 1.525 0.708 0 CA-C-O 117.882 -1.51 . . . . 0.0 114.593 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -107.69 134.97 49.91 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 164.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.416 ' CD1' HD11 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -96.06 153.66 17.66 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 165.756 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 36.4 t -133.46 150.24 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 124.057 0.943 . . . . 0.0 109.218 177.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.8 m -133.43 120.24 20.65 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.19 0.996 . . . . 0.0 108.312 162.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -83.28 156.57 66.17 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 125.302 1.441 . . . . 0.0 109.514 170.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -83.96 175.16 7.85 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.5 2.133 . . . . 0.0 109.818 174.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -78.03 102.19 7.29 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 166.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.78 80.79 1.54 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.391 0.996 . . . . 0.0 112.196 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 51.5 tp -141.77 155.45 45.61 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 126.024 1.73 . . . . 0.0 108.374 169.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.81 140.43 45.86 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 126.952 2.101 . . . . 0.0 106.722 175.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 3.9 p -168.73 161.09 11.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 118.55 0.614 . . . . 0.0 110.117 173.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -68.6 159.33 32.17 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.997 164.593 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -123.57 136.79 54.72 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 163.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -119.48 97.51 5.68 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 167.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.7 t -73.95 97.21 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.505 0 N-CA-C 103.45 -2.796 . . . . 0.0 103.45 169.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.578 HD12 ' HE2' ' A' ' 47' ' ' LYS . 68.1 mt -72.43 -31.21 65.3 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 119.058 -1.057 . . . . 0.0 108.957 178.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -143.17 144.34 28.22 Favored Pre-proline 0 N--CA 1.452 -0.339 0 CA-C-O 116.881 -1.533 . . . . 0.0 107.189 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -62.93 98.35 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 124.144 3.229 . . . . 0.0 110.2 -165.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.9 p -74.29 158.6 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.697 -171.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -139.02 120.5 15.01 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 168.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.453 ' HE2' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -131.38 154.29 48.77 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 -178.007 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 14.3 m80 -94.06 102.25 14.31 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 167.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -88.61 157.48 18.57 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.906 0.883 . . . . 0.0 110.271 171.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.422 ' HB2' ' CE3' ' A' ' 21' ' ' TRP . 34.3 t30 -154.58 122.18 5.78 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 121.333 -0.854 . . . . 0.0 110.403 167.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.6 mt -69.82 157.47 37.3 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.051 1.34 . . . . 0.0 109.335 176.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.251 1.17 0 CA-C-O 115.43 -2.224 . . . . 0.0 108.159 163.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 75.9 t . . . . . 0 C--O 1.235 0.323 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -88.85 139.63 30.26 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 166.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.6 mt -132.73 134.56 58.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 162.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -161.56 176.98 10.46 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.823 1.649 . . . . 0.0 109.199 166.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.38 86.0 3.16 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.777 1.231 . . . . 0.0 110.354 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.416 ' HG2' HD21 ' A' ' 13' ' ' LEU . 57.2 Cg_endo -64.5 171.49 8.06 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.819 2.346 . . . . 0.0 112.683 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 38.4 p -73.05 146.73 87.65 Favored Pre-proline 0 CA--C 1.536 0.404 0 O-C-N 121.571 -0.706 . . . . 0.0 109.536 173.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -70.45 -25.21 25.65 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.528 1.485 . . . . 0.0 112.198 -178.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -64.13 -45.18 89.67 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.616 0.644 . . . . 0.0 110.369 172.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.3 tptm -57.56 -33.9 68.62 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.846 0.748 . . . . 0.0 110.544 177.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.416 HD21 ' HG2' ' A' ' 8' ' ' PRO . 3.9 mm? -74.28 -15.06 60.98 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.232 0.613 . . . . 0.0 112.53 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -77.36 -39.73 46.42 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.726 1.148 . . . . 0.0 109.051 164.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -70.85 -20.92 62.49 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 118.254 0.479 . . . . 0.0 112.262 -176.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 mp -78.9 1.93 21.9 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-O 117.474 -1.251 . . . . 0.0 112.611 176.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.7 p 57.99 21.51 7.85 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.155 1.382 . . . . 0.0 114.2 -177.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.9 t -57.87 -37.58 61.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 CA-C-N 119.659 1.118 . . . . 0.0 111.837 -163.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -53.37 -24.63 12.73 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.936 0.895 . . . . 0.0 113.312 175.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.5 mttm -88.43 -25.16 22.79 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 117.677 -1.154 . . . . 0.0 111.153 -177.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 38.7 m0 -61.24 164.74 7.84 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 126.141 1.777 . . . . 0.0 110.261 -175.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.05 140.72 55.24 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 CA-C-N 121.52 1.579 . . . . 0.0 111.165 173.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.8 mt -85.6 155.51 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 169.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 27.8 t90 -141.76 133.93 27.76 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 164.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -138.25 132.88 32.43 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 126.807 2.043 . . . . 0.0 106.82 -177.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -134.27 169.6 16.96 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 121.384 -0.823 . . . . 0.0 110.062 -170.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.437 ' CD ' ' H ' ' A' ' 28' ' ' VAL . 1.4 tm-20 -72.7 177.54 4.71 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 122.755 1.264 . . . . 0.0 111.039 172.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.437 ' H ' ' CD ' ' A' ' 27' ' ' GLU . 16.3 t -102.24 45.87 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 127.351 2.26 . . . . 0.0 108.432 -165.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.7 t -108.52 -175.29 2.73 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 128.076 2.55 . . . . 0.0 108.682 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -109.05 163.26 13.48 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.803 0.811 . . . . 0.0 110.5 159.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -151.14 -164.73 2.08 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 163.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -142.05 148.36 38.33 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 126.095 1.758 . . . . 0.0 106.858 177.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 47.1 t-105 -135.13 145.89 48.28 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.129 0.572 . . . . 0.0 111.804 -172.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -112.54 109.76 19.52 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.543 1.537 . . . . 0.0 107.781 166.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -79.16 95.3 5.56 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 171.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -88.01 18.61 4.11 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.472 1.033 . . . . 0.0 110.4 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -168.31 164.26 13.01 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.779 1.631 . . . . 0.0 109.838 176.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -58.43 103.12 0.13 Allowed 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 126.903 2.081 . . . . 0.0 107.561 174.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -105.97 125.14 50.64 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 166.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 85.6 m -99.54 146.52 26.32 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 168.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 20.9 p -146.67 161.3 40.87 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 118.59 0.632 . . . . 0.0 110.643 164.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -129.63 106.2 8.57 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.494 1.518 . . . . 0.0 108.556 -176.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 26.0 mm -80.45 116.38 24.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 O-C-N 122.011 -0.43 . . . . 0.0 109.937 -169.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.5 mt -92.37 -32.46 14.95 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 117.875 -1.06 . . . . 0.0 112.951 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -165.8 163.58 18.8 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 118.953 0.797 . . . . 0.0 109.245 -173.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.09 -176.6 53.86 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.985 1.279 . . . . 0.0 111.825 -176.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.578 ' HE2' HD12 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -139.29 139.1 37.25 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 -171.482 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 76.8 t -136.13 158.24 38.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -131.72 97.44 4.21 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 127.155 2.182 . . . . 0.0 106.799 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . 0.727 0.1 OUTLIER -93.34 71.2 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 C-N-CA 130.822 3.649 . . . . 0.0 118.414 163.322 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 14.9 m -73.46 113.32 10.42 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 164.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.6 p -67.93 169.97 8.99 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 171.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -65.25 -22.3 66.85 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.786 -1.196 . . . . 0.0 110.08 170.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -77.73 3.39 14.19 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.286 1.834 . . . . 0.0 111.481 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.69 -9.1 8.87 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.01 1.29 . . . . 0.0 113.053 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -66.07 108.98 2.41 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 119.502 1.651 . . . . 0.0 106.834 171.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -88.64 131.78 34.84 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 124.214 0.946 . . . . 0.0 109.705 179.13 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.6 m-30 -115.54 85.08 2.21 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 127.685 2.394 . . . . 0.0 105.896 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.547 HG13 ' HE3' ' A' ' 47' ' ' LYS . 71.3 t -66.35 128.34 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 N-CA-C 103.981 -2.6 . . . . 0.0 103.981 156.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.7 pt -128.6 138.88 53.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 169.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -123.97 179.9 4.66 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.188 1.795 . . . . 0.0 107.137 -170.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.0 pttp -73.67 60.85 0.71 Allowed 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 124.988 1.315 . . . . 0.0 112.92 -173.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 164.41 34.36 0.02 OUTLIER Glycine 0 C--N 1.317 -0.524 0 O-C-N 120.15 -1.594 . . . . 0.0 112.458 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -122.18 139.37 53.83 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 118.961 1.38 . . . . 0.0 107.808 175.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.9 tp -94.57 141.09 29.0 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 164.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.5 t -126.35 139.65 51.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 175.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 46.2 m -120.71 102.64 8.53 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 165.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -70.41 151.61 95.64 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 169.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -75.74 -164.53 0.25 Allowed 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.692 2.928 . . . . 0.0 110.077 175.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -98.44 129.14 45.06 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 161.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.52 83.9 0.47 Allowed Glycine 0 CA--C 1.535 1.305 0 C-N-CA 127.494 2.473 . . . . 0.0 113.984 -178.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.6 tt -142.87 130.61 21.46 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 126.909 2.084 . . . . 0.0 108.213 171.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.83 128.09 55.65 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.977 0.911 . . . . 0.0 108.867 171.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 27.4 p -149.24 173.81 13.07 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.634 -0.667 . . . . 0.0 111.088 178.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.19 -178.04 4.86 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 118.386 -0.816 . . . . 0.0 111.079 166.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -155.46 90.4 1.25 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.801 1.24 . . . . 0.0 107.785 172.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -83.86 118.42 23.95 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 172.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.5 t -88.58 94.97 4.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 103.779 -2.674 . . . . 0.0 103.779 167.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.578 HD12 ' HE2' ' A' ' 47' ' ' LYS . 26.7 mt -71.02 -29.23 65.11 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 117.522 -1.228 . . . . 0.0 110.109 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -149.01 148.37 26.91 Favored Pre-proline 0 N--CA 1.453 -0.303 0 C-N-CA 125.143 1.377 . . . . 0.0 108.988 175.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -59.88 105.81 0.29 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 124.559 3.506 . . . . 0.0 109.602 -167.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.9 p -84.36 149.41 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -174.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.7 130.06 46.63 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 164.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.79 146.91 34.69 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 174.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -73.17 127.96 34.11 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 148.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -113.64 164.17 14.03 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 166.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -153.37 150.51 28.93 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 165.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 93.7 mt -101.63 161.45 13.64 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.641 1.176 . . . . 0.0 108.209 177.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 11.1 p90 . . . . . 0 C--O 1.246 0.915 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 159.868 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.7 t . . . . . 0 CA--C 1.536 0.427 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.2 tttt -129.78 89.71 2.86 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.6 mt -86.93 143.9 10.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 176.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -149.11 178.97 8.25 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 122.625 0.37 . . . . 0.0 110.074 154.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . 0.37 0.5 OUTLIER -128.5 85.01 61.47 Favored Pre-proline 0 N--CA 1.451 -0.411 0 O-C-N 121.179 -0.951 . . . . 0.0 111.855 -178.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -81.31 168.7 16.47 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 125.163 3.908 . . . . 0.0 113.517 -169.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.7 t -66.22 143.66 98.42 Favored Pre-proline 0 C--N 1.331 -0.202 0 C-N-CA 126.584 1.954 . . . . 0.0 109.188 172.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -71.01 -21.27 27.91 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.741 1.628 . . . . 0.0 112.166 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.84 -60.36 3.95 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.444 1.098 . . . . 0.0 109.131 -178.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.7 tttt -58.92 -29.7 67.29 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.008 -1.057 . . . . 0.0 111.606 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -71.3 -38.4 71.78 Favored 'General case' 0 C--N 1.334 -0.107 0 O-C-N 121.367 -0.833 . . . . 0.0 110.854 177.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -56.56 -53.55 56.22 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 119.426 1.012 . . . . 0.0 109.142 167.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -57.2 -39.78 76.11 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.266 0.626 . . . . 0.0 111.489 -174.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.43 -10.77 2.31 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.28 2.232 . . . . 0.0 115.266 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 63.4 m 57.32 43.85 22.76 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.929 1.292 . . . . 0.0 111.715 -177.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.428 ' HA ' ' CD2' ' A' ' 21' ' ' TRP . 54.8 t -56.05 -36.49 45.09 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 C-N-CA 126.699 2.0 . . . . 0.0 111.051 174.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -61.52 -13.49 21.69 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 176.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.5 mtpp -95.88 -10.98 27.47 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.467 1.107 . . . . 0.0 111.474 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.428 ' CD2' ' HA ' ' A' ' 18' ' ' VAL . 30.4 m0 -72.86 163.42 68.43 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 178.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -66.7 137.71 46.69 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 121.752 1.635 . . . . 0.0 110.736 170.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 81.4 mt -72.46 152.8 7.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 161.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 14.6 t90 -137.81 150.93 47.61 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 161.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -151.18 156.84 41.78 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.738 1.215 . . . . 0.0 110.465 -178.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.554 ' HE3' ' CE2' ' A' ' 31' ' ' PHE . 16.7 tptp -153.71 162.2 41.45 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 124.598 1.159 . . . . 0.0 108.67 -167.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -88.41 -178.07 5.78 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.126 0.971 . . . . 0.0 108.744 175.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.5 p -68.77 8.72 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 127.718 2.407 . . . . 0.0 113.16 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.3 p -85.93 124.71 32.7 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 126.417 1.887 . . . . 0.0 111.12 -173.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -79.28 152.62 30.44 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 124.288 0.993 . . . . 0.0 109.713 175.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.554 ' CE2' ' HE3' ' A' ' 26' ' ' LYS . 11.9 p90 -156.51 -170.83 3.47 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 176.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -124.7 121.0 33.43 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 127.542 2.337 . . . . 0.0 107.233 172.271 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 43.9 t-105 -109.17 155.77 20.65 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 123.743 0.652 . . . . 0.0 111.012 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -122.61 133.24 54.54 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.68 1.592 . . . . 0.0 110.437 175.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -105.37 108.17 19.55 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 175.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -101.14 4.11 41.78 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.006 1.322 . . . . 0.0 111.061 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.84 163.89 36.82 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 128.112 2.565 . . . . 0.0 108.055 170.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.66 142.0 57.59 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 175.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -147.36 136.99 22.84 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 -176.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.8 m -114.96 121.25 42.59 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 174.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 9.1 p -121.85 145.07 48.44 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.448 0.642 . . . . 0.0 109.357 173.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -121.69 109.1 14.33 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 127.401 2.28 . . . . 0.0 107.032 -175.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.6 mm -69.37 138.49 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 124.831 1.252 . . . . 0.0 107.887 175.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 mp -125.09 -32.19 3.02 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 122.795 0.438 . . . . 0.0 110.845 176.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -138.87 171.75 13.87 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.768 0.827 . . . . 0.0 108.875 168.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.71 -179.77 30.43 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 116.608 1.403 . . . . 0.0 116.608 167.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.821 ' HE3' HG13 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -140.07 151.39 45.35 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 127.924 2.49 . . . . 0.0 111.485 170.864 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.631 HG13 ' CG1' ' A' ' 60' ' ' ILE 0.421 0.2 OUTLIER -146.43 146.91 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 1 C-N-CA 133.253 4.621 . . . . 0.0 113.288 -174.914 . . . . . . . . 5 4 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -120.16 149.91 41.48 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.242 145.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.3 t -127.2 101.08 7.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 170.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.5 m -79.32 112.77 16.88 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 166.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.417 ' HA ' ' HB3' ' A' ' 74' ' ' CYS . 26.4 p -73.58 161.59 30.16 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 165.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -55.97 -35.58 66.89 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.801 -0.562 . . . . 0.0 111.182 -175.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -68.88 -1.79 8.1 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.054 1.742 . . . . 0.0 113.456 -174.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.66 -14.11 57.78 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 125.802 1.668 . . . . 0.0 112.472 172.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.2 mttt -71.35 123.01 21.34 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 118.809 1.304 . . . . 0.0 109.729 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.449 ' HD2' ' H ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -85.82 147.4 26.32 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 168.291 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -132.12 105.88 7.64 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 170.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.821 HG13 ' HE3' ' A' ' 47' ' ' LYS . 70.9 t -74.94 117.4 19.09 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 172.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.631 ' CG1' HG13 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -108.99 141.09 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-N 118.852 0.751 . . . . 0.0 109.956 175.804 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -145.59 -175.62 4.8 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-O 122.114 0.959 . . . . 0.0 112.607 171.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.3 pttm -57.49 65.24 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 130.528 3.531 . . . . 0.0 112.8 177.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 156.64 2.12 0.1 OUTLIER Glycine 0 CA--C 1.531 1.091 0 CA-C-O 117.323 -1.821 . . . . 0.0 115.636 -158.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -129.33 110.39 11.89 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.899 2.079 . . . . 0.0 107.286 177.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.6 tp -74.82 143.13 44.08 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 120.154 -1.591 . . . . 0.0 107.407 167.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 32.9 t -133.49 128.84 55.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 119.422 1.01 . . . . 0.0 109.676 175.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.8 m -99.16 140.21 33.66 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 160.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -104.83 156.56 35.81 Favored Pre-proline 0 C--O 1.236 0.39 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 163.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -79.65 175.33 10.72 Favored 'Trans proline' 0 N--CA 1.445 -1.348 0 N-CA-C 108.773 -1.28 . . . . 0.0 108.773 174.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -81.81 94.04 6.97 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 166.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 114.46 85.73 1.35 Allowed Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.67 1.605 . . . . 0.0 111.789 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 56.9 tp -162.0 135.08 6.11 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.314 1.557 . . . . 0.0 110.301 170.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.68 85.69 2.41 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 120.11 1.323 . . . . 0.0 112.381 -174.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.417 ' HB3' ' HA ' ' A' ' 52' ' ' THR . 61.0 m -121.81 165.82 15.28 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 119.627 -1.921 . . . . 0.0 110.766 -173.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 32' ' ' ASP . 0.3 OUTLIER -69.6 163.07 26.32 Favored 'General case' 0 CA--C 1.515 -0.4 0 O-C-N 121.984 -0.447 . . . . 0.0 111.072 177.033 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.4 ' CZ3' HG21 ' A' ' 48' ' ' VAL . 4.8 m95 -138.07 102.12 4.6 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.041 1.736 . . . . 0.0 106.875 173.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.32 100.56 12.38 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 168.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 80' ' ' GLU . 1.9 t -80.24 92.91 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 103.404 -2.814 . . . . 0.0 103.404 172.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.626 HD12 ' HE2' ' A' ' 47' ' ' LYS . 82.5 mt -69.0 -29.11 67.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.171 178.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.647 ' O ' HG12 ' A' ' 78' ' ' VAL . 3.2 mt-10 -141.06 165.62 28.05 Favored Pre-proline 0 N--CA 1.452 -0.373 0 C-N-CA 125.292 1.437 . . . . 0.0 108.884 176.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -61.35 116.87 3.68 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 123.899 3.066 . . . . 0.0 110.786 169.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.9 p -110.41 143.36 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 -177.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -124.99 29.66 6.08 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.755 0.707 . . . . 0.0 112.83 -168.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.27 161.33 4.37 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.338 1.455 . . . . 0.0 113.28 -159.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.3 m80 -89.05 130.1 35.57 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 163.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -121.39 154.52 36.39 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.42 1.009 . . . . 0.0 108.707 172.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.419 ' HB2' ' CE3' ' A' ' 21' ' ' TRP . 57.1 t30 -143.98 116.69 8.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 17.9 mt -71.77 140.07 49.31 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 125.417 1.487 . . . . 0.0 107.092 172.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.248 0.982 0 CA-C-O 117.143 -1.408 . . . . 0.0 109.316 172.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.2 p . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -134.05 152.05 51.68 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.444 1.498 . . . . 0.0 108.009 172.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 93.6 mt -131.71 137.06 55.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 165.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -141.18 172.74 12.27 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 117.841 0.291 . . . . 0.0 110.982 160.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.22 84.94 6.34 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 171.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -76.01 176.55 9.88 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.883 3.056 . . . . 0.0 112.188 -169.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.442 HG22 ' H ' ' A' ' 9' ' ' THR . 0.0 OUTLIER -67.66 144.48 97.6 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 170.302 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -70.27 -25.25 26.43 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.857 2.371 . . . . 0.0 111.887 172.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -75.32 -45.17 41.3 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 119.357 0.981 . . . . 0.0 110.362 -171.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.96 -44.14 70.49 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.912 0.778 . . . . 0.0 110.019 174.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.3 mt -62.24 -27.53 69.06 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 118.924 -0.56 . . . . 0.0 112.233 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -63.21 -47.59 81.9 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 119.748 1.158 . . . . 0.0 109.106 172.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -68.0 -43.2 79.4 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 124.402 1.064 . . . . 0.0 110.088 -169.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 18.5 mt -53.36 -20.5 4.53 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.183 0.993 . . . . 0.0 112.016 174.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.8 m 69.85 45.7 0.73 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 127.496 2.318 . . . . 0.0 109.398 172.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.7 t -55.19 -32.67 28.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 126.105 1.762 . . . . 0.0 112.014 -175.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -65.6 -21.76 66.61 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.634 -1.291 . . . . 0.0 113.413 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.3 mttt -78.73 -15.13 58.83 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.019 0.928 . . . . 0.0 110.979 175.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 16.3 m0 -75.68 159.99 80.14 Favored Pre-proline 0 N--CA 1.445 -0.705 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 176.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -64.97 139.14 60.3 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 121.545 1.497 . . . . 0.0 111.777 175.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 57.7 mt -76.21 147.69 7.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 163.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.473 ' CZ3' ' HE3' ' A' ' 84' ' ' LYS . 9.0 t90 -147.39 149.59 33.04 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 164.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -133.36 166.31 22.8 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 127.262 2.225 . . . . 0.0 106.351 -177.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -148.98 163.85 36.3 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 120.572 -1.33 . . . . 0.0 108.803 163.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.74 -172.88 3.19 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 125.348 1.459 . . . . 0.0 109.916 -178.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.3 p -77.34 -5.09 7.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 125.772 1.629 . . . . 0.0 113.636 178.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.97 176.67 4.85 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.02 1.328 . . . . 0.0 110.886 176.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -137.45 157.34 46.77 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.141 -0.974 . . . . 0.0 109.324 -174.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -164.82 -164.3 0.79 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.118 1.367 . . . . 0.0 108.88 -168.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -133.12 160.91 35.83 Favored 'General case' 0 C--O 1.242 0.703 0 O-C-N 120.89 -1.131 . . . . 0.0 108.822 165.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 67.3 t-105 -135.74 146.73 47.98 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.746 0.818 . . . . 0.0 109.811 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.415 ' CE2' ' HD3' ' A' ' 73' ' ' ARG . 1.2 t80 -115.69 94.56 4.74 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.712 1.605 . . . . 0.0 107.059 -177.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -65.72 115.01 5.43 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 168.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -108.53 -1.0 20.05 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.408 1.083 . . . . 0.0 111.734 174.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.415 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -144.06 171.42 14.28 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 127.542 2.337 . . . . 0.0 112.331 174.871 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -62.95 108.88 1.3 Allowed 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 103.765 -2.68 . . . . 0.0 103.765 168.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -126.94 80.87 1.98 Allowed 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 -173.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 81.7 m -64.51 152.21 42.38 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 25.4 p -144.93 150.01 36.25 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.458 163.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -122.6 108.27 12.92 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.572 1.549 . . . . 0.0 106.839 175.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.3 mm -64.54 138.21 23.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 127.217 2.207 . . . . 0.0 107.601 172.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 mp -128.05 -26.38 2.89 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 123.28 0.362 . . . . 0.0 111.188 173.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -153.46 158.15 40.94 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.634 1.174 . . . . 0.0 108.188 172.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.69 -178.93 52.38 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.321 0.962 . . . . 0.0 112.111 -175.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.79 146.1 27.87 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -168.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.3 t -137.31 156.57 33.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.319 0.581 . . . . 0.0 109.773 175.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -119.39 110.51 17.03 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.612 1.965 . . . . 0.0 106.872 160.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.7 t -94.16 111.32 25.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 170.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.5 m -112.22 113.19 25.29 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -173.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.9 p -75.4 170.16 16.64 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 122.122 0.963 . . . . 0.0 111.931 -170.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -60.35 -29.9 69.2 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.342 167.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -82.26 8.98 9.71 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.688 1.595 . . . . 0.0 111.547 175.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.1 -2.06 21.25 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 125.55 1.548 . . . . 0.0 114.814 175.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -64.17 136.98 57.72 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.4 mttp -93.33 153.13 18.73 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 121.892 0.853 . . . . 0.0 110.089 162.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -125.73 100.62 6.5 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 102.801 -3.037 . . . . 0.0 102.801 162.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.0 t -81.24 142.73 13.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 167.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 pt -148.01 119.77 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.488 0 C-N-CA 124.314 1.046 . . . . 0.0 108.197 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -80.07 177.44 8.93 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-O 122.196 0.998 . . . . 0.0 110.918 171.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.1 pttt -68.01 45.5 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 131.366 3.866 . . . . 0.0 115.103 178.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -174.41 -7.06 0.02 OUTLIER Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.033 0.825 . . . . 0.0 113.417 178.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -79.16 99.87 7.18 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.102 1.361 . . . . 0.0 111.337 -173.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.3 tp -64.36 136.84 57.52 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.95 1.25 . . . . 0.0 107.636 177.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.1 t -121.32 154.68 25.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 123.865 0.866 . . . . 0.0 108.952 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 67.0 m -143.65 121.36 11.87 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 160.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -87.78 164.58 33.75 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 126.483 1.913 . . . . 0.0 108.879 169.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -79.68 174.8 11.3 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 CA-C-O 122.974 1.156 . . . . 0.0 110.469 170.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.415 ' HG3' ' HA ' ' A' ' 37' ' ' THR . 36.0 tttm -80.18 88.73 5.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.446 -1.707 . . . . 0.0 106.887 173.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 116.66 85.1 1.13 Allowed Glycine 0 CA--C 1.527 0.797 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -176.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 62.1 tp -147.2 141.06 25.8 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.198 1.399 . . . . 0.0 108.848 166.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.415 ' HD3' ' CE2' ' A' ' 34' ' ' TYR . 3.5 ptt85 -136.93 103.89 5.3 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.417 1.487 . . . . 0.0 108.453 -176.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 86.0 m -148.61 164.42 34.34 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 125.264 1.426 . . . . 0.0 110.103 -175.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.58 163.01 22.18 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 124.452 1.101 . . . . 0.0 112.035 177.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -148.2 99.59 3.07 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.575 1.95 . . . . 0.0 107.372 -168.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 42.7 tttp -110.96 111.8 23.18 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 -176.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.1 t -87.34 111.68 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 104.264 -2.495 . . . . 0.0 104.264 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 20.6 mt -91.1 -24.04 20.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 118.782 -0.628 . . . . 0.0 109.836 177.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -148.75 152.36 37.31 Favored Pre-proline 0 C--O 1.236 0.384 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 168.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.41 91.69 0.77 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.377 2.718 . . . . 0.0 111.514 -153.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.8 p -69.51 105.82 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.017 -165.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -91.08 116.63 28.95 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 105.215 -2.142 . . . . 0.0 105.215 168.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.473 ' HE3' ' CZ3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -127.58 172.06 11.07 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 122.306 1.051 . . . . 0.0 108.382 175.277 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -113.22 122.77 48.47 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 102.578 -3.119 . . . . 0.0 102.578 168.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -117.89 157.03 27.4 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -152.4 134.83 15.19 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 118.71 0.686 . . . . 0.0 110.024 176.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 65.8 mt -94.45 125.48 39.13 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.401 1.88 . . . . 0.0 107.149 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.4 p90 . . . . . 0 C--O 1.247 0.968 0 C-N-CA 123.96 0.904 . . . . 0.0 110.361 -171.509 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 94.2 t . . . . . 0 CA--C 1.535 0.376 0 CA-C-O 121.41 0.624 . . . . 0.0 112.633 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -100.05 119.49 38.38 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.965 0.906 . . . . 0.0 109.148 -173.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.3 mt -139.81 132.47 35.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 C-N-CA 124.792 1.237 . . . . 0.0 108.022 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -143.97 176.66 9.11 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.483 1.513 . . . . 0.0 110.271 171.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.76 85.77 5.2 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 124.562 1.145 . . . . 0.0 108.151 173.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.09 157.64 60.92 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.442 2.095 . . . . 0.0 111.881 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.9 t -57.42 144.3 71.83 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 124.508 1.123 . . . . 0.0 109.19 169.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.58 -31.21 27.22 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.538 1.492 . . . . 0.0 112.735 -177.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -59.84 -42.72 94.21 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 119.407 1.003 . . . . 0.0 110.729 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.1 tptt -56.49 -41.37 76.53 Favored 'General case' 0 C--O 1.226 -0.167 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -69.9 -32.07 70.19 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.872 1.269 . . . . 0.0 111.511 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -61.46 -49.11 78.12 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 168.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -62.73 -47.99 81.19 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.373 0.533 . . . . 0.0 111.047 -176.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.7 mt -58.78 -7.34 0.97 Allowed 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 125.955 1.702 . . . . 0.0 112.662 -175.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.7 m 74.03 29.22 1.4 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.17 1.788 . . . . 0.0 110.402 165.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.9 t -57.01 -27.45 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 126.371 1.868 . . . . 0.0 112.499 -172.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -59.45 -28.41 66.94 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.828 1.194 . . . . 0.0 113.015 172.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.6 mttm -84.69 -13.21 52.09 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.632 1.173 . . . . 0.0 111.066 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.502 ' CE3' ' HB2' ' A' ' 87' ' ' ASN . 36.5 m0 -74.8 158.9 84.2 Favored Pre-proline 0 N--CA 1.448 -0.527 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -175.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.58 136.79 43.97 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 121.531 1.487 . . . . 0.0 111.44 175.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.1 mt -72.22 149.96 8.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 125.197 1.399 . . . . 0.0 109.332 166.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.432 ' CZ3' ' HE3' ' A' ' 84' ' ' LYS . 87.7 t90 -142.23 112.23 6.92 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 160.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.14 168.4 12.8 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.975 1.31 . . . . 0.0 110.576 164.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.3 tptt -155.94 162.45 40.38 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 120.647 -1.283 . . . . 0.0 109.841 165.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.27 170.59 15.27 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.204 1.001 . . . . 0.0 111.27 172.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.9 p -81.16 71.18 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 127.205 2.202 . . . . 0.0 109.463 175.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.91 -171.14 2.66 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 120.972 -1.08 . . . . 0.0 109.708 -177.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -130.89 154.14 48.39 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.003 -1.06 . . . . 0.0 108.845 170.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -160.6 -167.67 1.93 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.718 1.207 . . . . 0.0 108.511 173.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 4.6 p-10 -121.1 152.52 38.59 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 125.012 1.325 . . . . 0.0 107.896 169.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 25.7 t-105 -136.26 151.97 50.22 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.557 0.218 . . . . 0.0 111.002 178.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.435 ' CD2' ' HB3' ' A' ' 73' ' ' ARG . 1.4 t80 -124.78 129.63 50.83 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.632 1.573 . . . . 0.0 106.844 -175.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -111.29 112.39 24.13 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 175.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.39 2.8 19.23 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 125.148 1.379 . . . . 0.0 112.723 -176.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.8 p -145.9 171.17 15.21 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 130.556 3.543 . . . . 0.0 107.856 166.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -63.36 149.82 44.89 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -146.48 115.2 6.83 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 167.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.0 m -88.52 141.95 28.11 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 167.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.495 ' SG ' ' HB2' ' A' ' 84' ' ' LYS . 0.7 OUTLIER -149.97 150.18 31.45 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.032 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -125.36 112.07 15.9 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.473 1.509 . . . . 0.0 108.36 -177.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 8.5 mm -69.77 120.01 16.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 128.593 2.757 . . . . 0.0 107.601 174.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 mp -110.36 -24.77 10.45 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 178.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -160.14 157.32 28.22 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.898 1.679 . . . . 0.0 107.913 177.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 82' ' ' VAL . . . 82.55 177.9 52.13 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.597 2.046 . . . . 0.0 112.699 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.78 143.09 33.28 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.795 -0.827 . . . . 0.0 109.18 -167.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 86.9 t -138.12 156.46 30.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -124.52 118.23 26.13 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 160.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.5 t -94.01 106.8 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 169.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.4 m -93.04 105.95 17.98 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.439 ' HA ' ' SG ' ' A' ' 74' ' ' CYS . 18.0 p -69.33 168.6 13.97 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 121.792 -0.567 . . . . 0.0 110.542 -178.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -63.95 -32.8 74.46 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 170.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -68.59 -6.7 27.12 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 121.014 -1.054 . . . . 0.0 109.911 171.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.91 -3.36 70.45 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 125.943 1.735 . . . . 0.0 112.7 170.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.1 tttp -70.02 135.02 48.89 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-N 120.196 1.998 . . . . 0.0 107.964 -176.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.82 105.11 17.17 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.512 174.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -79.56 107.88 12.68 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 164.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.3 t -77.21 147.19 7.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 161.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 pt -148.59 121.78 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 C-N-CA 124.661 1.184 . . . . 0.0 108.499 173.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -101.75 175.4 5.56 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 122.469 1.128 . . . . 0.0 109.764 172.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.5 pttp -64.51 54.58 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 131.237 3.815 . . . . 0.0 116.363 -171.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -178.65 -16.15 0.03 OUTLIER Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.181 1.372 . . . . 0.0 113.42 176.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -77.76 103.63 7.81 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.8 1.3 . . . . 0.0 109.1 -177.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.3 tp -71.35 143.93 50.06 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 120.132 1.333 . . . . 0.0 108.319 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 45.1 t -124.14 154.87 31.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 125.074 1.35 . . . . 0.0 108.69 -174.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.9 m -146.09 103.18 3.71 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.626 1.17 . . . . 0.0 108.196 170.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -74.43 155.13 87.79 Favored Pre-proline 0 C--O 1.235 0.317 0 O-C-N 121.489 -0.757 . . . . 0.0 109.581 171.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -86.87 177.4 4.1 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.715 2.277 . . . . 0.0 110.699 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -81.26 90.6 6.12 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 164.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 110.25 90.33 2.03 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.415 1.483 . . . . 0.0 110.699 178.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 67.2 tp -156.02 152.56 28.26 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.721 2.008 . . . . 0.0 108.936 162.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.435 ' HB3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -137.36 126.07 23.88 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 119.215 0.916 . . . . 0.0 109.76 165.046 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.439 ' SG ' ' HA ' ' A' ' 52' ' ' THR . 84.1 m -145.49 170.01 17.23 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.127 1.771 . . . . 0.0 109.268 -178.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.418 ' HA ' ' HA ' ' A' ' 32' ' ' ASP . 0.6 OUTLIER -77.56 159.93 28.94 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 121.352 -0.842 . . . . 0.0 110.18 177.373 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -134.23 102.69 5.46 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.825 1.65 . . . . 0.0 107.68 177.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -100.78 112.27 24.65 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 174.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.0 t -84.68 106.63 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 173.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 95.6 mt -85.05 -26.03 27.26 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-O 118.878 -0.582 . . . . 0.0 109.743 175.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -147.69 149.35 33.41 Favored Pre-proline 0 N--CA 1.464 0.262 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 174.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -64.55 95.26 0.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.594 2.863 . . . . 0.0 110.673 -169.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.41 ' HA ' ' HA3' ' A' ' 46' ' ' GLY . 4.5 p -71.28 149.88 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.75 -174.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -126.98 112.25 15.04 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 104.232 -2.507 . . . . 0.0 104.232 164.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.495 ' HB2' ' SG ' ' A' ' 41' ' ' CYS . 0.0 OUTLIER -127.91 121.19 29.35 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.244 0.545 . . . . 0.0 110.651 176.725 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -69.32 111.08 4.99 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -101.3 163.74 12.12 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 121.013 1.733 . . . . 0.0 110.892 -176.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.502 ' HB2' ' CE3' ' A' ' 21' ' ' TRP . 44.2 t30 -153.74 115.51 4.25 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.862 0.865 . . . . 0.0 109.839 171.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.1 mt -66.47 145.63 55.45 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.922 1.289 . . . . 0.0 109.172 173.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.3 p90 . . . . . 0 C--O 1.251 1.143 0 C-N-CA 125.767 1.627 . . . . 0.0 107.852 172.276 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.7 t . . . . . 0 C--O 1.239 0.503 0 CA-C-O 122.846 1.308 . . . . 0.0 112.098 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 51.0 tttt -73.32 101.58 3.47 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.056 -0.974 . . . . 0.0 108.858 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 60.5 mt -103.22 112.67 37.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 104.605 -2.369 . . . . 0.0 104.605 174.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -142.38 178.64 7.44 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 122.829 0.451 . . . . 0.0 111.903 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -125.08 85.05 58.48 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 123.135 0.574 . . . . 0.0 111.387 -165.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.24 153.7 18.7 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.264 2.643 . . . . 0.0 112.998 -173.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.2 t -57.07 144.28 69.59 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 124.417 1.087 . . . . 0.0 109.752 170.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -71.39 -26.26 20.65 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 121.487 1.458 . . . . 0.0 113.003 -176.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -65.81 -42.86 90.14 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.17 0.895 . . . . 0.0 110.102 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.6 tptt -53.57 -45.56 69.97 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 123.461 0.705 . . . . 0.0 109.6 176.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.05 -31.98 73.25 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 121.729 -0.607 . . . . 0.0 111.341 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.56 -50.21 68.15 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 172.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -57.89 -50.78 72.17 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.661 1.184 . . . . 0.0 111.822 -176.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 55.4 mt -56.82 -8.96 0.68 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.29 1.836 . . . . 0.0 112.823 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.5 m 75.21 27.51 1.1 Allowed 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 128.124 2.57 . . . . 0.0 111.276 167.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.9 t -54.21 -28.61 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 128.48 2.712 . . . . 0.0 112.583 177.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.97 -29.31 70.71 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 120.239 1.382 . . . . 0.0 112.49 173.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.4 mtpp -82.51 -15.56 51.95 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.246 1.018 . . . . 0.0 112.205 176.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 38.2 m0 -69.32 165.17 42.25 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 119.169 0.895 . . . . 0.0 109.272 -173.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -67.39 141.73 57.3 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 121.464 1.443 . . . . 0.0 112.066 174.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.1 mt -88.56 142.97 12.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 125.909 1.683 . . . . 0.0 106.839 169.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.472 ' CE3' ' HE2' ' A' ' 84' ' ' LYS . 44.1 t90 -148.75 133.01 17.42 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 165.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.78 174.59 7.41 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.051 1.74 . . . . 0.0 107.677 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -154.21 161.77 41.62 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 173.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -73.68 170.53 15.06 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.625 0.726 . . . . 0.0 111.315 169.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -80.88 74.0 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 125.136 1.375 . . . . 0.0 108.571 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.0 t -141.23 -170.71 3.13 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.417 1.887 . . . . 0.0 107.824 -176.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.94 149.7 31.64 Favored 'General case' 0 CA--C 1.518 -0.263 0 O-C-N 120.386 -1.446 . . . . 0.0 111.733 -173.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -163.23 -164.76 0.98 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.248 1.819 . . . . 0.0 107.214 -171.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -130.02 161.79 30.16 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.095 -1.003 . . . . 0.0 109.184 170.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 12.6 t-105 -131.87 158.43 41.36 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 120.965 0.412 . . . . 0.0 110.471 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -132.73 96.24 3.77 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 176.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -72.05 123.27 22.45 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 176.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.38 1.02 6.32 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -171.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 p -140.87 174.42 10.53 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.553 2.341 . . . . 0.0 108.401 163.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -67.78 136.85 54.84 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -142.61 102.53 4.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -177.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.7 m -84.84 140.44 31.17 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 169.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 14.4 p -144.94 162.6 36.49 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 118.503 0.592 . . . . 0.0 111.577 162.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -124.64 111.85 16.1 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 126.058 1.743 . . . . 0.0 107.998 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 25.6 mm -72.8 111.97 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 128.798 2.839 . . . . 0.0 107.757 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.8 mt -92.01 -37.49 12.79 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 122.478 0.311 . . . . 0.0 111.235 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -162.44 165.22 26.56 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.631 0.772 . . . . 0.0 108.988 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.447 ' HA3' ' HA ' ' A' ' 82' ' ' VAL . . . 89.88 -176.57 42.67 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 124.246 0.927 . . . . 0.0 111.232 -177.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.495 ' HE2' HD12 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -147.48 147.35 30.08 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 117.538 0.669 . . . . 0.0 110.415 -179.424 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.6 t -139.64 156.34 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -178.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -124.37 133.7 53.34 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 122.589 1.185 . . . . 0.0 108.491 158.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.539 HG23 ' HB2' ' A' ' 58' ' ' TYR 0.627 0.1 OUTLIER -108.61 80.53 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.204 1 C-N-CA 133.629 4.771 . . . . 0.0 117.001 165.81 . . . . . . . . 5 4 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 82.9 m -71.04 122.7 20.53 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.078 162.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 74.9 p -82.52 -173.81 4.82 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.377 1.071 . . . . 0.0 111.811 174.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -62.77 -37.83 88.2 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.077 0.551 . . . . 0.0 110.255 170.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -63.59 -27.09 69.0 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.034 0.933 . . . . 0.0 111.677 177.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 103.86 -10.86 52.61 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-O 118.965 -0.908 . . . . 0.0 113.43 175.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.7 mttm -61.55 129.17 39.81 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 118.422 1.111 . . . . 0.0 108.78 173.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.38 103.84 16.48 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.186 0.994 . . . . 0.0 108.795 177.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.539 ' HB2' HG23 ' A' ' 50' ' ' VAL . 10.2 m-30 -68.29 100.05 1.0 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 167.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.7 t -81.68 137.82 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 165.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.8 pt -140.4 90.75 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -85.86 170.33 12.48 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.71 1.604 . . . . 0.0 110.729 172.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.1 pttm -60.57 111.29 1.54 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.748 1.219 . . . . 0.0 111.152 -176.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 121.5 -23.13 7.63 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 125.858 1.694 . . . . 0.0 113.208 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.24 100.88 3.83 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.26 1.53 . . . . 0.0 108.096 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.3 tp -71.61 145.54 48.93 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.8 t -129.85 138.73 53.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 125.733 1.613 . . . . 0.0 107.46 -171.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 98.5 m -130.38 100.06 5.23 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 162.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -70.68 146.8 94.04 Favored Pre-proline 0 C--O 1.238 0.486 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 165.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -82.54 175.69 8.61 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 122.097 1.864 . . . . 0.0 110.901 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -76.7 90.64 3.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 113.326 -1.761 . . . . 0.0 107.289 171.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 110.92 93.17 2.18 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.7 tp -153.16 142.26 21.37 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.874 1.67 . . . . 0.0 109.517 168.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 -115.96 133.53 55.93 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.821 2.049 . . . . 0.0 108.382 168.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 12.8 p -162.03 175.52 11.69 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.656 1.582 . . . . 0.0 108.365 169.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.56 -175.43 1.05 Allowed 'General case' 0 C--O 1.212 -0.869 0 CA-C-O 117.777 -1.106 . . . . 0.0 113.075 167.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -154.91 105.72 2.59 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.273 2.229 . . . . 0.0 105.65 163.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.0 tttt -103.83 116.77 32.89 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 176.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.0 t -83.84 106.87 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 174.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.495 HD12 ' HE2' ' A' ' 47' ' ' LYS . 81.9 mt -83.75 -20.95 32.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.042 178.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -158.49 152.05 19.21 Favored Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 126.994 2.118 . . . . 0.0 108.238 169.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -63.35 102.57 0.34 Allowed 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.715 2.944 . . . . 0.0 110.846 -168.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.447 ' HA ' ' HA3' ' A' ' 46' ' ' GLY . 7.1 p -83.38 144.74 9.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 123.699 0.8 . . . . 0.0 110.616 -173.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -116.75 131.88 56.84 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 163.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.472 ' HE2' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -134.62 150.01 50.63 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 173.483 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -96.24 114.02 25.67 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 105.844 -1.909 . . . . 0.0 105.844 165.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -106.87 166.6 10.48 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 119.612 1.096 . . . . 0.0 111.089 -176.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -151.54 130.76 12.75 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.694 0.679 . . . . 0.0 110.453 165.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 26.2 mt -85.99 136.44 33.26 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 126.797 2.039 . . . . 0.0 109.177 176.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.8 p90 . . . . . 0 C--O 1.248 1.02 0 C-N-CA 125.368 1.467 . . . . 0.0 111.172 179.439 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 82.7 t . . . . . 0 C--O 1.235 0.314 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -125.73 140.15 52.93 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 171.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.2 mt -137.52 146.5 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 175.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -154.57 -175.07 5.23 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.934 0.893 . . . . 0.0 109.861 160.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -118.96 80.75 18.58 Favored Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 169.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -67.7 172.12 11.03 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.896 2.397 . . . . 0.0 110.994 -177.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.414 HG23 ' H ' ' A' ' 12' ' ' LYS . 4.4 t -60.03 144.29 86.84 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 120.034 -0.666 . . . . 0.0 109.469 166.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.78 -20.18 46.26 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.149 1.899 . . . . 0.0 111.296 168.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -60.24 -50.38 73.89 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 119.772 1.169 . . . . 0.0 109.944 -177.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.414 ' H ' HG23 ' A' ' 9' ' ' THR . 47.8 tptt -55.73 -43.71 76.83 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 123.271 0.628 . . . . 0.0 109.762 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 70.6 mt -70.28 -33.66 71.83 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.732 1.213 . . . . 0.0 110.707 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -61.38 -32.3 72.22 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 120.429 -1.42 . . . . 0.0 110.92 168.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -73.75 -55.77 5.82 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 121.012 1.733 . . . . 0.0 109.722 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.1 tp -44.13 -66.25 0.41 Allowed 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 126.512 1.925 . . . . 0.0 112.682 -152.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.1 p 173.34 27.66 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 129.521 3.128 . . . . 0.0 109.784 150.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.1 t -59.92 -30.71 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 O-C-N 120.659 -1.275 . . . . 0.0 113.074 -160.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -60.01 -25.19 65.08 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 120.866 -1.146 . . . . 0.0 112.762 172.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.5 mttt -88.81 -31.4 18.35 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.498 1.519 . . . . 0.0 111.882 177.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.4 ' CD2' ' HB2' ' A' ' 87' ' ' ASN . 41.0 m0 -55.53 156.84 8.01 Favored Pre-proline 0 C--O 1.236 0.364 0 C-N-CA 124.021 0.928 . . . . 0.0 110.269 -175.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.91 138.59 40.96 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.465 1.443 . . . . 0.0 111.72 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.8 mt -71.48 150.96 8.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 164.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -137.35 134.86 36.48 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 159.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -141.15 120.71 13.27 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 126.374 1.87 . . . . 0.0 109.468 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.4 mmtt -109.49 152.28 25.63 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 123.733 0.813 . . . . 0.0 109.794 -178.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.5 pm0 -66.02 163.62 16.95 Favored 'General case' 0 N--CA 1.441 -0.876 0 O-C-N 124.915 1.385 . . . . 0.0 111.152 166.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.5 p -73.25 17.05 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 127.898 2.479 . . . . 0.0 113.966 -172.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.9 t -83.64 -171.27 3.49 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.89 1.276 . . . . 0.0 109.48 177.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -136.87 154.17 50.57 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 121.099 -1.0 . . . . 0.0 110.701 175.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -162.38 -164.45 1.04 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.826 1.651 . . . . 0.0 108.523 -172.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -135.28 154.91 51.39 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 126.068 1.747 . . . . 0.0 109.753 168.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 58.0 t-105 -138.16 127.58 24.72 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.059 0.544 . . . . 0.0 111.797 -174.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -80.95 130.48 35.04 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.421 1.089 . . . . 0.0 108.354 169.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -108.84 107.74 18.27 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.137 1.375 . . . . 0.0 107.312 166.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -114.08 21.2 15.02 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.812 0.845 . . . . 0.0 112.974 -179.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.41 167.0 31.48 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 127.445 2.298 . . . . 0.0 108.001 166.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -66.81 127.0 30.8 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -177.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -136.71 99.71 4.13 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -177.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 85.2 m -70.88 141.79 51.2 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 166.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.1 p -150.57 133.61 16.09 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 121.438 -0.788 . . . . 0.0 110.841 172.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -111.55 104.87 13.3 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 126.585 1.954 . . . . 0.0 109.362 -171.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 22.7 mm -76.65 114.92 17.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -175.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.79 -27.19 13.48 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 118.724 -0.655 . . . . 0.0 112.54 -178.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -158.84 153.01 23.76 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 119.492 1.042 . . . . 0.0 108.907 -178.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.64 -171.01 39.13 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.634 1.111 . . . . 0.0 113.035 -176.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.18 146.44 35.25 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.994 1.717 . . . . 0.0 108.171 -177.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.3 t -141.77 147.18 22.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -124.01 122.66 38.5 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 127.754 2.422 . . . . 0.0 107.175 167.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.6 t -110.76 117.24 54.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 46.3 m -111.02 120.55 42.74 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.484 ' HA ' ' SG ' ' A' ' 74' ' ' CYS . 27.2 p -73.43 162.36 29.39 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.517 0.675 . . . . 0.0 110.692 -179.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.83 -30.73 71.4 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.693 -0.63 . . . . 0.0 109.314 172.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -63.34 -15.65 58.0 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 127.342 2.257 . . . . 0.0 112.663 168.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 103.78 -12.25 53.33 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 125.235 1.398 . . . . 0.0 113.763 172.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -60.39 112.45 1.96 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 118.762 1.281 . . . . 0.0 108.45 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -70.12 153.64 42.9 Favored 'General case' 0 C--O 1.231 0.087 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 164.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -135.27 160.91 36.9 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 126.031 1.732 . . . . 0.0 106.724 159.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 88.7 t -123.06 150.22 26.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 170.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.5 pt -142.02 126.36 16.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 164.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -94.97 175.53 6.61 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.215 1.006 . . . . 0.0 109.241 173.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.0 pttm -62.4 68.54 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.664 1.985 . . . . 0.0 111.936 166.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 165.81 -9.44 0.07 OUTLIER Glycine 0 C--N 1.315 -0.618 0 CA-C-O 118.083 -1.399 . . . . 0.0 113.463 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -80.19 136.16 36.43 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.795 1.798 . . . . 0.0 106.545 167.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.7 tp -104.65 139.23 39.79 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 161.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 42.8 t -118.26 157.42 19.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 -177.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.7 m -138.14 101.62 4.46 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 168.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -72.8 153.35 91.26 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 173.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -84.06 173.26 9.15 Favored 'Trans proline' 0 N--CA 1.447 -1.226 0 C-N-CA 122.137 1.891 . . . . 0.0 110.682 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -80.63 90.42 5.75 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 164.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 118.24 78.32 0.62 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 123.812 0.72 . . . . 0.0 113.074 174.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 31.8 tp -147.49 154.77 41.18 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.97 1.308 . . . . 0.0 108.9 169.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.6 ptt85 -144.02 101.27 3.7 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 125.103 1.361 . . . . 0.0 107.664 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . 0.484 ' SG ' ' HA ' ' A' ' 52' ' ' THR . 73.7 m -145.21 161.97 38.25 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.801 0.84 . . . . 0.0 110.777 -170.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.2 152.36 38.39 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 122.846 0.458 . . . . 0.0 111.321 -173.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.8 m95 -127.89 97.1 4.69 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.732 2.013 . . . . 0.0 107.699 174.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.5 tptt -76.07 146.01 39.69 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 104.624 -2.361 . . . . 0.0 104.624 161.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.38 94.07 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 168.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.8 mt -67.08 -32.29 73.36 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 118.148 -0.93 . . . . 0.0 110.902 -177.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -134.64 144.78 52.22 Favored Pre-proline 0 N--CA 1.454 -0.232 0 CA-C-O 117.625 -1.178 . . . . 0.0 109.5 175.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -61.14 95.36 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.938 3.092 . . . . 0.0 109.872 -177.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.9 p -81.77 159.6 3.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 125.112 1.365 . . . . 0.0 110.049 -167.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.1 ttt85 -129.69 134.37 47.61 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 164.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.44 151.73 42.06 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 169.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -83.95 125.12 31.72 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 160.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -112.26 157.26 21.14 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 173.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.4 ' HB2' ' CD2' ' A' ' 21' ' ' TRP . 49.5 t30 -151.28 114.43 4.77 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 171.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 55.8 mt -65.96 143.65 57.26 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.192 1.397 . . . . 0.0 107.694 166.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 36.6 p90 . . . . . 0 C--O 1.255 1.359 0 CA-C-O 115.939 -1.981 . . . . 0.0 112.08 174.354 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 p . . . . . 0 C--O 1.239 0.535 0 CA-C-O 120.714 0.292 . . . . 0.0 110.751 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -98.2 140.04 33.1 Favored 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 160.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.2 mt -126.28 142.54 42.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 168.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -155.35 177.45 11.34 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.473 ' HE2' ' OD2' ' A' ' 64' ' ' ASP . 3.6 mmtp -120.6 82.72 33.84 Favored Pre-proline 0 C--N 1.346 0.428 0 C-N-CA 124.894 1.278 . . . . 0.0 110.8 -177.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.584 ' HG2' HD21 ' A' ' 13' ' ' LEU . 71.9 Cg_endo -78.21 169.63 19.93 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 123.639 2.893 . . . . 0.0 111.603 -178.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.6 p -77.07 150.23 80.61 Favored Pre-proline 0 C--O 1.235 0.329 0 O-C-N 121.947 -0.471 . . . . 0.0 109.97 178.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -64.62 -32.36 58.25 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 121.661 1.574 . . . . 0.0 111.387 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -57.43 -53.12 61.79 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.766 0.826 . . . . 0.0 110.509 176.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.0 tptt -55.0 -40.08 69.73 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.102 0.561 . . . . 0.0 110.177 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.584 HD21 ' HG2' ' A' ' 8' ' ' PRO . 4.1 mm? -65.33 -36.54 84.36 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 123.468 0.707 . . . . 0.0 111.173 -178.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -62.8 -48.16 80.32 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 121.177 -0.952 . . . . 0.0 109.361 171.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -61.45 -40.74 95.59 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.658 0.783 . . . . 0.0 112.364 -174.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 mp -55.46 -14.41 1.97 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.95 1.7 . . . . 0.0 113.133 175.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.4 m 57.97 40.37 25.67 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.302 1.841 . . . . 0.0 110.544 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.7 t -54.56 -31.33 23.22 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.257 0 C-N-CA 127.517 2.327 . . . . 0.0 111.024 174.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -56.92 -17.17 8.59 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 170.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -102.62 -5.76 23.51 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.097 1.759 . . . . 0.0 111.46 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.484 ' CE3' ' HB2' ' A' ' 87' ' ' ASN . 31.0 m0 -77.71 165.22 52.78 Favored Pre-proline 0 C--O 1.24 0.582 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.11 140.72 42.01 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 121.654 1.569 . . . . 0.0 111.151 171.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.0 mt -81.58 151.55 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 165.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.635 ' CE3' ' HE3' ' A' ' 84' ' ' LYS . 7.1 t90 -136.77 141.71 42.98 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 156.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.76 153.0 48.64 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 128.207 2.603 . . . . 0.0 108.917 174.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.523 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 1.7 tttt -153.25 165.14 36.64 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.316 -0.865 . . . . 0.0 109.876 172.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.69 176.78 4.57 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 126.135 1.774 . . . . 0.0 110.245 171.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.6 t -83.77 49.6 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 129.984 3.313 . . . . 0.0 109.088 -169.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.0 t -105.57 -169.07 1.54 Allowed 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 127.302 2.241 . . . . 0.0 109.706 -165.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.07 135.47 19.35 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 120.723 -1.235 . . . . 0.0 108.877 177.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -153.57 -164.94 2.01 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.361 1.064 . . . . 0.0 109.268 -176.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -137.65 152.1 48.97 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.86 1.264 . . . . 0.0 109.663 173.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 15.5 t-105 -128.46 135.2 49.14 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 125.137 1.375 . . . . 0.0 109.615 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -106.99 109.71 21.67 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 171.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -79.58 123.02 27.22 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 171.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -124.81 5.49 8.09 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.692 0.797 . . . . 0.0 111.446 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.94 177.09 9.64 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 126.806 2.042 . . . . 0.0 108.678 165.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -65.15 137.69 57.8 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 178.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -143.94 100.62 3.6 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -174.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 85.6 m -75.67 144.35 41.67 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 116.19 -1.862 . . . . 0.0 106.521 172.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 7.5 p -133.31 162.75 30.96 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 114.269 -2.973 . . . . 0.0 111.039 145.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -125.69 109.43 12.59 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 170.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.8 mm -73.82 131.28 35.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.42 -21.24 8.13 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.317 0.962 . . . . 0.0 112.964 -177.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -154.47 160.65 41.72 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 165.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.18 -174.0 24.74 Favored Glycine 0 N--CA 1.465 0.591 0 C-N-CA 124.11 0.862 . . . . 0.0 113.623 174.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.568 ' HE2' HG13 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -145.39 141.95 28.91 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.242 0.544 . . . . 0.0 109.717 173.54 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.526 ' C ' ' HZ3' ' A' ' 47' ' ' LYS . 3.3 t -127.77 136.27 60.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 176.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -99.66 131.62 45.53 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 157.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 94.1 t -114.02 140.78 32.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 171.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.8 m -136.89 108.34 6.9 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -175.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 49.7 p -77.42 177.26 8.13 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.707 -0.621 . . . . 0.0 109.486 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -72.56 -25.72 61.46 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 120.613 -1.304 . . . . 0.0 110.838 -174.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.18 -27.72 65.96 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.109 0.964 . . . . 0.0 111.981 169.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.68 8.79 69.64 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-O 118.648 -1.084 . . . . 0.0 113.357 -177.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp -52.45 117.98 3.25 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 156.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -74.5 153.4 39.13 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 158.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -136.91 150.59 48.31 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 170.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.568 HG13 ' HE2' ' A' ' 47' ' ' LYS . 63.0 t -127.1 141.08 47.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 176.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.8 pt -135.52 120.87 29.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 170.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.49 175.23 9.44 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.723 1.209 . . . . 0.0 109.231 169.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -64.13 43.31 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 130.557 3.543 . . . . 0.0 114.905 175.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -179.48 -0.67 0.02 OUTLIER Glycine 0 CA--C 1.525 0.659 0 C-N-CA 124.943 1.258 . . . . 0.0 112.697 -176.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.473 ' OD2' ' HE2' ' A' ' 7' ' ' LYS . 1.3 m-20 -72.54 114.06 10.26 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 166.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.2 tp -74.33 160.78 30.61 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 152.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.526 HG21 ' CE1' ' A' ' 68' ' ' PHE . 1.2 p -160.16 149.36 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 C-N-CA 126.958 2.103 . . . . 0.0 109.716 -175.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 84.2 m -136.63 97.56 3.58 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 173.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.526 ' CE1' HG21 ' A' ' 66' ' ' VAL . 91.0 m-85 -70.79 145.9 92.66 Favored Pre-proline 0 C--O 1.239 0.512 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 163.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -86.21 174.56 6.1 Favored 'Trans proline' 0 N--CA 1.443 -1.459 0 C-N-CA 121.685 1.59 . . . . 0.0 110.777 -174.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.2 tttm -71.08 96.79 1.38 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 113.214 -1.812 . . . . 0.0 106.838 165.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 102.42 88.64 2.05 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 126.307 1.908 . . . . 0.0 111.485 177.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.9 tt -148.8 139.41 22.68 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 126.861 2.064 . . . . 0.0 107.804 167.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -126.21 108.45 11.31 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.643 1.177 . . . . 0.0 108.156 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 24.6 p -145.85 168.81 19.89 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -175.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.44 162.12 21.09 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 123.478 0.711 . . . . 0.0 111.847 170.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -144.54 97.9 3.11 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 126.98 2.112 . . . . 0.0 109.135 -172.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.5 tptt -98.89 123.32 43.08 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 126.462 1.905 . . . . 0.0 107.445 -176.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.9 t -101.12 100.88 11.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.8 mt -82.8 -28.81 30.01 Favored 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 119.679 -0.809 . . . . 0.0 109.196 -177.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -144.95 150.47 46.08 Favored Pre-proline 0 C--O 1.238 0.499 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 175.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -65.65 135.21 41.03 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 122.79 2.326 . . . . 0.0 107.942 -169.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.9 p -131.73 119.88 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.456 -157.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.0 ttt85 -99.43 116.47 31.66 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 171.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.635 ' HE3' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -126.28 146.74 49.89 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 172.265 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 14.3 m80 -85.5 129.05 34.91 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 161.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -117.37 162.21 18.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 172.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.484 ' HB2' ' CE3' ' A' ' 21' ' ' TRP . 23.1 t30 -152.97 121.21 6.23 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 172.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 29.7 mt -75.58 134.59 40.66 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 126.11 1.764 . . . . 0.0 106.837 170.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.8 p90 . . . . . 0 C--O 1.256 1.416 0 CA-C-N 119.648 1.113 . . . . 0.0 110.988 -176.782 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.0 t . . . . . 0 N--CA 1.455 -0.211 0 CA-C-O 122.063 0.935 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.69 115.28 6.34 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.7 mt -110.58 148.19 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 168.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -157.75 175.51 13.79 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.389 1.075 . . . . 0.0 109.694 165.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.36 85.5 10.82 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 173.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -69.83 167.6 24.05 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.74 2.96 . . . . 0.0 111.551 -177.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.4 p -84.09 151.02 59.53 Favored Pre-proline 0 N--CA 1.448 -0.533 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -63.37 -31.49 72.74 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.541 2.161 . . . . 0.0 112.126 175.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -63.54 -48.93 75.47 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 119.292 0.951 . . . . 0.0 110.636 171.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -57.77 -38.14 74.92 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.779 0.718 . . . . 0.0 111.012 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 57.4 mt -63.33 -26.86 68.96 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 118.978 -0.534 . . . . 0.0 112.32 177.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -66.6 -43.22 85.44 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 119.713 1.142 . . . . 0.0 110.268 170.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -61.34 -47.23 86.87 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 122.04 0.924 . . . . 0.0 109.453 -174.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 88.1 mt -65.09 -4.26 4.63 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.094 1.757 . . . . 0.0 112.667 178.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 56.77 33.37 22.89 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.5 1.52 . . . . 0.0 111.945 175.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.1 t -56.6 -23.28 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.076 0.951 . . . . 0.0 111.697 -176.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -53.83 -29.97 43.17 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.416 -1.428 . . . . 0.0 113.954 167.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -84.8 -21.4 29.94 Favored 'General case' 0 C--O 1.226 -0.164 0 O-C-N 121.336 -0.852 . . . . 0.0 110.28 -170.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 31.0 m0 -71.88 163.75 64.18 Favored Pre-proline 0 N--CA 1.448 -0.555 0 C-N-CA 125.229 1.412 . . . . 0.0 109.37 -162.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.03 133.17 30.14 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 121.17 1.247 . . . . 0.0 110.315 172.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 63.6 mt -70.19 145.45 12.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 167.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.555 ' HE3' ' HD2' ' A' ' 84' ' ' LYS . 88.3 t90 -139.14 141.15 38.06 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 163.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -128.7 165.02 21.68 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 126.886 2.074 . . . . 0.0 107.991 173.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -149.87 158.83 44.55 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 167.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -84.45 175.68 9.16 Favored 'General case' 0 N--CA 1.435 -1.207 0 O-C-N 123.979 0.799 . . . . 0.0 111.167 172.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.5 p -66.53 11.34 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 129.128 2.971 . . . . 0.0 113.097 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.03 134.39 34.54 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 126.833 2.053 . . . . 0.0 109.191 178.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -72.68 168.09 19.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.915 0.864 . . . . 0.0 110.269 177.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -165.94 -172.13 2.23 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 169.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.438 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 1.8 p30 -123.33 146.72 47.69 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 119.888 -1.758 . . . . 0.0 106.929 157.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 12.8 t-105 -114.97 153.63 30.24 Favored 'General case' 0 C--O 1.239 0.549 0 O-C-N 123.897 0.748 . . . . 0.0 110.39 172.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -123.22 105.27 9.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 170.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -78.75 104.94 9.71 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 174.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -105.22 11.57 32.87 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -179.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.76 168.3 21.71 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 129.04 2.936 . . . . 0.0 107.749 157.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -58.29 137.74 56.91 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 125.433 1.493 . . . . 0.0 107.78 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -141.65 113.96 8.18 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 175.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 97.2 m -79.73 149.12 31.26 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 162.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.1 p -145.38 137.84 25.87 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 119.16 0.891 . . . . 0.0 111.265 157.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -100.93 111.52 23.74 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.928 1.691 . . . . 0.0 107.894 174.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.8 mm -75.31 120.57 25.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 C-N-CA 124.05 0.94 . . . . 0.0 108.734 177.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 mp -101.82 -25.38 13.83 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 118.812 -0.613 . . . . 0.0 111.969 176.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -169.62 158.65 7.82 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.222 1.009 . . . . 0.0 109.592 -177.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.75 -172.14 14.21 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.41 1.481 . . . . 0.0 111.871 177.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.533 ' HD2' ' H ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -138.23 151.87 48.07 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 123.209 1.481 . . . . 0.0 108.522 167.644 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.572 HG13 ' CG1' ' A' ' 60' ' ' ILE 0.266 0.4 OUTLIER -152.98 135.73 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.431 0 C-N-CA 130.206 3.402 . . . . 0.0 112.97 -171.017 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.436 ' HB3' ' HE3' ' A' ' 57' ' ' LYS . 10.3 mt-10 -128.51 107.77 9.99 Favored 'General case' 0 N--CA 1.428 -1.566 0 O-C-N 125.819 1.949 . . . . 0.0 109.231 155.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 78.3 t -83.24 146.45 6.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 168.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.1 m -139.77 117.14 11.32 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 175.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 47.3 p -65.05 169.24 5.58 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 174.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -53.36 -36.68 61.64 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.596 -0.69 . . . . 0.0 110.41 171.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -65.16 -2.06 2.65 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 129.406 3.082 . . . . 0.0 114.328 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.76 6.57 78.18 Favored Glycine 0 CA--C 1.533 1.206 0 O-C-N 121.156 -0.965 . . . . 0.0 113.11 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -73.51 102.32 3.8 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 168.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.436 ' HE3' ' HB3' ' A' ' 49' ' ' GLU . 3.1 tptt -75.12 146.2 41.59 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 170.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -142.35 107.38 4.93 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.451 1.9 . . . . 0.0 107.961 177.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.7 t -69.81 138.47 22.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 164.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.572 ' CG1' HG13 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -124.9 146.8 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 C-N-CA 123.849 0.859 . . . . 0.0 109.807 165.221 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -142.1 -178.37 5.68 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 122.221 1.01 . . . . 0.0 111.525 173.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.5 pttm -61.7 85.22 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.548 1.939 . . . . 0.0 111.548 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 144.83 -11.0 1.89 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 126.121 1.819 . . . . 0.0 113.04 177.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -90.34 106.54 18.56 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 175.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.8 tp -76.47 146.39 38.58 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 168.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.3 t -129.45 155.29 41.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 123.295 0.638 . . . . 0.0 109.403 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.7 m -138.76 123.41 18.57 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.179 0.992 . . . . 0.0 109.263 162.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -86.81 153.03 54.78 Favored Pre-proline 0 C--O 1.239 0.531 0 C-N-CA 125.215 1.406 . . . . 0.0 109.799 171.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -79.99 179.68 6.03 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.506 2.804 . . . . 0.0 109.491 175.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -83.49 103.83 13.15 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 164.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 102.73 62.97 0.71 Allowed Glycine 0 CA--C 1.523 0.547 0 C-N-CA 125.175 1.369 . . . . 0.0 112.297 166.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.8 tp -123.68 147.72 47.17 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.504 1.922 . . . . 0.0 108.501 174.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.22 142.33 47.58 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.624 1.57 . . . . 0.0 109.23 174.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 8.7 p -167.46 163.91 14.93 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 118.86 0.755 . . . . 0.0 112.275 167.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -77.22 145.33 37.64 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 118.516 -0.754 . . . . 0.0 109.967 167.544 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 6.6 m95 -104.65 136.97 43.2 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 158.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.0 tttt -113.69 103.75 11.53 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 158.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.6 t -76.88 106.43 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 103.475 -2.787 . . . . 0.0 103.475 174.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.9 mt -88.82 -16.06 33.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.594 -177.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -150.27 151.37 31.34 Favored Pre-proline 0 C--O 1.234 0.273 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.888 161.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -58.14 114.64 2.06 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.925 3.083 . . . . 0.0 110.439 -175.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.9 p -88.08 164.06 2.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 C-N-CA 123.604 0.762 . . . . 0.0 109.949 -168.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -134.97 122.79 22.38 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 155.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.555 ' HD2' ' HE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -134.05 140.13 46.45 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 171.489 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -77.49 104.65 8.14 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 103.763 -2.68 . . . . 0.0 103.763 164.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -85.13 161.28 19.71 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 167.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -149.74 140.1 22.32 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 119.538 -0.865 . . . . 0.0 109.986 152.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 44.4 mt -71.91 163.95 26.94 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 171.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 5.1 p90 . . . . . 0 C--O 1.246 0.891 0 O-C-N 121.305 -0.872 . . . . 0.0 108.747 160.019 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 C--O 1.235 0.298 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.9 tptt -113.73 136.53 52.74 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 171.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 55.7 mt -135.4 112.15 13.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -143.04 174.8 10.36 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.197 0.999 . . . . 0.0 109.615 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.8 82.38 6.54 Favored Pre-proline 0 CA--C 1.532 0.259 0 O-C-N 121.598 -0.689 . . . . 0.0 109.268 176.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.414 ' HG3' HD22 ' A' ' 65' ' ' LEU . 92.1 Cg_endo -74.8 165.87 30.53 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.542 2.161 . . . . 0.0 113.428 -174.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.9 t -61.58 144.13 92.89 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 124.794 1.238 . . . . 0.0 110.953 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.65 -23.17 63.84 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.786 2.324 . . . . 0.0 113.027 177.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.41 -61.14 2.65 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 125.064 1.345 . . . . 0.0 109.721 -176.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -56.77 -36.85 70.3 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 122.183 -0.323 . . . . 0.0 110.825 -175.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.2 mt -58.28 -41.61 84.72 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 173.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.3 -50.89 71.48 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.513 1.051 . . . . 0.0 108.323 173.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -63.84 -34.38 77.8 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 123.482 0.713 . . . . 0.0 111.847 -174.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.75 -5.97 3.23 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.564 1.546 . . . . 0.0 113.601 177.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . 0.254 98.8 p 63.17 28.24 15.87 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 128.332 2.653 . . . . 0.0 113.943 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 20.1 t -57.28 -31.96 39.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 118.941 0.791 . . . . 0.0 112.985 -170.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -62.96 -23.71 67.54 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.281 1.4 . . . . 0.0 113.027 176.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.9 mttm -88.59 -8.03 55.4 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 126.223 1.809 . . . . 0.0 111.045 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 39.8 m0 -74.36 163.31 69.2 Favored Pre-proline 0 N--CA 1.451 -0.39 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.12 133.58 31.28 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.003 1.136 . . . . 0.0 111.314 173.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.1 mt -70.44 149.18 10.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 124.654 1.182 . . . . 0.0 107.974 165.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.8 t90 -144.84 145.32 31.56 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.56 -1.2 . . . . 0.0 107.775 162.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.22 162.62 34.83 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.782 2.433 . . . . 0.0 108.344 176.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.525 ' HD3' ' H ' ' A' ' 27' ' ' GLU . 5.3 tmtt? -147.17 173.16 12.78 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.933 -1.105 . . . . 0.0 110.224 178.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.525 ' H ' ' HD3' ' A' ' 26' ' ' LYS . 6.0 tt0 -70.9 -179.77 2.38 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 127.612 2.365 . . . . 0.0 111.288 166.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.453 ' H ' ' HG2' ' A' ' 27' ' ' GLU . 11.3 t -97.89 6.96 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 C-N-CA 127.456 2.302 . . . . 0.0 111.91 -171.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.5 t -81.5 172.91 12.93 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 120.627 -1.296 . . . . 0.0 109.511 173.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -100.42 161.41 13.62 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.321 -0.862 . . . . 0.0 109.31 171.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.469 ' CE2' ' HE3' ' A' ' 26' ' ' LYS . 14.4 p90 -156.75 177.16 11.8 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 125.445 1.498 . . . . 0.0 109.138 170.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.11 129.47 51.81 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.062 2.145 . . . . 0.0 108.186 171.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 35.1 t-105 -118.65 146.15 44.9 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.909 173.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -117.46 143.81 45.65 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.123 1.369 . . . . 0.0 107.907 174.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -118.09 110.81 18.09 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 175.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -107.9 3.01 23.81 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.494 1.118 . . . . 0.0 111.429 -175.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.58 160.4 42.44 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 129.686 3.194 . . . . 0.0 107.318 173.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -64.34 127.74 32.77 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 -174.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -135.1 109.1 8.17 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 177.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 56.1 m -82.07 135.75 35.29 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 167.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 29.2 p -134.65 156.93 47.89 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.084 0.468 . . . . 0.0 110.186 163.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -133.45 116.64 16.25 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.932 1.293 . . . . 0.0 108.502 -175.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.8 mm -72.47 143.19 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 126.475 1.91 . . . . 0.0 109.274 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.0 mt -127.25 -37.14 2.07 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.229 0.611 . . . . 0.0 109.822 171.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -150.82 159.4 44.57 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 173.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 82' ' ' VAL . . . 101.17 177.27 29.01 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 126.305 1.907 . . . . 0.0 114.097 177.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.667 ' HE3' HG23 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -140.93 154.56 46.15 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-O 123.282 1.515 . . . . 0.0 110.054 -175.427 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.483 HG13 HG12 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -160.04 150.06 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.995 1 C-N-CA 133.539 4.735 . . . . 0.0 108.033 -161.677 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.422 ' OE1' HD11 ' A' ' 79' ' ' LEU . 15.8 mt-10 -135.21 115.61 13.53 Favored 'General case' 0 N--CA 1.414 -2.233 0 N-CA-C 104.23 -2.507 . . . . 0.0 104.23 152.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.4 t -89.56 121.86 40.22 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.993 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 172.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.5 m -111.34 122.84 48.9 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 82.4 p -74.08 178.52 4.96 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -71.77 -23.93 61.67 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 120.209 -1.557 . . . . 0.0 111.698 168.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.43 -7.99 29.64 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.825 1.25 . . . . 0.0 111.653 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.3 -13.56 61.55 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 126.261 1.886 . . . . 0.0 112.951 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -61.13 137.1 58.24 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.565 1.546 . . . . 0.0 107.542 178.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.4 tttm -120.67 130.52 54.15 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -172.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 13.5 m-30 -128.28 84.9 2.28 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 125.618 2.627 . . . . 0.0 108.962 -169.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.667 HG23 ' HE3' ' A' ' 47' ' ' LYS . 1.5 p -54.36 97.82 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 127.407 2.283 . . . . 0.0 112.587 152.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.483 HG12 HG13 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -80.59 156.54 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.062 0 CA-C-N 112.487 -2.142 . . . . 0.0 109.414 155.803 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -157.82 -179.84 8.52 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 171.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.4 82.42 0.05 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 126.068 1.747 . . . . 0.0 109.326 -176.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 160.32 -12.27 0.16 Allowed Glycine 0 CA--C 1.524 0.634 0 CA-C-O 118.082 -1.399 . . . . 0.0 115.662 -167.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -126.64 104.95 8.38 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 119.186 1.493 . . . . 0.0 109.17 -166.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.414 HD22 ' HG3' ' A' ' 8' ' ' PRO . 19.3 tp -65.86 150.53 48.44 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 172.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.0 t -128.93 156.68 41.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 121.909 0.862 . . . . 0.0 109.288 168.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 75.7 m -144.48 111.51 5.86 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.365 1.466 . . . . 0.0 108.09 162.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -78.36 155.68 79.06 Favored Pre-proline 0 C--O 1.234 0.272 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 170.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -80.84 177.83 7.58 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 121.396 1.398 . . . . 0.0 110.334 172.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 32.4 tttt -75.08 91.4 2.56 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 112.933 -1.94 . . . . 0.0 107.527 164.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 116.17 90.79 1.63 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.754 1.168 . . . . 0.0 111.441 173.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.9 tp -155.2 150.71 27.33 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.51 1.524 . . . . 0.0 110.087 173.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.2 ttp85 -128.78 122.96 31.69 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 126.285 1.834 . . . . 0.0 109.116 176.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 8.3 p -157.13 167.32 30.74 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.226 0.921 . . . . 0.0 110.919 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.91 173.71 12.26 Favored 'General case' 0 CA--C 1.516 -0.347 0 O-C-N 120.887 -1.133 . . . . 0.0 112.4 168.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 5.9 m95 -142.88 93.65 2.54 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 127.51 2.324 . . . . 0.0 106.728 167.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -79.83 105.31 11.02 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 170.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 t -86.14 86.92 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 -174.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.481 HD12 ' HE2' ' A' ' 47' ' ' LYS . 97.3 mt -64.72 -29.87 70.87 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.451 -178.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -142.74 154.57 62.79 Favored Pre-proline 0 N--CA 1.465 0.281 0 CA-C-N 119.481 1.037 . . . . 0.0 110.382 168.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.51 85.17 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 125.078 3.852 . . . . 0.0 111.753 -168.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.409 ' HA ' ' HA3' ' A' ' 46' ' ' GLY . 8.5 p -75.16 137.62 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 124.725 1.21 . . . . 0.0 109.674 -163.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.5 ttt180 -116.82 106.74 13.8 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 104.108 -2.553 . . . . 0.0 104.108 177.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.11 142.96 51.17 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 10.5 m80 -78.08 136.79 37.96 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 165.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -124.27 163.17 22.2 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 173.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 22.3 t30 -157.23 137.15 12.48 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 119.4 1.0 . . . . 0.0 109.113 169.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 66.3 mt -94.56 146.16 24.31 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.512 1.125 . . . . 0.0 108.909 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.5 p90 . . . . . 0 C--O 1.247 0.942 0 C-N-CA 125.173 1.389 . . . . 0.0 111.673 -176.427 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.639 HG12 HG13 ' A' ' 5' ' ' ILE . 85.5 t . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt -81.24 102.67 10.51 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 122.073 -0.392 . . . . 0.0 110.862 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.639 HG13 HG12 ' A' ' 3' ' ' VAL . 63.5 mt -111.09 124.69 68.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 O-C-N 123.433 0.458 . . . . 0.0 110.655 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -163.89 179.85 6.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.722 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.81 83.65 4.81 Favored Pre-proline 0 C--O 1.241 0.635 0 CA-C-O 121.885 0.85 . . . . 0.0 110.806 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.512 ' HG3' HD13 ' A' ' 65' ' ' LEU . 51.7 Cg_endo -69.3 139.44 41.83 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.145 1.896 . . . . 0.0 112.035 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -49.4 146.96 6.03 Favored Pre-proline 0 C--O 1.233 0.185 0 CA-C-O 121.383 0.611 . . . . 0.0 111.18 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.536 ' HA ' HD12 ' A' ' 13' ' ' LEU . 50.1 Cg_endo -69.01 -9.13 25.52 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.574 2.182 . . . . 0.0 112.553 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.91 -50.95 12.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.813 0.34 . . . . 0.0 110.673 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.11 -34.34 73.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.855 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.583 HD23 HG21 ' A' ' 18' ' ' VAL . 3.5 mt -62.82 -42.94 99.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.849 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -57.85 -33.92 69.17 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 119.104 -0.474 . . . . 0.0 110.987 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -78.03 -38.88 43.68 Favored 'General case' 0 C--N 1.332 -0.174 0 O-C-N 124.419 1.074 . . . . 0.0 110.503 -179.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.3 mp -59.11 -19.71 47.01 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 122.997 0.519 . . . . 0.0 111.165 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 63.32 43.2 6.32 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 123.445 0.466 . . . . 0.0 110.466 -178.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.583 HG21 HD23 ' A' ' 13' ' ' LEU . 22.7 t -56.93 -23.53 18.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.971 0.415 . . . . 0.0 110.964 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -72.2 -19.52 61.72 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.417 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.62 -7.75 54.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 179.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 40.1 m0 -79.72 155.16 75.94 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.875 0.369 . . . . 0.0 110.7 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 131.25 20.77 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.447 2.098 . . . . 0.0 112.253 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.0 mt -80.98 141.26 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.751 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 86.5 t90 -139.55 117.36 11.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.611 178.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.49 153.67 31.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.761 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.89 162.94 30.98 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.981 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.3 pm0 -70.12 176.48 3.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.207 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.483 HG13 ' O ' ' A' ' 79' ' ' LEU . 30.4 t -77.19 -4.3 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.373 0.606 . . . . 0.0 111.394 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.9 t -77.13 174.02 11.17 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.081 -0.648 . . . . 0.0 112.044 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -107.69 174.51 5.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.485 -177.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 18.7 p90 178.55 179.81 0.35 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.293 -178.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -119.77 111.9 18.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.231 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 10.3 t-105 -97.26 151.87 19.43 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-O 120.847 0.356 . . . . 0.0 110.188 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -131.23 113.17 13.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.453 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -91.89 135.07 34.22 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.556 0.535 . . . . 0.0 110.737 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.474 ' O ' HG23 ' A' ' 37' ' ' THR . 2.0 p30 -125.44 22.88 7.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.983 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -179.74 150.37 0.4 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.867 0.365 . . . . 0.0 110.936 -179.122 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.46 ' ND2' ' H ' ' A' ' 38' ' ' ASN . 4.3 m-80 -51.83 104.35 0.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.75 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -123.29 83.86 2.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.101 0.477 . . . . 0.0 109.97 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 80.2 m -60.1 147.35 39.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.077 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 4.1 p -146.28 133.69 20.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.871 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.457 ' CD1' HD12 ' A' ' 65' ' ' LEU . 51.1 t80 -116.19 116.25 27.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.935 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.566 HD13 ' HB3' ' A' ' 84' ' ' LYS . 25.0 mm -77.24 136.03 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.829 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.463 HD12 ' O ' ' A' ' 83' ' ' ARG . 0.9 OUTLIER -120.59 -30.04 4.59 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 123.524 0.515 . . . . 0.0 111.417 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.44 ' HA ' ' HB3' ' A' ' 62' ' ' LYS . 15.1 pt-20 -162.15 155.51 20.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.309 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.56 179.75 33.51 Favored Glycine 0 N--CA 1.451 -0.311 0 O-C-N 123.503 0.502 . . . . 0.0 112.217 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.786 ' HE3' HG23 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -127.17 166.87 16.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.033 0.444 . . . . 0.0 110.886 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.66 HG13 ' CG1' ' A' ' 60' ' ' ILE . 0.1 OUTLIER -174.08 141.65 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.355 -177.722 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 2.7 mt-10 -132.4 90.97 2.86 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.53 0.681 . . . . 0.0 110.202 178.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.655 HG23 HD11 ' A' ' 60' ' ' ILE . 48.9 t -78.43 110.57 14.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 O-C-N 122.022 -0.424 . . . . 0.0 110.966 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 90.6 m -107.76 105.66 15.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.737 0.303 . . . . 0.0 110.803 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.8 p -64.35 154.91 33.97 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.95 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -51.73 -38.19 54.26 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.023 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -52.84 -29.38 27.58 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.445 0.641 . . . . 0.0 110.85 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 113.79 0.62 24.37 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 121.326 -0.464 . . . . 0.0 112.057 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -85.06 115.9 23.13 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 122.535 -0.391 . . . . 0.0 110.473 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.5 mttm -79.92 157.05 26.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.891 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -148.63 92.26 1.98 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.146 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.786 HG23 ' HE3' ' A' ' 47' ' ' LYS . 1.8 p -83.92 123.7 39.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.154 0.502 . . . . 0.0 111.015 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.66 ' CG1' HG13 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -113.68 143.75 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.422 179.656 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -139.93 -173.44 3.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.447 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.44 ' HB3' ' HA ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -69.47 67.06 0.21 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.069 0.461 . . . . 0.0 111.421 179.288 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 160.23 37.66 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.383 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -154.36 102.94 2.47 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 117.206 0.503 . . . . 0.0 110.946 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.524 ' CD1' HD21 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -80.32 128.78 33.95 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.568 -179.397 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.605 HG22 HG12 ' A' ' 5' ' ' ILE . 8.2 t -117.91 147.09 21.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 O-C-N 123.647 0.592 . . . . 0.0 110.661 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.2 m -142.97 101.03 3.76 Favored 'General case' 0 C--O 1.25 1.107 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.947 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.6 ' CD1' HG22 ' A' ' 3' ' ' VAL . 59.5 m-85 -77.05 147.53 77.05 Favored Pre-proline 0 C--N 1.344 0.335 0 O-C-N 124.621 1.201 . . . . 0.0 111.259 178.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.12 -166.34 0.23 Allowed 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 123.51 2.806 . . . . 0.0 111.969 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -95.46 67.05 2.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.853 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.29 82.26 0.13 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.171 178.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.418 HD12 ' H ' ' A' ' 73' ' ' ARG . 49.3 tp -146.82 146.92 30.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.557 0.218 . . . . 0.0 110.859 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.418 ' H ' HD12 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -126.76 141.98 51.67 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.927 178.835 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 6.1 p -179.46 175.3 0.92 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.057 0.456 . . . . 0.0 110.962 176.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.624 ' O ' HG13 ' A' ' 50' ' ' VAL . 0.2 OUTLIER -95.15 159.61 14.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.018 179.635 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 2.0 m95 -131.84 78.22 1.81 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.836 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.69 93.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.642 -0.253 . . . . 0.0 111.0 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 80' ' ' GLU . 2.2 t -76.04 67.2 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.006 0.432 . . . . 0.0 110.699 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.75 HD12 ' HE2' ' A' ' 47' ' ' LYS . 81.1 mt -47.92 -29.41 3.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.292 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.64 ' O ' HG12 ' A' ' 78' ' ' VAL . 2.6 mt-10 -145.2 165.23 22.71 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.35 0.595 . . . . 0.0 111.054 178.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.95 87.49 0.45 Allowed 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 123.203 2.602 . . . . 0.0 112.356 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 45' ' ' GLU . 4.7 p -80.13 151.31 4.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.983 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.463 ' O ' HD12 ' A' ' 44' ' ' LEU . 3.5 ttt180 -136.4 64.23 1.56 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.728 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.566 ' HB3' HD13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -77.43 177.27 8.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.134 179.187 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -116.68 102.7 9.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.614 178.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -85.57 154.74 21.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.11 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -162.46 104.69 1.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.617 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 16.1 mt -68.47 149.36 49.37 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.672 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.8 p90 . . . . . 0 C--O 1.236 0.378 0 CA-C-O 118.773 -0.632 . . . . 0.0 110.712 179.964 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.714 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.329 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.3 mp0 -69.26 164.37 22.91 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 120.404 1.456 . . . . 0.0 109.326 163.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.1 t 50.2 79.88 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 126.909 2.084 . . . . 0.0 110.534 173.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.6 tptm -75.0 118.92 18.49 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 175.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 82.8 mt -130.81 129.64 63.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 174.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -155.38 175.58 13.69 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 122.973 0.509 . . . . 0.0 110.631 171.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.06 85.44 5.24 Favored Pre-proline 0 N--CA 1.451 -0.416 0 C-N-CA 124.312 1.045 . . . . 0.0 108.526 -177.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.42 165.18 31.45 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.977 2.452 . . . . 0.0 112.095 -175.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.3 t -61.18 144.22 91.56 Favored Pre-proline 0 C--O 1.239 0.551 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 164.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.81 -18.14 28.56 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.013 1.809 . . . . 0.0 112.146 175.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -64.33 -52.65 57.37 Favored 'General case' 0 C--N 1.339 0.145 0 CA-C-N 118.908 0.776 . . . . 0.0 110.158 -177.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.4 tttt -61.92 -33.16 73.75 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 123.205 0.602 . . . . 0.0 110.716 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 79.5 mt -63.82 -24.12 67.63 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.401 -0.812 . . . . 0.0 112.408 175.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -67.49 -49.14 64.84 Favored 'General case' 0 CA--C 1.522 -0.134 0 O-C-N 120.667 -1.27 . . . . 0.0 108.428 169.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -66.94 -36.04 81.35 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.093 0.957 . . . . 0.0 110.95 -169.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.28 -12.31 5.39 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 125.917 1.687 . . . . 0.0 112.932 172.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . 0.255 68.2 p 60.69 35.02 19.86 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 128.27 2.628 . . . . 0.0 113.021 -175.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.6 t -55.76 -30.46 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 C-N-CA 124.074 0.95 . . . . 0.0 112.801 -177.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -60.2 -26.23 66.2 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 120.437 1.471 . . . . 0.0 112.864 172.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.1 mttm -91.78 -9.03 45.04 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.127 1.371 . . . . 0.0 111.004 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 35.7 m0 -73.09 161.48 79.14 Favored Pre-proline 0 C--O 1.237 0.395 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -65.14 136.29 47.22 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 121.629 1.553 . . . . 0.0 111.063 173.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.6 mt -70.16 152.5 9.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 162.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.436 ' CE3' ' HD2' ' A' ' 84' ' ' LYS . 59.6 t90 -136.21 149.09 48.41 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 156.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.07 152.97 49.31 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 128.779 2.831 . . . . 0.0 107.996 177.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.514 ' HE3' ' CE2' ' A' ' 31' ' ' PHE . 21.6 tptp -156.6 159.33 38.38 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.231 -0.918 . . . . 0.0 109.748 176.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -69.49 167.81 15.91 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 127.759 2.424 . . . . 0.0 114.216 172.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.2 p -79.33 37.99 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 130.461 3.504 . . . . 0.0 112.73 -175.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.7 t -100.3 -167.71 1.48 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.211 1.405 . . . . 0.0 109.603 -173.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -139.6 145.28 38.35 Favored 'General case' 0 C--N 1.333 -0.114 0 O-C-N 120.461 -1.399 . . . . 0.0 108.867 161.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.514 ' CE2' ' HE3' ' A' ' 26' ' ' LYS . 18.4 p90 -151.13 179.22 8.47 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.629 1.572 . . . . 0.0 108.473 176.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -121.59 128.85 52.39 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.386 1.074 . . . . 0.0 108.981 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 40.2 t-105 -115.41 160.77 19.45 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 122.042 0.925 . . . . 0.0 112.626 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -128.74 111.94 13.67 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 127.22 2.208 . . . . 0.0 107.813 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -85.07 127.51 34.25 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 167.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -120.75 -3.12 9.76 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.966 1.706 . . . . 0.0 110.978 -173.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.57 171.61 16.83 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 129.853 3.261 . . . . 0.0 108.193 175.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -71.83 147.56 47.07 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -175.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -149.84 119.59 7.05 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 175.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 39.9 m -96.57 126.36 41.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 175.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -142.09 125.43 16.56 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.681 1.192 . . . . 0.0 109.525 -173.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -105.06 123.51 47.93 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.255 1.422 . . . . 0.0 108.534 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.545 HD13 ' HB3' ' A' ' 84' ' ' LYS . 48.8 mm -78.19 112.41 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 123.962 0.905 . . . . 0.0 108.702 177.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.5 ' O ' ' HE3' ' A' ' 62' ' ' LYS . 2.4 mp -97.69 -21.75 16.84 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 118.071 -0.966 . . . . 0.0 112.806 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -167.68 149.11 5.47 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 173.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.93 178.76 29.21 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 124.862 1.22 . . . . 0.0 114.448 173.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.451 ' HE3' HG23 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -133.79 140.61 47.03 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 118.017 0.908 . . . . 0.0 111.145 -173.616 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.428 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 66.1 t -141.19 147.79 22.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -112.68 99.74 8.17 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 160.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.9 t -70.61 157.78 6.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 164.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -147.86 136.0 21.3 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 164.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 74.5 p -83.3 175.7 9.69 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.027 0.376 . . . . 0.0 110.337 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -65.23 -27.05 68.4 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.423 0.63 . . . . 0.0 111.732 -177.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.08 -4.18 4.53 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.693 1.997 . . . . 0.0 111.94 171.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.27 5.09 65.67 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 126.04 1.781 . . . . 0.0 113.567 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 46.0 mmtt -65.94 127.81 33.54 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 105.547 -2.019 . . . . 0.0 105.547 174.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -86.24 145.51 26.93 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 171.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -134.38 84.82 2.14 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 124.127 1.917 . . . . 0.0 108.683 166.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.451 HG23 ' HE3' ' A' ' 47' ' ' LYS . 1.6 p -60.28 143.59 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 CA-C-N 111.765 -2.471 . . . . 0.0 109.931 152.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.402 HD12 HD11 ' A' ' 43' ' ' ILE . 2.9 pt -139.09 132.7 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 C-N-CA 128.208 2.603 . . . . 0.0 105.203 177.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -111.81 -179.39 3.68 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.147 0.979 . . . . 0.0 108.84 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.5 ' HE3' ' O ' ' A' ' 44' ' ' LEU . 75.0 tttt -64.25 107.91 1.44 Allowed 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 175.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 128.57 -15.71 5.99 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 118.578 -1.123 . . . . 0.0 112.979 -175.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -85.88 120.58 27.44 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 119.488 1.644 . . . . 0.0 108.408 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 25.3 tp -83.84 146.76 27.93 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 158.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 9.8 t -132.89 149.5 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 124.788 1.235 . . . . 0.0 108.104 177.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 87.9 m -131.8 111.68 11.83 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 159.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -80.38 144.82 58.28 Favored Pre-proline 0 C--O 1.236 0.363 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 165.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -85.98 178.08 4.37 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.203 1.935 . . . . 0.0 111.357 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -73.49 93.91 2.05 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 113.492 -1.686 . . . . 0.0 109.406 174.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.39 86.72 1.94 Allowed Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.263 1.411 . . . . 0.0 110.775 175.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 33.5 tp -153.67 140.62 19.23 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.084 0.954 . . . . 0.0 109.879 169.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.39 109.47 13.34 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.766 1.626 . . . . 0.0 108.192 -173.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 8.1 p -139.9 166.24 25.16 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.817 1.19 . . . . 0.0 110.179 -172.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.69 162.02 19.85 Favored 'General case' 0 CA--C 1.512 -0.502 0 O-C-N 120.819 -1.176 . . . . 0.0 109.53 174.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 7.8 m95 -131.99 110.36 10.7 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.468 1.507 . . . . 0.0 107.642 168.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.7 tttp -102.23 103.74 14.26 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 174.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.4 t -82.75 99.84 5.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 -176.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.6 mt -88.62 -12.76 41.66 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 118.293 -0.861 . . . . 0.0 110.87 -174.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -150.58 154.03 34.86 Favored Pre-proline 0 N--CA 1.45 -0.441 0 C-N-CA 126.616 1.966 . . . . 0.0 106.792 160.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -57.43 139.02 88.86 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 N-CA-C 108.135 -1.525 . . . . 0.0 108.135 177.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.4 p -125.09 156.0 33.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -168.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -130.15 117.0 19.26 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 173.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.545 ' HB3' HD13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -130.09 116.04 17.94 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 123.408 0.683 . . . . 0.0 112.368 177.713 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 11.4 m80 -66.69 119.95 12.65 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 105.931 -1.878 . . . . 0.0 105.931 170.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -119.51 164.88 15.13 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 123.76 0.824 . . . . 0.0 110.884 -177.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -152.52 125.91 8.74 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 162.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 32.4 mt -73.84 148.47 42.37 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.314 1.446 . . . . 0.0 108.804 174.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.4 p90 . . . . . 0 C--O 1.251 1.155 0 C-N-CA 126.578 1.951 . . . . 0.0 109.681 177.143 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 ttm . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 111.039 0.014 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -153.1 20.88 0.57 Allowed 'General case' 0 N--CA 1.471 0.587 0 O-C-N 120.14 -1.6 . . . . 0.0 112.338 171.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.8 t 49.0 93.62 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 128.447 2.699 . . . . 0.0 111.639 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -72.4 133.27 44.82 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -173.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.6 mt -134.84 133.18 54.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 171.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -134.36 171.58 14.08 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.632 0.773 . . . . 0.0 109.305 172.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.49 84.93 12.7 Favored Pre-proline 0 N--CA 1.464 0.271 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 175.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -75.07 159.54 40.98 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 121.937 1.758 . . . . 0.0 110.761 -175.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.4 ' H ' HG22 ' A' ' 9' ' ' THR . 1.7 t -64.87 143.45 98.82 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 170.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.51 -24.74 25.91 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 121.562 1.508 . . . . 0.0 112.439 -177.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -63.3 -42.13 99.02 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.348 1.459 . . . . 0.0 111.115 175.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.9 tptt -57.88 -43.62 86.18 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 175.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -66.97 -30.79 71.01 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 122.755 0.422 . . . . 0.0 110.752 -176.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.5 mtmp? -58.97 -52.54 65.31 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 119.122 0.874 . . . . 0.0 109.373 168.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -58.44 -46.48 86.44 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.898 0.879 . . . . 0.0 111.265 -174.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 75.5 mt -60.9 -5.7 1.48 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.703 1.201 . . . . 0.0 113.306 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.5 m 62.49 41.04 10.16 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 126.243 1.817 . . . . 0.0 109.742 167.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.9 t -58.83 -30.45 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 128.176 2.59 . . . . 0.0 110.379 176.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -58.44 -16.32 14.49 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.835 0.854 . . . . 0.0 112.823 170.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -102.44 -2.27 29.07 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.539 1.535 . . . . 0.0 112.048 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 33.2 m0 -82.69 165.28 42.78 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.79 143.04 54.29 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 121.939 1.759 . . . . 0.0 111.172 169.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 75.5 mt -79.32 151.83 4.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 164.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.441 ' CH2' ' HB2' ' A' ' 26' ' ' LYS . 14.9 t90 -138.84 144.99 39.48 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 154.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -145.69 162.8 36.74 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 124.824 1.25 . . . . 0.0 110.178 175.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.441 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 5.2 tmtt? -156.74 156.85 34.05 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 124.486 1.115 . . . . 0.0 108.036 -176.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.87 168.71 9.28 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-O 122.248 1.023 . . . . 0.0 112.175 174.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.5 p -75.74 62.97 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 128.711 2.804 . . . . 0.0 109.258 178.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.7 t -129.72 -162.46 1.21 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.4 2.28 . . . . 0.0 107.974 -175.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.36 159.66 43.43 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 120.337 -1.477 . . . . 0.0 110.321 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -171.41 -164.27 0.33 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.816 2.046 . . . . 0.0 108.399 -171.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -132.88 150.08 52.19 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.79 2.036 . . . . 0.0 107.406 170.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 34.4 t-105 -127.18 150.38 49.54 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.355 0.525 . . . . 0.0 111.04 174.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -120.66 121.98 39.49 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 124.691 1.196 . . . . 0.0 109.181 170.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -91.53 119.21 31.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.093 1.357 . . . . 0.0 107.432 174.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -117.01 12.43 14.59 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.584 1.154 . . . . 0.0 111.075 176.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.6 170.44 15.82 Favored 'General case' 0 CA--C 1.523 -0.079 0 C-N-CA 124.402 1.081 . . . . 0.0 110.65 158.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -60.89 117.07 4.98 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 103.178 -2.897 . . . . 0.0 103.178 166.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -130.63 76.44 1.72 Allowed 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -170.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.3 m -63.96 145.4 55.92 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -175.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 27.7 p -145.43 153.76 41.53 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 119.923 -0.711 . . . . 0.0 112.331 166.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -124.52 112.93 17.45 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.284 1.834 . . . . 0.0 107.854 -176.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.6 mm -69.88 136.67 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 126.487 1.915 . . . . 0.0 107.261 173.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 26.1 mt -125.08 -47.16 1.78 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.317 1.047 . . . . 0.0 108.805 -171.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -147.4 159.91 43.15 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 165.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.13 178.83 31.64 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 124.84 1.21 . . . . 0.0 113.528 174.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.432 ' HE2' HD12 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -144.76 144.92 31.43 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.651 0.739 . . . . 0.0 112.483 -170.343 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.3 t -142.63 159.73 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -122.54 119.61 31.38 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 159.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 41.2 t -103.14 92.29 2.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 51.3 m -79.09 103.1 8.8 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.647 1.179 . . . . 0.0 108.409 177.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 64.1 p -82.97 172.92 12.26 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.873 -0.517 . . . . 0.0 109.928 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -71.8 -29.01 64.0 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.385 0.612 . . . . 0.0 112.596 -166.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -73.62 0.16 13.57 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.464 1.105 . . . . 0.0 111.182 173.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.5 -14.86 64.32 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 127.951 2.691 . . . . 0.0 112.875 177.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -63.52 120.18 11.22 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.624 1.57 . . . . 0.0 107.718 -173.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.06 100.93 9.52 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.637 1.175 . . . . 0.0 110.068 -169.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -83.42 108.2 16.43 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 -177.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 40.3 t -66.92 140.18 19.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 104.77 -2.307 . . . . 0.0 104.77 154.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.1 pt -134.74 99.97 2.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 174.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -81.5 172.9 12.94 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.183 0.993 . . . . 0.0 109.916 168.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.2 pttm -52.87 127.16 22.6 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.812 0.815 . . . . 0.0 109.862 169.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.91 -28.47 13.84 Favored Glycine 0 CA--C 1.533 1.188 0 CA-C-O 117.965 -1.464 . . . . 0.0 114.321 175.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.22 101.71 1.94 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 120.736 2.268 . . . . 0.0 107.933 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.4 tp -77.44 134.28 38.42 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.7 t -116.75 146.9 20.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -174.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.8 m -138.83 99.7 3.86 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 125.09 1.356 . . . . 0.0 108.094 165.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -63.18 165.55 10.48 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 124.027 0.931 . . . . 0.0 109.403 161.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -88.41 174.76 4.16 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 CA-C-N 120.098 1.071 . . . . 0.0 112.357 164.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -74.73 91.77 2.41 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 168.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 117.9 84.33 0.99 Allowed Glycine 0 CA--C 1.528 0.883 0 C-N-CA 125.281 1.419 . . . . 0.0 110.473 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 6.5 tt -150.95 130.88 13.32 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.362 1.465 . . . . 0.0 108.806 171.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.6 ttt180 -104.52 134.31 47.92 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 165.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 26.7 p -151.49 167.3 28.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 119.138 0.881 . . . . 0.0 111.547 169.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.01 164.51 25.0 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.435 0.636 . . . . 0.0 111.484 168.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -143.42 101.02 3.72 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 113.76 -1.563 . . . . 0.0 108.805 -175.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 tptt -95.05 107.68 19.74 Favored 'General case' 0 CA--C 1.521 -0.156 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 168.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.1 t -75.67 111.82 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 104.335 -2.469 . . . . 0.0 104.335 165.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.432 HD12 ' HE2' ' A' ' 47' ' ' LYS . 74.7 mt -84.64 -27.32 27.23 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -152.06 153.98 31.96 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 124.966 1.306 . . . . 0.0 109.919 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -53.83 128.32 29.13 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.104 2.536 . . . . 0.0 109.467 175.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.5 p -135.76 138.21 48.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -167.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -128.25 67.98 1.36 Allowed 'General case' 0 C--O 1.223 -0.309 0 CA-C-O 121.16 0.505 . . . . 0.0 110.099 -171.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.436 ' HE3' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -80.1 154.52 28.03 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -175.323 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -94.38 142.43 27.43 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 163.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -131.22 159.02 38.99 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.205 0.911 . . . . 0.0 110.959 176.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -146.37 132.96 19.81 Favored 'General case' 0 CA--C 1.519 -0.238 0 C-N-CA 122.907 0.483 . . . . 0.0 109.71 170.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 90.0 mt -86.04 135.77 33.5 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.45 1.1 . . . . 0.0 108.463 174.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 6.0 p90 . . . . . 0 C--O 1.249 1.046 0 C-N-CA 124.029 0.932 . . . . 0.0 110.953 -176.67 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.7 mtp . . . . . 0 N--CA 1.469 0.507 0 CA-C-O 118.495 -0.764 . . . . 0.0 110.287 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -70.07 155.78 40.11 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 119.712 1.142 . . . . 0.0 110.452 178.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.1 t -75.12 142.0 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 125.377 1.471 . . . . 0.0 107.52 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.6 tmtt? -104.23 114.59 28.93 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 175.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.4 mt -132.36 129.78 59.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 124.747 1.219 . . . . 0.0 108.258 -176.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -162.42 171.23 17.47 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.395 1.078 . . . . 0.0 109.887 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.49 85.88 2.48 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 123.504 0.722 . . . . 0.0 110.132 176.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -65.56 162.8 32.52 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.474 2.116 . . . . 0.0 112.377 -177.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.4 t -58.3 144.64 77.08 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 123.55 0.74 . . . . 0.0 109.389 169.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.22 -30.77 30.45 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 121.338 1.359 . . . . 0.0 113.065 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -57.83 -44.55 86.52 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 119.768 1.167 . . . . 0.0 112.237 -175.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.3 tptt -57.16 -45.53 83.53 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 123.908 0.883 . . . . 0.0 110.143 177.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.49 -23.71 67.51 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.214 0.606 . . . . 0.0 111.527 -174.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.8 mttt -72.17 -48.56 42.43 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -58.67 -43.96 90.06 Favored 'General case' 0 CA--C 1.522 -0.107 0 C-N-CA 124.407 1.083 . . . . 0.0 110.329 -176.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 81.4 mt -62.05 -8.68 5.7 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.866 1.667 . . . . 0.0 114.811 -176.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.0 m 65.97 30.01 9.92 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.228 1.411 . . . . 0.0 112.182 175.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.9 t -52.27 -33.06 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 125.636 1.574 . . . . 0.0 110.412 173.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -53.62 -32.97 53.4 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 171.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -84.89 -19.69 31.91 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 118.128 -0.939 . . . . 0.0 112.179 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 41.1 m0 -66.01 160.16 65.28 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -171.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -65.96 132.59 30.66 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.84 1.693 . . . . 0.0 111.361 176.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.1 mt -71.14 139.5 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 107.329 -1.359 . . . . 0.0 107.329 162.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.531 ' CE3' ' HE3' ' A' ' 84' ' ' LYS . 69.7 t90 -133.49 122.56 23.81 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 161.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -124.47 159.36 30.68 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 125.462 1.505 . . . . 0.0 107.818 173.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -157.39 164.05 37.93 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -171.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.29 -176.38 2.62 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 122.425 1.107 . . . . 0.0 110.438 175.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.7 p -68.2 0.33 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 126.323 1.849 . . . . 0.0 112.383 167.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 p -71.74 129.59 39.04 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 120.065 -1.647 . . . . 0.0 110.81 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.51 157.5 16.99 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.238 1.015 . . . . 0.0 110.021 -177.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -164.21 -164.25 0.84 Allowed 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 126.503 1.921 . . . . 0.0 107.122 -171.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -138.75 157.24 46.45 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 126.09 1.756 . . . . 0.0 108.698 173.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 22.1 t-105 -144.27 138.39 27.93 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.561 0.744 . . . . 0.0 111.181 -174.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 68.8 t80 -103.15 145.1 30.43 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.714 1.606 . . . . 0.0 107.806 168.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -118.04 123.13 44.92 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.399 1.48 . . . . 0.0 107.737 173.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.71 -5.64 12.13 Favored 'General case' 0 N--CA 1.461 0.092 0 C-N-CA 126.232 1.813 . . . . 0.0 112.564 -170.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.81 175.19 9.9 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 131.512 3.925 . . . . 0.0 106.539 166.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -70.32 139.71 52.1 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -122.52 114.45 20.68 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 105.125 -2.176 . . . . 0.0 105.125 163.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 20.0 m -89.79 132.98 34.95 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 159.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 27.4 p -138.89 161.82 36.36 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.338 0.589 . . . . 0.0 110.812 164.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -122.52 128.76 51.2 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 37.0 mm -87.02 102.3 12.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 128.806 2.842 . . . . 0.0 106.797 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.442 ' O ' ' HE2' ' A' ' 62' ' ' LYS . 2.4 mm? -81.41 -26.5 35.35 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 123.504 0.722 . . . . 0.0 111.062 -174.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -176.67 148.94 0.73 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 127.144 2.177 . . . . 0.0 106.086 -174.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.26 -177.11 28.43 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.275 1.417 . . . . 0.0 113.788 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.0 148.48 38.62 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.116 0.958 . . . . 0.0 109.748 179.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.5 t -138.22 156.52 30.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 125.039 1.335 . . . . 0.0 107.731 176.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -120.81 139.05 53.68 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 125.597 1.559 . . . . 0.0 108.066 165.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.9 t -133.93 120.2 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 83.2 m -111.83 105.15 13.54 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 125.531 1.533 . . . . 0.0 107.902 167.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.0 p -68.08 165.5 17.94 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 173.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -74.32 -14.7 60.93 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 123.278 1.513 . . . . 0.0 113.29 -161.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -52.04 -21.63 3.34 Favored 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 127.437 2.295 . . . . 0.0 113.083 161.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.41 4.65 90.08 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.686 1.136 . . . . 0.0 111.868 -165.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -71.1 144.97 50.12 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 119.326 1.563 . . . . 0.0 108.125 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -108.09 145.2 34.4 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -173.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -141.73 132.15 25.2 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 177.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 69.4 t -136.36 118.59 20.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 -171.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 10.1 pt -124.63 106.1 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 O-C-N 123.808 0.693 . . . . 0.0 109.151 -169.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -90.72 178.05 6.17 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 122.677 1.227 . . . . 0.0 109.863 171.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.442 ' HE2' ' O ' ' A' ' 44' ' ' LEU . 22.9 tttm -51.11 108.06 0.22 Allowed 'General case' 0 C--O 1.237 0.423 0 C-N-CA 127.527 2.331 . . . . 0.0 109.805 176.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 111.52 -16.41 26.58 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 117.591 -1.672 . . . . 0.0 114.65 175.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -70.75 102.17 2.26 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 120.368 2.084 . . . . 0.0 108.901 177.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.0 tp -71.04 141.38 50.91 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.1 t -125.56 145.06 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 97.3 m -129.7 118.1 21.35 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 158.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -88.45 145.77 36.24 Favored Pre-proline 0 C--O 1.237 0.402 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 162.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -84.27 177.26 5.97 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.286 1.991 . . . . 0.0 112.259 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 30.3 tttm -76.82 81.39 3.41 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 113.95 -1.477 . . . . 0.0 107.851 169.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 124.59 81.32 0.47 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 125.504 1.526 . . . . 0.0 111.774 178.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.6 tt -148.2 128.24 13.64 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 118.535 1.167 . . . . 0.0 110.694 174.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.7 116.72 30.58 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.377 1.471 . . . . 0.0 108.436 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 17.6 p -148.85 176.63 10.24 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 119.509 1.05 . . . . 0.0 113.393 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.11 177.01 9.3 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.981 1.312 . . . . 0.0 111.855 171.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -158.16 100.59 1.7 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 119.932 1.242 . . . . 0.0 109.663 174.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 59.6 tttt -104.22 111.2 23.71 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.4 t -77.18 116.67 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 N-CA-C 103.157 -2.905 . . . . 0.0 103.157 171.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.9 mt -88.12 -25.52 22.96 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 119.346 -0.941 . . . . 0.0 109.381 171.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -144.36 150.16 47.1 Favored Pre-proline 0 C--O 1.232 0.136 0 CA-C-O 117.819 -1.086 . . . . 0.0 111.051 178.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -58.81 114.36 1.97 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.431 2.754 . . . . 0.0 108.232 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.1 p -124.39 143.84 36.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 C-N-CA 125.18 1.392 . . . . 0.0 107.446 -163.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.5 mtt180 -115.3 113.57 24.01 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 174.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.531 ' HE3' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -114.37 125.59 54.04 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 167.295 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -76.61 123.53 26.25 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 103.333 -2.84 . . . . 0.0 103.333 169.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -121.66 160.58 24.15 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 119.058 0.845 . . . . 0.0 110.361 -176.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -142.1 149.59 40.04 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 165.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 54.5 mt -108.71 129.05 55.36 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.5 p90 . . . . . 0 C--O 1.251 1.172 0 C-N-CA 124.818 1.247 . . . . 0.0 108.597 -173.56 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.3 mtt . . . . . 0 N--CA 1.47 0.557 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.42 ' HG2' ' H ' ' A' ' 3' ' ' VAL . 4.9 tt0 57.56 -173.21 0.08 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.148 0.979 . . . . 0.0 109.392 -158.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.42 ' H ' ' HG2' ' A' ' 2' ' ' GLU . 2.2 p -73.99 146.39 10.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 169.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -127.81 147.47 50.43 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.157 1.383 . . . . 0.0 107.379 174.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 90.5 mt -124.73 142.27 42.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 104.924 -2.25 . . . . 0.0 104.924 165.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -160.24 177.59 10.49 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.098 1.359 . . . . 0.0 110.283 166.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.448 ' HE2' ' OD1' ' A' ' 64' ' ' ASP . 0.5 OUTLIER -116.86 85.3 17.24 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 124.067 0.947 . . . . 0.0 108.667 -172.237 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.527 ' HG3' HD22 ' A' ' 65' ' ' LEU . 61.6 Cg_endo -72.16 -4.42 15.16 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 124.904 3.736 . . . . 0.0 114.687 -164.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.324 2.1 t 55.44 146.29 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 129.187 2.995 . . . . 0.0 113.39 -169.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -58.04 -17.76 32.81 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.632 2.221 . . . . 0.0 112.2 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -47.44 -61.55 1.86 Allowed 'General case' 0 C--O 1.231 0.112 0 CA-C-N 119.517 1.053 . . . . 0.0 111.297 165.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -67.4 -38.28 84.42 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -178.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.422 HD21 ' HG2' ' A' ' 8' ' ' PRO . 0.1 OUTLIER -72.17 -24.25 61.4 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 118.562 -0.732 . . . . 0.0 112.937 -175.434 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -60.93 -55.1 36.9 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 120.397 1.453 . . . . 0.0 107.541 167.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -74.42 -26.64 60.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.769 -164.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 mp -68.0 -9.92 49.47 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.24 1.416 . . . . 0.0 112.766 170.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.3 m 61.54 33.1 18.56 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.311 1.844 . . . . 0.0 112.369 -174.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.2 t -57.19 -27.59 28.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 O-C-N 121.633 -0.667 . . . . 0.0 111.97 -172.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -54.58 -26.39 32.04 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.763 1.165 . . . . 0.0 113.574 173.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? -86.56 -26.28 24.57 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.004 0.921 . . . . 0.0 111.64 -173.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 36.7 m0 -62.84 160.05 40.19 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 124.623 1.169 . . . . 0.0 109.529 -170.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -69.35 118.59 5.77 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.251 1.967 . . . . 0.0 112.407 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.6 mt -61.98 142.08 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 176.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.598 ' CE3' ' HE3' ' A' ' 84' ' ' LYS . 59.5 t90 -135.3 143.14 46.05 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 165.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -151.93 161.84 42.01 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.701 1.601 . . . . 0.0 111.067 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.0 mmtt -143.84 176.35 9.32 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 123.291 0.636 . . . . 0.0 109.347 -178.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.471 ' HG3' ' H ' ' A' ' 29' ' ' SER . 6.6 pt-20 -69.82 -165.95 0.1 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.781 2.033 . . . . 0.0 110.756 169.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.5 p -109.85 25.07 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 126.691 1.996 . . . . 0.0 111.447 -175.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.471 ' H ' ' HG3' ' A' ' 27' ' ' GLU . 14.7 t -96.29 -178.34 4.27 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 126.693 1.997 . . . . 0.0 109.199 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -120.79 161.46 21.44 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 123.937 0.895 . . . . 0.0 110.125 173.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -163.75 -168.03 1.53 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.712 2.005 . . . . 0.0 108.248 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -121.29 152.02 39.4 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 168.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 51.9 t-105 -130.97 179.55 5.92 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.607 0.763 . . . . 0.0 109.936 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -148.02 151.27 35.45 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.398 1.479 . . . . 0.0 107.287 171.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -131.41 98.97 4.68 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.624 1.17 . . . . 0.0 108.534 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -90.89 9.86 28.69 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 125.966 1.706 . . . . 0.0 112.202 -177.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -158.46 162.49 37.53 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 128.486 2.714 . . . . 0.0 108.321 -178.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -61.48 138.29 58.27 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -144.58 104.66 4.07 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.484 HG22 HD11 ' A' ' 65' ' ' LEU . 74.8 m -72.69 143.14 48.19 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 164.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.436 ' O ' HD12 ' A' ' 65' ' ' LEU . 1.7 p -153.53 131.62 11.83 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.49 1.041 . . . . 0.0 111.4 175.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -108.61 108.09 18.83 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 126.349 1.859 . . . . 0.0 108.828 -176.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.3 mm -74.8 114.76 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.812 1.245 . . . . 0.0 107.834 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.3 mp -101.19 -33.48 10.07 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 118.879 -0.581 . . . . 0.0 112.337 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 pm0 -154.04 162.73 40.99 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.975 0.91 . . . . 0.0 109.296 172.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.58 -172.37 48.47 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 127.061 2.267 . . . . 0.0 111.32 -173.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.81 148.28 31.73 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -177.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.3 t -136.95 151.96 27.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -123.07 98.01 5.69 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.362 2.265 . . . . 0.0 106.31 168.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.9 t -86.16 136.33 23.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 170.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 66.8 m -136.45 122.48 20.21 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.183 0.901 . . . . 0.0 108.776 -178.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 72.1 p -76.36 169.81 17.54 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.304 0.573 . . . . 0.0 109.858 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -62.98 -35.9 81.74 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.364 -0.835 . . . . 0.0 110.713 -178.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -82.65 16.16 2.3 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 128.516 2.726 . . . . 0.0 111.694 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.88 4.95 88.74 Favored Glycine 0 CA--C 1.525 0.687 0 O-C-N 119.884 -1.76 . . . . 0.0 114.649 162.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.2 mmtt -67.0 106.78 2.04 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 119.765 1.783 . . . . 0.0 107.025 167.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.5 tptt -67.2 157.55 33.5 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 163.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -137.0 155.58 49.52 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 104.064 -2.569 . . . . 0.0 104.064 166.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 75.5 t -138.76 129.07 33.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 103.053 -2.943 . . . . 0.0 103.053 178.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 8.9 pt -134.08 123.23 43.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -103.67 176.12 5.26 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 126.725 2.01 . . . . 0.0 107.817 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.3 pttp -58.11 125.2 22.16 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 164.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.8 -0.07 56.45 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 117.702 -1.61 . . . . 0.0 115.688 -178.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.448 ' OD1' ' HE2' ' A' ' 7' ' ' LYS . 19.1 m-20 -92.1 123.82 35.73 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 120.832 2.316 . . . . 0.0 106.567 166.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.527 HD22 ' HG3' ' A' ' 8' ' ' PRO . 14.2 tp -88.15 146.73 25.25 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 160.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.4 t -126.07 150.51 31.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 174.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 58.4 m -132.96 111.41 11.01 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 164.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -74.43 155.69 87.52 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 169.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -74.79 -165.2 0.27 Allowed 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.168 2.579 . . . . 0.0 109.381 174.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -95.25 120.82 36.14 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 162.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.97 87.66 1.06 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.401 1.477 . . . . 0.0 112.634 176.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 57.9 tp -143.88 143.54 31.34 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.952 1.701 . . . . 0.0 108.207 171.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.47 131.28 56.98 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 125.339 1.456 . . . . 0.0 108.11 167.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 7.8 p -165.43 168.43 16.67 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.48 1.112 . . . . 0.0 111.362 169.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.88 167.96 20.85 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 124.578 1.151 . . . . 0.0 112.028 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -144.4 113.11 6.68 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.462 1.105 . . . . 0.0 109.755 178.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.53 109.27 19.53 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 175.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.0 t -86.8 101.26 10.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 175.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.9 mt -83.39 -18.9 37.18 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-O 118.777 -0.63 . . . . 0.0 111.717 -175.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -148.25 146.15 22.4 Favored Pre-proline 0 C--O 1.236 0.356 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 166.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -61.54 90.74 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.491 1 C-N-CA 125.542 4.161 . . . . 0.0 110.87 -165.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.9 p -67.35 149.31 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 123.936 0.895 . . . . 0.0 109.754 -166.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -129.35 112.6 14.01 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 168.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.598 ' HE3' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -133.28 142.15 48.35 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.266 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -84.34 100.89 11.56 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 171.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -88.8 154.86 19.93 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.154 0.982 . . . . 0.0 110.546 171.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -151.54 112.93 4.35 Favored 'General case' 0 C--O 1.239 0.523 0 O-C-N 121.676 -0.64 . . . . 0.0 110.517 170.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 61.7 mt -61.59 153.29 28.19 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.406 1.482 . . . . 0.0 108.932 171.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.7 p90 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 116.173 -1.87 . . . . 0.0 110.443 166.332 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.2 mtt . . . . . 0 N--CA 1.471 0.584 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 53.99 -169.99 0.06 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.549 1.54 . . . . 0.0 111.413 -170.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.8 p -76.85 105.08 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 108.588 -0.894 . . . . 0.0 108.588 176.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 55.9 tttt -75.7 136.68 40.36 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 171.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.3 mt -135.73 139.74 45.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 169.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -165.32 175.22 9.36 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.145 2.178 . . . . 0.0 108.728 162.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.31 86.35 1.32 Allowed Pre-proline 0 C--O 1.237 0.444 0 CA-C-O 117.88 -1.057 . . . . 0.0 109.19 176.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -63.92 168.01 12.91 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.522 1.481 . . . . 0.0 111.014 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.0 t -69.85 143.5 92.18 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -66.42 -19.4 55.29 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.897 1.731 . . . . 0.0 113.178 176.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -59.89 -47.61 85.06 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 119.733 1.151 . . . . 0.0 109.622 171.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 35.9 tptt -65.34 -37.48 87.19 Favored 'General case' 0 N--CA 1.454 -0.266 0 O-C-N 121.45 -0.781 . . . . 0.0 110.451 -177.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 28.3 mt -67.97 -26.91 66.17 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 118.833 -0.603 . . . . 0.0 111.917 177.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -64.83 -46.87 80.13 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 119.386 0.994 . . . . 0.0 109.814 168.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -60.07 -48.58 81.12 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.387 0.613 . . . . 0.0 109.384 -176.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.7 mp -55.03 -14.76 1.65 Allowed 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 125.947 1.699 . . . . 0.0 112.817 176.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.4 m 53.01 45.01 29.69 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.015 1.326 . . . . 0.0 110.743 175.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 45.8 t -56.59 -31.45 34.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 124.27 1.028 . . . . 0.0 110.505 -175.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -44.92 -34.56 2.44 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.858 2.063 . . . . 0.0 114.454 167.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.9 mtmm -84.12 -23.53 30.66 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 119.531 1.059 . . . . 0.0 111.418 -177.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.401 ' CE3' ' HB2' ' A' ' 87' ' ' ASN . 35.1 m0 -64.72 164.43 20.84 Favored Pre-proline 0 C--O 1.24 0.574 0 C-N-CA 124.118 0.967 . . . . 0.0 109.816 -171.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -66.6 139.97 55.15 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 121.118 1.212 . . . . 0.0 110.144 171.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.2 mt -81.18 151.98 4.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 164.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.514 ' CE3' ' HE2' ' A' ' 84' ' ' LYS . 68.3 t90 -140.79 148.0 39.93 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 156.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.7 157.07 44.66 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 126.615 1.966 . . . . 0.0 109.169 -178.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.6 tttt -151.02 169.59 21.42 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.482 0.713 . . . . 0.0 111.625 -174.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -66.18 175.07 2.26 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 122.715 1.245 . . . . 0.0 111.006 164.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.3 t -94.62 27.4 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 128.418 2.687 . . . . 0.0 109.866 -167.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.9 t -91.99 176.59 6.45 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.573 1.149 . . . . 0.0 110.521 -173.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -104.61 142.55 34.46 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.448 1.099 . . . . 0.0 108.092 167.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -147.08 -170.34 3.52 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 127.644 2.377 . . . . 0.0 107.392 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.62 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 1.1 m-20 -128.3 154.87 45.45 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 169.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 48.1 t-105 -134.77 146.05 48.99 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 123.025 0.53 . . . . 0.0 111.787 175.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -113.82 111.11 21.2 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 171.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -79.49 122.61 26.67 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 170.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.9 p-10 -120.19 6.58 10.74 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 125.916 1.687 . . . . 0.0 111.323 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.96 174.31 15.71 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.082 1.353 . . . . 0.0 108.85 167.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -68.33 87.12 0.29 Allowed 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 125.584 1.554 . . . . 0.0 108.773 -178.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.33 110.32 18.02 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 173.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 73.0 m -88.14 134.7 33.7 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 163.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 24.6 p -140.23 149.18 42.56 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 118.714 0.688 . . . . 0.0 110.053 170.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -126.92 116.71 21.23 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.466 1.507 . . . . 0.0 107.979 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 18.9 mm -80.83 124.96 39.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 126.911 2.084 . . . . 0.0 107.567 -172.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 54.2 mt -103.12 -26.9 12.86 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 118.634 0.652 . . . . 0.0 112.486 -176.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -158.95 169.39 24.44 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.547 1.939 . . . . 0.0 107.404 174.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.23 -172.26 25.2 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.099 0.857 . . . . 0.0 113.078 169.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.95 143.57 30.61 Favored 'General case' 0 CA--C 1.517 -0.307 0 O-C-N 121.526 -0.985 . . . . 0.0 108.363 175.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 71.6 t -138.48 155.97 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -124.55 127.02 46.78 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 126.381 1.872 . . . . 0.0 106.345 163.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.1 t -113.53 113.06 42.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.53 ' HB ' ' HG2' ' A' ' 75' ' ' ARG . 26.2 m -114.72 103.01 10.56 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 -168.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 38.2 p -78.1 173.15 12.53 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -54.65 -40.6 69.17 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.651 0.78 . . . . 0.0 110.578 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -65.09 -17.38 64.41 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 123.794 0.838 . . . . 0.0 112.361 -175.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.68 0.7 88.26 Favored Glycine 0 CA--C 1.533 1.174 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -163.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.1 mmtp -63.06 118.36 7.76 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 164.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -130.05 133.29 46.62 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -162.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -127.27 116.64 20.87 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -170.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 77.6 t -76.76 144.88 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 160.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.9 pt -140.92 147.4 22.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 C-N-CA 124.795 1.238 . . . . 0.0 108.914 166.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -138.89 -175.33 4.11 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 126.939 2.096 . . . . 0.0 110.374 176.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -66.85 62.88 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 128.132 2.573 . . . . 0.0 115.795 -162.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 159.6 -6.9 0.13 Allowed Glycine 0 C--N 1.317 -0.475 0 CA-C-O 118.021 -1.433 . . . . 0.0 114.027 -178.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -71.47 128.53 36.15 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 166.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 17.0 tp -88.76 142.09 27.96 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 160.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.6 t -122.35 141.05 44.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 175.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 28.3 m -127.11 101.21 6.43 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 167.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -65.03 161.82 44.37 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 170.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -71.42 -164.03 0.15 Allowed 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.974 2.45 . . . . 0.0 108.684 167.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -110.14 108.85 19.16 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 165.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.69 85.64 1.88 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 125.453 1.502 . . . . 0.0 110.669 -175.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.1 tt -147.57 113.81 5.89 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.616 1.966 . . . . 0.0 107.499 173.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.1 ttt180 -81.98 133.18 35.28 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 161.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 29.2 p -147.32 -170.66 3.61 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.507 0.67 . . . . 0.0 109.896 159.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.62 ' HA ' ' HA ' ' A' ' 32' ' ' ASP . 5.8 ptp180 -108.06 164.7 12.06 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 105.803 -1.925 . . . . 0.0 105.803 173.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -134.07 122.87 23.57 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 119.591 1.087 . . . . 0.0 110.085 175.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.1 tttp -116.18 105.97 13.18 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.5 t -72.92 129.52 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 103.536 -2.764 . . . . 0.0 103.536 166.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 95.0 mt -109.9 -16.36 13.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 117.659 -1.162 . . . . 0.0 110.407 173.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -154.13 145.12 16.26 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 126.594 1.958 . . . . 0.0 107.61 167.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -56.92 125.87 20.38 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 124.345 3.363 . . . . 0.0 111.587 -167.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.419 ' O ' HG13 ' A' ' 82' ' ' VAL . 8.7 p -121.45 92.76 2.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 CA-C-O 124.978 2.323 . . . . 0.0 111.491 -161.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.9 mtm-85 -78.95 119.57 22.3 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 170.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.514 ' HE2' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -128.78 157.17 42.2 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.69 0.757 . . . . 0.0 109.257 173.016 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -94.79 135.85 35.8 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 161.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -130.15 160.48 33.67 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 123.052 0.541 . . . . 0.0 109.871 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.401 ' HB2' ' CE3' ' A' ' 21' ' ' TRP . 27.3 t-20 -156.55 103.43 2.12 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -172.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 65.5 mt -75.48 145.53 41.35 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 171.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 45.2 p90 . . . . . 0 C--O 1.252 1.187 0 CA-C-O 114.576 -2.63 . . . . 0.0 111.156 164.96 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 mpp? . . . . . 0 N--CA 1.471 0.6 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -150.73 173.65 13.94 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -175.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 74.3 t -95.57 106.84 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 C-N-CA 128.197 2.599 . . . . 0.0 106.868 -176.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.7 tptp -82.2 134.92 35.32 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 168.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.9 mt -140.81 120.2 11.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 168.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -138.45 175.16 9.81 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.323 1.449 . . . . 0.0 109.986 172.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.53 85.47 5.92 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 170.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -65.71 165.24 23.83 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.364 2.043 . . . . 0.0 112.111 178.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.19 144.72 84.95 Favored Pre-proline 0 C--O 1.239 0.553 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 174.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -68.15 -30.74 31.0 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.855 2.37 . . . . 0.0 112.334 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -56.84 -44.04 81.69 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.956 0.798 . . . . 0.0 110.686 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -64.64 -36.95 85.9 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.193 0.597 . . . . 0.0 109.493 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.494 HD21 ' CD1' ' A' ' 65' ' ' LEU . 96.1 mt -69.09 -28.54 66.58 Favored 'General case' 0 C--O 1.235 0.313 0 O-C-N 121.894 -0.504 . . . . 0.0 112.225 177.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.9 mtmt -55.56 -50.82 69.05 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 169.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -60.43 -52.78 63.78 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.408 1.083 . . . . 0.0 110.999 -176.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.453 HD12 HD23 ' A' ' 13' ' ' LEU . 93.1 mt -56.39 -20.76 21.02 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 125.962 1.705 . . . . 0.0 112.789 -178.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 74.3 42.51 0.32 Allowed 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.768 2.027 . . . . 0.0 111.149 170.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.7 t -54.33 -33.1 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 118.304 0.502 . . . . 0.0 110.765 -173.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -58.24 -24.76 60.39 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.0 pttp -83.76 -5.66 59.25 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.48 0.712 . . . . 0.0 111.049 -171.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 23.0 m0 -87.54 165.05 32.5 Favored Pre-proline 0 N--CA 1.438 -1.06 0 C-N-CA 124.922 1.289 . . . . 0.0 107.881 -169.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -66.93 135.16 36.88 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 121.653 1.569 . . . . 0.0 110.638 167.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 68.5 mt -78.9 143.1 13.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 164.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -127.24 153.15 46.48 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 162.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -150.72 162.69 40.22 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.902 1.281 . . . . 0.0 109.543 176.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -148.78 157.94 43.8 Favored 'General case' 0 CA--C 1.517 -0.301 0 C-N-CA 124.957 1.303 . . . . 0.0 109.565 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.3 pm0 -69.47 170.91 9.63 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 124.726 1.266 . . . . 0.0 112.061 167.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.4 t -82.49 74.21 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 125.79 1.636 . . . . 0.0 106.829 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.0 t -145.62 -173.12 4.04 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 175.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.96 149.32 30.22 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 122.417 1.103 . . . . 0.0 112.922 -169.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -157.53 -168.25 2.52 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.146 1.779 . . . . 0.0 108.093 -163.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 37.0 p30 -119.91 160.64 22.31 Favored 'General case' 0 C--O 1.236 0.362 0 O-C-N 121.257 -0.902 . . . . 0.0 108.648 166.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 10.2 t-105 -128.75 168.11 16.32 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.568 0.699 . . . . 0.0 111.257 172.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -142.32 92.35 2.42 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.722 1.609 . . . . 0.0 107.934 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -72.2 118.93 15.69 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 171.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -111.72 -5.12 14.49 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 125.344 1.458 . . . . 0.0 111.691 -176.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.53 172.56 12.53 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 127.167 2.187 . . . . 0.0 110.233 164.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -62.16 107.64 0.92 Allowed 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 176.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -121.3 75.11 1.14 Allowed 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -175.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.9 m -67.5 135.83 53.63 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 -175.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 29.3 p -142.54 155.96 45.07 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-O 120.966 0.413 . . . . 0.0 110.128 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.421 ' HD1' ' HG ' ' A' ' 65' ' ' LEU . 30.8 t80 -132.66 121.0 22.48 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.323 -170.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 16.1 mm -81.07 124.84 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -174.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.2 mt -122.45 -33.71 3.4 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.439 1.096 . . . . 0.0 111.51 -167.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -154.48 162.34 41.2 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 127.39 2.276 . . . . 0.0 105.252 165.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.44 176.51 51.05 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 124.695 1.14 . . . . 0.0 112.186 177.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -148.26 144.48 27.67 Favored 'General case' 0 CA--C 1.516 -0.356 0 O-C-N 122.249 -0.559 . . . . 0.0 110.27 -156.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 50.6 t -143.65 152.14 16.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-N 117.692 0.223 . . . . 0.0 110.57 -176.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -109.27 128.0 54.72 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.446 1.899 . . . . 0.0 106.951 153.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 94.0 t -107.42 140.06 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 N-CA-C 105.726 -1.954 . . . . 0.0 105.726 170.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.9 m -136.47 104.3 5.54 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.442 1.019 . . . . 0.0 109.72 -173.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.0 p -69.74 169.93 11.95 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.182 -0.949 . . . . 0.0 110.518 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -67.67 -29.7 69.05 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.511 -0.743 . . . . 0.0 110.774 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.74 -4.17 2.91 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.085 1.354 . . . . 0.0 112.279 172.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.38 -3.46 86.25 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-O 118.436 -1.202 . . . . 0.0 113.637 167.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -58.38 152.52 17.52 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 167.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -103.64 161.69 13.7 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 156.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -118.93 159.1 24.43 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 153.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 72.8 t -137.47 128.38 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 102.185 -3.265 . . . . 0.0 102.185 178.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 pt -139.61 142.95 31.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.432 ' OE1' ' HE3' ' A' ' 62' ' ' LYS . 1.3 pp20? -131.71 -176.22 3.97 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.192 1.797 . . . . 0.0 111.771 177.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.432 ' HE3' ' OE1' ' A' ' 61' ' ' GLU . 0.0 OUTLIER -75.23 54.49 0.7 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.38 2.272 . . . . 0.0 115.844 -157.287 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -177.63 -5.81 0.02 OUTLIER Glycine 0 CA--C 1.53 0.981 0 CA-C-O 118.183 -1.343 . . . . 0.0 113.166 172.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.94 140.83 36.51 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 119.253 1.526 . . . . 0.0 108.236 174.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.494 ' CD1' HD21 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -98.08 153.82 18.16 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 123.818 0.847 . . . . 0.0 109.592 167.596 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.8 t -137.07 137.53 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -174.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 98.0 m -131.15 110.48 11.19 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 166.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -73.53 162.9 72.12 Favored Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 126.142 1.777 . . . . 0.0 109.207 167.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -83.47 177.1 6.63 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 CA-C-O 122.921 1.134 . . . . 0.0 110.002 169.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.3 tttm -85.55 82.69 8.16 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.084 1.353 . . . . 0.0 107.715 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 125.21 86.44 0.66 Allowed Glycine 0 CA--C 1.522 0.522 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 58.9 tp -148.94 103.57 3.37 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.461 0.704 . . . . 0.0 110.823 174.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 27.2 ttt85 -72.86 126.89 31.0 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 156.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 20.4 p -154.14 170.68 20.61 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.899 1.279 . . . . 0.0 108.19 166.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' A' ' 32' ' ' ASP . 1.6 mpp_? -79.81 158.68 26.75 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 120.956 -1.09 . . . . 0.0 110.89 172.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -139.4 116.34 10.94 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.347 1.459 . . . . 0.0 108.433 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.0 102.39 8.14 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.632 1.573 . . . . 0.0 106.921 -173.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.2 t -80.26 105.22 9.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 104.402 -2.444 . . . . 0.0 104.402 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 17.6 mt -81.91 -27.45 33.38 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -151.22 153.62 32.88 Favored Pre-proline 0 N--CA 1.469 0.484 0 C-N-CA 125.67 1.588 . . . . 0.0 109.439 171.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -65.0 106.47 0.79 Allowed 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.125 2.55 . . . . 0.0 111.16 -164.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.3 p -93.17 111.31 24.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-O 121.774 0.797 . . . . 0.0 110.611 -166.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -94.45 43.12 1.1 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 123.754 0.821 . . . . 0.0 111.42 -171.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.62 146.98 39.0 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 120.967 -1.083 . . . . 0.0 111.133 -175.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -78.03 150.05 33.91 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 156.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -139.87 156.88 46.48 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.328 0.967 . . . . 0.0 110.545 172.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -143.36 131.91 22.37 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.143 0.977 . . . . 0.0 109.4 176.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 95.2 mt -93.01 129.83 38.79 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.297 1.039 . . . . 0.0 108.59 176.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.3 p90 . . . . . 0 C--O 1.247 0.949 0 C-N-CA 124.298 1.039 . . . . 0.0 110.231 -177.171 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.437 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -54.39 151.61 7.42 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.089 0.956 . . . . 0.0 110.015 178.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.1 p -54.33 110.84 0.28 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-O 121.594 0.711 . . . . 0.0 110.06 -174.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -109.68 147.82 32.46 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 125.564 1.546 . . . . 0.0 107.961 -176.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.8 mt -139.31 139.32 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 104.04 -2.578 . . . . 0.0 104.04 177.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -154.6 -178.95 7.54 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 123.729 0.812 . . . . 0.0 109.848 167.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.1 81.16 27.98 Favored Pre-proline 0 C--O 1.236 0.365 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -175.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.64 169.23 22.39 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.329 2.019 . . . . 0.0 111.462 -170.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.702 HG23 ' H ' ' A' ' 12' ' ' LYS . 6.9 t -66.26 145.02 98.96 Favored Pre-proline 0 CA--C 1.543 0.703 0 O-C-N 121.983 -0.448 . . . . 0.0 109.943 171.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.411 ' HA ' HD12 ' A' ' 13' ' ' LEU . 72.8 Cg_endo -67.01 -5.2 12.97 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.888 2.392 . . . . 0.0 112.716 169.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -87.8 -51.74 5.69 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 119.542 1.064 . . . . 0.0 110.752 -178.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.702 ' H ' HG23 ' A' ' 9' ' ' THR . 1.5 tptt -49.92 -45.89 51.52 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.354 1.062 . . . . 0.0 110.207 172.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 10' ' ' PRO . 34.1 mt -54.97 -33.29 62.29 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.346 1.058 . . . . 0.0 112.555 178.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.0 mttp -63.76 -51.5 64.57 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 118.911 0.778 . . . . 0.0 109.006 176.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -57.51 -49.11 77.38 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 123.001 1.382 . . . . 0.0 109.827 -172.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 98.5 mt -56.48 -12.04 1.55 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.204 1.801 . . . . 0.0 112.035 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 25.0 m 62.39 32.6 16.77 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 126.527 1.931 . . . . 0.0 111.05 174.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.412 ' HA ' ' CD2' ' A' ' 21' ' ' TRP . 59.6 t -50.81 -39.62 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 126.657 1.983 . . . . 0.0 110.496 175.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -57.68 -19.33 26.13 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -92.05 -25.43 18.79 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 124.297 1.039 . . . . 0.0 111.586 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.412 ' CD2' ' HA ' ' A' ' 18' ' ' VAL . 41.9 m0 -60.45 158.01 32.23 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 124.297 1.039 . . . . 0.0 109.49 -174.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -68.39 118.5 5.68 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.046 1.83 . . . . 0.0 111.401 -175.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.2 mt -62.09 144.75 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 174.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.558 ' CZ3' ' HE3' ' A' ' 84' ' ' LYS . 91.0 t90 -132.59 138.32 47.38 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 165.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -136.2 157.28 47.19 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 128.402 2.681 . . . . 0.0 108.622 -177.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 32.5 tptt -153.85 166.4 33.04 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 121.973 -0.454 . . . . 0.0 109.94 -177.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.84 175.19 3.77 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 122.25 1.024 . . . . 0.0 110.681 167.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.6 p -80.8 -6.93 10.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 113.381 -1.736 . . . . 0.0 112.533 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.1 t -73.88 152.14 40.28 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 122.863 1.316 . . . . 0.0 109.743 174.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -84.27 168.28 15.82 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 129.132 2.973 . . . . 0.0 109.929 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -169.35 -164.01 0.43 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.954 2.502 . . . . 0.0 107.176 176.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -122.55 164.05 18.84 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 120.206 -1.559 . . . . 0.0 107.213 157.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 54.5 t-105 -134.52 168.94 18.05 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.791 0.836 . . . . 0.0 109.791 -173.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -135.87 153.7 51.39 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.259 1.423 . . . . 0.0 107.858 175.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -134.42 120.23 19.54 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 170.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -123.79 27.29 7.34 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.923 1.238 . . . . 0.0 111.811 168.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.65 172.08 15.14 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 152.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -70.23 107.43 3.71 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 -171.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -107.58 98.87 8.42 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -173.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 88.2 m -68.7 148.0 51.03 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 161.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 26.7 p -146.75 159.51 43.41 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 121.468 -0.77 . . . . 0.0 111.539 154.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 19.1 t80 -126.16 126.05 43.49 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 126.385 1.874 . . . . 0.0 107.862 176.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.9 mm -101.28 111.77 32.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 123.24 0.616 . . . . 0.0 109.35 -169.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.0 mp -93.12 -29.65 15.65 Favored 'General case' 0 C--O 1.231 0.104 0 C-N-CA 123.945 0.898 . . . . 0.0 111.769 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -159.33 166.12 31.88 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.51 0.724 . . . . 0.0 109.086 -177.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.17 -178.85 52.91 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.631 1.11 . . . . 0.0 113.218 -177.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.55 ' HE3' HG23 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -148.64 143.17 26.35 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 125.028 1.331 . . . . 0.0 107.583 -178.653 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.9 t -139.17 149.22 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 176.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -116.87 88.6 2.93 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 103.448 -2.797 . . . . 0.0 103.448 166.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.3 t -75.64 144.39 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 173.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 96.5 m -145.69 115.06 7.13 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 120.062 1.301 . . . . 0.0 109.052 -175.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 57.5 p -65.72 162.59 18.28 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.94 -21.89 61.54 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.149 -0.97 . . . . 0.0 110.797 175.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -79.48 22.68 0.43 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.239 1.816 . . . . 0.0 111.232 165.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.74 -5.95 10.47 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 125.685 1.612 . . . . 0.0 115.637 166.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -66.95 110.41 3.34 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-N 119.939 1.869 . . . . 0.0 108.006 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt -87.69 134.08 33.72 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -130.41 85.01 2.24 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 124.26 1.981 . . . . 0.0 108.585 168.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.55 HG23 ' HE3' ' A' ' 47' ' ' LYS . 1.6 p -56.85 136.35 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 CA-C-N 112.51 -2.132 . . . . 0.0 108.646 146.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 pt -139.3 132.97 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 N-CA-C 101.719 -3.437 . . . . 0.0 101.719 173.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -90.46 -176.72 4.86 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 121.893 0.854 . . . . 0.0 108.919 171.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -66.16 126.16 27.79 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 147.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 117.61 14.41 6.87 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-O 118.051 -1.416 . . . . 0.0 114.296 -175.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -119.85 149.31 42.28 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 125.036 1.334 . . . . 0.0 108.545 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 6.7 tp -109.1 145.16 36.14 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 156.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 8.3 t -130.26 153.95 39.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 125.461 1.504 . . . . 0.0 107.476 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 93.0 m -135.31 108.6 7.78 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 161.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -79.01 153.53 77.48 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 123.831 0.852 . . . . 0.0 109.177 169.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.74 171.42 17.35 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 121.848 1.699 . . . . 0.0 111.305 173.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 31.9 tttt -78.1 106.67 10.13 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 111.485 -2.598 . . . . 0.0 106.21 161.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.66 70.09 0.9 Allowed Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.702 1.62 . . . . 0.0 111.918 171.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.1 tp -140.68 150.89 44.07 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 126.104 1.762 . . . . 0.0 109.125 176.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.35 134.2 43.45 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 126.924 2.09 . . . . 0.0 108.219 176.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 6.0 p -159.52 164.83 34.03 Favored 'General case' 0 C--N 1.334 -0.077 0 C-N-CA 123.082 0.553 . . . . 0.0 111.686 176.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.39 164.24 16.62 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 123.029 0.532 . . . . 0.0 112.009 167.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -144.37 104.9 4.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.859 1.264 . . . . 0.0 108.219 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.7 ttpm? -101.88 111.28 23.48 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 169.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.2 t -77.65 125.84 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 168.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.1 mt -103.03 -16.1 15.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 118.313 -0.851 . . . . 0.0 111.448 168.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -147.85 144.45 19.13 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-O 117.543 -1.218 . . . . 0.0 109.299 171.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -61.97 100.43 0.2 Allowed 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 124.24 3.293 . . . . 0.0 111.299 -174.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.5 p -70.51 156.49 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 124.535 1.134 . . . . 0.0 111.232 -169.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -139.99 110.21 6.57 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 103.435 -2.802 . . . . 0.0 103.435 161.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.558 ' HE3' ' CZ3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -132.16 148.26 52.46 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.217 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -90.56 101.04 13.78 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 105.674 -1.972 . . . . 0.0 105.674 174.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -90.92 159.16 16.34 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.69 0.677 . . . . 0.0 110.074 170.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -154.04 140.82 19.08 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 121.44 -0.788 . . . . 0.0 109.972 159.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 42.9 mt -84.23 165.92 17.97 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 124.484 1.113 . . . . 0.0 109.172 175.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.1 p90 . . . . . 0 C--O 1.255 1.367 0 CA-C-O 116.224 -1.846 . . . . 0.0 108.227 164.124 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mtm . . . . . 0 N--CA 1.473 0.682 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -154.43 172.82 17.13 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.449 1.099 . . . . 0.0 108.233 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 95.9 t -77.92 136.23 24.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 O-C-N 121.466 -0.771 . . . . 0.0 110.086 -171.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.6 ttpt -115.0 91.45 3.62 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 176.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.509 ' CG1' HG13 ' A' ' 66' ' ' VAL . 22.8 mt -87.77 139.77 16.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 167.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -154.06 171.8 18.51 Favored 'General case' 0 C--O 1.224 -0.26 0 O-C-N 123.998 0.811 . . . . 0.0 111.008 163.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.92 75.77 75.99 Favored Pre-proline 0 N--CA 1.47 0.572 0 C-N-CA 123.419 0.688 . . . . 0.0 111.368 -179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.468 ' HG2' HD21 ' A' ' 13' ' ' LEU . 41.5 Cg_endo -67.71 172.34 10.7 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 125.183 3.922 . . . . 0.0 114.234 -173.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.6 t -66.19 144.3 98.69 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 124.191 0.996 . . . . 0.0 109.913 173.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.25 -25.07 50.25 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.734 1.623 . . . . 0.0 112.924 176.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -61.24 -55.08 36.06 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.601 0.761 . . . . 0.0 109.184 -177.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -53.34 -38.16 62.99 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.327 1.051 . . . . 0.0 111.208 176.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.468 HD21 ' HG2' ' A' ' 8' ' ' PRO . 4.3 mm? -71.54 -22.19 61.79 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.325 -176.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -64.93 -48.88 72.55 Favored 'General case' 0 C--N 1.338 0.098 0 CA-C-N 120.053 1.297 . . . . 0.0 108.853 166.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -66.3 -37.93 86.55 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.281 0.632 . . . . 0.0 111.466 -167.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 34.4 mt -55.55 -12.09 1.07 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.93 1.292 . . . . 0.0 113.165 173.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.2 m 63.98 39.57 7.89 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 126.764 2.025 . . . . 0.0 109.668 172.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.6 t -53.63 -35.62 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 128.302 2.641 . . . . 0.0 110.55 173.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -61.48 -11.98 12.97 Favored 'General case' 0 CA--C 1.548 0.87 0 O-C-N 121.033 -1.042 . . . . 0.0 113.296 173.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.0 mttt -103.13 -3.73 25.44 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 126.271 1.828 . . . . 0.0 112.494 176.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 32.6 m0 -79.99 165.27 48.22 Favored Pre-proline 0 CA--C 1.538 0.49 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 176.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.52 136.13 35.56 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 121.492 1.461 . . . . 0.0 111.455 170.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.5 mt -76.09 149.69 6.61 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 165.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.483 ' CZ3' ' HE3' ' A' ' 84' ' ' LYS . 6.4 t90 -146.17 148.53 32.64 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.953 1.301 . . . . 0.0 108.261 164.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -138.06 163.22 32.15 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.277 2.231 . . . . 0.0 109.763 -177.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -145.99 159.72 42.85 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.597 1.089 . . . . 0.0 111.309 168.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -61.81 173.92 0.93 Allowed 'General case' 0 C--O 1.232 0.174 0 O-C-N 125.212 1.57 . . . . 0.0 110.792 163.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.9 t -90.78 33.72 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 125.865 1.666 . . . . 0.0 109.885 -173.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.9 t -107.25 -179.04 3.81 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 120.522 -1.361 . . . . 0.0 109.637 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -124.81 144.02 50.5 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.867 1.267 . . . . 0.0 109.724 -171.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -156.54 -164.93 1.76 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.349 1.06 . . . . 0.0 109.145 -174.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.51 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 0.7 OUTLIER -131.34 150.23 52.23 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.945 1.698 . . . . 0.0 109.482 172.503 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 29.6 t-105 -133.97 142.51 47.7 Favored 'General case' 0 C--O 1.236 0.39 0 O-C-N 123.35 0.406 . . . . 0.0 111.135 177.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -106.7 125.13 50.62 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 173.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -103.67 106.8 17.41 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 168.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -104.08 17.79 23.39 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.469 1.031 . . . . 0.0 111.471 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.89 168.14 26.08 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.177 1.391 . . . . 0.0 109.562 166.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -62.97 124.9 22.28 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 126.236 1.814 . . . . 0.0 107.303 -178.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -140.46 109.37 6.04 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.44 ' CG2' HD11 ' A' ' 65' ' ' LEU . 24.6 m -77.82 148.02 34.92 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 163.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 25.6 p -142.92 147.33 35.1 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 157.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -109.35 128.7 55.31 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 172.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.8 mm -90.83 129.3 41.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -108.99 -37.21 5.89 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.012 1.725 . . . . 0.0 113.033 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -163.7 161.11 23.38 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.098 1.759 . . . . 0.0 109.585 175.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.05 -163.64 12.88 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.056 1.312 . . . . 0.0 111.638 -174.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.404 ' HE3' ' O ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -150.82 145.12 25.5 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.618 1.209 . . . . 0.0 108.011 157.206 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.404 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 65.6 t -134.46 150.2 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 174.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -118.95 143.08 47.23 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 157.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.6 t -120.42 96.84 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 175.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.4 m -78.51 104.94 9.45 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 174.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.459 ' HA ' ' SG ' ' A' ' 74' ' ' CYS . 23.9 p -78.32 171.68 14.71 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 177.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -60.34 -31.92 70.77 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 121.062 -1.023 . . . . 0.0 111.904 -177.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.46 -15.43 60.68 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 127.578 2.351 . . . . 0.0 111.674 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 85.83 -2.93 87.7 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 124.641 1.115 . . . . 0.0 114.174 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.7 mmtp -59.75 142.25 53.6 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 163.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.0 ptmm? -125.7 94.11 4.03 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-O 123.118 1.437 . . . . 0.0 107.8 -176.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.441 ' HB3' HD11 ' A' ' 5' ' ' ILE . 92.4 m-85 -89.11 87.43 7.18 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 123.991 1.853 . . . . 0.0 109.01 -175.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.5 p -55.13 144.1 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 CA-C-N 112.092 -2.322 . . . . 0.0 111.103 149.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 pt -144.78 137.3 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 129.478 3.111 . . . . 0.0 104.094 176.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -109.29 -177.25 3.24 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 125.551 1.54 . . . . 0.0 109.412 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.5 pttt -64.62 42.47 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 130.238 3.415 . . . . 0.0 116.446 -174.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -179.46 11.91 0.03 OUTLIER Glycine 0 CA--C 1.524 0.608 0 C-N-CA 124.962 1.268 . . . . 0.0 113.251 169.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.98 131.04 40.36 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.54 1.67 . . . . 0.0 107.022 175.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.44 HD11 ' CG2' ' A' ' 40' ' ' THR . 26.0 tp -99.3 91.61 5.04 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.332 1.453 . . . . 0.0 108.025 164.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.509 HG13 ' CG1' ' A' ' 5' ' ' ILE 0.631 0.1 OUTLIER -61.89 145.96 12.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 120.808 3.632 . . . . 0.0 120.808 153.042 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.2 m -135.4 121.98 20.75 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 128.289 2.636 . . . . 0.0 105.761 162.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -92.61 148.32 35.97 Favored Pre-proline 0 C--O 1.237 0.422 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 170.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -78.14 179.73 6.22 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.937 2.425 . . . . 0.0 110.16 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -85.77 93.95 9.0 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 114.65 93.57 1.95 Allowed Glycine 0 CA--C 1.523 0.534 0 C-N-CA 125.175 1.369 . . . . 0.0 109.802 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.3 tt -151.23 133.34 15.22 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.038 1.335 . . . . 0.0 108.858 175.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 65.6 ttt-85 -130.23 81.87 2.03 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.616 1.098 . . . . 0.0 111.056 -175.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.459 ' SG ' ' HA ' ' A' ' 52' ' ' THR . 87.0 m -137.2 154.8 50.11 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 122.205 1.002 . . . . 0.0 112.634 -168.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.51 ' HA ' ' HA ' ' A' ' 32' ' ' ASP . 0.7 OUTLIER -70.27 152.53 44.08 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 114.043 -1.435 . . . . 0.0 109.858 -174.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -131.58 110.46 10.97 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.927 1.691 . . . . 0.0 107.215 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.4 tttp -108.73 107.96 18.61 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -177.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.5 t -86.09 102.57 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 69.1 mt -83.95 -21.84 31.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 118.493 -0.765 . . . . 0.0 110.509 175.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -152.6 151.9 27.77 Favored Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 173.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -72.1 86.28 0.95 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 125.05 3.833 . . . . 0.0 111.801 -158.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.3 p -71.69 139.79 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 123.912 0.885 . . . . 0.0 109.251 -172.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.0 ttt180 -120.8 59.37 0.92 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.986 0.898 . . . . 0.0 110.044 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.483 ' HE3' ' CZ3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -70.47 162.13 29.3 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 119.37 -2.081 . . . . 0.0 109.71 -172.554 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -101.18 125.35 47.8 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 104.375 -2.454 . . . . 0.0 104.375 167.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -115.53 160.87 19.4 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 119.478 1.036 . . . . 0.0 109.251 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -151.01 127.63 10.82 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 118.789 0.722 . . . . 0.0 109.237 173.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 19.8 mt -87.83 139.04 30.93 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 126.411 1.884 . . . . 0.0 108.015 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 34.0 p90 . . . . . 0 C--O 1.259 1.604 0 CA-C-O 117.335 -1.317 . . . . 0.0 110.397 179.063 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.471 0.575 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -159.69 12.89 0.13 Allowed 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 91.5 t 49.37 108.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.693 1 C-N-CA 132.616 4.366 . . . . 0.0 111.717 -174.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.16 130.81 44.3 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 177.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.0 mt -143.32 134.47 22.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 173.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -159.38 173.73 15.81 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.337 0.655 . . . . 0.0 110.199 172.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.82 85.3 4.87 Favored Pre-proline 0 C--O 1.234 0.256 0 C-N-CA 124.288 1.035 . . . . 0.0 108.911 177.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.87 169.91 19.18 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.248 2.632 . . . . 0.0 112.925 -176.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 t -69.63 149.79 96.85 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.82 1.248 . . . . 0.0 110.642 174.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.09 -31.16 75.91 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.834 2.356 . . . . 0.0 113.79 173.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -63.26 -53.56 50.98 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 118.65 0.659 . . . . 0.0 110.672 -171.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.5 tttp -54.42 -48.48 71.59 Favored 'General case' 0 C--O 1.224 -0.283 0 C-N-CA 124.833 1.253 . . . . 0.0 109.298 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.4 mt -58.02 -41.02 82.27 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.933 0.893 . . . . 0.0 112.019 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -59.94 -46.96 87.7 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.012 173.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -59.28 -45.77 90.35 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 119.129 0.877 . . . . 0.0 110.065 -178.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 59.8 mt -57.16 -12.02 2.0 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.572 1.949 . . . . 0.0 113.05 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.3 m 64.11 39.81 7.43 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.956 1.702 . . . . 0.0 111.844 168.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.3 t -58.03 -26.69 29.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 126.743 2.017 . . . . 0.0 111.92 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -61.53 -20.57 63.38 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 120.324 -1.485 . . . . 0.0 113.439 171.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.5 mtmt -98.02 4.15 49.34 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 125.159 1.384 . . . . 0.0 110.92 177.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 31.9 m0 -87.54 160.33 47.97 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 177.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.37 133.76 27.11 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.186 1.924 . . . . 0.0 112.415 177.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.9 mt -73.41 147.73 9.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 124.485 1.114 . . . . 0.0 109.694 166.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.482 ' CZ3' ' HE3' ' A' ' 84' ' ' LYS . 59.8 t90 -144.36 120.63 10.88 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.292 1.437 . . . . 0.0 107.876 168.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.77 168.51 10.28 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.763 1.625 . . . . 0.0 109.791 164.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.534 ' HD3' ' H ' ' A' ' 27' ' ' GLU . 6.1 tmtt? -152.07 165.73 33.81 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.827 0.822 . . . . 0.0 110.735 167.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.534 ' H ' ' HD3' ' A' ' 26' ' ' LYS . 1.0 OUTLIER -76.97 172.64 12.86 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 126.304 1.842 . . . . 0.0 109.216 174.732 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.2 t -100.33 59.32 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 -164.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.4 t -132.03 -178.29 4.83 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.893 1.677 . . . . 0.0 109.433 -167.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -122.64 150.65 42.39 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.907 0.883 . . . . 0.0 109.095 173.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -163.42 -164.79 0.97 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 125.881 1.673 . . . . 0.0 107.017 -177.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 2.6 p30 -131.0 154.65 47.95 Favored 'General case' 0 CA--C 1.514 -0.422 0 O-C-N 120.878 -1.139 . . . . 0.0 109.159 173.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 56.1 t-105 -144.11 152.25 40.69 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.015 0.435 . . . . 0.0 110.062 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -124.89 153.18 43.03 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.572 1.149 . . . . 0.0 108.526 -177.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -123.49 103.84 8.7 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.961 1.305 . . . . 0.0 107.626 175.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -104.74 13.45 31.36 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.232 1.413 . . . . 0.0 110.877 176.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.46 170.78 18.77 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 129.649 3.18 . . . . 0.0 108.624 164.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 19.0 m-80 -68.94 136.41 52.5 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 177.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -133.17 124.26 27.13 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 171.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 53.1 m -99.34 137.79 37.35 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 166.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 24.8 p -138.03 148.04 44.71 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 118.164 0.438 . . . . 0.0 110.101 167.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -112.11 126.03 54.74 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 171.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 17.6 mm -95.55 122.39 46.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 129.499 3.119 . . . . 0.0 107.47 -173.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -105.53 -27.55 11.33 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -175.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -164.86 156.64 15.46 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.508 1.123 . . . . 0.0 108.27 177.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.17 177.87 44.63 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.976 1.274 . . . . 0.0 112.205 -177.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.491 ' HE3' HG23 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -135.61 139.03 43.51 Favored 'General case' 0 CA--C 1.515 -0.378 0 O-C-N 121.618 -0.931 . . . . 0.0 108.857 -170.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.426 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 55.1 t -136.19 146.07 29.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 178.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -112.58 116.82 30.81 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 102.998 -2.964 . . . . 0.0 102.998 156.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.4 t -91.04 122.33 42.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 164.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 57.9 m -123.67 105.78 10.0 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 119.664 1.12 . . . . 0.0 108.386 -172.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 32.5 p -69.75 171.97 8.31 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -80.2 -11.2 59.76 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 120.264 -1.523 . . . . 0.0 112.267 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -65.05 -10.76 32.58 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 121.011 -1.056 . . . . 0.0 112.076 162.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.86 -9.24 77.93 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 125.115 1.34 . . . . 0.0 112.549 -178.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -61.19 124.01 19.33 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 124.957 1.303 . . . . 0.0 108.134 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.96 127.86 46.11 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 125.322 1.449 . . . . 0.0 108.229 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -124.21 84.01 2.22 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 124.478 2.085 . . . . 0.0 107.1 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.491 HG23 ' HE3' ' A' ' 47' ' ' LYS . 1.5 p -72.87 148.29 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 CA-C-N 111.138 -2.756 . . . . 0.0 109.454 162.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.6 pt -148.31 125.23 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 C-N-CA 126.837 2.055 . . . . 0.0 106.528 -175.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -88.3 178.58 6.55 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 122.454 1.121 . . . . 0.0 109.932 167.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -63.95 54.45 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 130.798 3.639 . . . . 0.0 115.525 176.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 173.64 -13.69 0.04 OUTLIER Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.731 1.634 . . . . 0.0 112.846 176.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -69.09 101.75 1.49 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.222 1.511 . . . . 0.0 108.739 176.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 10.4 tp -74.81 141.17 44.33 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 175.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.4 t -123.78 160.32 27.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 C-N-CA 123.818 0.847 . . . . 0.0 109.076 -175.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 33.6 m -143.24 109.94 5.51 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 161.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -80.04 148.37 67.79 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 169.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -87.22 178.57 3.45 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.624 2.216 . . . . 0.0 111.877 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -85.45 83.43 7.94 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 125.372 1.469 . . . . 0.0 107.524 173.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 129.8 79.18 0.21 Allowed Glycine 0 CA--C 1.532 1.096 0 C-N-CA 126.749 2.118 . . . . 0.0 111.142 175.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.445 HD21 ' HB3' ' A' ' 74' ' ' CYS . 8.1 tt -147.92 117.45 7.01 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 118.978 1.389 . . . . 0.0 111.467 175.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.5 tpp85 -85.92 133.8 33.92 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.945 0.898 . . . . 0.0 109.721 161.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.445 ' HB3' HD21 ' A' ' 72' ' ' LEU . 28.6 p -150.66 178.19 9.34 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.657 0.783 . . . . 0.0 112.973 166.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' A' ' 32' ' ' ASP . 0.2 OUTLIER -96.2 160.51 14.4 Favored 'General case' 0 CA--C 1.511 -0.527 0 C-N-CA 124.648 1.179 . . . . 0.0 109.295 167.656 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 2.5 m95 -132.36 117.32 17.97 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 173.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.403 ' HD2' HD23 ' A' ' 79' ' ' LEU . 3.6 tmtp? -104.68 112.09 25.04 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 168.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.6 t -81.26 91.3 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 103.833 -2.654 . . . . 0.0 103.833 171.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.465 HD12 ' HE2' ' A' ' 47' ' ' LYS . 50.7 mt -71.06 -33.83 70.63 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.214 -179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 75.0 mt-10 -142.3 147.01 41.81 Favored Pre-proline 0 C--O 1.234 0.237 0 CA-C-O 117.479 -1.248 . . . . 0.0 108.224 171.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -62.47 94.91 0.14 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 125.072 3.848 . . . . 0.0 110.896 -165.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.1 p -78.3 146.95 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.853 -167.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -128.01 114.5 17.18 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 169.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.482 ' HE3' ' CZ3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -131.17 139.68 49.79 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 123.164 0.586 . . . . 0.0 109.495 -179.262 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -81.9 114.78 20.73 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 170.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -102.18 165.18 11.29 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.642 1.11 . . . . 0.0 110.013 174.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -152.0 150.82 30.41 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 118.725 0.693 . . . . 0.0 109.82 163.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 39.0 mt -108.76 147.05 32.59 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.78 1.232 . . . . 0.0 108.751 -174.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.2 p90 . . . . . 0 C--O 1.253 1.244 0 C-N-CA 126.164 1.785 . . . . 0.0 110.035 -179.497 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.8 ptp . . . . . 0 N--CA 1.471 0.61 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -156.3 14.33 0.31 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.999 0.818 . . . . 0.0 111.561 -175.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.5 t 49.93 107.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 C-N-CA 131.611 3.964 . . . . 0.0 112.116 -161.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.9 tttt -69.78 125.3 26.34 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 174.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.0 mt -130.9 135.92 59.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 105.069 -2.196 . . . . 0.0 105.069 172.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -158.6 174.14 15.51 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 125.838 1.655 . . . . 0.0 109.425 167.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.41 85.0 15.37 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 119.197 0.908 . . . . 0.0 108.799 177.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.493 ' HG2' HD21 ' A' ' 13' ' ' LEU . 19.3 Cg_endo -65.31 163.16 30.4 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.728 2.952 . . . . 0.0 111.902 -172.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 t -66.98 142.69 97.52 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 175.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -72.54 -16.51 27.16 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.114 1.876 . . . . 0.0 113.73 -178.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -52.54 -62.87 1.37 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.828 0.851 . . . . 0.0 109.022 170.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 48.8 tptt -53.82 -37.06 63.19 Favored 'General case' 0 CA--C 1.522 -0.104 0 C-N-CA 124.921 1.288 . . . . 0.0 111.213 -176.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.493 HD21 ' HG2' ' A' ' 8' ' ' PRO . 3.9 mm? -65.17 -37.19 86.58 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.67 0.788 . . . . 0.0 111.003 -178.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -48.48 72.39 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 117.712 -1.137 . . . . 0.0 108.407 176.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -53.26 -49.17 67.46 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.454 1.102 . . . . 0.0 110.414 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.1 mp -52.24 -15.57 0.63 Allowed 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 126.616 1.967 . . . . 0.0 113.903 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.455 ' HB3' ' HE3' ' A' ' 20' ' ' LYS . 23.7 m 66.1 30.54 9.38 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.473 1.509 . . . . 0.0 110.783 175.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.5 t -55.16 -30.18 23.92 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.205 0 C-N-CA 125.159 1.384 . . . . 0.0 111.616 -178.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -55.01 -28.04 48.92 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.407 1.003 . . . . 0.0 112.867 173.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.455 ' HE3' ' HB3' ' A' ' 17' ' ' SER . 5.8 mtmp? -88.92 -23.55 22.68 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 124.742 1.217 . . . . 0.0 111.287 -176.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.422 ' CE3' ' HB2' ' A' ' 87' ' ' ASN . 37.5 m0 -61.21 156.94 46.97 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 123.26 0.624 . . . . 0.0 109.326 -174.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -71.32 121.47 7.8 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.235 1.957 . . . . 0.0 112.309 -175.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.1 mt -62.51 145.56 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 O-C-N 121.106 -0.996 . . . . 0.0 108.612 176.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.453 ' CE3' ' HE2' ' A' ' 84' ' ' LYS . 81.9 t90 -141.82 148.46 38.89 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 122.171 0.986 . . . . 0.0 108.721 161.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -140.17 168.39 19.91 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 128.286 2.634 . . . . 0.0 107.616 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.457 ' HE3' ' CD1' ' A' ' 31' ' ' PHE . 6.2 tmtt? -149.01 158.29 44.07 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 168.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -58.11 172.44 0.43 Allowed 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 123.142 1.449 . . . . 0.0 111.09 171.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.6 p -76.31 65.78 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 112.388 -2.187 . . . . 0.0 108.901 169.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.92 156.35 41.0 Favored 'General case' 0 CA--C 1.507 -0.706 0 O-C-N 120.555 -1.341 . . . . 0.0 109.888 172.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -78.14 165.51 23.87 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 113.233 -1.803 . . . . 0.0 109.469 -178.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.457 ' CD1' ' HE3' ' A' ' 26' ' ' LYS . 6.7 p90 -163.65 -173.18 3.17 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 164.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 8.8 p-10 -126.67 140.28 52.52 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 163.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 15.5 t-105 -113.87 140.29 48.47 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.163 -174.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -106.31 111.89 24.68 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 168.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -85.08 119.97 26.06 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 172.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.37 -5.6 9.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 117.854 -1.07 . . . . 0.0 113.613 -158.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 p -141.12 175.08 9.92 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 131.293 3.837 . . . . 0.0 106.853 164.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -67.84 129.35 39.63 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -135.46 107.22 7.01 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -176.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 89.1 m -75.77 142.91 42.23 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 166.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 19.8 p -138.46 146.49 42.15 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 119.5 1.045 . . . . 0.0 110.917 158.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -117.09 112.67 21.22 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 126.414 1.886 . . . . 0.0 107.457 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 29.4 mm -80.22 131.48 33.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -176.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.8 mp -114.01 -26.62 8.03 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 118.759 -0.639 . . . . 0.0 112.26 178.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -163.43 152.36 14.31 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 118.813 0.733 . . . . 0.0 109.849 -178.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.48 -177.27 21.32 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.721 1.629 . . . . 0.0 112.766 -176.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.578 ' HE2' HD12 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -135.54 142.93 45.47 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.11 1.364 . . . . 0.0 107.489 171.341 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.656 HG13 ' CG1' ' A' ' 60' ' ' ILE 0.634 0.2 OUTLIER -133.89 137.02 53.1 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.309 0 C-N-CA 129.648 3.179 . . . . 0.0 117.067 -176.139 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -125.46 112.68 16.54 Favored 'General case' 0 N--CA 1.429 -1.493 0 O-C-N 125.197 1.561 . . . . 0.0 109.157 158.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.499 HG23 HD11 ' A' ' 60' ' ' ILE . 70.5 t -91.99 139.57 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 166.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 90.5 m -136.28 115.52 12.55 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 177.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.5 p -72.21 178.57 3.8 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.812 1.245 . . . . 0.0 110.913 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -54.55 -34.17 61.35 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.182 0.593 . . . . 0.0 110.468 170.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.49 1.31 26.16 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 127.966 2.506 . . . . 0.0 113.124 -171.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.17 3.63 46.3 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-N 118.745 0.702 . . . . 0.0 114.6 177.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.497 ' HE2' ' HA ' ' A' ' 56' ' ' LYS . 6.0 mmpt? -65.42 111.8 3.24 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 166.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.41 150.18 46.51 Favored 'General case' 0 C--O 1.232 0.132 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 164.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -135.97 118.87 16.26 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 170.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.8 t -89.21 132.09 34.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 178.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.656 ' CG1' HG13 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -126.26 136.93 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 174.638 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -138.97 -179.01 5.58 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 172.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.3 81.24 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.192 1.797 . . . . 0.0 111.773 177.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 137.45 11.47 1.0 Allowed Glycine 0 CA--C 1.525 0.708 0 CA-C-O 117.882 -1.51 . . . . 0.0 114.593 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -107.69 134.97 49.91 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 164.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.416 ' CD1' HD11 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -96.06 153.66 17.66 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 165.756 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 36.4 t -133.46 150.24 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 124.057 0.943 . . . . 0.0 109.218 177.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.8 m -133.43 120.24 20.65 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.19 0.996 . . . . 0.0 108.312 162.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -83.28 156.57 66.17 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 125.302 1.441 . . . . 0.0 109.514 170.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -83.96 175.16 7.85 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 122.5 2.133 . . . . 0.0 109.818 174.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -78.03 102.19 7.29 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 104.909 -2.256 . . . . 0.0 104.909 166.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.78 80.79 1.54 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.391 0.996 . . . . 0.0 112.196 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 51.5 tp -141.77 155.45 45.61 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 126.024 1.73 . . . . 0.0 108.374 169.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.81 140.43 45.86 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 126.952 2.101 . . . . 0.0 106.722 175.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 3.9 p -168.73 161.09 11.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 118.55 0.614 . . . . 0.0 110.117 173.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -68.6 159.33 32.17 Favored 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.997 164.593 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -123.57 136.79 54.72 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 163.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -119.48 97.51 5.68 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 167.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.7 t -73.95 97.21 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.505 0 N-CA-C 103.45 -2.796 . . . . 0.0 103.45 169.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.578 HD12 ' HE2' ' A' ' 47' ' ' LYS . 68.1 mt -72.43 -31.21 65.3 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 119.058 -1.057 . . . . 0.0 108.957 178.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -143.17 144.34 28.22 Favored Pre-proline 0 N--CA 1.452 -0.339 0 CA-C-O 116.881 -1.533 . . . . 0.0 107.189 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -62.93 98.35 0.2 Allowed 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 124.144 3.229 . . . . 0.0 110.2 -165.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 6.9 p -74.29 158.6 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.697 -171.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -139.02 120.5 15.01 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 168.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.453 ' HE2' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -131.38 154.29 48.77 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 -178.007 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 14.3 m80 -94.06 102.25 14.31 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 167.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -88.61 157.48 18.57 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.906 0.883 . . . . 0.0 110.271 171.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.422 ' HB2' ' CE3' ' A' ' 21' ' ' TRP . 34.3 t30 -154.58 122.18 5.78 Favored 'General case' 0 C--O 1.236 0.365 0 O-C-N 121.333 -0.854 . . . . 0.0 110.403 167.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.6 mt -69.82 157.47 37.3 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.051 1.34 . . . . 0.0 109.335 176.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.251 1.17 0 CA-C-O 115.43 -2.224 . . . . 0.0 108.159 163.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 ttt . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 57.72 178.72 0.06 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.49 0.716 . . . . 0.0 109.197 -161.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 75.9 t -86.19 117.69 31.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 160.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -88.85 139.63 30.26 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 166.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.6 mt -132.73 134.56 58.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 162.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -161.56 176.98 10.46 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.823 1.649 . . . . 0.0 109.199 166.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.38 86.0 3.16 Favored Pre-proline 0 CA--C 1.535 0.399 0 C-N-CA 124.777 1.231 . . . . 0.0 110.354 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.416 ' HG2' HD21 ' A' ' 13' ' ' LEU . 57.2 Cg_endo -64.5 171.49 8.06 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.819 2.346 . . . . 0.0 112.683 179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 38.4 p -73.05 146.73 87.65 Favored Pre-proline 0 CA--C 1.536 0.404 0 O-C-N 121.571 -0.706 . . . . 0.0 109.536 173.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -70.45 -25.21 25.65 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.528 1.485 . . . . 0.0 112.198 -178.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -64.13 -45.18 89.67 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.616 0.644 . . . . 0.0 110.369 172.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.3 tptm -57.56 -33.9 68.62 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 118.846 0.748 . . . . 0.0 110.544 177.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.416 HD21 ' HG2' ' A' ' 8' ' ' PRO . 3.9 mm? -74.28 -15.06 60.98 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.232 0.613 . . . . 0.0 112.53 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -77.36 -39.73 46.42 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 119.726 1.148 . . . . 0.0 109.051 164.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -70.85 -20.92 62.49 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 118.254 0.479 . . . . 0.0 112.262 -176.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 mp -78.9 1.93 21.9 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-O 117.474 -1.251 . . . . 0.0 112.611 176.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.7 p 57.99 21.51 7.85 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.155 1.382 . . . . 0.0 114.2 -177.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.9 t -57.87 -37.58 61.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.368 0 CA-C-N 119.659 1.118 . . . . 0.0 111.837 -163.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -53.37 -24.63 12.73 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.936 0.895 . . . . 0.0 113.312 175.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.5 mttm -88.43 -25.16 22.79 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 117.677 -1.154 . . . . 0.0 111.153 -177.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 38.7 m0 -61.24 164.74 7.84 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 126.141 1.777 . . . . 0.0 110.261 -175.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.05 140.72 55.24 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 CA-C-N 121.52 1.579 . . . . 0.0 111.165 173.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.8 mt -85.6 155.51 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 169.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 27.8 t90 -141.76 133.93 27.76 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 164.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -138.25 132.88 32.43 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 126.807 2.043 . . . . 0.0 106.82 -177.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -134.27 169.6 16.96 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 121.384 -0.823 . . . . 0.0 110.062 -170.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.437 ' CD ' ' H ' ' A' ' 28' ' ' VAL . 1.4 tm-20 -72.7 177.54 4.71 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 122.755 1.264 . . . . 0.0 111.039 172.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.437 ' H ' ' CD ' ' A' ' 27' ' ' GLU . 16.3 t -102.24 45.87 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 127.351 2.26 . . . . 0.0 108.432 -165.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.7 t -108.52 -175.29 2.73 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 128.076 2.55 . . . . 0.0 108.682 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -109.05 163.26 13.48 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.803 0.811 . . . . 0.0 110.5 159.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -151.14 -164.73 2.08 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 163.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -142.05 148.36 38.33 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 126.095 1.758 . . . . 0.0 106.858 177.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 47.1 t-105 -135.13 145.89 48.28 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.129 0.572 . . . . 0.0 111.804 -172.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -112.54 109.76 19.52 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.543 1.537 . . . . 0.0 107.781 166.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -79.16 95.3 5.56 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 171.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -88.01 18.61 4.11 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.472 1.033 . . . . 0.0 110.4 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -168.31 164.26 13.01 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.779 1.631 . . . . 0.0 109.838 176.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -58.43 103.12 0.13 Allowed 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 126.903 2.081 . . . . 0.0 107.561 174.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -105.97 125.14 50.64 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 166.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 85.6 m -99.54 146.52 26.32 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 168.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 20.9 p -146.67 161.3 40.87 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 118.59 0.632 . . . . 0.0 110.643 164.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 34.9 t80 -129.63 106.2 8.57 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 125.494 1.518 . . . . 0.0 108.556 -176.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 26.0 mm -80.45 116.38 24.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 O-C-N 122.011 -0.43 . . . . 0.0 109.937 -169.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.5 mt -92.37 -32.46 14.95 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 117.875 -1.06 . . . . 0.0 112.951 178.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -165.8 163.58 18.8 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 118.953 0.797 . . . . 0.0 109.245 -173.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.09 -176.6 53.86 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.985 1.279 . . . . 0.0 111.825 -176.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.578 ' HE2' HD12 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -139.29 139.1 37.25 Favored 'General case' 0 CA--C 1.517 -0.309 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 -171.482 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 76.8 t -136.13 158.24 38.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -131.72 97.44 4.21 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 127.155 2.182 . . . . 0.0 106.799 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . 0.727 0.1 OUTLIER -93.34 71.2 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.007 0 C-N-CA 130.822 3.649 . . . . 0.0 118.414 163.322 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 57' ' ' LYS . 14.9 m -73.46 113.32 10.42 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 164.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.6 p -67.93 169.97 8.99 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 109.381 -0.599 . . . . 0.0 109.381 171.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -65.25 -22.3 66.85 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.786 -1.196 . . . . 0.0 110.08 170.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -77.73 3.39 14.19 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.286 1.834 . . . . 0.0 111.481 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.69 -9.1 8.87 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 125.01 1.29 . . . . 0.0 113.053 177.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -66.07 108.98 2.41 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 119.502 1.651 . . . . 0.0 106.834 171.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -88.64 131.78 34.84 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 124.214 0.946 . . . . 0.0 109.705 179.13 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 15.6 m-30 -115.54 85.08 2.21 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 127.685 2.394 . . . . 0.0 105.896 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.547 HG13 ' HE3' ' A' ' 47' ' ' LYS . 71.3 t -66.35 128.34 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 N-CA-C 103.981 -2.6 . . . . 0.0 103.981 156.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.7 pt -128.6 138.88 53.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 169.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -123.97 179.9 4.66 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.188 1.795 . . . . 0.0 107.137 -170.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.0 pttp -73.67 60.85 0.71 Allowed 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 124.988 1.315 . . . . 0.0 112.92 -173.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 164.41 34.36 0.02 OUTLIER Glycine 0 C--N 1.317 -0.524 0 O-C-N 120.15 -1.594 . . . . 0.0 112.458 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -122.18 139.37 53.83 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 118.961 1.38 . . . . 0.0 107.808 175.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.9 tp -94.57 141.09 29.0 Favored 'General case' 0 C--O 1.235 0.338 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 164.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.5 t -126.35 139.65 51.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 175.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 46.2 m -120.71 102.64 8.53 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 165.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -70.41 151.61 95.64 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 169.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -75.74 -164.53 0.25 Allowed 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.692 2.928 . . . . 0.0 110.077 175.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -98.44 129.14 45.06 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 161.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.52 83.9 0.47 Allowed Glycine 0 CA--C 1.535 1.305 0 C-N-CA 127.494 2.473 . . . . 0.0 113.984 -178.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.6 tt -142.87 130.61 21.46 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 126.909 2.084 . . . . 0.0 108.213 171.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.83 128.09 55.65 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.977 0.911 . . . . 0.0 108.867 171.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 27.4 p -149.24 173.81 13.07 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 121.634 -0.667 . . . . 0.0 111.088 178.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.19 -178.04 4.86 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 118.386 -0.816 . . . . 0.0 111.079 166.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -155.46 90.4 1.25 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.801 1.24 . . . . 0.0 107.785 172.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -83.86 118.42 23.95 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 172.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.5 t -88.58 94.97 4.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 N-CA-C 103.779 -2.674 . . . . 0.0 103.779 167.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.578 HD12 ' HE2' ' A' ' 47' ' ' LYS . 26.7 mt -71.02 -29.23 65.11 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 117.522 -1.228 . . . . 0.0 110.109 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -149.01 148.37 26.91 Favored Pre-proline 0 N--CA 1.453 -0.303 0 C-N-CA 125.143 1.377 . . . . 0.0 108.988 175.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -59.88 105.81 0.29 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 124.559 3.506 . . . . 0.0 109.602 -167.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.9 p -84.36 149.41 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -174.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.7 130.06 46.63 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 164.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.79 146.91 34.69 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 174.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -73.17 127.96 34.11 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 148.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 12.6 p90 -113.64 164.17 14.03 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 166.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -153.37 150.51 28.93 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 165.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 93.7 mt -101.63 161.45 13.64 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.641 1.176 . . . . 0.0 108.209 177.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 11.1 p90 . . . . . 0 C--O 1.246 0.915 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 159.868 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.1 ttt . . . . . 0 N--CA 1.47 0.527 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -164.42 164.9 21.93 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 -174.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.7 t -58.96 140.49 17.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 168.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.2 tttt -129.78 89.71 2.86 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.6 mt -86.93 143.9 10.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 176.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -149.11 178.97 8.25 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 122.625 0.37 . . . . 0.0 110.074 154.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . 0.37 0.5 OUTLIER -128.5 85.01 61.47 Favored Pre-proline 0 N--CA 1.451 -0.411 0 O-C-N 121.179 -0.951 . . . . 0.0 111.855 -178.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -81.31 168.7 16.47 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 125.163 3.908 . . . . 0.0 113.517 -169.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.7 t -66.22 143.66 98.42 Favored Pre-proline 0 C--N 1.331 -0.202 0 C-N-CA 126.584 1.954 . . . . 0.0 109.188 172.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -71.01 -21.27 27.91 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.741 1.628 . . . . 0.0 112.166 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.84 -60.36 3.95 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.444 1.098 . . . . 0.0 109.131 -178.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.7 tttt -58.92 -29.7 67.29 Favored 'General case' 0 N--CA 1.466 0.326 0 O-C-N 121.008 -1.057 . . . . 0.0 111.606 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -71.3 -38.4 71.78 Favored 'General case' 0 C--N 1.334 -0.107 0 O-C-N 121.367 -0.833 . . . . 0.0 110.854 177.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -56.56 -53.55 56.22 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 119.426 1.012 . . . . 0.0 109.142 167.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -57.2 -39.78 76.11 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.266 0.626 . . . . 0.0 111.489 -174.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.43 -10.77 2.31 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.28 2.232 . . . . 0.0 115.266 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 63.4 m 57.32 43.85 22.76 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.929 1.292 . . . . 0.0 111.715 -177.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.428 ' HA ' ' CD2' ' A' ' 21' ' ' TRP . 54.8 t -56.05 -36.49 45.09 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 C-N-CA 126.699 2.0 . . . . 0.0 111.051 174.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -61.52 -13.49 21.69 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 176.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.5 mtpp -95.88 -10.98 27.47 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.467 1.107 . . . . 0.0 111.474 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.428 ' CD2' ' HA ' ' A' ' 18' ' ' VAL . 30.4 m0 -72.86 163.42 68.43 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 178.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -66.7 137.71 46.69 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 121.752 1.635 . . . . 0.0 110.736 170.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 81.4 mt -72.46 152.8 7.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 161.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 14.6 t90 -137.81 150.93 47.61 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 161.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -151.18 156.84 41.78 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.738 1.215 . . . . 0.0 110.465 -178.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.554 ' HE3' ' CE2' ' A' ' 31' ' ' PHE . 16.7 tptp -153.71 162.2 41.45 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 124.598 1.159 . . . . 0.0 108.67 -167.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -88.41 -178.07 5.78 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.126 0.971 . . . . 0.0 108.744 175.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.5 p -68.77 8.72 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 C-N-CA 127.718 2.407 . . . . 0.0 113.16 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.3 p -85.93 124.71 32.7 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 126.417 1.887 . . . . 0.0 111.12 -173.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -79.28 152.62 30.44 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 124.288 0.993 . . . . 0.0 109.713 175.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.554 ' CE2' ' HE3' ' A' ' 26' ' ' LYS . 11.9 p90 -156.51 -170.83 3.47 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 176.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -124.7 121.0 33.43 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 127.542 2.337 . . . . 0.0 107.233 172.271 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 43.9 t-105 -109.17 155.77 20.65 Favored 'General case' 0 C--O 1.236 0.37 0 O-C-N 123.743 0.652 . . . . 0.0 111.012 178.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -122.61 133.24 54.54 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.68 1.592 . . . . 0.0 110.437 175.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -105.37 108.17 19.55 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 175.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -101.14 4.11 41.78 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.006 1.322 . . . . 0.0 111.061 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.84 163.89 36.82 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 128.112 2.565 . . . . 0.0 108.055 170.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -66.66 142.0 57.59 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 175.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -147.36 136.99 22.84 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 -176.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 61.8 m -114.96 121.25 42.59 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 174.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 9.1 p -121.85 145.07 48.44 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.448 0.642 . . . . 0.0 109.357 173.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -121.69 109.1 14.33 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 127.401 2.28 . . . . 0.0 107.032 -175.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.6 mm -69.37 138.49 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 C-N-CA 124.831 1.252 . . . . 0.0 107.887 175.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 mp -125.09 -32.19 3.02 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 122.795 0.438 . . . . 0.0 110.845 176.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -138.87 171.75 13.87 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 123.768 0.827 . . . . 0.0 108.875 168.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.71 -179.77 30.43 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 116.608 1.403 . . . . 0.0 116.608 167.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.821 ' HE3' HG13 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -140.07 151.39 45.35 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 127.924 2.49 . . . . 0.0 111.485 170.864 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.631 HG13 ' CG1' ' A' ' 60' ' ' ILE 0.421 0.2 OUTLIER -146.43 146.91 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 1 C-N-CA 133.253 4.621 . . . . 0.0 113.288 -174.914 . . . . . . . . 5 4 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -120.16 149.91 41.48 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.242 145.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.3 t -127.2 101.08 7.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 170.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 85.5 m -79.32 112.77 16.88 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 166.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.417 ' HA ' ' HB3' ' A' ' 74' ' ' CYS . 26.4 p -73.58 161.59 30.16 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 165.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -55.97 -35.58 66.89 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.801 -0.562 . . . . 0.0 111.182 -175.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -68.88 -1.79 8.1 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.054 1.742 . . . . 0.0 113.456 -174.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.66 -14.11 57.78 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 125.802 1.668 . . . . 0.0 112.472 172.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 32.2 mttt -71.35 123.01 21.34 Favored 'General case' 0 CA--C 1.508 -0.669 0 CA-C-N 118.809 1.304 . . . . 0.0 109.729 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.449 ' HD2' ' H ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -85.82 147.4 26.32 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 168.291 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -132.12 105.88 7.64 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 170.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.821 HG13 ' HE3' ' A' ' 47' ' ' LYS . 70.9 t -74.94 117.4 19.09 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 172.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.631 ' CG1' HG13 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -108.99 141.09 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-N 118.852 0.751 . . . . 0.0 109.956 175.804 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -145.59 -175.62 4.8 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-O 122.114 0.959 . . . . 0.0 112.607 171.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.3 pttm -57.49 65.24 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 130.528 3.531 . . . . 0.0 112.8 177.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 156.64 2.12 0.1 OUTLIER Glycine 0 CA--C 1.531 1.091 0 CA-C-O 117.323 -1.821 . . . . 0.0 115.636 -158.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -129.33 110.39 11.89 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.899 2.079 . . . . 0.0 107.286 177.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 26.6 tp -74.82 143.13 44.08 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 120.154 -1.591 . . . . 0.0 107.407 167.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 32.9 t -133.49 128.84 55.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-N 119.422 1.01 . . . . 0.0 109.676 175.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.8 m -99.16 140.21 33.66 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 160.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -104.83 156.56 35.81 Favored Pre-proline 0 C--O 1.236 0.39 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 163.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -79.65 175.33 10.72 Favored 'Trans proline' 0 N--CA 1.445 -1.348 0 N-CA-C 108.773 -1.28 . . . . 0.0 108.773 174.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -81.81 94.04 6.97 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 166.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 114.46 85.73 1.35 Allowed Glycine 0 CA--C 1.527 0.816 0 C-N-CA 125.67 1.605 . . . . 0.0 111.789 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 56.9 tp -162.0 135.08 6.11 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 119.314 1.557 . . . . 0.0 110.301 170.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.68 85.69 2.41 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 120.11 1.323 . . . . 0.0 112.381 -174.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.417 ' HB3' ' HA ' ' A' ' 52' ' ' THR . 61.0 m -121.81 165.82 15.28 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 119.627 -1.921 . . . . 0.0 110.766 -173.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 32' ' ' ASP . 0.3 OUTLIER -69.6 163.07 26.32 Favored 'General case' 0 CA--C 1.515 -0.4 0 O-C-N 121.984 -0.447 . . . . 0.0 111.072 177.033 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.4 ' CZ3' HG21 ' A' ' 48' ' ' VAL . 4.8 m95 -138.07 102.12 4.6 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 126.041 1.736 . . . . 0.0 106.875 173.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.32 100.56 12.38 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 168.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 80' ' ' GLU . 1.9 t -80.24 92.91 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 103.404 -2.814 . . . . 0.0 103.404 172.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.626 HD12 ' HE2' ' A' ' 47' ' ' LYS . 82.5 mt -69.0 -29.11 67.24 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.171 178.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.647 ' O ' HG12 ' A' ' 78' ' ' VAL . 3.2 mt-10 -141.06 165.62 28.05 Favored Pre-proline 0 N--CA 1.452 -0.373 0 C-N-CA 125.292 1.437 . . . . 0.0 108.884 176.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -61.35 116.87 3.68 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 123.899 3.066 . . . . 0.0 110.786 169.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.9 p -110.41 143.36 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 -177.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -124.99 29.66 6.08 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 118.755 0.707 . . . . 0.0 112.83 -168.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.27 161.33 4.37 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.338 1.455 . . . . 0.0 113.28 -159.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 3.3 m80 -89.05 130.1 35.57 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 163.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -121.39 154.52 36.39 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 119.42 1.009 . . . . 0.0 108.707 172.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.419 ' HB2' ' CE3' ' A' ' 21' ' ' TRP . 57.1 t30 -143.98 116.69 8.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 176.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 17.9 mt -71.77 140.07 49.31 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 125.417 1.487 . . . . 0.0 107.092 172.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.248 0.982 0 CA-C-O 117.143 -1.408 . . . . 0.0 109.316 172.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.9 mmt . . . . . 0 N--CA 1.476 0.848 0 CA-C-O 120.793 0.33 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.433 ' HG2' ' H ' ' A' ' 3' ' ' VAL . 18.6 tt0 55.66 -164.89 0.13 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.567 1.547 . . . . 0.0 109.961 -174.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.433 ' H ' ' HG2' ' A' ' 2' ' ' GLU . 3.2 p -70.39 142.13 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 176.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -134.05 152.05 51.68 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.444 1.498 . . . . 0.0 108.009 172.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 93.6 mt -131.71 137.06 55.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 105.166 -2.161 . . . . 0.0 105.166 165.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -141.18 172.74 12.27 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 117.841 0.291 . . . . 0.0 110.982 160.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.22 84.94 6.34 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 171.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -76.01 176.55 9.88 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 123.883 3.056 . . . . 0.0 112.188 -169.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.442 HG22 ' H ' ' A' ' 9' ' ' THR . 0.0 OUTLIER -67.66 144.48 97.6 Favored Pre-proline 0 CA--C 1.539 0.524 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 170.302 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -70.27 -25.25 26.43 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.857 2.371 . . . . 0.0 111.887 172.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -75.32 -45.17 41.3 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 119.357 0.981 . . . . 0.0 110.362 -171.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -53.96 -44.14 70.49 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 118.912 0.778 . . . . 0.0 110.019 174.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 84.3 mt -62.24 -27.53 69.06 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 118.924 -0.56 . . . . 0.0 112.233 -178.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -63.21 -47.59 81.9 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 119.748 1.158 . . . . 0.0 109.106 172.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -68.0 -43.2 79.4 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 124.402 1.064 . . . . 0.0 110.088 -169.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 18.5 mt -53.36 -20.5 4.53 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.183 0.993 . . . . 0.0 112.016 174.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.8 m 69.85 45.7 0.73 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 127.496 2.318 . . . . 0.0 109.398 172.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.7 t -55.19 -32.67 28.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 126.105 1.762 . . . . 0.0 112.014 -175.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -65.6 -21.76 66.61 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.634 -1.291 . . . . 0.0 113.413 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.3 mttt -78.73 -15.13 58.83 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.019 0.928 . . . . 0.0 110.979 175.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 16.3 m0 -75.68 159.99 80.14 Favored Pre-proline 0 N--CA 1.445 -0.705 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 176.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -64.97 139.14 60.3 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 121.545 1.497 . . . . 0.0 111.777 175.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 57.7 mt -76.21 147.69 7.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 163.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.473 ' CZ3' ' HE3' ' A' ' 84' ' ' LYS . 9.0 t90 -147.39 149.59 33.04 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 164.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -133.36 166.31 22.8 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 127.262 2.225 . . . . 0.0 106.351 -177.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -148.98 163.85 36.3 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 120.572 -1.33 . . . . 0.0 108.803 163.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.74 -172.88 3.19 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 125.348 1.459 . . . . 0.0 109.916 -178.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.3 p -77.34 -5.09 7.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 125.772 1.629 . . . . 0.0 113.636 178.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.97 176.67 4.85 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.02 1.328 . . . . 0.0 110.886 176.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -137.45 157.34 46.77 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 121.141 -0.974 . . . . 0.0 109.324 -174.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -164.82 -164.3 0.79 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 125.118 1.367 . . . . 0.0 108.88 -168.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -133.12 160.91 35.83 Favored 'General case' 0 C--O 1.242 0.703 0 O-C-N 120.89 -1.131 . . . . 0.0 108.822 165.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 67.3 t-105 -135.74 146.73 47.98 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.746 0.818 . . . . 0.0 109.811 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.415 ' CE2' ' HD3' ' A' ' 73' ' ' ARG . 1.2 t80 -115.69 94.56 4.74 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.712 1.605 . . . . 0.0 107.059 -177.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -65.72 115.01 5.43 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 168.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -108.53 -1.0 20.05 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 124.408 1.083 . . . . 0.0 111.734 174.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.415 ' HA ' ' HG3' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -144.06 171.42 14.28 Favored 'General case' 0 CA--C 1.521 -0.148 0 C-N-CA 127.542 2.337 . . . . 0.0 112.331 174.871 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -62.95 108.88 1.3 Allowed 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 103.765 -2.68 . . . . 0.0 103.765 168.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -126.94 80.87 1.98 Allowed 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 -173.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 81.7 m -64.51 152.21 42.38 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 25.4 p -144.93 150.01 36.25 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.458 163.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -122.6 108.27 12.92 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 125.572 1.549 . . . . 0.0 106.839 175.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.3 mm -64.54 138.21 23.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 C-N-CA 127.217 2.207 . . . . 0.0 107.601 172.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.6 mp -128.05 -26.38 2.89 Favored 'General case' 0 N--CA 1.464 0.265 0 O-C-N 123.28 0.362 . . . . 0.0 111.188 173.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -153.46 158.15 40.94 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.634 1.174 . . . . 0.0 108.188 172.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.69 -178.93 52.38 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 124.321 0.962 . . . . 0.0 112.111 -175.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.79 146.1 27.87 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -168.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.3 t -137.31 156.57 33.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 CA-C-O 121.319 0.581 . . . . 0.0 109.773 175.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -119.39 110.51 17.03 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.612 1.965 . . . . 0.0 106.872 160.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.7 t -94.16 111.32 25.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 170.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.5 m -112.22 113.19 25.29 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -173.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.9 p -75.4 170.16 16.64 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 122.122 0.963 . . . . 0.0 111.931 -170.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -60.35 -29.9 69.2 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.342 167.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -82.26 8.98 9.71 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.688 1.595 . . . . 0.0 111.547 175.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.1 -2.06 21.25 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 125.55 1.548 . . . . 0.0 114.814 175.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -64.17 136.98 57.72 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.4 mttp -93.33 153.13 18.73 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 121.892 0.853 . . . . 0.0 110.089 162.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -125.73 100.62 6.5 Favored 'General case' 0 N--CA 1.437 -1.097 0 N-CA-C 102.801 -3.037 . . . . 0.0 102.801 162.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.0 t -81.24 142.73 13.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 167.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.2 pt -148.01 119.77 1.55 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.488 0 C-N-CA 124.314 1.046 . . . . 0.0 108.197 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -80.07 177.44 8.93 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-O 122.196 0.998 . . . . 0.0 110.918 171.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.1 pttt -68.01 45.5 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 131.366 3.866 . . . . 0.0 115.103 178.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -174.41 -7.06 0.02 OUTLIER Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.033 0.825 . . . . 0.0 113.417 178.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -79.16 99.87 7.18 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.102 1.361 . . . . 0.0 111.337 -173.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.3 tp -64.36 136.84 57.52 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.95 1.25 . . . . 0.0 107.636 177.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.1 t -121.32 154.68 25.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 123.865 0.866 . . . . 0.0 108.952 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 67.0 m -143.65 121.36 11.87 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 160.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -87.78 164.58 33.75 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 126.483 1.913 . . . . 0.0 108.879 169.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -79.68 174.8 11.3 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 CA-C-O 122.974 1.156 . . . . 0.0 110.469 170.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.415 ' HG3' ' HA ' ' A' ' 37' ' ' THR . 36.0 tttm -80.18 88.73 5.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.446 -1.707 . . . . 0.0 106.887 173.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 116.66 85.1 1.13 Allowed Glycine 0 CA--C 1.527 0.797 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -176.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 62.1 tp -147.2 141.06 25.8 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.198 1.399 . . . . 0.0 108.848 166.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.415 ' HD3' ' CE2' ' A' ' 34' ' ' TYR . 3.5 ptt85 -136.93 103.89 5.3 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.417 1.487 . . . . 0.0 108.453 -176.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 86.0 m -148.61 164.42 34.34 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 125.264 1.426 . . . . 0.0 110.103 -175.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.58 163.01 22.18 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 124.452 1.101 . . . . 0.0 112.035 177.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -148.2 99.59 3.07 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.575 1.95 . . . . 0.0 107.372 -168.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 42.7 tttp -110.96 111.8 23.18 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 -176.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.1 t -87.34 111.68 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 104.264 -2.495 . . . . 0.0 104.264 -177.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 20.6 mt -91.1 -24.04 20.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 118.782 -0.628 . . . . 0.0 109.836 177.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -148.75 152.36 37.31 Favored Pre-proline 0 C--O 1.236 0.384 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 168.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.41 91.69 0.77 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.377 2.718 . . . . 0.0 111.514 -153.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.8 p -69.51 105.82 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.017 -165.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 13.9 ttt180 -91.08 116.63 28.95 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 105.215 -2.142 . . . . 0.0 105.215 168.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.473 ' HE3' ' CZ3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -127.58 172.06 11.07 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 122.306 1.051 . . . . 0.0 108.382 175.277 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -113.22 122.77 48.47 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 102.578 -3.119 . . . . 0.0 102.578 168.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -117.89 157.03 27.4 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -152.4 134.83 15.19 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 118.71 0.686 . . . . 0.0 110.024 176.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 65.8 mt -94.45 125.48 39.13 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.401 1.88 . . . . 0.0 107.149 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.4 p90 . . . . . 0 C--O 1.247 0.968 0 C-N-CA 123.96 0.904 . . . . 0.0 110.361 -171.509 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.7 mtp . . . . . 0 N--CA 1.47 0.526 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -83.07 146.83 28.48 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.27 -0.893 . . . . 0.0 110.474 164.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 94.2 t 53.04 106.77 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 130.872 3.669 . . . . 0.0 112.633 173.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -100.05 119.49 38.38 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 123.965 0.906 . . . . 0.0 109.148 -173.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.3 mt -139.81 132.47 35.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 C-N-CA 124.792 1.237 . . . . 0.0 108.022 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -143.97 176.66 9.11 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.483 1.513 . . . . 0.0 110.271 171.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.76 85.77 5.2 Favored Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 124.562 1.145 . . . . 0.0 108.151 173.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.09 157.64 60.92 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.442 2.095 . . . . 0.0 111.881 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.9 t -57.42 144.3 71.83 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 124.508 1.123 . . . . 0.0 109.19 169.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.58 -31.21 27.22 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.538 1.492 . . . . 0.0 112.735 -177.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -59.84 -42.72 94.21 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 119.407 1.003 . . . . 0.0 110.729 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.1 tptt -56.49 -41.37 76.53 Favored 'General case' 0 C--O 1.226 -0.167 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -69.9 -32.07 70.19 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.872 1.269 . . . . 0.0 111.511 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -61.46 -49.11 78.12 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 168.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -62.73 -47.99 81.19 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.373 0.533 . . . . 0.0 111.047 -176.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.7 mt -58.78 -7.34 0.97 Allowed 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 125.955 1.702 . . . . 0.0 112.662 -175.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.7 m 74.03 29.22 1.4 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.17 1.788 . . . . 0.0 110.402 165.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.9 t -57.01 -27.45 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 126.371 1.868 . . . . 0.0 112.499 -172.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -59.45 -28.41 66.94 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 119.828 1.194 . . . . 0.0 113.015 172.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.6 mttm -84.69 -13.21 52.09 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.632 1.173 . . . . 0.0 111.066 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.502 ' CE3' ' HB2' ' A' ' 87' ' ' ASN . 36.5 m0 -74.8 158.9 84.2 Favored Pre-proline 0 N--CA 1.448 -0.527 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -175.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.58 136.79 43.97 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 121.531 1.487 . . . . 0.0 111.44 175.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.1 mt -72.22 149.96 8.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 C-N-CA 125.197 1.399 . . . . 0.0 109.332 166.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.432 ' CZ3' ' HE3' ' A' ' 84' ' ' LYS . 87.7 t90 -142.23 112.23 6.92 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 160.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.14 168.4 12.8 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.975 1.31 . . . . 0.0 110.576 164.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.3 tptt -155.94 162.45 40.38 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 120.647 -1.283 . . . . 0.0 109.841 165.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.27 170.59 15.27 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.204 1.001 . . . . 0.0 111.27 172.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.9 p -81.16 71.18 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 127.205 2.202 . . . . 0.0 109.463 175.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -133.91 -171.14 2.66 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 120.972 -1.08 . . . . 0.0 109.708 -177.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -130.89 154.14 48.39 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 121.003 -1.06 . . . . 0.0 108.845 170.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -160.6 -167.67 1.93 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 124.718 1.207 . . . . 0.0 108.511 173.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 4.6 p-10 -121.1 152.52 38.59 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 125.012 1.325 . . . . 0.0 107.896 169.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 25.7 t-105 -136.26 151.97 50.22 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.557 0.218 . . . . 0.0 111.002 178.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.435 ' CD2' ' HB3' ' A' ' 73' ' ' ARG . 1.4 t80 -124.78 129.63 50.83 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.632 1.573 . . . . 0.0 106.844 -175.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -111.29 112.39 24.13 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 175.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.39 2.8 19.23 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 125.148 1.379 . . . . 0.0 112.723 -176.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.8 p -145.9 171.17 15.21 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 130.556 3.543 . . . . 0.0 107.856 166.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -63.36 149.82 44.89 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -146.48 115.2 6.83 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 167.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.0 m -88.52 141.95 28.11 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 167.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.495 ' SG ' ' HB2' ' A' ' 84' ' ' LYS . 0.7 OUTLIER -149.97 150.18 31.45 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.032 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -125.36 112.07 15.9 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.473 1.509 . . . . 0.0 108.36 -177.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 8.5 mm -69.77 120.01 16.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 128.593 2.757 . . . . 0.0 107.601 174.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 mp -110.36 -24.77 10.45 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 178.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -160.14 157.32 28.22 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 125.898 1.679 . . . . 0.0 107.913 177.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 82' ' ' VAL . . . 82.55 177.9 52.13 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.597 2.046 . . . . 0.0 112.699 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.78 143.09 33.28 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.795 -0.827 . . . . 0.0 109.18 -167.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 86.9 t -138.12 156.46 30.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -124.52 118.23 26.13 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 160.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 39.5 t -94.01 106.8 18.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 169.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.4 m -93.04 105.95 17.98 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.439 ' HA ' ' SG ' ' A' ' 74' ' ' CYS . 18.0 p -69.33 168.6 13.97 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 121.792 -0.567 . . . . 0.0 110.542 -178.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -63.95 -32.8 74.46 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 170.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -68.59 -6.7 27.12 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 121.014 -1.054 . . . . 0.0 109.911 171.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.91 -3.36 70.45 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 125.943 1.735 . . . . 0.0 112.7 170.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.1 tttp -70.02 135.02 48.89 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-N 120.196 1.998 . . . . 0.0 107.964 -176.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.82 105.11 17.17 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.489 -1.232 . . . . 0.0 108.512 174.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -79.56 107.88 12.68 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 164.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.3 t -77.21 147.19 7.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 104.974 -2.232 . . . . 0.0 104.974 161.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 pt -148.59 121.78 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 C-N-CA 124.661 1.184 . . . . 0.0 108.499 173.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -101.75 175.4 5.56 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 122.469 1.128 . . . . 0.0 109.764 172.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.5 pttp -64.51 54.58 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 131.237 3.815 . . . . 0.0 116.363 -171.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -178.65 -16.15 0.03 OUTLIER Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.181 1.372 . . . . 0.0 113.42 176.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -77.76 103.63 7.81 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 118.8 1.3 . . . . 0.0 109.1 -177.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.3 tp -71.35 143.93 50.06 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 120.132 1.333 . . . . 0.0 108.319 179.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 45.1 t -124.14 154.87 31.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 125.074 1.35 . . . . 0.0 108.69 -174.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.9 m -146.09 103.18 3.71 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 124.626 1.17 . . . . 0.0 108.196 170.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -74.43 155.13 87.79 Favored Pre-proline 0 C--O 1.235 0.317 0 O-C-N 121.489 -0.757 . . . . 0.0 109.581 171.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -86.87 177.4 4.1 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.715 2.277 . . . . 0.0 110.699 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -81.26 90.6 6.12 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 164.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 110.25 90.33 2.03 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 125.415 1.483 . . . . 0.0 110.699 178.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 67.2 tp -156.02 152.56 28.26 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.721 2.008 . . . . 0.0 108.936 162.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.435 ' HB3' ' CD2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -137.36 126.07 23.88 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 119.215 0.916 . . . . 0.0 109.76 165.046 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.439 ' SG ' ' HA ' ' A' ' 52' ' ' THR . 84.1 m -145.49 170.01 17.23 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.127 1.771 . . . . 0.0 109.268 -178.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.418 ' HA ' ' HA ' ' A' ' 32' ' ' ASP . 0.6 OUTLIER -77.56 159.93 28.94 Favored 'General case' 0 N--CA 1.464 0.26 0 O-C-N 121.352 -0.842 . . . . 0.0 110.18 177.373 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -134.23 102.69 5.46 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.825 1.65 . . . . 0.0 107.68 177.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -100.78 112.27 24.65 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 174.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.0 t -84.68 106.63 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 173.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 95.6 mt -85.05 -26.03 27.26 Favored 'General case' 0 C--O 1.224 -0.274 0 CA-C-O 118.878 -0.582 . . . . 0.0 109.743 175.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -147.69 149.35 33.41 Favored Pre-proline 0 N--CA 1.464 0.262 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 174.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -64.55 95.26 0.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 123.594 2.863 . . . . 0.0 110.673 -169.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.41 ' HA ' ' HA3' ' A' ' 46' ' ' GLY . 4.5 p -71.28 149.88 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.75 -174.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -126.98 112.25 15.04 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 104.232 -2.507 . . . . 0.0 104.232 164.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.495 ' HB2' ' SG ' ' A' ' 41' ' ' CYS . 0.0 OUTLIER -127.91 121.19 29.35 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.244 0.545 . . . . 0.0 110.651 176.725 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -69.32 111.08 4.99 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -101.3 163.74 12.12 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 121.013 1.733 . . . . 0.0 110.892 -176.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.502 ' HB2' ' CE3' ' A' ' 21' ' ' TRP . 44.2 t30 -153.74 115.51 4.25 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 123.862 0.865 . . . . 0.0 109.839 171.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 52.1 mt -66.47 145.63 55.45 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.922 1.289 . . . . 0.0 109.172 173.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 1.3 p90 . . . . . 0 C--O 1.251 1.143 0 C-N-CA 125.767 1.627 . . . . 0.0 107.852 172.276 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.7 tpp . . . . . 0 N--CA 1.468 0.426 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -81.17 151.34 28.27 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 120.99 -1.069 . . . . 0.0 109.381 -178.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.7 t 44.36 78.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 127.374 2.27 . . . . 0.0 112.098 164.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 51.0 tttt -73.32 101.58 3.47 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.056 -0.974 . . . . 0.0 108.858 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 60.5 mt -103.22 112.67 37.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 104.605 -2.369 . . . . 0.0 104.605 174.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -142.38 178.64 7.44 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 122.829 0.451 . . . . 0.0 111.903 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -125.08 85.05 58.48 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 123.135 0.574 . . . . 0.0 111.387 -165.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.24 153.7 18.7 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 123.264 2.643 . . . . 0.0 112.998 -173.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.2 t -57.07 144.28 69.59 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 124.417 1.087 . . . . 0.0 109.752 170.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -71.39 -26.26 20.65 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 121.487 1.458 . . . . 0.0 113.003 -176.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -65.81 -42.86 90.14 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.17 0.895 . . . . 0.0 110.102 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.6 tptt -53.57 -45.56 69.97 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 123.461 0.705 . . . . 0.0 109.6 176.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.05 -31.98 73.25 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 121.729 -0.607 . . . . 0.0 111.341 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.56 -50.21 68.15 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 172.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -57.89 -50.78 72.17 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.661 1.184 . . . . 0.0 111.822 -176.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 55.4 mt -56.82 -8.96 0.68 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.29 1.836 . . . . 0.0 112.823 -177.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.5 m 75.21 27.51 1.1 Allowed 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 128.124 2.57 . . . . 0.0 111.276 167.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 52.9 t -54.21 -28.61 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 128.48 2.712 . . . . 0.0 112.583 177.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.97 -29.31 70.71 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 120.239 1.382 . . . . 0.0 112.49 173.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.4 mtpp -82.51 -15.56 51.95 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.246 1.018 . . . . 0.0 112.205 176.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 38.2 m0 -69.32 165.17 42.25 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 119.169 0.895 . . . . 0.0 109.272 -173.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -67.39 141.73 57.3 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 121.464 1.443 . . . . 0.0 112.066 174.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.1 mt -88.56 142.97 12.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 125.909 1.683 . . . . 0.0 106.839 169.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.472 ' CE3' ' HE2' ' A' ' 84' ' ' LYS . 44.1 t90 -148.75 133.01 17.42 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 165.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.78 174.59 7.41 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 126.051 1.74 . . . . 0.0 107.677 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -154.21 161.77 41.62 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 173.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -73.68 170.53 15.06 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.625 0.726 . . . . 0.0 111.315 169.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -80.88 74.0 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 125.136 1.375 . . . . 0.0 108.571 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.0 t -141.23 -170.71 3.13 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.417 1.887 . . . . 0.0 107.824 -176.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.94 149.7 31.64 Favored 'General case' 0 CA--C 1.518 -0.263 0 O-C-N 120.386 -1.446 . . . . 0.0 111.733 -173.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -163.23 -164.76 0.98 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.248 1.819 . . . . 0.0 107.214 -171.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -130.02 161.79 30.16 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 121.095 -1.003 . . . . 0.0 109.184 170.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 12.6 t-105 -131.87 158.43 41.36 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 120.965 0.412 . . . . 0.0 110.471 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -132.73 96.24 3.77 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 176.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -72.05 123.27 22.45 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 176.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.38 1.02 6.32 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -171.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 p -140.87 174.42 10.53 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 127.553 2.341 . . . . 0.0 108.401 163.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -67.78 136.85 54.84 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -142.61 102.53 4.07 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -177.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 54.7 m -84.84 140.44 31.17 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 169.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 14.4 p -144.94 162.6 36.49 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 118.503 0.592 . . . . 0.0 111.577 162.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -124.64 111.85 16.1 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 126.058 1.743 . . . . 0.0 107.998 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 25.6 mm -72.8 111.97 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 128.798 2.839 . . . . 0.0 107.757 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 32.8 mt -92.01 -37.49 12.79 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 122.478 0.311 . . . . 0.0 111.235 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -162.44 165.22 26.56 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.631 0.772 . . . . 0.0 108.988 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.447 ' HA3' ' HA ' ' A' ' 82' ' ' VAL . . . 89.88 -176.57 42.67 Favored Glycine 0 C--N 1.334 0.463 0 C-N-CA 124.246 0.927 . . . . 0.0 111.232 -177.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.495 ' HE2' HD12 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -147.48 147.35 30.08 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 117.538 0.669 . . . . 0.0 110.415 -179.424 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 74.6 t -139.64 156.34 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 -178.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -124.37 133.7 53.34 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 122.589 1.185 . . . . 0.0 108.491 158.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.539 HG23 ' HB2' ' A' ' 58' ' ' TYR 0.627 0.1 OUTLIER -108.61 80.53 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.204 1 C-N-CA 133.629 4.771 . . . . 0.0 117.001 165.81 . . . . . . . . 5 4 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 82.9 m -71.04 122.7 20.53 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.078 162.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 74.9 p -82.52 -173.81 4.82 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.377 1.071 . . . . 0.0 111.811 174.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -62.77 -37.83 88.2 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.077 0.551 . . . . 0.0 110.255 170.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -63.59 -27.09 69.0 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.034 0.933 . . . . 0.0 111.677 177.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 103.86 -10.86 52.61 Favored Glycine 0 CA--C 1.524 0.64 0 CA-C-O 118.965 -0.908 . . . . 0.0 113.43 175.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.7 mttm -61.55 129.17 39.81 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 118.422 1.111 . . . . 0.0 108.78 173.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.38 103.84 16.48 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.186 0.994 . . . . 0.0 108.795 177.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.539 ' HB2' HG23 ' A' ' 50' ' ' VAL . 10.2 m-30 -68.29 100.05 1.0 Allowed 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 167.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.7 t -81.68 137.82 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 104.603 -2.369 . . . . 0.0 104.603 165.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.8 pt -140.4 90.75 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -85.86 170.33 12.48 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.71 1.604 . . . . 0.0 110.729 172.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.1 pttm -60.57 111.29 1.54 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.748 1.219 . . . . 0.0 111.152 -176.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 121.5 -23.13 7.63 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 125.858 1.694 . . . . 0.0 113.208 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.24 100.88 3.83 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.26 1.53 . . . . 0.0 108.096 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 11.3 tp -71.61 145.54 48.93 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.8 t -129.85 138.73 53.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 C-N-CA 125.733 1.613 . . . . 0.0 107.46 -171.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 98.5 m -130.38 100.06 5.23 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 162.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -70.68 146.8 94.04 Favored Pre-proline 0 C--O 1.238 0.486 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 165.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -82.54 175.69 8.61 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 122.097 1.864 . . . . 0.0 110.901 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -76.7 90.64 3.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 113.326 -1.761 . . . . 0.0 107.289 171.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 110.92 93.17 2.18 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 42.7 tp -153.16 142.26 21.37 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.874 1.67 . . . . 0.0 109.517 168.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 -115.96 133.53 55.93 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 126.821 2.049 . . . . 0.0 108.382 168.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 12.8 p -162.03 175.52 11.69 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.656 1.582 . . . . 0.0 108.365 169.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.56 -175.43 1.05 Allowed 'General case' 0 C--O 1.212 -0.869 0 CA-C-O 117.777 -1.106 . . . . 0.0 113.075 167.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -154.91 105.72 2.59 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.273 2.229 . . . . 0.0 105.65 163.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 60.0 tttt -103.83 116.77 32.89 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 176.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.0 t -83.84 106.87 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 174.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.495 HD12 ' HE2' ' A' ' 47' ' ' LYS . 81.9 mt -83.75 -20.95 32.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.042 178.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -158.49 152.05 19.21 Favored Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 126.994 2.118 . . . . 0.0 108.238 169.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -63.35 102.57 0.34 Allowed 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.715 2.944 . . . . 0.0 110.846 -168.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.447 ' HA ' ' HA3' ' A' ' 46' ' ' GLY . 7.1 p -83.38 144.74 9.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 123.699 0.8 . . . . 0.0 110.616 -173.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -116.75 131.88 56.84 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 163.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.472 ' HE2' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -134.62 150.01 50.63 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 173.483 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -96.24 114.02 25.67 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 105.844 -1.909 . . . . 0.0 105.844 165.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -106.87 166.6 10.48 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 119.612 1.096 . . . . 0.0 111.089 -176.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -151.54 130.76 12.75 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 118.694 0.679 . . . . 0.0 110.453 165.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 26.2 mt -85.99 136.44 33.26 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 126.797 2.039 . . . . 0.0 109.177 176.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.8 p90 . . . . . 0 C--O 1.248 1.02 0 C-N-CA 125.368 1.467 . . . . 0.0 111.172 179.439 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.8 mtm . . . . . 0 N--CA 1.469 0.506 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.495 ' HG2' ' H ' ' A' ' 3' ' ' VAL . 15.1 tt0 52.84 -164.88 0.08 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.481 1.112 . . . . 0.0 109.834 -166.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.495 ' H ' ' HG2' ' A' ' 2' ' ' GLU . 82.7 t -102.43 158.08 4.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 126.496 1.919 . . . . 0.0 106.34 169.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -125.73 140.15 52.93 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 171.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.2 mt -137.52 146.5 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 175.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -154.57 -175.07 5.23 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 123.934 0.893 . . . . 0.0 109.861 160.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -118.96 80.75 18.58 Favored Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 169.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -67.7 172.12 11.03 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.896 2.397 . . . . 0.0 110.994 -177.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.414 HG23 ' H ' ' A' ' 12' ' ' LYS . 4.4 t -60.03 144.29 86.84 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 120.034 -0.666 . . . . 0.0 109.469 166.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.78 -20.18 46.26 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.149 1.899 . . . . 0.0 111.296 168.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -60.24 -50.38 73.89 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 119.772 1.169 . . . . 0.0 109.944 -177.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.414 ' H ' HG23 ' A' ' 9' ' ' THR . 47.8 tptt -55.73 -43.71 76.83 Favored 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 123.271 0.628 . . . . 0.0 109.762 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 70.6 mt -70.28 -33.66 71.83 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.732 1.213 . . . . 0.0 110.707 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -61.38 -32.3 72.22 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 120.429 -1.42 . . . . 0.0 110.92 168.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -73.75 -55.77 5.82 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 121.012 1.733 . . . . 0.0 109.722 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.1 tp -44.13 -66.25 0.41 Allowed 'General case' 0 CA--C 1.516 -0.336 0 C-N-CA 126.512 1.925 . . . . 0.0 112.682 -152.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.1 p 173.34 27.66 0.0 OUTLIER 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 129.521 3.128 . . . . 0.0 109.784 150.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.1 t -59.92 -30.71 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 O-C-N 120.659 -1.275 . . . . 0.0 113.074 -160.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -60.01 -25.19 65.08 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 120.866 -1.146 . . . . 0.0 112.762 172.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.5 mttt -88.81 -31.4 18.35 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.498 1.519 . . . . 0.0 111.882 177.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.4 ' CD2' ' HB2' ' A' ' 87' ' ' ASN . 41.0 m0 -55.53 156.84 8.01 Favored Pre-proline 0 C--O 1.236 0.364 0 C-N-CA 124.021 0.928 . . . . 0.0 110.269 -175.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.91 138.59 40.96 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.465 1.443 . . . . 0.0 111.72 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.8 mt -71.48 150.96 8.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 164.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -137.35 134.86 36.48 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 159.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -141.15 120.71 13.27 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 126.374 1.87 . . . . 0.0 109.468 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.4 mmtt -109.49 152.28 25.63 Favored 'General case' 0 CA--C 1.509 -0.624 0 C-N-CA 123.733 0.813 . . . . 0.0 109.794 -178.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.5 pm0 -66.02 163.62 16.95 Favored 'General case' 0 N--CA 1.441 -0.876 0 O-C-N 124.915 1.385 . . . . 0.0 111.152 166.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.5 p -73.25 17.05 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 127.898 2.479 . . . . 0.0 113.966 -172.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.9 t -83.64 -171.27 3.49 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.89 1.276 . . . . 0.0 109.48 177.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -136.87 154.17 50.57 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 121.099 -1.0 . . . . 0.0 110.701 175.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -162.38 -164.45 1.04 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.826 1.651 . . . . 0.0 108.523 -172.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -135.28 154.91 51.39 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 126.068 1.747 . . . . 0.0 109.753 168.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 58.0 t-105 -138.16 127.58 24.72 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.059 0.544 . . . . 0.0 111.797 -174.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -80.95 130.48 35.04 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.421 1.089 . . . . 0.0 108.354 169.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -108.84 107.74 18.27 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 125.137 1.375 . . . . 0.0 107.312 166.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -114.08 21.2 15.02 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 123.812 0.845 . . . . 0.0 112.974 -179.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.41 167.0 31.48 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 127.445 2.298 . . . . 0.0 108.001 166.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -66.81 127.0 30.8 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -177.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.3 tt0 -136.71 99.71 4.13 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -177.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 85.2 m -70.88 141.79 51.2 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 166.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.1 p -150.57 133.61 16.09 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 121.438 -0.788 . . . . 0.0 110.841 172.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -111.55 104.87 13.3 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 126.585 1.954 . . . . 0.0 109.362 -171.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 22.7 mm -76.65 114.92 17.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -175.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.79 -27.19 13.48 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 118.724 -0.655 . . . . 0.0 112.54 -178.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -158.84 153.01 23.76 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 119.492 1.042 . . . . 0.0 108.907 -178.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.64 -171.01 39.13 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.634 1.111 . . . . 0.0 113.035 -176.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.18 146.44 35.25 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.994 1.717 . . . . 0.0 108.171 -177.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.3 t -141.77 147.18 22.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -124.01 122.66 38.5 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 127.754 2.422 . . . . 0.0 107.175 167.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.6 t -110.76 117.24 54.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 46.3 m -111.02 120.55 42.74 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.484 ' HA ' ' SG ' ' A' ' 74' ' ' CYS . 27.2 p -73.43 162.36 29.39 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.517 0.675 . . . . 0.0 110.692 -179.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.83 -30.73 71.4 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.693 -0.63 . . . . 0.0 109.314 172.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -63.34 -15.65 58.0 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 127.342 2.257 . . . . 0.0 112.663 168.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 103.78 -12.25 53.33 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 125.235 1.398 . . . . 0.0 113.763 172.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -60.39 112.45 1.96 Allowed 'General case' 0 C--O 1.233 0.227 0 CA-C-N 118.762 1.281 . . . . 0.0 108.45 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.2 mppt? -70.12 153.64 42.9 Favored 'General case' 0 C--O 1.231 0.087 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 164.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -135.27 160.91 36.9 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 126.031 1.732 . . . . 0.0 106.724 159.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 88.7 t -123.06 150.22 26.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 170.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.5 pt -142.02 126.36 16.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 164.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -94.97 175.53 6.61 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.215 1.006 . . . . 0.0 109.241 173.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.0 pttm -62.4 68.54 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.664 1.985 . . . . 0.0 111.936 166.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 165.81 -9.44 0.07 OUTLIER Glycine 0 C--N 1.315 -0.618 0 CA-C-O 118.083 -1.399 . . . . 0.0 113.463 178.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -80.19 136.16 36.43 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 119.795 1.798 . . . . 0.0 106.545 167.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.7 tp -104.65 139.23 39.79 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 105.28 -2.118 . . . . 0.0 105.28 161.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 42.8 t -118.26 157.42 19.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 -177.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.7 m -138.14 101.62 4.46 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 168.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -72.8 153.35 91.26 Favored Pre-proline 0 C--O 1.241 0.637 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 173.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -84.06 173.26 9.15 Favored 'Trans proline' 0 N--CA 1.447 -1.226 0 C-N-CA 122.137 1.891 . . . . 0.0 110.682 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -80.63 90.42 5.75 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 164.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 118.24 78.32 0.62 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 123.812 0.72 . . . . 0.0 113.074 174.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 31.8 tp -147.49 154.77 41.18 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.97 1.308 . . . . 0.0 108.9 169.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.6 ptt85 -144.02 101.27 3.7 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 125.103 1.361 . . . . 0.0 107.664 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . 0.484 ' SG ' ' HA ' ' A' ' 52' ' ' THR . 73.7 m -145.21 161.97 38.25 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.801 0.84 . . . . 0.0 110.777 -170.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.2 152.36 38.39 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 122.846 0.458 . . . . 0.0 111.321 -173.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.8 m95 -127.89 97.1 4.69 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.732 2.013 . . . . 0.0 107.699 174.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.5 tptt -76.07 146.01 39.69 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 104.624 -2.361 . . . . 0.0 104.624 161.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.7 t -122.38 94.07 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 168.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.8 mt -67.08 -32.29 73.36 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 118.148 -0.93 . . . . 0.0 110.902 -177.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -134.64 144.78 52.22 Favored Pre-proline 0 N--CA 1.454 -0.232 0 CA-C-O 117.625 -1.178 . . . . 0.0 109.5 175.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -61.14 95.36 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.938 3.092 . . . . 0.0 109.872 -177.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.9 p -81.77 159.6 3.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 125.112 1.365 . . . . 0.0 110.049 -167.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.1 ttt85 -129.69 134.37 47.61 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 164.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.44 151.73 42.06 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 169.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -83.95 125.12 31.72 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 160.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -112.26 157.26 21.14 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 173.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.4 ' HB2' ' CD2' ' A' ' 21' ' ' TRP . 49.5 t30 -151.28 114.43 4.77 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 171.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 55.8 mt -65.96 143.65 57.26 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.192 1.397 . . . . 0.0 107.694 166.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 36.6 p90 . . . . . 0 C--O 1.255 1.359 0 CA-C-O 115.939 -1.981 . . . . 0.0 112.08 174.354 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 mtp . . . . . 0 N--CA 1.471 0.62 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -146.67 168.53 21.09 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.192 -0.942 . . . . 0.0 108.867 -174.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 p -73.53 125.63 32.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 124.489 1.115 . . . . 0.0 110.751 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -98.2 140.04 33.1 Favored 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 160.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.2 mt -126.28 142.54 42.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 168.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -155.35 177.45 11.34 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.473 ' HE2' ' OD2' ' A' ' 64' ' ' ASP . 3.6 mmtp -120.6 82.72 33.84 Favored Pre-proline 0 C--N 1.346 0.428 0 C-N-CA 124.894 1.278 . . . . 0.0 110.8 -177.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.584 ' HG2' HD21 ' A' ' 13' ' ' LEU . 71.9 Cg_endo -78.21 169.63 19.93 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 123.639 2.893 . . . . 0.0 111.603 -178.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.6 p -77.07 150.23 80.61 Favored Pre-proline 0 C--O 1.235 0.329 0 O-C-N 121.947 -0.471 . . . . 0.0 109.97 178.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -64.62 -32.36 58.25 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 121.661 1.574 . . . . 0.0 111.387 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -57.43 -53.12 61.79 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.766 0.826 . . . . 0.0 110.509 176.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 9.0 tptt -55.0 -40.08 69.73 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.102 0.561 . . . . 0.0 110.177 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.584 HD21 ' HG2' ' A' ' 8' ' ' PRO . 4.1 mm? -65.33 -36.54 84.36 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 123.468 0.707 . . . . 0.0 111.173 -178.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -62.8 -48.16 80.32 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 121.177 -0.952 . . . . 0.0 109.361 171.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -61.45 -40.74 95.59 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.658 0.783 . . . . 0.0 112.364 -174.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 mp -55.46 -14.41 1.97 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.95 1.7 . . . . 0.0 113.133 175.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.4 m 57.97 40.37 25.67 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.302 1.841 . . . . 0.0 110.544 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.7 t -54.56 -31.33 23.22 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.257 0 C-N-CA 127.517 2.327 . . . . 0.0 111.024 174.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -56.92 -17.17 8.59 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 170.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -102.62 -5.76 23.51 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.097 1.759 . . . . 0.0 111.46 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.484 ' CE3' ' HB2' ' A' ' 87' ' ' ASN . 31.0 m0 -77.71 165.22 52.78 Favored Pre-proline 0 C--O 1.24 0.582 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 178.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.11 140.72 42.01 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 121.654 1.569 . . . . 0.0 111.151 171.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.0 mt -81.58 151.55 4.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 165.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.635 ' CE3' ' HE3' ' A' ' 84' ' ' LYS . 7.1 t90 -136.77 141.71 42.98 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 156.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.76 153.0 48.64 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 128.207 2.603 . . . . 0.0 108.917 174.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.523 ' HB2' ' CH2' ' A' ' 24' ' ' TRP . 1.7 tttt -153.25 165.14 36.64 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.316 -0.865 . . . . 0.0 109.876 172.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.69 176.78 4.57 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 126.135 1.774 . . . . 0.0 110.245 171.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.6 t -83.77 49.6 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 129.984 3.313 . . . . 0.0 109.088 -169.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.0 t -105.57 -169.07 1.54 Allowed 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 127.302 2.241 . . . . 0.0 109.706 -165.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.07 135.47 19.35 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 120.723 -1.235 . . . . 0.0 108.877 177.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -153.57 -164.94 2.01 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.361 1.064 . . . . 0.0 109.268 -176.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -137.65 152.1 48.97 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.86 1.264 . . . . 0.0 109.663 173.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 15.5 t-105 -128.46 135.2 49.14 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 125.137 1.375 . . . . 0.0 109.615 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -106.99 109.71 21.67 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 171.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -79.58 123.02 27.22 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 171.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -124.81 5.49 8.09 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.692 0.797 . . . . 0.0 111.446 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.94 177.09 9.64 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 126.806 2.042 . . . . 0.0 108.678 165.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -65.15 137.69 57.8 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 178.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -143.94 100.62 3.6 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -174.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 85.6 m -75.67 144.35 41.67 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 116.19 -1.862 . . . . 0.0 106.521 172.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 7.5 p -133.31 162.75 30.96 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 114.269 -2.973 . . . . 0.0 111.039 145.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -125.69 109.43 12.59 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 170.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.8 mm -73.82 131.28 35.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.42 -21.24 8.13 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.317 0.962 . . . . 0.0 112.964 -177.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -154.47 160.65 41.72 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 165.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.18 -174.0 24.74 Favored Glycine 0 N--CA 1.465 0.591 0 C-N-CA 124.11 0.862 . . . . 0.0 113.623 174.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.568 ' HE2' HG13 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -145.39 141.95 28.91 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.242 0.544 . . . . 0.0 109.717 173.54 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.526 ' C ' ' HZ3' ' A' ' 47' ' ' LYS . 3.3 t -127.77 136.27 60.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 176.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -99.66 131.62 45.53 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 157.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 94.1 t -114.02 140.78 32.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 171.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.8 m -136.89 108.34 6.9 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -175.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 49.7 p -77.42 177.26 8.13 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.707 -0.621 . . . . 0.0 109.486 -179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.4 tt0 -72.56 -25.72 61.46 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 120.613 -1.304 . . . . 0.0 110.838 -174.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.18 -27.72 65.96 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.109 0.964 . . . . 0.0 111.981 169.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.68 8.79 69.64 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-O 118.648 -1.084 . . . . 0.0 113.357 -177.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp -52.45 117.98 3.25 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 156.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -74.5 153.4 39.13 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 158.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -136.91 150.59 48.31 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 170.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.568 HG13 ' HE2' ' A' ' 47' ' ' LYS . 63.0 t -127.1 141.08 47.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 176.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.8 pt -135.52 120.87 29.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 170.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.49 175.23 9.44 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 124.723 1.209 . . . . 0.0 109.231 169.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -64.13 43.31 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 130.557 3.543 . . . . 0.0 114.905 175.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -179.48 -0.67 0.02 OUTLIER Glycine 0 CA--C 1.525 0.659 0 C-N-CA 124.943 1.258 . . . . 0.0 112.697 -176.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.473 ' OD2' ' HE2' ' A' ' 7' ' ' LYS . 1.3 m-20 -72.54 114.06 10.26 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 166.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.2 tp -74.33 160.78 30.61 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 152.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.526 HG21 ' CE1' ' A' ' 68' ' ' PHE . 1.2 p -160.16 149.36 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 C-N-CA 126.958 2.103 . . . . 0.0 109.716 -175.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 84.2 m -136.63 97.56 3.58 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 173.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.526 ' CE1' HG21 ' A' ' 66' ' ' VAL . 91.0 m-85 -70.79 145.9 92.66 Favored Pre-proline 0 C--O 1.239 0.512 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 163.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -86.21 174.56 6.1 Favored 'Trans proline' 0 N--CA 1.443 -1.459 0 C-N-CA 121.685 1.59 . . . . 0.0 110.777 -174.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.2 tttm -71.08 96.79 1.38 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 113.214 -1.812 . . . . 0.0 106.838 165.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 102.42 88.64 2.05 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 126.307 1.908 . . . . 0.0 111.485 177.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.9 tt -148.8 139.41 22.68 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 126.861 2.064 . . . . 0.0 107.804 167.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.1 ttp180 -126.21 108.45 11.31 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.643 1.177 . . . . 0.0 108.156 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 24.6 p -145.85 168.81 19.89 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -175.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.44 162.12 21.09 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 123.478 0.711 . . . . 0.0 111.847 170.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -144.54 97.9 3.11 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 126.98 2.112 . . . . 0.0 109.135 -172.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.5 tptt -98.89 123.32 43.08 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 126.462 1.905 . . . . 0.0 107.445 -176.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.9 t -101.12 100.88 11.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.8 mt -82.8 -28.81 30.01 Favored 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 119.679 -0.809 . . . . 0.0 109.196 -177.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -144.95 150.47 46.08 Favored Pre-proline 0 C--O 1.238 0.499 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 175.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -65.65 135.21 41.03 Favored 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 122.79 2.326 . . . . 0.0 107.942 -169.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.9 p -131.73 119.88 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.456 -157.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 5.0 ttt85 -99.43 116.47 31.66 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 171.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.635 ' HE3' ' CE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -126.28 146.74 49.89 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 172.265 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 14.3 m80 -85.5 129.05 34.91 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 161.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -117.37 162.21 18.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 172.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.484 ' HB2' ' CE3' ' A' ' 21' ' ' TRP . 23.1 t30 -152.97 121.21 6.23 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 172.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 29.7 mt -75.58 134.59 40.66 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 126.11 1.764 . . . . 0.0 106.837 170.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.8 p90 . . . . . 0 C--O 1.256 1.416 0 CA-C-N 119.648 1.113 . . . . 0.0 110.988 -176.782 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ptt? . . . . . 0 N--CA 1.473 0.711 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -118.94 155.12 31.87 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 118.738 0.699 . . . . 0.0 110.095 172.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.0 t 44.89 85.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 129.035 2.934 . . . . 0.0 110.959 173.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.69 115.28 6.34 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.7 mt -110.58 148.19 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 168.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -157.75 175.51 13.79 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 124.389 1.075 . . . . 0.0 109.694 165.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.36 85.5 10.82 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 173.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -69.83 167.6 24.05 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.74 2.96 . . . . 0.0 111.551 -177.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.4 p -84.09 151.02 59.53 Favored Pre-proline 0 N--CA 1.448 -0.533 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -63.37 -31.49 72.74 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.541 2.161 . . . . 0.0 112.126 175.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -63.54 -48.93 75.47 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-N 119.292 0.951 . . . . 0.0 110.636 171.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.3 tptm -57.77 -38.14 74.92 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 118.779 0.718 . . . . 0.0 111.012 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 57.4 mt -63.33 -26.86 68.96 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 118.978 -0.534 . . . . 0.0 112.32 177.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -66.6 -43.22 85.44 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 119.713 1.142 . . . . 0.0 110.268 170.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -61.34 -47.23 86.87 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 122.04 0.924 . . . . 0.0 109.453 -174.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 88.1 mt -65.09 -4.26 4.63 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.094 1.757 . . . . 0.0 112.667 178.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 56.77 33.37 22.89 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.5 1.52 . . . . 0.0 111.945 175.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.1 t -56.6 -23.28 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.076 0.951 . . . . 0.0 111.697 -176.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -53.83 -29.97 43.17 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.416 -1.428 . . . . 0.0 113.954 167.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -84.8 -21.4 29.94 Favored 'General case' 0 C--O 1.226 -0.164 0 O-C-N 121.336 -0.852 . . . . 0.0 110.28 -170.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 31.0 m0 -71.88 163.75 64.18 Favored Pre-proline 0 N--CA 1.448 -0.555 0 C-N-CA 125.229 1.412 . . . . 0.0 109.37 -162.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.03 133.17 30.14 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 121.17 1.247 . . . . 0.0 110.315 172.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 63.6 mt -70.19 145.45 12.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 167.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.555 ' HE3' ' HD2' ' A' ' 84' ' ' LYS . 88.3 t90 -139.14 141.15 38.06 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 163.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -128.7 165.02 21.68 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 126.886 2.074 . . . . 0.0 107.991 173.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -149.87 158.83 44.55 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 167.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -84.45 175.68 9.16 Favored 'General case' 0 N--CA 1.435 -1.207 0 O-C-N 123.979 0.799 . . . . 0.0 111.167 172.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.5 p -66.53 11.34 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 129.128 2.971 . . . . 0.0 113.097 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.03 134.39 34.54 Favored 'General case' 0 N--CA 1.435 -1.181 0 C-N-CA 126.833 2.053 . . . . 0.0 109.191 178.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -72.68 168.09 19.44 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.915 0.864 . . . . 0.0 110.269 177.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -165.94 -172.13 2.23 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 169.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.438 ' HA ' ' HA ' ' A' ' 75' ' ' ARG . 1.8 p30 -123.33 146.72 47.69 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 119.888 -1.758 . . . . 0.0 106.929 157.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 12.8 t-105 -114.97 153.63 30.24 Favored 'General case' 0 C--O 1.239 0.549 0 O-C-N 123.897 0.748 . . . . 0.0 110.39 172.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -123.22 105.27 9.74 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 170.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -78.75 104.94 9.71 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 174.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -105.22 11.57 32.87 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -179.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.76 168.3 21.71 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 129.04 2.936 . . . . 0.0 107.749 157.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -58.29 137.74 56.91 Favored 'General case' 0 C--O 1.232 0.158 0 C-N-CA 125.433 1.493 . . . . 0.0 107.78 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -141.65 113.96 8.18 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 175.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 97.2 m -79.73 149.12 31.26 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 162.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 28.1 p -145.38 137.84 25.87 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 119.16 0.891 . . . . 0.0 111.265 157.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -100.93 111.52 23.74 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.928 1.691 . . . . 0.0 107.894 174.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.8 mm -75.31 120.57 25.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 C-N-CA 124.05 0.94 . . . . 0.0 108.734 177.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 mp -101.82 -25.38 13.83 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 118.812 -0.613 . . . . 0.0 111.969 176.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -169.62 158.65 7.82 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.222 1.009 . . . . 0.0 109.592 -177.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.75 -172.14 14.21 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.41 1.481 . . . . 0.0 111.871 177.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.533 ' HD2' ' H ' ' A' ' 48' ' ' VAL . 0.0 OUTLIER -138.23 151.87 48.07 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 123.209 1.481 . . . . 0.0 108.522 167.644 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.572 HG13 ' CG1' ' A' ' 60' ' ' ILE 0.266 0.4 OUTLIER -152.98 135.73 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.431 0 C-N-CA 130.206 3.402 . . . . 0.0 112.97 -171.017 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.436 ' HB3' ' HE3' ' A' ' 57' ' ' LYS . 10.3 mt-10 -128.51 107.77 9.99 Favored 'General case' 0 N--CA 1.428 -1.566 0 O-C-N 125.819 1.949 . . . . 0.0 109.231 155.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 78.3 t -83.24 146.45 6.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 168.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.1 m -139.77 117.14 11.32 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 175.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 47.3 p -65.05 169.24 5.58 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 174.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -53.36 -36.68 61.64 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.596 -0.69 . . . . 0.0 110.41 171.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -65.16 -2.06 2.65 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 129.406 3.082 . . . . 0.0 114.328 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.76 6.57 78.18 Favored Glycine 0 CA--C 1.533 1.206 0 O-C-N 121.156 -0.965 . . . . 0.0 113.11 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -73.51 102.32 3.8 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 168.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.436 ' HE3' ' HB3' ' A' ' 49' ' ' GLU . 3.1 tptt -75.12 146.2 41.59 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 170.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -142.35 107.38 4.93 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 126.451 1.9 . . . . 0.0 107.961 177.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 53.7 t -69.81 138.47 22.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 164.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.572 ' CG1' HG13 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -124.9 146.8 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 C-N-CA 123.849 0.859 . . . . 0.0 109.807 165.221 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -142.1 -178.37 5.68 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 122.221 1.01 . . . . 0.0 111.525 173.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 13.5 pttm -61.7 85.22 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.548 1.939 . . . . 0.0 111.548 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 144.83 -11.0 1.89 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 126.121 1.819 . . . . 0.0 113.04 177.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -90.34 106.54 18.56 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 175.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.8 tp -76.47 146.39 38.58 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 168.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.3 t -129.45 155.29 41.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 123.295 0.638 . . . . 0.0 109.403 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.7 m -138.76 123.41 18.57 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.179 0.992 . . . . 0.0 109.263 162.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -86.81 153.03 54.78 Favored Pre-proline 0 C--O 1.239 0.531 0 C-N-CA 125.215 1.406 . . . . 0.0 109.799 171.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -79.99 179.68 6.03 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.506 2.804 . . . . 0.0 109.491 175.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -83.49 103.83 13.15 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 164.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 102.73 62.97 0.71 Allowed Glycine 0 CA--C 1.523 0.547 0 C-N-CA 125.175 1.369 . . . . 0.0 112.297 166.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.8 tp -123.68 147.72 47.17 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.504 1.922 . . . . 0.0 108.501 174.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.22 142.33 47.58 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 125.624 1.57 . . . . 0.0 109.23 174.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 8.7 p -167.46 163.91 14.93 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 118.86 0.755 . . . . 0.0 112.275 167.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' A' ' 32' ' ' ASP . 0.1 OUTLIER -77.22 145.33 37.64 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 118.516 -0.754 . . . . 0.0 109.967 167.544 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 6.6 m95 -104.65 136.97 43.2 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 158.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 15.0 tttt -113.69 103.75 11.53 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 158.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 4.6 t -76.88 106.43 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 103.475 -2.787 . . . . 0.0 103.475 174.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.9 mt -88.82 -16.06 33.02 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.594 -177.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -150.27 151.37 31.34 Favored Pre-proline 0 C--O 1.234 0.273 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.888 161.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -58.14 114.64 2.06 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 123.925 3.083 . . . . 0.0 110.439 -175.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.9 p -88.08 164.06 2.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 C-N-CA 123.604 0.762 . . . . 0.0 109.949 -168.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -134.97 122.79 22.38 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 155.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.555 ' HD2' ' HE3' ' A' ' 24' ' ' TRP . 0.0 OUTLIER -134.05 140.13 46.45 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 171.489 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 6.2 m80 -77.49 104.65 8.14 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 103.763 -2.68 . . . . 0.0 103.763 164.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -85.13 161.28 19.71 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 167.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -149.74 140.1 22.32 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 119.538 -0.865 . . . . 0.0 109.986 152.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 44.4 mt -71.91 163.95 26.94 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 171.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 5.1 p90 . . . . . 0 C--O 1.246 0.891 0 O-C-N 121.305 -0.872 . . . . 0.0 108.747 160.019 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.481 1.123 0 CA-C-O 118.547 -0.739 . . . . 0.0 110.982 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 49.18 -176.71 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 128.035 2.534 . . . . 0.0 113.846 -178.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.6 p -68.64 137.26 24.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 167.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.9 tptt -113.73 136.53 52.74 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 171.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 55.7 mt -135.4 112.15 13.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 178.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -143.04 174.8 10.36 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 124.197 0.999 . . . . 0.0 109.615 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.8 82.38 6.54 Favored Pre-proline 0 CA--C 1.532 0.259 0 O-C-N 121.598 -0.689 . . . . 0.0 109.268 176.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.414 ' HG3' HD22 ' A' ' 65' ' ' LEU . 92.1 Cg_endo -74.8 165.87 30.53 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.542 2.161 . . . . 0.0 113.428 -174.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.9 t -61.58 144.13 92.89 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 124.794 1.238 . . . . 0.0 110.953 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.65 -23.17 63.84 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.786 2.324 . . . . 0.0 113.027 177.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.41 -61.14 2.65 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 125.064 1.345 . . . . 0.0 109.721 -176.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.8 tptm -56.77 -36.85 70.3 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 122.183 -0.323 . . . . 0.0 110.825 -175.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.2 mt -58.28 -41.61 84.72 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 173.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.3 -50.89 71.48 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 119.513 1.051 . . . . 0.0 108.323 173.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -63.84 -34.38 77.8 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 123.482 0.713 . . . . 0.0 111.847 -174.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -62.75 -5.97 3.23 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.564 1.546 . . . . 0.0 113.601 177.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . 0.254 98.8 p 63.17 28.24 15.87 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 128.332 2.653 . . . . 0.0 113.943 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 20.1 t -57.28 -31.96 39.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 118.941 0.791 . . . . 0.0 112.985 -170.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -62.96 -23.71 67.54 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.281 1.4 . . . . 0.0 113.027 176.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.9 mttm -88.59 -8.03 55.4 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 126.223 1.809 . . . . 0.0 111.045 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 39.8 m0 -74.36 163.31 69.2 Favored Pre-proline 0 N--CA 1.451 -0.39 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.12 133.58 31.28 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.003 1.136 . . . . 0.0 111.314 173.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.1 mt -70.44 149.18 10.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 124.654 1.182 . . . . 0.0 107.974 165.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.8 t90 -144.84 145.32 31.56 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.56 -1.2 . . . . 0.0 107.775 162.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.22 162.62 34.83 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.782 2.433 . . . . 0.0 108.344 176.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.525 ' HD3' ' H ' ' A' ' 27' ' ' GLU . 5.3 tmtt? -147.17 173.16 12.78 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.933 -1.105 . . . . 0.0 110.224 178.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.525 ' H ' ' HD3' ' A' ' 26' ' ' LYS . 6.0 tt0 -70.9 -179.77 2.38 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 127.612 2.365 . . . . 0.0 111.288 166.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.453 ' H ' ' HG2' ' A' ' 27' ' ' GLU . 11.3 t -97.89 6.96 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 C-N-CA 127.456 2.302 . . . . 0.0 111.91 -171.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.5 t -81.5 172.91 12.93 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 120.627 -1.296 . . . . 0.0 109.511 173.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -100.42 161.41 13.62 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 121.321 -0.862 . . . . 0.0 109.31 171.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.469 ' CE2' ' HE3' ' A' ' 26' ' ' LYS . 14.4 p90 -156.75 177.16 11.8 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 125.445 1.498 . . . . 0.0 109.138 170.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.11 129.47 51.81 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 127.062 2.145 . . . . 0.0 108.186 171.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 35.1 t-105 -118.65 146.15 44.9 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.909 173.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -117.46 143.81 45.65 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 125.123 1.369 . . . . 0.0 107.907 174.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -118.09 110.81 18.09 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 175.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -107.9 3.01 23.81 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.494 1.118 . . . . 0.0 111.429 -175.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.58 160.4 42.44 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 129.686 3.194 . . . . 0.0 107.318 173.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -64.34 127.74 32.77 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 -174.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -135.1 109.1 8.17 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 177.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 56.1 m -82.07 135.75 35.29 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 167.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 29.2 p -134.65 156.93 47.89 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.084 0.468 . . . . 0.0 110.186 163.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -133.45 116.64 16.25 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 124.932 1.293 . . . . 0.0 108.502 -175.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.8 mm -72.47 143.19 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 126.475 1.91 . . . . 0.0 109.274 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.0 mt -127.25 -37.14 2.07 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.229 0.611 . . . . 0.0 109.822 171.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -150.82 159.4 44.57 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 173.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 82' ' ' VAL . . . 101.17 177.27 29.01 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 126.305 1.907 . . . . 0.0 114.097 177.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.667 ' HE3' HG23 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -140.93 154.56 46.15 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-O 123.282 1.515 . . . . 0.0 110.054 -175.427 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.483 HG13 HG12 ' A' ' 60' ' ' ILE . 0.4 OUTLIER -160.04 150.06 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.995 1 C-N-CA 133.539 4.735 . . . . 0.0 108.033 -161.677 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.422 ' OE1' HD11 ' A' ' 79' ' ' LEU . 15.8 mt-10 -135.21 115.61 13.53 Favored 'General case' 0 N--CA 1.414 -2.233 0 N-CA-C 104.23 -2.507 . . . . 0.0 104.23 152.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.4 t -89.56 121.86 40.22 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.993 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 172.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.5 m -111.34 122.84 48.9 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 82.4 p -74.08 178.52 4.96 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -71.77 -23.93 61.67 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 120.209 -1.557 . . . . 0.0 111.698 168.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -67.43 -7.99 29.64 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.825 1.25 . . . . 0.0 111.653 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.3 -13.56 61.55 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 126.261 1.886 . . . . 0.0 112.951 178.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -61.13 137.1 58.24 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.565 1.546 . . . . 0.0 107.542 178.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.4 tttm -120.67 130.52 54.15 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -172.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 13.5 m-30 -128.28 84.9 2.28 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 125.618 2.627 . . . . 0.0 108.962 -169.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.667 HG23 ' HE3' ' A' ' 47' ' ' LYS . 1.5 p -54.36 97.82 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 127.407 2.283 . . . . 0.0 112.587 152.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.483 HG12 HG13 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -80.59 156.54 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.062 0 CA-C-N 112.487 -2.142 . . . . 0.0 109.414 155.803 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -157.82 -179.84 8.52 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 171.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.4 82.42 0.05 Allowed 'General case' 0 C--O 1.233 0.218 0 C-N-CA 126.068 1.747 . . . . 0.0 109.326 -176.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 160.32 -12.27 0.16 Allowed Glycine 0 CA--C 1.524 0.634 0 CA-C-O 118.082 -1.399 . . . . 0.0 115.662 -167.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -126.64 104.95 8.38 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 119.186 1.493 . . . . 0.0 109.17 -166.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.414 HD22 ' HG3' ' A' ' 8' ' ' PRO . 19.3 tp -65.86 150.53 48.44 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 172.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.0 t -128.93 156.68 41.67 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-O 121.909 0.862 . . . . 0.0 109.288 168.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 75.7 m -144.48 111.51 5.86 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.365 1.466 . . . . 0.0 108.09 162.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -78.36 155.68 79.06 Favored Pre-proline 0 C--O 1.234 0.272 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 170.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -80.84 177.83 7.58 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 121.396 1.398 . . . . 0.0 110.334 172.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 32.4 tttt -75.08 91.4 2.56 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 112.933 -1.94 . . . . 0.0 107.527 164.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 116.17 90.79 1.63 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.754 1.168 . . . . 0.0 111.441 173.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 47.9 tp -155.2 150.71 27.33 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.51 1.524 . . . . 0.0 110.087 173.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 51.2 ttp85 -128.78 122.96 31.69 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 126.285 1.834 . . . . 0.0 109.116 176.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 8.3 p -157.13 167.32 30.74 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.226 0.921 . . . . 0.0 110.919 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.91 173.71 12.26 Favored 'General case' 0 CA--C 1.516 -0.347 0 O-C-N 120.887 -1.133 . . . . 0.0 112.4 168.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 5.9 m95 -142.88 93.65 2.54 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 127.51 2.324 . . . . 0.0 106.728 167.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.8 tppt? -79.83 105.31 11.02 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 170.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.5 t -86.14 86.92 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 -174.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.481 HD12 ' HE2' ' A' ' 47' ' ' LYS . 97.3 mt -64.72 -29.87 70.87 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.451 -178.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -142.74 154.57 62.79 Favored Pre-proline 0 N--CA 1.465 0.281 0 CA-C-N 119.481 1.037 . . . . 0.0 110.382 168.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.51 85.17 0.46 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 125.078 3.852 . . . . 0.0 111.753 -168.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.409 ' HA ' ' HA3' ' A' ' 46' ' ' GLY . 8.5 p -75.16 137.62 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 C-N-CA 124.725 1.21 . . . . 0.0 109.674 -163.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 10.5 ttt180 -116.82 106.74 13.8 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 104.108 -2.553 . . . . 0.0 104.108 177.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.11 142.96 51.17 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 10.5 m80 -78.08 136.79 37.96 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 165.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -124.27 163.17 22.2 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 173.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 22.3 t30 -157.23 137.15 12.48 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 119.4 1.0 . . . . 0.0 109.113 169.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 66.3 mt -94.56 146.16 24.31 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.512 1.125 . . . . 0.0 108.909 -179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.5 p90 . . . . . 0 C--O 1.247 0.942 0 C-N-CA 125.173 1.389 . . . . 0.0 111.673 -176.427 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.422 -0.799 . . . . 0.0 110.788 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -109.58 161.05 15.74 Favored 'General case' 0 CA--C 1.515 -0.396 0 O-C-N 125.859 1.975 . . . . 0.0 110.078 -178.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.639 HG12 HG13 ' A' ' 5' ' ' ILE . 85.5 t 40.16 91.56 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -174.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt -81.24 102.67 10.51 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 122.073 -0.392 . . . . 0.0 110.862 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.639 HG13 HG12 ' A' ' 3' ' ' VAL . 63.5 mt -111.09 124.69 68.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 O-C-N 123.433 0.458 . . . . 0.0 110.655 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -163.89 179.85 6.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.722 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.81 83.65 4.81 Favored Pre-proline 0 C--O 1.241 0.635 0 CA-C-O 121.885 0.85 . . . . 0.0 110.806 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.512 ' HG3' HD13 ' A' ' 65' ' ' LEU . 51.7 Cg_endo -69.3 139.44 41.83 Favored 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.145 1.896 . . . . 0.0 112.035 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -49.4 146.96 6.03 Favored Pre-proline 0 C--O 1.233 0.185 0 CA-C-O 121.383 0.611 . . . . 0.0 111.18 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.536 ' HA ' HD12 ' A' ' 13' ' ' LEU . 50.1 Cg_endo -69.01 -9.13 25.52 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.574 2.182 . . . . 0.0 112.553 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.91 -50.95 12.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.813 0.34 . . . . 0.0 110.673 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.11 -34.34 73.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.855 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.583 HD23 HG21 ' A' ' 18' ' ' VAL . 3.5 mt -62.82 -42.94 99.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.849 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -57.85 -33.92 69.17 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 119.104 -0.474 . . . . 0.0 110.987 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -78.03 -38.88 43.68 Favored 'General case' 0 C--N 1.332 -0.174 0 O-C-N 124.419 1.074 . . . . 0.0 110.503 -179.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.3 mp -59.11 -19.71 47.01 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 122.997 0.519 . . . . 0.0 111.165 178.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 63.32 43.2 6.32 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 123.445 0.466 . . . . 0.0 110.466 -178.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.583 HG21 HD23 ' A' ' 13' ' ' LEU . 22.7 t -56.93 -23.53 18.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.971 0.415 . . . . 0.0 110.964 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -72.2 -19.52 61.72 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.417 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.62 -7.75 54.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.891 179.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 40.1 m0 -79.72 155.16 75.94 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.875 0.369 . . . . 0.0 110.7 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 131.25 20.77 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.447 2.098 . . . . 0.0 112.253 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.0 mt -80.98 141.26 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.751 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 86.5 t90 -139.55 117.36 11.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.611 178.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.49 153.67 31.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.761 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.89 162.94 30.98 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.981 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.3 pm0 -70.12 176.48 3.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.207 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.483 HG13 ' O ' ' A' ' 79' ' ' LEU . 30.4 t -77.19 -4.3 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.373 0.606 . . . . 0.0 111.394 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.9 t -77.13 174.02 11.17 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.081 -0.648 . . . . 0.0 112.044 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -107.69 174.51 5.85 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.485 -177.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 18.7 p90 178.55 179.81 0.35 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.293 -178.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -119.77 111.9 18.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.231 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . . . . . . . . . 10.3 t-105 -97.26 151.87 19.43 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-O 120.847 0.356 . . . . 0.0 110.188 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -131.23 113.17 13.51 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.453 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -91.89 135.07 34.22 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 123.556 0.535 . . . . 0.0 110.737 179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.474 ' O ' HG23 ' A' ' 37' ' ' THR . 2.0 p30 -125.44 22.88 7.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.983 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 36' ' ' ASP . 0.0 OUTLIER -179.74 150.37 0.4 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.867 0.365 . . . . 0.0 110.936 -179.122 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.46 ' ND2' ' H ' ' A' ' 38' ' ' ASN . 4.3 m-80 -51.83 104.35 0.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.75 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 68.0 tt0 -123.29 83.86 2.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.101 0.477 . . . . 0.0 109.97 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 80.2 m -60.1 147.35 39.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.077 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 4.1 p -146.28 133.69 20.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.871 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.457 ' CD1' HD12 ' A' ' 65' ' ' LEU . 51.1 t80 -116.19 116.25 27.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.935 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.566 HD13 ' HB3' ' A' ' 84' ' ' LYS . 25.0 mm -77.24 136.03 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.829 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.463 HD12 ' O ' ' A' ' 83' ' ' ARG . 0.9 OUTLIER -120.59 -30.04 4.59 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 123.524 0.515 . . . . 0.0 111.417 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.44 ' HA ' ' HB3' ' A' ' 62' ' ' LYS . 15.1 pt-20 -162.15 155.51 20.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.309 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.56 179.75 33.51 Favored Glycine 0 N--CA 1.451 -0.311 0 O-C-N 123.503 0.502 . . . . 0.0 112.217 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.786 ' HE3' HG23 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -127.17 166.87 16.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.033 0.444 . . . . 0.0 110.886 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.66 HG13 ' CG1' ' A' ' 60' ' ' ILE . 0.1 OUTLIER -174.08 141.65 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.355 -177.722 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 2.7 mt-10 -132.4 90.97 2.86 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.53 0.681 . . . . 0.0 110.202 178.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.655 HG23 HD11 ' A' ' 60' ' ' ILE . 48.9 t -78.43 110.57 14.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 O-C-N 122.022 -0.424 . . . . 0.0 110.966 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 90.6 m -107.76 105.66 15.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.737 0.303 . . . . 0.0 110.803 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.8 p -64.35 154.91 33.97 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.95 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -51.73 -38.19 54.26 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.023 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -52.84 -29.38 27.58 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.445 0.641 . . . . 0.0 110.85 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 113.79 0.62 24.37 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 121.326 -0.464 . . . . 0.0 112.057 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -85.06 115.9 23.13 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 122.535 -0.391 . . . . 0.0 110.473 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.5 mttm -79.92 157.05 26.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.891 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -148.63 92.26 1.98 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.146 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.786 HG23 ' HE3' ' A' ' 47' ' ' LYS . 1.8 p -83.92 123.7 39.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.154 0.502 . . . . 0.0 111.015 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.66 ' CG1' HG13 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -113.68 143.75 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.422 179.656 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -139.93 -173.44 3.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.447 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.44 ' HB3' ' HA ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -69.47 67.06 0.21 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.069 0.461 . . . . 0.0 111.421 179.288 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 160.23 37.66 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.383 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -154.36 102.94 2.47 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 117.206 0.503 . . . . 0.0 110.946 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.524 ' CD1' HD21 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -80.32 128.78 33.95 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.561 -0.291 . . . . 0.0 110.568 -179.397 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.605 HG22 HG12 ' A' ' 5' ' ' ILE . 8.2 t -117.91 147.09 21.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 O-C-N 123.647 0.592 . . . . 0.0 110.661 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.2 m -142.97 101.03 3.76 Favored 'General case' 0 C--O 1.25 1.107 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.947 179.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.6 ' CD1' HG22 ' A' ' 3' ' ' VAL . 59.5 m-85 -77.05 147.53 77.05 Favored Pre-proline 0 C--N 1.344 0.335 0 O-C-N 124.621 1.201 . . . . 0.0 111.259 178.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.12 -166.34 0.23 Allowed 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 123.51 2.806 . . . . 0.0 111.969 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -95.46 67.05 2.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.853 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 136.29 82.26 0.13 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.171 178.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.418 HD12 ' H ' ' A' ' 73' ' ' ARG . 49.3 tp -146.82 146.92 30.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.557 0.218 . . . . 0.0 110.859 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.418 ' H ' HD12 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -126.76 141.98 51.67 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.927 178.835 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' CYS . . . . . . . . . . . . . 6.1 p -179.46 175.3 0.92 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.057 0.456 . . . . 0.0 110.962 176.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.624 ' O ' HG13 ' A' ' 50' ' ' VAL . 0.2 OUTLIER -95.15 159.61 14.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.018 179.635 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 2.0 m95 -131.84 78.22 1.81 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.836 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.69 93.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.642 -0.253 . . . . 0.0 111.0 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 80' ' ' GLU . 2.2 t -76.04 67.2 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.006 0.432 . . . . 0.0 110.699 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.75 HD12 ' HE2' ' A' ' 47' ' ' LYS . 81.1 mt -47.92 -29.41 3.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.292 179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.64 ' O ' HG12 ' A' ' 78' ' ' VAL . 2.6 mt-10 -145.2 165.23 22.71 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.35 0.595 . . . . 0.0 111.054 178.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.95 87.49 0.45 Allowed 'Trans proline' 0 N--CA 1.464 -0.238 0 C-N-CA 123.203 2.602 . . . . 0.0 112.356 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 45' ' ' GLU . 4.7 p -80.13 151.31 4.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.983 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.463 ' O ' HD12 ' A' ' 44' ' ' LEU . 3.5 ttt180 -136.4 64.23 1.56 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.728 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.566 ' HB3' HD13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -77.43 177.27 8.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.134 179.187 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -116.68 102.7 9.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.614 178.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -85.57 154.74 21.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.11 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -162.46 104.69 1.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.617 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 16.1 mt -68.47 149.36 49.37 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.672 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.8 p90 . . . . . 0 C--O 1.236 0.378 0 CA-C-O 118.773 -0.632 . . . . 0.0 110.712 179.964 . . . . . . . . 0 0 . 1 stop_ save_